data_2k0q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k0q _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.418 ' HA ' HG13 ' A' ' 6' ' ' VAL . 76.5 mmm . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.145 0.498 . . . . 2.68 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -91.45 -23.82 19.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.857 -0.611 . . . . 1.7 111.006 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.536 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -109.44 7.77 25.05 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 120.526 -0.47 . . . . 1.89 111.399 -176.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 19' ' ' HIS . 8.8 p -108.47 128.9 63.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.32 -0.4 . . . . 1.89 110.991 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.452 HG11 ' CG ' ' A' ' 22' ' ' LYS . 4.7 m -81.77 -27.85 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.214 -0.448 . . . . 1.66 111.094 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -167.35 134.31 2.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 1.89 110.582 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.522 HG21 ' HD1' ' A' ' 19' ' ' HIS . 3.2 m -108.22 137.25 46.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.26 -0.882 . . . . 1.11 109.943 175.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.655 ' HH ' ' HE ' ' A' ' 61' ' ' ARG . 1.4 m-85 -110.61 127.29 55.18 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.348 -0.842 . . . . 1.56 111.133 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -100.09 119.25 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.711 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 9.4 mp -80.5 149.56 29.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.998 -1.001 . . . . 1.71 109.581 -175.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -65.55 -11.83 47.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.663 0.744 . . . . 2.16 110.595 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.46 -16.49 28.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.11 109.702 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 110.49 -22.19 22.63 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.803 -1.09 . . . . 1.28 112.223 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.555 ' HB2' HD22 ' A' ' 12' ' ' LEU . 19.6 m -67.71 161.92 24.9 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.071 -0.714 . . . . 1.33 109.071 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -133.81 146.53 50.76 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.43 0.529 . . . . 2.39 112.43 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 12' ' ' LEU . 68.9 t -123.58 148.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.264 -0.88 . . . . 1.13 109.073 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 26' ' ' MET . 6.0 m-70 -134.46 130.4 36.67 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.317 -0.553 . . . . 0.95 109.995 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -93.5 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.922 -1.51 . . . . 1.4 106.922 171.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 81.2 m-85 -89.35 155.9 19.05 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.018 0.437 . . . . 0.81 111.236 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 40.1 mtpt -68.19 -12.0 60.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.705 -0.68 . . . . 3.36 110.563 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -90.76 -4.33 56.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.613 -0.884 . . . . 1.97 108.613 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.57 -12.61 64.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 114.875 -1.057 . . . . 0.58 114.766 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 -177.03 5.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 117.892 0.846 . . . . 2.19 110.824 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.764 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -140.31 145.61 37.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.726 -0.67 . . . . 1.25 109.76 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.07 136.74 9.76 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.861 -0.896 . . . . 0.45 110.861 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.494 ' HG2' ' SD ' ' A' ' 36' ' ' MET . 28.4 ttt -118.51 140.9 49.16 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.392 0.615 . . . . 1.24 110.957 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 33.1 mt-10 -130.66 154.88 47.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.116 -0.947 . . . . 1.14 108.831 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 32' ' ' PHE . 32.0 p-10 -87.51 169.8 11.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.049 -0.352 . . . . 1.45 110.049 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 55.2 pttt -52.84 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.607 1.336 . . . . 2.25 114.607 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.512 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.7 m-85 -119.81 7.7 11.03 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.893 -0.504 . . . . 1.23 110.392 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.42 24.85 58.19 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.762 -0.732 . . . . 0.59 112.36 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 38.8 mmtm -114.02 136.98 52.32 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.693 0.758 . . . . 3.65 111.924 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 m -78.13 129.47 35.21 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.923 -1.49 . . . . 1.9 111.548 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.494 ' SD ' ' HG2' ' A' ' 28' ' ' MET . 1.3 ppp? -148.12 153.52 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.7 110.18 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -67.25 141.12 57.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 3.13 111.129 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.457 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 28.1 ttt -87.77 122.71 70.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.668 -0.696 . . . . 1.91 109.956 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.81 122.28 9.84 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.064 2.51 . . . . 1.43 112.446 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.6 tt0 -69.46 142.91 53.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.224 -0.444 . . . . 1.15 110.362 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.55 -11.1 73.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.516 -0.85 . . . . 0.8 112.862 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -99.75 123.32 43.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.922 0.391 . . . . 2.7 111.957 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.535 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.2 p -91.36 129.71 41.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.563 -0.744 . . . . 1.55 109.403 174.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.7 mtm -126.98 159.96 32.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 1.68 110.526 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -104.63 160.43 14.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.063 0.935 . . . . 1.64 112.429 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 50.6 p -113.95 165.25 12.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.006 -1.452 . . . . 1.31 109.732 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 15.4 ptt180 -65.35 -18.17 65.1 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.669 0.747 . . . . 4.27 110.966 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.99 -15.19 30.08 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.561 -1.2 . . . . 2.7 110.62 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.35 17.87 20.81 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.518 -0.848 . . . . 0.87 112.585 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -97.74 154.74 17.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.338 -0.616 . . . . 1.91 109.338 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -117.87 135.73 53.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.393 -0.595 . . . . 2.32 109.393 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.24 157.99 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.671 -0.695 . . . . 1.35 110.92 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.712 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -157.11 148.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 1.69 110.486 174.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.528 ' N ' HG12 ' A' ' 53' ' ' ILE . 26.8 ttt -100.19 118.29 36.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.415 -0.957 . . . . 2.09 108.415 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 52.4 tptt -140.61 130.77 24.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.918 -0.401 . . . . 2.17 109.918 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 38.79 94.88 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.979 -0.555 . . . . 1.21 113.061 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.62 9.52 7.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.496 0.665 . . . . 3.61 110.425 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.61 -177.64 3.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.881 -0.599 . . . . 1.66 110.455 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.764 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -134.49 122.16 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 121.347 0.594 . . . . 1.53 110.192 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.712 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.06 117.07 22.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.079 -1.082 . . . . 0.92 108.079 171.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.655 ' HE ' ' HH ' ' A' ' 10' ' ' TYR . 42.9 ttt180 -112.65 100.89 9.07 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.594 -1.632 . . . . 4.02 106.594 168.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 O-C-N 124.477 1.111 . . . . 1.96 112.919 -163.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.9 mtp . . . . . 0 N--CA 1.447 -0.603 0 CA-C-O 121.6 0.715 . . . . 2.68 110.544 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.6 t -90.26 -22.3 21.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.542 -0.753 . . . . 1.7 109.929 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.489 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -104.44 14.92 29.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 1.89 112.091 -177.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.6 p -101.24 137.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.954 -0.298 . . . . 1.89 111.348 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 22' ' ' LYS . 27.5 m -83.6 -29.23 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.022 0.439 . . . . 1.66 110.064 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -168.48 130.6 1.37 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.602 0.715 . . . . 1.89 110.946 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.497 HG22 ' HD1' ' A' ' 19' ' ' HIS . 14.9 m -100.89 140.84 34.61 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.727 -1.124 . . . . 1.11 109.389 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.927 ' HH ' ' CD ' ' A' ' 61' ' ' ARG . 25.7 m-85 -121.4 134.14 55.1 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.967 0.889 . . . . 1.56 111.755 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.532 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 2.9 m-20 -96.47 120.96 37.73 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.613 -1.631 . . . . 1.94 108.853 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 16' ' ' SER . 23.4 mt -78.99 146.12 33.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.414 -1.328 . . . . 1.71 107.414 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.454 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 2.7 tt0 -66.17 -4.36 7.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.205 0.526 . . . . 2.16 111.925 -173.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -98.44 -17.81 18.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.495 -0.775 . . . . 2.11 110.326 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.558 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.07 -28.48 4.85 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.686 -0.688 . . . . 1.28 113.199 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.588 ' HB2' HD11 ' A' ' 12' ' ' LEU . 12.4 m -65.75 155.81 35.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.768 0.318 . . . . 1.33 110.77 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -124.0 129.81 51.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.908 0.385 . . . . 2.39 111.06 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.98 143.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.898 -0.779 . . . . 1.13 108.898 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.497 ' HD1' HG22 ' A' ' 9' ' ' THR . 5.7 m-70 -130.56 129.91 43.39 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.214 -0.595 . . . . 0.95 110.494 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.51 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 28.3 t -96.43 114.81 34.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 106.537 -1.653 . . . . 1.4 106.537 168.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 92.9 m-85 -85.47 152.44 23.2 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.045 -0.525 . . . . 0.81 110.355 -172.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.585 ' HA ' HG13 ' A' ' 7' ' ' VAL . 87.7 mttt -62.08 -15.32 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.923 -0.58 . . . . 3.36 111.553 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.99 -6.99 53.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.83 -0.804 . . . . 1.97 108.83 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.88 -9.59 51.5 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.376 -0.916 . . . . 0.58 114.989 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -92.85 177.6 6.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 118.692 1.246 . . . . 2.19 110.648 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.768 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -137.77 146.23 43.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.151 -0.477 . . . . 1.25 110.483 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.51 146.06 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.074 -0.811 . . . . 0.45 111.074 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.2 ttt -120.5 142.36 49.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.088 0.471 . . . . 1.24 110.979 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.82 150.55 49.13 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.037 -1.098 . . . . 1.14 108.037 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 32' ' ' PHE . 30.7 p-10 -86.58 167.03 14.95 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.322 -0.551 . . . . 1.45 110.133 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 27.8 pttt -50.54 2.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.771 1.397 . . . . 2.25 114.771 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.2 m-85 -118.97 2.04 11.49 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.051 -0.406 . . . . 1.23 110.701 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.37 19.88 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.425 -0.893 . . . . 0.59 112.997 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -100.17 132.73 45.37 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.887 0.851 . . . . 3.65 110.899 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 p -79.05 133.78 36.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.732 -1.576 . . . . 1.9 111.93 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 ptm -147.41 -172.94 4.13 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.641 -0.709 . . . . 1.7 109.829 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.68 150.87 24.34 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.124 -0.324 . . . . 3.13 110.124 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.13 132.47 43.42 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 1.91 110.786 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.12 120.49 7.65 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.623 2.216 . . . . 1.43 112.843 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -80.66 128.3 33.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 1.15 110.132 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.98 -9.65 51.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.92 -0.657 . . . . 0.8 112.389 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -101.69 122.98 44.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.899 0.333 . . . . 2.7 111.899 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.482 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 12.7 p -94.25 128.4 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.706 -0.85 . . . . 1.55 108.706 171.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.5 mtm -124.6 160.29 28.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 1.68 110.651 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.5 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 20.5 mt-10 -93.13 145.22 24.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.786 0.803 . . . . 1.64 111.635 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -105.16 160.2 15.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.254 -1.339 . . . . 1.31 109.522 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HD2' ' HB3' ' A' ' 11' ' ' ASP . 98.8 mtt180 -64.45 -17.89 64.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.437 0.637 . . . . 4.27 109.59 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.89 -22.97 45.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.125 -0.943 . . . . 2.7 110.3 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.03 55.72 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.794 -0.717 . . . . 0.87 111.522 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -97.15 155.31 16.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.886 -0.783 . . . . 1.91 108.886 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 40.1 mmtm -112.88 136.95 51.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.943 -0.762 . . . . 2.32 108.943 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 39.0 pt -136.17 153.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 1.35 110.549 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.697 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -154.01 145.61 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.935 -0.575 . . . . 1.69 110.23 176.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.49 ' HE3' ' HA ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -94.35 122.04 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.106 -1.442 . . . . 2.09 107.106 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -144.0 121.96 12.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.843 -0.343 . . . . 2.17 110.924 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.37 45.04 93.31 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 1.21 112.863 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.518 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.9 OUTLIER 67.74 10.98 8.15 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.848 0.459 . . . . 3.61 111.481 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.47 -173.01 2.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.66 109.826 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.768 HD12 ' HG2' ' A' ' 26' ' ' MET . 2.5 tt -139.22 128.87 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 122.009 0.909 . . . . 1.53 110.062 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.697 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.19 121.44 27.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.091 -1.448 . . . . 0.92 107.091 170.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.927 ' CD ' ' HH ' ' A' ' 10' ' ' TYR . 33.1 ttp180 -109.29 96.1 6.07 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.319 -2.104 . . . . 4.02 105.319 164.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.564 1.501 0 O-C-N 125.011 1.444 . . . . 1.96 113.52 -171.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.4 mtp . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 112.22 0.452 . . . . 2.68 112.22 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 p -78.63 -26.29 45.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.399 0.619 . . . . 1.7 110.334 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.479 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -104.74 5.19 33.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 1.89 110.837 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.428 HG21 ' ND2' ' A' ' 5' ' ' ASN . 89.5 t -103.66 115.42 45.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.56 -0.745 . . . . 1.89 110.144 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 m -79.15 -23.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 1.66 111.267 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -167.99 137.77 2.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.176 0.512 . . . . 1.89 110.854 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.4 ' OG1' HG13 ' A' ' 6' ' ' VAL . 34.3 m -114.0 143.52 44.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.463 -0.79 . . . . 1.11 109.898 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.896 ' HH ' ' HD2' ' A' ' 61' ' ' ARG . 35.9 m-85 -121.26 133.74 55.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.877 0.846 . . . . 1.56 111.948 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 1.2 m-20 -100.44 124.46 45.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.742 -1.572 . . . . 1.94 109.73 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 16' ' ' SER . 7.6 mt -87.73 148.41 24.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.02 -0.733 . . . . 1.71 109.02 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.9 tt0 -62.74 -25.49 68.22 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.23 1.196 . . . . 2.16 114.23 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -98.99 -50.89 4.02 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.684 0.754 . . . . 2.11 110.205 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.547 ' CA ' ' HB3' ' A' ' 31' ' ' LYS . . . 166.44 67.86 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.664 -1.153 . . . . 1.28 112.267 -170.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.56 ' HB2' HD13 ' A' ' 12' ' ' LEU . 2.5 m -157.5 143.36 17.49 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.175 -1.046 . . . . 1.33 108.175 172.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -127.5 125.18 39.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.146 0.498 . . . . 2.39 109.906 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.19 148.1 13.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.84 -0.8 . . . . 1.13 108.84 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 26' ' ' MET . 7.3 m-70 -131.16 133.15 45.28 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.156 -0.618 . . . . 0.95 109.432 173.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.67 114.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.613 -1.625 . . . . 1.4 106.613 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -83.43 150.58 25.96 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.738 -0.665 . . . . 0.81 110.119 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 21.2 pttm -61.24 -20.3 62.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 3.36 110.574 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.65 -0.78 57.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.735 -0.839 . . . . 1.97 108.735 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.48 -8.15 62.02 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 114.727 -1.124 . . . . 0.58 115.05 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -85.3 177.24 7.9 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.731 1.265 . . . . 2.19 110.663 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.881 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.7 mpp? -137.69 141.19 41.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.25 109.86 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.27 128.18 7.97 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.735 -0.666 . . . . 0.45 111.51 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.25 124.15 49.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.76 0.314 . . . . 1.24 110.255 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 25.3 mt-10 -124.01 153.89 40.66 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.374 -0.602 . . . . 1.14 109.374 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 10.9 p30 -104.5 174.59 5.81 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.287 -0.565 . . . . 1.45 110.148 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HB3' ' CA ' ' A' ' 15' ' ' GLY . 14.0 pttm -49.63 -19.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.543 1.312 . . . . 2.25 114.543 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 92.2 m-85 -92.97 6.43 47.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.353 0.524 . . . . 1.23 110.586 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.67 26.91 59.94 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.706 -0.557 . . . . 0.59 111.706 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.471 ' HB2' HD22 ' A' ' 30' ' ' ASN . 35.8 mmtm -113.31 136.07 53.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 3.65 111.329 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t -83.52 129.74 34.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.121 -1.4 . . . . 1.9 110.428 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.13 179.84 6.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.323 -0.399 . . . . 1.7 110.919 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -80.24 143.14 33.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.058 0.456 . . . . 3.13 111.287 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.484 ' HE1' HD12 ' A' ' 59' ' ' ILE . 26.3 ttt -94.65 127.16 44.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.655 . . . . 1.91 110.529 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.06 138.72 20.88 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.714 2.276 . . . . 1.43 112.834 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 33.3 tt0 -94.11 147.99 22.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.958 -0.565 . . . . 1.15 110.616 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.47 68.02 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.034 -0.603 . . . . 0.8 112.622 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -107.57 129.57 54.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.827 0.346 . . . . 2.7 111.562 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.565 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 8.1 p -90.85 127.23 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.888 -0.782 . . . . 1.55 108.888 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 17.8 ptp -117.03 147.57 42.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.059 -0.519 . . . . 1.68 110.003 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.03 151.35 24.76 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.338 0.59 . . . . 1.64 110.741 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.5 p -100.75 162.86 12.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.218 -0.901 . . . . 1.31 110.103 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.482 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 48.9 mtt180 -57.86 -21.24 41.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.145 0.424 . . . . 4.27 112.145 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.07 -17.48 19.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 121.064 -0.254 . . . . 2.7 111.202 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.25 22.83 6.0 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.291 -0.957 . . . . 0.87 113.319 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -99.83 147.49 25.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 1.91 109.293 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -111.79 132.74 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.055 -0.35 . . . . 2.32 110.055 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.7 pt -136.63 160.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 1.35 110.83 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.64 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -162.45 151.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.044 -0.525 . . . . 1.69 109.891 175.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.538 ' N ' HG12 ' A' ' 53' ' ' ILE . 14.1 tmm? -104.63 121.48 43.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.057 -1.09 . . . . 2.09 108.057 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 49.6 tptt -134.85 116.58 14.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.288 -0.414 . . . . 2.17 110.216 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.93 44.19 98.16 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.815 -0.63 . . . . 1.21 112.752 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 72.59 -1.74 2.88 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.361 0.6 . . . . 3.61 111.42 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -105.72 147.99 27.93 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.519 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.881 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -100.32 124.32 53.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.727 0.775 . . . . 1.53 111.277 177.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.02 118.36 23.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.702 -1.222 . . . . 0.92 107.702 168.211 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.896 ' HD2' ' HH ' ' A' ' 10' ' ' TYR . 47.0 ttp180 -113.68 100.56 8.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.344 -1.354 . . . . 4.02 107.344 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 1.1 pp . . . . . 0 CA--C 1.548 0.876 0 O-C-N 125.164 1.54 . . . . 1.96 113.654 -167.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.512 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 42.7 mtp . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 113.57 0.952 . . . . 2.68 113.57 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 m -83.82 -27.31 28.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.238 0.542 . . . . 1.7 110.696 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.527 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -103.72 6.0 36.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.734 0.778 . . . . 1.89 110.019 175.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 3' ' ' MET . 72.0 t -102.74 116.59 46.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.97 -1.013 . . . . 1.89 109.806 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.83 -20.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.689 -0.405 . . . . 1.66 111.403 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -168.18 128.35 1.29 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.411 0.624 . . . . 1.89 110.987 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 m -101.64 138.45 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.987 -1.006 . . . . 1.11 109.611 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.864 ' HH ' ' HD3' ' A' ' 61' ' ' ARG . 18.6 m-85 -113.64 128.45 56.44 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.736 0.779 . . . . 1.56 111.379 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.52 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 3.0 m-20 -95.14 115.04 26.91 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.02 -1.445 . . . . 1.94 108.296 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.577 HD13 ' HB2' ' A' ' 16' ' ' SER . 10.4 mt -80.57 149.43 29.93 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.009 -0.737 . . . . 1.71 109.009 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -67.79 -7.71 29.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.1 0.476 . . . . 2.16 112.019 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.0 -20.98 19.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.422 0.63 . . . . 2.11 109.895 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 122.07 -14.32 8.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.188 -0.914 . . . . 1.28 112.534 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.577 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -66.3 153.19 43.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.539 0.209 . . . . 1.33 110.758 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 30.2 mttp -113.56 143.49 44.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.144 0.497 . . . . 2.39 110.813 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 93.4 t -126.36 149.47 31.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.808 -1.182 . . . . 1.13 107.808 171.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 26' ' ' MET . 6.5 m-70 -139.0 128.89 24.97 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.291 -0.633 . . . . 0.95 109.291 175.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.11 116.77 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.423 -1.695 . . . . 1.4 106.423 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -85.92 153.12 22.42 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.797 -0.638 . . . . 0.81 110.628 -173.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 53.6 pttt -59.53 -16.51 25.29 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 3.36 111.539 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.31 -15.41 46.69 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.038 -0.727 . . . . 1.97 109.038 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.24 -2.35 54.48 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.107 -1.044 . . . . 0.58 113.876 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -94.46 -175.37 3.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.821 0.811 . . . . 2.19 110.776 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 1.013 ' HG2' HD11 ' A' ' 59' ' ' ILE . 2.1 mpp? -144.42 149.29 35.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.721 -0.672 . . . . 1.25 110.438 -175.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.95 139.49 11.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.285 -0.726 . . . . 0.45 111.285 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.555 ' SD ' ' HG3' ' A' ' 36' ' ' MET . 1.6 tmt? -117.77 137.51 52.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.163 0.506 . . . . 1.24 111.001 -175.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 30.2 mt-10 -124.6 149.78 46.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.47 -0.786 . . . . 1.14 109.034 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.614 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.8 p-10 -85.91 166.16 16.19 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.44 -0.578 . . . . 1.45 109.44 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 38.0 pttt -56.92 5.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.217 1.192 . . . . 2.25 114.217 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 30' ' ' ASN . 45.3 m-85 -113.66 5.82 16.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.064 0.459 . . . . 1.23 109.778 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.77 25.1 60.98 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.972 -0.558 . . . . 0.59 114.264 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.614 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.3 145.96 43.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.16 0.505 . . . . 3.65 110.218 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -80.28 142.16 34.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.489 -0.778 . . . . 1.9 111.588 -171.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.555 ' HG3' ' SD ' ' A' ' 28' ' ' MET . 9.6 ptm -153.53 -179.52 7.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.746 -0.661 . . . . 1.7 109.856 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -100.42 151.08 21.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 3.13 110.751 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 ttm -101.42 126.63 33.85 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.2 -0.455 . . . . 1.91 110.714 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.51 142.34 23.34 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.723 2.282 . . . . 1.43 112.181 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.545 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.7 tt0 -79.81 154.35 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.493 -0.321 . . . . 1.15 110.646 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.27 -19.56 54.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.8 113.337 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' N ' HD11 ' A' ' 53' ' ' ILE . 48.6 mtpt -98.5 126.65 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.244 0.522 . . . . 2.7 111.582 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.89 124.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.655 -0.498 . . . . 1.55 109.655 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.81 149.97 28.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.1 -0.5 . . . . 1.68 110.205 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 50' ' ' THR . 32.8 mt-10 -109.77 157.99 18.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.001 0.905 . . . . 1.64 112.01 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 72.2 p -105.29 165.34 11.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.03 -1.441 . . . . 1.31 110.319 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.52 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 58.6 mtp180 -51.25 -27.83 10.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.82 -0.627 . . . . 4.27 111.803 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -92.62 -21.8 19.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.385 -0.825 . . . . 2.7 111.2 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.36 27.25 5.1 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.145 -1.026 . . . . 0.87 112.339 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 26.5 m -100.73 145.27 28.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.396 -0.594 . . . . 1.91 109.396 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -109.21 131.4 55.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.064 -0.347 . . . . 2.32 110.064 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.02 159.17 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.929 0.395 . . . . 1.35 111.383 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.478 HG23 ' HB3' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -159.35 143.34 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.824 -0.625 . . . . 1.69 110.438 175.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.426 ' H ' HD12 ' A' ' 53' ' ' ILE . 1.5 tmt? -97.28 106.01 18.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.689 -1.226 . . . . 2.09 107.689 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 74.8 tttt -138.36 136.33 36.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.975 -0.557 . . . . 2.17 110.489 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.36 33.5 82.32 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.787 -0.642 . . . . 1.21 112.733 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.482 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.9 OUTLIER 66.81 19.76 10.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.587 0.708 . . . . 3.61 110.991 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.34 -165.61 1.71 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.289 -0.869 . . . . 1.66 109.403 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 1.013 HD11 ' HG2' ' A' ' 26' ' ' MET . 0.5 OUTLIER -135.82 131.3 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.184 0.992 . . . . 1.53 110.994 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.479 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -82.75 111.75 18.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.863 -1.532 . . . . 0.92 106.863 168.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.864 ' HD3' ' HH ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -119.27 107.51 13.49 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.128 -1.804 . . . . 4.02 106.128 173.106 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 4.3 mm? . . . . . 0 N--CA 1.474 0.736 0 O-C-N 123.925 0.765 . . . . 1.96 111.881 -165.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.7 mmm . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 112.638 0.607 . . . . 2.68 112.638 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.6 p -94.4 -27.01 16.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.298 -0.561 . . . . 1.7 110.639 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.464 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -101.95 13.69 34.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.436 -0.347 . . . . 1.89 111.901 -177.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 13.3 p -111.68 130.03 66.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 120.162 -0.615 . . . . 1.89 111.936 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -96.19 -22.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.038 -0.528 . . . . 1.66 111.399 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -160.29 138.52 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 1.89 111.156 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' HD1' ' A' ' 19' ' ' HIS . 5.3 m -123.4 141.34 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.407 -0.815 . . . . 1.11 110.276 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.609 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 33.7 m-85 -121.51 134.51 55.05 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-O 121.679 0.752 . . . . 1.56 111.837 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 46' ' ' THR . 11.6 t70 -101.38 126.63 48.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.878 -1.51 . . . . 1.94 109.092 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.603 HD22 ' HB2' ' A' ' 16' ' ' SER . 10.5 mp -78.47 -2.2 37.42 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.415 -1.266 . . . . 1.71 112.947 -171.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.548 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.4 tt0 86.88 -31.26 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.138 0.575 . . . . 2.16 110.48 172.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.74 -9.58 28.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.338 0.59 . . . . 2.11 109.428 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 31' ' ' LYS . . . 138.23 -36.82 1.87 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.056 -1.068 . . . . 1.28 114.434 172.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.603 ' HB2' HD22 ' A' ' 12' ' ' LEU . 11.3 m -71.59 160.0 33.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.615 -0.513 . . . . 1.33 109.615 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -133.36 143.52 49.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.289 0.566 . . . . 2.39 111.732 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.525 HG21 HD11 ' A' ' 12' ' ' LEU . 36.1 t -118.22 142.67 31.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.64 -0.709 . . . . 1.13 109.251 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.436 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 10.0 m-70 -128.82 133.02 47.86 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 120.225 -0.59 . . . . 0.95 111.074 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.84 111.65 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 106.566 -1.642 . . . . 1.4 106.566 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' HE2' ' N ' ' A' ' 27' ' ' GLY . 87.7 m-85 -83.77 156.18 22.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.929 -0.578 . . . . 0.81 110.807 -171.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -60.61 -20.46 60.69 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.122 -0.945 . . . . 3.36 111.798 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.95 7.39 46.75 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.496 0.665 . . . . 1.97 109.297 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.17 -7.59 80.55 Favored Glycine 0 N--CA 1.427 -1.91 0 CA-C-N 114.868 -1.06 . . . . 0.58 114.517 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -86.53 175.51 8.3 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 117.86 0.83 . . . . 2.19 110.651 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.834 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.2 mpp? -135.88 148.7 48.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.967 0.413 . . . . 1.25 110.193 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.518 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -143.47 148.84 20.74 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.636 -0.711 . . . . 0.45 111.403 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ttt -117.62 144.51 45.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.857 0.361 . . . . 1.24 110.637 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.01 146.64 47.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.304 -0.998 . . . . 1.14 108.304 171.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.698 ' ND2' ' HG3' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -89.63 164.72 14.62 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.619 -0.882 . . . . 1.45 108.619 176.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.4 ' CB ' ' HA3' ' A' ' 15' ' ' GLY . 9.7 ptpp? -51.03 -11.21 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.951 1.093 . . . . 2.25 113.951 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -96.65 9.19 42.32 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.107 -0.371 . . . . 1.23 110.81 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.65 26.23 65.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.167 -0.54 . . . . 0.59 113.67 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.698 ' HG3' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.23 147.44 42.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.067 -0.653 . . . . 3.65 110.273 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 p -83.64 139.1 33.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.332 -0.849 . . . . 1.9 112.159 -172.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.0 ptm -148.78 175.26 11.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 1.7 109.577 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -95.11 151.82 18.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.913 0.387 . . . . 3.13 110.132 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.408 ' HE2' ' HE1' ' A' ' 44' ' ' MET . 28.2 ttt -91.03 128.91 45.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.993 -0.549 . . . . 1.91 110.768 -174.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.3 114.72 3.16 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.45 2.1 . . . . 1.43 112.066 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 54' ' ' MET . 42.3 tt0 -74.51 133.3 42.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.652 -0.704 . . . . 1.15 110.696 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.495 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 117.12 -8.96 15.77 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.8 113.773 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.55 142.05 48.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 117.63 0.715 . . . . 2.7 112.304 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.592 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -99.43 135.64 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.332 -0.849 . . . . 1.55 108.885 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.408 ' HE1' ' HE2' ' A' ' 38' ' ' MET . 70.2 mtm -127.4 159.26 35.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.249 -0.432 . . . . 1.68 109.872 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -99.66 163.63 12.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.741 0.781 . . . . 1.64 111.995 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 45.7 p -119.68 162.69 18.59 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.28 -1.327 . . . . 1.31 110.79 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.548 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 6.8 mtt180 -55.63 -27.38 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.757 0.651 . . . . 4.27 112.757 177.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -95.76 -2.52 47.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.503 -0.479 . . . . 2.7 111.969 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.31 20.7 19.47 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.853 -1.165 . . . . 0.87 114.053 170.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -112.63 167.22 10.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.717 0.758 . . . . 1.91 109.514 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -122.66 143.8 49.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.79 -0.448 . . . . 2.32 109.79 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 pt -139.55 154.22 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.346 -0.388 . . . . 1.35 111.247 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.686 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -155.02 149.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.957 0.408 . . . . 1.69 110.596 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.513 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 27.5 ttt -108.39 113.17 26.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.777 -1.194 . . . . 2.09 107.777 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 22.4 tptm -144.35 138.91 28.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.177 -0.675 . . . . 2.17 109.177 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.29 31.01 76.1 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 1.21 111.742 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 62.12 23.42 13.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.171 0.51 . . . . 3.61 111.339 -178.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 54' ' ' MET . 36.7 mt-10 -132.07 160.02 37.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.519 -0.764 . . . . 1.66 110.19 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.834 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.49 124.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.523 0.678 . . . . 1.53 110.906 177.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -82.46 109.76 16.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.508 -1.664 . . . . 0.92 106.508 166.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.609 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 2.0 tmm_? -121.49 105.51 10.55 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.817 -1.549 . . . . 4.02 106.817 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 62' ' ' LEU . 3.9 mm? . . . . . 0 C--N 1.323 -0.57 0 O-C-N 124.222 0.951 . . . . 1.96 112.898 -164.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.451 ' HA ' HG13 ' A' ' 6' ' ' VAL . 20.7 mmt . . . . . 0 C--O 1.228 -0.071 0 CA-C-O 120.914 0.387 . . . . 2.68 111.291 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 m -86.37 -26.93 24.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.281 0.563 . . . . 1.7 110.793 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.477 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -114.42 12.39 17.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.715 -0.675 . . . . 1.89 111.511 -173.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.2 p -109.9 134.65 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.195 -0.457 . . . . 1.89 111.393 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.423 HG11 ' HA ' ' A' ' 22' ' ' LYS . 22.4 m -86.84 -26.45 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.3 -0.409 . . . . 1.66 111.164 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -168.5 132.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.42 . . . . 1.89 110.566 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.456 HG22 ' HD1' ' A' ' 19' ' ' HIS . 3.2 m -110.41 143.47 40.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.61 -0.723 . . . . 1.11 109.98 176.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -117.98 133.2 56.14 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.766 0.793 . . . . 1.56 111.353 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.29 119.49 37.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.088 -1.414 . . . . 1.94 109.203 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 16' ' ' SER . 7.3 mt -83.1 138.99 33.47 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.686 -0.688 . . . . 1.71 109.378 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -61.99 -19.2 62.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.41 0.893 . . . . 2.16 113.41 -166.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -44.0 5.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 2.11 110.41 -175.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.656 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 159.77 78.86 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 119.621 -1.276 . . . . 1.28 113.144 -172.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.593 ' HB3' HD11 ' A' ' 12' ' ' LEU . 48.3 t -176.59 153.49 1.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.199 -0.667 . . . . 1.33 109.199 175.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -128.3 125.71 39.35 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.193 -0.458 . . . . 2.39 110.61 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.82 148.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.788 . . . . 1.13 108.871 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -138.83 131.99 29.83 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.858 -0.526 . . . . 0.95 109.992 177.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.96 118.49 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.085 -1.45 . . . . 1.4 107.085 170.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 78.3 m-85 -86.58 155.35 20.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.132 0.492 . . . . 0.81 111.46 -171.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HA ' HG11 ' A' ' 7' ' ' VAL . 28.9 mtpp -64.24 -22.08 66.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.335 -0.848 . . . . 3.36 111.526 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.02 -1.87 57.75 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.031 -1.1 . . . . 1.97 108.031 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.8 -8.1 50.23 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.81 -1.087 . . . . 0.58 114.555 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.94 174.02 5.78 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 118.627 1.213 . . . . 2.19 112.747 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.575 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -138.13 131.43 30.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.266 -1.334 . . . . 1.25 109.168 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.23 144.15 15.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.885 -0.674 . . . . 0.45 112.088 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.3 ttt -123.76 139.87 53.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.816 0.308 . . . . 1.24 110.996 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 19.6 mm-40 -113.15 158.21 20.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.727 -0.842 . . . . 1.14 108.727 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 32' ' ' PHE . 38.6 p30 -88.14 164.78 15.53 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.613 -0.514 . . . . 1.45 109.613 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.656 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 ptpt -51.63 -2.86 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.978 1.103 . . . . 2.25 113.978 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 30' ' ' ASN . 65.8 m-85 -106.73 0.21 24.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.647 -0.501 . . . . 1.23 109.647 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.33 37.11 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.738 -0.744 . . . . 0.59 112.864 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 14.6 mmmm -112.15 145.57 39.59 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.339 0.59 . . . . 3.65 111.639 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.4 m -86.75 123.71 32.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.487 -1.233 . . . . 1.9 110.753 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -138.52 178.31 7.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.863 -0.608 . . . . 1.7 110.421 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -91.3 141.38 28.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.874 0.369 . . . . 3.13 110.623 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ttt -86.88 126.44 63.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 1.91 110.815 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.37 124.91 9.76 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.752 2.301 . . . . 1.43 112.864 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 47.3 tt0 -79.33 134.71 36.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 1.15 111.365 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.3 24.36 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.788 -0.72 . . . . 0.8 113.647 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 53' ' ' ILE . 48.7 mtpt -105.07 126.9 52.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 117.075 0.438 . . . . 2.7 111.941 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.598 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.7 p -91.1 122.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.014 -0.735 . . . . 1.55 109.014 171.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.0 mtm -119.11 155.69 31.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.389 -0.823 . . . . 1.68 109.548 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -107.33 156.55 18.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.245 1.021 . . . . 1.64 112.515 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.7 p -109.48 159.78 16.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.446 -1.706 . . . . 1.31 110.28 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 47' ' ' ARG . 57.7 mtt-85 -59.34 -24.0 62.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.588 0.588 . . . . 4.27 112.588 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -96.07 -2.44 46.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.178 0.513 . . . . 2.7 110.64 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.68 15.12 32.61 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.761 -0.733 . . . . 0.87 113.068 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.8 m -93.9 146.11 24.14 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 110.201 -0.296 . . . . 1.91 110.201 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -107.73 134.07 51.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.691 -0.485 . . . . 2.32 109.691 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.511 HD11 HD23 ' A' ' 12' ' ' LEU . 33.0 pt -138.17 156.83 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 1.35 111.462 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.769 HG23 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -158.41 154.03 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.811 -0.631 . . . . 1.69 109.678 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.583 ' N ' HG12 ' A' ' 53' ' ' ILE . 28.0 ttt -107.73 119.53 39.7 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.658 -1.238 . . . . 2.09 107.658 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 1.9 mmmt -138.57 134.85 34.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.083 -0.34 . . . . 2.17 110.083 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.22 30.35 75.65 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.836 -0.697 . . . . 1.21 111.821 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' HA ' ' HE2' ' A' ' 54' ' ' MET . 0.9 OUTLIER 62.44 25.78 15.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.37 0.605 . . . . 3.61 111.542 -176.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 54' ' ' MET . 41.8 mt-10 -123.59 151.41 42.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.384 -0.825 . . . . 1.66 110.251 175.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.575 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.19 121.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.774 0.797 . . . . 1.53 111.353 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.769 ' CD1' HG23 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -83.91 111.9 19.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.893 -1.049 . . . . 0.92 108.277 168.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 2.8 tmm_? -122.14 108.86 13.82 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.613 -1.625 . . . . 4.02 106.613 171.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 3.8 mm? . . . . . 0 N--CA 1.476 0.872 0 O-C-N 124.268 0.98 . . . . 1.96 112.749 -166.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.425 ' HE1' HG12 ' A' ' 6' ' ' VAL . 64.8 mmm . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 112.411 0.522 . . . . 2.68 112.411 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -101.49 -25.71 13.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 1.7 110.985 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.533 ' ND2' ' HD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -99.94 13.54 33.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.006 0.431 . . . . 1.89 111.177 -177.275 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.466 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 12.9 p -102.35 129.3 54.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 1.89 110.257 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.32 -21.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.642 -0.423 . . . . 1.66 111.46 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -166.64 142.84 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.437 0.637 . . . . 1.89 111.211 176.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.404 HG23 ' HD1' ' A' ' 19' ' ' HIS . 9.5 m -121.02 144.73 48.37 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.961 -1.018 . . . . 1.11 109.823 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.487 ' CD1' HG23 ' A' ' 46' ' ' THR . 29.9 m-85 -123.03 133.14 54.35 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.855 0.836 . . . . 1.56 111.953 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.575 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 9.8 m-20 -97.94 121.83 40.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.928 -1.487 . . . . 1.94 108.911 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.888 ' HG ' ' HB2' ' A' ' 16' ' ' SER . 0.6 OUTLIER -67.48 -10.11 48.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.497 -1.229 . . . . 1.71 112.458 -173.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 35.9 tt0 94.03 -22.65 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.4 1.062 . . . . 2.16 109.253 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -96.25 -34.9 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.688 -0.687 . . . . 2.11 109.473 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.643 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 155.19 -30.91 0.65 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.478 -0.868 . . . . 1.28 112.926 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.888 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.7 OUTLIER -57.79 141.37 49.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 1.33 110.29 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 127.44 50.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.236 -0.438 . . . . 2.39 111.071 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 12' ' ' LEU . 75.0 t -107.19 138.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.212 -0.662 . . . . 1.13 109.212 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.466 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 4.3 m-70 -127.01 132.82 50.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 109.641 -0.503 . . . . 0.95 109.641 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 59' ' ' ILE . 69.4 t -102.12 122.4 54.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 106.947 -1.501 . . . . 1.4 106.947 170.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HD2' ' ND2' ' A' ' 5' ' ' ASN . 94.2 m-85 -92.11 155.26 18.18 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.559 -0.746 . . . . 0.81 110.757 -169.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.75 -8.61 29.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.303 -0.862 . . . . 3.36 111.755 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -92.48 0.96 57.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.17 -13.81 64.34 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.807 -1.088 . . . . 0.58 113.878 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.87 -174.52 4.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.603 0.702 . . . . 2.19 109.448 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.539 ' HG3' HG12 ' A' ' 59' ' ' ILE . 1.6 pmm? -152.83 154.2 34.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.901 0.381 . . . . 1.25 110.15 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.6 153.49 24.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.5 -0.64 . . . . 0.45 111.5 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 ttt -125.75 139.8 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.27 0.557 . . . . 1.24 111.539 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.41 155.67 36.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 1.14 109.441 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.456 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 65.2 t30 -94.12 159.73 15.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.285 -0.635 . . . . 1.45 109.285 175.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.643 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.8 ptmt -48.73 -23.73 1.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.076 1.139 . . . . 2.25 114.076 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.456 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 36.2 m-85 -90.45 -2.63 57.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.472 . . . . 1.23 110.152 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.13 26.36 16.45 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.59 112.01 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -100.7 135.82 41.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.724 0.773 . . . . 3.65 111.855 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 p -79.33 110.69 14.86 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.948 -1.478 . . . . 1.9 110.243 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -127.25 177.07 6.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.321 -0.4 . . . . 1.7 111.128 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -88.4 132.9 34.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.234 0.54 . . . . 3.13 111.755 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.416 ' HE2' HD13 ' A' ' 59' ' ' ILE . 27.1 ttt -91.83 125.55 56.83 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.743 -0.662 . . . . 1.91 109.948 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.87 124.08 7.22 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.605 2.204 . . . . 1.43 113.037 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.624 ' HG2' ' HD2' ' A' ' 55' ' ' LYS . 38.2 tt0 -82.11 133.98 35.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 1.15 110.34 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 102.88 -12.4 56.2 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.783 -0.723 . . . . 0.8 111.901 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 29.5 mmmt -96.53 123.9 40.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.626 0.25 . . . . 2.7 111.41 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.603 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -90.7 127.56 43.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.885 -0.783 . . . . 1.55 108.885 172.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.4 mtm -126.16 156.95 39.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.069 -0.514 . . . . 1.68 109.901 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.511 ' HG2' ' HG3' ' A' ' 51' ' ' LYS . 38.9 mt-10 -108.58 169.4 8.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.982 0.896 . . . . 1.64 112.281 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.487 HG23 ' CD1' ' A' ' 10' ' ' TYR . 42.7 p -120.33 168.31 11.41 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.862 -1.517 . . . . 1.31 110.73 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.575 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 11.2 ptt180 -59.49 -21.83 60.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.473 0.654 . . . . 4.27 111.086 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -97.81 -5.86 33.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.94 -1.027 . . . . 2.7 110.921 -170.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.56 11.26 58.35 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.52 -0.848 . . . . 0.87 112.999 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.607 HG21 HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -90.05 148.18 23.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.426 -0.583 . . . . 1.91 109.426 177.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 1.9 mptp? -111.87 130.55 55.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.157 -0.683 . . . . 2.32 109.157 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.46 157.64 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.238 -0.437 . . . . 1.35 110.826 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.603 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -158.81 150.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 1.69 110.266 177.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.52 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 60.2 ttp -105.72 123.79 48.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.581 -1.266 . . . . 2.09 107.581 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.624 ' HD2' ' HG2' ' A' ' 40' ' ' GLU . 21.6 tptp -144.5 133.63 22.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.88 -0.415 . . . . 2.17 109.88 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.56 30.58 78.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.117 -0.563 . . . . 1.21 111.768 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.27 24.77 14.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.445 0.64 . . . . 3.61 111.009 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.25 152.22 36.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.198 -0.91 . . . . 1.66 109.581 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.539 HG12 ' HG3' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.38 120.21 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.054 0.931 . . . . 1.53 110.879 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.511 ' HE1' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -84.03 119.18 24.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.188 -1.369 . . . . 0.92 107.435 166.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -111.28 100.18 8.85 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.54 -2.022 . . . . 4.02 105.54 166.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.607 HD22 HG21 ' A' ' 50' ' ' THR . 29.7 mt . . . . . 0 C--N 1.321 -0.645 0 O-C-N 124.327 1.017 . . . . 1.96 113.076 -171.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.508 ' HA ' ' HE1' ' A' ' 3' ' ' MET . 25.8 mmt . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.754 0.311 . . . . 2.68 111.033 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -82.29 -32.41 29.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.418 0.628 . . . . 1.7 110.245 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.498 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 4.3 t30 -94.74 -1.29 53.25 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.333 -0.849 . . . . 1.89 111.065 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 19' ' ' HIS . 8.6 p -107.39 131.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 119.102 -1.039 . . . . 1.89 111.643 -175.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.65 -25.59 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.961 -0.563 . . . . 1.66 112.398 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -167.38 136.08 2.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.81 0.814 . . . . 1.89 112.036 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 m -108.54 142.09 39.48 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.198 -1.365 . . . . 1.11 109.819 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -122.85 136.69 54.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.852 0.834 . . . . 1.56 112.122 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.98 120.36 34.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.81 -1.541 . . . . 1.94 109.114 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.594 HD13 ' HB2' ' A' ' 16' ' ' SER . 15.1 mt -80.4 145.88 31.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.531 -1.285 . . . . 1.71 107.531 173.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.546 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 7.9 tt0 -62.8 -13.98 39.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.22 0.452 . . . . 2.16 112.22 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.68 -20.99 21.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.093 0.473 . . . . 2.11 110.151 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.556 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.65 -20.44 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.854 -0.689 . . . . 1.28 113.325 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.594 ' HB2' HD13 ' A' ' 12' ' ' LEU . 15.8 m -63.34 152.28 38.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.93 0.395 . . . . 1.33 110.466 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 28' ' ' MET . 59.0 mttp -122.98 127.9 49.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.05 0.452 . . . . 2.39 111.362 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.04 149.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.041 -0.725 . . . . 1.13 109.041 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.593 ' HB3' HG22 ' A' ' 6' ' ' VAL . 1.2 m-70 -140.14 139.82 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.769 -0.582 . . . . 0.95 110.377 172.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.55 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 47.2 t -102.1 122.57 54.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.42 -1.326 . . . . 1.4 107.42 171.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.455 ' HE1' ' N ' ' A' ' 27' ' ' GLY . 95.9 m-85 -96.27 157.21 16.0 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.233 -0.44 . . . . 0.81 111.512 -169.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 22.7 mtpp -62.67 -23.15 66.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.181 0.592 . . . . 3.36 111.765 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.99 6.37 48.13 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.342 -0.984 . . . . 1.97 108.342 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.64 -5.38 76.91 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 114.347 -1.297 . . . . 0.58 114.923 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -90.3 178.34 6.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.266 1.033 . . . . 2.19 110.757 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 1.049 ' HG2' HD11 ' A' ' 59' ' ' ILE . 4.2 mpp? -138.35 145.55 41.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.954 -0.566 . . . . 1.25 109.979 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.455 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -132.48 148.21 19.11 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.838 -0.696 . . . . 0.45 111.713 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 27.4 ttt -127.88 146.84 50.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.407 0.622 . . . . 1.24 112.09 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.518 ' CD ' ' HE2' ' A' ' 19' ' ' HIS . 3.1 mp0 -129.73 157.89 40.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.101 -1.074 . . . . 1.14 108.101 171.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -86.47 171.0 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.028 -0.36 . . . . 1.45 110.028 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.556 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 62.6 pttt -54.06 -14.23 1.01 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.129 0.788 . . . . 2.25 113.129 174.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -91.15 -0.82 57.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.011 0.434 . . . . 1.23 110.22 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.44 65.06 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.079 -0.581 . . . . 0.59 112.047 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 34' ' ' LYS . 1.7 mmmp? -103.12 135.36 44.93 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.739 0.78 . . . . 3.65 111.0 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 p -77.31 122.1 24.64 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 113.85 -1.523 . . . . 1.9 111.451 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -151.07 148.59 28.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 1.7 110.168 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.55 140.87 32.14 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.662 -0.415 . . . . 3.13 110.221 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.415 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -98.78 150.44 36.69 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.062 -0.517 . . . . 1.91 110.888 -177.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.6 154.45 64.41 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.062 2.508 . . . . 1.43 112.183 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.55 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 26.7 tt0 -75.62 141.23 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 1.15 110.416 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.4 -10.76 19.55 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.508 -0.853 . . . . 0.8 113.758 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.6 mtpt -92.61 115.65 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.832 0.678 . . . . 2.7 112.832 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.517 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.2 p -86.32 125.35 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.563 -0.902 . . . . 1.55 108.563 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.9 mtm -120.56 152.92 37.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.333 -0.394 . . . . 1.68 110.62 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.59 140.53 29.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.629 0.728 . . . . 1.64 111.247 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 44.4 p -103.18 162.47 12.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.661 -1.154 . . . . 1.31 110.225 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.546 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 2.8 mmt85 -59.42 -21.08 59.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.582 0.706 . . . . 4.27 111.289 171.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -88.9 0.82 56.25 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.921 -1.036 . . . . 2.7 111.418 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.03 72.72 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.57 -0.824 . . . . 0.87 111.272 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.527 HG22 HD23 ' A' ' 62' ' ' LEU . 11.1 p -115.08 171.74 7.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.803 -0.443 . . . . 1.91 109.803 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.62 145.08 50.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.31 -0.404 . . . . 2.32 110.07 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.491 HG21 ' HD3' ' A' ' 61' ' ' ARG . 34.5 pt -137.77 159.2 34.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.801 -0.636 . . . . 1.35 110.719 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.672 HG23 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -156.88 153.34 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 1.69 109.817 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.596 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -114.05 106.76 14.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.609 -0.886 . . . . 2.09 108.609 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 36.0 tttm -144.27 145.96 32.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.868 0.366 . . . . 2.17 110.524 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 63.28 31.92 82.37 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.637 -0.711 . . . . 1.21 112.379 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 72.37 -9.35 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.409 0.623 . . . . 3.61 110.902 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 56' ' ' GLY . 47.9 mt-10 -96.17 -179.07 4.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.487 -0.779 . . . . 1.66 110.51 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 1.049 HD11 ' HG2' ' A' ' 26' ' ' MET . 0.0 OUTLIER -135.98 128.38 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.581 0.705 . . . . 1.53 109.86 173.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.672 ' CD1' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.39 111.99 19.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.008 -0.996 . . . . 0.92 108.612 172.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.616 ' HG3' HH11 ' A' ' 61' ' ' ARG . 6.0 tpt85 -120.55 107.17 12.53 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.951 -1.5 . . . . 4.02 106.951 171.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.527 HD23 HG22 ' A' ' 50' ' ' THR . 4.0 mm? . . . . . 0 N--CA 1.472 0.634 0 CA-C-N 114.724 -1.126 . . . . 1.96 112.982 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 mmt . . . . . 0 C--O 1.234 0.255 0 CA-C-O 120.912 0.387 . . . . 2.68 111.431 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.7 m -97.25 -27.49 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.833 0.349 . . . . 1.7 111.044 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.707 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -101.46 12.37 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.315 0.579 . . . . 1.89 111.026 -178.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.595 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 9.2 p -107.69 127.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.092 -0.643 . . . . 1.89 111.659 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 20' ' ' VAL . 23.5 m -80.3 -23.88 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.639 -0.71 . . . . 1.66 111.025 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -167.87 129.21 1.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 1.89 111.029 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.8 m -102.48 138.19 39.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.808 -1.087 . . . . 1.11 109.558 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.63 ' HH ' ' HG3' ' A' ' 61' ' ' ARG . 39.2 m-85 -108.09 123.19 48.33 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.076 0.941 . . . . 1.56 111.809 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.91 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 6.1 m-20 -94.9 114.0 25.79 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.442 -1.708 . . . . 1.94 109.92 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -87.68 152.49 22.11 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.386 -0.825 . . . . 1.71 109.089 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -69.45 -6.32 29.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.432 0.634 . . . . 2.16 110.746 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -95.09 -7.94 38.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.582 -0.735 . . . . 2.11 109.29 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 101.43 -19.08 52.3 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.22 -0.9 . . . . 1.28 111.88 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.574 ' HB2' HD11 ' A' ' 12' ' ' LEU . 5.0 m -61.96 145.9 51.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 1.33 110.491 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.7 125.16 46.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.16 0.505 . . . . 2.39 110.594 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -105.76 154.71 6.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.482 -0.933 . . . . 1.13 108.482 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 51.8 m-70 -136.58 134.65 37.66 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.848 -0.532 . . . . 0.95 109.737 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 7' ' ' VAL . 47.3 t -97.31 111.98 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 106.298 -1.741 . . . . 1.4 106.298 166.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 19' ' ' HIS . 80.9 m-85 -84.39 154.83 22.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.715 -0.675 . . . . 0.81 110.72 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.707 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 7.7 ptmm? -58.58 -23.45 58.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.318 -0.856 . . . . 3.36 112.68 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.613 ' HB2' ' HE2' ' A' ' 25' ' ' LYS . 7.7 m-20 -98.01 6.66 47.4 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.156 -0.683 . . . . 1.97 109.156 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 -5.03 66.79 Favored Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 115.078 -0.964 . . . . 0.58 114.787 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.613 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -81.88 171.75 14.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.272 1.036 . . . . 2.19 110.382 176.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.695 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.5 mpp? -137.0 143.51 42.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.974 -0.557 . . . . 1.25 109.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.87 143.21 14.81 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.383 -0.687 . . . . 0.45 111.383 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.125 0.488 . . . . 1.24 110.799 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.78 153.88 43.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.338 -0.847 . . . . 1.14 109.149 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.561 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 38.3 p-10 -88.98 168.31 12.47 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.61 -0.515 . . . . 1.45 109.61 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.564 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 63.9 pttt -53.31 1.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.053 1.131 . . . . 2.25 114.053 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 30' ' ' ASN . 84.7 m-85 -111.09 -2.7 15.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.939 -0.476 . . . . 1.23 110.522 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.92 32.69 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.294 -0.955 . . . . 0.59 113.598 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -120.42 147.46 45.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.129 -0.628 . . . . 3.65 110.683 174.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -74.57 128.05 34.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.991 -1.004 . . . . 1.9 111.351 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 ptm -126.85 -179.72 4.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.08 -0.509 . . . . 1.7 110.666 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.05 154.38 37.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 3.13 110.109 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.2 ttt -119.88 127.28 26.47 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.178 -0.305 . . . . 1.91 110.178 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.43 148.57 33.85 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.458 2.106 . . . . 1.43 112.863 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.15 139.72 43.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.722 -0.672 . . . . 1.15 109.512 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.52 -31.53 5.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.495 -0.86 . . . . 0.8 112.648 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -82.08 142.19 32.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.72 0.295 . . . . 2.7 110.848 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.569 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.0 p -97.55 130.21 46.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.215 0.531 . . . . 1.55 110.472 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -102.83 140.55 36.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.777 -0.647 . . . . 1.68 109.7 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.51 146.99 27.71 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.21 0.528 . . . . 1.64 110.314 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.3 p -100.46 168.23 9.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.573 -0.74 . . . . 1.31 110.72 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.91 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 39.3 mtt180 -46.57 -41.29 14.19 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.413 0.894 . . . . 4.27 113.413 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.02 -43.48 7.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.871 -0.731 . . . . 2.7 112.098 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.26 28.82 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 119.308 -1.425 . . . . 0.87 113.587 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.0 m -102.44 149.28 24.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.291 -1.003 . . . . 1.91 108.291 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 94.3 mttt -126.15 144.17 50.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.614 -0.434 . . . . 2.32 111.794 -173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.3 pt -138.0 157.92 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.44 -0.8 . . . . 1.35 110.786 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.596 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -159.94 148.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.818 0.342 . . . . 1.69 110.359 176.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -111.52 127.02 55.58 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.562 -0.533 . . . . 2.09 109.562 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -145.24 129.38 17.59 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.791 -0.448 . . . . 2.17 109.791 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.19 36.58 89.33 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.941 -0.647 . . . . 1.21 112.711 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.442 ' HA ' ' HE1' ' A' ' 54' ' ' MET . 33.0 m-80 71.85 -9.63 0.95 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.483 0.713 . . . . 3.61 111.355 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 56' ' ' GLY . 55.4 mm-40 -86.05 139.15 31.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.161 -0.472 . . . . 1.66 111.16 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.695 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -102.08 124.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.576 0.703 . . . . 1.53 110.901 176.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.596 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.48 119.63 25.37 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.076 -1.083 . . . . 0.92 108.076 169.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.63 ' HG3' ' HH ' ' A' ' 10' ' ' TYR . 11.1 ttm180 -116.07 101.01 8.36 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.515 -1.661 . . . . 4.02 106.515 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 O-C-N 124.895 1.372 . . . . 1.96 113.532 -163.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.3 mtp . . . . . 0 N--CA 1.444 -0.772 0 CA-C-O 121.207 0.527 . . . . 2.68 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 m -112.95 -36.53 5.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.629 -0.714 . . . . 1.7 111.271 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.987 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 3.4 t30 -114.84 -0.57 13.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.55 0.691 . . . . 1.89 111.779 -174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 19' ' ' HIS . 7.8 p -102.73 134.38 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.917 -1.114 . . . . 1.89 111.381 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -87.13 -23.86 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.932 0.345 . . . . 1.66 111.932 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.9 131.45 1.65 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.727 0.775 . . . . 1.89 111.736 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.595 HG23 ' HD1' ' A' ' 19' ' ' HIS . 5.6 m -105.64 142.62 35.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.439 -1.255 . . . . 1.11 109.479 171.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.791 ' HH ' ' HD3' ' A' ' 61' ' ' ARG . 21.2 m-85 -121.7 134.74 54.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.382 -0.827 . . . . 1.56 111.15 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.594 ' CB ' ' HD3' ' A' ' 47' ' ' ARG . 1.2 m-20 -97.03 117.24 30.76 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.987 -1.46 . . . . 1.94 108.454 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.576 HD13 ' HB2' ' A' ' 16' ' ' SER . 5.9 mt -72.15 0.81 8.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.891 0.7 . . . . 1.71 112.891 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.518 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 88.72 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.787 0.803 . . . . 2.16 108.999 173.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -80.52 -35.74 34.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.685 -1.143 . . . . 2.11 108.564 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.599 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 148.3 -26.72 1.39 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.431 -1.258 . . . . 1.28 113.315 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.576 ' HB2' HD13 ' A' ' 12' ' ' LEU . 1.4 m -60.64 146.39 45.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.758 -0.46 . . . . 1.33 109.758 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -121.94 126.42 48.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.107 0.479 . . . . 2.39 110.538 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.418 HG11 ' HE2' ' A' ' 38' ' ' MET . 78.3 t -108.46 141.79 22.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.04 -0.726 . . . . 1.13 109.04 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.639 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -137.53 131.11 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.174 -0.61 . . . . 0.95 110.428 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG22 HG13 ' A' ' 59' ' ' ILE . 60.7 t -102.89 123.98 56.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 107.522 -1.288 . . . . 1.4 107.522 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.494 ' HB3' ' ND2' ' A' ' 5' ' ' ASN . 97.9 m-85 -98.61 161.4 13.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.963 -0.562 . . . . 0.81 111.219 -167.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.987 ' HE2' ' HA ' ' A' ' 5' ' ' ASN . 41.4 mtmt -62.15 -19.56 63.18 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.179 -0.464 . . . . 3.36 111.95 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.872 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 2.1 m-20 -83.98 -9.39 58.71 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.275 -1.009 . . . . 1.97 108.275 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.89 -5.06 59.5 Favored Glycine 0 N--CA 1.421 -2.358 0 CA-C-N 114.731 -1.122 . . . . 0.58 113.338 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.872 ' HD3' ' HB2' ' A' ' 23' ' ' ASP . 1.6 mppt? -82.62 -177.1 6.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 117.748 0.774 . . . . 2.19 109.417 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.514 ' HE1' HG12 ' A' ' 59' ' ' ILE . 1.7 pmm? -153.81 147.61 25.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.757 -0.656 . . . . 1.25 109.676 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.27 155.05 21.91 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.786 -0.721 . . . . 0.45 111.964 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.6 ttt -124.95 141.53 52.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.121 0.486 . . . . 1.24 111.656 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 27.2 mt-10 -126.45 153.49 44.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.098 -1.075 . . . . 1.14 108.098 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -93.42 172.63 8.16 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.403 -0.519 . . . . 1.45 110.542 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 60.8 pttt -53.07 -14.78 0.67 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.605 0.965 . . . . 2.25 113.605 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -95.9 -3.12 45.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.065 -0.397 . . . . 1.23 110.914 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.34 22.65 47.04 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.825 -0.702 . . . . 0.59 112.199 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 mmtt -102.34 134.04 46.29 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.875 0.845 . . . . 3.65 110.81 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 p -76.75 129.21 35.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.665 -1.607 . . . . 1.9 111.545 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 55.4 mtm -136.77 162.9 31.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 1.7 110.064 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -90.96 156.47 17.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.343 -0.389 . . . . 3.13 110.03 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.418 ' HE2' HG11 ' A' ' 18' ' ' VAL . 41.5 ttm -99.98 127.66 32.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 1.91 111.612 -173.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.13 118.5 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.539 2.159 . . . . 1.43 111.922 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.1 tt0 -68.58 137.06 53.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.759 -0.655 . . . . 1.15 110.802 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -9.14 37.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.8 113.471 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -104.22 130.29 51.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.335 0.568 . . . . 2.7 112.132 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.667 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.2 p -93.78 132.66 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 1.55 110.366 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.4 mtm -124.8 153.18 42.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.487 -0.779 . . . . 1.68 109.712 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -107.4 167.78 9.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.523 0.678 . . . . 1.64 111.688 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 54.3 p -127.59 164.87 21.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.655 -1.157 . . . . 1.31 112.067 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 75.0 mtp180 -59.65 -29.66 68.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.413 -0.812 . . . . 4.27 111.423 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -95.18 -7.33 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 2.7 111.333 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.37 16.42 27.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.328 -0.939 . . . . 0.87 112.913 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.509 HG21 ' CD2' ' A' ' 62' ' ' LEU . 99.3 m -93.31 139.8 30.25 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.95 -0.389 . . . . 1.91 109.95 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -106.64 132.7 52.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.104 -0.702 . . . . 2.32 109.104 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.4 ' HA ' ' HD1' ' A' ' 60' ' ' PHE . 17.3 pt -136.6 152.82 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.901 0.334 . . . . 1.35 111.901 -175.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.667 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.56 149.81 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.945 -0.571 . . . . 1.69 110.359 174.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.546 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.6 ttt -103.86 123.33 46.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.102 -0.703 . . . . 2.09 109.102 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 23.2 tptm -145.48 128.14 16.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.754 -0.461 . . . . 2.17 109.754 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.14 43.32 97.34 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.61 -0.596 . . . . 1.21 111.61 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 50.12 21.17 0.71 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.182 0.993 . . . . 3.61 112.174 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -116.9 152.09 35.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 1.66 110.511 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.514 HG12 ' HE1' ' A' ' 26' ' ' MET . 0.4 OUTLIER -98.93 122.63 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.133 0.968 . . . . 1.53 111.666 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.491 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -82.66 111.6 18.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.238 -1.393 . . . . 0.92 107.238 164.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.791 ' HD3' ' HH ' ' A' ' 10' ' ' TYR . 5.8 ttm180 -116.47 103.93 10.93 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.709 -1.96 . . . . 4.02 105.709 170.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.509 ' CD2' HG21 ' A' ' 50' ' ' THR . 3.8 mm? . . . . . 0 N--CA 1.473 0.709 0 O-C-N 124.082 0.864 . . . . 1.96 112.202 -166.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.0 mtp . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.9 0.381 . . . . 2.68 111.65 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m -78.93 -27.77 43.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.35 0.595 . . . . 1.7 110.504 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.589 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -108.28 9.61 27.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.769 0.795 . . . . 1.89 110.558 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.752 HG11 ' HG1' ' A' ' 9' ' ' THR . 84.5 t -102.48 127.74 55.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.399 -0.819 . . . . 1.89 110.842 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 22' ' ' LYS . 24.5 m -86.7 -23.27 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 1.66 110.964 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.37 138.76 3.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 1.89 110.581 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.752 ' HG1' HG11 ' A' ' 6' ' ' VAL . 3.4 m -120.76 143.97 48.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.484 -0.78 . . . . 1.11 109.728 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.76 129.39 51.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.372 1.082 . . . . 1.56 111.653 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -96.76 125.47 41.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.117 -1.856 . . . . 1.94 108.99 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 16' ' ' SER . 16.7 mt -80.84 148.81 29.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.117 -1.068 . . . . 1.71 108.117 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.541 ' HG2' ' HA ' ' A' ' 47' ' ' ARG . 51.9 mt-30 -65.06 -5.34 6.2 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.98 0.363 . . . . 2.16 111.98 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.33 -27.11 14.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.518 . . . . 2.11 110.129 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 135.24 -19.58 3.84 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.771 -0.728 . . . . 1.28 113.124 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 12' ' ' LEU . 6.3 m -68.56 155.55 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.827 0.346 . . . . 1.33 110.584 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -124.99 127.72 47.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.265 -0.425 . . . . 2.39 111.069 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -108.23 143.47 18.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.754 -0.832 . . . . 1.13 108.754 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 26' ' ' MET . 4.0 m-70 -131.14 130.12 42.69 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.088 -0.645 . . . . 0.95 110.62 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 116.38 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.79 -1.559 . . . . 1.4 106.79 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.47 ' HE1' ' N ' ' A' ' 27' ' ' GLY . 73.1 m-85 -85.63 155.28 21.19 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.72 -0.673 . . . . 0.81 111.316 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 12.8 ptmm? -57.49 -22.85 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.964 -1.016 . . . . 3.36 112.273 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -94.46 2.52 55.73 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.843 -0.799 . . . . 1.97 108.843 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.39 -11.57 59.91 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.83 -1.077 . . . . 0.58 114.386 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.66 179.87 7.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.082 0.941 . . . . 2.19 111.19 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.584 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -139.44 143.62 37.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.144 0.497 . . . . 1.25 109.983 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -136.79 146.28 18.21 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.932 -0.867 . . . . 0.45 110.932 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.4 ttt -122.62 144.73 48.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.932 0.396 . . . . 1.24 111.302 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -126.75 148.89 49.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.946 -1.131 . . . . 1.14 107.946 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 32' ' ' PHE . 35.3 p30 -86.38 170.44 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.231 -0.588 . . . . 1.45 110.121 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 19.3 pttm -58.02 1.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.626 0.972 . . . . 2.25 113.626 173.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.0 m-85 -107.47 -1.84 21.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 1.23 109.521 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.3 22.17 52.4 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.819 -0.705 . . . . 0.59 112.268 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -110.97 137.82 48.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.413 0.625 . . . . 3.65 111.414 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -74.65 139.12 43.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.163 -1.38 . . . . 1.9 111.869 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.1 ptm -150.45 178.82 8.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.612 -0.722 . . . . 1.7 109.602 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -104.84 158.95 16.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 3.13 110.629 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.591 ' HE2' ' HE3' ' A' ' 44' ' ' MET . 27.8 ttt -101.45 130.2 25.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 1.91 110.091 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.98 132.86 17.4 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.71 2.273 . . . . 1.43 112.772 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 54' ' ' MET . 36.6 tt0 -73.89 138.42 44.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.15 110.23 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.93 62.73 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.824 -0.703 . . . . 0.8 112.979 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -102.93 127.02 50.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 2.7 111.887 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.574 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.7 p -95.6 132.27 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.582 -0.735 . . . . 1.55 109.138 178.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.591 ' HE3' ' HE2' ' A' ' 38' ' ' MET . 71.6 mtm -119.48 148.55 43.13 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.792 -0.447 . . . . 1.68 109.792 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -102.99 147.32 27.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.228 0.537 . . . . 1.64 110.746 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.83 162.34 14.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.325 -0.852 . . . . 1.31 111.264 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.541 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 99.7 mtt180 -58.85 -26.2 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.88 -0.6 . . . . 4.27 111.786 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.68 -14.94 38.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 2.7 110.402 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.79 26.33 6.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.912 -0.661 . . . . 0.87 112.95 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.757 HG22 HH11 ' A' ' 61' ' ' ARG . 43.6 m -111.13 165.16 12.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.505 -0.554 . . . . 1.91 109.505 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.489 ' N ' HG21 ' A' ' 50' ' ' THR . 68.1 mttm -122.42 143.83 49.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.592 -0.522 . . . . 2.32 109.592 176.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.6 pt -136.32 150.5 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 1.35 111.141 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.693 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.15 144.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.313 -0.403 . . . . 1.69 110.732 177.073 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.535 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 25.8 ttt -99.99 138.18 37.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.597 -0.52 . . . . 2.09 109.597 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 21.0 tptp -144.41 103.35 3.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 2.17 107.883 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 -152.1 45.63 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.055 -1.618 . . . . 1.21 109.055 -164.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.63 8.48 14.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.106 0.479 . . . . 3.61 110.644 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -104.76 177.87 4.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.994 0.425 . . . . 1.66 110.481 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.584 HD12 ' HG2' ' A' ' 26' ' ' MET . 11.2 tt -143.59 141.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.746 0.784 . . . . 1.53 110.884 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.693 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -82.49 114.72 21.1 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.438 -1.319 . . . . 0.92 107.438 169.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.757 HH11 HG22 ' A' ' 50' ' ' THR . 0.4 OUTLIER -114.49 102.75 10.36 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.527 -1.657 . . . . 4.02 106.527 170.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.594 ' C ' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.571 1.768 0 O-C-N 124.457 1.098 . . . . 1.96 111.746 -172.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 121.039 0.447 . . . . 2.68 111.117 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 p -81.52 -7.21 59.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.57 0.7 . . . . 1.7 110.917 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.444 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -129.44 11.75 5.86 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.068 0.937 . . . . 1.89 109.039 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -117.37 133.47 64.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.016 -1.447 . . . . 1.89 111.658 -175.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 22' ' ' LYS . 35.6 m -88.24 -26.37 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.541 -0.754 . . . . 1.66 111.536 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -167.15 135.79 2.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.344 0.593 . . . . 1.89 111.167 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 m -114.23 144.45 43.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.907 -1.042 . . . . 1.11 110.102 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.483 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 30.9 m-85 -120.15 132.19 55.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.552 0.692 . . . . 1.56 111.136 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.55 125.76 51.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.238 -1.346 . . . . 1.94 108.698 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 17.4 mt -81.16 153.63 27.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.377 -1.283 . . . . 1.71 107.832 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -65.85 -7.31 15.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.217 0.532 . . . . 2.16 111.232 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 31.6 t70 -98.45 -13.52 20.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 2.11 109.98 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.539 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 116.07 -13.45 16.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.651 -0.785 . . . . 1.28 113.425 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.542 ' HB2' HD13 ' A' ' 12' ' ' LEU . 4.9 m -72.96 148.19 44.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.792 0.296 . . . . 1.33 110.592 -176.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -118.93 127.58 53.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.308 0.575 . . . . 2.39 112.454 -172.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.9 t -109.57 143.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.165 -1.05 . . . . 1.13 108.165 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 26' ' ' MET . 5.5 m-70 -132.28 137.98 47.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.738 -0.785 . . . . 0.95 110.602 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 7' ' ' VAL . 46.5 t -97.67 115.21 36.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.131 -1.433 . . . . 1.4 107.131 169.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 49.5 m-85 -80.6 153.66 27.88 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.933 -0.576 . . . . 0.81 111.167 -173.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.75 ' HA ' HG11 ' A' ' 7' ' ' VAL . 16.7 pttm -57.58 -27.01 62.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.998 -1.001 . . . . 3.36 111.756 -176.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.36 -1.23 54.12 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.209 -0.663 . . . . 1.97 109.209 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.41 41.0 Favored Glycine 0 N--CA 1.423 -2.168 0 C-N-CA 119.92 -1.133 . . . . 0.58 114.879 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -75.05 176.38 7.29 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.934 1.367 . . . . 2.19 111.737 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 2.2 mpp? -140.44 148.82 41.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.25 109.945 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.83 145.26 17.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.619 -0.801 . . . . 0.45 111.724 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 ttt -119.27 137.8 53.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.511 . . . . 1.24 110.924 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -130.58 154.25 48.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.308 -0.86 . . . . 1.14 109.035 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.489 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 41.7 p30 -88.42 169.1 12.08 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.275 -0.57 . . . . 1.45 110.053 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.598 ' HD3' ' O ' ' A' ' 14' ' ' ASP . 40.6 pttt -53.6 -10.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.097 1.147 . . . . 2.25 114.097 175.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -99.03 -1.52 39.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 1.23 110.602 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.52 20.53 51.28 Favored Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.856 -0.688 . . . . 0.59 111.909 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 27.9 mmmt -102.17 135.62 43.45 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.644 0.735 . . . . 3.65 111.334 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -74.7 127.57 33.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.032 -1.44 . . . . 1.9 111.011 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.3 ptm -138.27 176.49 8.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 1.7 110.736 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -96.56 131.19 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.118 -0.492 . . . . 3.13 109.849 179.451 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.615 ' HE1' ' HB2' ' A' ' 54' ' ' MET . 25.8 ttp -85.2 117.64 69.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.965 -0.562 . . . . 1.91 110.445 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.46 147.43 64.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.86 2.373 . . . . 1.43 112.809 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.57 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 34.6 tt0 -88.82 144.82 25.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.001 -0.545 . . . . 1.15 110.385 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.87 -16.73 60.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.014 -0.613 . . . . 0.8 112.569 176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -94.88 119.73 33.93 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.116 0.413 . . . . 2.7 112.116 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 10.7 p -94.02 119.58 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.078 -0.712 . . . . 1.55 109.078 174.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 65.3 mtm -107.74 152.17 24.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.603 -0.726 . . . . 1.68 110.613 -170.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -104.64 145.41 30.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.538 0.685 . . . . 1.64 111.497 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.0 p -94.93 166.63 11.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.746 -1.115 . . . . 1.31 109.925 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -35.92 -49.37 0.62 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.57 1.322 . . . . 4.27 114.57 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.84 -33.69 15.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.48 -0.488 . . . . 2.7 111.978 -170.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.79 34.23 0.17 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.985 -1.102 . . . . 0.87 112.837 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.5 m -100.87 153.32 19.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.486 -0.931 . . . . 1.91 108.486 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.492 ' HB3' HG21 ' A' ' 43' ' ' VAL . 93.4 mttt -124.26 139.55 53.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.432 -0.507 . . . . 2.32 112.075 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.473 ' HA ' ' CD1' ' A' ' 60' ' ' PHE . 31.6 pt -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.148 -0.933 . . . . 1.35 110.201 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.728 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -163.41 155.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.825 0.345 . . . . 1.69 111.137 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.646 ' N ' HG12 ' A' ' 53' ' ' ILE . 13.4 tmm? -104.79 117.22 33.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.247 -1.019 . . . . 2.09 108.247 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 20.2 tptp -134.0 125.6 28.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.31 -0.626 . . . . 2.17 109.31 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.07 38.13 88.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.756 -0.735 . . . . 1.21 112.155 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 62.46 28.57 16.85 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.607 0.718 . . . . 3.61 110.852 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 54' ' ' MET . 46.0 mt-10 -141.29 159.87 41.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.656 -0.702 . . . . 1.66 110.409 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -102.16 126.64 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.456 0.646 . . . . 1.53 111.404 -177.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.728 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.81 110.35 18.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.313 -1.736 . . . . 0.92 106.313 164.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.483 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 1.2 tmm_? -114.47 103.64 11.24 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.632 -1.618 . . . . 4.02 106.632 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.476 0.845 0 O-C-N 124.385 1.053 . . . . 1.96 113.404 -165.442 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.522 ' HA ' HG13 ' A' ' 6' ' ' VAL . 22.6 mmt . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.731 0.3 . . . . 2.68 111.466 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -92.74 -37.36 12.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 1.7 111.004 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.523 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -107.0 -6.47 17.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.235 0.541 . . . . 1.89 111.417 -176.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 4.8 p -94.73 141.1 15.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.95 -0.469 . . . . 1.89 110.502 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -94.98 -23.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.865 -0.334 . . . . 1.66 110.9 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -160.15 136.53 8.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.383 0.611 . . . . 1.89 110.82 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -121.2 135.2 55.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.024 -0.989 . . . . 1.11 109.538 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -117.26 134.06 55.25 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.864 0.84 . . . . 1.56 111.754 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.575 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 10.7 t70 -104.08 126.15 50.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.188 -1.369 . . . . 1.94 108.517 176.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' ' 16' ' ' SER . 8.8 mt -71.51 0.09 9.26 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.423 -1.262 . . . . 1.71 112.623 -172.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.481 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 7.6 tt0 86.87 -24.37 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.963 -0.754 . . . . 2.16 108.963 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -95.15 -21.13 18.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.102 -0.954 . . . . 2.11 109.16 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 139.36 -29.97 2.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.543 -0.837 . . . . 1.28 113.945 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.553 ' HB2' HD12 ' A' ' 12' ' ' LEU . 3.8 m -66.05 149.07 50.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 117.09 0.445 . . . . 1.33 110.264 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -124.44 126.72 46.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 2.39 111.432 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.58 141.81 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.897 -0.779 . . . . 1.13 108.897 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.566 ' O ' ' HA ' ' A' ' 26' ' ' MET . 4.9 m-70 -130.59 130.19 43.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.331 -0.547 . . . . 0.95 110.27 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.09 111.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.058 -1.46 . . . . 1.4 107.058 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 85.6 m-85 -89.72 163.09 15.24 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.02 -0.536 . . . . 0.81 110.888 -168.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.523 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 24.9 mtpp -66.82 -21.05 66.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.423 0.63 . . . . 3.36 110.387 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.41 -13.33 59.95 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.276 -1.009 . . . . 1.97 108.276 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.99 71.14 Favored Glycine 0 N--CA 1.422 -2.258 0 CA-C-N 114.043 -1.435 . . . . 0.58 112.93 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -78.49 171.9 14.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.622 0.725 . . . . 2.19 111.452 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.679 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.0 mpp? -130.74 138.14 49.82 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.625 -1.171 . . . . 1.25 110.022 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.37 139.27 10.83 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 111.218 -0.753 . . . . 0.45 111.218 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.487 ' HE2' HD13 ' A' ' 12' ' ' LEU . 27.9 ttt -117.73 133.97 55.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.253 0.549 . . . . 1.24 110.877 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.03 149.33 42.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.11 -0.95 . . . . 1.14 108.64 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 32' ' ' PHE . 43.9 p30 -86.96 169.5 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.658 -0.417 . . . . 1.45 110.132 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 45.8 pttt -59.24 5.08 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.44 0.904 . . . . 2.25 113.44 172.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 30' ' ' ASN . 89.5 m-85 -106.78 -2.9 21.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.169 -0.678 . . . . 1.23 109.169 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.07 27.48 40.6 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.789 -0.641 . . . . 0.59 114.074 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 157.14 42.55 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.054 -0.658 . . . . 3.65 111.332 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 p -74.66 126.52 31.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 1.9 111.181 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -126.27 -175.61 3.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.977 -0.556 . . . . 1.7 110.804 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.22 132.06 35.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 3.13 110.233 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.435 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 27.6 ttt -97.62 123.55 51.65 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.204 -0.453 . . . . 1.91 110.41 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.73 152.09 82.62 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.81 2.34 . . . . 1.43 111.731 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.509 ' O ' HG12 ' A' ' 53' ' ' ILE . 32.8 tt0 -83.75 -90.59 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.052 -0.259 . . . . 1.15 111.042 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 53' ' ' ILE . . . -81.15 40.76 2.56 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.179 -0.534 . . . . 0.8 113.85 -170.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -109.44 119.63 40.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.652 0.263 . . . . 2.7 110.818 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.53 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.4 p -81.34 117.91 28.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 1.55 109.361 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.8 mtm -103.2 146.4 28.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 1.68 110.996 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.602 ' HB2' ' HZ1' ' A' ' 51' ' ' LYS . 32.9 tt0 -98.75 151.64 20.55 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.353 -0.839 . . . . 1.64 109.866 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -126.41 164.75 20.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.004 0.431 . . . . 1.31 112.14 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.575 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -60.43 -28.7 68.49 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.749 -0.659 . . . . 4.27 111.91 176.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 20.0 t70 -90.71 -19.15 23.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.618 -0.719 . . . . 2.7 110.87 -171.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.25 15.62 18.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.632 -0.794 . . . . 0.87 112.488 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.492 HG23 HD21 ' A' ' 62' ' ' LEU . 63.8 m -94.75 142.93 26.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.906 -0.405 . . . . 1.91 109.906 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.602 ' HZ1' ' HB2' ' A' ' 45' ' ' GLU . 67.1 mmtt -108.67 132.33 54.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 2.32 108.848 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.3 pt -135.99 156.91 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.763 0.283 . . . . 1.35 111.763 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.729 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -165.19 150.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.764 -0.653 . . . . 1.69 110.121 176.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 16.6 tmm? -111.43 129.94 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.968 -0.382 . . . . 2.09 109.968 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -144.35 124.69 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.589 -0.278 . . . . 2.17 110.272 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 62.54 39.51 97.94 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.835 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.427 ' O ' ' HE2' ' A' ' 26' ' ' MET . 0.2 OUTLIER 72.55 -10.66 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.213 0.53 . . . . 3.61 111.208 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 54' ' ' MET . 45.2 mt-10 -89.79 167.84 12.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.138 -0.483 . . . . 1.66 109.98 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.679 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -126.26 125.66 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.879 0.847 . . . . 1.53 110.875 -178.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.729 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -81.56 110.41 16.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.248 -1.39 . . . . 0.92 107.248 169.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 38.7 ttp-105 -125.96 112.01 15.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.43 -1.693 . . . . 4.02 106.43 174.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.492 HD21 HG23 ' A' ' 50' ' ' THR . 4.2 mm? . . . . . 0 N--CA 1.474 0.771 0 O-C-N 124.196 0.935 . . . . 1.96 112.668 -166.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.806 0.336 . . . . 2.68 111.444 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -73.57 -24.94 60.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.903 0.859 . . . . 1.7 109.873 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.503 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -105.3 10.39 33.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.664 -1.153 . . . . 1.89 110.595 -177.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.454 HG22 ' ND2' ' A' ' 5' ' ' ASN . 74.5 t -105.87 135.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.479 -0.782 . . . . 1.89 109.959 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -105.84 -18.46 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.035 -0.53 . . . . 1.66 111.072 -178.121 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -169.01 132.95 1.4 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.123 0.487 . . . . 1.89 110.613 171.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.0 m -110.89 143.8 40.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.381 -0.827 . . . . 1.11 110.583 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.551 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 20.7 m-85 -124.9 139.82 53.49 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.425 0.631 . . . . 1.56 111.441 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.723 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.587 HD12 ' HB2' ' A' ' 16' ' ' SER . 43.3 mt -83.21 148.96 27.12 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.99 -1.004 . . . . 1.71 109.654 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.27 -15.49 35.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.309 0.576 . . . . 2.16 111.618 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 20.7 t70 -96.39 -1.79 46.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.545 -0.752 . . . . 2.11 109.785 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 104.58 -19.3 42.37 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.113 -0.949 . . . . 1.28 112.832 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.587 ' HB2' HD12 ' A' ' 12' ' ' LEU . 40.1 m -72.84 159.97 32.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.574 -0.313 . . . . 1.33 110.671 -177.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 32.8 mttt -119.43 152.55 36.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.136 0.493 . . . . 2.39 110.694 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.44 HG22 HD11 ' A' ' 52' ' ' ILE . 75.4 t -131.48 144.25 38.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.855 -0.794 . . . . 1.13 108.855 174.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' MET . 3.1 m-70 -134.6 135.15 42.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.48 -0.563 . . . . 0.95 109.48 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 7' ' ' VAL . 48.2 t -93.63 118.24 39.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 106.579 -1.638 . . . . 1.4 106.579 168.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -81.98 150.36 27.68 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.77 -0.65 . . . . 0.81 110.9 -172.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -61.34 -22.33 64.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 3.36 111.768 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -99.69 6.65 45.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.76 0.791 . . . . 1.97 109.079 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.24 1.49 60.97 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.711 -1.131 . . . . 0.58 115.007 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -75.89 173.11 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.827 1.314 . . . . 2.19 111.21 172.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.666 ' HG2' HD12 ' A' ' 59' ' ' ILE . 3.2 mpp? -138.07 131.33 30.43 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.343 -0.984 . . . . 1.25 108.343 171.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.0 141.92 13.82 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.249 -0.977 . . . . 0.45 111.922 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.5 ttt -113.64 141.0 47.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.793 0.33 . . . . 1.24 110.191 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 16.6 mt-10 -123.53 144.66 49.42 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.619 -1.252 . . . . 1.14 107.619 169.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.436 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 29.9 p-10 -87.62 165.91 15.09 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.87 -0.732 . . . . 1.45 109.169 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 pttm -52.22 -13.21 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.607 0.966 . . . . 2.25 113.607 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.436 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 93.7 m-85 -98.73 7.77 45.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.923 0.392 . . . . 1.23 110.669 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.02 20.57 64.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.248 -0.501 . . . . 0.59 113.0 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.3 mmtm -102.01 140.83 35.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.746 0.784 . . . . 3.65 111.024 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.3 p -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.913 -1.494 . . . . 1.9 112.327 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.2 mtp -139.07 178.34 7.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.032 -0.985 . . . . 1.7 109.83 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -114.79 139.25 49.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.058 -0.719 . . . . 3.13 109.058 173.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.0 ttm -71.24 127.11 91.78 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.648 0.261 . . . . 1.91 110.86 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.87 114.49 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.19 1.927 . . . . 1.43 111.253 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.5 tt0 -61.87 129.45 41.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.807 -0.633 . . . . 1.15 110.373 -176.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.41 -20.22 30.51 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.125 -0.56 . . . . 0.8 112.781 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' HE3' ' HB3' ' A' ' 42' ' ' LYS . 22.2 mmmt -88.55 119.83 29.36 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 2.7 111.907 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.632 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.98 136.47 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.554 -0.535 . . . . 1.55 109.554 172.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 68.2 mtm -132.22 157.12 45.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.579 -0.282 . . . . 1.68 110.751 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.33 150.75 20.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.882 0.849 . . . . 1.64 111.941 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 30.1 p -97.19 165.78 11.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.29 -1.323 . . . . 1.31 108.87 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -46.66 -36.33 6.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.996 0.739 . . . . 4.27 112.996 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -96.78 -49.96 4.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.356 0.502 . . . . 2.7 112.356 -168.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.9 32.24 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.411 -1.376 . . . . 0.87 113.712 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.6 t -114.03 156.65 23.72 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.457 -0.942 . . . . 1.91 108.457 168.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -120.38 145.67 46.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.651 0.263 . . . . 2.32 110.596 -171.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 12' ' ' LEU . 22.6 pt -136.46 152.28 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.887 -0.597 . . . . 1.35 110.863 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.662 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -159.97 147.38 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.066 -0.515 . . . . 1.69 110.549 176.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.453 ' N ' HG12 ' A' ' 53' ' ' ILE . 26.2 ttt -97.53 129.66 44.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.26 -0.644 . . . . 2.09 109.26 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -144.99 128.33 16.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.159 -0.311 . . . . 2.17 110.159 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.32 37.25 93.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.471 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.401 HD21 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 61.24 25.33 15.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.674 0.749 . . . . 3.61 111.05 -178.024 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -128.06 -169.51 2.08 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.807 -1.088 . . . . 1.66 108.45 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.666 HD12 ' HG2' ' A' ' 26' ' ' MET . 3.3 tt -143.54 136.43 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.792 0.806 . . . . 1.53 111.529 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.662 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.1 109.41 17.13 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.795 -1.557 . . . . 0.92 106.795 167.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.551 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 1.3 tmm_? -121.35 108.87 14.22 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 105.031 -2.211 . . . . 4.02 105.031 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 4.5 mm? . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 1.96 109.163 -156.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.573 ' C ' ' H ' ' A' ' 5' ' ' ASN . 21.0 mmt . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 111.89 0.33 . . . . 2.68 111.89 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 3' ' ' MET . 73.6 m 73.53 -27.62 0.19 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.809 0.843 . . . . 1.7 109.335 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.573 ' H ' ' C ' ' A' ' 3' ' ' MET . 1.3 t30 -95.85 -14.7 22.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.939 -1.028 . . . . 1.89 109.914 168.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.8 p -89.18 136.11 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 119.384 -0.926 . . . . 1.89 110.088 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.25 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.962 -0.295 . . . . 1.66 111.499 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' LYS . 16.7 tppt? -169.32 151.49 4.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.228 0.537 . . . . 1.89 111.286 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.474 HG21 ' HD1' ' A' ' 19' ' ' HIS . 3.9 m -133.08 145.75 51.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.553 -0.749 . . . . 1.11 109.795 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.463 ' CE2' ' HG2' ' A' ' 61' ' ' ARG . 38.7 m-85 -128.61 144.63 51.19 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.723 0.773 . . . . 1.56 112.333 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.89 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 6.5 m-20 -106.56 123.7 48.5 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.782 -1.553 . . . . 1.94 110.026 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -77.34 1.84 17.63 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.92 -1.491 . . . . 1.71 113.022 -173.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.525 ' HB2' ' HA ' ' A' ' 47' ' ' ARG . 62.7 tt0 83.68 -32.61 0.07 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.059 0.544 . . . . 2.16 109.998 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.8 t70 -79.87 -20.14 46.63 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.429 -1.323 . . . . 2.11 107.429 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.571 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.54 -17.2 6.53 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.266 -1.334 . . . . 1.28 113.485 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.572 ' HB2' HD12 ' A' ' 12' ' ' LEU . 11.3 m -62.51 143.74 56.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.841 0.353 . . . . 1.33 110.414 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 65.7 mttm -116.46 126.96 54.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.088 -0.505 . . . . 2.39 110.713 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 9' ' ' THR . 97.1 t -109.58 136.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.524 -0.547 . . . . 1.13 109.524 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' A' ' 26' ' ' MET . 2.5 m-70 -123.34 127.43 48.49 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.366 -0.534 . . . . 0.95 110.418 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.46 115.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.555 -1.276 . . . . 1.4 107.555 171.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.571 ' HE1' ' HG3' ' A' ' 3' ' ' MET . 91.0 m-85 -94.93 164.41 12.92 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.273 -0.421 . . . . 0.81 111.248 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.495 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 54.1 mttm -60.53 -26.25 66.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.931 0.492 . . . . 3.36 112.26 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -91.07 3.56 54.42 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.653 0.739 . . . . 1.97 109.07 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.08 -2.02 81.01 Favored Glycine 0 N--CA 1.427 -1.919 0 CA-C-N 114.562 -1.199 . . . . 0.58 113.589 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -81.05 173.35 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.332 0.566 . . . . 2.19 110.792 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.588 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 3.7 mpp? -134.43 138.64 44.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.498 -0.773 . . . . 1.25 109.627 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.55 134.22 9.89 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.096 -0.802 . . . . 0.45 111.096 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.522 ' HE3' ' HB3' ' A' ' 16' ' ' SER . 1.7 tmt? -113.73 134.63 54.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.811 0.339 . . . . 1.24 110.211 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 35.8 mt-10 -126.49 148.52 49.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 1.14 109.294 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.576 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.2 p-10 -85.95 171.33 11.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.678 -0.49 . . . . 1.45 109.678 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.571 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 37.3 pttt -59.18 5.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.982 1.104 . . . . 2.25 113.982 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.1 m-85 -113.05 3.28 16.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.306 0.574 . . . . 1.23 109.711 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.36 23.56 65.2 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.59 113.711 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -112.55 144.86 41.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.333 -0.547 . . . . 3.65 110.48 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.9 t -78.83 136.69 37.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.203 -0.908 . . . . 1.9 111.553 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.479 ' HE3' ' HB3' ' A' ' 30' ' ' ASN . 68.6 mtm -133.62 175.04 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.05 -0.722 . . . . 1.7 109.05 172.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -96.19 140.49 30.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.9 0.381 . . . . 3.13 110.618 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -95.52 121.6 61.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.828 -0.624 . . . . 1.91 110.953 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HG2' ' HG3' ' A' ' 42' ' ' LYS . 59.3 Cg_endo -75.18 125.23 9.07 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.407 2.071 . . . . 1.43 112.299 176.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 43.9 tt0 -66.72 142.0 57.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.15 110.606 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.04 -2.85 51.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.862 -0.685 . . . . 0.8 112.835 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' HG3' ' HG2' ' A' ' 39' ' ' PRO . 11.7 mmpt? -100.8 122.73 43.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.749 -0.265 . . . . 2.7 111.384 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.597 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.84 124.59 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.678 0.751 . . . . 1.55 109.084 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtt -116.6 148.32 41.04 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.359 -0.837 . . . . 1.68 109.257 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -102.85 155.95 17.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.981 0.42 . . . . 1.64 110.587 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.6 p -104.24 163.42 12.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 1.31 110.951 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.89 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 1.7 ptt180 -50.12 -30.03 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.686 0.995 . . . . 4.27 113.686 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.49 -31.06 16.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.461 -0.336 . . . . 2.7 111.318 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.92 19.64 1.58 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.164 -1.017 . . . . 0.87 113.299 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.2 m -100.38 160.02 14.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 1.91 109.072 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -117.08 139.07 51.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.713 0.292 . . . . 2.32 110.589 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.792 HG23 ' HD3' ' A' ' 61' ' ' ARG . 17.1 pt -132.89 158.39 43.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.146 -0.479 . . . . 1.35 109.719 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.626 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -158.28 143.15 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.252 0.548 . . . . 1.69 111.765 175.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.1 ttt -90.96 112.62 24.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.489 -0.93 . . . . 2.09 108.489 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 50.9 tptt -145.13 130.25 18.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.198 -0.456 . . . . 2.17 110.059 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.7 40.43 37.6 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.132 -0.556 . . . . 1.21 112.559 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.14 31.74 20.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.456 0.646 . . . . 3.61 110.402 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -149.27 175.81 11.08 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.722 -0.844 . . . . 1.66 108.722 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -126.77 134.98 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.704 0.764 . . . . 1.53 111.158 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.626 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -93.81 131.4 39.23 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.855 -1.066 . . . . 0.92 108.748 171.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.792 ' HD3' HG23 ' A' ' 52' ' ' ILE . 14.8 tpt85 -157.12 100.42 1.86 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 104.56 -2.385 . . . . 4.02 104.56 170.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.9 mm? . . . . . 0 CA--C 1.516 -0.357 0 CA-C-N 118.677 0.671 . . . . 1.96 111.117 -174.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 31.8 mmt . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.857 0.36 . . . . 2.68 110.741 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 m -71.59 -27.25 63.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.814 0.816 . . . . 1.7 110.191 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.494 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -115.13 17.76 16.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.597 -1.183 . . . . 1.89 111.238 -174.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 19' ' ' HIS . 76.3 t -111.79 115.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.666 -0.697 . . . . 1.89 109.974 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 20' ' ' VAL . 2.8 p -90.71 -18.54 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.575 -0.738 . . . . 1.66 110.578 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -167.23 130.09 1.73 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.482 0.658 . . . . 1.89 110.782 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.403 ' OG1' HG12 ' A' ' 6' ' ' VAL . 83.7 m -108.35 145.81 33.92 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.646 -1.161 . . . . 1.11 109.935 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.912 ' HH ' ' HD2' ' A' ' 61' ' ' ARG . 26.7 m-85 -123.91 133.23 53.78 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 121.743 0.783 . . . . 1.56 111.384 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.653 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -101.53 122.71 44.32 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.024 -1.444 . . . . 1.94 109.071 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 16' ' ' SER . 41.0 mt -83.46 151.24 25.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.898 -1.046 . . . . 1.71 108.487 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -66.69 -8.16 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.643 0.735 . . . . 2.16 111.355 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.403 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 3.9 t70 -87.14 -23.14 24.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.051 -0.977 . . . . 2.11 109.378 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 115.34 -25.2 9.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.758 -1.11 . . . . 1.28 111.699 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.556 ' HB2' HD13 ' A' ' 12' ' ' LEU . 49.5 m -66.53 157.13 33.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.97 0.414 . . . . 1.33 110.234 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -125.51 147.41 49.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.243 0.544 . . . . 2.39 112.056 -171.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.95 148.59 24.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.993 -1.003 . . . . 1.13 108.487 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' HB3' HG13 ' A' ' 6' ' ' VAL . 12.8 m-70 -135.06 137.15 42.63 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.254 -0.579 . . . . 0.95 109.923 172.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 7' ' ' VAL . 49.7 t -95.52 109.41 22.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 106.573 -1.64 . . . . 1.4 106.573 166.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.57 155.82 29.48 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.37 -0.832 . . . . 0.81 110.714 -171.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 47.7 mtpt -68.85 -18.53 64.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.68 0.752 . . . . 3.36 110.217 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.43 -6.22 59.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.571 -1.195 . . . . 1.97 108.056 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.23 6.3 71.51 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 113.986 -1.461 . . . . 0.58 112.995 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -86.75 177.44 7.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.297 0.57 . . . . 2.19 110.653 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.954 ' HG2' HD12 ' A' ' 59' ' ' ILE . 4.5 mpp? -139.91 140.21 36.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.122 -0.945 . . . . 1.25 109.221 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.78 151.2 21.91 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.252 -0.975 . . . . 0.45 112.242 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 ttt -122.05 142.28 50.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.999 0.428 . . . . 1.24 110.746 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -130.68 151.47 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.013 -1.106 . . . . 1.14 108.013 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 32' ' ' PHE . 27.4 p-10 -84.6 167.71 16.01 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.45 109.657 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.557 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 15.0 pttm -50.9 4.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.868 1.433 . . . . 2.25 114.868 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.3 m-85 -122.96 2.82 9.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.255 -0.278 . . . . 1.23 111.155 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.39 27.61 43.03 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.479 -0.867 . . . . 0.59 112.964 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -100.85 130.09 46.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.717 0.77 . . . . 3.65 110.247 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -80.82 127.55 32.66 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.152 -1.386 . . . . 1.9 112.593 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 65.4 mtm -127.63 -171.96 2.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.58 -0.736 . . . . 1.7 109.431 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.0 OUTLIER -97.86 156.01 16.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.885 -0.413 . . . . 3.13 109.885 176.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.444 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 17.4 tpt -82.81 122.77 78.38 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 1.91 110.809 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 69.5 Cg_endo -79.13 117.83 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.517 2.144 . . . . 1.43 112.841 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -87.64 139.54 30.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.624 -0.716 . . . . 1.15 110.447 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.596 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 108.13 -9.37 36.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.988 -0.625 . . . . 0.8 113.284 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -109.64 131.19 55.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.242 0.46 . . . . 2.7 112.242 -175.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.587 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.5 p -100.91 131.18 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.136 -0.69 . . . . 1.55 109.136 170.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.4 mtm -135.16 173.12 12.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.812 -0.631 . . . . 1.68 109.927 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -107.12 164.75 11.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.308 1.051 . . . . 1.64 112.259 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -108.85 162.35 14.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.359 -1.746 . . . . 1.31 108.93 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.653 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 75.9 mtp180 -55.47 -23.52 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.233 0.457 . . . . 4.27 112.233 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.43 -2.99 37.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.323 . . . . 2.7 111.091 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.24 23.9 13.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.547 -0.835 . . . . 0.87 113.326 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.739 HG22 HD21 ' A' ' 62' ' ' LEU . 64.4 m -95.04 137.08 34.57 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.773 -0.251 . . . . 1.91 110.431 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -99.59 127.98 45.69 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.044 -0.354 . . . . 2.32 110.044 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 18.8 pt -135.09 155.07 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.984 -0.553 . . . . 1.35 110.685 -176.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -157.35 149.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.922 0.391 . . . . 1.69 110.41 174.278 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.3 ttt -108.19 118.73 37.52 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.073 -1.084 . . . . 2.09 108.073 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.596 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 23.9 tptp -144.68 135.52 24.83 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.203 -0.665 . . . . 2.17 109.203 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.83 32.12 82.69 Favored Glycine 0 C--N 1.322 -0.212 0 C-N-CA 121.018 -0.61 . . . . 1.21 112.647 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.81 19.6 11.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.232 0.539 . . . . 3.61 111.31 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.74 152.56 39.3 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.593 -0.73 . . . . 1.66 109.276 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.954 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -114.22 127.86 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.62 0.724 . . . . 1.53 111.889 177.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.538 ' CD1' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -96.06 130.81 42.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.728 -1.212 . . . . 0.92 107.728 167.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.912 ' HD2' ' HH ' ' A' ' 10' ' ' TYR . 7.8 ptt180 -156.46 100.39 1.96 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.047 -1.834 . . . . 4.02 106.047 173.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.739 HD21 HG22 ' A' ' 50' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 109.002 -0.74 . . . . 1.96 109.002 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.425 ' HE1' ' CE1' ' A' ' 19' ' ' HIS . 19.5 mmt . . . . . 0 C--O 1.231 0.082 0 N-CA-C 112.108 0.41 . . . . 2.68 112.108 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -78.34 -33.01 49.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.453 . . . . 1.7 110.449 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.571 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -97.79 1.81 48.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 1.89 110.696 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.419 HG21 ' ND2' ' A' ' 5' ' ' ASN . 77.7 t -94.03 130.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 1.89 110.204 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -93.3 -25.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.465 -0.494 . . . . 1.66 111.918 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -164.16 142.61 7.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 1.89 110.489 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 53.4 m -125.05 140.84 52.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.226 -0.443 . . . . 1.11 110.458 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.463 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 36.2 m-85 -112.38 128.83 56.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.693 0.759 . . . . 1.56 112.001 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -102.15 114.9 29.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.717 -1.583 . . . . 1.94 109.826 -178.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.654 ' O ' ' HB2' ' A' ' 13' ' ' GLN . 6.6 mt -75.22 -0.8 20.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.352 1.242 . . . . 1.71 114.352 -168.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.654 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 56.9 mt-30 90.84 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.672 0.789 . . . . 2.16 110.17 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.58 -28.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.412 -0.959 . . . . 2.11 108.412 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.649 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 140.24 -22.66 2.74 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.42 -1.264 . . . . 1.28 113.57 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.572 ' HB3' HD11 ' A' ' 12' ' ' LEU . 23.0 t -64.39 141.89 58.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.772 0.796 . . . . 1.33 110.456 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -120.78 126.72 50.84 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.201 -1.363 . . . . 2.39 110.297 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 9' ' ' THR . 86.3 t -112.69 126.25 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.437 -0.801 . . . . 1.13 109.041 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 26' ' ' MET . 11.9 m-70 -115.62 128.7 56.13 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.565 -0.854 . . . . 0.95 109.733 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.459 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 46.3 t -90.33 112.55 24.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 106.737 -1.579 . . . . 1.4 106.737 172.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -88.16 161.8 17.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.857 -0.61 . . . . 0.81 110.614 -173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 8.1 mtpm? -61.02 -26.35 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.331 0.586 . . . . 3.36 111.28 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.08 -7.2 59.68 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.162 -0.926 . . . . 1.97 108.836 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.62 -0.99 68.33 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.573 -1.194 . . . . 0.58 113.172 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -85.82 179.68 7.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.309 0.576 . . . . 2.19 110.775 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.747 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 59.5 mtm -143.15 148.1 36.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.955 -1.021 . . . . 1.25 110.381 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.12 135.28 8.74 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.228 -0.896 . . . . 0.45 111.052 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' SER . 26.8 ttt -111.05 126.61 55.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.082 -0.34 . . . . 1.24 110.082 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 48.6 mt-10 -128.11 155.83 43.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.662 -0.866 . . . . 1.14 108.662 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.4 p30 -91.79 175.32 6.93 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.418 -0.513 . . . . 1.45 110.238 176.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.649 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 4.4 pttm -51.53 -11.45 0.13 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.604 0.964 . . . . 2.25 113.604 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -105.28 -5.02 20.93 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.321 -0.237 . . . . 1.23 111.179 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.41 25.38 28.43 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.798 -0.715 . . . . 0.59 112.417 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 26.3 mmtp -108.68 137.66 46.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.324 0.583 . . . . 3.65 111.845 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 28' ' ' MET . 47.3 t -71.97 131.33 42.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.438 -1.255 . . . . 1.9 111.266 -175.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.461 ' HE3' ' HE2' ' A' ' 28' ' ' MET . 64.0 mtm -126.04 177.03 6.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 1.7 109.45 177.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -97.82 127.11 43.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.895 -0.409 . . . . 3.13 109.895 179.042 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.499 ' HE1' ' HB2' ' A' ' 54' ' ' MET . 23.9 ttt -83.01 126.18 73.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.855 -0.611 . . . . 1.91 111.044 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.68 153.32 38.54 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.999 2.466 . . . . 1.43 112.88 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.526 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.5 tt0 -112.51 141.89 45.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 1.15 109.983 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.03 2.84 64.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.43 -0.89 . . . . 0.8 112.603 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 42' ' ' LYS . 12.4 mmmm -109.58 138.73 45.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.585 0.231 . . . . 2.7 111.38 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 59.4 t -90.0 119.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.513 -0.551 . . . . 1.55 109.513 171.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -109.74 154.0 23.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 1.68 110.303 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -104.26 155.61 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.546 0.689 . . . . 1.64 111.517 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 47.8 p -111.32 156.83 20.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.28 -1.327 . . . . 1.31 109.869 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 47.8 mtp180 -57.53 -21.89 41.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.798 0.296 . . . . 4.27 111.798 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -89.99 -3.39 58.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 2.7 110.84 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 26.9 25.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.73 -0.748 . . . . 0.87 113.669 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.2 p -108.19 159.69 16.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.331 0.566 . . . . 1.91 110.038 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -111.01 135.72 51.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.244 -0.435 . . . . 2.32 109.953 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.536 HG22 ' CG ' ' A' ' 61' ' ' ARG . 8.8 pt -132.17 165.98 30.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 1.35 111.067 -173.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.526 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -159.44 142.22 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.342 -0.39 . . . . 1.69 110.974 167.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.499 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 17.1 tmm? -95.62 120.71 36.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.922 -1.14 . . . . 2.09 107.922 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.526 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.6 tptt -137.43 112.5 9.08 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.323 -0.621 . . . . 2.17 109.323 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 67.26 52.2 33.19 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.811 -0.631 . . . . 1.21 112.61 -176.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' O ' ' HE3' ' A' ' 26' ' ' MET . 40.4 m-80 73.99 -35.24 0.3 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.818 0.847 . . . . 3.61 111.796 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' A' ' 56' ' ' GLY . 43.1 mt-10 -78.92 156.27 28.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.106 -0.497 . . . . 1.66 110.841 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.747 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -113.79 129.69 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.47 0.652 . . . . 1.53 109.681 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -93.91 112.93 24.85 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.874 -0.787 . . . . 0.92 108.874 169.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.648 ' HD3' HD23 ' A' ' 62' ' ' LEU . 2.7 tmt_? -140.29 103.75 4.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.442 -2.059 . . . . 4.02 105.442 160.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.648 HD23 ' HD3' ' A' ' 61' ' ' ARG . 3.5 mm? . . . . . 0 N--CA 1.471 0.603 0 CA-C-N 118.607 0.639 . . . . 1.96 111.658 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.458 ' HA ' HG13 ' A' ' 6' ' ' VAL . 36.5 mtp . . . . . 0 N--CA 1.442 -0.837 0 CA-C-O 121.544 0.688 . . . . 2.68 109.76 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -92.8 -45.07 8.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.042 . . . . 1.7 110.704 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.42 -5.54 35.97 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.321 0.582 . . . . 1.89 110.891 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.9 p -86.81 125.36 40.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.68 -0.808 . . . . 1.89 109.932 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.87 -23.42 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 1.66 111.001 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -167.5 133.21 2.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.43 0.633 . . . . 1.89 111.2 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.624 HG21 ' HD1' ' A' ' 19' ' ' HIS . 2.3 m -111.63 139.78 46.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.946 -1.025 . . . . 1.11 109.635 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -115.14 129.66 56.72 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.227 1.013 . . . . 1.56 111.727 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -100.73 124.49 46.42 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.14 -1.845 . . . . 1.94 108.176 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' ' 16' ' ' SER . 10.2 mp -77.68 4.78 10.68 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.455 -0.793 . . . . 1.71 112.231 -174.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.711 ' HG3' ' HD2' ' A' ' 47' ' ' ARG . 25.2 tt0 82.36 -26.99 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.127 0.489 . . . . 2.16 110.315 167.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 12' ' ' LEU . 18.0 t70 -103.39 -49.58 3.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.572 -0.74 . . . . 2.11 110.149 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.587 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . -166.32 -52.58 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.366 -1.397 . . . . 1.28 115.301 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.631 ' HB2' HD21 ' A' ' 12' ' ' LEU . 4.2 m -70.86 161.95 30.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.327 0.564 . . . . 1.33 111.163 -171.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -129.6 145.98 51.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 2.39 110.772 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.523 HG21 HD13 ' A' ' 12' ' ' LEU . 48.6 t -122.34 145.38 29.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.433 -0.951 . . . . 1.13 108.433 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.624 ' HD1' HG21 ' A' ' 9' ' ' THR . 3.0 m-70 -135.55 134.05 39.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.804 -0.759 . . . . 0.95 110.969 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.93 114.97 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.204 -1.406 . . . . 1.4 107.204 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 95.2 m-85 -91.73 159.56 15.78 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.974 -0.557 . . . . 0.81 110.524 -171.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -68.97 -18.66 64.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.512 0.672 . . . . 3.36 110.053 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.439 ' OD2' ' HE3' ' A' ' 25' ' ' LYS . 26.2 t70 -79.22 -7.95 58.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.812 -1.181 . . . . 1.97 107.812 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.07 -5.86 75.82 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.74 -1.573 . . . . 0.58 113.257 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.666 ' HB2' ' HZ1' ' A' ' 25' ' ' LYS . 9.4 mtmp? -80.3 175.4 10.68 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.413 0.625 . . . . 2.19 111.479 177.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 3.3 mpp? -136.2 138.03 41.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.78 -1.1 . . . . 1.25 109.572 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.42 142.36 13.74 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.45 111.854 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.701 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 23.6 ttt -118.54 142.86 47.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.961 0.41 . . . . 1.24 111.099 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 19.5 mt-10 -128.53 147.71 50.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.802 -0.814 . . . . 1.14 108.802 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.489 ' HB3' ' SD ' ' A' ' 36' ' ' MET . 41.6 p30 -87.54 172.34 9.83 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.574 -0.451 . . . . 1.45 110.294 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.587 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.4 ptpt -51.75 -16.73 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.418 0.896 . . . . 2.25 113.418 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.61 -4.43 50.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.721 0.296 . . . . 1.23 110.543 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.67 20.86 49.68 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.902 -0.666 . . . . 0.59 111.827 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.7 mmtm -106.69 139.52 41.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.419 0.628 . . . . 3.65 111.756 -176.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 p -70.25 131.84 44.81 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.516 -1.22 . . . . 1.9 110.549 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.489 ' SD ' ' HB3' ' A' ' 30' ' ' ASN . 19.4 ptm -153.47 174.65 14.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.304 -0.407 . . . . 1.7 110.83 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -123.55 140.89 52.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.745 -0.661 . . . . 3.13 109.562 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.701 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 22.3 ptt? -100.45 150.42 36.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.179 -0.464 . . . . 1.91 110.565 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.84 142.06 50.97 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.825 2.35 . . . . 1.43 112.221 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.522 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 29.7 tt0 -71.35 136.6 47.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 1.15 109.833 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -16.04 27.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.362 -0.923 . . . . 0.8 113.459 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -97.31 132.17 43.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.122 0.461 . . . . 2.7 111.756 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.571 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.8 p -99.41 133.92 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.861 -0.608 . . . . 1.55 110.159 174.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.94 151.4 32.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.807 -0.633 . . . . 1.68 109.946 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -94.78 145.73 24.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.678 -0.49 . . . . 1.64 109.678 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -115.96 159.95 20.9 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.82 -0.627 . . . . 1.31 111.057 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.711 ' HD2' ' HG3' ' A' ' 13' ' ' GLN . 18.0 mmm180 -49.13 -28.03 3.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.593 0.757 . . . . 4.27 112.901 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.67 -6.89 59.44 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.567 -0.742 . . . . 2.7 111.363 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.32 58.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.385 -0.912 . . . . 0.87 111.396 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.71 174.42 5.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.208 -0.496 . . . . 1.91 110.392 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 71.3 mmtt -119.24 148.18 43.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.417 -0.356 . . . . 2.32 110.142 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.51 152.39 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 1.35 110.565 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.628 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -159.21 153.95 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.302 -0.408 . . . . 1.69 110.167 176.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.568 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 56.7 ttp -108.51 109.09 20.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.775 -0.824 . . . . 2.09 108.775 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.522 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 51.7 tptt -127.42 131.14 50.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.266 -0.642 . . . . 2.17 109.266 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.99 73.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.831 -0.699 . . . . 1.21 111.859 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.26 27.21 16.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.479 0.657 . . . . 3.61 110.112 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' MET . 47.4 mt-10 -123.84 147.6 47.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.536 -0.756 . . . . 1.66 109.36 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.542 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -93.67 118.89 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 122.095 0.95 . . . . 1.53 111.152 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.628 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -84.34 116.12 22.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.397 -1.274 . . . . 0.92 108.152 168.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.493 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 19.5 tpt180 -114.94 102.28 9.82 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 106.604 -1.628 . . . . 4.02 106.604 169.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.072 0 O-C-N 125.089 1.493 . . . . 1.96 113.179 -163.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.46 0.034 0 N-CA-C 112.177 0.436 . . . . 2.68 112.177 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -87.68 -35.21 18.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.801 0.334 . . . . 1.7 111.309 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.442 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -105.42 3.13 29.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 1.89 111.846 -169.047 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 19' ' ' HIS . 10.4 p -106.62 135.9 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.014 -0.539 . . . . 1.89 111.493 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.463 HG21 HG11 ' A' ' 20' ' ' VAL . 14.6 m -94.17 -30.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.989 0.423 . . . . 1.66 111.701 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -157.21 138.17 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.389 0.614 . . . . 1.89 110.917 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 1.4 m -119.47 138.54 53.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.294 -0.866 . . . . 1.11 110.083 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.488 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 24.4 m-85 -108.9 125.66 52.25 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.738 0.78 . . . . 1.56 111.487 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -98.57 115.35 28.42 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.037 -1.438 . . . . 1.94 110.501 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 16' ' ' SER . 10.2 mt -81.2 149.75 28.93 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.691 -0.855 . . . . 1.71 108.691 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -60.7 -19.44 58.69 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.794 0.665 . . . . 2.16 112.794 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.6 -26.24 23.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 2.11 109.646 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.07 -15.41 6.5 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.277 -0.874 . . . . 1.28 112.284 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.565 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -58.03 140.19 52.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.861 -0.792 . . . . 1.33 108.861 176.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.493 ' HG2' ' CE1' ' A' ' 19' ' ' HIS . 24.4 ttmm -125.35 124.22 41.07 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.024 0.44 . . . . 2.39 110.613 -171.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 47.0 t -109.17 151.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.95 -0.759 . . . . 1.13 108.95 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.493 ' CE1' ' HG2' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -141.29 137.37 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.153 -0.619 . . . . 0.95 110.924 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.544 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 7.2 p -102.8 125.39 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 1.4 108.03 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -93.1 161.59 14.37 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.155 -0.929 . . . . 0.81 111.883 -168.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -67.04 -20.48 65.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.621 -0.718 . . . . 3.36 110.966 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.447 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 29.0 t70 -83.73 -6.05 59.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.153 0.978 . . . . 1.97 108.527 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.79 0.98 68.35 Favored Glycine 0 N--CA 1.427 -1.939 0 CA-C-N 114.287 -1.324 . . . . 0.58 112.718 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 23' ' ' ASP . 31.3 pttt -91.56 179.73 5.58 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.597 -0.149 . . . . 2.19 110.597 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.841 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mtm -141.62 153.89 45.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.742 0.306 . . . . 1.25 110.192 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.63 147.24 18.9 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.558 -0.617 . . . . 0.45 111.558 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.0 ttt -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.293 0.568 . . . . 1.24 111.148 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.4 mt-10 -128.15 157.17 41.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.796 -0.816 . . . . 1.14 108.796 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.483 ' C ' ' H ' ' A' ' 32' ' ' PHE . 35.3 p-10 -91.51 173.11 8.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.093 -0.336 . . . . 1.45 110.093 174.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.614 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 43.2 pttt -55.92 5.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.409 1.263 . . . . 2.25 114.409 175.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 30' ' ' ASN . 97.0 m-85 -115.91 1.18 13.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.018 0.437 . . . . 1.23 110.196 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.25 21.52 62.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.616 -0.802 . . . . 0.59 111.648 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 67.7 mmtt -103.62 131.53 50.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.377 0.608 . . . . 3.65 110.706 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.3 t -67.42 133.76 50.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.434 -1.257 . . . . 1.9 110.597 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.8 ptm -143.46 160.17 41.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.934 -0.576 . . . . 1.7 110.323 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.78 147.59 39.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.193 -0.458 . . . . 3.13 110.213 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.33 130.82 22.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 1.91 110.67 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.41 160.0 29.07 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.933 2.422 . . . . 1.43 112.963 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 54' ' ' MET . 35.1 tt0 -118.89 145.59 45.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.248 -0.433 . . . . 1.15 110.551 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.57 4.26 68.09 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.8 113.009 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.77 138.44 48.35 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.923 -0.163 . . . . 2.7 110.762 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 63.1 t -87.94 120.42 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.831 -0.433 . . . . 1.55 109.831 172.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -106.79 149.84 26.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.741 -0.663 . . . . 1.68 109.788 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -109.68 148.45 31.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.131 0.967 . . . . 1.64 112.208 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 46.0 p -97.72 168.54 10.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.872 -1.513 . . . . 1.31 109.966 -175.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -59.93 -21.96 61.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.971 0.891 . . . . 4.27 110.976 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.22 -13.72 49.02 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.025 -1.443 . . . . 2.7 110.984 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.39 53.06 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.684 -0.77 . . . . 0.87 111.993 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.87 153.62 19.34 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.955 -0.387 . . . . 1.91 109.955 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -112.18 129.3 56.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.979 -0.555 . . . . 2.32 109.753 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 1.8 pt -129.87 164.97 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.333 -0.394 . . . . 1.35 110.08 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.442 HG22 ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -164.63 143.14 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.062 0.458 . . . . 1.69 111.336 173.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.433 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 21.6 ttt -99.87 134.1 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 2.09 110.112 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -145.7 121.89 10.83 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.775 -0.454 . . . . 2.17 109.775 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.61 52.67 51.68 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.202 -0.523 . . . . 1.21 113.529 177.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.69 -13.27 0.49 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.81 0.444 . . . . 3.61 112.054 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 56' ' ' GLY . 44.1 mt-10 -96.96 148.84 22.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.206 -0.294 . . . . 1.66 110.206 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.841 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -115.96 124.45 72.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.58 0.705 . . . . 1.53 109.694 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.442 ' CD2' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -84.83 128.33 34.56 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.833 0.825 . . . . 0.92 109.102 171.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 2.3 tmm_? -158.23 102.41 1.77 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 103.863 -2.643 . . . . 4.02 103.863 170.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.1 mm? . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 119.312 0.96 . . . . 1.96 110.816 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.863 0.364 . . . . 2.68 111.553 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.2 m -89.7 -35.4 15.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.286 -0.416 . . . . 1.7 111.215 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.504 ' HB2' ' HD3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -91.9 11.26 25.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.886 0.851 . . . . 1.89 109.608 -177.188 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 HG13 ' HB3' ' A' ' 19' ' ' HIS . 57.6 t -108.64 106.85 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.223 -1.353 . . . . 1.89 108.768 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.95 -12.63 11.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.641 -0.709 . . . . 1.66 110.993 -173.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -163.86 139.55 6.38 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.798 -0.637 . . . . 1.89 110.564 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 m -119.23 138.37 53.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.373 -0.83 . . . . 1.11 110.056 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 21.3 m-85 -108.84 123.14 48.58 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.934 0.874 . . . . 1.56 110.958 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.557 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -91.71 113.24 25.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.382 -1.735 . . . . 1.94 110.406 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.612 HD13 ' HB2' ' A' ' 16' ' ' SER . 45.2 mt -85.47 144.5 27.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.678 -0.86 . . . . 1.71 108.678 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.501 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 8.0 tt0 -72.84 -0.9 14.74 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.497 0.554 . . . . 2.16 112.497 -170.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -98.44 -16.5 19.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.406 0.622 . . . . 2.11 109.666 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 124.49 -21.39 6.78 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.06 -0.973 . . . . 1.28 112.44 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.612 ' HB2' HD13 ' A' ' 12' ' ' LEU . 25.5 m -70.29 158.1 36.5 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.118 0.485 . . . . 1.33 110.848 -176.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 57.7 mttt -125.19 149.88 47.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.335 -0.393 . . . . 2.39 110.896 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 60.8 t -129.79 122.3 54.4 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.13 -0.693 . . . . 1.13 109.13 173.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 26' ' ' MET . 54.1 m-70 -108.8 132.0 54.42 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.161 -1.016 . . . . 0.95 110.114 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.82 102.08 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 106.47 -1.678 . . . . 1.4 106.47 168.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.71 155.53 38.86 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.262 -0.881 . . . . 0.81 110.694 -172.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HD3' ' HB2' ' A' ' 5' ' ' ASN . 19.5 pttm -51.63 -32.33 28.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.177 -0.919 . . . . 3.36 112.04 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 2.7 p-10 -97.75 10.17 40.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.61 0.719 . . . . 1.97 109.432 -171.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.89 4.68 72.02 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 114.872 -1.058 . . . . 0.58 114.586 172.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -87.68 175.94 7.65 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.124 0.962 . . . . 2.19 111.095 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.615 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 4.2 mpp? -140.36 141.72 35.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.888 -1.051 . . . . 1.25 110.339 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.03 146.65 18.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.37 -0.832 . . . . 0.45 111.336 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 24.7 ttt -114.62 129.01 56.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.261 0.553 . . . . 1.24 111.061 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.0 mt-10 -110.0 147.13 34.09 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.159 -1.052 . . . . 1.14 108.159 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.735 ' H ' ' HB2' ' A' ' 34' ' ' LYS . 63.8 t30 -92.05 162.68 14.27 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.742 -1.207 . . . . 1.45 107.742 170.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.604 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 22.3 ptmt -50.72 -20.68 1.31 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.363 0.875 . . . . 2.25 113.363 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.422 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 21.9 m-85 -96.52 -6.74 36.35 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.941 -0.475 . . . . 1.23 110.905 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.82 38.73 3.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.826 -0.702 . . . . 0.59 112.807 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.735 ' HB2' ' H ' ' A' ' 30' ' ' ASN . 24.4 mmtt -43.91 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.657 0.614 . . . . 3.65 112.657 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 34' ' ' LYS . 36.5 t 89.09 68.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.233 0.958 . . . . 1.9 109.073 175.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.502 ' HG3' ' HB3' ' A' ' 34' ' ' LYS . 31.6 mtm -119.76 -171.46 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.309 -1.314 . . . . 1.7 109.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -98.07 157.74 15.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.506 0.193 . . . . 3.13 110.695 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.511 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 16.7 tpt -80.24 125.16 81.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.229 -0.441 . . . . 1.91 111.173 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.511 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 70.7 Cg_endo -76.37 153.9 35.75 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.615 2.21 . . . . 1.43 112.707 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.559 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 38.2 tt0 -94.23 144.13 25.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 1.15 111.359 -177.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.98 57.65 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.171 -0.538 . . . . 0.8 113.591 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.3 mtpt -90.99 119.36 31.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.076 0.438 . . . . 2.7 111.632 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.597 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 14.5 p -91.85 126.75 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.331 -0.618 . . . . 1.55 109.331 171.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.475 ' HE1' ' HE1' ' A' ' 38' ' ' MET . 68.9 mtm -124.17 154.97 39.3 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.22 -0.659 . . . . 1.68 109.22 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.47 149.68 23.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.087 0.946 . . . . 1.64 112.408 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 47.2 p -103.13 162.09 13.25 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.726 -1.579 . . . . 1.31 110.221 -176.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.557 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 80.3 mtm180 -59.52 -19.42 48.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 4.27 110.971 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.09 -24.47 43.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 2.7 111.12 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.06 21.17 12.16 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.87 111.289 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.0 m -115.83 160.81 19.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.545 -0.539 . . . . 1.91 109.545 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.19 144.88 43.02 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.297 -0.261 . . . . 2.32 110.297 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.8 pt -136.84 150.76 26.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 120.439 0.161 . . . . 1.35 111.428 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.674 HG23 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.96 149.46 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 1.69 109.719 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.5 ttt -112.29 133.71 54.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.074 -0.343 . . . . 2.09 110.074 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.2 tptp -142.32 127.68 18.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.571 -0.286 . . . . 2.17 110.583 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 73.15 -28.81 0.8 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 115.244 0.857 . . . . 1.21 115.244 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 56' ' ' GLY . 8.7 t30 150.39 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.584 0.754 . . . . 3.61 109.058 -165.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -97.94 144.71 27.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.293 -0.867 . . . . 1.66 111.796 -171.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.495 HG12 ' HE1' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.36 124.31 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.019 0.914 . . . . 1.53 111.473 176.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.674 ' CD1' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.5 128.31 34.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.644 -1.162 . . . . 0.92 108.743 170.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HD2' ' OH ' ' A' ' 10' ' ' TYR . 52.2 ttt-85 -125.28 126.54 45.29 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.14 -1.8 . . . . 4.02 106.14 162.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.268 0 O-C-N 125.176 1.548 . . . . 1.96 113.288 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 73.4 t . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 110.334 -0.247 . . . . 2.95 110.334 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 67.27 108.56 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 123.912 0.758 . . . . 3.48 110.224 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.418 ' HA ' HG13 ' A' ' 6' ' ' VAL . 76.5 mmm -80.62 0.44 34.12 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.145 0.498 . . . . 2.68 110.688 -176.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -91.45 -23.82 19.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.857 -0.611 . . . . 1.7 111.006 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.536 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -109.44 7.77 25.05 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 120.526 -0.47 . . . . 1.89 111.399 -176.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 19' ' ' HIS . 8.8 p -108.47 128.9 63.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.32 -0.4 . . . . 1.89 110.991 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.452 HG11 ' CG ' ' A' ' 22' ' ' LYS . 4.7 m -81.77 -27.85 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.214 -0.448 . . . . 1.66 111.094 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -167.35 134.31 2.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 1.89 110.582 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.522 HG21 ' HD1' ' A' ' 19' ' ' HIS . 3.2 m -108.22 137.25 46.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.26 -0.882 . . . . 1.11 109.943 175.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.655 ' HH ' ' HE ' ' A' ' 61' ' ' ARG . 1.4 m-85 -110.61 127.29 55.18 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.348 -0.842 . . . . 1.56 111.133 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -100.09 119.25 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.711 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 9.4 mp -80.5 149.56 29.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.998 -1.001 . . . . 1.71 109.581 -175.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -65.55 -11.83 47.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.663 0.744 . . . . 2.16 110.595 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.46 -16.49 28.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.11 109.702 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 110.49 -22.19 22.63 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.803 -1.09 . . . . 1.28 112.223 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.555 ' HB2' HD22 ' A' ' 12' ' ' LEU . 19.6 m -67.71 161.92 24.9 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.071 -0.714 . . . . 1.33 109.071 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -133.81 146.53 50.76 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.43 0.529 . . . . 2.39 112.43 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 12' ' ' LEU . 68.9 t -123.58 148.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.264 -0.88 . . . . 1.13 109.073 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 26' ' ' MET . 6.0 m-70 -134.46 130.4 36.67 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.317 -0.553 . . . . 0.95 109.995 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -93.5 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.922 -1.51 . . . . 1.4 106.922 171.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 81.2 m-85 -89.35 155.9 19.05 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.018 0.437 . . . . 0.81 111.236 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 40.1 mtpt -68.19 -12.0 60.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.705 -0.68 . . . . 3.36 110.563 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -90.76 -4.33 56.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.613 -0.884 . . . . 1.97 108.613 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.57 -12.61 64.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 114.875 -1.057 . . . . 0.58 114.766 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 -177.03 5.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 117.892 0.846 . . . . 2.19 110.824 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.764 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -140.31 145.61 37.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.726 -0.67 . . . . 1.25 109.76 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.07 136.74 9.76 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.861 -0.896 . . . . 0.45 110.861 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.494 ' HG2' ' SD ' ' A' ' 36' ' ' MET . 28.4 ttt -118.51 140.9 49.16 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.392 0.615 . . . . 1.24 110.957 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 33.1 mt-10 -130.66 154.88 47.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.116 -0.947 . . . . 1.14 108.831 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 32' ' ' PHE . 32.0 p-10 -87.51 169.8 11.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.049 -0.352 . . . . 1.45 110.049 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 55.2 pttt -52.84 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.607 1.336 . . . . 2.25 114.607 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.512 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.7 m-85 -119.81 7.7 11.03 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.893 -0.504 . . . . 1.23 110.392 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.42 24.85 58.19 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.762 -0.732 . . . . 0.59 112.36 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 38.8 mmtm -114.02 136.98 52.32 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.693 0.758 . . . . 3.65 111.924 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 m -78.13 129.47 35.21 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.923 -1.49 . . . . 1.9 111.548 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.494 ' SD ' ' HG2' ' A' ' 28' ' ' MET . 1.3 ppp? -148.12 153.52 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.7 110.18 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -67.25 141.12 57.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 3.13 111.129 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.457 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 28.1 ttt -87.77 122.71 70.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.668 -0.696 . . . . 1.91 109.956 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.81 122.28 9.84 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.064 2.51 . . . . 1.43 112.446 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.6 tt0 -69.46 142.91 53.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.224 -0.444 . . . . 1.15 110.362 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.55 -11.1 73.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.516 -0.85 . . . . 0.8 112.862 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -99.75 123.32 43.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.922 0.391 . . . . 2.7 111.957 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.535 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.2 p -91.36 129.71 41.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.563 -0.744 . . . . 1.55 109.403 174.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.7 mtm -126.98 159.96 32.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 1.68 110.526 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -104.63 160.43 14.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.063 0.935 . . . . 1.64 112.429 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 50.6 p -113.95 165.25 12.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.006 -1.452 . . . . 1.31 109.732 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 15.4 ptt180 -65.35 -18.17 65.1 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.669 0.747 . . . . 4.27 110.966 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.99 -15.19 30.08 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.561 -1.2 . . . . 2.7 110.62 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.35 17.87 20.81 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.518 -0.848 . . . . 0.87 112.585 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -97.74 154.74 17.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.338 -0.616 . . . . 1.91 109.338 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -117.87 135.73 53.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.393 -0.595 . . . . 2.32 109.393 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.24 157.99 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.671 -0.695 . . . . 1.35 110.92 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.712 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -157.11 148.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 1.69 110.486 174.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.528 ' N ' HG12 ' A' ' 53' ' ' ILE . 26.8 ttt -100.19 118.29 36.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.415 -0.957 . . . . 2.09 108.415 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 52.4 tptt -140.61 130.77 24.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.918 -0.401 . . . . 2.17 109.918 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 38.79 94.88 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.979 -0.555 . . . . 1.21 113.061 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.62 9.52 7.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.496 0.665 . . . . 3.61 110.425 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.61 -177.64 3.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.881 -0.599 . . . . 1.66 110.455 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.764 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -134.49 122.16 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 121.347 0.594 . . . . 1.53 110.192 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.712 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.06 117.07 22.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.079 -1.082 . . . . 0.92 108.079 171.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.655 ' HE ' ' HH ' ' A' ' 10' ' ' TYR . 42.9 ttt180 -112.65 100.89 9.07 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.594 -1.632 . . . . 4.02 106.594 168.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER 36.97 15.11 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.477 1.111 . . . . 1.96 112.919 -163.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 61' ' ' ARG . 8.2 t70 63.66 -51.45 0.24 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.711 1.204 . . . . 2.14 113.353 -176.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 67' ' ' ARG . 36.4 mt-10 -69.77 -15.54 63.15 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.359 0.503 . . . . 3.8 112.359 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.0 -25.77 63.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.84 0.829 . . . . 1.84 109.636 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 59' ' ' ILE . 11.1 mt -87.35 -31.24 20.25 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.661 -1.154 . . . . 2.83 109.304 174.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.467 ' CB ' ' HA ' ' A' ' 64' ' ' GLU . 75.0 ttt180 -59.39 -66.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.92 -1.036 . . . . 5.07 111.264 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -132.23 16.06 4.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.165 0.507 . . . . 6.23 111.178 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.78 24.35 31.35 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.837 -0.696 . . . . 5.06 112.528 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -86.15 110.07 19.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.102 0.477 . . . . 7.25 109.906 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 m -114.56 -22.16 9.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.693 -0.685 . . . . 8.65 111.298 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 64.2 88.21 0.1 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.576 0.703 . . . . 10.75 109.408 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.11 -101.79 1.15 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.097 -0.801 . . . . 11.62 111.097 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.346 -1.252 . . . . 12.99 111.769 178.215 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.673 HG22 ' CD2' ' A' ' 19' ' ' HIS . 20.6 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.629 0.252 . . . . 2.95 110.361 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.64 135.08 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.516 -0.55 . . . . 3.48 109.516 172.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.9 mtp -112.13 15.8 20.4 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.6 0.715 . . . . 2.68 110.544 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.6 t -90.26 -22.3 21.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.542 -0.753 . . . . 1.7 109.929 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.489 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -104.44 14.92 29.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 1.89 112.091 -177.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.6 p -101.24 137.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.954 -0.298 . . . . 1.89 111.348 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 22' ' ' LYS . 27.5 m -83.6 -29.23 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.022 0.439 . . . . 1.66 110.064 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -168.48 130.6 1.37 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.602 0.715 . . . . 1.89 110.946 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.497 HG22 ' HD1' ' A' ' 19' ' ' HIS . 14.9 m -100.89 140.84 34.61 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.727 -1.124 . . . . 1.11 109.389 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.927 ' HH ' ' CD ' ' A' ' 61' ' ' ARG . 25.7 m-85 -121.4 134.14 55.1 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.967 0.889 . . . . 1.56 111.755 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.532 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 2.9 m-20 -96.47 120.96 37.73 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.613 -1.631 . . . . 1.94 108.853 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 16' ' ' SER . 23.4 mt -78.99 146.12 33.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.414 -1.328 . . . . 1.71 107.414 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.454 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 2.7 tt0 -66.17 -4.36 7.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.205 0.526 . . . . 2.16 111.925 -173.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -98.44 -17.81 18.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.495 -0.775 . . . . 2.11 110.326 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.558 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.07 -28.48 4.85 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.686 -0.688 . . . . 1.28 113.199 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.588 ' HB2' HD11 ' A' ' 12' ' ' LEU . 12.4 m -65.75 155.81 35.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.768 0.318 . . . . 1.33 110.77 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -124.0 129.81 51.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.908 0.385 . . . . 2.39 111.06 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.98 143.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.898 -0.779 . . . . 1.13 108.898 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.673 ' CD2' HG22 ' A' ' 1' ' ' VAL . 5.7 m-70 -130.56 129.91 43.39 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.214 -0.595 . . . . 0.95 110.494 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.51 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 28.3 t -96.43 114.81 34.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 106.537 -1.653 . . . . 1.4 106.537 168.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 92.9 m-85 -85.47 152.44 23.2 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.045 -0.525 . . . . 0.81 110.355 -172.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.585 ' HA ' HG13 ' A' ' 7' ' ' VAL . 87.7 mttt -62.08 -15.32 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.923 -0.58 . . . . 3.36 111.553 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.99 -6.99 53.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.83 -0.804 . . . . 1.97 108.83 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.88 -9.59 51.5 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.376 -0.916 . . . . 0.58 114.989 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -92.85 177.6 6.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 118.692 1.246 . . . . 2.19 110.648 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.768 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -137.77 146.23 43.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.151 -0.477 . . . . 1.25 110.483 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.51 146.06 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.074 -0.811 . . . . 0.45 111.074 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.2 ttt -120.5 142.36 49.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.088 0.471 . . . . 1.24 110.979 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.82 150.55 49.13 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.037 -1.098 . . . . 1.14 108.037 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 32' ' ' PHE . 30.7 p-10 -86.58 167.03 14.95 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.322 -0.551 . . . . 1.45 110.133 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 27.8 pttt -50.54 2.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.771 1.397 . . . . 2.25 114.771 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.2 m-85 -118.97 2.04 11.49 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.051 -0.406 . . . . 1.23 110.701 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.37 19.88 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.425 -0.893 . . . . 0.59 112.997 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -100.17 132.73 45.37 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.887 0.851 . . . . 3.65 110.899 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 p -79.05 133.78 36.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.732 -1.576 . . . . 1.9 111.93 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 ptm -147.41 -172.94 4.13 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.641 -0.709 . . . . 1.7 109.829 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.68 150.87 24.34 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.124 -0.324 . . . . 3.13 110.124 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.13 132.47 43.42 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 1.91 110.786 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.12 120.49 7.65 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.623 2.216 . . . . 1.43 112.843 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -80.66 128.3 33.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 1.15 110.132 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.98 -9.65 51.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.92 -0.657 . . . . 0.8 112.389 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -101.69 122.98 44.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.899 0.333 . . . . 2.7 111.899 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.482 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 12.7 p -94.25 128.4 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.706 -0.85 . . . . 1.55 108.706 171.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.5 mtm -124.6 160.29 28.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 1.68 110.651 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.5 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 20.5 mt-10 -93.13 145.22 24.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.786 0.803 . . . . 1.64 111.635 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -105.16 160.2 15.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.254 -1.339 . . . . 1.31 109.522 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HD2' ' HB3' ' A' ' 11' ' ' ASP . 98.8 mtt180 -64.45 -17.89 64.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.437 0.637 . . . . 4.27 109.59 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.89 -22.97 45.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.125 -0.943 . . . . 2.7 110.3 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.03 55.72 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.794 -0.717 . . . . 0.87 111.522 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -97.15 155.31 16.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.886 -0.783 . . . . 1.91 108.886 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 40.1 mmtm -112.88 136.95 51.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.943 -0.762 . . . . 2.32 108.943 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 39.0 pt -136.17 153.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 1.35 110.549 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.697 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -154.01 145.61 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.935 -0.575 . . . . 1.69 110.23 176.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.49 ' HE3' ' HA ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -94.35 122.04 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.106 -1.442 . . . . 2.09 107.106 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -144.0 121.96 12.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.843 -0.343 . . . . 2.17 110.924 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.37 45.04 93.31 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 1.21 112.863 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.518 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.9 OUTLIER 67.74 10.98 8.15 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.848 0.459 . . . . 3.61 111.481 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.47 -173.01 2.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.66 109.826 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.768 HD12 ' HG2' ' A' ' 26' ' ' MET . 2.5 tt -139.22 128.87 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 122.009 0.909 . . . . 1.53 110.062 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.697 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.19 121.44 27.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.091 -1.448 . . . . 0.92 107.091 170.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.927 ' CD ' ' HH ' ' A' ' 10' ' ' TYR . 33.1 ttp180 -109.29 96.1 6.07 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.319 -2.104 . . . . 4.02 105.319 164.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.436 HD22 ' HB1' ' A' ' 65' ' ' ALA . 0.1 OUTLIER 53.03 -13.16 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 O-C-N 125.011 1.444 . . . . 1.96 113.52 -171.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.633 ' H ' ' C ' ' A' ' 61' ' ' ARG . 12.5 t70 67.06 148.15 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.56 1.144 . . . . 2.14 110.872 -171.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 78.9 -45.83 0.38 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.512 1.125 . . . . 3.8 110.35 -174.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.436 ' HB1' HD22 ' A' ' 62' ' ' LEU . . . -50.13 -56.56 10.44 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.98 0.895 . . . . 1.84 112.609 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.631 HD11 ' H ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -95.0 -7.72 38.94 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.325 -1.307 . . . . 2.83 110.779 -174.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 14.2 ttt180 -102.3 -166.46 1.29 Allowed 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.008 -0.996 . . . . 5.07 108.608 -170.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.427 ' H ' ' HG2' ' A' ' 67' ' ' ARG . 21.1 ptmt -108.82 168.67 9.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.725 -0.472 . . . . 6.23 109.725 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.41 121.87 25.88 Favored Glycine 0 N--CA 1.45 -0.396 0 O-C-N 123.773 0.671 . . . . 5.06 112.377 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -69.21 127.82 34.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.89 -0.411 . . . . 7.25 109.89 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.2 m -58.88 123.18 15.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 8.65 111.381 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.77 -29.07 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 10.75 111.521 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.66 -74.3 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.4 -0.905 . . . . 11.62 111.911 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.996 0 CA-C-O 119.005 -0.886 . . . . 12.99 111.101 179.361 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 121.024 0.44 . . . . 2.95 110.571 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -86.12 149.98 24.75 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.552 -0.907 . . . . 3.48 108.552 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.4 mtp -102.12 7.35 41.05 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.22 0.452 . . . . 2.68 112.22 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 p -78.63 -26.29 45.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.399 0.619 . . . . 1.7 110.334 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.479 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -104.74 5.19 33.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 1.89 110.837 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.428 HG21 ' ND2' ' A' ' 5' ' ' ASN . 89.5 t -103.66 115.42 45.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.56 -0.745 . . . . 1.89 110.144 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 m -79.15 -23.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 1.66 111.267 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -167.99 137.77 2.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.176 0.512 . . . . 1.89 110.854 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.4 ' OG1' HG13 ' A' ' 6' ' ' VAL . 34.3 m -114.0 143.52 44.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.463 -0.79 . . . . 1.11 109.898 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.896 ' HH ' ' HD2' ' A' ' 61' ' ' ARG . 35.9 m-85 -121.26 133.74 55.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.877 0.846 . . . . 1.56 111.948 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 1.2 m-20 -100.44 124.46 45.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.742 -1.572 . . . . 1.94 109.73 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 16' ' ' SER . 7.6 mt -87.73 148.41 24.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.02 -0.733 . . . . 1.71 109.02 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.9 tt0 -62.74 -25.49 68.22 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.23 1.196 . . . . 2.16 114.23 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -98.99 -50.89 4.02 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.684 0.754 . . . . 2.11 110.205 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.547 ' CA ' ' HB3' ' A' ' 31' ' ' LYS . . . 166.44 67.86 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.664 -1.153 . . . . 1.28 112.267 -170.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.56 ' HB2' HD13 ' A' ' 12' ' ' LEU . 2.5 m -157.5 143.36 17.49 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.175 -1.046 . . . . 1.33 108.175 172.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -127.5 125.18 39.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.146 0.498 . . . . 2.39 109.906 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.19 148.1 13.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.84 -0.8 . . . . 1.13 108.84 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 26' ' ' MET . 7.3 m-70 -131.16 133.15 45.28 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.156 -0.618 . . . . 0.95 109.432 173.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.67 114.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.613 -1.625 . . . . 1.4 106.613 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -83.43 150.58 25.96 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.738 -0.665 . . . . 0.81 110.119 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 21.2 pttm -61.24 -20.3 62.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 3.36 110.574 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.65 -0.78 57.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.735 -0.839 . . . . 1.97 108.735 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.48 -8.15 62.02 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 114.727 -1.124 . . . . 0.58 115.05 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -85.3 177.24 7.9 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.731 1.265 . . . . 2.19 110.663 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.881 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.7 mpp? -137.69 141.19 41.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.25 109.86 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.27 128.18 7.97 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.735 -0.666 . . . . 0.45 111.51 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.25 124.15 49.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.76 0.314 . . . . 1.24 110.255 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 25.3 mt-10 -124.01 153.89 40.66 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.374 -0.602 . . . . 1.14 109.374 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 10.9 p30 -104.5 174.59 5.81 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.287 -0.565 . . . . 1.45 110.148 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HB3' ' CA ' ' A' ' 15' ' ' GLY . 14.0 pttm -49.63 -19.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.543 1.312 . . . . 2.25 114.543 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 92.2 m-85 -92.97 6.43 47.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.353 0.524 . . . . 1.23 110.586 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.67 26.91 59.94 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.706 -0.557 . . . . 0.59 111.706 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.471 ' HB2' HD22 ' A' ' 30' ' ' ASN . 35.8 mmtm -113.31 136.07 53.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 3.65 111.329 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t -83.52 129.74 34.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.121 -1.4 . . . . 1.9 110.428 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.13 179.84 6.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.323 -0.399 . . . . 1.7 110.919 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -80.24 143.14 33.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.058 0.456 . . . . 3.13 111.287 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.484 ' HE1' HD12 ' A' ' 59' ' ' ILE . 26.3 ttt -94.65 127.16 44.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.655 . . . . 1.91 110.529 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.06 138.72 20.88 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.714 2.276 . . . . 1.43 112.834 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 33.3 tt0 -94.11 147.99 22.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.958 -0.565 . . . . 1.15 110.616 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.47 68.02 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.034 -0.603 . . . . 0.8 112.622 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -107.57 129.57 54.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.827 0.346 . . . . 2.7 111.562 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.565 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 8.1 p -90.85 127.23 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.888 -0.782 . . . . 1.55 108.888 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 17.8 ptp -117.03 147.57 42.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.059 -0.519 . . . . 1.68 110.003 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.03 151.35 24.76 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.338 0.59 . . . . 1.64 110.741 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.5 p -100.75 162.86 12.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.218 -0.901 . . . . 1.31 110.103 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.482 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 48.9 mtt180 -57.86 -21.24 41.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.145 0.424 . . . . 4.27 112.145 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.07 -17.48 19.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 121.064 -0.254 . . . . 2.7 111.202 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.25 22.83 6.0 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.291 -0.957 . . . . 0.87 113.319 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -99.83 147.49 25.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 1.91 109.293 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -111.79 132.74 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.055 -0.35 . . . . 2.32 110.055 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.7 pt -136.63 160.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 1.35 110.83 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.64 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -162.45 151.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.044 -0.525 . . . . 1.69 109.891 175.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.538 ' N ' HG12 ' A' ' 53' ' ' ILE . 14.1 tmm? -104.63 121.48 43.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.057 -1.09 . . . . 2.09 108.057 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 49.6 tptt -134.85 116.58 14.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.288 -0.414 . . . . 2.17 110.216 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.93 44.19 98.16 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.815 -0.63 . . . . 1.21 112.752 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 72.59 -1.74 2.88 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.361 0.6 . . . . 3.61 111.42 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -105.72 147.99 27.93 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.519 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.881 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -100.32 124.32 53.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.727 0.775 . . . . 1.53 111.277 177.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.02 118.36 23.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.702 -1.222 . . . . 0.92 107.702 168.211 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.896 ' HD2' ' HH ' ' A' ' 10' ' ' TYR . 47.0 ttp180 -113.68 100.56 8.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.344 -1.354 . . . . 4.02 107.344 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 1.1 pp 37.81 14.21 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 O-C-N 125.164 1.54 . . . . 1.96 113.654 -167.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.506 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 25.8 t70 36.31 76.56 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.156 0.982 . . . . 2.14 111.973 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.574 ' HB3' HD13 ' A' ' 62' ' ' LEU . 35.9 tt0 177.77 -41.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.866 -1.061 . . . . 3.8 108.701 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.55 -5.97 13.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.196 -0.911 . . . . 1.84 110.915 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.6 mt -117.04 -14.02 10.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.683 -1.144 . . . . 2.83 110.214 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.449 ' HA ' ' HD2' ' A' ' 67' ' ' ARG . 22.8 tpt180 -74.98 -51.68 13.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.874 -0.603 . . . . 5.07 111.392 -170.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -95.63 11.56 32.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.227 0.537 . . . . 6.23 110.438 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.65 -153.31 43.97 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.033 -0.827 . . . . 5.06 111.033 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -158.85 102.04 1.65 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.409 -0.589 . . . . 7.25 109.409 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.0 m -133.71 106.12 7.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.267 -0.424 . . . . 8.65 110.553 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -71.96 -38.96 69.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.044 -0.525 . . . . 10.75 110.796 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.99 73.39 0.46 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.653 -0.784 . . . . 11.62 112.285 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.654 -1.081 . . . . 12.99 112.003 -179.85 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 3' ' ' MET . 29.8 m . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.925 -0.398 . . . . 2.95 109.925 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.62 -12.06 35.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.21 1.005 . . . . 3.48 110.241 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.512 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 42.7 mtp 61.2 4.85 0.95 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.583 -1.644 . . . . 2.68 113.57 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 m -83.82 -27.31 28.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.238 0.542 . . . . 1.7 110.696 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.527 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -103.72 6.0 36.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.734 0.778 . . . . 1.89 110.019 175.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 3' ' ' MET . 72.0 t -102.74 116.59 46.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.97 -1.013 . . . . 1.89 109.806 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.83 -20.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.689 -0.405 . . . . 1.66 111.403 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -168.18 128.35 1.29 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.411 0.624 . . . . 1.89 110.987 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 m -101.64 138.45 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.987 -1.006 . . . . 1.11 109.611 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.864 ' HH ' ' HD3' ' A' ' 61' ' ' ARG . 18.6 m-85 -113.64 128.45 56.44 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.736 0.779 . . . . 1.56 111.379 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.52 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 3.0 m-20 -95.14 115.04 26.91 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.02 -1.445 . . . . 1.94 108.296 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.577 HD13 ' HB2' ' A' ' 16' ' ' SER . 10.4 mt -80.57 149.43 29.93 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.009 -0.737 . . . . 1.71 109.009 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -67.79 -7.71 29.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.1 0.476 . . . . 2.16 112.019 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.0 -20.98 19.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.422 0.63 . . . . 2.11 109.895 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 122.07 -14.32 8.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.188 -0.914 . . . . 1.28 112.534 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.577 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -66.3 153.19 43.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.539 0.209 . . . . 1.33 110.758 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 30.2 mttp -113.56 143.49 44.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.144 0.497 . . . . 2.39 110.813 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 93.4 t -126.36 149.47 31.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.808 -1.182 . . . . 1.13 107.808 171.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.536 ' O ' ' HA ' ' A' ' 26' ' ' MET . 6.5 m-70 -139.0 128.89 24.97 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.291 -0.633 . . . . 0.95 109.291 175.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.11 116.77 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.423 -1.695 . . . . 1.4 106.423 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -85.92 153.12 22.42 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.797 -0.638 . . . . 0.81 110.628 -173.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 53.6 pttt -59.53 -16.51 25.29 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 3.36 111.539 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.31 -15.41 46.69 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.038 -0.727 . . . . 1.97 109.038 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.24 -2.35 54.48 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.107 -1.044 . . . . 0.58 113.876 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -94.46 -175.37 3.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.821 0.811 . . . . 2.19 110.776 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 1.013 ' HG2' HD11 ' A' ' 59' ' ' ILE . 2.1 mpp? -144.42 149.29 35.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.721 -0.672 . . . . 1.25 110.438 -175.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.95 139.49 11.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.285 -0.726 . . . . 0.45 111.285 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.555 ' SD ' ' HG3' ' A' ' 36' ' ' MET . 1.6 tmt? -117.77 137.51 52.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.163 0.506 . . . . 1.24 111.001 -175.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 30.2 mt-10 -124.6 149.78 46.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.47 -0.786 . . . . 1.14 109.034 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.614 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.8 p-10 -85.91 166.16 16.19 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.44 -0.578 . . . . 1.45 109.44 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 38.0 pttt -56.92 5.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.217 1.192 . . . . 2.25 114.217 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 30' ' ' ASN . 45.3 m-85 -113.66 5.82 16.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.064 0.459 . . . . 1.23 109.778 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.77 25.1 60.98 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.972 -0.558 . . . . 0.59 114.264 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.614 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.3 145.96 43.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.16 0.505 . . . . 3.65 110.218 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -80.28 142.16 34.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.489 -0.778 . . . . 1.9 111.588 -171.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.555 ' HG3' ' SD ' ' A' ' 28' ' ' MET . 9.6 ptm -153.53 -179.52 7.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.746 -0.661 . . . . 1.7 109.856 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -100.42 151.08 21.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 3.13 110.751 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 ttm -101.42 126.63 33.85 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.2 -0.455 . . . . 1.91 110.714 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.51 142.34 23.34 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.723 2.282 . . . . 1.43 112.181 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.545 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.7 tt0 -79.81 154.35 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.493 -0.321 . . . . 1.15 110.646 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.27 -19.56 54.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.8 113.337 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' N ' HD11 ' A' ' 53' ' ' ILE . 48.6 mtpt -98.5 126.65 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.244 0.522 . . . . 2.7 111.582 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.89 124.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.655 -0.498 . . . . 1.55 109.655 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.81 149.97 28.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.1 -0.5 . . . . 1.68 110.205 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 50' ' ' THR . 32.8 mt-10 -109.77 157.99 18.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.001 0.905 . . . . 1.64 112.01 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 72.2 p -105.29 165.34 11.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.03 -1.441 . . . . 1.31 110.319 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.52 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 58.6 mtp180 -51.25 -27.83 10.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.82 -0.627 . . . . 4.27 111.803 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -92.62 -21.8 19.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.385 -0.825 . . . . 2.7 111.2 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.36 27.25 5.1 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.145 -1.026 . . . . 0.87 112.339 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 26.5 m -100.73 145.27 28.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.396 -0.594 . . . . 1.91 109.396 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -109.21 131.4 55.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.064 -0.347 . . . . 2.32 110.064 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.02 159.17 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.929 0.395 . . . . 1.35 111.383 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.478 HG23 ' HB3' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -159.35 143.34 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.824 -0.625 . . . . 1.69 110.438 175.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.426 ' H ' HD12 ' A' ' 53' ' ' ILE . 1.5 tmt? -97.28 106.01 18.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.689 -1.226 . . . . 2.09 107.689 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 74.8 tttt -138.36 136.33 36.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.975 -0.557 . . . . 2.17 110.489 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.36 33.5 82.32 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.787 -0.642 . . . . 1.21 112.733 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.482 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.9 OUTLIER 66.81 19.76 10.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.587 0.708 . . . . 3.61 110.991 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.34 -165.61 1.71 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.289 -0.869 . . . . 1.66 109.403 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 1.013 HD11 ' HG2' ' A' ' 26' ' ' MET . 0.5 OUTLIER -135.82 131.3 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.184 0.992 . . . . 1.53 110.994 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.778 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -82.75 111.75 18.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.863 -1.532 . . . . 0.92 106.863 168.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.864 ' HD3' ' HH ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -119.27 107.51 13.49 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.128 -1.804 . . . . 4.02 106.128 173.106 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.606 ' HB2' ' HB1' ' A' ' 65' ' ' ALA . 4.3 mm? 62.23 -35.22 0.12 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.925 0.765 . . . . 1.96 111.881 -165.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.778 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 16.9 t70 83.75 -39.66 0.08 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.349 1.459 . . . . 2.14 110.101 -171.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.589 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 26.1 tt0 -95.84 -8.38 34.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.735 -0.666 . . . . 3.8 111.087 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 62' ' ' LEU . . . -62.89 -41.09 99.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.449 0.642 . . . . 1.84 109.64 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -85.33 -24.55 27.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.841 -1.072 . . . . 2.83 110.317 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.566 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 54.8 ttt180 -67.21 -61.52 1.88 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.218 -0.901 . . . . 5.07 110.991 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.589 ' HG3' ' HG2' ' A' ' 64' ' ' GLU . 26.8 mtmm -84.24 161.31 20.56 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.824 -0.435 . . . . 6.23 109.824 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.97 12.76 15.1 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.93 -0.868 . . . . 5.06 110.93 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -171.43 -46.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.37 -0.415 . . . . 7.25 110.001 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -102.57 77.57 1.63 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.46 0.648 . . . . 8.65 109.946 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.03 -39.24 23.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.774 . . . . 10.75 110.116 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.13 175.54 22.65 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.255 -0.884 . . . . 11.62 111.337 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 118.783 -1.01 . . . . 12.99 111.963 -178.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.442 ' HB ' ' OE1' ' A' ' 29' ' ' GLU . 4.4 p . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.711 -0.477 . . . . 2.95 109.711 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.43 134.16 37.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.698 -0.482 . . . . 3.48 109.698 173.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.7 mmm -101.87 8.43 41.24 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.638 0.607 . . . . 2.68 112.638 -172.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.6 p -94.4 -27.01 16.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.298 -0.561 . . . . 1.7 110.639 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.464 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -101.95 13.69 34.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.436 -0.347 . . . . 1.89 111.901 -177.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 13.3 p -111.68 130.03 66.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 120.162 -0.615 . . . . 1.89 111.936 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -96.19 -22.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.038 -0.528 . . . . 1.66 111.399 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -160.29 138.52 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 1.89 111.156 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' HD1' ' A' ' 19' ' ' HIS . 5.3 m -123.4 141.34 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.407 -0.815 . . . . 1.11 110.276 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.609 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 33.7 m-85 -121.51 134.51 55.05 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-O 121.679 0.752 . . . . 1.56 111.837 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 46' ' ' THR . 11.6 t70 -101.38 126.63 48.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.878 -1.51 . . . . 1.94 109.092 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.603 HD22 ' HB2' ' A' ' 16' ' ' SER . 10.5 mp -78.47 -2.2 37.42 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.415 -1.266 . . . . 1.71 112.947 -171.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.548 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.4 tt0 86.88 -31.26 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.138 0.575 . . . . 2.16 110.48 172.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.74 -9.58 28.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.338 0.59 . . . . 2.11 109.428 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 31' ' ' LYS . . . 138.23 -36.82 1.87 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.056 -1.068 . . . . 1.28 114.434 172.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.603 ' HB2' HD22 ' A' ' 12' ' ' LEU . 11.3 m -71.59 160.0 33.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.615 -0.513 . . . . 1.33 109.615 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -133.36 143.52 49.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.289 0.566 . . . . 2.39 111.732 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.525 HG21 HD11 ' A' ' 12' ' ' LEU . 36.1 t -118.22 142.67 31.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.64 -0.709 . . . . 1.13 109.251 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.436 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 10.0 m-70 -128.82 133.02 47.86 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 120.225 -0.59 . . . . 0.95 111.074 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.84 111.65 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 106.566 -1.642 . . . . 1.4 106.566 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' HE2' ' N ' ' A' ' 27' ' ' GLY . 87.7 m-85 -83.77 156.18 22.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.929 -0.578 . . . . 0.81 110.807 -171.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -60.61 -20.46 60.69 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.122 -0.945 . . . . 3.36 111.798 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.95 7.39 46.75 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.496 0.665 . . . . 1.97 109.297 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.17 -7.59 80.55 Favored Glycine 0 N--CA 1.427 -1.91 0 CA-C-N 114.868 -1.06 . . . . 0.58 114.517 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -86.53 175.51 8.3 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 117.86 0.83 . . . . 2.19 110.651 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.834 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.2 mpp? -135.88 148.7 48.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.967 0.413 . . . . 1.25 110.193 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.518 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -143.47 148.84 20.74 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.636 -0.711 . . . . 0.45 111.403 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ttt -117.62 144.51 45.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.857 0.361 . . . . 1.24 110.637 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.442 ' OE1' ' HB ' ' A' ' 1' ' ' VAL . 28.8 mt-10 -123.01 146.64 47.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.304 -0.998 . . . . 1.14 108.304 171.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.698 ' ND2' ' HG3' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -89.63 164.72 14.62 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.619 -0.882 . . . . 1.45 108.619 176.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.4 ' CB ' ' HA3' ' A' ' 15' ' ' GLY . 9.7 ptpp? -51.03 -11.21 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.951 1.093 . . . . 2.25 113.951 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -96.65 9.19 42.32 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.107 -0.371 . . . . 1.23 110.81 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.65 26.23 65.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.167 -0.54 . . . . 0.59 113.67 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.698 ' HG3' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.23 147.44 42.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.067 -0.653 . . . . 3.65 110.273 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 p -83.64 139.1 33.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.332 -0.849 . . . . 1.9 112.159 -172.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.0 ptm -148.78 175.26 11.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 1.7 109.577 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -95.11 151.82 18.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.913 0.387 . . . . 3.13 110.132 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.408 ' HE2' ' HE1' ' A' ' 44' ' ' MET . 28.2 ttt -91.03 128.91 45.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.993 -0.549 . . . . 1.91 110.768 -174.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.3 114.72 3.16 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.45 2.1 . . . . 1.43 112.066 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 54' ' ' MET . 42.3 tt0 -74.51 133.3 42.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.652 -0.704 . . . . 1.15 110.696 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.495 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 117.12 -8.96 15.77 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.8 113.773 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.55 142.05 48.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 117.63 0.715 . . . . 2.7 112.304 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.592 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -99.43 135.64 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.332 -0.849 . . . . 1.55 108.885 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.408 ' HE1' ' HE2' ' A' ' 38' ' ' MET . 70.2 mtm -127.4 159.26 35.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.249 -0.432 . . . . 1.68 109.872 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -99.66 163.63 12.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.741 0.781 . . . . 1.64 111.995 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 45.7 p -119.68 162.69 18.59 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.28 -1.327 . . . . 1.31 110.79 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.548 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 6.8 mtt180 -55.63 -27.38 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.757 0.651 . . . . 4.27 112.757 177.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -95.76 -2.52 47.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.503 -0.479 . . . . 2.7 111.969 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.31 20.7 19.47 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.853 -1.165 . . . . 0.87 114.053 170.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -112.63 167.22 10.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.717 0.758 . . . . 1.91 109.514 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -122.66 143.8 49.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.79 -0.448 . . . . 2.32 109.79 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 pt -139.55 154.22 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.346 -0.388 . . . . 1.35 111.247 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.686 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -155.02 149.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.957 0.408 . . . . 1.69 110.596 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.513 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 27.5 ttt -108.39 113.17 26.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.777 -1.194 . . . . 2.09 107.777 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 22.4 tptm -144.35 138.91 28.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.177 -0.675 . . . . 2.17 109.177 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.29 31.01 76.1 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 1.21 111.742 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 62.12 23.42 13.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.171 0.51 . . . . 3.61 111.339 -178.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 54' ' ' MET . 36.7 mt-10 -132.07 160.02 37.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.519 -0.764 . . . . 1.66 110.19 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.834 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.49 124.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.523 0.678 . . . . 1.53 110.906 177.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -82.46 109.76 16.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.508 -1.664 . . . . 0.92 106.508 166.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.609 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 2.0 tmm_? -121.49 105.51 10.55 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.817 -1.549 . . . . 4.02 106.817 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.551 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 3.9 mm? 57.82 -47.99 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.222 0.951 . . . . 1.96 112.898 -164.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 11.9 t70 80.78 -26.71 0.15 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 124.939 1.295 . . . . 2.14 109.581 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.2 tm-20 -84.79 -38.63 19.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.055 -0.975 . . . . 3.8 109.935 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.53 -35.61 78.24 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.581 0.705 . . . . 1.84 110.64 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.6 mt -89.96 -1.55 57.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.622 -1.172 . . . . 2.83 110.527 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -77.5 -66.93 0.77 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.606 -0.725 . . . . 5.07 110.83 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -108.75 160.51 15.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.803 -0.635 . . . . 6.23 110.947 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.55 -16.82 9.66 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.073 -0.584 . . . . 5.06 111.671 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -158.74 130.13 6.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.063 -0.347 . . . . 7.25 110.063 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.2 m -71.47 -42.7 67.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.383 0.611 . . . . 8.65 109.523 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.82 -60.93 0.81 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.865 -1.061 . . . . 10.75 109.273 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 160.9 114.59 0.35 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.2 -0.76 . . . . 11.62 111.2 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.364 -1.242 . . . . 12.99 111.455 -179.105 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.432 -0.581 . . . . 2.95 109.432 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.85 124.2 25.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 3.48 110.639 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.451 ' HA ' HG13 ' A' ' 6' ' ' VAL . 20.7 mmt -87.62 9.04 22.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.286 -0.416 . . . . 2.68 111.291 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 m -86.37 -26.93 24.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.281 0.563 . . . . 1.7 110.793 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.477 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -114.42 12.39 17.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.715 -0.675 . . . . 1.89 111.511 -173.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 8.2 p -109.9 134.65 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.195 -0.457 . . . . 1.89 111.393 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.423 HG11 ' HA ' ' A' ' 22' ' ' LYS . 22.4 m -86.84 -26.45 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.3 -0.409 . . . . 1.66 111.164 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -168.5 132.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.42 . . . . 1.89 110.566 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.456 HG22 ' HD1' ' A' ' 19' ' ' HIS . 3.2 m -110.41 143.47 40.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.61 -0.723 . . . . 1.11 109.98 176.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -117.98 133.2 56.14 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.766 0.793 . . . . 1.56 111.353 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.29 119.49 37.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.088 -1.414 . . . . 1.94 109.203 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 16' ' ' SER . 7.3 mt -83.1 138.99 33.47 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.686 -0.688 . . . . 1.71 109.378 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -61.99 -19.2 62.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.41 0.893 . . . . 2.16 113.41 -166.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -44.0 5.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 2.11 110.41 -175.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.656 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 159.77 78.86 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 119.621 -1.276 . . . . 1.28 113.144 -172.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.593 ' HB3' HD11 ' A' ' 12' ' ' LEU . 48.3 t -176.59 153.49 1.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.199 -0.667 . . . . 1.33 109.199 175.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -128.3 125.71 39.35 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.193 -0.458 . . . . 2.39 110.61 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.82 148.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.788 . . . . 1.13 108.871 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' MET . 0.8 OUTLIER -138.83 131.99 29.83 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.858 -0.526 . . . . 0.95 109.992 177.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.96 118.49 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.085 -1.45 . . . . 1.4 107.085 170.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 78.3 m-85 -86.58 155.35 20.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.132 0.492 . . . . 0.81 111.46 -171.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HA ' HG11 ' A' ' 7' ' ' VAL . 28.9 mtpp -64.24 -22.08 66.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.335 -0.848 . . . . 3.36 111.526 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.02 -1.87 57.75 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.031 -1.1 . . . . 1.97 108.031 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.8 -8.1 50.23 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.81 -1.087 . . . . 0.58 114.555 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.94 174.02 5.78 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 118.627 1.213 . . . . 2.19 112.747 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.575 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -138.13 131.43 30.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.266 -1.334 . . . . 1.25 109.168 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.23 144.15 15.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.885 -0.674 . . . . 0.45 112.088 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.3 ttt -123.76 139.87 53.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.816 0.308 . . . . 1.24 110.996 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 19.6 mm-40 -113.15 158.21 20.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.727 -0.842 . . . . 1.14 108.727 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 32' ' ' PHE . 38.6 p30 -88.14 164.78 15.53 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.613 -0.514 . . . . 1.45 109.613 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.656 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 ptpt -51.63 -2.86 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.978 1.103 . . . . 2.25 113.978 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 30' ' ' ASN . 65.8 m-85 -106.73 0.21 24.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.647 -0.501 . . . . 1.23 109.647 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.33 37.11 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.738 -0.744 . . . . 0.59 112.864 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 14.6 mmmm -112.15 145.57 39.59 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.339 0.59 . . . . 3.65 111.639 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.4 m -86.75 123.71 32.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.487 -1.233 . . . . 1.9 110.753 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -138.52 178.31 7.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.863 -0.608 . . . . 1.7 110.421 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -91.3 141.38 28.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.874 0.369 . . . . 3.13 110.623 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ttt -86.88 126.44 63.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 1.91 110.815 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.37 124.91 9.76 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.752 2.301 . . . . 1.43 112.864 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 47.3 tt0 -79.33 134.71 36.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 1.15 111.365 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.3 24.36 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.788 -0.72 . . . . 0.8 113.647 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' HG13 ' A' ' 53' ' ' ILE . 48.7 mtpt -105.07 126.9 52.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 117.075 0.438 . . . . 2.7 111.941 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.598 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.7 p -91.1 122.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.014 -0.735 . . . . 1.55 109.014 171.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.0 mtm -119.11 155.69 31.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.389 -0.823 . . . . 1.68 109.548 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -107.33 156.55 18.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.245 1.021 . . . . 1.64 112.515 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.7 p -109.48 159.78 16.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.446 -1.706 . . . . 1.31 110.28 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 47' ' ' ARG . 57.7 mtt-85 -59.34 -24.0 62.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.588 0.588 . . . . 4.27 112.588 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -96.07 -2.44 46.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.178 0.513 . . . . 2.7 110.64 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.68 15.12 32.61 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.761 -0.733 . . . . 0.87 113.068 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.8 m -93.9 146.11 24.14 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 110.201 -0.296 . . . . 1.91 110.201 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -107.73 134.07 51.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.691 -0.485 . . . . 2.32 109.691 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.511 HD11 HD23 ' A' ' 12' ' ' LEU . 33.0 pt -138.17 156.83 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 1.35 111.462 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.769 HG23 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -158.41 154.03 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.811 -0.631 . . . . 1.69 109.678 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.583 ' N ' HG12 ' A' ' 53' ' ' ILE . 28.0 ttt -107.73 119.53 39.7 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.658 -1.238 . . . . 2.09 107.658 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 1.9 mmmt -138.57 134.85 34.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.083 -0.34 . . . . 2.17 110.083 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.22 30.35 75.65 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.836 -0.697 . . . . 1.21 111.821 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' HA ' ' HE2' ' A' ' 54' ' ' MET . 0.9 OUTLIER 62.44 25.78 15.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.37 0.605 . . . . 3.61 111.542 -176.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 54' ' ' MET . 41.8 mt-10 -123.59 151.41 42.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.384 -0.825 . . . . 1.66 110.251 175.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.575 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.19 121.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.774 0.797 . . . . 1.53 111.353 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.769 ' CD1' HG23 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -83.91 111.9 19.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.893 -1.049 . . . . 0.92 108.277 168.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.652 ' C ' ' H ' ' A' ' 63' ' ' ASP . 2.8 tmm_? -122.14 108.86 13.82 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.613 -1.625 . . . . 4.02 106.613 171.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.576 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 3.8 mm? 59.64 -35.53 0.07 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 124.268 0.98 . . . . 1.96 112.749 -166.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.652 ' H ' ' C ' ' A' ' 61' ' ' ARG . 2.6 t70 79.33 -48.33 0.39 Allowed 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.738 1.215 . . . . 2.14 109.54 -167.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 40.1 mt-10 -68.61 -27.07 65.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.326 -0.852 . . . . 3.8 110.891 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 62' ' ' LEU . . . -65.18 -47.41 77.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 1.84 110.885 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -74.63 -31.27 61.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.426 0.631 . . . . 2.83 109.857 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.549 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 41.8 ttt180 -54.12 -62.03 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.906 -1.043 . . . . 5.07 111.644 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -152.85 5.03 0.36 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.916 0.339 . . . . 6.23 111.916 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.12 56.25 2.13 Favored Glycine 0 C--N 1.316 -0.573 0 C-N-CA 120.894 -0.669 . . . . 5.06 112.556 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -86.86 70.89 10.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.897 0.379 . . . . 7.25 110.468 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.5 t -164.83 102.93 0.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.961 -0.563 . . . . 8.65 109.822 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -126.54 150.28 48.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.176 -0.466 . . . . 10.75 109.871 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.91 104.25 2.31 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.846 -0.692 . . . . 11.62 112.246 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 CA-C-O 118.693 -1.06 . . . . 12.99 111.502 177.108 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 111.538 0.199 . . . . 2.95 111.538 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 65.09 121.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.44 0.638 . . . . 3.48 110.656 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.425 ' HE1' HG12 ' A' ' 6' ' ' VAL . 64.8 mmm -91.81 17.15 9.47 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.752 -0.593 . . . . 2.68 112.411 -171.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -101.49 -25.71 13.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 1.7 110.985 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.533 ' ND2' ' HD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -99.94 13.54 33.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.006 0.431 . . . . 1.89 111.177 -177.275 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.466 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 12.9 p -102.35 129.3 54.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 1.89 110.257 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.32 -21.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.642 -0.423 . . . . 1.66 111.46 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -166.64 142.84 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.437 0.637 . . . . 1.89 111.211 176.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.404 HG23 ' HD1' ' A' ' 19' ' ' HIS . 9.5 m -121.02 144.73 48.37 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.961 -1.018 . . . . 1.11 109.823 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.487 ' CD1' HG23 ' A' ' 46' ' ' THR . 29.9 m-85 -123.03 133.14 54.35 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.855 0.836 . . . . 1.56 111.953 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.575 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 9.8 m-20 -97.94 121.83 40.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.928 -1.487 . . . . 1.94 108.911 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.888 ' HG ' ' HB2' ' A' ' 16' ' ' SER . 0.6 OUTLIER -67.48 -10.11 48.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.497 -1.229 . . . . 1.71 112.458 -173.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 35.9 tt0 94.03 -22.65 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.4 1.062 . . . . 2.16 109.253 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -96.25 -34.9 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.688 -0.687 . . . . 2.11 109.473 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.643 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 155.19 -30.91 0.65 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.478 -0.868 . . . . 1.28 112.926 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.888 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.7 OUTLIER -57.79 141.37 49.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 1.33 110.29 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 127.44 50.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.236 -0.438 . . . . 2.39 111.071 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 12' ' ' LEU . 75.0 t -107.19 138.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.212 -0.662 . . . . 1.13 109.212 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.466 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 4.3 m-70 -127.01 132.82 50.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 109.641 -0.503 . . . . 0.95 109.641 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 59' ' ' ILE . 69.4 t -102.12 122.4 54.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 106.947 -1.501 . . . . 1.4 106.947 170.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HD2' ' ND2' ' A' ' 5' ' ' ASN . 94.2 m-85 -92.11 155.26 18.18 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.559 -0.746 . . . . 0.81 110.757 -169.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.75 -8.61 29.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.303 -0.862 . . . . 3.36 111.755 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -92.48 0.96 57.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.17 -13.81 64.34 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.807 -1.088 . . . . 0.58 113.878 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.87 -174.52 4.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.603 0.702 . . . . 2.19 109.448 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.539 ' HG3' HG12 ' A' ' 59' ' ' ILE . 1.6 pmm? -152.83 154.2 34.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.901 0.381 . . . . 1.25 110.15 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.6 153.49 24.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.5 -0.64 . . . . 0.45 111.5 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 ttt -125.75 139.8 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.27 0.557 . . . . 1.24 111.539 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.41 155.67 36.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 1.14 109.441 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.456 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 65.2 t30 -94.12 159.73 15.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.285 -0.635 . . . . 1.45 109.285 175.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.643 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.8 ptmt -48.73 -23.73 1.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.076 1.139 . . . . 2.25 114.076 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.456 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 36.2 m-85 -90.45 -2.63 57.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.472 . . . . 1.23 110.152 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.13 26.36 16.45 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.59 112.01 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -100.7 135.82 41.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.724 0.773 . . . . 3.65 111.855 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 p -79.33 110.69 14.86 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.948 -1.478 . . . . 1.9 110.243 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -127.25 177.07 6.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.321 -0.4 . . . . 1.7 111.128 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -88.4 132.9 34.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.234 0.54 . . . . 3.13 111.755 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.416 ' HE2' HD13 ' A' ' 59' ' ' ILE . 27.1 ttt -91.83 125.55 56.83 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.743 -0.662 . . . . 1.91 109.948 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.87 124.08 7.22 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.605 2.204 . . . . 1.43 113.037 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.624 ' HG2' ' HD2' ' A' ' 55' ' ' LYS . 38.2 tt0 -82.11 133.98 35.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 1.15 110.34 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 102.88 -12.4 56.2 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.783 -0.723 . . . . 0.8 111.901 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 29.5 mmmt -96.53 123.9 40.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.626 0.25 . . . . 2.7 111.41 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.603 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -90.7 127.56 43.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.885 -0.783 . . . . 1.55 108.885 172.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.4 mtm -126.16 156.95 39.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.069 -0.514 . . . . 1.68 109.901 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.511 ' HG2' ' HG3' ' A' ' 51' ' ' LYS . 38.9 mt-10 -108.58 169.4 8.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.982 0.896 . . . . 1.64 112.281 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.487 HG23 ' CD1' ' A' ' 10' ' ' TYR . 42.7 p -120.33 168.31 11.41 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.862 -1.517 . . . . 1.31 110.73 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.575 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 11.2 ptt180 -59.49 -21.83 60.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.473 0.654 . . . . 4.27 111.086 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -97.81 -5.86 33.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.94 -1.027 . . . . 2.7 110.921 -170.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.56 11.26 58.35 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.52 -0.848 . . . . 0.87 112.999 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.607 HG21 HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -90.05 148.18 23.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.426 -0.583 . . . . 1.91 109.426 177.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 1.9 mptp? -111.87 130.55 55.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.157 -0.683 . . . . 2.32 109.157 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.46 157.64 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.238 -0.437 . . . . 1.35 110.826 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.603 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -158.81 150.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 1.69 110.266 177.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.52 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 60.2 ttp -105.72 123.79 48.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.581 -1.266 . . . . 2.09 107.581 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.624 ' HD2' ' HG2' ' A' ' 40' ' ' GLU . 21.6 tptp -144.5 133.63 22.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.88 -0.415 . . . . 2.17 109.88 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.56 30.58 78.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.117 -0.563 . . . . 1.21 111.768 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.27 24.77 14.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.445 0.64 . . . . 3.61 111.009 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.25 152.22 36.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.198 -0.91 . . . . 1.66 109.581 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.539 HG12 ' HG3' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.38 120.21 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.054 0.931 . . . . 1.53 110.879 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.511 ' HE1' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -84.03 119.18 24.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.188 -1.369 . . . . 0.92 107.435 166.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.654 ' C ' ' H ' ' A' ' 63' ' ' ASP . 12.0 ttm180 -111.28 100.18 8.85 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.54 -2.022 . . . . 4.02 105.54 166.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.607 HD22 HG21 ' A' ' 50' ' ' THR . 29.7 mt 57.67 -17.92 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 O-C-N 124.327 1.017 . . . . 1.96 113.076 -171.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.654 ' H ' ' C ' ' A' ' 61' ' ' ARG . 0.4 OUTLIER 76.07 -25.38 0.2 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.151 0.98 . . . . 2.14 110.092 -170.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 62' ' ' LEU . 11.7 tp10 -100.94 -14.24 17.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.294 -0.866 . . . . 3.8 110.914 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.52 -33.37 75.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.468 0.651 . . . . 1.84 110.561 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -83.55 14.5 3.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 2.83 111.149 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -101.94 -165.01 1.15 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.391 0.615 . . . . 5.07 109.848 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -111.79 108.47 17.89 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.315 -0.857 . . . . 6.23 109.861 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.08 78.9 0.98 Allowed Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.523 -0.762 . . . . 5.06 111.385 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.467 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 17.6 m-70 -64.75 137.98 58.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.814 0.34 . . . . 7.25 111.676 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -92.96 -31.9 14.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.174 -0.466 . . . . 8.65 110.776 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.467 ' OE1' ' HB3' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -86.08 -36.65 19.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.999 -0.546 . . . . 10.75 110.342 -175.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.59 -57.19 0.73 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.865 -0.607 . . . . 11.62 111.702 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.491 -1.171 . . . . 12.99 111.701 179.696 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.496 HG11 ' CZ ' ' A' ' 21' ' ' PHE . 72.2 t . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.418 -0.216 . . . . 2.95 110.418 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -88.55 141.19 28.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.898 0.38 . . . . 3.48 110.717 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.508 ' HA ' ' HE1' ' A' ' 3' ' ' MET . 25.8 mmt -90.13 -16.85 28.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.764 -0.653 . . . . 2.68 111.033 -176.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -82.29 -32.41 29.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.418 0.628 . . . . 1.7 110.245 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.498 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 4.3 t30 -94.74 -1.29 53.25 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.333 -0.849 . . . . 1.89 111.065 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 19' ' ' HIS . 8.6 p -107.39 131.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 119.102 -1.039 . . . . 1.89 111.643 -175.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.65 -25.59 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.961 -0.563 . . . . 1.66 112.398 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -167.38 136.08 2.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.81 0.814 . . . . 1.89 112.036 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 m -108.54 142.09 39.48 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.198 -1.365 . . . . 1.11 109.819 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -122.85 136.69 54.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.852 0.834 . . . . 1.56 112.122 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.98 120.36 34.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.81 -1.541 . . . . 1.94 109.114 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.594 HD13 ' HB2' ' A' ' 16' ' ' SER . 15.1 mt -80.4 145.88 31.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.531 -1.285 . . . . 1.71 107.531 173.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.546 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 7.9 tt0 -62.8 -13.98 39.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.22 0.452 . . . . 2.16 112.22 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.68 -20.99 21.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.093 0.473 . . . . 2.11 110.151 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.556 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.65 -20.44 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.854 -0.689 . . . . 1.28 113.325 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.594 ' HB2' HD13 ' A' ' 12' ' ' LEU . 15.8 m -63.34 152.28 38.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.93 0.395 . . . . 1.33 110.466 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 28' ' ' MET . 59.0 mttp -122.98 127.9 49.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.05 0.452 . . . . 2.39 111.362 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.04 149.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.041 -0.725 . . . . 1.13 109.041 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.593 ' HB3' HG22 ' A' ' 6' ' ' VAL . 1.2 m-70 -140.14 139.82 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.769 -0.582 . . . . 0.95 110.377 172.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.55 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 47.2 t -102.1 122.57 54.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.42 -1.326 . . . . 1.4 107.42 171.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' CZ ' HG11 ' A' ' 1' ' ' VAL . 95.9 m-85 -96.27 157.21 16.0 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.233 -0.44 . . . . 0.81 111.512 -169.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 22.7 mtpp -62.67 -23.15 66.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.181 0.592 . . . . 3.36 111.765 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.99 6.37 48.13 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.342 -0.984 . . . . 1.97 108.342 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.64 -5.38 76.91 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 114.347 -1.297 . . . . 0.58 114.923 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -90.3 178.34 6.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.266 1.033 . . . . 2.19 110.757 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 1.049 ' HG2' HD11 ' A' ' 59' ' ' ILE . 4.2 mpp? -138.35 145.55 41.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.954 -0.566 . . . . 1.25 109.979 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.455 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -132.48 148.21 19.11 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.838 -0.696 . . . . 0.45 111.713 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 27.4 ttt -127.88 146.84 50.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.407 0.622 . . . . 1.24 112.09 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.518 ' CD ' ' HE2' ' A' ' 19' ' ' HIS . 3.1 mp0 -129.73 157.89 40.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.101 -1.074 . . . . 1.14 108.101 171.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -86.47 171.0 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.028 -0.36 . . . . 1.45 110.028 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.556 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 62.6 pttt -54.06 -14.23 1.01 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.129 0.788 . . . . 2.25 113.129 174.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -91.15 -0.82 57.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.011 0.434 . . . . 1.23 110.22 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.44 65.06 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.079 -0.581 . . . . 0.59 112.047 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 34' ' ' LYS . 1.7 mmmp? -103.12 135.36 44.93 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.739 0.78 . . . . 3.65 111.0 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 p -77.31 122.1 24.64 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 113.85 -1.523 . . . . 1.9 111.451 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -151.07 148.59 28.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 1.7 110.168 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.55 140.87 32.14 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.662 -0.415 . . . . 3.13 110.221 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.415 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -98.78 150.44 36.69 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.062 -0.517 . . . . 1.91 110.888 -177.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.6 154.45 64.41 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.062 2.508 . . . . 1.43 112.183 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.55 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 26.7 tt0 -75.62 141.23 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 1.15 110.416 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.4 -10.76 19.55 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.508 -0.853 . . . . 0.8 113.758 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.6 mtpt -92.61 115.65 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.832 0.678 . . . . 2.7 112.832 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.517 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.2 p -86.32 125.35 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.563 -0.902 . . . . 1.55 108.563 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.9 mtm -120.56 152.92 37.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.333 -0.394 . . . . 1.68 110.62 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.59 140.53 29.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.629 0.728 . . . . 1.64 111.247 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 44.4 p -103.18 162.47 12.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.661 -1.154 . . . . 1.31 110.225 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.546 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 2.8 mmt85 -59.42 -21.08 59.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.582 0.706 . . . . 4.27 111.289 171.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -88.9 0.82 56.25 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.921 -1.036 . . . . 2.7 111.418 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.03 72.72 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.57 -0.824 . . . . 0.87 111.272 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.527 HG22 HD23 ' A' ' 62' ' ' LEU . 11.1 p -115.08 171.74 7.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.803 -0.443 . . . . 1.91 109.803 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.62 145.08 50.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.31 -0.404 . . . . 2.32 110.07 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.491 HG21 ' HD3' ' A' ' 61' ' ' ARG . 34.5 pt -137.77 159.2 34.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.801 -0.636 . . . . 1.35 110.719 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.672 HG23 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -156.88 153.34 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 1.69 109.817 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.596 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -114.05 106.76 14.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.609 -0.886 . . . . 2.09 108.609 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.55 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 36.0 tttm -144.27 145.96 32.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.868 0.366 . . . . 2.17 110.524 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 63.28 31.92 82.37 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.637 -0.711 . . . . 1.21 112.379 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 72.37 -9.35 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.409 0.623 . . . . 3.61 110.902 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 56' ' ' GLY . 47.9 mt-10 -96.17 -179.07 4.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.487 -0.779 . . . . 1.66 110.51 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 1.049 HD11 ' HG2' ' A' ' 26' ' ' MET . 0.0 OUTLIER -135.98 128.38 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.581 0.705 . . . . 1.53 109.86 173.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.672 ' CD1' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.39 111.99 19.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.008 -0.996 . . . . 0.92 108.612 172.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.616 ' HG3' HH11 ' A' ' 61' ' ' ARG . 6.0 tpt85 -120.55 107.17 12.53 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.951 -1.5 . . . . 4.02 106.951 171.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 4.0 mm? 58.91 -46.76 0.06 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.724 -1.126 . . . . 1.96 112.982 -166.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 16.6 t70 77.09 -46.67 0.5 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.176 0.99 . . . . 2.14 109.332 -169.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HA ' ' HG2' ' A' ' 67' ' ' ARG . 5.8 mm-40 -61.12 -40.75 94.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.894 -1.048 . . . . 3.8 111.361 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.28 90.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.29 0.567 . . . . 1.84 111.117 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mt -81.89 -40.66 22.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.099 -0.955 . . . . 2.83 111.353 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 5.4 ptm180 -66.81 -38.18 85.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.748 0.309 . . . . 5.07 111.039 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.584 ' HG3' ' HG3' ' A' ' 67' ' ' ARG . 53.8 mtmt -100.05 65.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.706 . . . . 6.23 110.593 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.64 48.89 0.62 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.882 -1.054 . . . . 5.06 110.747 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -116.0 102.91 10.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.014 0.435 . . . . 7.25 110.703 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.1 t -90.86 110.73 21.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.218 -0.446 . . . . 8.65 110.142 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -101.46 -21.8 14.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.324 0.583 . . . . 10.75 109.946 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.35 -138.87 14.4 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.537 -0.756 . . . . 11.62 111.634 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 CA-C-O 117.995 -1.447 . . . . 12.99 111.34 178.903 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.044 -0.354 . . . . 2.95 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.61 133.96 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.478 -0.328 . . . . 3.48 111.253 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 mmt -104.23 10.76 35.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 2.68 111.431 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.7 m -97.25 -27.49 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.833 0.349 . . . . 1.7 111.044 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.707 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -101.46 12.37 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.315 0.579 . . . . 1.89 111.026 -178.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.595 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 9.2 p -107.69 127.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.092 -0.643 . . . . 1.89 111.659 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 20' ' ' VAL . 23.5 m -80.3 -23.88 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.639 -0.71 . . . . 1.66 111.025 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -167.87 129.21 1.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 1.89 111.029 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.8 m -102.48 138.19 39.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.808 -1.087 . . . . 1.11 109.558 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.63 ' HH ' ' HG3' ' A' ' 61' ' ' ARG . 39.2 m-85 -108.09 123.19 48.33 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.076 0.941 . . . . 1.56 111.809 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.91 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 6.1 m-20 -94.9 114.0 25.79 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.442 -1.708 . . . . 1.94 109.92 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -87.68 152.49 22.11 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.386 -0.825 . . . . 1.71 109.089 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -69.45 -6.32 29.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.432 0.634 . . . . 2.16 110.746 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -95.09 -7.94 38.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.582 -0.735 . . . . 2.11 109.29 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 101.43 -19.08 52.3 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.22 -0.9 . . . . 1.28 111.88 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.574 ' HB2' HD11 ' A' ' 12' ' ' LEU . 5.0 m -61.96 145.9 51.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 1.33 110.491 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.7 125.16 46.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.16 0.505 . . . . 2.39 110.594 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -105.76 154.71 6.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.482 -0.933 . . . . 1.13 108.482 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 51.8 m-70 -136.58 134.65 37.66 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.848 -0.532 . . . . 0.95 109.737 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 7' ' ' VAL . 47.3 t -97.31 111.98 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 106.298 -1.741 . . . . 1.4 106.298 166.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 19' ' ' HIS . 80.9 m-85 -84.39 154.83 22.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.715 -0.675 . . . . 0.81 110.72 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.707 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 7.7 ptmm? -58.58 -23.45 58.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.318 -0.856 . . . . 3.36 112.68 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.613 ' HB2' ' HE2' ' A' ' 25' ' ' LYS . 7.7 m-20 -98.01 6.66 47.4 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.156 -0.683 . . . . 1.97 109.156 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 -5.03 66.79 Favored Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 115.078 -0.964 . . . . 0.58 114.787 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.613 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -81.88 171.75 14.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.272 1.036 . . . . 2.19 110.382 176.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.695 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.5 mpp? -137.0 143.51 42.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.974 -0.557 . . . . 1.25 109.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.87 143.21 14.81 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.383 -0.687 . . . . 0.45 111.383 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.125 0.488 . . . . 1.24 110.799 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -125.78 153.88 43.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.338 -0.847 . . . . 1.14 109.149 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.561 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 38.3 p-10 -88.98 168.31 12.47 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.61 -0.515 . . . . 1.45 109.61 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.564 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 63.9 pttt -53.31 1.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.053 1.131 . . . . 2.25 114.053 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 30' ' ' ASN . 84.7 m-85 -111.09 -2.7 15.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.939 -0.476 . . . . 1.23 110.522 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.92 32.69 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.294 -0.955 . . . . 0.59 113.598 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -120.42 147.46 45.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.129 -0.628 . . . . 3.65 110.683 174.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -74.57 128.05 34.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.991 -1.004 . . . . 1.9 111.351 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 ptm -126.85 -179.72 4.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.08 -0.509 . . . . 1.7 110.666 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.05 154.38 37.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 3.13 110.109 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.2 ttt -119.88 127.28 26.47 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.178 -0.305 . . . . 1.91 110.178 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.43 148.57 33.85 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.458 2.106 . . . . 1.43 112.863 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.15 139.72 43.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.722 -0.672 . . . . 1.15 109.512 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.52 -31.53 5.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.495 -0.86 . . . . 0.8 112.648 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -82.08 142.19 32.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.72 0.295 . . . . 2.7 110.848 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.569 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.0 p -97.55 130.21 46.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.215 0.531 . . . . 1.55 110.472 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -102.83 140.55 36.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.777 -0.647 . . . . 1.68 109.7 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.51 146.99 27.71 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.21 0.528 . . . . 1.64 110.314 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.3 p -100.46 168.23 9.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.573 -0.74 . . . . 1.31 110.72 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.91 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 39.3 mtt180 -46.57 -41.29 14.19 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.413 0.894 . . . . 4.27 113.413 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.02 -43.48 7.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.871 -0.731 . . . . 2.7 112.098 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.26 28.82 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 119.308 -1.425 . . . . 0.87 113.587 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.0 m -102.44 149.28 24.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.291 -1.003 . . . . 1.91 108.291 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 94.3 mttt -126.15 144.17 50.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.614 -0.434 . . . . 2.32 111.794 -173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.3 pt -138.0 157.92 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.44 -0.8 . . . . 1.35 110.786 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.596 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -159.94 148.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.818 0.342 . . . . 1.69 110.359 176.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -111.52 127.02 55.58 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.562 -0.533 . . . . 2.09 109.562 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -145.24 129.38 17.59 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.791 -0.448 . . . . 2.17 109.791 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.19 36.58 89.33 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.941 -0.647 . . . . 1.21 112.711 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' HA ' ' HE1' ' A' ' 54' ' ' MET . 33.0 m-80 71.85 -9.63 0.95 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.483 0.713 . . . . 3.61 111.355 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 56' ' ' GLY . 55.4 mm-40 -86.05 139.15 31.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.161 -0.472 . . . . 1.66 111.16 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.695 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -102.08 124.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.576 0.703 . . . . 1.53 110.901 176.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.596 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.48 119.63 25.37 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.076 -1.083 . . . . 0.92 108.076 169.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.63 ' HG3' ' HH ' ' A' ' 10' ' ' TYR . 11.1 ttm180 -116.07 101.01 8.36 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.515 -1.661 . . . . 4.02 106.515 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER 38.44 5.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.895 1.372 . . . . 1.96 113.532 -163.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 61' ' ' ARG . 21.5 t0 54.17 168.6 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.203 1.001 . . . . 2.14 111.24 -168.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.587 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 10.0 tp10 76.05 -40.6 0.4 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.938 0.895 . . . . 3.8 110.466 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.33 -38.2 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.629 0.728 . . . . 1.84 111.096 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.798 ' HA ' ' HB2' ' A' ' 70' ' ' HIS . 1.9 mp -96.08 -24.38 16.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.119 -0.946 . . . . 2.83 110.018 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.587 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 25.9 ttm180 -61.87 -53.75 51.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.207 -0.906 . . . . 5.07 110.088 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -132.68 105.4 7.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.004 -0.544 . . . . 6.23 110.422 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.91 21.47 3.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.2 -1.0 . . . . 5.06 112.973 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.798 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 10.1 t-160 -87.21 -75.8 0.39 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.52 -0.548 . . . . 7.25 109.52 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.1 m 49.53 40.05 18.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.457 0.646 . . . . 8.65 111.247 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -80.2 146.08 31.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.316 -0.857 . . . . 10.75 110.927 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.78 -52.59 4.72 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.863 -0.684 . . . . 11.62 111.789 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.462 -1.188 . . . . 12.99 111.294 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 2' ' ' ASP . 12.2 p . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.483 0.182 . . . . 2.95 111.007 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.534 ' O ' HG21 ' A' ' 1' ' ' VAL . 1.8 p-10 -80.89 170.92 15.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.05 -0.722 . . . . 3.48 109.05 171.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.3 mtp -131.03 27.84 4.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.207 0.527 . . . . 2.68 110.569 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 m -112.95 -36.53 5.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.629 -0.714 . . . . 1.7 111.271 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.987 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 3.4 t30 -114.84 -0.57 13.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.55 0.691 . . . . 1.89 111.779 -174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 19' ' ' HIS . 7.8 p -102.73 134.38 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.917 -1.114 . . . . 1.89 111.381 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -87.13 -23.86 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.932 0.345 . . . . 1.66 111.932 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.9 131.45 1.65 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.727 0.775 . . . . 1.89 111.736 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.595 HG23 ' HD1' ' A' ' 19' ' ' HIS . 5.6 m -105.64 142.62 35.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.439 -1.255 . . . . 1.11 109.479 171.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.791 ' HH ' ' HD3' ' A' ' 61' ' ' ARG . 21.2 m-85 -121.7 134.74 54.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.382 -0.827 . . . . 1.56 111.15 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.594 ' CB ' ' HD3' ' A' ' 47' ' ' ARG . 1.2 m-20 -97.03 117.24 30.76 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.987 -1.46 . . . . 1.94 108.454 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.576 HD13 ' HB2' ' A' ' 16' ' ' SER . 5.9 mt -72.15 0.81 8.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.891 0.7 . . . . 1.71 112.891 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.518 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 88.72 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.787 0.803 . . . . 2.16 108.999 173.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -80.52 -35.74 34.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.685 -1.143 . . . . 2.11 108.564 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.599 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 148.3 -26.72 1.39 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.431 -1.258 . . . . 1.28 113.315 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.576 ' HB2' HD13 ' A' ' 12' ' ' LEU . 1.4 m -60.64 146.39 45.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.758 -0.46 . . . . 1.33 109.758 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -121.94 126.42 48.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.107 0.479 . . . . 2.39 110.538 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.418 HG11 ' HE2' ' A' ' 38' ' ' MET . 78.3 t -108.46 141.79 22.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.04 -0.726 . . . . 1.13 109.04 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.639 ' HB3' HG23 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -137.53 131.11 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.174 -0.61 . . . . 0.95 110.428 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG22 HG13 ' A' ' 59' ' ' ILE . 60.7 t -102.89 123.98 56.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 107.522 -1.288 . . . . 1.4 107.522 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.494 ' HB3' ' ND2' ' A' ' 5' ' ' ASN . 97.9 m-85 -98.61 161.4 13.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.963 -0.562 . . . . 0.81 111.219 -167.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.987 ' HE2' ' HA ' ' A' ' 5' ' ' ASN . 41.4 mtmt -62.15 -19.56 63.18 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.179 -0.464 . . . . 3.36 111.95 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.872 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 2.1 m-20 -83.98 -9.39 58.71 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.275 -1.009 . . . . 1.97 108.275 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.89 -5.06 59.5 Favored Glycine 0 N--CA 1.421 -2.358 0 CA-C-N 114.731 -1.122 . . . . 0.58 113.338 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.872 ' HD3' ' HB2' ' A' ' 23' ' ' ASP . 1.6 mppt? -82.62 -177.1 6.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 117.748 0.774 . . . . 2.19 109.417 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.514 ' HE1' HG12 ' A' ' 59' ' ' ILE . 1.7 pmm? -153.81 147.61 25.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.757 -0.656 . . . . 1.25 109.676 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.27 155.05 21.91 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.786 -0.721 . . . . 0.45 111.964 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.6 ttt -124.95 141.53 52.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.121 0.486 . . . . 1.24 111.656 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 27.2 mt-10 -126.45 153.49 44.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.098 -1.075 . . . . 1.14 108.098 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -93.42 172.63 8.16 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.403 -0.519 . . . . 1.45 110.542 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 60.8 pttt -53.07 -14.78 0.67 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.605 0.965 . . . . 2.25 113.605 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -95.9 -3.12 45.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.065 -0.397 . . . . 1.23 110.914 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.34 22.65 47.04 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.825 -0.702 . . . . 0.59 112.199 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 mmtt -102.34 134.04 46.29 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.875 0.845 . . . . 3.65 110.81 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 p -76.75 129.21 35.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.665 -1.607 . . . . 1.9 111.545 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 55.4 mtm -136.77 162.9 31.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 1.7 110.064 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -90.96 156.47 17.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.343 -0.389 . . . . 3.13 110.03 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.418 ' HE2' HG11 ' A' ' 18' ' ' VAL . 41.5 ttm -99.98 127.66 32.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 1.91 111.612 -173.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.13 118.5 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.539 2.159 . . . . 1.43 111.922 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.1 tt0 -68.58 137.06 53.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.759 -0.655 . . . . 1.15 110.802 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -9.14 37.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.8 113.471 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -104.22 130.29 51.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.335 0.568 . . . . 2.7 112.132 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.667 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.2 p -93.78 132.66 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 1.55 110.366 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.4 mtm -124.8 153.18 42.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.487 -0.779 . . . . 1.68 109.712 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -107.4 167.78 9.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.523 0.678 . . . . 1.64 111.688 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 54.3 p -127.59 164.87 21.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.655 -1.157 . . . . 1.31 112.067 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 75.0 mtp180 -59.65 -29.66 68.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.413 -0.812 . . . . 4.27 111.423 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -95.18 -7.33 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 2.7 111.333 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.37 16.42 27.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.328 -0.939 . . . . 0.87 112.913 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.509 HG21 ' CD2' ' A' ' 62' ' ' LEU . 99.3 m -93.31 139.8 30.25 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.95 -0.389 . . . . 1.91 109.95 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -106.64 132.7 52.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.104 -0.702 . . . . 2.32 109.104 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.4 ' HA ' ' HD1' ' A' ' 60' ' ' PHE . 17.3 pt -136.6 152.82 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.901 0.334 . . . . 1.35 111.901 -175.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.667 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.56 149.81 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.945 -0.571 . . . . 1.69 110.359 174.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.546 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.6 ttt -103.86 123.33 46.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.102 -0.703 . . . . 2.09 109.102 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 23.2 tptm -145.48 128.14 16.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.754 -0.461 . . . . 2.17 109.754 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.14 43.32 97.34 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.61 -0.596 . . . . 1.21 111.61 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 50.12 21.17 0.71 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.182 0.993 . . . . 3.61 112.174 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -116.9 152.09 35.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 1.66 110.511 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.514 HG12 ' HE1' ' A' ' 26' ' ' MET . 0.4 OUTLIER -98.93 122.63 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.133 0.968 . . . . 1.53 111.666 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.84 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -82.66 111.6 18.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.238 -1.393 . . . . 0.92 107.238 164.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.791 ' HD3' ' HH ' ' A' ' 10' ' ' TYR . 5.8 ttm180 -116.47 103.93 10.93 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.709 -1.96 . . . . 4.02 105.709 170.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.567 ' HB2' ' HB1' ' A' ' 65' ' ' ALA . 3.8 mm? 62.54 -34.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.082 0.864 . . . . 1.96 112.202 -166.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.84 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 14.6 t70 81.83 -43.88 0.17 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.266 1.426 . . . . 2.14 109.168 -169.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.76 -32.63 63.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.898 -1.046 . . . . 3.8 110.839 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 62' ' ' LEU . . . -56.13 -40.47 73.85 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.056 -0.52 . . . . 1.84 111.59 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.44 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.5 mm? -64.12 -30.57 71.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.487 -0.779 . . . . 2.83 112.267 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.563 ' HD2' ' N ' ' A' ' 67' ' ' ARG . 3.0 mmm180 -83.0 -41.98 18.07 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.592 0.71 . . . . 5.07 109.332 -174.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -74.42 116.89 15.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.392 -1.276 . . . . 6.23 110.926 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.61 90.28 0.24 Allowed Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.835 -0.621 . . . . 5.06 112.135 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -74.21 79.26 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.731 0.777 . . . . 7.25 110.666 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.9 t -164.78 -57.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.174 -1.375 . . . . 8.65 107.413 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.53 -48.53 15.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.782 -1.099 . . . . 10.75 108.652 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.49 61.41 0.32 Allowed Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.293 -0.867 . . . . 11.62 111.284 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.657 -1.079 . . . . 12.99 111.751 -178.312 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.652 ' HB ' ' OE1' ' A' ' 29' ' ' GLU . 7.3 p . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.116 -0.327 . . . . 2.95 110.116 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.04 111.3 18.06 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.998 -0.741 . . . . 3.48 108.998 170.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.0 mtp -86.21 17.8 3.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.693 -0.685 . . . . 2.68 111.65 -170.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m -78.93 -27.77 43.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.35 0.595 . . . . 1.7 110.504 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.589 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -108.28 9.61 27.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.769 0.795 . . . . 1.89 110.558 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.752 HG11 ' HG1' ' A' ' 9' ' ' THR . 84.5 t -102.48 127.74 55.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.399 -0.819 . . . . 1.89 110.842 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 22' ' ' LYS . 24.5 m -86.7 -23.27 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 1.66 110.964 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.37 138.76 3.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 1.89 110.581 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.752 ' HG1' HG11 ' A' ' 6' ' ' VAL . 3.4 m -120.76 143.97 48.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.484 -0.78 . . . . 1.11 109.728 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.76 129.39 51.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.372 1.082 . . . . 1.56 111.653 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -96.76 125.47 41.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.117 -1.856 . . . . 1.94 108.99 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 16' ' ' SER . 16.7 mt -80.84 148.81 29.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.117 -1.068 . . . . 1.71 108.117 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.541 ' HG2' ' HA ' ' A' ' 47' ' ' ARG . 51.9 mt-30 -65.06 -5.34 6.2 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.98 0.363 . . . . 2.16 111.98 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.33 -27.11 14.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.518 . . . . 2.11 110.129 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 135.24 -19.58 3.84 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.771 -0.728 . . . . 1.28 113.124 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 12' ' ' LEU . 6.3 m -68.56 155.55 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.827 0.346 . . . . 1.33 110.584 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -124.99 127.72 47.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.265 -0.425 . . . . 2.39 111.069 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -108.23 143.47 18.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.754 -0.832 . . . . 1.13 108.754 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 26' ' ' MET . 4.0 m-70 -131.14 130.12 42.69 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.088 -0.645 . . . . 0.95 110.62 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 116.38 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.79 -1.559 . . . . 1.4 106.79 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.47 ' HE1' ' N ' ' A' ' 27' ' ' GLY . 73.1 m-85 -85.63 155.28 21.19 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.72 -0.673 . . . . 0.81 111.316 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 12.8 ptmm? -57.49 -22.85 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.964 -1.016 . . . . 3.36 112.273 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -94.46 2.52 55.73 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.843 -0.799 . . . . 1.97 108.843 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.39 -11.57 59.91 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.83 -1.077 . . . . 0.58 114.386 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.66 179.87 7.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.082 0.941 . . . . 2.19 111.19 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.584 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -139.44 143.62 37.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.144 0.497 . . . . 1.25 109.983 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -136.79 146.28 18.21 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.932 -0.867 . . . . 0.45 110.932 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.4 ttt -122.62 144.73 48.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.932 0.396 . . . . 1.24 111.302 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.652 ' OE1' ' HB ' ' A' ' 1' ' ' VAL . 22.9 mt-10 -126.75 148.89 49.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.946 -1.131 . . . . 1.14 107.946 172.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 32' ' ' PHE . 35.3 p30 -86.38 170.44 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.231 -0.588 . . . . 1.45 110.121 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 19.3 pttm -58.02 1.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.626 0.972 . . . . 2.25 113.626 173.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.0 m-85 -107.47 -1.84 21.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 1.23 109.521 176.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.3 22.17 52.4 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.819 -0.705 . . . . 0.59 112.268 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -110.97 137.82 48.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.413 0.625 . . . . 3.65 111.414 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -74.65 139.12 43.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.163 -1.38 . . . . 1.9 111.869 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.1 ptm -150.45 178.82 8.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.612 -0.722 . . . . 1.7 109.602 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -104.84 158.95 16.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 3.13 110.629 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.591 ' HE2' ' HE3' ' A' ' 44' ' ' MET . 27.8 ttt -101.45 130.2 25.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 1.91 110.091 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.98 132.86 17.4 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.71 2.273 . . . . 1.43 112.772 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 54' ' ' MET . 36.6 tt0 -73.89 138.42 44.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.15 110.23 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.93 62.73 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.824 -0.703 . . . . 0.8 112.979 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -102.93 127.02 50.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 2.7 111.887 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.574 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.7 p -95.6 132.27 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.582 -0.735 . . . . 1.55 109.138 178.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.591 ' HE3' ' HE2' ' A' ' 38' ' ' MET . 71.6 mtm -119.48 148.55 43.13 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.792 -0.447 . . . . 1.68 109.792 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -102.99 147.32 27.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.228 0.537 . . . . 1.64 110.746 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.83 162.34 14.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.325 -0.852 . . . . 1.31 111.264 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.541 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 99.7 mtt180 -58.85 -26.2 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.88 -0.6 . . . . 4.27 111.786 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.68 -14.94 38.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 2.7 110.402 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.79 26.33 6.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.912 -0.661 . . . . 0.87 112.95 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.757 HG22 HH11 ' A' ' 61' ' ' ARG . 43.6 m -111.13 165.16 12.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.505 -0.554 . . . . 1.91 109.505 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.489 ' N ' HG21 ' A' ' 50' ' ' THR . 68.1 mttm -122.42 143.83 49.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.592 -0.522 . . . . 2.32 109.592 176.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.6 pt -136.32 150.5 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 1.35 111.141 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.693 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.15 144.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.313 -0.403 . . . . 1.69 110.732 177.073 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.535 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 25.8 ttt -99.99 138.18 37.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.597 -0.52 . . . . 2.09 109.597 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 21.0 tptp -144.41 103.35 3.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 2.17 107.883 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 -152.1 45.63 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.055 -1.618 . . . . 1.21 109.055 -164.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.63 8.48 14.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.106 0.479 . . . . 3.61 110.644 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -104.76 177.87 4.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.994 0.425 . . . . 1.66 110.481 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.584 HD12 ' HG2' ' A' ' 26' ' ' MET . 11.2 tt -143.59 141.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.746 0.784 . . . . 1.53 110.884 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.915 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -82.49 114.72 21.1 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.438 -1.319 . . . . 0.92 107.438 169.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.757 HH11 HG22 ' A' ' 50' ' ' THR . 0.4 OUTLIER -114.49 102.75 10.36 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.527 -1.657 . . . . 4.02 106.527 170.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.918 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER 60.4 -25.44 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.768 0 O-C-N 124.457 1.098 . . . . 1.96 111.746 -172.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.915 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 22.0 t0 71.18 60.33 0.17 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.39 1.476 . . . . 2.14 111.723 -176.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.775 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 40.7 tt0 168.16 -40.92 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.467 -1.242 . . . . 3.8 108.992 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.918 ' H ' HD12 ' A' ' 62' ' ' LEU . . . -49.84 -59.36 3.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.119 -0.946 . . . . 1.84 111.45 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.531 HD11 ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -89.56 -11.48 42.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.475 -0.784 . . . . 2.83 109.907 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.775 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 78.4 ttt180 -77.83 -59.82 2.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.665 -1.152 . . . . 5.07 111.403 -172.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -107.92 74.18 0.93 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.102 0.477 . . . . 6.23 110.495 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.43 51.85 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.581 -0.819 . . . . 5.06 112.134 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -86.42 -35.23 19.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.88 0.371 . . . . 7.25 110.584 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.2 m -105.64 105.35 15.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.208 -0.451 . . . . 8.65 110.568 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -119.41 175.75 5.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.979 -0.555 . . . . 10.75 110.306 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.39 23.11 77.92 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.731 -0.747 . . . . 11.62 111.806 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 N-CA-C 111.072 -0.811 . . . . 12.99 111.072 -177.224 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 19' ' ' HIS . 83.9 t . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.753 0.311 . . . . 2.95 110.599 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.94 162.51 13.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.922 -0.581 . . . . 3.48 110.387 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mmt -92.89 1.6 57.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.039 0.447 . . . . 2.68 111.117 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 p -81.52 -7.21 59.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.57 0.7 . . . . 1.7 110.917 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.444 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -129.44 11.75 5.86 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.068 0.937 . . . . 1.89 109.039 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -117.37 133.47 64.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.016 -1.447 . . . . 1.89 111.658 -175.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 22' ' ' LYS . 35.6 m -88.24 -26.37 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.541 -0.754 . . . . 1.66 111.536 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -167.15 135.79 2.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.344 0.593 . . . . 1.89 111.167 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 m -114.23 144.45 43.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.907 -1.042 . . . . 1.11 110.102 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 30.9 m-85 -120.15 132.19 55.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.552 0.692 . . . . 1.56 111.136 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.55 125.76 51.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.238 -1.346 . . . . 1.94 108.698 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 17.4 mt -81.16 153.63 27.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.377 -1.283 . . . . 1.71 107.832 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -65.85 -7.31 15.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.217 0.532 . . . . 2.16 111.232 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 31.6 t70 -98.45 -13.52 20.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 2.11 109.98 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.539 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 116.07 -13.45 16.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.651 -0.785 . . . . 1.28 113.425 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.542 ' HB2' HD13 ' A' ' 12' ' ' LEU . 4.9 m -72.96 148.19 44.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.792 0.296 . . . . 1.33 110.592 -176.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -118.93 127.58 53.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.308 0.575 . . . . 2.39 112.454 -172.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.9 t -109.57 143.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.165 -1.05 . . . . 1.13 108.165 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 26' ' ' MET . 5.5 m-70 -132.28 137.98 47.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.738 -0.785 . . . . 0.95 110.602 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 7' ' ' VAL . 46.5 t -97.67 115.21 36.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.131 -1.433 . . . . 1.4 107.131 169.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 49.5 m-85 -80.6 153.66 27.88 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.933 -0.576 . . . . 0.81 111.167 -173.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.75 ' HA ' HG11 ' A' ' 7' ' ' VAL . 16.7 pttm -57.58 -27.01 62.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.998 -1.001 . . . . 3.36 111.756 -176.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.36 -1.23 54.12 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.209 -0.663 . . . . 1.97 109.209 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.41 41.0 Favored Glycine 0 N--CA 1.423 -2.168 0 C-N-CA 119.92 -1.133 . . . . 0.58 114.879 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -75.05 176.38 7.29 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.934 1.367 . . . . 2.19 111.737 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 2.2 mpp? -140.44 148.82 41.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.25 109.945 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.83 145.26 17.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.619 -0.801 . . . . 0.45 111.724 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 ttt -119.27 137.8 53.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.511 . . . . 1.24 110.924 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -130.58 154.25 48.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.308 -0.86 . . . . 1.14 109.035 176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.489 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 41.7 p30 -88.42 169.1 12.08 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.275 -0.57 . . . . 1.45 110.053 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.598 ' HD3' ' O ' ' A' ' 14' ' ' ASP . 40.6 pttt -53.6 -10.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.097 1.147 . . . . 2.25 114.097 175.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -99.03 -1.52 39.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 1.23 110.602 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.52 20.53 51.28 Favored Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.856 -0.688 . . . . 0.59 111.909 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 27.9 mmmt -102.17 135.62 43.45 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.644 0.735 . . . . 3.65 111.334 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -74.7 127.57 33.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.032 -1.44 . . . . 1.9 111.011 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.3 ptm -138.27 176.49 8.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 1.7 110.736 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -96.56 131.19 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.118 -0.492 . . . . 3.13 109.849 179.451 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.615 ' HE1' ' HB2' ' A' ' 54' ' ' MET . 25.8 ttp -85.2 117.64 69.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.965 -0.562 . . . . 1.91 110.445 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.46 147.43 64.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.86 2.373 . . . . 1.43 112.809 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.57 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 34.6 tt0 -88.82 144.82 25.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.001 -0.545 . . . . 1.15 110.385 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.87 -16.73 60.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.014 -0.613 . . . . 0.8 112.569 176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -94.88 119.73 33.93 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.116 0.413 . . . . 2.7 112.116 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 10.7 p -94.02 119.58 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.078 -0.712 . . . . 1.55 109.078 174.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 65.3 mtm -107.74 152.17 24.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.603 -0.726 . . . . 1.68 110.613 -170.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -104.64 145.41 30.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.538 0.685 . . . . 1.64 111.497 -176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.0 p -94.93 166.63 11.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.746 -1.115 . . . . 1.31 109.925 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -35.92 -49.37 0.62 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.57 1.322 . . . . 4.27 114.57 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.84 -33.69 15.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.48 -0.488 . . . . 2.7 111.978 -170.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.79 34.23 0.17 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.985 -1.102 . . . . 0.87 112.837 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.5 m -100.87 153.32 19.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.486 -0.931 . . . . 1.91 108.486 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.492 ' HB3' HG21 ' A' ' 43' ' ' VAL . 93.4 mttt -124.26 139.55 53.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.432 -0.507 . . . . 2.32 112.075 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.473 ' HA ' ' CD1' ' A' ' 60' ' ' PHE . 31.6 pt -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.148 -0.933 . . . . 1.35 110.201 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.728 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -163.41 155.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.825 0.345 . . . . 1.69 111.137 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.646 ' N ' HG12 ' A' ' 53' ' ' ILE . 13.4 tmm? -104.79 117.22 33.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.247 -1.019 . . . . 2.09 108.247 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 20.2 tptp -134.0 125.6 28.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.31 -0.626 . . . . 2.17 109.31 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.07 38.13 88.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.756 -0.735 . . . . 1.21 112.155 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 62.46 28.57 16.85 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.607 0.718 . . . . 3.61 110.852 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 54' ' ' MET . 46.0 mt-10 -141.29 159.87 41.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.656 -0.702 . . . . 1.66 110.409 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -102.16 126.64 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.456 0.646 . . . . 1.53 111.404 -177.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.728 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.81 110.35 18.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.313 -1.736 . . . . 0.92 106.313 164.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.641 ' C ' ' H ' ' A' ' 63' ' ' ASP . 1.2 tmm_? -114.47 103.64 11.24 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.632 -1.618 . . . . 4.02 106.632 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.737 ' HB2' ' HB1' ' A' ' 65' ' ' ALA . 4.0 mm? 55.72 -37.49 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.385 1.053 . . . . 1.96 113.404 -165.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.674 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 0.3 OUTLIER 79.89 -58.73 0.35 Allowed 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.839 1.255 . . . . 2.14 109.076 -168.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -19.13 65.32 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.417 -0.811 . . . . 3.8 111.219 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.737 ' HB1' ' HB2' ' A' ' 62' ' ' LEU . . . -67.49 -28.06 67.53 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.437 0.637 . . . . 1.84 110.654 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.7 -33.61 14.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.151 -0.931 . . . . 2.83 110.526 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.674 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 16.2 mmt180 -69.43 -64.83 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.263 1.03 . . . . 5.07 110.647 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 67' ' ' ARG . 60.6 mmtt -90.4 139.53 30.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.881 -1.509 . . . . 6.23 110.564 -164.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.92 9.86 70.36 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.016 -0.612 . . . . 5.06 112.258 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -120.0 -83.39 0.65 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.946 -0.391 . . . . 7.25 109.946 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.6 m 56.97 -152.2 0.4 Allowed 'General case' 0 C--O 1.235 0.322 0 O-C-N 123.655 0.597 . . . . 8.65 111.149 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -153.4 -73.99 0.13 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.092 0.473 . . . . 10.75 109.893 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.99 25.84 1.01 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.937 -0.649 . . . . 11.62 111.715 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.822 -0.988 . . . . 12.99 111.347 -179.146 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.414 HG11 ' HE1' ' A' ' 3' ' ' MET . 52.7 t . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.785 0.326 . . . . 2.95 110.85 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.7 t70 67.08 105.42 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.208 -0.905 . . . . 3.48 110.809 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.522 ' HA ' HG13 ' A' ' 6' ' ' VAL . 22.6 mmt -84.62 11.36 9.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.348 -0.842 . . . . 2.68 111.466 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -92.74 -37.36 12.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 1.7 111.004 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.523 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -107.0 -6.47 17.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.235 0.541 . . . . 1.89 111.417 -176.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 4.8 p -94.73 141.1 15.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.95 -0.469 . . . . 1.89 110.502 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -94.98 -23.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.865 -0.334 . . . . 1.66 110.9 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -160.15 136.53 8.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.383 0.611 . . . . 1.89 110.82 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -121.2 135.2 55.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.024 -0.989 . . . . 1.11 109.538 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -117.26 134.06 55.25 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.864 0.84 . . . . 1.56 111.754 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.575 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 10.7 t70 -104.08 126.15 50.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.188 -1.369 . . . . 1.94 108.517 176.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.553 HD12 ' HB2' ' A' ' 16' ' ' SER . 8.8 mt -71.51 0.09 9.26 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.423 -1.262 . . . . 1.71 112.623 -172.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.481 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 7.6 tt0 86.87 -24.37 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.963 -0.754 . . . . 2.16 108.963 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -95.15 -21.13 18.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.102 -0.954 . . . . 2.11 109.16 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 139.36 -29.97 2.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.543 -0.837 . . . . 1.28 113.945 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.553 ' HB2' HD12 ' A' ' 12' ' ' LEU . 3.8 m -66.05 149.07 50.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 117.09 0.445 . . . . 1.33 110.264 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -124.44 126.72 46.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 2.39 111.432 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.58 141.81 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.897 -0.779 . . . . 1.13 108.897 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.566 ' O ' ' HA ' ' A' ' 26' ' ' MET . 4.9 m-70 -130.59 130.19 43.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.331 -0.547 . . . . 0.95 110.27 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.09 111.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.058 -1.46 . . . . 1.4 107.058 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 85.6 m-85 -89.72 163.09 15.24 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.02 -0.536 . . . . 0.81 110.888 -168.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.523 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 24.9 mtpp -66.82 -21.05 66.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.423 0.63 . . . . 3.36 110.387 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.41 -13.33 59.95 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.276 -1.009 . . . . 1.97 108.276 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.99 71.14 Favored Glycine 0 N--CA 1.422 -2.258 0 CA-C-N 114.043 -1.435 . . . . 0.58 112.93 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -78.49 171.9 14.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.622 0.725 . . . . 2.19 111.452 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.679 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.0 mpp? -130.74 138.14 49.82 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.625 -1.171 . . . . 1.25 110.022 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.37 139.27 10.83 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 111.218 -0.753 . . . . 0.45 111.218 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.487 ' HE2' HD13 ' A' ' 12' ' ' LEU . 27.9 ttt -117.73 133.97 55.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.253 0.549 . . . . 1.24 110.877 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.03 149.33 42.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.11 -0.95 . . . . 1.14 108.64 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 32' ' ' PHE . 43.9 p30 -86.96 169.5 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.658 -0.417 . . . . 1.45 110.132 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 45.8 pttt -59.24 5.08 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.44 0.904 . . . . 2.25 113.44 172.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 30' ' ' ASN . 89.5 m-85 -106.78 -2.9 21.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.169 -0.678 . . . . 1.23 109.169 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.07 27.48 40.6 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.789 -0.641 . . . . 0.59 114.074 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 157.14 42.55 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.054 -0.658 . . . . 3.65 111.332 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 p -74.66 126.52 31.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 1.9 111.181 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -126.27 -175.61 3.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.977 -0.556 . . . . 1.7 110.804 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.22 132.06 35.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 3.13 110.233 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.435 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 27.6 ttt -97.62 123.55 51.65 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.204 -0.453 . . . . 1.91 110.41 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.73 152.09 82.62 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.81 2.34 . . . . 1.43 111.731 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.509 ' O ' HG12 ' A' ' 53' ' ' ILE . 32.8 tt0 -83.75 -90.59 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.052 -0.259 . . . . 1.15 111.042 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 53' ' ' ILE . . . -81.15 40.76 2.56 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.179 -0.534 . . . . 0.8 113.85 -170.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -109.44 119.63 40.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.652 0.263 . . . . 2.7 110.818 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.53 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.4 p -81.34 117.91 28.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 1.55 109.361 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.8 mtm -103.2 146.4 28.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 1.68 110.996 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.602 ' HB2' ' HZ1' ' A' ' 51' ' ' LYS . 32.9 tt0 -98.75 151.64 20.55 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.353 -0.839 . . . . 1.64 109.866 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -126.41 164.75 20.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.004 0.431 . . . . 1.31 112.14 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.575 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -60.43 -28.7 68.49 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.749 -0.659 . . . . 4.27 111.91 176.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 20.0 t70 -90.71 -19.15 23.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.618 -0.719 . . . . 2.7 110.87 -171.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.25 15.62 18.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.632 -0.794 . . . . 0.87 112.488 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.492 HG23 HD21 ' A' ' 62' ' ' LEU . 63.8 m -94.75 142.93 26.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.906 -0.405 . . . . 1.91 109.906 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.602 ' HZ1' ' HB2' ' A' ' 45' ' ' GLU . 67.1 mmtt -108.67 132.33 54.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 2.32 108.848 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.3 pt -135.99 156.91 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.763 0.283 . . . . 1.35 111.763 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.729 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -165.19 150.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.764 -0.653 . . . . 1.69 110.121 176.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 16.6 tmm? -111.43 129.94 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.968 -0.382 . . . . 2.09 109.968 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -144.35 124.69 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.589 -0.278 . . . . 2.17 110.272 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 62.54 39.51 97.94 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.835 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.427 ' O ' ' HE2' ' A' ' 26' ' ' MET . 0.2 OUTLIER 72.55 -10.66 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.213 0.53 . . . . 3.61 111.208 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 54' ' ' MET . 45.2 mt-10 -89.79 167.84 12.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.138 -0.483 . . . . 1.66 109.98 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.679 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -126.26 125.66 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.879 0.847 . . . . 1.53 110.875 -178.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.729 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -81.56 110.41 16.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.248 -1.39 . . . . 0.92 107.248 169.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 63' ' ' ASP . 38.7 ttp-105 -125.96 112.01 15.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.43 -1.693 . . . . 4.02 106.43 174.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.595 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 4.2 mm? 59.89 -37.05 0.08 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.196 0.935 . . . . 1.96 112.668 -166.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.659 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 2.1 t70 81.54 -34.22 0.1 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.768 1.227 . . . . 2.14 110.088 -174.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 62' ' ' LEU . 9.0 pt-20 -94.21 -16.07 23.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.115 -0.948 . . . . 3.8 111.127 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 62' ' ' LEU . . . -64.3 -49.2 72.74 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.251 0.548 . . . . 1.84 111.181 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 mp -73.25 -31.96 64.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.56 -0.745 . . . . 2.83 110.487 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.653 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 37.2 ttm180 -68.48 -64.23 0.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.029 -0.987 . . . . 5.07 111.172 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.653 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 73.7 mmtt -105.28 78.99 1.43 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.921 -0.581 . . . . 6.23 110.474 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.7 65.5 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.66 -0.781 . . . . 5.06 112.334 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -72.26 122.08 20.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.269 0.556 . . . . 7.25 109.682 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.9 t -82.06 121.49 26.62 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.364 -0.835 . . . . 8.65 112.392 -167.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -76.22 -42.8 44.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.308 -0.997 . . . . 10.75 108.308 168.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.82 153.99 13.41 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.325 -0.852 . . . . 11.62 112.451 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.567 -1.129 . . . . 12.99 111.583 177.912 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.464 -0.198 . . . . 2.95 110.464 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -77.03 149.33 35.85 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.065 -0.346 . . . . 3.48 110.065 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.9 mmt -101.04 -3.16 29.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.806 0.336 . . . . 2.68 111.444 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -73.57 -24.94 60.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.903 0.859 . . . . 1.7 109.873 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.503 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -105.3 10.39 33.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.664 -1.153 . . . . 1.89 110.595 -177.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.454 HG22 ' ND2' ' A' ' 5' ' ' ASN . 74.5 t -105.87 135.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.479 -0.782 . . . . 1.89 109.959 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -105.84 -18.46 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.035 -0.53 . . . . 1.66 111.072 -178.121 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -169.01 132.95 1.4 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.123 0.487 . . . . 1.89 110.613 171.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.0 m -110.89 143.8 40.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.381 -0.827 . . . . 1.11 110.583 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.551 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 20.7 m-85 -124.9 139.82 53.49 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.425 0.631 . . . . 1.56 111.441 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.723 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.587 HD12 ' HB2' ' A' ' 16' ' ' SER . 43.3 mt -83.21 148.96 27.12 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.99 -1.004 . . . . 1.71 109.654 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.27 -15.49 35.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.309 0.576 . . . . 2.16 111.618 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 20.7 t70 -96.39 -1.79 46.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.545 -0.752 . . . . 2.11 109.785 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 104.58 -19.3 42.37 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.113 -0.949 . . . . 1.28 112.832 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.587 ' HB2' HD12 ' A' ' 12' ' ' LEU . 40.1 m -72.84 159.97 32.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.574 -0.313 . . . . 1.33 110.671 -177.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 32.8 mttt -119.43 152.55 36.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.136 0.493 . . . . 2.39 110.694 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.44 HG22 HD11 ' A' ' 52' ' ' ILE . 75.4 t -131.48 144.25 38.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.855 -0.794 . . . . 1.13 108.855 174.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' MET . 3.1 m-70 -134.6 135.15 42.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.48 -0.563 . . . . 0.95 109.48 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 7' ' ' VAL . 48.2 t -93.63 118.24 39.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 106.579 -1.638 . . . . 1.4 106.579 168.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -81.98 150.36 27.68 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.77 -0.65 . . . . 0.81 110.9 -172.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -61.34 -22.33 64.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 3.36 111.768 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -99.69 6.65 45.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.76 0.791 . . . . 1.97 109.079 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.24 1.49 60.97 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.711 -1.131 . . . . 0.58 115.007 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -75.89 173.11 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.827 1.314 . . . . 2.19 111.21 172.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.666 ' HG2' HD12 ' A' ' 59' ' ' ILE . 3.2 mpp? -138.07 131.33 30.43 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.343 -0.984 . . . . 1.25 108.343 171.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.0 141.92 13.82 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.249 -0.977 . . . . 0.45 111.922 -175.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.5 ttt -113.64 141.0 47.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.793 0.33 . . . . 1.24 110.191 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 16.6 mt-10 -123.53 144.66 49.42 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.619 -1.252 . . . . 1.14 107.619 169.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.436 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 29.9 p-10 -87.62 165.91 15.09 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.87 -0.732 . . . . 1.45 109.169 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 pttm -52.22 -13.21 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.607 0.966 . . . . 2.25 113.607 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 93.7 m-85 -98.73 7.77 45.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.923 0.392 . . . . 1.23 110.669 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.02 20.57 64.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.248 -0.501 . . . . 0.59 113.0 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.3 mmtm -102.01 140.83 35.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.746 0.784 . . . . 3.65 111.024 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.3 p -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.913 -1.494 . . . . 1.9 112.327 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.2 mtp -139.07 178.34 7.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.032 -0.985 . . . . 1.7 109.83 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -114.79 139.25 49.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.058 -0.719 . . . . 3.13 109.058 173.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.0 ttm -71.24 127.11 91.78 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.648 0.261 . . . . 1.91 110.86 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.87 114.49 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.19 1.927 . . . . 1.43 111.253 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.5 tt0 -61.87 129.45 41.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.807 -0.633 . . . . 1.15 110.373 -176.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.41 -20.22 30.51 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.125 -0.56 . . . . 0.8 112.781 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' HE3' ' HB3' ' A' ' 42' ' ' LYS . 22.2 mmmt -88.55 119.83 29.36 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 2.7 111.907 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.632 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.98 136.47 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.554 -0.535 . . . . 1.55 109.554 172.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 68.2 mtm -132.22 157.12 45.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.579 -0.282 . . . . 1.68 110.751 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.33 150.75 20.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.882 0.849 . . . . 1.64 111.941 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 30.1 p -97.19 165.78 11.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.29 -1.323 . . . . 1.31 108.87 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -46.66 -36.33 6.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.996 0.739 . . . . 4.27 112.996 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -96.78 -49.96 4.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.356 0.502 . . . . 2.7 112.356 -168.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.9 32.24 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.411 -1.376 . . . . 0.87 113.712 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.6 t -114.03 156.65 23.72 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.457 -0.942 . . . . 1.91 108.457 168.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -120.38 145.67 46.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.651 0.263 . . . . 2.32 110.596 -171.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 12' ' ' LEU . 22.6 pt -136.46 152.28 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.887 -0.597 . . . . 1.35 110.863 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.662 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -159.97 147.38 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.066 -0.515 . . . . 1.69 110.549 176.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.453 ' N ' HG12 ' A' ' 53' ' ' ILE . 26.2 ttt -97.53 129.66 44.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.26 -0.644 . . . . 2.09 109.26 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -144.99 128.33 16.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.159 -0.311 . . . . 2.17 110.159 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.32 37.25 93.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.471 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.401 HD21 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 61.24 25.33 15.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.674 0.749 . . . . 3.61 111.05 -178.024 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -128.06 -169.51 2.08 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.807 -1.088 . . . . 1.66 108.45 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.666 HD12 ' HG2' ' A' ' 26' ' ' MET . 3.3 tt -143.54 136.43 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.792 0.806 . . . . 1.53 111.529 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.662 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.1 109.41 17.13 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.795 -1.557 . . . . 0.92 106.795 167.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.551 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 1.3 tmm_? -121.35 108.87 14.22 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 105.031 -2.211 . . . . 4.02 105.031 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 4.5 mm? 62.41 -60.04 0.13 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 1.96 109.163 -156.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.621 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 5.3 t70 139.23 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.065 2.146 . . . . 2.14 107.771 175.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 67' ' ' ARG . 8.5 pt-20 -101.9 -29.75 11.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.198 -1.365 . . . . 3.8 111.546 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.41 -53.18 61.25 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.016 -0.538 . . . . 1.84 112.1 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.567 HD11 ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -89.64 -16.06 31.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.995 0.426 . . . . 2.83 110.486 179.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 63.4 ttt180 -56.0 -57.38 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.134 -0.939 . . . . 5.07 110.324 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.32 82.59 2.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.85 -0.796 . . . . 6.23 108.85 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.41 -52.62 0.17 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.713 -1.13 . . . . 5.06 111.087 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -98.81 89.79 4.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.423 -0.584 . . . . 7.25 109.423 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.1 p -128.93 165.96 20.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.532 -0.758 . . . . 8.65 110.094 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 61.56 28.27 17.55 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.685 0.615 . . . . 10.75 111.191 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.71 24.58 6.06 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.879 -0.6 . . . . 11.62 111.665 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.802 -0.999 . . . . 12.99 111.76 178.435 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.864 ' HB ' ' HE1' ' A' ' 3' ' ' MET . 29.9 m . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 110.741 -0.096 . . . . 2.95 110.741 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 45.59 65.57 1.11 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.638 0.732 . . . . 3.48 111.921 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.864 ' HE1' ' HB ' ' A' ' 1' ' ' VAL . 21.0 mmt -69.92 -20.91 63.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.08 -0.963 . . . . 2.68 111.89 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 3' ' ' MET . 73.6 m 73.53 -27.62 0.19 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.809 0.843 . . . . 1.7 109.335 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.573 ' H ' ' C ' ' A' ' 3' ' ' MET . 1.3 t30 -95.85 -14.7 22.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.939 -1.028 . . . . 1.89 109.914 168.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.8 p -89.18 136.11 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 119.384 -0.926 . . . . 1.89 110.088 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.25 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.962 -0.295 . . . . 1.66 111.499 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' LYS . 16.7 tppt? -169.32 151.49 4.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.228 0.537 . . . . 1.89 111.286 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.474 HG21 ' HD1' ' A' ' 19' ' ' HIS . 3.9 m -133.08 145.75 51.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.553 -0.749 . . . . 1.11 109.795 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.463 ' CE2' ' HG2' ' A' ' 61' ' ' ARG . 38.7 m-85 -128.61 144.63 51.19 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.723 0.773 . . . . 1.56 112.333 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.89 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 6.5 m-20 -106.56 123.7 48.5 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.782 -1.553 . . . . 1.94 110.026 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -77.34 1.84 17.63 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.92 -1.491 . . . . 1.71 113.022 -173.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.525 ' HB2' ' HA ' ' A' ' 47' ' ' ARG . 62.7 tt0 83.68 -32.61 0.07 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.059 0.544 . . . . 2.16 109.998 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.8 t70 -79.87 -20.14 46.63 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.429 -1.323 . . . . 2.11 107.429 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.571 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.54 -17.2 6.53 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.266 -1.334 . . . . 1.28 113.485 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.572 ' HB2' HD12 ' A' ' 12' ' ' LEU . 11.3 m -62.51 143.74 56.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.841 0.353 . . . . 1.33 110.414 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 65.7 mttm -116.46 126.96 54.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.088 -0.505 . . . . 2.39 110.713 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 9' ' ' THR . 97.1 t -109.58 136.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.524 -0.547 . . . . 1.13 109.524 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.588 ' O ' ' HA ' ' A' ' 26' ' ' MET . 2.5 m-70 -123.34 127.43 48.49 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.366 -0.534 . . . . 0.95 110.418 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.46 115.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.555 -1.276 . . . . 1.4 107.555 171.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.571 ' HE1' ' HG3' ' A' ' 3' ' ' MET . 91.0 m-85 -94.93 164.41 12.92 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.273 -0.421 . . . . 0.81 111.248 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.495 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 54.1 mttm -60.53 -26.25 66.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.931 0.492 . . . . 3.36 112.26 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -91.07 3.56 54.42 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.653 0.739 . . . . 1.97 109.07 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.08 -2.02 81.01 Favored Glycine 0 N--CA 1.427 -1.919 0 CA-C-N 114.562 -1.199 . . . . 0.58 113.589 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -81.05 173.35 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.332 0.566 . . . . 2.19 110.792 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.588 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 3.7 mpp? -134.43 138.64 44.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.498 -0.773 . . . . 1.25 109.627 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.55 134.22 9.89 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.096 -0.802 . . . . 0.45 111.096 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.522 ' HE3' ' HB3' ' A' ' 16' ' ' SER . 1.7 tmt? -113.73 134.63 54.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.811 0.339 . . . . 1.24 110.211 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 35.8 mt-10 -126.49 148.52 49.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 1.14 109.294 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.576 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.2 p-10 -85.95 171.33 11.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.678 -0.49 . . . . 1.45 109.678 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.571 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 37.3 pttt -59.18 5.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.982 1.104 . . . . 2.25 113.982 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.1 m-85 -113.05 3.28 16.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.306 0.574 . . . . 1.23 109.711 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.36 23.56 65.2 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.59 113.711 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.576 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -112.55 144.86 41.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.333 -0.547 . . . . 3.65 110.48 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.9 t -78.83 136.69 37.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.203 -0.908 . . . . 1.9 111.553 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.479 ' HE3' ' HB3' ' A' ' 30' ' ' ASN . 68.6 mtm -133.62 175.04 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.05 -0.722 . . . . 1.7 109.05 172.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -96.19 140.49 30.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.9 0.381 . . . . 3.13 110.618 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -95.52 121.6 61.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.828 -0.624 . . . . 1.91 110.953 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HG2' ' HG3' ' A' ' 42' ' ' LYS . 59.3 Cg_endo -75.18 125.23 9.07 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.407 2.071 . . . . 1.43 112.299 176.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 43.9 tt0 -66.72 142.0 57.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.15 110.606 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.04 -2.85 51.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.862 -0.685 . . . . 0.8 112.835 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' HG3' ' HG2' ' A' ' 39' ' ' PRO . 11.7 mmpt? -100.8 122.73 43.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.749 -0.265 . . . . 2.7 111.384 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.597 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.84 124.59 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.678 0.751 . . . . 1.55 109.084 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtt -116.6 148.32 41.04 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.359 -0.837 . . . . 1.68 109.257 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -102.85 155.95 17.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.981 0.42 . . . . 1.64 110.587 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.6 p -104.24 163.42 12.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 1.31 110.951 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.89 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 1.7 ptt180 -50.12 -30.03 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.686 0.995 . . . . 4.27 113.686 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.49 -31.06 16.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.461 -0.336 . . . . 2.7 111.318 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.92 19.64 1.58 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.164 -1.017 . . . . 0.87 113.299 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.2 m -100.38 160.02 14.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 1.91 109.072 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -117.08 139.07 51.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.713 0.292 . . . . 2.32 110.589 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.792 HG23 ' HD3' ' A' ' 61' ' ' ARG . 17.1 pt -132.89 158.39 43.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.146 -0.479 . . . . 1.35 109.719 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.626 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -158.28 143.15 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.252 0.548 . . . . 1.69 111.765 175.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.1 ttt -90.96 112.62 24.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.489 -0.93 . . . . 2.09 108.489 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 50.9 tptt -145.13 130.25 18.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.198 -0.456 . . . . 2.17 110.059 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.7 40.43 37.6 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.132 -0.556 . . . . 1.21 112.559 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.14 31.74 20.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.456 0.646 . . . . 3.61 110.402 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -149.27 175.81 11.08 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.722 -0.844 . . . . 1.66 108.722 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -126.77 134.98 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.704 0.764 . . . . 1.53 111.158 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.626 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -93.81 131.4 39.23 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.855 -1.066 . . . . 0.92 108.748 171.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.792 ' HD3' HG23 ' A' ' 52' ' ' ILE . 14.8 tpt85 -157.12 100.42 1.86 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 104.56 -2.385 . . . . 4.02 104.56 170.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.9 mm? 74.77 -48.82 0.65 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.677 0.671 . . . . 1.96 111.117 -174.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 11.0 t70 71.29 -56.7 0.62 Allowed 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 123.974 0.796 . . . . 2.14 109.696 -175.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -57.73 -36.06 71.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.173 -0.921 . . . . 3.8 111.488 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.72 2.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.126 -0.488 . . . . 1.84 111.946 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.615 ' HA ' ' HB3' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -83.75 -14.52 51.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.216 -0.447 . . . . 2.83 111.343 -178.372 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.557 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 41.4 ttt180 -70.6 -68.37 0.43 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.121 -0.491 . . . . 5.07 110.04 176.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.557 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 31.3 mmmt -132.56 106.04 7.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.812 -0.631 . . . . 6.23 109.657 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.89 -65.67 0.41 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.5 -1.04 . . . . 5.06 110.5 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 76.5 t60 -69.34 -33.12 72.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.001 0.429 . . . . 7.25 110.174 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.5 m -84.37 3.94 33.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.0 -0.546 . . . . 8.65 111.343 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -82.15 -72.26 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.234 0.54 . . . . 10.75 109.588 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.23 130.05 2.2 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.632 -0.713 . . . . 11.62 111.461 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.637 -1.091 . . . . 12.99 111.859 -177.729 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.578 0.228 . . . . 2.95 110.45 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -80.16 157.55 26.56 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.024 0.44 . . . . 3.48 110.892 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 31.8 mmt -92.51 0.76 57.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.783 -0.644 . . . . 2.68 110.741 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 m -71.59 -27.25 63.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.814 0.816 . . . . 1.7 110.191 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.494 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -115.13 17.76 16.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.597 -1.183 . . . . 1.89 111.238 -174.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 19' ' ' HIS . 76.3 t -111.79 115.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.666 -0.697 . . . . 1.89 109.974 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 20' ' ' VAL . 2.8 p -90.71 -18.54 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.575 -0.738 . . . . 1.66 110.578 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -167.23 130.09 1.73 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.482 0.658 . . . . 1.89 110.782 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.403 ' OG1' HG12 ' A' ' 6' ' ' VAL . 83.7 m -108.35 145.81 33.92 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.646 -1.161 . . . . 1.11 109.935 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.912 ' HH ' ' HD2' ' A' ' 61' ' ' ARG . 26.7 m-85 -123.91 133.23 53.78 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 121.743 0.783 . . . . 1.56 111.384 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.653 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -101.53 122.71 44.32 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.024 -1.444 . . . . 1.94 109.071 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 16' ' ' SER . 41.0 mt -83.46 151.24 25.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.898 -1.046 . . . . 1.71 108.487 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -66.69 -8.16 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.643 0.735 . . . . 2.16 111.355 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.403 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 3.9 t70 -87.14 -23.14 24.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.051 -0.977 . . . . 2.11 109.378 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 115.34 -25.2 9.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.758 -1.11 . . . . 1.28 111.699 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.556 ' HB2' HD13 ' A' ' 12' ' ' LEU . 49.5 m -66.53 157.13 33.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.97 0.414 . . . . 1.33 110.234 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -125.51 147.41 49.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.243 0.544 . . . . 2.39 112.056 -171.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.95 148.59 24.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.993 -1.003 . . . . 1.13 108.487 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' HB3' HG13 ' A' ' 6' ' ' VAL . 12.8 m-70 -135.06 137.15 42.63 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.254 -0.579 . . . . 0.95 109.923 172.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 7' ' ' VAL . 49.7 t -95.52 109.41 22.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 106.573 -1.64 . . . . 1.4 106.573 166.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.57 155.82 29.48 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.37 -0.832 . . . . 0.81 110.714 -171.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 47.7 mtpt -68.85 -18.53 64.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.68 0.752 . . . . 3.36 110.217 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.43 -6.22 59.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.571 -1.195 . . . . 1.97 108.056 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.23 6.3 71.51 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 113.986 -1.461 . . . . 0.58 112.995 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -86.75 177.44 7.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.297 0.57 . . . . 2.19 110.653 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.954 ' HG2' HD12 ' A' ' 59' ' ' ILE . 4.5 mpp? -139.91 140.21 36.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.122 -0.945 . . . . 1.25 109.221 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.78 151.2 21.91 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.252 -0.975 . . . . 0.45 112.242 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 ttt -122.05 142.28 50.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.999 0.428 . . . . 1.24 110.746 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -130.68 151.47 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.013 -1.106 . . . . 1.14 108.013 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 32' ' ' PHE . 27.4 p-10 -84.6 167.71 16.01 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.45 109.657 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.557 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 15.0 pttm -50.9 4.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.868 1.433 . . . . 2.25 114.868 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.3 m-85 -122.96 2.82 9.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.255 -0.278 . . . . 1.23 111.155 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.39 27.61 43.03 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.479 -0.867 . . . . 0.59 112.964 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -100.85 130.09 46.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.717 0.77 . . . . 3.65 110.247 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -80.82 127.55 32.66 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.152 -1.386 . . . . 1.9 112.593 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 65.4 mtm -127.63 -171.96 2.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.58 -0.736 . . . . 1.7 109.431 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.0 OUTLIER -97.86 156.01 16.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.885 -0.413 . . . . 3.13 109.885 176.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.444 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 17.4 tpt -82.81 122.77 78.38 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 1.91 110.809 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.444 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 69.5 Cg_endo -79.13 117.83 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.517 2.144 . . . . 1.43 112.841 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -87.64 139.54 30.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.624 -0.716 . . . . 1.15 110.447 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.596 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 108.13 -9.37 36.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.988 -0.625 . . . . 0.8 113.284 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -109.64 131.19 55.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.242 0.46 . . . . 2.7 112.242 -175.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.587 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.5 p -100.91 131.18 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.136 -0.69 . . . . 1.55 109.136 170.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.4 mtm -135.16 173.12 12.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.812 -0.631 . . . . 1.68 109.927 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -107.12 164.75 11.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.308 1.051 . . . . 1.64 112.259 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -108.85 162.35 14.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.359 -1.746 . . . . 1.31 108.93 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.653 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 75.9 mtp180 -55.47 -23.52 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.233 0.457 . . . . 4.27 112.233 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.43 -2.99 37.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.323 . . . . 2.7 111.091 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.24 23.9 13.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.547 -0.835 . . . . 0.87 113.326 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.739 HG22 HD21 ' A' ' 62' ' ' LEU . 64.4 m -95.04 137.08 34.57 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.773 -0.251 . . . . 1.91 110.431 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -99.59 127.98 45.69 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.044 -0.354 . . . . 2.32 110.044 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 18.8 pt -135.09 155.07 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.984 -0.553 . . . . 1.35 110.685 -176.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -157.35 149.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.922 0.391 . . . . 1.69 110.41 174.278 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.3 ttt -108.19 118.73 37.52 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.073 -1.084 . . . . 2.09 108.073 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.596 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 23.9 tptp -144.68 135.52 24.83 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.203 -0.665 . . . . 2.17 109.203 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.83 32.12 82.69 Favored Glycine 0 C--N 1.322 -0.212 0 C-N-CA 121.018 -0.61 . . . . 1.21 112.647 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.81 19.6 11.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.232 0.539 . . . . 3.61 111.31 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.74 152.56 39.3 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.593 -0.73 . . . . 1.66 109.276 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.954 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -114.22 127.86 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.62 0.724 . . . . 1.53 111.889 177.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.538 ' CD1' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -96.06 130.81 42.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.728 -1.212 . . . . 0.92 107.728 167.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.912 ' HD2' ' HH ' ' A' ' 10' ' ' TYR . 7.8 ptt180 -156.46 100.39 1.96 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.047 -1.834 . . . . 4.02 106.047 173.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.739 HD21 HG22 ' A' ' 50' ' ' THR . 0.4 OUTLIER 77.58 -42.01 0.37 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.002 -0.74 . . . . 1.96 109.002 178.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 61' ' ' ARG . 1.3 t70 71.27 -25.75 0.17 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.535 1.134 . . . . 2.14 111.493 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 62' ' ' LEU . 39.2 mt-10 -90.01 -37.45 14.3 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.74 -0.663 . . . . 3.8 110.389 174.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.53 -42.37 87.62 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.595 -0.729 . . . . 1.84 112.72 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.584 ' O ' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -97.75 6.34 48.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.872 0.844 . . . . 2.83 110.583 -178.124 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -101.94 -53.35 2.96 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.803 -1.09 . . . . 5.07 109.975 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 68' ' ' LYS . 25.8 mtpp -145.42 -163.8 1.8 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.041 -0.725 . . . . 6.23 109.041 174.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.22 41.4 9.36 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.528 -0.844 . . . . 5.06 112.173 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -133.2 157.12 46.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.676 0.274 . . . . 7.25 110.313 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.8 m -113.15 147.63 37.01 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.693 -0.484 . . . . 8.65 109.693 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.03 139.98 53.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.451 . . . . 10.75 110.872 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.69 86.85 1.4 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.82 -0.705 . . . . 11.62 111.726 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-O 118.718 -1.046 . . . . 12.99 111.555 -179.491 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.309 0.099 . . . . 2.95 111.183 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 69.3 142.19 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.505 0.669 . . . . 3.48 111.515 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.425 ' HE1' ' CE1' ' A' ' 19' ' ' HIS . 19.5 mmt -98.54 3.51 48.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.907 -0.588 . . . . 2.68 112.108 -171.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -78.34 -33.01 49.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.453 . . . . 1.7 110.449 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.571 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -97.79 1.81 48.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 1.89 110.696 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.419 HG21 ' ND2' ' A' ' 5' ' ' ASN . 77.7 t -94.03 130.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 1.89 110.204 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -93.3 -25.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.465 -0.494 . . . . 1.66 111.918 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -164.16 142.61 7.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 1.89 110.489 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 53.4 m -125.05 140.84 52.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.226 -0.443 . . . . 1.11 110.458 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.463 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 36.2 m-85 -112.38 128.83 56.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.693 0.759 . . . . 1.56 112.001 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -102.15 114.9 29.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.717 -1.583 . . . . 1.94 109.826 -178.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.654 ' O ' ' HB2' ' A' ' 13' ' ' GLN . 6.6 mt -75.22 -0.8 20.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.352 1.242 . . . . 1.71 114.352 -168.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.654 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 56.9 mt-30 90.84 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.672 0.789 . . . . 2.16 110.17 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.58 -28.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.412 -0.959 . . . . 2.11 108.412 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.649 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 140.24 -22.66 2.74 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.42 -1.264 . . . . 1.28 113.57 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.572 ' HB3' HD11 ' A' ' 12' ' ' LEU . 23.0 t -64.39 141.89 58.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.772 0.796 . . . . 1.33 110.456 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -120.78 126.72 50.84 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.201 -1.363 . . . . 2.39 110.297 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 9' ' ' THR . 86.3 t -112.69 126.25 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.437 -0.801 . . . . 1.13 109.041 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 26' ' ' MET . 11.9 m-70 -115.62 128.7 56.13 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.565 -0.854 . . . . 0.95 109.733 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.459 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 46.3 t -90.33 112.55 24.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 106.737 -1.579 . . . . 1.4 106.737 172.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -88.16 161.8 17.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.857 -0.61 . . . . 0.81 110.614 -173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 8.1 mtpm? -61.02 -26.35 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.331 0.586 . . . . 3.36 111.28 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.08 -7.2 59.68 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.162 -0.926 . . . . 1.97 108.836 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.62 -0.99 68.33 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.573 -1.194 . . . . 0.58 113.172 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -85.82 179.68 7.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.309 0.576 . . . . 2.19 110.775 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.747 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 59.5 mtm -143.15 148.1 36.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.955 -1.021 . . . . 1.25 110.381 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.12 135.28 8.74 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.228 -0.896 . . . . 0.45 111.052 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' SER . 26.8 ttt -111.05 126.61 55.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.082 -0.34 . . . . 1.24 110.082 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 48.6 mt-10 -128.11 155.83 43.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.662 -0.866 . . . . 1.14 108.662 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.4 p30 -91.79 175.32 6.93 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.418 -0.513 . . . . 1.45 110.238 176.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.649 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 4.4 pttm -51.53 -11.45 0.13 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.604 0.964 . . . . 2.25 113.604 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -105.28 -5.02 20.93 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.321 -0.237 . . . . 1.23 111.179 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.41 25.38 28.43 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.798 -0.715 . . . . 0.59 112.417 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 26.3 mmtp -108.68 137.66 46.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.324 0.583 . . . . 3.65 111.845 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 28' ' ' MET . 47.3 t -71.97 131.33 42.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.438 -1.255 . . . . 1.9 111.266 -175.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.461 ' HE3' ' HE2' ' A' ' 28' ' ' MET . 64.0 mtm -126.04 177.03 6.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 1.7 109.45 177.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -97.82 127.11 43.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.895 -0.409 . . . . 3.13 109.895 179.042 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.499 ' HE1' ' HB2' ' A' ' 54' ' ' MET . 23.9 ttt -83.01 126.18 73.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.855 -0.611 . . . . 1.91 111.044 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.68 153.32 38.54 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.999 2.466 . . . . 1.43 112.88 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.526 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.5 tt0 -112.51 141.89 45.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 1.15 109.983 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.03 2.84 64.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.43 -0.89 . . . . 0.8 112.603 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 42' ' ' LYS . 12.4 mmmm -109.58 138.73 45.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.585 0.231 . . . . 2.7 111.38 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 59.4 t -90.0 119.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.513 -0.551 . . . . 1.55 109.513 171.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -109.74 154.0 23.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 1.68 110.303 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -104.26 155.61 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.546 0.689 . . . . 1.64 111.517 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 47.8 p -111.32 156.83 20.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.28 -1.327 . . . . 1.31 109.869 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 47.8 mtp180 -57.53 -21.89 41.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.798 0.296 . . . . 4.27 111.798 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -89.99 -3.39 58.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 2.7 110.84 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 26.9 25.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.73 -0.748 . . . . 0.87 113.669 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.2 p -108.19 159.69 16.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.331 0.566 . . . . 1.91 110.038 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -111.01 135.72 51.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.244 -0.435 . . . . 2.32 109.953 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.536 HG22 ' CG ' ' A' ' 61' ' ' ARG . 8.8 pt -132.17 165.98 30.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 1.35 111.067 -173.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.526 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -159.44 142.22 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.342 -0.39 . . . . 1.69 110.974 167.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.499 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 17.1 tmm? -95.62 120.71 36.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.922 -1.14 . . . . 2.09 107.922 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.526 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.6 tptt -137.43 112.5 9.08 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.323 -0.621 . . . . 2.17 109.323 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 67.26 52.2 33.19 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.811 -0.631 . . . . 1.21 112.61 -176.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' O ' ' HE3' ' A' ' 26' ' ' MET . 40.4 m-80 73.99 -35.24 0.3 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.818 0.847 . . . . 3.61 111.796 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' A' ' 56' ' ' GLY . 43.1 mt-10 -78.92 156.27 28.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.106 -0.497 . . . . 1.66 110.841 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.747 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -113.79 129.69 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.47 0.652 . . . . 1.53 109.681 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -93.91 112.93 24.85 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.874 -0.787 . . . . 0.92 108.874 169.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.648 ' HD3' HD23 ' A' ' 62' ' ' LEU . 2.7 tmt_? -140.29 103.75 4.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.442 -2.059 . . . . 4.02 105.442 160.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.648 HD23 ' HD3' ' A' ' 61' ' ' ARG . 3.5 mm? 75.22 -38.38 0.37 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.607 0.639 . . . . 1.96 111.658 -175.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 12.4 t70 76.28 -57.47 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.941 0.775 . . . . 2.14 111.286 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 40.0 tt0 -77.67 -26.31 50.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.139 -0.482 . . . . 3.8 110.483 -176.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.75 77.78 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.465 0.65 . . . . 1.84 110.898 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 63' ' ' ASP . 3.5 pp -96.82 -16.98 20.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.091 -0.959 . . . . 2.83 110.606 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.673 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 15.8 ttm180 -71.64 -54.11 11.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.717 -0.674 . . . . 5.07 110.559 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.673 ' HG3' ' HG2' ' A' ' 67' ' ' ARG . 97.0 mttt -139.81 -174.85 4.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.862 -0.608 . . . . 6.23 110.073 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.1 -163.02 30.18 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.792 -0.718 . . . . 5.06 112.351 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 71.8 -63.66 0.42 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.559 0.744 . . . . 7.25 111.425 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.9 t -126.01 170.69 11.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 8.65 110.279 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.31 -35.84 7.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 10.75 110.728 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.32 34.87 0.51 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.404 -0.903 . . . . 11.62 112.706 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.332 -1.26 . . . . 12.99 112.026 179.492 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.651 HG22 ' CD2' ' A' ' 19' ' ' HIS . 7.1 p . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.409 0.147 . . . . 2.95 110.745 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -76.1 143.89 41.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.744 -0.836 . . . . 3.48 108.744 170.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.458 ' HA ' HG13 ' A' ' 6' ' ' VAL . 36.5 mtp -118.42 21.22 12.75 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.544 0.688 . . . . 2.68 109.76 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -92.8 -45.07 8.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.042 . . . . 1.7 110.704 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.42 -5.54 35.97 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.321 0.582 . . . . 1.89 110.891 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.9 p -86.81 125.36 40.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.68 -0.808 . . . . 1.89 109.932 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.87 -23.42 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 1.66 111.001 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -167.5 133.21 2.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.43 0.633 . . . . 1.89 111.2 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.624 HG21 ' HD1' ' A' ' 19' ' ' HIS . 2.3 m -111.63 139.78 46.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.946 -1.025 . . . . 1.11 109.635 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -115.14 129.66 56.72 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.227 1.013 . . . . 1.56 111.727 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -100.73 124.49 46.42 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.14 -1.845 . . . . 1.94 108.176 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' ' 16' ' ' SER . 10.2 mp -77.68 4.78 10.68 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.455 -0.793 . . . . 1.71 112.231 -174.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.711 ' HG3' ' HD2' ' A' ' 47' ' ' ARG . 25.2 tt0 82.36 -26.99 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.127 0.489 . . . . 2.16 110.315 167.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 12' ' ' LEU . 18.0 t70 -103.39 -49.58 3.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.572 -0.74 . . . . 2.11 110.149 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.587 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . -166.32 -52.58 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.366 -1.397 . . . . 1.28 115.301 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.631 ' HB2' HD21 ' A' ' 12' ' ' LEU . 4.2 m -70.86 161.95 30.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.327 0.564 . . . . 1.33 111.163 -171.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -129.6 145.98 51.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 2.39 110.772 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.523 HG21 HD13 ' A' ' 12' ' ' LEU . 48.6 t -122.34 145.38 29.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.433 -0.951 . . . . 1.13 108.433 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.651 ' CD2' HG22 ' A' ' 1' ' ' VAL . 3.0 m-70 -135.55 134.05 39.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.804 -0.759 . . . . 0.95 110.969 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.93 114.97 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.204 -1.406 . . . . 1.4 107.204 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 95.2 m-85 -91.73 159.56 15.78 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.974 -0.557 . . . . 0.81 110.524 -171.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -68.97 -18.66 64.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.512 0.672 . . . . 3.36 110.053 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.439 ' OD2' ' HE3' ' A' ' 25' ' ' LYS . 26.2 t70 -79.22 -7.95 58.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.812 -1.181 . . . . 1.97 107.812 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.07 -5.86 75.82 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.74 -1.573 . . . . 0.58 113.257 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.666 ' HB2' ' HZ1' ' A' ' 25' ' ' LYS . 9.4 mtmp? -80.3 175.4 10.68 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.413 0.625 . . . . 2.19 111.479 177.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.563 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 3.3 mpp? -136.2 138.03 41.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.78 -1.1 . . . . 1.25 109.572 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.42 142.36 13.74 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.45 111.854 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.701 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 23.6 ttt -118.54 142.86 47.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.961 0.41 . . . . 1.24 111.099 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.55 ' OE1' ' HB ' ' A' ' 1' ' ' VAL . 19.5 mt-10 -128.53 147.71 50.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.802 -0.814 . . . . 1.14 108.802 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.489 ' HB3' ' SD ' ' A' ' 36' ' ' MET . 41.6 p30 -87.54 172.34 9.83 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.574 -0.451 . . . . 1.45 110.294 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.587 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.4 ptpt -51.75 -16.73 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.418 0.896 . . . . 2.25 113.418 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.61 -4.43 50.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.721 0.296 . . . . 1.23 110.543 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.67 20.86 49.68 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.902 -0.666 . . . . 0.59 111.827 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.7 mmtm -106.69 139.52 41.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.419 0.628 . . . . 3.65 111.756 -176.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 p -70.25 131.84 44.81 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.516 -1.22 . . . . 1.9 110.549 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.489 ' SD ' ' HB3' ' A' ' 30' ' ' ASN . 19.4 ptm -153.47 174.65 14.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.304 -0.407 . . . . 1.7 110.83 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -123.55 140.89 52.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.745 -0.661 . . . . 3.13 109.562 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.701 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 22.3 ptt? -100.45 150.42 36.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.179 -0.464 . . . . 1.91 110.565 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.84 142.06 50.97 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.825 2.35 . . . . 1.43 112.221 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.522 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 29.7 tt0 -71.35 136.6 47.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 1.15 109.833 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -16.04 27.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.362 -0.923 . . . . 0.8 113.459 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -97.31 132.17 43.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.122 0.461 . . . . 2.7 111.756 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.571 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.8 p -99.41 133.92 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.861 -0.608 . . . . 1.55 110.159 174.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.94 151.4 32.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.807 -0.633 . . . . 1.68 109.946 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -94.78 145.73 24.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.678 -0.49 . . . . 1.64 109.678 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -115.96 159.95 20.9 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.82 -0.627 . . . . 1.31 111.057 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.711 ' HD2' ' HG3' ' A' ' 13' ' ' GLN . 18.0 mmm180 -49.13 -28.03 3.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.593 0.757 . . . . 4.27 112.901 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.67 -6.89 59.44 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.567 -0.742 . . . . 2.7 111.363 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.32 58.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.385 -0.912 . . . . 0.87 111.396 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.71 174.42 5.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.208 -0.496 . . . . 1.91 110.392 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 71.3 mmtt -119.24 148.18 43.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.417 -0.356 . . . . 2.32 110.142 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.51 152.39 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 1.35 110.565 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.628 HG21 ' CD1' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -159.21 153.95 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.302 -0.408 . . . . 1.69 110.167 176.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.568 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 56.7 ttp -108.51 109.09 20.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.775 -0.824 . . . . 2.09 108.775 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.522 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 51.7 tptt -127.42 131.14 50.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.266 -0.642 . . . . 2.17 109.266 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.99 73.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.831 -0.699 . . . . 1.21 111.859 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.26 27.21 16.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.479 0.657 . . . . 3.61 110.112 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' MET . 47.4 mt-10 -123.84 147.6 47.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.536 -0.756 . . . . 1.66 109.36 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.542 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -93.67 118.89 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 122.095 0.95 . . . . 1.53 111.152 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.628 ' CD1' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -84.34 116.12 22.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.397 -1.274 . . . . 0.92 108.152 168.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.553 ' C ' ' H ' ' A' ' 63' ' ' ASP . 19.5 tpt180 -114.94 102.28 9.82 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 106.604 -1.628 . . . . 4.02 106.604 169.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER 41.22 4.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.089 1.493 . . . . 1.96 113.179 -163.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.553 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 34.7 t70 55.67 149.14 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.653 1.181 . . . . 2.14 112.112 -169.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.865 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 23.2 tt0 82.66 -22.64 0.24 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.887 -1.051 . . . . 3.8 111.201 177.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.22 -33.07 72.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.927 0.87 . . . . 1.84 109.877 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.44 HD13 ' HB3' ' A' ' 61' ' ' ARG . 1.8 mp -96.88 -22.2 17.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.385 -1.28 . . . . 2.83 109.792 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.865 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 64.2 ttt180 -69.07 -50.01 52.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.384 -0.825 . . . . 5.07 110.519 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -145.34 125.22 13.47 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.184 0.516 . . . . 6.23 110.975 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.1 -42.21 0.56 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.447 -0.797 . . . . 5.06 111.518 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -160.12 38.54 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.852 0.834 . . . . 7.25 108.854 175.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -77.6 144.81 37.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.801 -1.09 . . . . 8.65 111.424 -172.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.52 92.93 9.27 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.815 -0.809 . . . . 10.75 108.815 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.69 89.18 0.16 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.701 -0.761 . . . . 11.62 112.277 -176.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 CA-C-O 118.43 -1.205 . . . . 12.99 111.493 177.845 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.521 ' HB ' ' NE2' ' A' ' 19' ' ' HIS . 7.3 p . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.877 0.37 . . . . 2.95 110.987 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -86.42 132.98 33.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.998 -0.741 . . . . 3.48 108.998 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 mmt -78.54 -3.93 46.16 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.177 0.436 . . . . 2.68 112.177 -172.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -87.68 -35.21 18.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.801 0.334 . . . . 1.7 111.309 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.442 ' C ' HD21 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -105.42 3.13 29.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 1.89 111.846 -169.047 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 19' ' ' HIS . 10.4 p -106.62 135.9 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.014 -0.539 . . . . 1.89 111.493 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.463 HG21 HG11 ' A' ' 20' ' ' VAL . 14.6 m -94.17 -30.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.989 0.423 . . . . 1.66 111.701 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -157.21 138.17 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.389 0.614 . . . . 1.89 110.917 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 1.4 m -119.47 138.54 53.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.294 -0.866 . . . . 1.11 110.083 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.488 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 24.4 m-85 -108.9 125.66 52.25 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.738 0.78 . . . . 1.56 111.487 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -98.57 115.35 28.42 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.037 -1.438 . . . . 1.94 110.501 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 16' ' ' SER . 10.2 mt -81.2 149.75 28.93 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.691 -0.855 . . . . 1.71 108.691 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -60.7 -19.44 58.69 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.794 0.665 . . . . 2.16 112.794 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.6 -26.24 23.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 2.11 109.646 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.07 -15.41 6.5 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.277 -0.874 . . . . 1.28 112.284 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.565 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -58.03 140.19 52.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.861 -0.792 . . . . 1.33 108.861 176.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.493 ' HG2' ' CE1' ' A' ' 19' ' ' HIS . 24.4 ttmm -125.35 124.22 41.07 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.024 0.44 . . . . 2.39 110.613 -171.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 47.0 t -109.17 151.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.95 -0.759 . . . . 1.13 108.95 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.521 ' NE2' ' HB ' ' A' ' 1' ' ' VAL . 0.3 OUTLIER -141.29 137.37 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.153 -0.619 . . . . 0.95 110.924 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.544 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 7.2 p -102.8 125.39 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 1.4 108.03 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -93.1 161.59 14.37 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.155 -0.929 . . . . 0.81 111.883 -168.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -67.04 -20.48 65.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.621 -0.718 . . . . 3.36 110.966 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.447 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 29.0 t70 -83.73 -6.05 59.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.153 0.978 . . . . 1.97 108.527 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.79 0.98 68.35 Favored Glycine 0 N--CA 1.427 -1.939 0 CA-C-N 114.287 -1.324 . . . . 0.58 112.718 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 23' ' ' ASP . 31.3 pttt -91.56 179.73 5.58 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.597 -0.149 . . . . 2.19 110.597 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.841 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mtm -141.62 153.89 45.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.742 0.306 . . . . 1.25 110.192 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.63 147.24 18.9 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.558 -0.617 . . . . 0.45 111.558 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.0 ttt -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.293 0.568 . . . . 1.24 111.148 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.4 mt-10 -128.15 157.17 41.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.796 -0.816 . . . . 1.14 108.796 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.483 ' C ' ' H ' ' A' ' 32' ' ' PHE . 35.3 p-10 -91.51 173.11 8.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.093 -0.336 . . . . 1.45 110.093 174.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.614 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 43.2 pttt -55.92 5.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.409 1.263 . . . . 2.25 114.409 175.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 30' ' ' ASN . 97.0 m-85 -115.91 1.18 13.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.018 0.437 . . . . 1.23 110.196 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.25 21.52 62.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.616 -0.802 . . . . 0.59 111.648 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 67.7 mmtt -103.62 131.53 50.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.377 0.608 . . . . 3.65 110.706 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.3 t -67.42 133.76 50.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.434 -1.257 . . . . 1.9 110.597 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.8 ptm -143.46 160.17 41.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.934 -0.576 . . . . 1.7 110.323 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.78 147.59 39.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.193 -0.458 . . . . 3.13 110.213 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.33 130.82 22.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 1.91 110.67 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.41 160.0 29.07 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.933 2.422 . . . . 1.43 112.963 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 54' ' ' MET . 35.1 tt0 -118.89 145.59 45.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.248 -0.433 . . . . 1.15 110.551 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.57 4.26 68.09 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.8 113.009 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.77 138.44 48.35 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.923 -0.163 . . . . 2.7 110.762 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 63.1 t -87.94 120.42 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.831 -0.433 . . . . 1.55 109.831 172.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -106.79 149.84 26.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.741 -0.663 . . . . 1.68 109.788 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -109.68 148.45 31.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.131 0.967 . . . . 1.64 112.208 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 46.0 p -97.72 168.54 10.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.872 -1.513 . . . . 1.31 109.966 -175.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -59.93 -21.96 61.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.971 0.891 . . . . 4.27 110.976 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.22 -13.72 49.02 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.025 -1.443 . . . . 2.7 110.984 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.39 53.06 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.684 -0.77 . . . . 0.87 111.993 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.87 153.62 19.34 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.955 -0.387 . . . . 1.91 109.955 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -112.18 129.3 56.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.979 -0.555 . . . . 2.32 109.753 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 1.8 pt -129.87 164.97 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.333 -0.394 . . . . 1.35 110.08 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.442 HG22 ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -164.63 143.14 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.062 0.458 . . . . 1.69 111.336 173.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.433 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 21.6 ttt -99.87 134.1 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 2.09 110.112 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -145.7 121.89 10.83 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.775 -0.454 . . . . 2.17 109.775 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.61 52.67 51.68 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.202 -0.523 . . . . 1.21 113.529 177.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.69 -13.27 0.49 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.81 0.444 . . . . 3.61 112.054 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 56' ' ' GLY . 44.1 mt-10 -96.96 148.84 22.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.206 -0.294 . . . . 1.66 110.206 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.841 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -115.96 124.45 72.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.58 0.705 . . . . 1.53 109.694 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.442 ' CD2' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -84.83 128.33 34.56 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.833 0.825 . . . . 0.92 109.102 171.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 2.3 tmm_? -158.23 102.41 1.77 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 103.863 -2.643 . . . . 4.02 103.863 170.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.1 mm? 75.8 -52.12 0.63 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.312 0.96 . . . . 1.96 110.816 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 72.85 -48.32 0.68 Allowed 'General case' 0 C--O 1.219 -0.516 0 O-C-N 124.071 0.857 . . . . 2.14 110.958 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.62 -24.78 63.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.921 -0.581 . . . . 3.8 110.626 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.12 -64.51 0.86 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.197 0.523 . . . . 1.84 110.904 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -91.87 -15.8 27.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.443 -0.799 . . . . 2.83 111.104 -177.271 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 41.41 82.05 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.424 1.09 . . . . 5.07 113.01 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.7 pttm 42.06 49.08 4.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.125 0.97 . . . . 6.23 112.746 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.463 ' H ' ' CD2' ' A' ' 66' ' ' LEU . . . -78.82 60.62 4.12 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.66 -0.976 . . . . 5.06 110.66 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -88.35 117.21 27.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.428 -0.386 . . . . 7.25 110.197 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.2 m 72.97 161.77 0.25 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.104 0.877 . . . . 8.65 110.71 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -121.66 144.3 48.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.072 -0.513 . . . . 10.75 109.981 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.21 -147.43 17.89 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.359 -0.924 . . . . 11.62 112.604 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.202 -1.332 . . . . 12.99 111.33 -178.938 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 109.97 -0.381 . . . . 2.95 109.97 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 58.72 103.57 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.575 0.75 . . . . 3.48 112.698 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.4 mmt -71.4 1.47 6.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.863 0.364 . . . . 2.68 111.553 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.2 m -89.7 -35.4 15.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.286 -0.416 . . . . 1.7 111.215 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.504 ' HB2' ' HD3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -91.9 11.26 25.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.886 0.851 . . . . 1.89 109.608 -177.188 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 HG13 ' HB3' ' A' ' 19' ' ' HIS . 57.6 t -108.64 106.85 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.223 -1.353 . . . . 1.89 108.768 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.95 -12.63 11.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.641 -0.709 . . . . 1.66 110.993 -173.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -163.86 139.55 6.38 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.798 -0.637 . . . . 1.89 110.564 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 m -119.23 138.37 53.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.373 -0.83 . . . . 1.11 110.056 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 21.3 m-85 -108.84 123.14 48.58 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.934 0.874 . . . . 1.56 110.958 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.557 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -91.71 113.24 25.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.382 -1.735 . . . . 1.94 110.406 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.612 HD13 ' HB2' ' A' ' 16' ' ' SER . 45.2 mt -85.47 144.5 27.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.678 -0.86 . . . . 1.71 108.678 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.501 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 8.0 tt0 -72.84 -0.9 14.74 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.497 0.554 . . . . 2.16 112.497 -170.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -98.44 -16.5 19.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.406 0.622 . . . . 2.11 109.666 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 124.49 -21.39 6.78 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.06 -0.973 . . . . 1.28 112.44 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.612 ' HB2' HD13 ' A' ' 12' ' ' LEU . 25.5 m -70.29 158.1 36.5 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.118 0.485 . . . . 1.33 110.848 -176.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 57.7 mttt -125.19 149.88 47.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.335 -0.393 . . . . 2.39 110.896 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 60.8 t -129.79 122.3 54.4 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.13 -0.693 . . . . 1.13 109.13 173.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.615 ' O ' ' HA ' ' A' ' 26' ' ' MET . 54.1 m-70 -108.8 132.0 54.42 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.161 -1.016 . . . . 0.95 110.114 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.82 102.08 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 106.47 -1.678 . . . . 1.4 106.47 168.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.71 155.53 38.86 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.262 -0.881 . . . . 0.81 110.694 -172.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.504 ' HD3' ' HB2' ' A' ' 5' ' ' ASN . 19.5 pttm -51.63 -32.33 28.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.177 -0.919 . . . . 3.36 112.04 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 2.7 p-10 -97.75 10.17 40.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.61 0.719 . . . . 1.97 109.432 -171.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.89 4.68 72.02 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 114.872 -1.058 . . . . 0.58 114.586 172.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -87.68 175.94 7.65 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.124 0.962 . . . . 2.19 111.095 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.615 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 4.2 mpp? -140.36 141.72 35.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.888 -1.051 . . . . 1.25 110.339 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.03 146.65 18.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.37 -0.832 . . . . 0.45 111.336 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 24.7 ttt -114.62 129.01 56.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.261 0.553 . . . . 1.24 111.061 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.0 mt-10 -110.0 147.13 34.09 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.159 -1.052 . . . . 1.14 108.159 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.735 ' H ' ' HB2' ' A' ' 34' ' ' LYS . 63.8 t30 -92.05 162.68 14.27 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.742 -1.207 . . . . 1.45 107.742 170.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.604 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 22.3 ptmt -50.72 -20.68 1.31 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.363 0.875 . . . . 2.25 113.363 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.422 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 21.9 m-85 -96.52 -6.74 36.35 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.941 -0.475 . . . . 1.23 110.905 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.82 38.73 3.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.826 -0.702 . . . . 0.59 112.807 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.735 ' HB2' ' H ' ' A' ' 30' ' ' ASN . 24.4 mmtt -43.91 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.657 0.614 . . . . 3.65 112.657 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 34' ' ' LYS . 36.5 t 89.09 68.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.233 0.958 . . . . 1.9 109.073 175.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.502 ' HG3' ' HB3' ' A' ' 34' ' ' LYS . 31.6 mtm -119.76 -171.46 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.309 -1.314 . . . . 1.7 109.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -98.07 157.74 15.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.506 0.193 . . . . 3.13 110.695 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.511 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 16.7 tpt -80.24 125.16 81.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.229 -0.441 . . . . 1.91 111.173 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.511 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 70.7 Cg_endo -76.37 153.9 35.75 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.615 2.21 . . . . 1.43 112.707 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.559 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 38.2 tt0 -94.23 144.13 25.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 1.15 111.359 -177.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.98 57.65 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.171 -0.538 . . . . 0.8 113.591 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.3 mtpt -90.99 119.36 31.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.076 0.438 . . . . 2.7 111.632 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.597 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 14.5 p -91.85 126.75 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.331 -0.618 . . . . 1.55 109.331 171.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.475 ' HE1' ' HE1' ' A' ' 38' ' ' MET . 68.9 mtm -124.17 154.97 39.3 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.22 -0.659 . . . . 1.68 109.22 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.47 149.68 23.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.087 0.946 . . . . 1.64 112.408 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 47.2 p -103.13 162.09 13.25 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.726 -1.579 . . . . 1.31 110.221 -176.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.557 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 80.3 mtm180 -59.52 -19.42 48.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 4.27 110.971 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.09 -24.47 43.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 2.7 111.12 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.06 21.17 12.16 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.87 111.289 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.0 m -115.83 160.81 19.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.545 -0.539 . . . . 1.91 109.545 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.19 144.88 43.02 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.297 -0.261 . . . . 2.32 110.297 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.8 pt -136.84 150.76 26.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 120.439 0.161 . . . . 1.35 111.428 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.674 HG23 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.96 149.46 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 1.69 109.719 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.5 ttt -112.29 133.71 54.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.074 -0.343 . . . . 2.09 110.074 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.2 tptp -142.32 127.68 18.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.571 -0.286 . . . . 2.17 110.583 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 73.15 -28.81 0.8 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 115.244 0.857 . . . . 1.21 115.244 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 56' ' ' GLY . 8.7 t30 150.39 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.584 0.754 . . . . 3.61 109.058 -165.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.736 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 35.3 mt-10 -97.94 144.71 27.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.293 -0.867 . . . . 1.66 111.796 -171.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.495 HG12 ' HE1' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.36 124.31 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.019 0.914 . . . . 1.53 111.473 176.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.674 ' CD1' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.5 128.31 34.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.644 -1.162 . . . . 0.92 108.743 170.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.645 ' HB3' HD13 ' A' ' 66' ' ' LEU . 52.2 ttt-85 -125.28 126.54 45.29 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.14 -1.8 . . . . 4.02 106.14 162.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.4 OUTLIER 58.16 -16.41 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 O-C-N 125.176 1.548 . . . . 1.96 113.288 -177.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 61' ' ' ARG . 4.6 t70 174.9 -170.47 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.675 -1.602 . . . . 2.14 106.675 -167.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.604 ' HB2' ' HE ' ' A' ' 67' ' ' ARG . 12.4 pt-20 -93.69 15.17 16.97 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.233 1.015 . . . . 3.8 108.402 169.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.522 ' H ' ' HB3' ' A' ' 63' ' ' ASP . . . -54.46 -25.49 25.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 112.774 -2.012 . . . . 1.84 112.656 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 61' ' ' ARG . 16.5 mt -115.14 -1.18 13.06 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.143 0.423 . . . . 2.83 112.143 -174.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.77 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 25.5 ptt180 -98.07 -33.37 11.19 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.104 -0.702 . . . . 5.07 109.104 173.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.77 ' HG3' ' HG3' ' A' ' 67' ' ' ARG . 60.4 mttm -125.14 -176.21 3.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.262 -0.881 . . . . 6.23 108.855 177.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 71' ' ' SER . . . 95.34 -42.75 2.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 5.06 111.386 -177.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -76.24 17.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.967 0.413 . . . . 7.25 111.038 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 69' ' ' GLY . 1.5 m -105.62 19.04 21.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.375 -0.602 . . . . 8.65 109.375 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -83.45 -18.4 38.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.159 -0.928 . . . . 10.75 111.594 -174.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.28 15.27 51.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.656 -0.783 . . . . 11.62 111.224 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.027 0 CA-C-O 118.759 -1.023 . . . . 12.99 111.317 -178.795 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.445 ' HA ' HG12 ' A' ' 6' ' ' VAL . 76.5 mmm . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.145 0.498 . . . . 2.17 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -91.45 -23.82 19.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.857 -0.611 . . . . 1.47 111.006 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.541 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 26.1 p30 -109.44 7.77 25.05 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 120.526 -0.47 . . . . 1.89 111.399 -176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.8 p -108.47 128.9 63.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.32 -0.4 . . . . 1.25 110.991 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.48 HG13 ' HG2' ' A' ' 22' ' ' LYS . 4.7 m -81.77 -27.85 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.094 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -167.35 134.31 2.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 1.41 110.582 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -108.22 137.25 46.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.26 -0.882 . . . . 0.4 109.943 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.656 ' CD1' HG21 ' A' ' 46' ' ' THR . 1.4 m-85 -110.61 127.29 55.18 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.348 -0.842 . . . . 1.06 111.133 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -100.09 119.25 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.711 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 9.4 mp -80.5 149.56 29.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.998 -1.001 . . . . 1.5 109.581 -175.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -65.55 -11.83 47.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.663 0.744 . . . . 1.68 110.595 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.46 -16.49 28.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.11 109.702 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.542 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 110.49 -22.19 22.63 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.803 -1.09 . . . . 1.28 112.223 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.587 ' HB2' HD22 ' A' ' 12' ' ' LEU . 19.6 m -67.71 161.92 24.9 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.071 -0.714 . . . . 1.07 109.071 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -133.81 146.53 50.76 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.43 0.529 . . . . 1.84 112.43 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.643 HG23 HD11 ' A' ' 12' ' ' LEU . 68.9 t -123.58 148.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.264 -0.88 . . . . 0.41 109.073 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HB3' HG21 ' A' ' 6' ' ' VAL . 6.0 m-70 -134.46 130.4 36.67 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.317 -0.553 . . . . 0.67 109.995 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 40.4 t -93.5 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.922 -1.51 . . . . 0.81 106.922 171.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 81.2 m-85 -89.35 155.9 19.05 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.018 0.437 . . . . 0.64 111.236 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 40.1 mtpt -68.19 -12.0 60.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.705 -0.68 . . . . 2.87 110.563 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -90.76 -4.33 56.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.613 -0.884 . . . . 1.97 108.613 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.57 -12.61 64.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 114.875 -1.057 . . . . 0.58 114.766 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 -177.03 5.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 117.892 0.846 . . . . 1.74 110.824 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.79 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -140.31 145.61 37.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.726 -0.67 . . . . 1.07 109.76 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.07 136.74 9.76 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.861 -0.896 . . . . 0.39 110.861 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.485 ' HG2' ' SD ' ' A' ' 36' ' ' MET . 28.4 ttt -118.51 140.9 49.16 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.392 0.615 . . . . 0.87 110.957 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 33.1 mt-10 -130.66 154.88 47.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.116 -0.947 . . . . 1.14 108.831 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.465 ' C ' ' H ' ' A' ' 32' ' ' PHE . 32.0 p-10 -87.51 169.8 11.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.049 -0.352 . . . . 1.41 110.049 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.542 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 55.2 pttt -52.84 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.607 1.336 . . . . 1.77 114.607 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.7 m-85 -119.81 7.7 11.03 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.893 -0.504 . . . . 1.08 110.392 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.42 24.85 58.19 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.762 -0.732 . . . . 0.54 112.36 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 38.8 mmtm -114.02 136.98 52.32 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.693 0.758 . . . . 3.25 111.924 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 m -78.13 129.47 35.21 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.923 -1.49 . . . . 1.55 111.548 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.485 ' SD ' ' HG2' ' A' ' 28' ' ' MET . 1.3 ppp? -148.12 153.52 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.38 110.18 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -67.25 141.12 57.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 2.78 111.129 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.47 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 28.1 ttt -87.77 122.71 70.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.668 -0.696 . . . . 1.32 109.956 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.81 122.28 9.84 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.064 2.51 . . . . 1.24 112.446 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.6 tt0 -69.46 142.91 53.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.224 -0.444 . . . . 1.15 110.362 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.55 -11.1 73.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.516 -0.85 . . . . 0.68 112.862 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -99.75 123.32 43.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.922 0.391 . . . . 2.3 111.957 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.562 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.2 p -91.36 129.71 41.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.563 -0.744 . . . . 0.93 109.403 174.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.7 mtm -126.98 159.96 32.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 1.31 110.526 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -104.63 160.43 14.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.063 0.935 . . . . 1.64 112.429 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.659 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 50.6 p -113.95 165.25 12.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.006 -1.452 . . . . 0.53 109.732 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 15.4 ptt180 -65.35 -18.17 65.1 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.669 0.747 . . . . 3.73 110.966 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.99 -15.19 30.08 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.561 -1.2 . . . . 2.7 110.62 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.35 17.87 20.81 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.518 -0.848 . . . . 0.77 112.585 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -97.74 154.74 17.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.338 -0.616 . . . . 1.35 109.338 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -117.87 135.73 53.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.393 -0.595 . . . . 1.84 109.393 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.24 157.99 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.671 -0.695 . . . . 0.66 110.92 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.694 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -157.11 148.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 0.98 110.486 174.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.554 ' N ' HG12 ' A' ' 53' ' ' ILE . 26.8 ttt -100.19 118.29 36.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.415 -0.957 . . . . 1.5 108.415 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 52.4 tptt -140.61 130.77 24.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.918 -0.401 . . . . 1.69 109.918 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 38.79 94.88 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.979 -0.555 . . . . 1.21 113.061 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.62 9.52 7.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.496 0.665 . . . . 2.9 110.425 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.61 -177.64 3.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.881 -0.599 . . . . 1.66 110.455 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.79 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -134.49 122.16 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 121.347 0.594 . . . . 0.92 110.192 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.694 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.06 117.07 22.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.079 -1.082 . . . . 0.71 108.079 171.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.497 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 42.9 ttt180 -112.65 100.89 9.07 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.594 -1.632 . . . . 3.56 106.594 168.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 O-C-N 124.477 1.111 . . . . 1.4 112.919 -163.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.9 mtp . . . . . 0 N--CA 1.447 -0.603 0 CA-C-O 121.6 0.715 . . . . 2.17 110.544 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.6 t -90.26 -22.3 21.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.542 -0.753 . . . . 1.47 109.929 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -104.44 14.92 29.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 1.89 112.091 -177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.6 p -101.24 137.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.954 -0.298 . . . . 1.25 111.348 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.59 HG13 ' HA ' ' A' ' 22' ' ' LYS . 27.5 m -83.6 -29.23 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.022 0.439 . . . . 1.03 110.064 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -168.48 130.6 1.37 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.602 0.715 . . . . 1.41 110.946 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 m -100.89 140.84 34.61 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.727 -1.124 . . . . 0.4 109.389 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.891 ' OH ' ' HD2' ' A' ' 61' ' ' ARG . 25.7 m-85 -121.4 134.14 55.1 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.967 0.889 . . . . 1.06 111.755 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.53 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 2.9 m-20 -96.47 120.96 37.73 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.613 -1.631 . . . . 1.94 108.853 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 16' ' ' SER . 23.4 mt -78.99 146.12 33.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.414 -1.328 . . . . 1.5 107.414 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 2.7 tt0 -66.17 -4.36 7.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.205 0.526 . . . . 1.68 111.925 -173.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -98.44 -17.81 18.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.495 -0.775 . . . . 2.11 110.326 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.07 -28.48 4.85 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.686 -0.688 . . . . 1.28 113.199 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.632 ' HB2' HD12 ' A' ' 12' ' ' LEU . 12.4 m -65.75 155.81 35.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.768 0.318 . . . . 1.07 110.77 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -124.0 129.81 51.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.908 0.385 . . . . 1.84 111.06 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.98 143.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.898 -0.779 . . . . 0.41 108.898 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.42 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 5.7 m-70 -130.56 129.91 43.39 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.214 -0.595 . . . . 0.67 110.494 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.565 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 28.3 t -96.43 114.81 34.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 106.537 -1.653 . . . . 0.81 106.537 168.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 92.9 m-85 -85.47 152.44 23.2 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.045 -0.525 . . . . 0.64 110.355 -172.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.59 ' HA ' HG13 ' A' ' 7' ' ' VAL . 87.7 mttt -62.08 -15.32 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.923 -0.58 . . . . 2.87 111.553 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.99 -6.99 53.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.83 -0.804 . . . . 1.97 108.83 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.88 -9.59 51.5 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.376 -0.916 . . . . 0.58 114.989 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -92.85 177.6 6.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 118.692 1.246 . . . . 1.74 110.648 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.76 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -137.77 146.23 43.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.151 -0.477 . . . . 1.07 110.483 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.51 146.06 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.074 -0.811 . . . . 0.39 111.074 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.2 ttt -120.5 142.36 49.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.088 0.471 . . . . 0.87 110.979 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.82 150.55 49.13 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.037 -1.098 . . . . 1.14 108.037 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 32' ' ' PHE . 30.7 p-10 -86.58 167.03 14.95 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.322 -0.551 . . . . 1.41 110.133 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 27.8 pttt -50.54 2.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.771 1.397 . . . . 1.77 114.771 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.2 m-85 -118.97 2.04 11.49 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.051 -0.406 . . . . 1.08 110.701 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.37 19.88 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.425 -0.893 . . . . 0.54 112.997 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 11.9 mmmm -100.17 132.73 45.37 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.887 0.851 . . . . 3.25 110.899 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 p -79.05 133.78 36.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.732 -1.576 . . . . 1.55 111.93 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 ptm -147.41 -172.94 4.13 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.641 -0.709 . . . . 1.38 109.829 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.68 150.87 24.34 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.124 -0.324 . . . . 2.78 110.124 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.13 132.47 43.42 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 1.32 110.786 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.12 120.49 7.65 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.623 2.216 . . . . 1.24 112.843 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -80.66 128.3 33.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 1.15 110.132 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.98 -9.65 51.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.92 -0.657 . . . . 0.68 112.389 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -101.69 122.98 44.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.899 0.333 . . . . 2.3 111.899 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.521 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 12.7 p -94.25 128.4 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.706 -0.85 . . . . 0.93 108.706 171.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.5 mtm -124.6 160.29 28.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 1.31 110.651 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 20.5 mt-10 -93.13 145.22 24.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.786 0.803 . . . . 1.64 111.635 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -105.16 160.2 15.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.254 -1.339 . . . . 0.53 109.522 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.53 ' HD2' ' HB3' ' A' ' 11' ' ' ASP . 98.8 mtt180 -64.45 -17.89 64.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.437 0.637 . . . . 3.73 109.59 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.89 -22.97 45.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.125 -0.943 . . . . 2.7 110.3 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.03 55.72 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.794 -0.717 . . . . 0.77 111.522 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -97.15 155.31 16.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.886 -0.783 . . . . 1.35 108.886 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.513 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 40.1 mmtm -112.88 136.95 51.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.943 -0.762 . . . . 1.84 108.943 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 39.0 pt -136.17 153.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 0.66 110.549 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.675 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -154.01 145.61 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.935 -0.575 . . . . 0.98 110.23 176.445 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.35 122.04 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.106 -1.442 . . . . 1.5 107.106 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -144.0 121.96 12.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.843 -0.343 . . . . 1.69 110.924 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.37 45.04 93.31 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 1.21 112.863 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.74 10.98 8.15 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.848 0.459 . . . . 2.9 111.481 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.47 -173.01 2.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.66 109.826 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.76 HD12 ' HG2' ' A' ' 26' ' ' MET . 2.5 tt -139.22 128.87 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 122.009 0.909 . . . . 0.92 110.062 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.19 121.44 27.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.091 -1.448 . . . . 0.71 107.091 170.095 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.891 ' HD2' ' OH ' ' A' ' 10' ' ' TYR . 33.1 ttp180 -109.29 96.1 6.07 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.319 -2.104 . . . . 3.56 105.319 164.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.564 1.501 0 O-C-N 125.011 1.444 . . . . 1.4 113.52 -171.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.4 mtp . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 112.22 0.452 . . . . 2.17 112.22 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 p -78.63 -26.29 45.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.399 0.619 . . . . 1.47 110.334 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.8 p30 -104.74 5.19 33.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 1.89 110.837 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.421 HG11 ' OG1' ' A' ' 9' ' ' THR . 89.5 t -103.66 115.42 45.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.56 -0.745 . . . . 1.25 110.144 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 m -79.15 -23.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 1.03 111.267 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -167.99 137.77 2.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.176 0.512 . . . . 1.41 110.854 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 6' ' ' VAL . 34.3 m -114.0 143.52 44.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.463 -0.79 . . . . 0.4 109.898 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.52 ' OH ' ' HD2' ' A' ' 61' ' ' ARG . 35.9 m-85 -121.26 133.74 55.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.877 0.846 . . . . 1.06 111.948 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 1.2 m-20 -100.44 124.46 45.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.742 -1.572 . . . . 1.94 109.73 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 16' ' ' SER . 7.6 mt -87.73 148.41 24.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.02 -0.733 . . . . 1.5 109.02 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.9 tt0 -62.74 -25.49 68.22 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.23 1.196 . . . . 1.68 114.23 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -98.99 -50.89 4.02 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.684 0.754 . . . . 2.11 110.205 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 166.44 67.86 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.664 -1.153 . . . . 1.28 112.267 -170.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.608 ' HB2' HD12 ' A' ' 12' ' ' LEU . 2.5 m -157.5 143.36 17.49 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.175 -1.046 . . . . 1.07 108.175 172.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -127.5 125.18 39.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.146 0.498 . . . . 1.84 109.906 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.19 148.1 13.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.84 -0.8 . . . . 0.41 108.84 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.559 ' O ' ' HA ' ' A' ' 26' ' ' MET . 7.3 m-70 -131.16 133.15 45.28 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.156 -0.618 . . . . 0.67 109.432 173.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.67 114.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.613 -1.625 . . . . 0.81 106.613 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -83.43 150.58 25.96 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.738 -0.665 . . . . 0.64 110.119 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.486 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 21.2 pttm -61.24 -20.3 62.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 2.87 110.574 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.65 -0.78 57.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.735 -0.839 . . . . 1.97 108.735 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.48 -8.15 62.02 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 114.727 -1.124 . . . . 0.58 115.05 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -85.3 177.24 7.9 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.731 1.265 . . . . 1.74 110.663 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.906 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.7 mpp? -137.69 141.19 41.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.07 109.86 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.27 128.18 7.97 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.735 -0.666 . . . . 0.39 111.51 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.25 124.15 49.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.76 0.314 . . . . 0.87 110.255 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 25.3 mt-10 -124.01 153.89 40.66 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.374 -0.602 . . . . 1.14 109.374 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.547 HD21 ' HB2' ' A' ' 34' ' ' LYS . 10.9 p30 -104.5 174.59 5.81 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.287 -0.565 . . . . 1.41 110.148 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 14.0 pttm -49.63 -19.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.543 1.312 . . . . 1.77 114.543 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 92.2 m-85 -92.97 6.43 47.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.353 0.524 . . . . 1.08 110.586 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.67 26.91 59.94 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.706 -0.557 . . . . 0.54 111.706 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HB2' HD21 ' A' ' 30' ' ' ASN . 35.8 mmtm -113.31 136.07 53.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 3.25 111.329 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t -83.52 129.74 34.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.121 -1.4 . . . . 1.55 110.428 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.13 179.84 6.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.323 -0.399 . . . . 1.38 110.919 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -80.24 143.14 33.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.058 0.456 . . . . 2.78 111.287 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.3 ttt -94.65 127.16 44.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.655 . . . . 1.32 110.529 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.06 138.72 20.88 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.714 2.276 . . . . 1.24 112.834 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 33.3 tt0 -94.11 147.99 22.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.958 -0.565 . . . . 1.15 110.616 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.47 68.02 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.034 -0.603 . . . . 0.68 112.622 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -107.57 129.57 54.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.827 0.346 . . . . 2.3 111.562 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.58 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 8.1 p -90.85 127.23 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.888 -0.782 . . . . 0.93 108.888 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.404 ' SD ' HD11 ' A' ' 12' ' ' LEU . 17.8 ptp -117.03 147.57 42.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.059 -0.519 . . . . 1.31 110.003 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.03 151.35 24.76 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.338 0.59 . . . . 1.64 110.741 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.5 p -100.75 162.86 12.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.218 -0.901 . . . . 0.53 110.103 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.506 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 48.9 mtt180 -57.86 -21.24 41.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.145 0.424 . . . . 3.73 112.145 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.07 -17.48 19.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 121.064 -0.254 . . . . 2.7 111.202 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.25 22.83 6.0 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.291 -0.957 . . . . 0.77 113.319 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -99.83 147.49 25.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 1.35 109.293 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -111.79 132.74 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.055 -0.35 . . . . 1.84 110.055 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 61' ' ' ARG . 38.7 pt -136.63 160.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 0.66 110.83 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.619 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -162.45 151.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.044 -0.525 . . . . 0.98 109.891 175.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.566 ' N ' HG12 ' A' ' 53' ' ' ILE . 14.1 tmm? -104.63 121.48 43.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.057 -1.09 . . . . 1.5 108.057 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 49.6 tptt -134.85 116.58 14.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.288 -0.414 . . . . 1.69 110.216 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.93 44.19 98.16 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.815 -0.63 . . . . 1.21 112.752 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 72.59 -1.74 2.88 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.361 0.6 . . . . 2.9 111.42 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -105.72 147.99 27.93 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.519 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.906 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -100.32 124.32 53.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.727 0.775 . . . . 0.92 111.277 177.603 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.619 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.02 118.36 23.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.702 -1.222 . . . . 0.71 107.702 168.211 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.651 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 47.0 ttp180 -113.68 100.56 8.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.344 -1.354 . . . . 3.56 107.344 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 1.1 pp . . . . . 0 CA--C 1.548 0.876 0 O-C-N 125.164 1.54 . . . . 1.4 113.654 -167.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.512 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 42.7 mtp . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 113.57 0.952 . . . . 2.17 113.57 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 m -83.82 -27.31 28.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.238 0.542 . . . . 1.47 110.696 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.42 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 17.6 p30 -103.72 6.0 36.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.734 0.778 . . . . 1.89 110.019 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 3' ' ' MET . 72.0 t -102.74 116.59 46.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.97 -1.013 . . . . 1.25 109.806 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.83 -20.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.689 -0.405 . . . . 1.03 111.403 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -168.18 128.35 1.29 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.411 0.624 . . . . 1.41 110.987 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 m -101.64 138.45 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.987 -1.006 . . . . 0.4 109.611 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.608 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 18.6 m-85 -113.64 128.45 56.44 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.736 0.779 . . . . 1.06 111.379 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 3.0 m-20 -95.14 115.04 26.91 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.02 -1.445 . . . . 1.94 108.296 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 16' ' ' SER . 10.4 mt -80.57 149.43 29.93 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.009 -0.737 . . . . 1.5 109.009 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -67.79 -7.71 29.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.1 0.476 . . . . 1.68 112.019 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.0 -20.98 19.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.422 0.63 . . . . 2.11 109.895 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 122.07 -14.32 8.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.188 -0.914 . . . . 1.28 112.534 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -66.3 153.19 43.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.539 0.209 . . . . 1.07 110.758 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 30.2 mttp -113.56 143.49 44.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.144 0.497 . . . . 1.84 110.813 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 93.4 t -126.36 149.47 31.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.808 -1.182 . . . . 0.41 107.808 171.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' MET . 6.5 m-70 -139.0 128.89 24.97 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.291 -0.633 . . . . 0.67 109.291 175.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.11 116.77 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.423 -1.695 . . . . 0.81 106.423 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -85.92 153.12 22.42 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.797 -0.638 . . . . 0.64 110.628 -173.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 53.6 pttt -59.53 -16.51 25.29 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 2.87 111.539 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.31 -15.41 46.69 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.038 -0.727 . . . . 1.97 109.038 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.24 -2.35 54.48 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.107 -1.044 . . . . 0.58 113.876 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -94.46 -175.37 3.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.821 0.811 . . . . 1.74 110.776 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . 1.017 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.1 mpp? -144.42 149.29 35.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.721 -0.672 . . . . 1.07 110.438 -175.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.95 139.49 11.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.285 -0.726 . . . . 0.39 111.285 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.566 ' SD ' ' HG3' ' A' ' 36' ' ' MET . 1.6 tmt? -117.77 137.51 52.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.163 0.506 . . . . 0.87 111.001 -175.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 30.2 mt-10 -124.6 149.78 46.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.47 -0.786 . . . . 1.14 109.034 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.633 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.8 p-10 -85.91 166.16 16.19 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.44 -0.578 . . . . 1.41 109.44 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 38.0 pttt -56.92 5.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.217 1.192 . . . . 1.77 114.217 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 45.3 m-85 -113.66 5.82 16.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.064 0.459 . . . . 1.08 109.778 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.77 25.1 60.98 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.972 -0.558 . . . . 0.54 114.264 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.633 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.3 145.96 43.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.16 0.505 . . . . 3.25 110.218 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -80.28 142.16 34.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.489 -0.778 . . . . 1.55 111.588 -171.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.566 ' HG3' ' SD ' ' A' ' 28' ' ' MET . 9.6 ptm -153.53 -179.52 7.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.746 -0.661 . . . . 1.38 109.856 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -100.42 151.08 21.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 2.78 110.751 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 ttm -101.42 126.63 33.85 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.2 -0.455 . . . . 1.32 110.714 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.51 142.34 23.34 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.723 2.282 . . . . 1.24 112.181 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.544 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.7 tt0 -79.81 154.35 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.493 -0.321 . . . . 1.15 110.646 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.604 ' H ' HD11 ' A' ' 53' ' ' ILE . . . 97.27 -19.56 54.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.68 113.337 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.557 ' O ' HD13 ' A' ' 53' ' ' ILE . 48.6 mtpt -98.5 126.65 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.244 0.522 . . . . 2.3 111.582 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.89 124.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.655 -0.498 . . . . 0.93 109.655 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.81 149.97 28.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.1 -0.5 . . . . 1.31 110.205 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' THR . 32.8 mt-10 -109.77 157.99 18.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.001 0.905 . . . . 1.64 112.01 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 72.2 p -105.29 165.34 11.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.03 -1.441 . . . . 0.53 110.319 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 58.6 mtp180 -51.25 -27.83 10.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.82 -0.627 . . . . 3.73 111.803 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -92.62 -21.8 19.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.385 -0.825 . . . . 2.7 111.2 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.36 27.25 5.1 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.145 -1.026 . . . . 0.77 112.339 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 26.5 m -100.73 145.27 28.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.396 -0.594 . . . . 1.35 109.396 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.512 ' O ' ' HE1' ' A' ' 60' ' ' PHE . 55.9 mttp -109.21 131.4 55.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.064 -0.347 . . . . 1.84 110.064 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 12' ' ' LEU . 36.0 pt -137.02 159.17 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.929 0.395 . . . . 0.66 111.383 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.604 HD11 ' H ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -159.35 143.34 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.824 -0.625 . . . . 0.98 110.438 175.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.503 ' H ' HD12 ' A' ' 53' ' ' ILE . 1.5 tmt? -97.28 106.01 18.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.689 -1.226 . . . . 1.5 107.689 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.544 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 74.8 tttt -138.36 136.33 36.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.975 -0.557 . . . . 1.69 110.489 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.36 33.5 82.32 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.787 -0.642 . . . . 1.21 112.733 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 66.81 19.76 10.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.587 0.708 . . . . 2.9 110.991 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.34 -165.61 1.71 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.289 -0.869 . . . . 1.66 109.403 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.017 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.5 OUTLIER -135.82 131.3 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.184 0.992 . . . . 0.92 110.994 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.512 ' HE1' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -82.75 111.75 18.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.863 -1.532 . . . . 0.71 106.863 168.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.608 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -119.27 107.51 13.49 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.128 -1.804 . . . . 3.56 106.128 173.106 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 4.3 mm? . . . . . 0 N--CA 1.474 0.736 0 O-C-N 123.925 0.765 . . . . 1.4 111.881 -165.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.7 mmm . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 112.638 0.607 . . . . 2.17 112.638 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.6 p -94.4 -27.01 16.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.298 -0.561 . . . . 1.47 110.639 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -101.95 13.69 34.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.436 -0.347 . . . . 1.89 111.901 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 13.3 p -111.68 130.03 66.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 120.162 -0.615 . . . . 1.25 111.936 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -96.19 -22.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.038 -0.528 . . . . 1.03 111.399 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -160.29 138.52 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 1.41 111.156 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -123.4 141.34 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.407 -0.815 . . . . 0.4 110.276 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.614 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 33.7 m-85 -121.51 134.51 55.05 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-O 121.679 0.752 . . . . 1.06 111.837 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 46' ' ' THR . 11.6 t70 -101.38 126.63 48.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.878 -1.51 . . . . 1.94 109.092 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.873 HD22 ' HB2' ' A' ' 16' ' ' SER . 10.5 mp -78.47 -2.2 37.42 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.415 -1.266 . . . . 1.5 112.947 -171.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.567 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.4 tt0 86.88 -31.26 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.138 0.575 . . . . 1.68 110.48 172.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.74 -9.58 28.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.338 0.59 . . . . 2.11 109.428 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' A' ' 31' ' ' LYS . . . 138.23 -36.82 1.87 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.056 -1.068 . . . . 1.28 114.434 172.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.873 ' HB2' HD22 ' A' ' 12' ' ' LEU . 11.3 m -71.59 160.0 33.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.615 -0.513 . . . . 1.07 109.615 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -133.36 143.52 49.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.289 0.566 . . . . 1.84 111.732 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.657 HG23 HD11 ' A' ' 12' ' ' LEU . 36.1 t -118.22 142.67 31.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.64 -0.709 . . . . 0.41 109.251 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 10.0 m-70 -128.82 133.02 47.86 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 120.225 -0.59 . . . . 0.67 111.074 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.84 111.65 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 106.566 -1.642 . . . . 0.81 106.566 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.517 ' HE2' ' N ' ' A' ' 27' ' ' GLY . 87.7 m-85 -83.77 156.18 22.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.929 -0.578 . . . . 0.64 110.807 -171.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -60.61 -20.46 60.69 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.122 -0.945 . . . . 2.87 111.798 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.95 7.39 46.75 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.496 0.665 . . . . 1.97 109.297 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.17 -7.59 80.55 Favored Glycine 0 N--CA 1.427 -1.91 0 CA-C-N 114.868 -1.06 . . . . 0.58 114.517 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -86.53 175.51 8.3 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 117.86 0.83 . . . . 1.74 110.651 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.854 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.2 mpp? -135.88 148.7 48.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.967 0.413 . . . . 1.07 110.193 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.517 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -143.47 148.84 20.74 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.636 -0.711 . . . . 0.39 111.403 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ttt -117.62 144.51 45.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.857 0.361 . . . . 0.87 110.637 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.01 146.64 47.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.304 -0.998 . . . . 1.14 108.304 171.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.567 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 15.9 p-10 -89.63 164.72 14.62 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.619 -0.882 . . . . 1.41 108.619 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.403 ' CB ' ' HA3' ' A' ' 15' ' ' GLY . 9.7 ptpp? -51.03 -11.21 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.951 1.093 . . . . 1.77 113.951 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.506 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 97.2 m-85 -96.65 9.19 42.32 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.107 -0.371 . . . . 1.08 110.81 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.65 26.23 65.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.167 -0.54 . . . . 0.54 113.67 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.23 147.44 42.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.067 -0.653 . . . . 3.25 110.273 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 p -83.64 139.1 33.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.332 -0.849 . . . . 1.55 112.159 -172.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.0 ptm -148.78 175.26 11.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 1.38 109.577 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -95.11 151.82 18.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.913 0.387 . . . . 2.78 110.132 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.03 128.91 45.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.993 -0.549 . . . . 1.32 110.768 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.3 114.72 3.16 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.45 2.1 . . . . 1.24 112.066 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 54' ' ' MET . 42.3 tt0 -74.51 133.3 42.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.652 -0.704 . . . . 1.15 110.696 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.517 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 117.12 -8.96 15.77 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.68 113.773 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.55 142.05 48.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 117.63 0.715 . . . . 2.3 112.304 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.633 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -99.43 135.64 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.93 108.885 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 70.2 mtm -127.4 159.26 35.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.249 -0.432 . . . . 1.31 109.872 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -99.66 163.63 12.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.741 0.781 . . . . 1.64 111.995 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 45.7 p -119.68 162.69 18.59 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.28 -1.327 . . . . 0.53 110.79 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.567 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 6.8 mtt180 -55.63 -27.38 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.757 0.651 . . . . 3.73 112.757 177.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -95.76 -2.52 47.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.503 -0.479 . . . . 2.7 111.969 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.31 20.7 19.47 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.853 -1.165 . . . . 0.77 114.053 170.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -112.63 167.22 10.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.717 0.758 . . . . 1.35 109.514 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -122.66 143.8 49.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.79 -0.448 . . . . 1.84 109.79 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 pt -139.55 154.22 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.346 -0.388 . . . . 0.66 111.247 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.728 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -155.02 149.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.957 0.408 . . . . 0.98 110.596 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.524 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 27.5 ttt -108.39 113.17 26.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.777 -1.194 . . . . 1.5 107.777 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 22.4 tptm -144.35 138.91 28.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.177 -0.675 . . . . 1.69 109.177 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.29 31.01 76.1 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 1.21 111.742 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 62.12 23.42 13.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.171 0.51 . . . . 2.9 111.339 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 54' ' ' MET . 36.7 mt-10 -132.07 160.02 37.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.519 -0.764 . . . . 1.66 110.19 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.854 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.49 124.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.523 0.678 . . . . 0.92 110.906 177.713 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.728 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -82.46 109.76 16.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.508 -1.664 . . . . 0.71 106.508 166.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.614 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 2.0 tmm_? -121.49 105.51 10.55 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.817 -1.549 . . . . 3.56 106.817 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 62' ' ' LEU . 3.9 mm? . . . . . 0 C--N 1.323 -0.57 0 O-C-N 124.222 0.951 . . . . 1.4 112.898 -164.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.486 ' HA ' HG12 ' A' ' 6' ' ' VAL . 20.7 mmt . . . . . 0 C--O 1.228 -0.071 0 CA-C-O 120.914 0.387 . . . . 2.17 111.291 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 m -86.37 -26.93 24.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.281 0.563 . . . . 1.47 110.793 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.9 p30 -114.42 12.39 17.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.715 -0.675 . . . . 1.89 111.511 -173.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.575 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.2 p -109.9 134.65 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.195 -0.457 . . . . 1.25 111.393 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 20' ' ' VAL . 22.4 m -86.84 -26.45 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.3 -0.409 . . . . 1.03 111.164 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -168.5 132.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.42 . . . . 1.41 110.566 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -110.41 143.47 40.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.61 -0.723 . . . . 0.4 109.98 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -117.98 133.2 56.14 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.766 0.793 . . . . 1.06 111.353 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.29 119.49 37.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.088 -1.414 . . . . 1.94 109.203 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 16' ' ' SER . 7.3 mt -83.1 138.99 33.47 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.686 -0.688 . . . . 1.5 109.378 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -61.99 -19.2 62.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.41 0.893 . . . . 1.68 113.41 -166.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -44.0 5.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 2.11 110.41 -175.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.72 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 159.77 78.86 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 119.621 -1.276 . . . . 1.28 113.144 -172.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.622 ' HB3' HD12 ' A' ' 12' ' ' LEU . 48.3 t -176.59 153.49 1.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.199 -0.667 . . . . 1.07 109.199 175.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -128.3 125.71 39.35 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.193 -0.458 . . . . 1.84 110.61 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.82 148.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.788 . . . . 0.41 108.871 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.575 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -138.83 131.99 29.83 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.858 -0.526 . . . . 0.67 109.992 177.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 7' ' ' VAL . 46.8 t -96.96 118.49 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.085 -1.45 . . . . 0.81 107.085 170.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 78.3 m-85 -86.58 155.35 20.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.132 0.492 . . . . 0.64 111.46 -171.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 28.9 mtpp -64.24 -22.08 66.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.335 -0.848 . . . . 2.87 111.526 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.02 -1.87 57.75 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.031 -1.1 . . . . 1.97 108.031 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.8 -8.1 50.23 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.81 -1.087 . . . . 0.58 114.555 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.94 174.02 5.78 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 118.627 1.213 . . . . 1.74 112.747 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.61 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -138.13 131.43 30.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.266 -1.334 . . . . 1.07 109.168 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.23 144.15 15.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.885 -0.674 . . . . 0.39 112.088 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.3 ttt -123.76 139.87 53.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.816 0.308 . . . . 0.87 110.996 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 19.6 mm-40 -113.15 158.21 20.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.727 -0.842 . . . . 1.14 108.727 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 38.6 p30 -88.14 164.78 15.53 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.613 -0.514 . . . . 1.41 109.613 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.72 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 ptpt -51.63 -2.86 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.978 1.103 . . . . 1.77 113.978 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 30' ' ' ASN . 65.8 m-85 -106.73 0.21 24.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.647 -0.501 . . . . 1.08 109.647 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.33 37.11 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.738 -0.744 . . . . 0.54 112.864 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 14.6 mmmm -112.15 145.57 39.59 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.339 0.59 . . . . 3.25 111.639 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.4 m -86.75 123.71 32.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.487 -1.233 . . . . 1.55 110.753 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -138.52 178.31 7.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.863 -0.608 . . . . 1.38 110.421 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -91.3 141.38 28.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.874 0.369 . . . . 2.78 110.623 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ttt -86.88 126.44 63.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 1.32 110.815 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.37 124.91 9.76 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.752 2.301 . . . . 1.24 112.864 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.556 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 47.3 tt0 -79.33 134.71 36.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 1.15 111.365 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.3 24.36 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.788 -0.72 . . . . 0.68 113.647 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 53' ' ' ILE . 48.7 mtpt -105.07 126.9 52.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 117.075 0.438 . . . . 2.3 111.941 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.657 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.7 p -91.1 122.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.014 -0.735 . . . . 0.93 109.014 171.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.0 mtm -119.11 155.69 31.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.389 -0.823 . . . . 1.31 109.548 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -107.33 156.55 18.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.245 1.021 . . . . 1.64 112.515 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.7 p -109.48 159.78 16.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.446 -1.706 . . . . 0.53 110.28 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 47' ' ' ARG . 57.7 mtt-85 -59.34 -24.0 62.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.588 0.588 . . . . 3.73 112.588 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -96.07 -2.44 46.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.178 0.513 . . . . 2.7 110.64 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.68 15.12 32.61 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.761 -0.733 . . . . 0.77 113.068 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.8 m -93.9 146.11 24.14 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 110.201 -0.296 . . . . 1.35 110.201 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -107.73 134.07 51.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.691 -0.485 . . . . 1.84 109.691 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 12' ' ' LEU . 33.0 pt -138.17 156.83 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 0.66 111.462 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.79 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -158.41 154.03 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.811 -0.631 . . . . 0.98 109.678 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.608 ' N ' HG12 ' A' ' 53' ' ' ILE . 28.0 ttt -107.73 119.53 39.7 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.658 -1.238 . . . . 1.5 107.658 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 1.9 mmmt -138.57 134.85 34.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.083 -0.34 . . . . 1.69 110.083 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.22 30.35 75.65 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.836 -0.697 . . . . 1.21 111.821 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.44 25.78 15.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.37 0.605 . . . . 2.9 111.542 -176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 54' ' ' MET . 41.8 mt-10 -123.59 151.41 42.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.384 -0.825 . . . . 1.66 110.251 175.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.61 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.19 121.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.774 0.797 . . . . 0.92 111.353 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.79 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -83.91 111.9 19.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.893 -1.049 . . . . 0.71 108.277 168.622 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 2.8 tmm_? -122.14 108.86 13.82 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.613 -1.625 . . . . 3.56 106.613 171.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 3.8 mm? . . . . . 0 N--CA 1.476 0.872 0 O-C-N 124.268 0.98 . . . . 1.4 112.749 -166.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.8 mmm . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 112.411 0.522 . . . . 2.17 112.411 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -101.49 -25.71 13.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 1.47 110.985 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -99.94 13.54 33.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.006 0.431 . . . . 1.89 111.177 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 12.9 p -102.35 129.3 54.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 1.25 110.257 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.32 -21.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.642 -0.423 . . . . 1.03 111.46 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -166.64 142.84 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.437 0.637 . . . . 1.41 111.211 176.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -121.02 144.73 48.37 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.961 -1.018 . . . . 0.4 109.823 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.474 ' CD1' HG21 ' A' ' 46' ' ' THR . 29.9 m-85 -123.03 133.14 54.35 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.855 0.836 . . . . 1.06 111.953 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.6 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 9.8 m-20 -97.94 121.83 40.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.928 -1.487 . . . . 1.94 108.911 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.903 ' HG ' ' HB2' ' A' ' 16' ' ' SER . 0.6 OUTLIER -67.48 -10.11 48.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.497 -1.229 . . . . 1.5 112.458 -173.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 28.5 tt0 94.03 -22.65 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.4 1.062 . . . . 1.68 109.253 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -96.25 -34.9 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.688 -0.687 . . . . 2.11 109.473 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 155.19 -30.91 0.65 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.478 -0.868 . . . . 1.28 112.926 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.903 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.7 OUTLIER -57.79 141.37 49.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 1.07 110.29 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 127.44 50.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.236 -0.438 . . . . 1.84 111.071 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.511 HG23 HD21 ' A' ' 12' ' ' LEU . 75.0 t -107.19 138.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.212 -0.662 . . . . 0.41 109.212 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 4.3 m-70 -127.01 132.82 50.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 109.641 -0.503 . . . . 0.67 109.641 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 59' ' ' ILE . 69.4 t -102.12 122.4 54.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 106.947 -1.501 . . . . 0.81 106.947 170.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -92.11 155.26 18.18 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.559 -0.746 . . . . 0.64 110.757 -169.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.75 -8.61 29.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.303 -0.862 . . . . 2.87 111.755 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -92.48 0.96 57.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.17 -13.81 64.34 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.807 -1.088 . . . . 0.58 113.878 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.87 -174.52 4.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.603 0.702 . . . . 1.74 109.448 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.551 ' HG3' HG12 ' A' ' 59' ' ' ILE . 1.6 pmm? -152.83 154.2 34.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.901 0.381 . . . . 1.07 110.15 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.6 153.49 24.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.5 -0.64 . . . . 0.39 111.5 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 ttt -125.75 139.8 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.27 0.557 . . . . 0.87 111.539 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.41 155.67 36.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 1.14 109.441 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.463 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 65.2 t30 -94.12 159.73 15.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.285 -0.635 . . . . 1.41 109.285 175.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.679 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.8 ptmt -48.73 -23.73 1.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.076 1.139 . . . . 1.77 114.076 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.463 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 36.2 m-85 -90.45 -2.63 57.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.472 . . . . 1.08 110.152 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.13 26.36 16.45 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.54 112.01 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -100.7 135.82 41.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.724 0.773 . . . . 3.25 111.855 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 p -79.33 110.69 14.86 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.948 -1.478 . . . . 1.55 110.243 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -127.25 177.07 6.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.321 -0.4 . . . . 1.38 111.128 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -88.4 132.9 34.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.234 0.54 . . . . 2.78 111.755 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.1 ttt -91.83 125.55 56.83 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.743 -0.662 . . . . 1.32 109.948 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.87 124.08 7.22 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.605 2.204 . . . . 1.24 113.037 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.653 ' HG2' ' HD2' ' A' ' 55' ' ' LYS . 38.2 tt0 -82.11 133.98 35.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 1.15 110.34 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 102.88 -12.4 56.2 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.783 -0.723 . . . . 0.68 111.901 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -96.53 123.9 40.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.626 0.25 . . . . 2.3 111.41 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.636 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -90.7 127.56 43.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.885 -0.783 . . . . 0.93 108.885 172.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.4 mtm -126.16 156.95 39.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.069 -0.514 . . . . 1.31 109.901 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.553 ' HG2' ' HG3' ' A' ' 51' ' ' LYS . 38.9 mt-10 -108.58 169.4 8.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.982 0.896 . . . . 1.64 112.281 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.474 HG21 ' CD1' ' A' ' 10' ' ' TYR . 42.7 p -120.33 168.31 11.41 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.862 -1.517 . . . . 0.53 110.73 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 11.2 ptt180 -59.49 -21.83 60.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.473 0.654 . . . . 3.73 111.086 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -97.81 -5.86 33.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.94 -1.027 . . . . 2.7 110.921 -170.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.56 11.26 58.35 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.52 -0.848 . . . . 0.77 112.999 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.704 HG22 HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -90.05 148.18 23.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.426 -0.583 . . . . 1.35 109.426 177.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.595 ' O ' ' HE1' ' A' ' 60' ' ' PHE . 1.9 mptp? -111.87 130.55 55.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.157 -0.683 . . . . 1.84 109.157 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.46 157.64 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.238 -0.437 . . . . 0.66 110.826 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -158.81 150.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 0.98 110.266 177.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.535 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 60.2 ttp -105.72 123.79 48.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.581 -1.266 . . . . 1.5 107.581 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HD2' ' HG2' ' A' ' 40' ' ' GLU . 21.6 tptp -144.5 133.63 22.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.88 -0.415 . . . . 1.69 109.88 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.56 30.58 78.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.117 -0.563 . . . . 1.21 111.768 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 60.27 24.77 14.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.445 0.64 . . . . 2.9 111.009 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.25 152.22 36.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.198 -0.91 . . . . 1.66 109.581 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.38 120.21 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.054 0.931 . . . . 0.92 110.879 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.595 ' HE1' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -84.03 119.18 24.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.188 -1.369 . . . . 0.71 107.435 166.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -111.28 100.18 8.85 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.54 -2.022 . . . . 3.56 105.54 166.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.704 HD21 HG22 ' A' ' 50' ' ' THR . 29.7 mt . . . . . 0 C--N 1.321 -0.645 0 O-C-N 124.327 1.017 . . . . 1.4 113.076 -171.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.754 0.311 . . . . 2.17 111.033 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -82.29 -32.41 29.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.418 0.628 . . . . 1.47 110.245 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.3 t-20 -94.74 -1.29 53.25 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.333 -0.849 . . . . 1.89 111.065 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.6 p -107.39 131.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 119.102 -1.039 . . . . 1.25 111.643 -175.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.65 -25.59 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.961 -0.563 . . . . 1.03 112.398 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -167.38 136.08 2.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.81 0.814 . . . . 1.41 112.036 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 m -108.54 142.09 39.48 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.198 -1.365 . . . . 0.4 109.819 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -122.85 136.69 54.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.852 0.834 . . . . 1.06 112.122 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.98 120.36 34.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.81 -1.541 . . . . 1.94 109.114 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 16' ' ' SER . 15.1 mt -80.4 145.88 31.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.531 -1.285 . . . . 1.5 107.531 173.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.556 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 7.9 tt0 -62.8 -13.98 39.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.22 0.452 . . . . 1.68 112.22 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.68 -20.99 21.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.093 0.473 . . . . 2.11 110.151 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.65 -20.44 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.854 -0.689 . . . . 1.28 113.325 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 12' ' ' LEU . 15.8 m -63.34 152.28 38.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.93 0.395 . . . . 1.07 110.466 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' MET . 59.0 mttp -122.98 127.9 49.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.05 0.452 . . . . 1.84 111.362 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.04 149.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.041 -0.725 . . . . 0.41 109.041 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.663 ' HB3' HG21 ' A' ' 6' ' ' VAL . 1.2 m-70 -140.14 139.82 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.769 -0.582 . . . . 0.67 110.377 172.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.599 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 47.2 t -102.1 122.57 54.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.42 -1.326 . . . . 0.81 107.42 171.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.454 ' HE1' ' N ' ' A' ' 27' ' ' GLY . 95.9 m-85 -96.27 157.21 16.0 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.233 -0.44 . . . . 0.64 111.512 -169.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 22.7 mtpp -62.67 -23.15 66.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.181 0.592 . . . . 2.87 111.765 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.99 6.37 48.13 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.342 -0.984 . . . . 1.97 108.342 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.64 -5.38 76.91 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 114.347 -1.297 . . . . 0.58 114.923 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -90.3 178.34 6.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.266 1.033 . . . . 1.74 110.757 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . 1.048 ' HG2' HD12 ' A' ' 59' ' ' ILE . 4.2 mpp? -138.35 145.55 41.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.954 -0.566 . . . . 1.07 109.979 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -132.48 148.21 19.11 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.838 -0.696 . . . . 0.39 111.713 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 27.4 ttt -127.88 146.84 50.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.407 0.622 . . . . 0.87 112.09 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' CD ' ' HE2' ' A' ' 19' ' ' HIS . 3.1 mp0 -129.73 157.89 40.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.101 -1.074 . . . . 1.14 108.101 171.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -86.47 171.0 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.028 -0.36 . . . . 1.41 110.028 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 62.6 pttt -54.06 -14.23 1.01 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.129 0.788 . . . . 1.77 113.129 174.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -91.15 -0.82 57.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.011 0.434 . . . . 1.08 110.22 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.44 65.06 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.079 -0.581 . . . . 0.54 112.047 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 34' ' ' LYS . 1.7 mmmp? -103.12 135.36 44.93 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.739 0.78 . . . . 3.25 111.0 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 p -77.31 122.1 24.64 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 113.85 -1.523 . . . . 1.55 111.451 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -151.07 148.59 28.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 1.38 110.168 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.55 140.87 32.14 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.662 -0.415 . . . . 2.78 110.221 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.42 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -98.78 150.44 36.69 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.062 -0.517 . . . . 1.32 110.888 -177.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.6 154.45 64.41 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.062 2.508 . . . . 1.24 112.183 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.573 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 26.7 tt0 -75.62 141.23 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 1.15 110.416 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.4 -10.76 19.55 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.508 -0.853 . . . . 0.68 113.758 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.6 mtpt -92.61 115.65 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.832 0.678 . . . . 2.3 112.832 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.2 p -86.32 125.35 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.563 -0.902 . . . . 0.93 108.563 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.9 mtm -120.56 152.92 37.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.333 -0.394 . . . . 1.31 110.62 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.59 140.53 29.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.629 0.728 . . . . 1.64 111.247 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 44.4 p -103.18 162.47 12.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.661 -1.154 . . . . 0.53 110.225 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 2.8 mmt85 -59.42 -21.08 59.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.582 0.706 . . . . 3.73 111.289 171.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -88.9 0.82 56.25 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.921 -1.036 . . . . 2.7 111.418 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.03 72.72 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.57 -0.824 . . . . 0.77 111.272 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.541 ' CG2' HD21 ' A' ' 62' ' ' LEU . 11.1 p -115.08 171.74 7.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.803 -0.443 . . . . 1.35 109.803 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.62 145.08 50.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.31 -0.404 . . . . 1.84 110.07 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 61' ' ' ARG . 34.5 pt -137.77 159.2 34.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.801 -0.636 . . . . 0.66 110.719 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.73 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -156.88 153.34 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 0.98 109.817 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.62 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -114.05 106.76 14.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.609 -0.886 . . . . 1.5 108.609 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 36.0 tttm -144.27 145.96 32.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.868 0.366 . . . . 1.69 110.524 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.28 31.92 82.37 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.637 -0.711 . . . . 1.21 112.379 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 72.37 -9.35 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.409 0.623 . . . . 2.9 110.902 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -96.17 -179.07 4.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.487 -0.779 . . . . 1.66 110.51 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.048 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.0 OUTLIER -135.98 128.38 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.581 0.705 . . . . 0.92 109.86 173.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.73 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.39 111.99 19.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.008 -0.996 . . . . 0.71 108.612 172.588 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.639 ' HG3' HH11 ' A' ' 61' ' ' ARG . 6.0 tpt85 -120.55 107.17 12.53 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.951 -1.5 . . . . 3.56 106.951 171.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' A' ' 50' ' ' THR . 4.0 mm? . . . . . 0 N--CA 1.472 0.634 0 CA-C-N 114.724 -1.126 . . . . 1.4 112.982 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 mmt . . . . . 0 C--O 1.234 0.255 0 CA-C-O 120.912 0.387 . . . . 2.17 111.431 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.7 m -97.25 -27.49 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.833 0.349 . . . . 1.47 111.044 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.695 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 20.4 p30 -101.46 12.37 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.315 0.579 . . . . 1.89 111.026 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 9.2 p -107.69 127.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.092 -0.643 . . . . 1.25 111.659 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 20' ' ' VAL . 23.5 m -80.3 -23.88 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.639 -0.71 . . . . 1.03 111.025 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -167.87 129.21 1.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 1.41 111.029 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.8 m -102.48 138.19 39.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.808 -1.087 . . . . 0.4 109.558 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 39.2 m-85 -108.09 123.19 48.33 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.076 0.941 . . . . 1.06 111.809 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.961 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 6.1 m-20 -94.9 114.0 25.79 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.442 -1.708 . . . . 1.94 109.92 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -87.68 152.49 22.11 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.386 -0.825 . . . . 1.5 109.089 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -69.45 -6.32 29.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.432 0.634 . . . . 1.68 110.746 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -95.09 -7.94 38.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.582 -0.735 . . . . 2.11 109.29 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 101.43 -19.08 52.3 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.22 -0.9 . . . . 1.28 111.88 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.624 ' HB2' HD12 ' A' ' 12' ' ' LEU . 5.0 m -61.96 145.9 51.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 1.07 110.491 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.7 125.16 46.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.16 0.505 . . . . 1.84 110.594 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -105.76 154.71 6.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.482 -0.933 . . . . 0.41 108.482 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.607 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 51.8 m-70 -136.58 134.65 37.66 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.848 -0.532 . . . . 0.67 109.737 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 7' ' ' VAL . 47.3 t -97.31 111.98 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 106.298 -1.741 . . . . 0.81 106.298 166.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 19' ' ' HIS . 80.9 m-85 -84.39 154.83 22.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.715 -0.675 . . . . 0.64 110.72 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 7.7 ptmm? -58.58 -23.45 58.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.318 -0.856 . . . . 2.87 112.68 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.646 ' HB2' ' HE2' ' A' ' 25' ' ' LYS . 7.7 m-20 -98.01 6.66 47.4 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.156 -0.683 . . . . 1.97 109.156 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 -5.03 66.79 Favored Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 115.078 -0.964 . . . . 0.58 114.787 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -81.88 171.75 14.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.272 1.036 . . . . 1.74 110.382 176.013 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.719 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.5 mpp? -137.0 143.51 42.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.974 -0.557 . . . . 1.07 109.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.87 143.21 14.81 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.383 -0.687 . . . . 0.39 111.383 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.125 0.488 . . . . 0.87 110.799 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 45.8 mt-10 -125.78 153.88 43.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.338 -0.847 . . . . 1.14 109.149 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.57 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 38.3 p-10 -88.98 168.31 12.47 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.61 -0.515 . . . . 1.41 109.61 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 63.9 pttt -53.31 1.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.053 1.131 . . . . 1.77 114.053 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 30' ' ' ASN . 84.7 m-85 -111.09 -2.7 15.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.939 -0.476 . . . . 1.08 110.522 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.92 32.69 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.294 -0.955 . . . . 0.54 113.598 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.57 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -120.42 147.46 45.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.129 -0.628 . . . . 3.25 110.683 174.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -74.57 128.05 34.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.991 -1.004 . . . . 1.55 111.351 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 ptm -126.85 -179.72 4.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.08 -0.509 . . . . 1.38 110.666 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.05 154.38 37.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 2.78 110.109 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.2 ttt -119.88 127.28 26.47 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.178 -0.305 . . . . 1.32 110.178 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.43 148.57 33.85 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.458 2.106 . . . . 1.24 112.863 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.15 139.72 43.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.722 -0.672 . . . . 1.15 109.512 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.52 -31.53 5.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.495 -0.86 . . . . 0.68 112.648 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -82.08 142.19 32.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.72 0.295 . . . . 2.3 110.848 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.596 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.0 p -97.55 130.21 46.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.215 0.531 . . . . 0.93 110.472 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -102.83 140.55 36.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.777 -0.647 . . . . 1.31 109.7 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.51 146.99 27.71 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.21 0.528 . . . . 1.64 110.314 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.3 p -100.46 168.23 9.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.573 -0.74 . . . . 0.53 110.72 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.961 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 39.3 mtt180 -46.57 -41.29 14.19 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.413 0.894 . . . . 3.73 113.413 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.02 -43.48 7.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.871 -0.731 . . . . 2.7 112.098 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.26 28.82 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 119.308 -1.425 . . . . 0.77 113.587 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.0 m -102.44 149.28 24.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.291 -1.003 . . . . 1.35 108.291 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 94.3 mttt -126.15 144.17 50.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.614 -0.434 . . . . 1.84 111.794 -173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 61' ' ' ARG . 39.3 pt -138.0 157.92 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.44 -0.8 . . . . 0.66 110.786 -176.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.94 148.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.818 0.342 . . . . 0.98 110.359 176.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.47 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -111.52 127.02 55.58 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.562 -0.533 . . . . 1.5 109.562 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 55' ' ' LYS . 51.3 tptt -145.24 129.38 17.59 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.791 -0.448 . . . . 1.69 109.791 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.19 36.58 89.33 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.941 -0.647 . . . . 1.21 112.711 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 71.85 -9.63 0.95 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.483 0.713 . . . . 2.9 111.355 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 56' ' ' GLY . 55.4 mm-40 -86.05 139.15 31.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.161 -0.472 . . . . 1.66 111.16 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.719 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -102.08 124.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.576 0.703 . . . . 0.92 110.901 176.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.48 119.63 25.37 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.076 -1.083 . . . . 0.71 108.076 169.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.555 ' HG3' ' OH ' ' A' ' 10' ' ' TYR . 11.1 ttm180 -116.07 101.01 8.36 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.515 -1.661 . . . . 3.56 106.515 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 O-C-N 124.895 1.372 . . . . 1.4 113.532 -163.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.3 mtp . . . . . 0 N--CA 1.444 -0.772 0 CA-C-O 121.207 0.527 . . . . 2.17 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 m -112.95 -36.53 5.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.629 -0.714 . . . . 1.47 111.271 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 1.008 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 10.6 t-20 -114.84 -0.57 13.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.55 0.691 . . . . 1.89 111.779 -174.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.689 HG21 ' HB3' ' A' ' 19' ' ' HIS . 7.8 p -102.73 134.38 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.917 -1.114 . . . . 1.25 111.381 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -87.13 -23.86 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.932 0.345 . . . . 1.03 111.932 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.9 131.45 1.65 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.727 0.775 . . . . 1.41 111.736 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -105.64 142.62 35.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.439 -1.255 . . . . 0.4 109.479 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.483 ' CD1' HG21 ' A' ' 46' ' ' THR . 21.2 m-85 -121.7 134.74 54.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.382 -0.827 . . . . 1.06 111.15 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.602 ' CB ' ' HD3' ' A' ' 47' ' ' ARG . 1.2 m-20 -97.03 117.24 30.76 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.987 -1.46 . . . . 1.94 108.454 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 16' ' ' SER . 5.9 mt -72.15 0.81 8.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.891 0.7 . . . . 1.5 112.891 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.548 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 88.72 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.787 0.803 . . . . 1.68 108.999 173.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -80.52 -35.74 34.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.685 -1.143 . . . . 2.11 108.564 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.633 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 148.3 -26.72 1.39 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.431 -1.258 . . . . 1.28 113.315 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.677 ' HB2' HD12 ' A' ' 12' ' ' LEU . 1.4 m -60.64 146.39 45.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.758 -0.46 . . . . 1.07 109.758 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -121.94 126.42 48.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.107 0.479 . . . . 1.84 110.538 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.3 t -108.46 141.79 22.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.04 -0.726 . . . . 0.41 109.04 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.689 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -137.53 131.11 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.174 -0.61 . . . . 0.67 110.428 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 59' ' ' ILE . 60.7 t -102.89 123.98 56.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 107.522 -1.288 . . . . 0.81 107.522 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 97.9 m-85 -98.61 161.4 13.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.963 -0.562 . . . . 0.64 111.219 -167.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.008 ' HE2' ' HA ' ' A' ' 5' ' ' ASN . 41.4 mtmt -62.15 -19.56 63.18 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.179 -0.464 . . . . 2.87 111.95 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.911 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 2.1 m-20 -83.98 -9.39 58.71 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.275 -1.009 . . . . 1.97 108.275 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.89 -5.06 59.5 Favored Glycine 0 N--CA 1.421 -2.358 0 CA-C-N 114.731 -1.122 . . . . 0.58 113.338 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.911 ' HD3' ' HB2' ' A' ' 23' ' ' ASP . 1.6 mppt? -82.62 -177.1 6.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 117.748 0.774 . . . . 1.74 109.417 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 1.7 pmm? -153.81 147.61 25.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.757 -0.656 . . . . 1.07 109.676 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.406 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.27 155.05 21.91 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.786 -0.721 . . . . 0.39 111.964 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.6 ttt -124.95 141.53 52.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.121 0.486 . . . . 0.87 111.656 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 27.2 mt-10 -126.45 153.49 44.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.098 -1.075 . . . . 1.14 108.098 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -93.42 172.63 8.16 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.403 -0.519 . . . . 1.41 110.542 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.633 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 60.8 pttt -53.07 -14.78 0.67 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.605 0.965 . . . . 1.77 113.605 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -95.9 -3.12 45.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.065 -0.397 . . . . 1.08 110.914 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.34 22.65 47.04 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.825 -0.702 . . . . 0.54 112.199 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 mmtt -102.34 134.04 46.29 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.875 0.845 . . . . 3.25 110.81 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 p -76.75 129.21 35.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.665 -1.607 . . . . 1.55 111.545 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 55.4 mtm -136.77 162.9 31.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 1.38 110.064 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -90.96 156.47 17.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.343 -0.389 . . . . 2.78 110.03 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 41.5 ttm -99.98 127.66 32.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 1.32 111.612 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.13 118.5 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.539 2.159 . . . . 1.24 111.922 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.1 tt0 -68.58 137.06 53.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.759 -0.655 . . . . 1.15 110.802 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -9.14 37.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.68 113.471 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -104.22 130.29 51.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.335 0.568 . . . . 2.3 112.132 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.696 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.2 p -93.78 132.66 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 0.93 110.366 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.4 mtm -124.8 153.18 42.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.487 -0.779 . . . . 1.31 109.712 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -107.4 167.78 9.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.523 0.678 . . . . 1.64 111.688 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 54.3 p -127.59 164.87 21.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.655 -1.157 . . . . 0.53 112.067 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.602 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 75.0 mtp180 -59.65 -29.66 68.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.413 -0.812 . . . . 3.73 111.423 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -95.18 -7.33 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 2.7 111.333 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.37 16.42 27.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.328 -0.939 . . . . 0.77 112.913 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.519 HG23 ' CD2' ' A' ' 62' ' ' LEU . 99.3 m -93.31 139.8 30.25 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.95 -0.389 . . . . 1.35 109.95 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -106.64 132.7 52.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.104 -0.702 . . . . 1.84 109.104 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.417 ' HA ' ' HD1' ' A' ' 60' ' ' PHE . 17.3 pt -136.6 152.82 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.901 0.334 . . . . 0.66 111.901 -175.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.696 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.56 149.81 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.945 -0.571 . . . . 0.98 110.359 174.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.563 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.6 ttt -103.86 123.33 46.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.102 -0.703 . . . . 1.5 109.102 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 23.2 tptm -145.48 128.14 16.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.754 -0.461 . . . . 1.69 109.754 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.14 43.32 97.34 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.61 -0.596 . . . . 1.21 111.61 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 50.12 21.17 0.71 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.182 0.993 . . . . 2.9 112.174 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -116.9 152.09 35.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 1.66 110.511 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.507 HG13 HG22 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -98.93 122.63 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.133 0.968 . . . . 0.92 111.666 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.501 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -82.66 111.6 18.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.238 -1.393 . . . . 0.71 107.238 164.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.506 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 5.8 ttm180 -116.47 103.93 10.93 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.709 -1.96 . . . . 3.56 105.709 170.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD2' HG23 ' A' ' 50' ' ' THR . 3.8 mm? . . . . . 0 N--CA 1.473 0.709 0 O-C-N 124.082 0.864 . . . . 1.4 112.202 -166.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.0 mtp . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.9 0.381 . . . . 2.17 111.65 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m -78.93 -27.77 43.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.35 0.595 . . . . 1.47 110.504 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 17.3 p30 -108.28 9.61 27.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.769 0.795 . . . . 1.89 110.558 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.415 HG11 ' OG1' ' A' ' 9' ' ' THR . 84.5 t -102.48 127.74 55.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.399 -0.819 . . . . 1.25 110.842 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 22' ' ' LYS . 24.5 m -86.7 -23.27 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 1.03 110.964 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.37 138.76 3.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 1.41 110.581 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.415 ' OG1' HG11 ' A' ' 6' ' ' VAL . 3.4 m -120.76 143.97 48.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.484 -0.78 . . . . 0.4 109.728 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.76 129.39 51.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.372 1.082 . . . . 1.06 111.653 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -96.76 125.47 41.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.117 -1.856 . . . . 1.94 108.99 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.613 HD12 ' HB2' ' A' ' 16' ' ' SER . 16.7 mt -80.84 148.81 29.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.117 -1.068 . . . . 1.5 108.117 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.562 ' HG2' ' HA ' ' A' ' 47' ' ' ARG . 51.9 mt-30 -65.06 -5.34 6.2 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.98 0.363 . . . . 1.68 111.98 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.33 -27.11 14.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.518 . . . . 2.11 110.129 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 135.24 -19.58 3.84 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.771 -0.728 . . . . 1.28 113.124 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.613 ' HB2' HD12 ' A' ' 12' ' ' LEU . 6.3 m -68.56 155.55 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.827 0.346 . . . . 1.07 110.584 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -124.99 127.72 47.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.265 -0.425 . . . . 1.84 111.069 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -108.23 143.47 18.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.754 -0.832 . . . . 0.41 108.754 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' MET . 4.0 m-70 -131.14 130.12 42.69 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.088 -0.645 . . . . 0.67 110.62 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 116.38 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.79 -1.559 . . . . 0.81 106.79 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' HE1' ' N ' ' A' ' 27' ' ' GLY . 73.1 m-85 -85.63 155.28 21.19 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.72 -0.673 . . . . 0.64 111.316 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 12.8 ptmm? -57.49 -22.85 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.964 -1.016 . . . . 2.87 112.273 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -94.46 2.52 55.73 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.843 -0.799 . . . . 1.97 108.843 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.39 -11.57 59.91 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.83 -1.077 . . . . 0.58 114.386 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.66 179.87 7.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.082 0.941 . . . . 1.74 111.19 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.622 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -139.44 143.62 37.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.144 0.497 . . . . 1.07 109.983 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -136.79 146.28 18.21 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.932 -0.867 . . . . 0.39 110.932 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.4 ttt -122.62 144.73 48.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.932 0.396 . . . . 0.87 111.302 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -126.75 148.89 49.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.946 -1.131 . . . . 1.14 107.946 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -86.38 170.44 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.231 -0.588 . . . . 1.41 110.121 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 19.3 pttm -58.02 1.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.626 0.972 . . . . 1.77 113.626 173.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -107.47 -1.84 21.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 1.08 109.521 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.3 22.17 52.4 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.819 -0.705 . . . . 0.54 112.268 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -110.97 137.82 48.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.413 0.625 . . . . 3.25 111.414 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -74.65 139.12 43.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.163 -1.38 . . . . 1.55 111.869 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.1 ptm -150.45 178.82 8.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.612 -0.722 . . . . 1.38 109.602 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -104.84 158.95 16.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 2.78 110.629 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.8 ttt -101.45 130.2 25.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 1.32 110.091 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.98 132.86 17.4 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.71 2.273 . . . . 1.24 112.772 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 54' ' ' MET . 36.6 tt0 -73.89 138.42 44.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.15 110.23 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.93 62.73 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.824 -0.703 . . . . 0.68 112.979 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -102.93 127.02 50.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 2.3 111.887 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.609 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.7 p -95.6 132.27 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.582 -0.735 . . . . 0.93 109.138 178.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.6 mtm -119.48 148.55 43.13 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.792 -0.447 . . . . 1.31 109.792 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -102.99 147.32 27.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.228 0.537 . . . . 1.64 110.746 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.83 162.34 14.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.325 -0.852 . . . . 0.53 111.264 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.562 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 99.7 mtt180 -58.85 -26.2 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.88 -0.6 . . . . 3.73 111.786 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.68 -14.94 38.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 2.7 110.402 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.79 26.33 6.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.912 -0.661 . . . . 0.77 112.95 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.786 HG21 HH11 ' A' ' 61' ' ' ARG . 43.6 m -111.13 165.16 12.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.505 -0.554 . . . . 1.35 109.505 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' N ' HG22 ' A' ' 50' ' ' THR . 68.1 mttm -122.42 143.83 49.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.592 -0.522 . . . . 1.84 109.592 176.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 20.6 pt -136.32 150.5 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 0.66 111.141 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.699 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.15 144.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.313 -0.403 . . . . 0.98 110.732 177.073 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 25.8 ttt -99.99 138.18 37.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.597 -0.52 . . . . 1.5 109.597 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 21.0 tptp -144.41 103.35 3.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 1.69 107.883 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 -152.1 45.63 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.055 -1.618 . . . . 1.21 109.055 -164.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.63 8.48 14.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.106 0.479 . . . . 2.9 110.644 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -104.76 177.87 4.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.994 0.425 . . . . 1.66 110.481 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.622 HD12 ' HG2' ' A' ' 26' ' ' MET . 11.2 tt -143.59 141.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.746 0.784 . . . . 0.92 110.884 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -82.49 114.72 21.1 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.438 -1.319 . . . . 0.71 107.438 169.306 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.786 HH11 HG21 ' A' ' 50' ' ' THR . 0.4 OUTLIER -114.49 102.75 10.36 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.527 -1.657 . . . . 3.56 106.527 170.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.66 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.571 1.768 0 O-C-N 124.457 1.098 . . . . 1.4 111.746 -172.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 121.039 0.447 . . . . 2.17 111.117 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 p -81.52 -7.21 59.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.57 0.7 . . . . 1.47 110.917 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -129.44 11.75 5.86 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.068 0.937 . . . . 1.89 109.039 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -117.37 133.47 64.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.016 -1.447 . . . . 1.25 111.658 -175.369 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 22' ' ' LYS . 35.6 m -88.24 -26.37 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.541 -0.754 . . . . 1.03 111.536 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -167.15 135.79 2.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.344 0.593 . . . . 1.41 111.167 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 m -114.23 144.45 43.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.907 -1.042 . . . . 0.4 110.102 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.49 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 30.9 m-85 -120.15 132.19 55.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.552 0.692 . . . . 1.06 111.136 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.55 125.76 51.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.238 -1.346 . . . . 1.94 108.698 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 16' ' ' SER . 17.4 mt -81.16 153.63 27.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.377 -1.283 . . . . 1.5 107.832 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -65.85 -7.31 15.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.217 0.532 . . . . 1.68 111.232 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.615 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 31.6 t70 -98.45 -13.52 20.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 2.11 109.98 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.551 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 116.07 -13.45 16.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.651 -0.785 . . . . 1.28 113.425 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.602 ' HB2' HD12 ' A' ' 12' ' ' LEU . 4.9 m -72.96 148.19 44.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.792 0.296 . . . . 1.07 110.592 -176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -118.93 127.58 53.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.308 0.575 . . . . 1.84 112.454 -172.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.9 t -109.57 143.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.165 -1.05 . . . . 0.41 108.165 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' MET . 5.5 m-70 -132.28 137.98 47.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.738 -0.785 . . . . 0.67 110.602 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.48 ' O ' HG22 ' A' ' 7' ' ' VAL . 46.5 t -97.67 115.21 36.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.131 -1.433 . . . . 0.81 107.131 169.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 49.5 m-85 -80.6 153.66 27.88 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.933 -0.576 . . . . 0.64 111.167 -173.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.768 ' HA ' HG13 ' A' ' 7' ' ' VAL . 16.7 pttm -57.58 -27.01 62.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.998 -1.001 . . . . 2.87 111.756 -176.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.36 -1.23 54.12 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.209 -0.663 . . . . 1.97 109.209 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.41 41.0 Favored Glycine 0 N--CA 1.423 -2.168 0 C-N-CA 119.92 -1.133 . . . . 0.58 114.879 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -75.05 176.38 7.29 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.934 1.367 . . . . 1.74 111.737 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 2.2 mpp? -140.44 148.82 41.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.07 109.945 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.83 145.26 17.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.619 -0.801 . . . . 0.39 111.724 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 ttt -119.27 137.8 53.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.511 . . . . 0.87 110.924 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 23.1 mt-10 -130.58 154.25 48.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.308 -0.86 . . . . 1.14 109.035 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 41.7 p30 -88.42 169.1 12.08 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.275 -0.57 . . . . 1.41 110.053 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 14' ' ' ASP . 40.6 pttt -53.6 -10.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.097 1.147 . . . . 1.77 114.097 175.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -99.03 -1.52 39.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 1.08 110.602 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.52 20.53 51.28 Favored Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.856 -0.688 . . . . 0.54 111.909 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 27.9 mmmt -102.17 135.62 43.45 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.644 0.735 . . . . 3.25 111.334 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -74.7 127.57 33.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.032 -1.44 . . . . 1.55 111.011 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.3 ptm -138.27 176.49 8.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 1.38 110.736 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.56 131.19 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.118 -0.492 . . . . 2.78 109.849 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.8 ttp -85.2 117.64 69.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.965 -0.562 . . . . 1.32 110.445 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.46 147.43 64.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.86 2.373 . . . . 1.24 112.809 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 34.6 tt0 -88.82 144.82 25.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.001 -0.545 . . . . 1.15 110.385 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.87 -16.73 60.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.014 -0.613 . . . . 0.68 112.569 176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 42' ' ' LYS . 42.3 mmtm -94.88 119.73 33.93 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.116 0.413 . . . . 2.3 112.116 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.576 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 10.7 p -94.02 119.58 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.078 -0.712 . . . . 0.93 109.078 174.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 65.3 mtm -107.74 152.17 24.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.603 -0.726 . . . . 1.31 110.613 -170.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 50' ' ' THR . 38.1 tt0 -104.64 145.41 30.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.538 0.685 . . . . 1.64 111.497 -176.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.0 p -94.93 166.63 11.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.746 -1.115 . . . . 0.53 109.925 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -35.92 -49.37 0.62 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.57 1.322 . . . . 3.73 114.57 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.84 -33.69 15.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.48 -0.488 . . . . 2.7 111.978 -170.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.79 34.23 0.17 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.985 -1.102 . . . . 0.77 112.837 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.5 m -100.87 153.32 19.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.486 -0.931 . . . . 1.35 108.486 176.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB3' HG22 ' A' ' 43' ' ' VAL . 93.4 mttt -124.26 139.55 53.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.432 -0.507 . . . . 1.84 112.075 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.479 ' HA ' ' CE1' ' A' ' 60' ' ' PHE . 31.6 pt -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.148 -0.933 . . . . 0.66 110.201 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.733 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -163.41 155.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.825 0.345 . . . . 0.98 111.137 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.67 ' N ' HG12 ' A' ' 53' ' ' ILE . 13.4 tmm? -104.79 117.22 33.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.247 -1.019 . . . . 1.5 108.247 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 20.2 tptp -134.0 125.6 28.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.31 -0.626 . . . . 1.69 109.31 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.07 38.13 88.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.756 -0.735 . . . . 1.21 112.155 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.6 t30 62.46 28.57 16.85 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.607 0.718 . . . . 2.9 110.852 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' MET . 46.0 mt-10 -141.29 159.87 41.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.656 -0.702 . . . . 1.66 110.409 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -102.16 126.64 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.456 0.646 . . . . 0.92 111.404 -177.273 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.733 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.81 110.35 18.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.313 -1.736 . . . . 0.71 106.313 164.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 1.2 tmm_? -114.47 103.64 11.24 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.632 -1.618 . . . . 3.56 106.632 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.476 0.845 0 O-C-N 124.385 1.053 . . . . 1.4 113.404 -165.442 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.573 ' HA ' HG12 ' A' ' 6' ' ' VAL . 22.6 mmt . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.731 0.3 . . . . 2.17 111.466 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -92.74 -37.36 12.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 1.47 111.004 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.56 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -107.0 -6.47 17.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.235 0.541 . . . . 1.89 111.417 -176.269 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 19' ' ' HIS . 4.8 p -94.73 141.1 15.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.95 -0.469 . . . . 1.25 110.502 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -94.98 -23.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.865 -0.334 . . . . 1.03 110.9 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -160.15 136.53 8.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.383 0.611 . . . . 1.41 110.82 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -121.2 135.2 55.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.024 -0.989 . . . . 0.4 109.538 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 27.8 m-85 -117.26 134.06 55.25 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.864 0.84 . . . . 1.06 111.754 -177.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 10.7 t70 -104.08 126.15 50.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.188 -1.369 . . . . 1.94 108.517 176.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 16' ' ' SER . 8.8 mt -71.51 0.09 9.26 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.423 -1.262 . . . . 1.5 112.623 -172.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 7.6 tt0 86.87 -24.37 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.963 -0.754 . . . . 1.68 108.963 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -95.15 -21.13 18.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.102 -0.954 . . . . 2.11 109.16 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.584 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 139.36 -29.97 2.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.543 -0.837 . . . . 1.28 113.945 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' HD12 ' A' ' 12' ' ' LEU . 3.8 m -66.05 149.07 50.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 117.09 0.445 . . . . 1.07 110.264 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 46.8 mttm -124.44 126.72 46.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 1.84 111.432 -172.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.58 141.81 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.897 -0.779 . . . . 0.41 108.897 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.585 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.9 m-70 -130.59 130.19 43.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.331 -0.547 . . . . 0.67 110.27 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.09 111.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.058 -1.46 . . . . 0.81 107.058 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 85.6 m-85 -89.72 163.09 15.24 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.02 -0.536 . . . . 0.64 110.888 -168.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 24.9 mtpp -66.82 -21.05 66.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.423 0.63 . . . . 2.87 110.387 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.41 -13.33 59.95 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.276 -1.009 . . . . 1.97 108.276 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.99 71.14 Favored Glycine 0 N--CA 1.422 -2.258 0 CA-C-N 114.043 -1.435 . . . . 0.58 112.93 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -78.49 171.9 14.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.622 0.725 . . . . 1.74 111.452 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.707 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.0 mpp? -130.74 138.14 49.82 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.625 -1.171 . . . . 1.07 110.022 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.37 139.27 10.83 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 111.218 -0.753 . . . . 0.39 111.218 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.9 ttt -117.73 133.97 55.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.253 0.549 . . . . 0.87 110.877 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.03 149.33 42.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.11 -0.95 . . . . 1.14 108.64 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 32' ' ' PHE . 43.9 p30 -86.96 169.5 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.658 -0.417 . . . . 1.41 110.132 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 45.8 pttt -59.24 5.08 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.44 0.904 . . . . 1.77 113.44 172.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 30' ' ' ASN . 89.5 m-85 -106.78 -2.9 21.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.169 -0.678 . . . . 1.08 109.169 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.07 27.48 40.6 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.789 -0.641 . . . . 0.54 114.074 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 157.14 42.55 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.054 -0.658 . . . . 3.25 111.332 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 p -74.66 126.52 31.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 1.55 111.181 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -126.27 -175.61 3.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.977 -0.556 . . . . 1.38 110.804 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.22 132.06 35.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 2.78 110.233 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 27.6 ttt -97.62 123.55 51.65 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.204 -0.453 . . . . 1.32 110.41 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.73 152.09 82.62 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.81 2.34 . . . . 1.24 111.731 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 53' ' ' ILE . 32.8 tt0 -83.75 -90.59 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.052 -0.259 . . . . 1.15 111.042 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.539 ' HA2' HD11 ' A' ' 53' ' ' ILE . . . -81.15 40.76 2.56 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.179 -0.534 . . . . 0.68 113.85 -170.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -109.44 119.63 40.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.652 0.263 . . . . 2.3 110.818 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.544 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.4 p -81.34 117.91 28.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 0.93 109.361 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.8 mtm -103.2 146.4 28.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 1.31 110.996 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 51' ' ' LYS . 32.9 tt0 -98.75 151.64 20.55 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.353 -0.839 . . . . 1.64 109.866 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -126.41 164.75 20.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.004 0.431 . . . . 0.53 112.14 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -60.43 -28.7 68.49 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.749 -0.659 . . . . 3.73 111.91 176.169 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 20.0 t70 -90.71 -19.15 23.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.618 -0.719 . . . . 2.7 110.87 -171.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.25 15.62 18.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.632 -0.794 . . . . 0.77 112.488 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.519 HG23 HD22 ' A' ' 62' ' ' LEU . 63.8 m -94.75 142.93 26.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.906 -0.405 . . . . 1.35 109.906 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' NZ ' ' HB2' ' A' ' 45' ' ' GLU . 67.1 mmtt -108.67 132.33 54.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 1.84 108.848 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.3 pt -135.99 156.91 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.763 0.283 . . . . 0.66 111.763 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -165.19 150.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.764 -0.653 . . . . 0.98 110.121 176.218 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 16.6 tmm? -111.43 129.94 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.968 -0.382 . . . . 1.5 109.968 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -144.35 124.69 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.589 -0.278 . . . . 1.69 110.272 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 62.54 39.51 97.94 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.835 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 72.55 -10.66 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.213 0.53 . . . . 2.9 111.208 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 54' ' ' MET . 45.2 mt-10 -89.79 167.84 12.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.138 -0.483 . . . . 1.66 109.98 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -126.26 125.66 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.879 0.847 . . . . 0.92 110.875 -178.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.762 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -81.56 110.41 16.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.248 -1.39 . . . . 0.71 107.248 169.211 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 38.7 ttp-105 -125.96 112.01 15.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.43 -1.693 . . . . 3.56 106.43 174.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 50' ' ' THR . 4.2 mm? . . . . . 0 N--CA 1.474 0.771 0 O-C-N 124.196 0.935 . . . . 1.4 112.668 -166.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.806 0.336 . . . . 2.17 111.444 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -73.57 -24.94 60.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.903 0.859 . . . . 1.47 109.873 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -105.3 10.39 33.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.664 -1.153 . . . . 1.89 110.595 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 19' ' ' HIS . 74.5 t -105.87 135.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.479 -0.782 . . . . 1.25 109.959 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -105.84 -18.46 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.035 -0.53 . . . . 1.03 111.072 -178.121 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -169.01 132.95 1.4 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.123 0.487 . . . . 1.41 110.613 171.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.0 m -110.89 143.8 40.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.381 -0.827 . . . . 0.4 110.583 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.563 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 20.7 m-85 -124.9 139.82 53.49 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.425 0.631 . . . . 1.06 111.441 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.723 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 16' ' ' SER . 43.3 mt -83.21 148.96 27.12 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.99 -1.004 . . . . 1.5 109.654 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.27 -15.49 35.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.309 0.576 . . . . 1.68 111.618 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 20.7 t70 -96.39 -1.79 46.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.545 -0.752 . . . . 2.11 109.785 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 104.58 -19.3 42.37 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.113 -0.949 . . . . 1.28 112.832 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.669 ' HB2' HD12 ' A' ' 12' ' ' LEU . 40.1 m -72.84 159.97 32.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.574 -0.313 . . . . 1.07 110.671 -177.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 32.8 mttt -119.43 152.55 36.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.136 0.493 . . . . 1.84 110.694 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.408 HG11 HD12 ' A' ' 52' ' ' ILE . 75.4 t -131.48 144.25 38.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.855 -0.794 . . . . 0.41 108.855 174.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HB3' HG13 ' A' ' 6' ' ' VAL . 3.1 m-70 -134.6 135.15 42.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.48 -0.563 . . . . 0.67 109.48 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 7' ' ' VAL . 48.2 t -93.63 118.24 39.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 106.579 -1.638 . . . . 0.81 106.579 168.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.401 ' HE1' ' HA3' ' A' ' 27' ' ' GLY . 48.7 m-85 -81.98 150.36 27.68 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.77 -0.65 . . . . 0.64 110.9 -172.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -61.34 -22.33 64.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 2.87 111.768 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -99.69 6.65 45.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.76 0.791 . . . . 1.97 109.079 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.24 1.49 60.97 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.711 -1.131 . . . . 0.58 115.007 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -75.89 173.11 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.827 1.314 . . . . 1.74 111.21 172.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.701 ' HG2' HD12 ' A' ' 59' ' ' ILE . 3.2 mpp? -138.07 131.33 30.43 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.343 -0.984 . . . . 1.07 108.343 171.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA3' ' HE1' ' A' ' 21' ' ' PHE . . . -124.0 141.92 13.82 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.249 -0.977 . . . . 0.39 111.922 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.5 ttt -113.64 141.0 47.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.793 0.33 . . . . 0.87 110.191 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 16.6 mt-10 -123.53 144.66 49.42 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.619 -1.252 . . . . 1.14 107.619 169.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.434 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 29.9 p-10 -87.62 165.91 15.09 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.87 -0.732 . . . . 1.41 109.169 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 pttm -52.22 -13.21 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.607 0.966 . . . . 1.77 113.607 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.434 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 93.7 m-85 -98.73 7.77 45.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.923 0.392 . . . . 1.08 110.669 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.02 20.57 64.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.248 -0.501 . . . . 0.54 113.0 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.3 mmtm -102.01 140.83 35.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.746 0.784 . . . . 3.25 111.024 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.3 p -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.913 -1.494 . . . . 1.55 112.327 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.2 mtp -139.07 178.34 7.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.032 -0.985 . . . . 1.38 109.83 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -114.79 139.25 49.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.058 -0.719 . . . . 2.78 109.058 173.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.0 ttm -71.24 127.11 91.78 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.648 0.261 . . . . 1.32 110.86 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.87 114.49 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.19 1.927 . . . . 1.24 111.253 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.5 tt0 -61.87 129.45 41.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.807 -0.633 . . . . 1.15 110.373 -176.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.41 -20.22 30.51 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.125 -0.56 . . . . 0.68 112.781 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 42' ' ' LYS . 22.2 mmmt -88.55 119.83 29.36 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 2.3 111.907 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.675 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.98 136.47 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.554 -0.535 . . . . 0.93 109.554 172.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 68.2 mtm -132.22 157.12 45.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.579 -0.282 . . . . 1.31 110.751 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.33 150.75 20.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.882 0.849 . . . . 1.64 111.941 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 30.1 p -97.19 165.78 11.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.29 -1.323 . . . . 0.53 108.87 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -46.66 -36.33 6.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.996 0.739 . . . . 3.73 112.996 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -96.78 -49.96 4.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.356 0.502 . . . . 2.7 112.356 -168.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.9 32.24 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.411 -1.376 . . . . 0.77 113.712 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.6 t -114.03 156.65 23.72 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.457 -0.942 . . . . 1.35 108.457 168.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -120.38 145.67 46.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.651 0.263 . . . . 1.84 110.596 -171.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 12' ' ' LEU . 22.6 pt -136.46 152.28 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.887 -0.597 . . . . 0.66 110.863 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.97 147.38 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.066 -0.515 . . . . 0.98 110.549 176.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 26.2 ttt -97.53 129.66 44.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.26 -0.644 . . . . 1.5 109.26 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -144.99 128.33 16.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.159 -0.311 . . . . 1.69 110.159 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.32 37.25 93.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.471 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 61.24 25.33 15.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.674 0.749 . . . . 2.9 111.05 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -128.06 -169.51 2.08 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.807 -1.088 . . . . 1.66 108.45 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.701 HD12 ' HG2' ' A' ' 26' ' ' MET . 3.3 tt -143.54 136.43 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.792 0.806 . . . . 0.92 111.529 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.665 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.1 109.41 17.13 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.795 -1.557 . . . . 0.71 106.795 167.18 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.563 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 1.3 tmm_? -121.35 108.87 14.22 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 105.031 -2.211 . . . . 3.56 105.031 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 4.5 mm? . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 1.4 109.163 -156.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.582 ' HG3' ' HE1' ' A' ' 21' ' ' PHE . 21.0 mmt . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 111.89 0.33 . . . . 2.17 111.89 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 3' ' ' MET . 73.6 m 73.53 -27.62 0.19 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.809 0.843 . . . . 1.47 109.335 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 3' ' ' MET . 2.4 t-20 -95.85 -14.7 22.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.939 -1.028 . . . . 1.89 109.914 168.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.8 p -89.18 136.11 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 119.384 -0.926 . . . . 1.25 110.088 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.25 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.962 -0.295 . . . . 1.03 111.499 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 16.7 tppt? -169.32 151.49 4.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.228 0.537 . . . . 1.41 111.286 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 3.9 m -133.08 145.75 51.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.553 -0.749 . . . . 0.4 109.795 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 61' ' ' ARG . 38.7 m-85 -128.61 144.63 51.19 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.723 0.773 . . . . 1.06 112.333 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.948 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 6.5 m-20 -106.56 123.7 48.5 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.782 -1.553 . . . . 1.94 110.026 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -77.34 1.84 17.63 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.92 -1.491 . . . . 1.5 113.022 -173.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 47' ' ' ARG . 62.7 tt0 83.68 -32.61 0.07 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.059 0.544 . . . . 1.68 109.998 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.8 t70 -79.87 -20.14 46.63 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.429 -1.323 . . . . 2.11 107.429 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.598 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.54 -17.2 6.53 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.266 -1.334 . . . . 1.28 113.485 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' HD12 ' A' ' 12' ' ' LEU . 11.3 m -62.51 143.74 56.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.841 0.353 . . . . 1.07 110.414 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 65.7 mttm -116.46 126.96 54.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.088 -0.505 . . . . 1.84 110.713 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' THR . 97.1 t -109.58 136.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.524 -0.547 . . . . 0.41 109.524 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.65 ' HB3' HG21 ' A' ' 6' ' ' VAL . 2.5 m-70 -123.34 127.43 48.49 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.366 -0.534 . . . . 0.67 110.418 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.46 115.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.555 -1.276 . . . . 0.81 107.555 171.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HE1' ' HG3' ' A' ' 3' ' ' MET . 91.0 m-85 -94.93 164.41 12.92 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.273 -0.421 . . . . 0.64 111.248 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 54.1 mttm -60.53 -26.25 66.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.931 0.492 . . . . 2.87 112.26 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -91.07 3.56 54.42 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.653 0.739 . . . . 1.97 109.07 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.08 -2.02 81.01 Favored Glycine 0 N--CA 1.427 -1.919 0 CA-C-N 114.562 -1.199 . . . . 0.58 113.589 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -81.05 173.35 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.332 0.566 . . . . 1.74 110.792 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 3.7 mpp? -134.43 138.64 44.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.498 -0.773 . . . . 1.07 109.627 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.55 134.22 9.89 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.096 -0.802 . . . . 0.39 111.096 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' SER . 1.7 tmt? -113.73 134.63 54.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.811 0.339 . . . . 0.87 110.211 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 35.8 mt-10 -126.49 148.52 49.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 1.14 109.294 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.588 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.2 p-10 -85.95 171.33 11.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.678 -0.49 . . . . 1.41 109.678 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.598 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 37.3 pttt -59.18 5.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.982 1.104 . . . . 1.77 113.982 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.1 m-85 -113.05 3.28 16.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.306 0.574 . . . . 1.08 109.711 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.36 23.56 65.2 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.54 113.711 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.588 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -112.55 144.86 41.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.333 -0.547 . . . . 3.25 110.48 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 28' ' ' MET . 24.9 t -78.83 136.69 37.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.203 -0.908 . . . . 1.55 111.553 -173.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.6 mtm -133.62 175.04 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.05 -0.722 . . . . 1.38 109.05 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -96.19 140.49 30.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.9 0.381 . . . . 2.78 110.618 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -95.52 121.6 61.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.828 -0.624 . . . . 1.32 110.953 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.547 ' HG2' ' HG3' ' A' ' 42' ' ' LYS . 59.3 Cg_endo -75.18 125.23 9.07 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.407 2.071 . . . . 1.24 112.299 176.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.512 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 43.9 tt0 -66.72 142.0 57.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.15 110.606 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.04 -2.85 51.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.862 -0.685 . . . . 0.68 112.835 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HG3' ' HG2' ' A' ' 39' ' ' PRO . 11.7 mmpt? -100.8 122.73 43.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.749 -0.265 . . . . 2.3 111.384 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.644 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.84 124.59 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.678 0.751 . . . . 0.93 109.084 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtt -116.6 148.32 41.04 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.359 -0.837 . . . . 1.31 109.257 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -102.85 155.95 17.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.981 0.42 . . . . 1.64 110.587 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.6 p -104.24 163.42 12.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 0.53 110.951 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.948 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 1.7 ptt180 -50.12 -30.03 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.686 0.995 . . . . 3.73 113.686 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.49 -31.06 16.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.461 -0.336 . . . . 2.7 111.318 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.92 19.64 1.58 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.164 -1.017 . . . . 0.77 113.299 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.2 m -100.38 160.02 14.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 1.35 109.072 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -117.08 139.07 51.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.713 0.292 . . . . 1.84 110.589 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.824 HG22 ' HD3' ' A' ' 61' ' ' ARG . 17.1 pt -132.89 158.39 43.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.146 -0.479 . . . . 0.66 109.719 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.686 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -158.28 143.15 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.252 0.548 . . . . 0.98 111.765 175.271 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.452 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.1 ttt -90.96 112.62 24.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.489 -0.93 . . . . 1.5 108.489 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 50.9 tptt -145.13 130.25 18.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.198 -0.456 . . . . 1.69 110.059 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.7 40.43 37.6 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.132 -0.556 . . . . 1.21 112.559 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.14 31.74 20.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.456 0.646 . . . . 2.9 110.402 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -149.27 175.81 11.08 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.722 -0.844 . . . . 1.66 108.722 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -126.77 134.98 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.704 0.764 . . . . 0.92 111.158 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -93.81 131.4 39.23 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.855 -1.066 . . . . 0.71 108.748 171.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.824 ' HD3' HG22 ' A' ' 52' ' ' ILE . 14.8 tpt85 -157.12 100.42 1.86 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 104.56 -2.385 . . . . 3.56 104.56 170.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.9 mm? . . . . . 0 CA--C 1.516 -0.357 0 CA-C-N 118.677 0.671 . . . . 1.4 111.117 -174.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 31.8 mmt . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.857 0.36 . . . . 2.17 110.741 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 m -71.59 -27.25 63.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.814 0.816 . . . . 1.47 110.191 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 19.5 p30 -115.13 17.76 16.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.597 -1.183 . . . . 1.89 111.238 -174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 19' ' ' HIS . 76.3 t -111.79 115.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.666 -0.697 . . . . 1.25 109.974 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 20' ' ' VAL . 2.8 p -90.71 -18.54 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.575 -0.738 . . . . 1.03 110.578 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -167.23 130.09 1.73 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.482 0.658 . . . . 1.41 110.782 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 6' ' ' VAL . 83.7 m -108.35 145.81 33.92 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.646 -1.161 . . . . 0.4 109.935 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HE2' ' HD3' ' A' ' 61' ' ' ARG . 26.7 m-85 -123.91 133.23 53.78 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 121.743 0.783 . . . . 1.06 111.384 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.674 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -101.53 122.71 44.32 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.024 -1.444 . . . . 1.94 109.071 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.587 HD12 ' HB2' ' A' ' 16' ' ' SER . 41.0 mt -83.46 151.24 25.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.898 -1.046 . . . . 1.5 108.487 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 47' ' ' ARG . 75.8 mt-30 -66.69 -8.16 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.643 0.735 . . . . 1.68 111.355 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 3.9 t70 -87.14 -23.14 24.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.051 -0.977 . . . . 2.11 109.378 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.566 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 115.34 -25.2 9.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.758 -1.11 . . . . 1.28 111.699 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.587 ' HB2' HD12 ' A' ' 12' ' ' LEU . 49.5 m -66.53 157.13 33.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.97 0.414 . . . . 1.07 110.234 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -125.51 147.41 49.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.243 0.544 . . . . 1.84 112.056 -171.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.95 148.59 24.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.993 -1.003 . . . . 0.41 108.487 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.552 ' HB3' HG13 ' A' ' 6' ' ' VAL . 12.8 m-70 -135.06 137.15 42.63 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.254 -0.579 . . . . 0.67 109.923 172.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 7' ' ' VAL . 49.7 t -95.52 109.41 22.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 106.573 -1.64 . . . . 0.81 106.573 166.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.57 155.82 29.48 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.37 -0.832 . . . . 0.64 110.714 -171.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 47.7 mtpt -68.85 -18.53 64.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.68 0.752 . . . . 2.87 110.217 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.43 -6.22 59.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.571 -1.195 . . . . 1.97 108.056 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.23 6.3 71.51 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 113.986 -1.461 . . . . 0.58 112.995 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -86.75 177.44 7.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.297 0.57 . . . . 1.74 110.653 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.961 ' HG2' HD12 ' A' ' 59' ' ' ILE . 4.5 mpp? -139.91 140.21 36.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.122 -0.945 . . . . 1.07 109.221 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.78 151.2 21.91 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.252 -0.975 . . . . 0.39 112.242 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 ttt -122.05 142.28 50.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.999 0.428 . . . . 0.87 110.746 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 34.5 mt-10 -130.68 151.47 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.013 -1.106 . . . . 1.14 108.013 175.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 32' ' ' PHE . 27.4 p-10 -84.6 167.71 16.01 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.41 109.657 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.566 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 15.0 pttm -50.9 4.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.868 1.433 . . . . 1.77 114.868 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.3 m-85 -122.96 2.82 9.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.255 -0.278 . . . . 1.08 111.155 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.39 27.61 43.03 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.479 -0.867 . . . . 0.54 112.964 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 25.7 mmmt -100.85 130.09 46.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.717 0.77 . . . . 3.25 110.247 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -80.82 127.55 32.66 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.152 -1.386 . . . . 1.55 112.593 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 65.4 mtm -127.63 -171.96 2.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.58 -0.736 . . . . 1.38 109.431 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -97.86 156.01 16.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.885 -0.413 . . . . 2.78 109.885 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.457 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 17.4 tpt -82.81 122.77 78.38 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 1.32 110.809 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 69.5 Cg_endo -79.13 117.83 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.517 2.144 . . . . 1.24 112.841 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -87.64 139.54 30.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.624 -0.716 . . . . 1.15 110.447 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.62 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 108.13 -9.37 36.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.988 -0.625 . . . . 0.68 113.284 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 42' ' ' LYS . 29.4 mtpp -109.64 131.19 55.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.242 0.46 . . . . 2.3 112.242 -175.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.638 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.5 p -100.91 131.18 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.136 -0.69 . . . . 0.93 109.136 170.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.4 mtm -135.16 173.12 12.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.812 -0.631 . . . . 1.31 109.927 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -107.12 164.75 11.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.308 1.051 . . . . 1.64 112.259 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -108.85 162.35 14.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.359 -1.746 . . . . 0.53 108.93 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.674 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 75.9 mtp180 -55.47 -23.52 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.233 0.457 . . . . 3.73 112.233 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.43 -2.99 37.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.323 . . . . 2.7 111.091 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.24 23.9 13.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.547 -0.835 . . . . 0.77 113.326 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.753 HG23 HD23 ' A' ' 62' ' ' LEU . 64.4 m -95.04 137.08 34.57 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.773 -0.251 . . . . 1.35 110.431 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -99.59 127.98 45.69 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.044 -0.354 . . . . 1.84 110.044 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 18.8 pt -135.09 155.07 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.984 -0.553 . . . . 0.66 110.685 -176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -157.35 149.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.922 0.391 . . . . 0.98 110.41 174.278 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.3 ttt -108.19 118.73 37.52 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.073 -1.084 . . . . 1.5 108.073 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.62 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 23.9 tptp -144.68 135.52 24.83 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.203 -0.665 . . . . 1.69 109.203 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.83 32.12 82.69 Favored Glycine 0 C--N 1.322 -0.212 0 C-N-CA 121.018 -0.61 . . . . 1.21 112.647 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 62.81 19.6 11.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.232 0.539 . . . . 2.9 111.31 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.74 152.56 39.3 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.593 -0.73 . . . . 1.66 109.276 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.961 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -114.22 127.86 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.62 0.724 . . . . 0.92 111.889 177.76 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.621 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -96.06 130.81 42.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.728 -1.212 . . . . 0.71 107.728 167.309 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.557 ' HD3' ' HE2' ' A' ' 10' ' ' TYR . 7.8 ptt180 -156.46 100.39 1.96 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.047 -1.834 . . . . 3.56 106.047 173.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.753 HD23 HG23 ' A' ' 50' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 109.002 -0.74 . . . . 1.4 109.002 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 C--O 1.231 0.082 0 N-CA-C 112.108 0.41 . . . . 2.17 112.108 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -78.34 -33.01 49.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.453 . . . . 1.47 110.449 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.617 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 25.4 p-10 -97.79 1.81 48.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 1.89 110.696 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.7 t -94.03 130.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 1.25 110.204 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 20' ' ' VAL . 20.2 m -93.3 -25.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.465 -0.494 . . . . 1.03 111.918 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -164.16 142.61 7.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 1.41 110.489 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 53.4 m -125.05 140.84 52.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.226 -0.443 . . . . 0.4 110.458 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 36.2 m-85 -112.38 128.83 56.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.693 0.759 . . . . 1.06 112.001 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -102.15 114.9 29.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.717 -1.583 . . . . 1.94 109.826 -178.102 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' A' ' 13' ' ' GLN . 6.6 mt -75.22 -0.8 20.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.352 1.242 . . . . 1.5 114.352 -168.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.656 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 56.9 mt-30 90.84 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.672 0.789 . . . . 1.68 110.17 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.58 -28.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.412 -0.959 . . . . 2.11 108.412 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.693 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 140.24 -22.66 2.74 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.42 -1.264 . . . . 1.28 113.57 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.623 ' HB3' HD12 ' A' ' 12' ' ' LEU . 23.0 t -64.39 141.89 58.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.772 0.796 . . . . 1.07 110.456 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -120.78 126.72 50.84 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.201 -1.363 . . . . 1.84 110.297 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 9' ' ' THR . 86.3 t -112.69 126.25 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.437 -0.801 . . . . 0.41 109.041 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 26' ' ' MET . 11.9 m-70 -115.62 128.7 56.13 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.565 -0.854 . . . . 0.67 109.733 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.496 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 46.3 t -90.33 112.55 24.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 106.737 -1.579 . . . . 0.81 106.737 172.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -88.16 161.8 17.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.857 -0.61 . . . . 0.64 110.614 -173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 8.1 mtpm? -61.02 -26.35 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.331 0.586 . . . . 2.87 111.28 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.08 -7.2 59.68 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.162 -0.926 . . . . 1.97 108.836 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.62 -0.99 68.33 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.573 -1.194 . . . . 0.58 113.172 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -85.82 179.68 7.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.309 0.576 . . . . 1.74 110.775 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.747 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 59.5 mtm -143.15 148.1 36.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.955 -1.021 . . . . 1.07 110.381 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.12 135.28 8.74 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.228 -0.896 . . . . 0.39 111.052 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 35' ' ' SER . 26.8 ttt -111.05 126.61 55.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.082 -0.34 . . . . 0.87 110.082 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 48.6 mt-10 -128.11 155.83 43.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.662 -0.866 . . . . 1.14 108.662 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 39.4 p30 -91.79 175.32 6.93 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.418 -0.513 . . . . 1.41 110.238 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.693 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 4.4 pttm -51.53 -11.45 0.13 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.604 0.964 . . . . 1.77 113.604 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -105.28 -5.02 20.93 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.321 -0.237 . . . . 1.08 111.179 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.41 25.38 28.43 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.798 -0.715 . . . . 0.54 112.417 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 26.3 mmtp -108.68 137.66 46.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.324 0.583 . . . . 3.25 111.845 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 28' ' ' MET . 47.3 t -71.97 131.33 42.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.438 -1.255 . . . . 1.55 111.266 -175.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 64.0 mtm -126.04 177.03 6.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 1.38 109.45 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -97.82 127.11 43.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.895 -0.409 . . . . 2.78 109.895 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.456 ' HE2' ' HB2' ' A' ' 54' ' ' MET . 23.9 ttt -83.01 126.18 73.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.855 -0.611 . . . . 1.32 111.044 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.68 153.32 38.54 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.999 2.466 . . . . 1.24 112.88 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.5 tt0 -112.51 141.89 45.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 1.15 109.983 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.03 2.84 64.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.43 -0.89 . . . . 0.68 112.603 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -109.58 138.73 45.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.585 0.231 . . . . 2.3 111.38 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 59.4 t -90.0 119.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.513 -0.551 . . . . 0.93 109.513 171.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -109.74 154.0 23.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 1.31 110.303 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -104.26 155.61 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.546 0.689 . . . . 1.64 111.517 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 47.8 p -111.32 156.83 20.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.28 -1.327 . . . . 0.53 109.869 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.536 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 47.8 mtp180 -57.53 -21.89 41.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.798 0.296 . . . . 3.73 111.798 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -89.99 -3.39 58.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 2.7 110.84 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 26.9 25.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.73 -0.748 . . . . 0.77 113.669 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.2 p -108.19 159.69 16.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.331 0.566 . . . . 1.35 110.038 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -111.01 135.72 51.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.244 -0.435 . . . . 1.84 109.953 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.563 HG22 ' CG ' ' A' ' 61' ' ' ARG . 8.8 pt -132.17 165.98 30.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 0.66 111.067 -173.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.678 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -159.44 142.22 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.342 -0.39 . . . . 0.98 110.974 167.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.456 ' HB2' ' HE2' ' A' ' 38' ' ' MET . 17.1 tmm? -95.62 120.71 36.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.922 -1.14 . . . . 1.5 107.922 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.6 tptt -137.43 112.5 9.08 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.323 -0.621 . . . . 1.69 109.323 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 67.26 52.2 33.19 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.811 -0.631 . . . . 1.21 112.61 -176.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 73.99 -35.24 0.3 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.818 0.847 . . . . 2.9 111.796 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' GLY . 43.1 mt-10 -78.92 156.27 28.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.106 -0.497 . . . . 1.66 110.841 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.747 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -113.79 129.69 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.47 0.652 . . . . 0.92 109.681 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.678 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -93.91 112.93 24.85 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.874 -0.787 . . . . 0.71 108.874 169.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.68 ' HD3' HD23 ' A' ' 62' ' ' LEU . 2.7 tmt_? -140.29 103.75 4.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.442 -2.059 . . . . 3.56 105.442 160.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.68 HD23 ' HD3' ' A' ' 61' ' ' ARG . 3.5 mm? . . . . . 0 N--CA 1.471 0.603 0 CA-C-N 118.607 0.639 . . . . 1.4 111.658 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.478 ' HA ' HG12 ' A' ' 6' ' ' VAL . 36.5 mtp . . . . . 0 N--CA 1.442 -0.837 0 CA-C-O 121.544 0.688 . . . . 2.17 109.76 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -92.8 -45.07 8.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.042 . . . . 1.47 110.704 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.42 -5.54 35.97 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.321 0.582 . . . . 1.89 110.891 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.9 p -86.81 125.36 40.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.68 -0.808 . . . . 1.25 109.932 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.87 -23.42 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 1.03 111.001 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -167.5 133.21 2.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.43 0.633 . . . . 1.41 111.2 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.41 HG23 ' ND1' ' A' ' 19' ' ' HIS . 2.3 m -111.63 139.78 46.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.946 -1.025 . . . . 0.4 109.635 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -115.14 129.66 56.72 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.227 1.013 . . . . 1.06 111.727 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -100.73 124.49 46.42 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.14 -1.845 . . . . 1.94 108.176 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.897 HD22 ' HB2' ' A' ' 16' ' ' SER . 10.2 mp -77.68 4.78 10.68 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.455 -0.793 . . . . 1.5 112.231 -174.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.722 ' HG3' ' HD2' ' A' ' 47' ' ' ARG . 25.2 tt0 82.36 -26.99 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.127 0.489 . . . . 1.68 110.315 167.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -103.39 -49.58 3.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.572 -0.74 . . . . 2.11 110.149 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.634 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . -166.32 -52.58 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.366 -1.397 . . . . 1.28 115.301 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.897 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.2 m -70.86 161.95 30.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.327 0.564 . . . . 1.07 111.163 -171.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -129.6 145.98 51.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 1.84 110.772 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.635 HG23 HD11 ' A' ' 12' ' ' LEU . 48.6 t -122.34 145.38 29.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.433 -0.951 . . . . 0.41 108.433 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.678 ' HB3' HG21 ' A' ' 6' ' ' VAL . 3.0 m-70 -135.55 134.05 39.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.804 -0.759 . . . . 0.67 110.969 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.93 114.97 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.204 -1.406 . . . . 0.81 107.204 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 95.2 m-85 -91.73 159.56 15.78 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.974 -0.557 . . . . 0.64 110.524 -171.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -68.97 -18.66 64.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.512 0.672 . . . . 2.87 110.053 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD2' ' HE3' ' A' ' 25' ' ' LYS . 26.2 t70 -79.22 -7.95 58.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.812 -1.181 . . . . 1.97 107.812 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.07 -5.86 75.82 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.74 -1.573 . . . . 0.58 113.257 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HE3' ' OD2' ' A' ' 23' ' ' ASP . 9.4 mtmp? -80.3 175.4 10.68 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.413 0.625 . . . . 1.74 111.479 177.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.582 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.3 mpp? -136.2 138.03 41.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.78 -1.1 . . . . 1.07 109.572 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.42 142.36 13.74 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.39 111.854 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.705 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 23.6 ttt -118.54 142.86 47.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.961 0.41 . . . . 0.87 111.099 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 19.5 mt-10 -128.53 147.71 50.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.802 -0.814 . . . . 1.14 108.802 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.499 ' HB3' ' SD ' ' A' ' 36' ' ' MET . 41.6 p30 -87.54 172.34 9.83 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.574 -0.451 . . . . 1.41 110.294 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.634 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.4 ptpt -51.75 -16.73 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.418 0.896 . . . . 1.77 113.418 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.61 -4.43 50.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.721 0.296 . . . . 1.08 110.543 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.67 20.86 49.68 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.902 -0.666 . . . . 0.54 111.827 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.7 mmtm -106.69 139.52 41.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.419 0.628 . . . . 3.25 111.756 -176.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 p -70.25 131.84 44.81 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.516 -1.22 . . . . 1.55 110.549 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.499 ' SD ' ' HB3' ' A' ' 30' ' ' ASN . 19.4 ptm -153.47 174.65 14.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.304 -0.407 . . . . 1.38 110.83 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -123.55 140.89 52.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.745 -0.661 . . . . 2.78 109.562 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.705 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 22.3 ptt? -100.45 150.42 36.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.179 -0.464 . . . . 1.32 110.565 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.84 142.06 50.97 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.825 2.35 . . . . 1.24 112.221 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 29.7 tt0 -71.35 136.6 47.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 1.15 109.833 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -16.04 27.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.362 -0.923 . . . . 0.68 113.459 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -97.31 132.17 43.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.122 0.461 . . . . 2.3 111.756 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.605 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.8 p -99.41 133.92 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.861 -0.608 . . . . 0.93 110.159 174.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.94 151.4 32.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.807 -0.633 . . . . 1.31 109.946 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -94.78 145.73 24.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.678 -0.49 . . . . 1.64 109.678 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -115.96 159.95 20.9 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.82 -0.627 . . . . 0.53 111.057 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.722 ' HD2' ' HG3' ' A' ' 13' ' ' GLN . 18.0 mmm180 -49.13 -28.03 3.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.593 0.757 . . . . 3.73 112.901 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.67 -6.89 59.44 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.567 -0.742 . . . . 2.7 111.363 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.32 58.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.385 -0.912 . . . . 0.77 111.396 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.71 174.42 5.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.208 -0.496 . . . . 1.35 110.392 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 71.3 mmtt -119.24 148.18 43.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.417 -0.356 . . . . 1.84 110.142 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.51 152.39 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 0.66 110.565 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.632 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -159.21 153.95 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.302 -0.408 . . . . 0.98 110.167 176.729 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.506 ' N ' HG12 ' A' ' 53' ' ' ILE . 56.7 ttp -108.51 109.09 20.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.775 -0.824 . . . . 1.5 108.775 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 51.7 tptt -127.42 131.14 50.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.266 -0.642 . . . . 1.69 109.266 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.99 73.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.831 -0.699 . . . . 1.21 111.859 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.26 27.21 16.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.479 0.657 . . . . 2.9 110.112 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 54' ' ' MET . 47.4 mt-10 -123.84 147.6 47.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.536 -0.756 . . . . 1.66 109.36 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.582 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -93.67 118.89 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 122.095 0.95 . . . . 0.92 111.152 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -84.34 116.12 22.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.397 -1.274 . . . . 0.71 108.152 168.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.494 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 19.5 tpt180 -114.94 102.28 9.82 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 106.604 -1.628 . . . . 3.56 106.604 169.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.072 0 O-C-N 125.089 1.493 . . . . 1.4 113.179 -163.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.46 0.034 0 N-CA-C 112.177 0.436 . . . . 2.17 112.177 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -87.68 -35.21 18.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.801 0.334 . . . . 1.47 111.309 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -105.42 3.13 29.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 1.89 111.846 -169.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 19' ' ' HIS . 10.4 p -106.62 135.9 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.014 -0.539 . . . . 1.25 111.493 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.453 HG23 HG13 ' A' ' 20' ' ' VAL . 14.6 m -94.17 -30.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.989 0.423 . . . . 1.03 111.701 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -157.21 138.17 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.389 0.614 . . . . 1.41 110.917 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 1.4 m -119.47 138.54 53.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.294 -0.866 . . . . 0.4 110.083 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 24.4 m-85 -108.9 125.66 52.25 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.738 0.78 . . . . 1.06 111.487 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 71.7 m-20 -98.57 115.35 28.42 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.037 -1.438 . . . . 1.94 110.501 -176.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 16' ' ' SER . 10.2 mt -81.2 149.75 28.93 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.691 -0.855 . . . . 1.5 108.691 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -60.7 -19.44 58.69 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.794 0.665 . . . . 1.68 112.794 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.6 -26.24 23.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 2.11 109.646 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.07 -15.41 6.5 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.277 -0.874 . . . . 1.28 112.284 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.623 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -58.03 140.19 52.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.861 -0.792 . . . . 1.07 108.861 176.607 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.487 ' HG2' ' CE1' ' A' ' 19' ' ' HIS . 24.4 ttmm -125.35 124.22 41.07 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.024 0.44 . . . . 1.84 110.613 -171.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 47.0 t -109.17 151.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.95 -0.759 . . . . 0.41 108.95 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -141.29 137.37 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.153 -0.619 . . . . 0.67 110.924 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.597 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 7.2 p -102.8 125.39 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 0.81 108.03 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.426 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . 71.3 m-85 -93.1 161.59 14.37 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.155 -0.929 . . . . 0.64 111.883 -168.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -67.04 -20.48 65.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.621 -0.718 . . . . 2.87 110.966 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.452 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 29.0 t70 -83.73 -6.05 59.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.153 0.978 . . . . 1.97 108.527 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.79 0.98 68.35 Favored Glycine 0 N--CA 1.427 -1.939 0 CA-C-N 114.287 -1.324 . . . . 0.58 112.718 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 23' ' ' ASP . 31.3 pttt -91.56 179.73 5.58 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.597 -0.149 . . . . 1.74 110.597 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.847 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mtm -141.62 153.89 45.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.742 0.306 . . . . 1.07 110.192 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.63 147.24 18.9 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.558 -0.617 . . . . 0.39 111.558 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.0 ttt -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.293 0.568 . . . . 0.87 111.148 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.4 mt-10 -128.15 157.17 41.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.796 -0.816 . . . . 1.14 108.796 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.444 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 35.3 p-10 -91.51 173.11 8.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.093 -0.336 . . . . 1.41 110.093 174.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.639 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 43.2 pttt -55.92 5.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.409 1.263 . . . . 1.77 114.409 175.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.444 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 97.0 m-85 -115.91 1.18 13.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.018 0.437 . . . . 1.08 110.196 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.25 21.52 62.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.616 -0.802 . . . . 0.54 111.648 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 67.7 mmtt -103.62 131.53 50.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.377 0.608 . . . . 3.25 110.706 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.3 t -67.42 133.76 50.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.434 -1.257 . . . . 1.55 110.597 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.8 ptm -143.46 160.17 41.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.934 -0.576 . . . . 1.38 110.323 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.78 147.59 39.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.193 -0.458 . . . . 2.78 110.213 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.33 130.82 22.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 1.32 110.67 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.41 160.0 29.07 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.933 2.422 . . . . 1.24 112.963 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 54' ' ' MET . 35.1 tt0 -118.89 145.59 45.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.248 -0.433 . . . . 1.15 110.551 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.57 4.26 68.09 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.68 113.009 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.77 138.44 48.35 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.923 -0.163 . . . . 2.3 110.762 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 63.1 t -87.94 120.42 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.831 -0.433 . . . . 0.93 109.831 172.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -106.79 149.84 26.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.741 -0.663 . . . . 1.31 109.788 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -109.68 148.45 31.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.131 0.967 . . . . 1.64 112.208 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 46.0 p -97.72 168.54 10.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.872 -1.513 . . . . 0.53 109.966 -175.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.426 ' HE ' ' CB ' ' A' ' 11' ' ' ASP . 9.2 ptt85 -59.93 -21.96 61.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.971 0.891 . . . . 3.73 110.976 170.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.22 -13.72 49.02 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.025 -1.443 . . . . 2.7 110.984 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.39 53.06 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.684 -0.77 . . . . 0.77 111.993 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.87 153.62 19.34 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.955 -0.387 . . . . 1.35 109.955 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -112.18 129.3 56.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.979 -0.555 . . . . 1.84 109.753 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.702 HG22 ' HG2' ' A' ' 61' ' ' ARG . 1.8 pt -129.87 164.97 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.333 -0.394 . . . . 0.66 110.08 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.497 HG22 ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -164.63 143.14 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.062 0.458 . . . . 0.98 111.336 173.493 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.45 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 21.6 ttt -99.87 134.1 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 1.5 110.112 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -145.7 121.89 10.83 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.775 -0.454 . . . . 1.69 109.775 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.61 52.67 51.68 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.202 -0.523 . . . . 1.21 113.529 177.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.69 -13.27 0.49 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.81 0.444 . . . . 2.9 112.054 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' GLY . 44.1 mt-10 -96.96 148.84 22.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.206 -0.294 . . . . 1.66 110.206 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.847 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -115.96 124.45 72.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.58 0.705 . . . . 0.92 109.694 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -84.83 128.33 34.56 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.833 0.825 . . . . 0.71 109.102 171.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.702 ' HG2' HG22 ' A' ' 52' ' ' ILE . 2.3 tmm_? -158.23 102.41 1.77 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 103.863 -2.643 . . . . 3.56 103.863 170.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.1 mm? . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 119.312 0.96 . . . . 1.4 110.816 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.863 0.364 . . . . 2.17 111.553 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.2 m -89.7 -35.4 15.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.286 -0.416 . . . . 1.47 111.215 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.502 ' HB2' ' HD3' ' A' ' 22' ' ' LYS . 12.2 p-10 -91.9 11.26 25.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.886 0.851 . . . . 1.89 109.608 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 19' ' ' HIS . 57.6 t -108.64 106.85 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.223 -1.353 . . . . 1.25 108.768 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.95 -12.63 11.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.641 -0.709 . . . . 1.03 110.993 -173.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -163.86 139.55 6.38 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.798 -0.637 . . . . 1.41 110.564 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 m -119.23 138.37 53.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.373 -0.83 . . . . 0.4 110.056 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 21.3 m-85 -108.84 123.14 48.58 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.934 0.874 . . . . 1.06 110.958 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.554 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -91.71 113.24 25.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.382 -1.735 . . . . 1.94 110.406 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.78 HD12 ' HB2' ' A' ' 16' ' ' SER . 45.2 mt -85.47 144.5 27.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.678 -0.86 . . . . 1.5 108.678 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 8.0 tt0 -72.84 -0.9 14.74 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.497 0.554 . . . . 1.68 112.497 -170.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -98.44 -16.5 19.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.406 0.622 . . . . 2.11 109.666 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 124.49 -21.39 6.78 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.06 -0.973 . . . . 1.28 112.44 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.78 ' HB2' HD12 ' A' ' 12' ' ' LEU . 25.5 m -70.29 158.1 36.5 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.118 0.485 . . . . 1.07 110.848 -176.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 57.7 mttt -125.19 149.88 47.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.335 -0.393 . . . . 1.84 110.896 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 60.8 t -129.79 122.3 54.4 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.13 -0.693 . . . . 0.41 109.13 173.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 26' ' ' MET . 54.1 m-70 -108.8 132.0 54.42 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.161 -1.016 . . . . 0.67 110.114 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.82 102.08 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 106.47 -1.678 . . . . 0.81 106.47 168.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.71 155.53 38.86 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.262 -0.881 . . . . 0.64 110.694 -172.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HD3' ' HB2' ' A' ' 5' ' ' ASN . 19.5 pttm -51.63 -32.33 28.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.177 -0.919 . . . . 2.87 112.04 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 2.7 p-10 -97.75 10.17 40.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.61 0.719 . . . . 1.97 109.432 -171.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.89 4.68 72.02 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 114.872 -1.058 . . . . 0.58 114.586 172.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -87.68 175.94 7.65 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.124 0.962 . . . . 1.74 111.095 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 4.2 mpp? -140.36 141.72 35.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.888 -1.051 . . . . 1.07 110.339 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.03 146.65 18.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.37 -0.832 . . . . 0.39 111.336 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 24.7 ttt -114.62 129.01 56.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.261 0.553 . . . . 0.87 111.061 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.0 mt-10 -110.0 147.13 34.09 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.159 -1.052 . . . . 1.14 108.159 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.779 ' H ' ' HB2' ' A' ' 34' ' ' LYS . 63.8 t30 -92.05 162.68 14.27 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.742 -1.207 . . . . 1.41 107.742 170.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.629 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 22.3 ptmt -50.72 -20.68 1.31 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.363 0.875 . . . . 1.77 113.363 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 21.9 m-85 -96.52 -6.74 36.35 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.941 -0.475 . . . . 1.08 110.905 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.82 38.73 3.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.826 -0.702 . . . . 0.54 112.807 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.779 ' HB2' ' H ' ' A' ' 30' ' ' ASN . 24.4 mmtt -43.91 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.657 0.614 . . . . 3.25 112.657 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 34' ' ' LYS . 36.5 t 89.09 68.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.233 0.958 . . . . 1.55 109.073 175.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 34' ' ' LYS . 31.6 mtm -119.76 -171.46 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.309 -1.314 . . . . 1.38 109.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -98.07 157.74 15.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.506 0.193 . . . . 2.78 110.695 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.513 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 16.7 tpt -80.24 125.16 81.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.229 -0.441 . . . . 1.32 111.173 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 70.7 Cg_endo -76.37 153.9 35.75 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.615 2.21 . . . . 1.24 112.707 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 38.2 tt0 -94.23 144.13 25.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 1.15 111.359 -177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.98 57.65 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.171 -0.538 . . . . 0.68 113.591 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.3 mtpt -90.99 119.36 31.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.076 0.438 . . . . 2.3 111.632 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.638 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 14.5 p -91.85 126.75 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.331 -0.618 . . . . 0.93 109.331 171.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 68.9 mtm -124.17 154.97 39.3 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.22 -0.659 . . . . 1.31 109.22 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.47 149.68 23.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.087 0.946 . . . . 1.64 112.408 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 47.2 p -103.13 162.09 13.25 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.726 -1.579 . . . . 0.53 110.221 -176.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 80.3 mtm180 -59.52 -19.42 48.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 3.73 110.971 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.09 -24.47 43.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 2.7 111.12 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.06 21.17 12.16 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.77 111.289 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.0 m -115.83 160.81 19.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.545 -0.539 . . . . 1.35 109.545 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.19 144.88 43.02 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.297 -0.261 . . . . 1.84 110.297 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.8 pt -136.84 150.76 26.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 120.439 0.161 . . . . 0.66 111.428 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.675 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.96 149.46 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 0.98 109.719 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.5 ttt -112.29 133.71 54.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.074 -0.343 . . . . 1.5 110.074 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.578 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.2 tptp -142.32 127.68 18.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.571 -0.286 . . . . 1.69 110.583 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 73.15 -28.81 0.8 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 115.244 0.857 . . . . 1.21 115.244 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 56' ' ' GLY . 8.7 t30 150.39 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.584 0.754 . . . . 2.9 109.058 -165.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -97.94 144.71 27.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.293 -0.867 . . . . 1.66 111.796 -171.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.36 124.31 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.019 0.914 . . . . 0.92 111.473 176.108 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.5 128.31 34.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.644 -1.162 . . . . 0.71 108.743 170.218 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.531 ' HD2' ' OH ' ' A' ' 10' ' ' TYR . 52.2 ttt-85 -125.28 126.54 45.29 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.14 -1.8 . . . . 3.56 106.14 162.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.268 0 O-C-N 125.176 1.548 . . . . 1.4 113.288 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 73.4 t . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 110.334 -0.247 . . . . 2.46 110.334 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 67.27 108.56 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 123.912 0.758 . . . . 3.48 110.224 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.445 ' HA ' HG12 ' A' ' 6' ' ' VAL . 76.5 mmm -80.62 0.44 34.12 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.145 0.498 . . . . 2.17 110.688 -176.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -91.45 -23.82 19.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.857 -0.611 . . . . 1.47 111.006 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.541 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 26.1 p30 -109.44 7.77 25.05 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 120.526 -0.47 . . . . 1.89 111.399 -176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.8 p -108.47 128.9 63.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.32 -0.4 . . . . 1.25 110.991 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.48 HG13 ' HG2' ' A' ' 22' ' ' LYS . 4.7 m -81.77 -27.85 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.094 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -167.35 134.31 2.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 1.41 110.582 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -108.22 137.25 46.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.26 -0.882 . . . . 0.4 109.943 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.656 ' CD1' HG21 ' A' ' 46' ' ' THR . 1.4 m-85 -110.61 127.29 55.18 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.348 -0.842 . . . . 1.06 111.133 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -100.09 119.25 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.711 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 9.4 mp -80.5 149.56 29.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.998 -1.001 . . . . 1.5 109.581 -175.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -65.55 -11.83 47.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.663 0.744 . . . . 1.68 110.595 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.46 -16.49 28.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.11 109.702 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.542 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 110.49 -22.19 22.63 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.803 -1.09 . . . . 1.28 112.223 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.587 ' HB2' HD22 ' A' ' 12' ' ' LEU . 19.6 m -67.71 161.92 24.9 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.071 -0.714 . . . . 1.07 109.071 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -133.81 146.53 50.76 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.43 0.529 . . . . 1.84 112.43 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.643 HG23 HD11 ' A' ' 12' ' ' LEU . 68.9 t -123.58 148.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.264 -0.88 . . . . 0.41 109.073 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HB3' HG21 ' A' ' 6' ' ' VAL . 6.0 m-70 -134.46 130.4 36.67 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.317 -0.553 . . . . 0.67 109.995 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 40.4 t -93.5 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.922 -1.51 . . . . 0.81 106.922 171.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 81.2 m-85 -89.35 155.9 19.05 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.018 0.437 . . . . 0.64 111.236 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 40.1 mtpt -68.19 -12.0 60.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.705 -0.68 . . . . 2.87 110.563 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -90.76 -4.33 56.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.613 -0.884 . . . . 1.97 108.613 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.57 -12.61 64.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 114.875 -1.057 . . . . 0.58 114.766 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 -177.03 5.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 117.892 0.846 . . . . 1.74 110.824 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.79 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -140.31 145.61 37.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.726 -0.67 . . . . 1.07 109.76 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.07 136.74 9.76 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.861 -0.896 . . . . 0.39 110.861 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.485 ' HG2' ' SD ' ' A' ' 36' ' ' MET . 28.4 ttt -118.51 140.9 49.16 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.392 0.615 . . . . 0.87 110.957 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 33.1 mt-10 -130.66 154.88 47.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.116 -0.947 . . . . 1.14 108.831 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' C ' ' H ' ' A' ' 32' ' ' PHE . 32.0 p-10 -87.51 169.8 11.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.049 -0.352 . . . . 1.41 110.049 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 55.2 pttt -52.84 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.607 1.336 . . . . 1.77 114.607 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.7 m-85 -119.81 7.7 11.03 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.893 -0.504 . . . . 1.08 110.392 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.42 24.85 58.19 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.762 -0.732 . . . . 0.54 112.36 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 38.8 mmtm -114.02 136.98 52.32 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.693 0.758 . . . . 3.25 111.924 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 m -78.13 129.47 35.21 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.923 -1.49 . . . . 1.55 111.548 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.485 ' SD ' ' HG2' ' A' ' 28' ' ' MET . 1.3 ppp? -148.12 153.52 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.38 110.18 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -67.25 141.12 57.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 2.78 111.129 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.47 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 28.1 ttt -87.77 122.71 70.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.668 -0.696 . . . . 1.32 109.956 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.81 122.28 9.84 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.064 2.51 . . . . 1.24 112.446 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.6 tt0 -69.46 142.91 53.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.224 -0.444 . . . . 1.15 110.362 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.55 -11.1 73.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.516 -0.85 . . . . 0.68 112.862 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -99.75 123.32 43.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.922 0.391 . . . . 2.3 111.957 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.562 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.2 p -91.36 129.71 41.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.563 -0.744 . . . . 0.93 109.403 174.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.7 mtm -126.98 159.96 32.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 1.31 110.526 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -104.63 160.43 14.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.063 0.935 . . . . 1.64 112.429 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.659 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 50.6 p -113.95 165.25 12.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.006 -1.452 . . . . 0.53 109.732 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 15.4 ptt180 -65.35 -18.17 65.1 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.669 0.747 . . . . 3.73 110.966 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.99 -15.19 30.08 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.561 -1.2 . . . . 2.7 110.62 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.35 17.87 20.81 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.518 -0.848 . . . . 0.77 112.585 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -97.74 154.74 17.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.338 -0.616 . . . . 1.35 109.338 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -117.87 135.73 53.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.393 -0.595 . . . . 1.84 109.393 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.24 157.99 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.671 -0.695 . . . . 0.66 110.92 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.694 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -157.11 148.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 0.98 110.486 174.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.554 ' N ' HG12 ' A' ' 53' ' ' ILE . 26.8 ttt -100.19 118.29 36.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.415 -0.957 . . . . 1.5 108.415 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 52.4 tptt -140.61 130.77 24.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.918 -0.401 . . . . 1.69 109.918 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 38.79 94.88 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.979 -0.555 . . . . 1.21 113.061 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.62 9.52 7.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.496 0.665 . . . . 2.9 110.425 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.61 -177.64 3.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.881 -0.599 . . . . 1.66 110.455 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.79 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -134.49 122.16 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 121.347 0.594 . . . . 0.92 110.192 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.694 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.06 117.07 22.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.079 -1.082 . . . . 0.71 108.079 171.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.497 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 42.9 ttt180 -112.65 100.89 9.07 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.594 -1.632 . . . . 3.56 106.594 168.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER 36.97 15.11 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.477 1.111 . . . . 1.4 112.919 -163.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB2' ' HD2' ' A' ' 60' ' ' PHE . 8.2 t70 63.66 -51.45 0.24 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.711 1.204 . . . . 2.14 113.353 -176.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' HA ' ' CB ' ' A' ' 67' ' ' ARG . 36.4 mt-10 -69.77 -15.54 63.15 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.359 0.503 . . . . 3.8 112.359 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.0 -25.77 63.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.84 0.829 . . . . 1.76 109.636 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 59' ' ' ILE . 11.1 mt -87.35 -31.24 20.25 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.661 -1.154 . . . . 2.36 109.304 174.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.477 ' CB ' ' HA ' ' A' ' 64' ' ' GLU . 75.0 ttt180 -59.39 -66.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.92 -1.036 . . . . 4.45 111.264 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -132.23 16.06 4.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.165 0.507 . . . . 5.92 111.178 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.78 24.35 31.35 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.837 -0.696 . . . . 5.06 112.528 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -86.15 110.07 19.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.102 0.477 . . . . 6.88 109.906 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 m -114.56 -22.16 9.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.693 -0.685 . . . . 8.52 111.298 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 64.2 88.21 0.1 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.576 0.703 . . . . 10.75 109.408 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.11 -101.79 1.15 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.097 -0.801 . . . . 11.62 111.097 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.346 -1.252 . . . . 12.99 111.769 178.215 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.673 HG21 ' CD2' ' A' ' 19' ' ' HIS . 20.6 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.629 0.252 . . . . 2.46 110.361 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.64 135.08 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.516 -0.55 . . . . 3.48 109.516 172.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.9 mtp -112.13 15.8 20.4 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.6 0.715 . . . . 2.17 110.544 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.6 t -90.26 -22.3 21.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.542 -0.753 . . . . 1.47 109.929 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -104.44 14.92 29.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 1.89 112.091 -177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.6 p -101.24 137.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.954 -0.298 . . . . 1.25 111.348 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.59 HG13 ' HA ' ' A' ' 22' ' ' LYS . 27.5 m -83.6 -29.23 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.022 0.439 . . . . 1.03 110.064 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -168.48 130.6 1.37 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.602 0.715 . . . . 1.41 110.946 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 m -100.89 140.84 34.61 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.727 -1.124 . . . . 0.4 109.389 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.891 ' OH ' ' HD2' ' A' ' 61' ' ' ARG . 25.7 m-85 -121.4 134.14 55.1 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.967 0.889 . . . . 1.06 111.755 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.53 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 2.9 m-20 -96.47 120.96 37.73 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.613 -1.631 . . . . 1.94 108.853 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 16' ' ' SER . 23.4 mt -78.99 146.12 33.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.414 -1.328 . . . . 1.5 107.414 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 2.7 tt0 -66.17 -4.36 7.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.205 0.526 . . . . 1.68 111.925 -173.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -98.44 -17.81 18.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.495 -0.775 . . . . 2.11 110.326 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.07 -28.48 4.85 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.686 -0.688 . . . . 1.28 113.199 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.632 ' HB2' HD12 ' A' ' 12' ' ' LEU . 12.4 m -65.75 155.81 35.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.768 0.318 . . . . 1.07 110.77 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -124.0 129.81 51.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.908 0.385 . . . . 1.84 111.06 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.98 143.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.898 -0.779 . . . . 0.41 108.898 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.673 ' CD2' HG21 ' A' ' 1' ' ' VAL . 5.7 m-70 -130.56 129.91 43.39 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.214 -0.595 . . . . 0.67 110.494 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.565 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 28.3 t -96.43 114.81 34.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 106.537 -1.653 . . . . 0.81 106.537 168.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 92.9 m-85 -85.47 152.44 23.2 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.045 -0.525 . . . . 0.64 110.355 -172.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.59 ' HA ' HG13 ' A' ' 7' ' ' VAL . 87.7 mttt -62.08 -15.32 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.923 -0.58 . . . . 2.87 111.553 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.99 -6.99 53.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.83 -0.804 . . . . 1.97 108.83 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.88 -9.59 51.5 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.376 -0.916 . . . . 0.58 114.989 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -92.85 177.6 6.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 118.692 1.246 . . . . 1.74 110.648 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.76 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -137.77 146.23 43.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.151 -0.477 . . . . 1.07 110.483 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.51 146.06 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.074 -0.811 . . . . 0.39 111.074 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.2 ttt -120.5 142.36 49.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.088 0.471 . . . . 0.87 110.979 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.82 150.55 49.13 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.037 -1.098 . . . . 1.14 108.037 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 32' ' ' PHE . 30.7 p-10 -86.58 167.03 14.95 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.322 -0.551 . . . . 1.41 110.133 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 27.8 pttt -50.54 2.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.771 1.397 . . . . 1.77 114.771 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.2 m-85 -118.97 2.04 11.49 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.051 -0.406 . . . . 1.08 110.701 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.37 19.88 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.425 -0.893 . . . . 0.54 112.997 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 11.9 mmmm -100.17 132.73 45.37 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.887 0.851 . . . . 3.25 110.899 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 p -79.05 133.78 36.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.732 -1.576 . . . . 1.55 111.93 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 ptm -147.41 -172.94 4.13 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.641 -0.709 . . . . 1.38 109.829 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.68 150.87 24.34 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.124 -0.324 . . . . 2.78 110.124 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.13 132.47 43.42 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 1.32 110.786 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.12 120.49 7.65 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.623 2.216 . . . . 1.24 112.843 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -80.66 128.3 33.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 1.15 110.132 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.98 -9.65 51.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.92 -0.657 . . . . 0.68 112.389 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -101.69 122.98 44.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.899 0.333 . . . . 2.3 111.899 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.521 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 12.7 p -94.25 128.4 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.706 -0.85 . . . . 0.93 108.706 171.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.5 mtm -124.6 160.29 28.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 1.31 110.651 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 20.5 mt-10 -93.13 145.22 24.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.786 0.803 . . . . 1.64 111.635 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -105.16 160.2 15.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.254 -1.339 . . . . 0.53 109.522 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.53 ' HD2' ' HB3' ' A' ' 11' ' ' ASP . 98.8 mtt180 -64.45 -17.89 64.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.437 0.637 . . . . 3.73 109.59 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.89 -22.97 45.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.125 -0.943 . . . . 2.7 110.3 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.03 55.72 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.794 -0.717 . . . . 0.77 111.522 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -97.15 155.31 16.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.886 -0.783 . . . . 1.35 108.886 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.513 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 40.1 mmtm -112.88 136.95 51.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.943 -0.762 . . . . 1.84 108.943 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 39.0 pt -136.17 153.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 0.66 110.549 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.675 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -154.01 145.61 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.935 -0.575 . . . . 0.98 110.23 176.445 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.35 122.04 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.106 -1.442 . . . . 1.5 107.106 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -144.0 121.96 12.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.843 -0.343 . . . . 1.69 110.924 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.37 45.04 93.31 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 1.21 112.863 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 67.74 10.98 8.15 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.848 0.459 . . . . 2.9 111.481 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.47 -173.01 2.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.66 109.826 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.76 HD12 ' HG2' ' A' ' 26' ' ' MET . 2.5 tt -139.22 128.87 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 122.009 0.909 . . . . 0.92 110.062 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.19 121.44 27.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.091 -1.448 . . . . 0.71 107.091 170.095 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.891 ' HD2' ' OH ' ' A' ' 10' ' ' TYR . 33.1 ttp180 -109.29 96.1 6.07 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.319 -2.104 . . . . 3.56 105.319 164.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.603 HD23 ' HB2' ' A' ' 65' ' ' ALA . 0.1 OUTLIER 53.03 -13.16 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 O-C-N 125.011 1.444 . . . . 1.4 113.52 -171.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.601 ' H ' ' C ' ' A' ' 61' ' ' ARG . 12.5 t70 67.06 148.15 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.56 1.144 . . . . 2.14 110.872 -171.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 12.1 tp10 78.9 -45.83 0.38 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.512 1.125 . . . . 3.8 110.35 -174.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.643 ' HB1' HH21 ' A' ' 61' ' ' ARG . . . -50.13 -56.56 10.44 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.98 0.895 . . . . 1.76 112.609 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.7 ' H ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -95.0 -7.72 38.94 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.325 -1.307 . . . . 2.36 110.779 -174.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.459 ' HG2' ' H ' ' A' ' 68' ' ' LYS . 14.2 ttt180 -102.3 -166.46 1.29 Allowed 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.008 -0.996 . . . . 4.45 108.608 -170.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' H ' ' HG2' ' A' ' 67' ' ' ARG . 21.1 ptmt -108.82 168.67 9.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.725 -0.472 . . . . 5.92 109.725 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.41 121.87 25.88 Favored Glycine 0 N--CA 1.45 -0.396 0 O-C-N 123.773 0.671 . . . . 5.06 112.377 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -69.21 127.82 34.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.89 -0.411 . . . . 6.88 109.89 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.2 m -58.88 123.18 15.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 8.52 111.381 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.77 -29.07 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 10.75 111.521 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.66 -74.3 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.4 -0.905 . . . . 11.62 111.911 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.996 0 CA-C-O 119.005 -0.886 . . . . 12.99 111.101 179.361 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 121.024 0.44 . . . . 2.46 110.571 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -86.12 149.98 24.75 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.552 -0.907 . . . . 3.48 108.552 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.4 mtp -102.12 7.35 41.05 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.22 0.452 . . . . 2.17 112.22 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 p -78.63 -26.29 45.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.399 0.619 . . . . 1.47 110.334 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.8 p30 -104.74 5.19 33.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 1.89 110.837 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.421 HG11 ' OG1' ' A' ' 9' ' ' THR . 89.5 t -103.66 115.42 45.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.56 -0.745 . . . . 1.25 110.144 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 m -79.15 -23.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 1.03 111.267 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -167.99 137.77 2.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.176 0.512 . . . . 1.41 110.854 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 6' ' ' VAL . 34.3 m -114.0 143.52 44.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.463 -0.79 . . . . 0.4 109.898 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' OH ' ' HD2' ' A' ' 61' ' ' ARG . 35.9 m-85 -121.26 133.74 55.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.877 0.846 . . . . 1.06 111.948 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 1.2 m-20 -100.44 124.46 45.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.742 -1.572 . . . . 1.94 109.73 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 16' ' ' SER . 7.6 mt -87.73 148.41 24.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.02 -0.733 . . . . 1.5 109.02 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.9 tt0 -62.74 -25.49 68.22 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.23 1.196 . . . . 1.68 114.23 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -98.99 -50.89 4.02 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.684 0.754 . . . . 2.11 110.205 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 166.44 67.86 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.664 -1.153 . . . . 1.28 112.267 -170.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.608 ' HB2' HD12 ' A' ' 12' ' ' LEU . 2.5 m -157.5 143.36 17.49 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.175 -1.046 . . . . 1.07 108.175 172.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -127.5 125.18 39.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.146 0.498 . . . . 1.84 109.906 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.19 148.1 13.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.84 -0.8 . . . . 0.41 108.84 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.559 ' O ' ' HA ' ' A' ' 26' ' ' MET . 7.3 m-70 -131.16 133.15 45.28 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.156 -0.618 . . . . 0.67 109.432 173.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.67 114.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.613 -1.625 . . . . 0.81 106.613 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -83.43 150.58 25.96 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.738 -0.665 . . . . 0.64 110.119 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.486 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 21.2 pttm -61.24 -20.3 62.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 2.87 110.574 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.65 -0.78 57.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.735 -0.839 . . . . 1.97 108.735 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.48 -8.15 62.02 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 114.727 -1.124 . . . . 0.58 115.05 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -85.3 177.24 7.9 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.731 1.265 . . . . 1.74 110.663 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.906 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.7 mpp? -137.69 141.19 41.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.07 109.86 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.27 128.18 7.97 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.735 -0.666 . . . . 0.39 111.51 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.25 124.15 49.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.76 0.314 . . . . 0.87 110.255 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 25.3 mt-10 -124.01 153.89 40.66 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.374 -0.602 . . . . 1.14 109.374 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.547 HD21 ' HB2' ' A' ' 34' ' ' LYS . 10.9 p30 -104.5 174.59 5.81 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.287 -0.565 . . . . 1.41 110.148 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 14.0 pttm -49.63 -19.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.543 1.312 . . . . 1.77 114.543 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 92.2 m-85 -92.97 6.43 47.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.353 0.524 . . . . 1.08 110.586 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.67 26.91 59.94 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.706 -0.557 . . . . 0.54 111.706 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HB2' HD21 ' A' ' 30' ' ' ASN . 35.8 mmtm -113.31 136.07 53.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 3.25 111.329 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t -83.52 129.74 34.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.121 -1.4 . . . . 1.55 110.428 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.13 179.84 6.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.323 -0.399 . . . . 1.38 110.919 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -80.24 143.14 33.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.058 0.456 . . . . 2.78 111.287 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.3 ttt -94.65 127.16 44.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.655 . . . . 1.32 110.529 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.06 138.72 20.88 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.714 2.276 . . . . 1.24 112.834 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 33.3 tt0 -94.11 147.99 22.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.958 -0.565 . . . . 1.15 110.616 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.47 68.02 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.034 -0.603 . . . . 0.68 112.622 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -107.57 129.57 54.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.827 0.346 . . . . 2.3 111.562 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.58 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 8.1 p -90.85 127.23 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.888 -0.782 . . . . 0.93 108.888 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.404 ' SD ' HD11 ' A' ' 12' ' ' LEU . 17.8 ptp -117.03 147.57 42.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.059 -0.519 . . . . 1.31 110.003 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.03 151.35 24.76 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.338 0.59 . . . . 1.64 110.741 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.5 p -100.75 162.86 12.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.218 -0.901 . . . . 0.53 110.103 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.506 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 48.9 mtt180 -57.86 -21.24 41.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.145 0.424 . . . . 3.73 112.145 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.07 -17.48 19.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 121.064 -0.254 . . . . 2.7 111.202 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.25 22.83 6.0 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.291 -0.957 . . . . 0.77 113.319 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -99.83 147.49 25.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 1.35 109.293 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -111.79 132.74 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.055 -0.35 . . . . 1.84 110.055 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 61' ' ' ARG . 38.7 pt -136.63 160.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 0.66 110.83 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.619 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -162.45 151.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.044 -0.525 . . . . 0.98 109.891 175.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.566 ' N ' HG12 ' A' ' 53' ' ' ILE . 14.1 tmm? -104.63 121.48 43.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.057 -1.09 . . . . 1.5 108.057 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 49.6 tptt -134.85 116.58 14.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.288 -0.414 . . . . 1.69 110.216 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.93 44.19 98.16 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.815 -0.63 . . . . 1.21 112.752 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 72.59 -1.74 2.88 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.361 0.6 . . . . 2.9 111.42 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -105.72 147.99 27.93 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.519 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.906 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -100.32 124.32 53.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.727 0.775 . . . . 0.92 111.277 177.603 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.619 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.02 118.36 23.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.702 -1.222 . . . . 0.71 107.702 168.211 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.651 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 47.0 ttp180 -113.68 100.56 8.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.344 -1.354 . . . . 3.56 107.344 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 1.1 pp 37.81 14.21 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 O-C-N 125.164 1.54 . . . . 1.4 113.654 -167.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 25.8 t70 36.31 76.56 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.156 0.982 . . . . 2.14 111.973 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.627 ' HB3' HD12 ' A' ' 62' ' ' LEU . 35.9 tt0 177.77 -41.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.866 -1.061 . . . . 3.8 108.701 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.55 -5.97 13.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.196 -0.911 . . . . 1.76 110.915 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.445 HD11 ' H ' ' A' ' 61' ' ' ARG . 9.6 mt -117.04 -14.02 10.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.683 -1.144 . . . . 2.36 110.214 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.449 ' HA ' ' HD2' ' A' ' 67' ' ' ARG . 22.8 tpt180 -74.98 -51.68 13.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.874 -0.603 . . . . 4.45 111.392 -170.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -95.63 11.56 32.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.227 0.537 . . . . 5.92 110.438 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.65 -153.31 43.97 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.033 -0.827 . . . . 5.06 111.033 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -158.85 102.04 1.65 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.409 -0.589 . . . . 6.88 109.409 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.0 m -133.71 106.12 7.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.267 -0.424 . . . . 8.52 110.553 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -71.96 -38.96 69.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.044 -0.525 . . . . 10.75 110.796 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.99 73.39 0.46 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.653 -0.784 . . . . 11.62 112.285 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.654 -1.081 . . . . 12.99 112.003 -179.85 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 3' ' ' MET . 29.8 m . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.925 -0.398 . . . . 2.46 109.925 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.62 -12.06 35.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.21 1.005 . . . . 3.48 110.241 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.512 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 42.7 mtp 61.2 4.85 0.95 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.583 -1.644 . . . . 2.17 113.57 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 m -83.82 -27.31 28.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.238 0.542 . . . . 1.47 110.696 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.42 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 17.6 p30 -103.72 6.0 36.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.734 0.778 . . . . 1.89 110.019 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 3' ' ' MET . 72.0 t -102.74 116.59 46.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.97 -1.013 . . . . 1.25 109.806 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.83 -20.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.689 -0.405 . . . . 1.03 111.403 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -168.18 128.35 1.29 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.411 0.624 . . . . 1.41 110.987 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 m -101.64 138.45 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.987 -1.006 . . . . 0.4 109.611 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.608 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 18.6 m-85 -113.64 128.45 56.44 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.736 0.779 . . . . 1.06 111.379 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 3.0 m-20 -95.14 115.04 26.91 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.02 -1.445 . . . . 1.94 108.296 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 16' ' ' SER . 10.4 mt -80.57 149.43 29.93 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.009 -0.737 . . . . 1.5 109.009 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -67.79 -7.71 29.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.1 0.476 . . . . 1.68 112.019 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.0 -20.98 19.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.422 0.63 . . . . 2.11 109.895 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 122.07 -14.32 8.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.188 -0.914 . . . . 1.28 112.534 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -66.3 153.19 43.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.539 0.209 . . . . 1.07 110.758 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 30.2 mttp -113.56 143.49 44.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.144 0.497 . . . . 1.84 110.813 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 93.4 t -126.36 149.47 31.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.808 -1.182 . . . . 0.41 107.808 171.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' MET . 6.5 m-70 -139.0 128.89 24.97 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.291 -0.633 . . . . 0.67 109.291 175.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.11 116.77 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.423 -1.695 . . . . 0.81 106.423 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -85.92 153.12 22.42 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.797 -0.638 . . . . 0.64 110.628 -173.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 53.6 pttt -59.53 -16.51 25.29 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 2.87 111.539 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.31 -15.41 46.69 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.038 -0.727 . . . . 1.97 109.038 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.24 -2.35 54.48 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.107 -1.044 . . . . 0.58 113.876 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -94.46 -175.37 3.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.821 0.811 . . . . 1.74 110.776 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 1.017 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.1 mpp? -144.42 149.29 35.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.721 -0.672 . . . . 1.07 110.438 -175.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.95 139.49 11.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.285 -0.726 . . . . 0.39 111.285 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.566 ' SD ' ' HG3' ' A' ' 36' ' ' MET . 1.6 tmt? -117.77 137.51 52.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.163 0.506 . . . . 0.87 111.001 -175.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 30.2 mt-10 -124.6 149.78 46.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.47 -0.786 . . . . 1.14 109.034 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.633 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.8 p-10 -85.91 166.16 16.19 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.44 -0.578 . . . . 1.41 109.44 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 38.0 pttt -56.92 5.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.217 1.192 . . . . 1.77 114.217 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 45.3 m-85 -113.66 5.82 16.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.064 0.459 . . . . 1.08 109.778 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.77 25.1 60.98 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.972 -0.558 . . . . 0.54 114.264 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.633 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.3 145.96 43.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.16 0.505 . . . . 3.25 110.218 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -80.28 142.16 34.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.489 -0.778 . . . . 1.55 111.588 -171.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.566 ' HG3' ' SD ' ' A' ' 28' ' ' MET . 9.6 ptm -153.53 -179.52 7.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.746 -0.661 . . . . 1.38 109.856 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -100.42 151.08 21.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 2.78 110.751 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 ttm -101.42 126.63 33.85 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.2 -0.455 . . . . 1.32 110.714 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.51 142.34 23.34 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.723 2.282 . . . . 1.24 112.181 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.544 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.7 tt0 -79.81 154.35 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.493 -0.321 . . . . 1.15 110.646 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.604 ' H ' HD11 ' A' ' 53' ' ' ILE . . . 97.27 -19.56 54.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.68 113.337 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.557 ' O ' HD13 ' A' ' 53' ' ' ILE . 48.6 mtpt -98.5 126.65 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.244 0.522 . . . . 2.3 111.582 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.89 124.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.655 -0.498 . . . . 0.93 109.655 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.81 149.97 28.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.1 -0.5 . . . . 1.31 110.205 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' THR . 32.8 mt-10 -109.77 157.99 18.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.001 0.905 . . . . 1.64 112.01 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 72.2 p -105.29 165.34 11.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.03 -1.441 . . . . 0.53 110.319 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 58.6 mtp180 -51.25 -27.83 10.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.82 -0.627 . . . . 3.73 111.803 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -92.62 -21.8 19.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.385 -0.825 . . . . 2.7 111.2 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.36 27.25 5.1 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.145 -1.026 . . . . 0.77 112.339 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 26.5 m -100.73 145.27 28.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.396 -0.594 . . . . 1.35 109.396 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.512 ' O ' ' HE1' ' A' ' 60' ' ' PHE . 55.9 mttp -109.21 131.4 55.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.064 -0.347 . . . . 1.84 110.064 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 12' ' ' LEU . 36.0 pt -137.02 159.17 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.929 0.395 . . . . 0.66 111.383 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.604 HD11 ' H ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -159.35 143.34 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.824 -0.625 . . . . 0.98 110.438 175.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.503 ' H ' HD12 ' A' ' 53' ' ' ILE . 1.5 tmt? -97.28 106.01 18.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.689 -1.226 . . . . 1.5 107.689 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.544 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 74.8 tttt -138.36 136.33 36.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.975 -0.557 . . . . 1.69 110.489 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.36 33.5 82.32 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.787 -0.642 . . . . 1.21 112.733 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 66.81 19.76 10.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.587 0.708 . . . . 2.9 110.991 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.34 -165.61 1.71 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.289 -0.869 . . . . 1.66 109.403 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.017 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.5 OUTLIER -135.82 131.3 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.184 0.992 . . . . 0.92 110.994 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.791 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -82.75 111.75 18.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.863 -1.532 . . . . 0.71 106.863 168.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.647 ' C ' ' H ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -119.27 107.51 13.49 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.128 -1.804 . . . . 3.56 106.128 173.106 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.547 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 4.3 mm? 62.23 -35.22 0.12 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.925 0.765 . . . . 1.4 111.881 -165.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.791 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 16.9 t70 83.75 -39.66 0.08 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.349 1.459 . . . . 2.14 110.101 -171.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 26.1 tt0 -95.84 -8.38 34.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.735 -0.666 . . . . 3.8 111.087 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . . . -62.89 -41.09 99.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.449 0.642 . . . . 1.76 109.64 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -85.33 -24.55 27.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.841 -1.072 . . . . 2.36 110.317 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.601 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 54.8 ttt180 -67.21 -61.52 1.88 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.218 -0.901 . . . . 4.45 110.991 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.61 ' HG3' ' HG2' ' A' ' 64' ' ' GLU . 26.8 mtmm -84.24 161.31 20.56 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.824 -0.435 . . . . 5.92 109.824 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.97 12.76 15.1 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.93 -0.868 . . . . 5.06 110.93 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -171.43 -46.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.37 -0.415 . . . . 6.88 110.001 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -102.57 77.57 1.63 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.46 0.648 . . . . 8.52 109.946 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.03 -39.24 23.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.774 . . . . 10.75 110.116 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.13 175.54 22.65 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.255 -0.884 . . . . 11.62 111.337 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 118.783 -1.01 . . . . 12.99 111.963 -178.919 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.444 ' HB ' ' OE1' ' A' ' 29' ' ' GLU . 4.4 p . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.711 -0.477 . . . . 2.46 109.711 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.43 134.16 37.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.698 -0.482 . . . . 3.48 109.698 173.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.7 mmm -101.87 8.43 41.24 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.638 0.607 . . . . 2.17 112.638 -172.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.6 p -94.4 -27.01 16.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.298 -0.561 . . . . 1.47 110.639 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -101.95 13.69 34.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.436 -0.347 . . . . 1.89 111.901 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 13.3 p -111.68 130.03 66.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 120.162 -0.615 . . . . 1.25 111.936 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -96.19 -22.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.038 -0.528 . . . . 1.03 111.399 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -160.29 138.52 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 1.41 111.156 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -123.4 141.34 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.407 -0.815 . . . . 0.4 110.276 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.614 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 33.7 m-85 -121.51 134.51 55.05 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-O 121.679 0.752 . . . . 1.06 111.837 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 46' ' ' THR . 11.6 t70 -101.38 126.63 48.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.878 -1.51 . . . . 1.94 109.092 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.873 HD22 ' HB2' ' A' ' 16' ' ' SER . 10.5 mp -78.47 -2.2 37.42 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.415 -1.266 . . . . 1.5 112.947 -171.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.567 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.4 tt0 86.88 -31.26 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.138 0.575 . . . . 1.68 110.48 172.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.74 -9.58 28.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.338 0.59 . . . . 2.11 109.428 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' A' ' 31' ' ' LYS . . . 138.23 -36.82 1.87 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.056 -1.068 . . . . 1.28 114.434 172.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.873 ' HB2' HD22 ' A' ' 12' ' ' LEU . 11.3 m -71.59 160.0 33.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.615 -0.513 . . . . 1.07 109.615 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -133.36 143.52 49.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.289 0.566 . . . . 1.84 111.732 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.657 HG23 HD11 ' A' ' 12' ' ' LEU . 36.1 t -118.22 142.67 31.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.64 -0.709 . . . . 0.41 109.251 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 10.0 m-70 -128.82 133.02 47.86 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 120.225 -0.59 . . . . 0.67 111.074 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.84 111.65 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 106.566 -1.642 . . . . 0.81 106.566 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.517 ' HE2' ' N ' ' A' ' 27' ' ' GLY . 87.7 m-85 -83.77 156.18 22.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.929 -0.578 . . . . 0.64 110.807 -171.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -60.61 -20.46 60.69 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.122 -0.945 . . . . 2.87 111.798 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.95 7.39 46.75 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.496 0.665 . . . . 1.97 109.297 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.17 -7.59 80.55 Favored Glycine 0 N--CA 1.427 -1.91 0 CA-C-N 114.868 -1.06 . . . . 0.58 114.517 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -86.53 175.51 8.3 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 117.86 0.83 . . . . 1.74 110.651 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.854 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.2 mpp? -135.88 148.7 48.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.967 0.413 . . . . 1.07 110.193 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.517 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -143.47 148.84 20.74 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.636 -0.711 . . . . 0.39 111.403 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ttt -117.62 144.51 45.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.857 0.361 . . . . 0.87 110.637 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.444 ' OE1' ' HB ' ' A' ' 1' ' ' VAL . 28.8 mt-10 -123.01 146.64 47.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.304 -0.998 . . . . 1.14 108.304 171.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.567 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 15.9 p-10 -89.63 164.72 14.62 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.619 -0.882 . . . . 1.41 108.619 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.403 ' CB ' ' HA3' ' A' ' 15' ' ' GLY . 9.7 ptpp? -51.03 -11.21 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.951 1.093 . . . . 1.77 113.951 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.506 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 97.2 m-85 -96.65 9.19 42.32 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.107 -0.371 . . . . 1.08 110.81 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.65 26.23 65.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.167 -0.54 . . . . 0.54 113.67 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.23 147.44 42.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.067 -0.653 . . . . 3.25 110.273 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 p -83.64 139.1 33.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.332 -0.849 . . . . 1.55 112.159 -172.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.0 ptm -148.78 175.26 11.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 1.38 109.577 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -95.11 151.82 18.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.913 0.387 . . . . 2.78 110.132 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.03 128.91 45.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.993 -0.549 . . . . 1.32 110.768 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.3 114.72 3.16 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.45 2.1 . . . . 1.24 112.066 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 54' ' ' MET . 42.3 tt0 -74.51 133.3 42.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.652 -0.704 . . . . 1.15 110.696 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.517 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 117.12 -8.96 15.77 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.68 113.773 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.55 142.05 48.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 117.63 0.715 . . . . 2.3 112.304 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.633 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -99.43 135.64 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.93 108.885 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 70.2 mtm -127.4 159.26 35.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.249 -0.432 . . . . 1.31 109.872 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -99.66 163.63 12.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.741 0.781 . . . . 1.64 111.995 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 45.7 p -119.68 162.69 18.59 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.28 -1.327 . . . . 0.53 110.79 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.567 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 6.8 mtt180 -55.63 -27.38 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.757 0.651 . . . . 3.73 112.757 177.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -95.76 -2.52 47.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.503 -0.479 . . . . 2.7 111.969 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.31 20.7 19.47 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.853 -1.165 . . . . 0.77 114.053 170.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -112.63 167.22 10.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.717 0.758 . . . . 1.35 109.514 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -122.66 143.8 49.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.79 -0.448 . . . . 1.84 109.79 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 pt -139.55 154.22 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.346 -0.388 . . . . 0.66 111.247 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.728 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -155.02 149.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.957 0.408 . . . . 0.98 110.596 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.524 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 27.5 ttt -108.39 113.17 26.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.777 -1.194 . . . . 1.5 107.777 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 22.4 tptm -144.35 138.91 28.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.177 -0.675 . . . . 1.69 109.177 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.29 31.01 76.1 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 1.21 111.742 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 62.12 23.42 13.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.171 0.51 . . . . 2.9 111.339 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 54' ' ' MET . 36.7 mt-10 -132.07 160.02 37.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.519 -0.764 . . . . 1.66 110.19 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.854 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.49 124.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.523 0.678 . . . . 0.92 110.906 177.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.728 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -82.46 109.76 16.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.508 -1.664 . . . . 0.71 106.508 166.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.614 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 2.0 tmm_? -121.49 105.51 10.55 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.817 -1.549 . . . . 3.56 106.817 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.554 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 3.9 mm? 57.82 -47.99 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.222 0.951 . . . . 1.4 112.898 -164.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.554 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 11.9 t70 80.78 -26.71 0.15 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 124.939 1.295 . . . . 2.14 109.581 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.2 tm-20 -84.79 -38.63 19.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.055 -0.975 . . . . 3.8 109.935 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.53 -35.61 78.24 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.581 0.705 . . . . 1.76 110.64 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 61' ' ' ARG . 8.6 mt -89.96 -1.55 57.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.622 -1.172 . . . . 2.36 110.527 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -77.5 -66.93 0.77 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.606 -0.725 . . . . 4.45 110.83 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -108.75 160.51 15.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.803 -0.635 . . . . 5.92 110.947 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.55 -16.82 9.66 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.073 -0.584 . . . . 5.06 111.671 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -158.74 130.13 6.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.063 -0.347 . . . . 6.88 110.063 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.2 m -71.47 -42.7 67.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.383 0.611 . . . . 8.52 109.523 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.82 -60.93 0.81 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.865 -1.061 . . . . 10.75 109.273 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 160.9 114.59 0.35 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.2 -0.76 . . . . 11.62 111.2 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.364 -1.242 . . . . 12.99 111.455 -179.105 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.432 -0.581 . . . . 2.46 109.432 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.85 124.2 25.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 3.48 110.639 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.486 ' HA ' HG12 ' A' ' 6' ' ' VAL . 20.7 mmt -87.62 9.04 22.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.286 -0.416 . . . . 2.17 111.291 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 m -86.37 -26.93 24.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.281 0.563 . . . . 1.47 110.793 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.9 p30 -114.42 12.39 17.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.715 -0.675 . . . . 1.89 111.511 -173.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.575 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.2 p -109.9 134.65 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.195 -0.457 . . . . 1.25 111.393 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 20' ' ' VAL . 22.4 m -86.84 -26.45 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.3 -0.409 . . . . 1.03 111.164 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -168.5 132.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.42 . . . . 1.41 110.566 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -110.41 143.47 40.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.61 -0.723 . . . . 0.4 109.98 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -117.98 133.2 56.14 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.766 0.793 . . . . 1.06 111.353 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.29 119.49 37.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.088 -1.414 . . . . 1.94 109.203 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 16' ' ' SER . 7.3 mt -83.1 138.99 33.47 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.686 -0.688 . . . . 1.5 109.378 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -61.99 -19.2 62.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.41 0.893 . . . . 1.68 113.41 -166.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -44.0 5.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 2.11 110.41 -175.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.72 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 159.77 78.86 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 119.621 -1.276 . . . . 1.28 113.144 -172.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.622 ' HB3' HD12 ' A' ' 12' ' ' LEU . 48.3 t -176.59 153.49 1.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.199 -0.667 . . . . 1.07 109.199 175.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -128.3 125.71 39.35 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.193 -0.458 . . . . 1.84 110.61 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.82 148.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.788 . . . . 0.41 108.871 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.575 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -138.83 131.99 29.83 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.858 -0.526 . . . . 0.67 109.992 177.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 7' ' ' VAL . 46.8 t -96.96 118.49 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.085 -1.45 . . . . 0.81 107.085 170.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 78.3 m-85 -86.58 155.35 20.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.132 0.492 . . . . 0.64 111.46 -171.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 28.9 mtpp -64.24 -22.08 66.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.335 -0.848 . . . . 2.87 111.526 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.02 -1.87 57.75 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.031 -1.1 . . . . 1.97 108.031 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.8 -8.1 50.23 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.81 -1.087 . . . . 0.58 114.555 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.94 174.02 5.78 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 118.627 1.213 . . . . 1.74 112.747 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.61 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -138.13 131.43 30.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.266 -1.334 . . . . 1.07 109.168 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.23 144.15 15.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.885 -0.674 . . . . 0.39 112.088 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.3 ttt -123.76 139.87 53.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.816 0.308 . . . . 0.87 110.996 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 19.6 mm-40 -113.15 158.21 20.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.727 -0.842 . . . . 1.14 108.727 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 38.6 p30 -88.14 164.78 15.53 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.613 -0.514 . . . . 1.41 109.613 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.72 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 ptpt -51.63 -2.86 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.978 1.103 . . . . 1.77 113.978 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 30' ' ' ASN . 65.8 m-85 -106.73 0.21 24.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.647 -0.501 . . . . 1.08 109.647 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.33 37.11 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.738 -0.744 . . . . 0.54 112.864 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 14.6 mmmm -112.15 145.57 39.59 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.339 0.59 . . . . 3.25 111.639 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.4 m -86.75 123.71 32.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.487 -1.233 . . . . 1.55 110.753 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -138.52 178.31 7.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.863 -0.608 . . . . 1.38 110.421 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -91.3 141.38 28.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.874 0.369 . . . . 2.78 110.623 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ttt -86.88 126.44 63.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 1.32 110.815 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.37 124.91 9.76 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.752 2.301 . . . . 1.24 112.864 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.556 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 47.3 tt0 -79.33 134.71 36.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 1.15 111.365 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.3 24.36 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.788 -0.72 . . . . 0.68 113.647 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 53' ' ' ILE . 48.7 mtpt -105.07 126.9 52.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 117.075 0.438 . . . . 2.3 111.941 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.657 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.7 p -91.1 122.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.014 -0.735 . . . . 0.93 109.014 171.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.0 mtm -119.11 155.69 31.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.389 -0.823 . . . . 1.31 109.548 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -107.33 156.55 18.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.245 1.021 . . . . 1.64 112.515 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.7 p -109.48 159.78 16.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.446 -1.706 . . . . 0.53 110.28 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 47' ' ' ARG . 57.7 mtt-85 -59.34 -24.0 62.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.588 0.588 . . . . 3.73 112.588 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -96.07 -2.44 46.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.178 0.513 . . . . 2.7 110.64 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.68 15.12 32.61 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.761 -0.733 . . . . 0.77 113.068 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.8 m -93.9 146.11 24.14 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 110.201 -0.296 . . . . 1.35 110.201 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -107.73 134.07 51.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.691 -0.485 . . . . 1.84 109.691 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 12' ' ' LEU . 33.0 pt -138.17 156.83 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 0.66 111.462 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.79 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -158.41 154.03 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.811 -0.631 . . . . 0.98 109.678 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.608 ' N ' HG12 ' A' ' 53' ' ' ILE . 28.0 ttt -107.73 119.53 39.7 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.658 -1.238 . . . . 1.5 107.658 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 1.9 mmmt -138.57 134.85 34.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.083 -0.34 . . . . 1.69 110.083 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.22 30.35 75.65 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.836 -0.697 . . . . 1.21 111.821 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 62.44 25.78 15.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.37 0.605 . . . . 2.9 111.542 -176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 54' ' ' MET . 41.8 mt-10 -123.59 151.41 42.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.384 -0.825 . . . . 1.66 110.251 175.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.61 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.19 121.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.774 0.797 . . . . 0.92 111.353 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.79 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -83.91 111.9 19.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.893 -1.049 . . . . 0.71 108.277 168.622 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.631 ' C ' ' H ' ' A' ' 63' ' ' ASP . 2.8 tmm_? -122.14 108.86 13.82 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.613 -1.625 . . . . 3.56 106.613 171.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 3.8 mm? 59.64 -35.53 0.07 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 124.268 0.98 . . . . 1.4 112.749 -166.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.631 ' H ' ' C ' ' A' ' 61' ' ' ARG . 2.6 t70 79.33 -48.33 0.39 Allowed 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.738 1.215 . . . . 2.14 109.54 -167.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 40.1 mt-10 -68.61 -27.07 65.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.326 -0.852 . . . . 3.8 110.891 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.41 77.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 1.76 110.885 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -74.63 -31.27 61.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.426 0.631 . . . . 2.36 109.857 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 41.8 ttt180 -54.12 -62.03 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.906 -1.043 . . . . 4.45 111.644 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -152.85 5.03 0.36 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.916 0.339 . . . . 5.92 111.916 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.12 56.25 2.13 Favored Glycine 0 C--N 1.316 -0.573 0 C-N-CA 120.894 -0.669 . . . . 5.06 112.556 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -86.86 70.89 10.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.897 0.379 . . . . 6.88 110.468 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.5 t -164.83 102.93 0.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.961 -0.563 . . . . 8.52 109.822 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -126.54 150.28 48.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.176 -0.466 . . . . 10.75 109.871 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.91 104.25 2.31 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.846 -0.692 . . . . 11.62 112.246 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 CA-C-O 118.693 -1.06 . . . . 12.99 111.502 177.108 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 111.538 0.199 . . . . 2.46 111.538 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 65.09 121.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.44 0.638 . . . . 3.48 110.656 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.8 mmm -91.81 17.15 9.47 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.752 -0.593 . . . . 2.17 112.411 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -101.49 -25.71 13.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 1.47 110.985 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -99.94 13.54 33.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.006 0.431 . . . . 1.89 111.177 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 12.9 p -102.35 129.3 54.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 1.25 110.257 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.32 -21.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.642 -0.423 . . . . 1.03 111.46 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -166.64 142.84 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.437 0.637 . . . . 1.41 111.211 176.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -121.02 144.73 48.37 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.961 -1.018 . . . . 0.4 109.823 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.474 ' CD1' HG21 ' A' ' 46' ' ' THR . 29.9 m-85 -123.03 133.14 54.35 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.855 0.836 . . . . 1.06 111.953 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.6 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 9.8 m-20 -97.94 121.83 40.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.928 -1.487 . . . . 1.94 108.911 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.903 ' HG ' ' HB2' ' A' ' 16' ' ' SER . 0.6 OUTLIER -67.48 -10.11 48.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.497 -1.229 . . . . 1.5 112.458 -173.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 28.5 tt0 94.03 -22.65 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.4 1.062 . . . . 1.68 109.253 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -96.25 -34.9 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.688 -0.687 . . . . 2.11 109.473 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 155.19 -30.91 0.65 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.478 -0.868 . . . . 1.28 112.926 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.903 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.7 OUTLIER -57.79 141.37 49.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 1.07 110.29 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 127.44 50.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.236 -0.438 . . . . 1.84 111.071 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.511 HG23 HD21 ' A' ' 12' ' ' LEU . 75.0 t -107.19 138.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.212 -0.662 . . . . 0.41 109.212 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 4.3 m-70 -127.01 132.82 50.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 109.641 -0.503 . . . . 0.67 109.641 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 59' ' ' ILE . 69.4 t -102.12 122.4 54.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 106.947 -1.501 . . . . 0.81 106.947 170.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -92.11 155.26 18.18 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.559 -0.746 . . . . 0.64 110.757 -169.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.75 -8.61 29.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.303 -0.862 . . . . 2.87 111.755 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -92.48 0.96 57.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.17 -13.81 64.34 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.807 -1.088 . . . . 0.58 113.878 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.87 -174.52 4.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.603 0.702 . . . . 1.74 109.448 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.551 ' HG3' HG12 ' A' ' 59' ' ' ILE . 1.6 pmm? -152.83 154.2 34.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.901 0.381 . . . . 1.07 110.15 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.6 153.49 24.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.5 -0.64 . . . . 0.39 111.5 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 ttt -125.75 139.8 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.27 0.557 . . . . 0.87 111.539 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.41 155.67 36.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 1.14 109.441 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.463 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 65.2 t30 -94.12 159.73 15.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.285 -0.635 . . . . 1.41 109.285 175.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.679 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.8 ptmt -48.73 -23.73 1.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.076 1.139 . . . . 1.77 114.076 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.463 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 36.2 m-85 -90.45 -2.63 57.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.472 . . . . 1.08 110.152 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.13 26.36 16.45 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.54 112.01 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -100.7 135.82 41.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.724 0.773 . . . . 3.25 111.855 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 p -79.33 110.69 14.86 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.948 -1.478 . . . . 1.55 110.243 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -127.25 177.07 6.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.321 -0.4 . . . . 1.38 111.128 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -88.4 132.9 34.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.234 0.54 . . . . 2.78 111.755 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.1 ttt -91.83 125.55 56.83 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.743 -0.662 . . . . 1.32 109.948 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.87 124.08 7.22 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.605 2.204 . . . . 1.24 113.037 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.653 ' HG2' ' HD2' ' A' ' 55' ' ' LYS . 38.2 tt0 -82.11 133.98 35.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 1.15 110.34 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 102.88 -12.4 56.2 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.783 -0.723 . . . . 0.68 111.901 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -96.53 123.9 40.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.626 0.25 . . . . 2.3 111.41 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.636 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -90.7 127.56 43.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.885 -0.783 . . . . 0.93 108.885 172.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.4 mtm -126.16 156.95 39.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.069 -0.514 . . . . 1.31 109.901 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.553 ' HG2' ' HG3' ' A' ' 51' ' ' LYS . 38.9 mt-10 -108.58 169.4 8.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.982 0.896 . . . . 1.64 112.281 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.474 HG21 ' CD1' ' A' ' 10' ' ' TYR . 42.7 p -120.33 168.31 11.41 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.862 -1.517 . . . . 0.53 110.73 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 11.2 ptt180 -59.49 -21.83 60.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.473 0.654 . . . . 3.73 111.086 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -97.81 -5.86 33.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.94 -1.027 . . . . 2.7 110.921 -170.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.56 11.26 58.35 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.52 -0.848 . . . . 0.77 112.999 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.704 HG22 HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -90.05 148.18 23.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.426 -0.583 . . . . 1.35 109.426 177.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.595 ' O ' ' HE1' ' A' ' 60' ' ' PHE . 1.9 mptp? -111.87 130.55 55.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.157 -0.683 . . . . 1.84 109.157 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.46 157.64 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.238 -0.437 . . . . 0.66 110.826 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -158.81 150.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 0.98 110.266 177.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.535 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 60.2 ttp -105.72 123.79 48.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.581 -1.266 . . . . 1.5 107.581 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HD2' ' HG2' ' A' ' 40' ' ' GLU . 21.6 tptp -144.5 133.63 22.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.88 -0.415 . . . . 1.69 109.88 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.56 30.58 78.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.117 -0.563 . . . . 1.21 111.768 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 60.27 24.77 14.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.445 0.64 . . . . 2.9 111.009 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.25 152.22 36.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.198 -0.91 . . . . 1.66 109.581 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.38 120.21 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.054 0.931 . . . . 0.92 110.879 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.595 ' HE1' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -84.03 119.18 24.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.188 -1.369 . . . . 0.71 107.435 166.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 63' ' ' ASP . 12.0 ttm180 -111.28 100.18 8.85 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.54 -2.022 . . . . 3.56 105.54 166.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.704 HD21 HG22 ' A' ' 50' ' ' THR . 29.7 mt 57.67 -17.92 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 O-C-N 124.327 1.017 . . . . 1.4 113.076 -171.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 61' ' ' ARG . 0.4 OUTLIER 76.07 -25.38 0.2 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.151 0.98 . . . . 2.14 110.092 -170.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 62' ' ' LEU . 11.7 tp10 -100.94 -14.24 17.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.294 -0.866 . . . . 3.8 110.914 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . . . -65.52 -33.37 75.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.468 0.651 . . . . 1.76 110.561 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.501 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.6 mm? -83.55 14.5 3.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 2.36 111.149 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -101.94 -165.01 1.15 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.391 0.615 . . . . 4.45 109.848 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -111.79 108.47 17.89 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.315 -0.857 . . . . 5.92 109.861 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.08 78.9 0.98 Allowed Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.523 -0.762 . . . . 5.06 111.385 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.455 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 17.6 m-70 -64.75 137.98 58.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.814 0.34 . . . . 6.88 111.676 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -92.96 -31.9 14.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.174 -0.466 . . . . 8.52 110.776 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.455 ' OE1' ' HB3' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -86.08 -36.65 19.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.999 -0.546 . . . . 10.75 110.342 -175.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.59 -57.19 0.73 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.865 -0.607 . . . . 11.62 111.702 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.491 -1.171 . . . . 12.99 111.701 179.696 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.501 HG13 ' CZ ' ' A' ' 21' ' ' PHE . 72.2 t . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.418 -0.216 . . . . 2.46 110.418 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -88.55 141.19 28.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.898 0.38 . . . . 3.48 110.717 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.8 mmt -90.13 -16.85 28.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.764 -0.653 . . . . 2.17 111.033 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -82.29 -32.41 29.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.418 0.628 . . . . 1.47 110.245 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.3 t-20 -94.74 -1.29 53.25 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.333 -0.849 . . . . 1.89 111.065 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.6 p -107.39 131.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 119.102 -1.039 . . . . 1.25 111.643 -175.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.65 -25.59 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.961 -0.563 . . . . 1.03 112.398 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -167.38 136.08 2.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.81 0.814 . . . . 1.41 112.036 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 m -108.54 142.09 39.48 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.198 -1.365 . . . . 0.4 109.819 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -122.85 136.69 54.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.852 0.834 . . . . 1.06 112.122 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.98 120.36 34.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.81 -1.541 . . . . 1.94 109.114 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 16' ' ' SER . 15.1 mt -80.4 145.88 31.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.531 -1.285 . . . . 1.5 107.531 173.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.556 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 7.9 tt0 -62.8 -13.98 39.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.22 0.452 . . . . 1.68 112.22 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.68 -20.99 21.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.093 0.473 . . . . 2.11 110.151 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.65 -20.44 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.854 -0.689 . . . . 1.28 113.325 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 12' ' ' LEU . 15.8 m -63.34 152.28 38.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.93 0.395 . . . . 1.07 110.466 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' MET . 59.0 mttp -122.98 127.9 49.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.05 0.452 . . . . 1.84 111.362 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.04 149.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.041 -0.725 . . . . 0.41 109.041 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.663 ' HB3' HG21 ' A' ' 6' ' ' VAL . 1.2 m-70 -140.14 139.82 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.769 -0.582 . . . . 0.67 110.377 172.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.599 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 47.2 t -102.1 122.57 54.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.42 -1.326 . . . . 0.81 107.42 171.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.501 ' CZ ' HG13 ' A' ' 1' ' ' VAL . 95.9 m-85 -96.27 157.21 16.0 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.233 -0.44 . . . . 0.64 111.512 -169.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 22.7 mtpp -62.67 -23.15 66.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.181 0.592 . . . . 2.87 111.765 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.99 6.37 48.13 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.342 -0.984 . . . . 1.97 108.342 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.64 -5.38 76.91 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 114.347 -1.297 . . . . 0.58 114.923 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -90.3 178.34 6.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.266 1.033 . . . . 1.74 110.757 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . 1.048 ' HG2' HD12 ' A' ' 59' ' ' ILE . 4.2 mpp? -138.35 145.55 41.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.954 -0.566 . . . . 1.07 109.979 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -132.48 148.21 19.11 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.838 -0.696 . . . . 0.39 111.713 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 27.4 ttt -127.88 146.84 50.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.407 0.622 . . . . 0.87 112.09 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' CD ' ' HE2' ' A' ' 19' ' ' HIS . 3.1 mp0 -129.73 157.89 40.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.101 -1.074 . . . . 1.14 108.101 171.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -86.47 171.0 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.028 -0.36 . . . . 1.41 110.028 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 62.6 pttt -54.06 -14.23 1.01 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.129 0.788 . . . . 1.77 113.129 174.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -91.15 -0.82 57.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.011 0.434 . . . . 1.08 110.22 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.44 65.06 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.079 -0.581 . . . . 0.54 112.047 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 34' ' ' LYS . 1.7 mmmp? -103.12 135.36 44.93 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.739 0.78 . . . . 3.25 111.0 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 p -77.31 122.1 24.64 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 113.85 -1.523 . . . . 1.55 111.451 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -151.07 148.59 28.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 1.38 110.168 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.55 140.87 32.14 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.662 -0.415 . . . . 2.78 110.221 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.42 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -98.78 150.44 36.69 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.062 -0.517 . . . . 1.32 110.888 -177.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.6 154.45 64.41 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.062 2.508 . . . . 1.24 112.183 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 26.7 tt0 -75.62 141.23 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 1.15 110.416 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.4 -10.76 19.55 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.508 -0.853 . . . . 0.68 113.758 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.6 mtpt -92.61 115.65 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.832 0.678 . . . . 2.3 112.832 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.2 p -86.32 125.35 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.563 -0.902 . . . . 0.93 108.563 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.9 mtm -120.56 152.92 37.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.333 -0.394 . . . . 1.31 110.62 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.59 140.53 29.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.629 0.728 . . . . 1.64 111.247 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 44.4 p -103.18 162.47 12.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.661 -1.154 . . . . 0.53 110.225 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 2.8 mmt85 -59.42 -21.08 59.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.582 0.706 . . . . 3.73 111.289 171.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -88.9 0.82 56.25 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.921 -1.036 . . . . 2.7 111.418 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.03 72.72 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.57 -0.824 . . . . 0.77 111.272 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.541 ' CG2' HD21 ' A' ' 62' ' ' LEU . 11.1 p -115.08 171.74 7.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.803 -0.443 . . . . 1.35 109.803 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.62 145.08 50.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.31 -0.404 . . . . 1.84 110.07 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 61' ' ' ARG . 34.5 pt -137.77 159.2 34.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.801 -0.636 . . . . 0.66 110.719 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.73 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -156.88 153.34 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 0.98 109.817 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.62 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -114.05 106.76 14.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.609 -0.886 . . . . 1.5 108.609 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 36.0 tttm -144.27 145.96 32.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.868 0.366 . . . . 1.69 110.524 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.28 31.92 82.37 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.637 -0.711 . . . . 1.21 112.379 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 72.37 -9.35 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.409 0.623 . . . . 2.9 110.902 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -96.17 -179.07 4.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.487 -0.779 . . . . 1.66 110.51 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.048 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.0 OUTLIER -135.98 128.38 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.581 0.705 . . . . 0.92 109.86 173.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.73 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.39 111.99 19.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.008 -0.996 . . . . 0.71 108.612 172.588 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.639 ' HG3' HH11 ' A' ' 61' ' ' ARG . 6.0 tpt85 -120.55 107.17 12.53 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.951 -1.5 . . . . 3.56 106.951 171.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 4.0 mm? 58.91 -46.76 0.06 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.724 -1.126 . . . . 1.4 112.982 -166.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 16.6 t70 77.09 -46.67 0.5 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.176 0.99 . . . . 2.14 109.332 -169.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.503 ' HA ' ' HG2' ' A' ' 67' ' ' ARG . 5.8 mm-40 -61.12 -40.75 94.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.894 -1.048 . . . . 3.8 111.361 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.28 90.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.29 0.567 . . . . 1.76 111.117 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mt -81.89 -40.66 22.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.099 -0.955 . . . . 2.36 111.353 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.612 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 5.4 ptm180 -66.81 -38.18 85.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.748 0.309 . . . . 4.45 111.039 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.612 ' HG3' ' HG3' ' A' ' 67' ' ' ARG . 53.8 mtmt -100.05 65.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.706 . . . . 5.92 110.593 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.64 48.89 0.62 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.882 -1.054 . . . . 5.06 110.747 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -116.0 102.91 10.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.014 0.435 . . . . 6.88 110.703 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.1 t -90.86 110.73 21.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.218 -0.446 . . . . 8.52 110.142 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -101.46 -21.8 14.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.324 0.583 . . . . 10.75 109.946 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.35 -138.87 14.4 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.537 -0.756 . . . . 11.62 111.634 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 CA-C-O 117.995 -1.447 . . . . 12.99 111.34 178.903 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.044 -0.354 . . . . 2.46 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.61 133.96 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.478 -0.328 . . . . 3.48 111.253 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 mmt -104.23 10.76 35.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 2.17 111.431 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.7 m -97.25 -27.49 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.833 0.349 . . . . 1.47 111.044 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.695 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 20.4 p30 -101.46 12.37 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.315 0.579 . . . . 1.89 111.026 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 9.2 p -107.69 127.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.092 -0.643 . . . . 1.25 111.659 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 20' ' ' VAL . 23.5 m -80.3 -23.88 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.639 -0.71 . . . . 1.03 111.025 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -167.87 129.21 1.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 1.41 111.029 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.8 m -102.48 138.19 39.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.808 -1.087 . . . . 0.4 109.558 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 39.2 m-85 -108.09 123.19 48.33 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.076 0.941 . . . . 1.06 111.809 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.961 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 6.1 m-20 -94.9 114.0 25.79 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.442 -1.708 . . . . 1.94 109.92 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -87.68 152.49 22.11 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.386 -0.825 . . . . 1.5 109.089 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -69.45 -6.32 29.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.432 0.634 . . . . 1.68 110.746 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -95.09 -7.94 38.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.582 -0.735 . . . . 2.11 109.29 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 101.43 -19.08 52.3 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.22 -0.9 . . . . 1.28 111.88 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.624 ' HB2' HD12 ' A' ' 12' ' ' LEU . 5.0 m -61.96 145.9 51.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 1.07 110.491 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.7 125.16 46.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.16 0.505 . . . . 1.84 110.594 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -105.76 154.71 6.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.482 -0.933 . . . . 0.41 108.482 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.607 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 51.8 m-70 -136.58 134.65 37.66 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.848 -0.532 . . . . 0.67 109.737 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 7' ' ' VAL . 47.3 t -97.31 111.98 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 106.298 -1.741 . . . . 0.81 106.298 166.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 19' ' ' HIS . 80.9 m-85 -84.39 154.83 22.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.715 -0.675 . . . . 0.64 110.72 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 7.7 ptmm? -58.58 -23.45 58.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.318 -0.856 . . . . 2.87 112.68 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.646 ' HB2' ' HE2' ' A' ' 25' ' ' LYS . 7.7 m-20 -98.01 6.66 47.4 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.156 -0.683 . . . . 1.97 109.156 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 -5.03 66.79 Favored Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 115.078 -0.964 . . . . 0.58 114.787 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -81.88 171.75 14.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.272 1.036 . . . . 1.74 110.382 176.013 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.719 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.5 mpp? -137.0 143.51 42.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.974 -0.557 . . . . 1.07 109.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.87 143.21 14.81 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.383 -0.687 . . . . 0.39 111.383 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.125 0.488 . . . . 0.87 110.799 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 45.8 mt-10 -125.78 153.88 43.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.338 -0.847 . . . . 1.14 109.149 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.57 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 38.3 p-10 -88.98 168.31 12.47 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.61 -0.515 . . . . 1.41 109.61 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 63.9 pttt -53.31 1.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.053 1.131 . . . . 1.77 114.053 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 30' ' ' ASN . 84.7 m-85 -111.09 -2.7 15.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.939 -0.476 . . . . 1.08 110.522 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.92 32.69 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.294 -0.955 . . . . 0.54 113.598 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.57 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -120.42 147.46 45.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.129 -0.628 . . . . 3.25 110.683 174.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -74.57 128.05 34.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.991 -1.004 . . . . 1.55 111.351 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 ptm -126.85 -179.72 4.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.08 -0.509 . . . . 1.38 110.666 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.05 154.38 37.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 2.78 110.109 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.2 ttt -119.88 127.28 26.47 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.178 -0.305 . . . . 1.32 110.178 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.43 148.57 33.85 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.458 2.106 . . . . 1.24 112.863 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.15 139.72 43.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.722 -0.672 . . . . 1.15 109.512 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.52 -31.53 5.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.495 -0.86 . . . . 0.68 112.648 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -82.08 142.19 32.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.72 0.295 . . . . 2.3 110.848 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.596 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.0 p -97.55 130.21 46.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.215 0.531 . . . . 0.93 110.472 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -102.83 140.55 36.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.777 -0.647 . . . . 1.31 109.7 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.51 146.99 27.71 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.21 0.528 . . . . 1.64 110.314 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.3 p -100.46 168.23 9.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.573 -0.74 . . . . 0.53 110.72 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.961 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 39.3 mtt180 -46.57 -41.29 14.19 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.413 0.894 . . . . 3.73 113.413 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.02 -43.48 7.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.871 -0.731 . . . . 2.7 112.098 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.26 28.82 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 119.308 -1.425 . . . . 0.77 113.587 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.0 m -102.44 149.28 24.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.291 -1.003 . . . . 1.35 108.291 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 94.3 mttt -126.15 144.17 50.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.614 -0.434 . . . . 1.84 111.794 -173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 61' ' ' ARG . 39.3 pt -138.0 157.92 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.44 -0.8 . . . . 0.66 110.786 -176.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.94 148.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.818 0.342 . . . . 0.98 110.359 176.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.47 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -111.52 127.02 55.58 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.562 -0.533 . . . . 1.5 109.562 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 55' ' ' LYS . 51.3 tptt -145.24 129.38 17.59 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.791 -0.448 . . . . 1.69 109.791 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.19 36.58 89.33 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.941 -0.647 . . . . 1.21 112.711 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 71.85 -9.63 0.95 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.483 0.713 . . . . 2.9 111.355 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 56' ' ' GLY . 55.4 mm-40 -86.05 139.15 31.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.161 -0.472 . . . . 1.66 111.16 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.719 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -102.08 124.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.576 0.703 . . . . 0.92 110.901 176.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.48 119.63 25.37 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.076 -1.083 . . . . 0.71 108.076 169.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.623 ' H ' HD11 ' A' ' 66' ' ' LEU . 11.1 ttm180 -116.07 101.01 8.36 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.515 -1.661 . . . . 3.56 106.515 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER 38.44 5.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.895 1.372 . . . . 1.4 113.532 -163.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 61' ' ' ARG . 21.5 t0 54.17 168.6 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.203 1.001 . . . . 2.14 111.24 -168.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 10.0 tp10 76.05 -40.6 0.4 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.938 0.895 . . . . 3.8 110.466 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.33 -38.2 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.629 0.728 . . . . 1.76 111.096 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.818 ' HA ' ' HB2' ' A' ' 70' ' ' HIS . 1.9 mp -96.08 -24.38 16.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.119 -0.946 . . . . 2.36 110.018 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 25.9 ttm180 -61.87 -53.75 51.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.207 -0.906 . . . . 4.45 110.088 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -132.68 105.4 7.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.004 -0.544 . . . . 5.92 110.422 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.91 21.47 3.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.2 -1.0 . . . . 5.06 112.973 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.818 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 10.1 t-160 -87.21 -75.8 0.39 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.52 -0.548 . . . . 6.88 109.52 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.1 m 49.53 40.05 18.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.457 0.646 . . . . 8.52 111.247 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -80.2 146.08 31.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.316 -0.857 . . . . 10.75 110.927 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.78 -52.59 4.72 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.863 -0.684 . . . . 11.62 111.789 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.462 -1.188 . . . . 12.99 111.294 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 2' ' ' ASP . 12.2 p . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.483 0.182 . . . . 2.46 111.007 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 1' ' ' VAL . 1.8 p-10 -80.89 170.92 15.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.05 -0.722 . . . . 3.48 109.05 171.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.3 mtp -131.03 27.84 4.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.207 0.527 . . . . 2.17 110.569 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 m -112.95 -36.53 5.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.629 -0.714 . . . . 1.47 111.271 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 1.008 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 10.6 t-20 -114.84 -0.57 13.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.55 0.691 . . . . 1.89 111.779 -174.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.689 HG21 ' HB3' ' A' ' 19' ' ' HIS . 7.8 p -102.73 134.38 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.917 -1.114 . . . . 1.25 111.381 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -87.13 -23.86 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.932 0.345 . . . . 1.03 111.932 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.9 131.45 1.65 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.727 0.775 . . . . 1.41 111.736 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -105.64 142.62 35.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.439 -1.255 . . . . 0.4 109.479 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' CD1' HG21 ' A' ' 46' ' ' THR . 21.2 m-85 -121.7 134.74 54.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.382 -0.827 . . . . 1.06 111.15 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.602 ' CB ' ' HD3' ' A' ' 47' ' ' ARG . 1.2 m-20 -97.03 117.24 30.76 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.987 -1.46 . . . . 1.94 108.454 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 16' ' ' SER . 5.9 mt -72.15 0.81 8.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.891 0.7 . . . . 1.5 112.891 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.548 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 88.72 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.787 0.803 . . . . 1.68 108.999 173.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -80.52 -35.74 34.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.685 -1.143 . . . . 2.11 108.564 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.633 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 148.3 -26.72 1.39 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.431 -1.258 . . . . 1.28 113.315 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.677 ' HB2' HD12 ' A' ' 12' ' ' LEU . 1.4 m -60.64 146.39 45.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.758 -0.46 . . . . 1.07 109.758 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -121.94 126.42 48.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.107 0.479 . . . . 1.84 110.538 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.3 t -108.46 141.79 22.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.04 -0.726 . . . . 0.41 109.04 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.689 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -137.53 131.11 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.174 -0.61 . . . . 0.67 110.428 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 59' ' ' ILE . 60.7 t -102.89 123.98 56.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 107.522 -1.288 . . . . 0.81 107.522 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 97.9 m-85 -98.61 161.4 13.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.963 -0.562 . . . . 0.64 111.219 -167.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.008 ' HE2' ' HA ' ' A' ' 5' ' ' ASN . 41.4 mtmt -62.15 -19.56 63.18 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.179 -0.464 . . . . 2.87 111.95 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.911 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 2.1 m-20 -83.98 -9.39 58.71 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.275 -1.009 . . . . 1.97 108.275 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.89 -5.06 59.5 Favored Glycine 0 N--CA 1.421 -2.358 0 CA-C-N 114.731 -1.122 . . . . 0.58 113.338 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.911 ' HD3' ' HB2' ' A' ' 23' ' ' ASP . 1.6 mppt? -82.62 -177.1 6.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 117.748 0.774 . . . . 1.74 109.417 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 1.7 pmm? -153.81 147.61 25.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.757 -0.656 . . . . 1.07 109.676 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.27 155.05 21.91 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.786 -0.721 . . . . 0.39 111.964 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.6 ttt -124.95 141.53 52.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.121 0.486 . . . . 0.87 111.656 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 27.2 mt-10 -126.45 153.49 44.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.098 -1.075 . . . . 1.14 108.098 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -93.42 172.63 8.16 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.403 -0.519 . . . . 1.41 110.542 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.633 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 60.8 pttt -53.07 -14.78 0.67 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.605 0.965 . . . . 1.77 113.605 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -95.9 -3.12 45.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.065 -0.397 . . . . 1.08 110.914 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.34 22.65 47.04 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.825 -0.702 . . . . 0.54 112.199 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 mmtt -102.34 134.04 46.29 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.875 0.845 . . . . 3.25 110.81 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 p -76.75 129.21 35.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.665 -1.607 . . . . 1.55 111.545 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 55.4 mtm -136.77 162.9 31.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 1.38 110.064 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -90.96 156.47 17.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.343 -0.389 . . . . 2.78 110.03 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 41.5 ttm -99.98 127.66 32.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 1.32 111.612 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.13 118.5 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.539 2.159 . . . . 1.24 111.922 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.1 tt0 -68.58 137.06 53.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.759 -0.655 . . . . 1.15 110.802 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -9.14 37.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.68 113.471 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -104.22 130.29 51.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.335 0.568 . . . . 2.3 112.132 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.696 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.2 p -93.78 132.66 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 0.93 110.366 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.4 mtm -124.8 153.18 42.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.487 -0.779 . . . . 1.31 109.712 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -107.4 167.78 9.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.523 0.678 . . . . 1.64 111.688 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 54.3 p -127.59 164.87 21.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.655 -1.157 . . . . 0.53 112.067 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.602 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 75.0 mtp180 -59.65 -29.66 68.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.413 -0.812 . . . . 3.73 111.423 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -95.18 -7.33 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 2.7 111.333 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.37 16.42 27.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.328 -0.939 . . . . 0.77 112.913 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.519 HG23 ' CD2' ' A' ' 62' ' ' LEU . 99.3 m -93.31 139.8 30.25 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.95 -0.389 . . . . 1.35 109.95 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -106.64 132.7 52.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.104 -0.702 . . . . 1.84 109.104 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.417 ' HA ' ' HD1' ' A' ' 60' ' ' PHE . 17.3 pt -136.6 152.82 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.901 0.334 . . . . 0.66 111.901 -175.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.696 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.56 149.81 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.945 -0.571 . . . . 0.98 110.359 174.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.563 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.6 ttt -103.86 123.33 46.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.102 -0.703 . . . . 1.5 109.102 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 23.2 tptm -145.48 128.14 16.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.754 -0.461 . . . . 1.69 109.754 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.14 43.32 97.34 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.61 -0.596 . . . . 1.21 111.61 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 50.12 21.17 0.71 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.182 0.993 . . . . 2.9 112.174 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -116.9 152.09 35.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 1.66 110.511 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.507 HG13 HG22 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -98.93 122.63 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.133 0.968 . . . . 0.92 111.666 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.854 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -82.66 111.6 18.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.238 -1.393 . . . . 0.71 107.238 164.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.649 ' C ' ' H ' ' A' ' 63' ' ' ASP . 5.8 ttm180 -116.47 103.93 10.93 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.709 -1.96 . . . . 3.56 105.709 170.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD2' HG23 ' A' ' 50' ' ' THR . 3.8 mm? 62.54 -34.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.082 0.864 . . . . 1.4 112.202 -166.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.854 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 14.6 t70 81.83 -43.88 0.17 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.266 1.426 . . . . 2.14 109.168 -169.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.76 -32.63 63.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.898 -1.046 . . . . 3.8 110.839 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 61' ' ' ARG . . . -56.13 -40.47 73.85 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.056 -0.52 . . . . 1.76 111.59 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.5 mm? -64.12 -30.57 71.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.487 -0.779 . . . . 2.36 112.267 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HD2' ' N ' ' A' ' 67' ' ' ARG . 3.0 mmm180 -83.0 -41.98 18.07 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.592 0.71 . . . . 4.45 109.332 -174.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -74.42 116.89 15.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.392 -1.276 . . . . 5.92 110.926 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.61 90.28 0.24 Allowed Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.835 -0.621 . . . . 5.06 112.135 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -74.21 79.26 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.731 0.777 . . . . 6.88 110.666 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.9 t -164.78 -57.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.174 -1.375 . . . . 8.52 107.413 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.53 -48.53 15.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.782 -1.099 . . . . 10.75 108.652 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.49 61.41 0.32 Allowed Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.293 -0.867 . . . . 11.62 111.284 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.657 -1.079 . . . . 12.99 111.751 -178.312 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.664 ' HB ' ' OE1' ' A' ' 29' ' ' GLU . 7.3 p . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.116 -0.327 . . . . 2.46 110.116 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.04 111.3 18.06 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.998 -0.741 . . . . 3.48 108.998 170.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.0 mtp -86.21 17.8 3.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.693 -0.685 . . . . 2.17 111.65 -170.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m -78.93 -27.77 43.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.35 0.595 . . . . 1.47 110.504 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 17.3 p30 -108.28 9.61 27.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.769 0.795 . . . . 1.89 110.558 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.415 HG11 ' OG1' ' A' ' 9' ' ' THR . 84.5 t -102.48 127.74 55.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.399 -0.819 . . . . 1.25 110.842 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 22' ' ' LYS . 24.5 m -86.7 -23.27 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 1.03 110.964 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.37 138.76 3.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 1.41 110.581 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.415 ' OG1' HG11 ' A' ' 6' ' ' VAL . 3.4 m -120.76 143.97 48.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.484 -0.78 . . . . 0.4 109.728 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.76 129.39 51.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.372 1.082 . . . . 1.06 111.653 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -96.76 125.47 41.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.117 -1.856 . . . . 1.94 108.99 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.613 HD12 ' HB2' ' A' ' 16' ' ' SER . 16.7 mt -80.84 148.81 29.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.117 -1.068 . . . . 1.5 108.117 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.562 ' HG2' ' HA ' ' A' ' 47' ' ' ARG . 51.9 mt-30 -65.06 -5.34 6.2 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.98 0.363 . . . . 1.68 111.98 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.33 -27.11 14.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.518 . . . . 2.11 110.129 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 135.24 -19.58 3.84 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.771 -0.728 . . . . 1.28 113.124 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.613 ' HB2' HD12 ' A' ' 12' ' ' LEU . 6.3 m -68.56 155.55 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.827 0.346 . . . . 1.07 110.584 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -124.99 127.72 47.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.265 -0.425 . . . . 1.84 111.069 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -108.23 143.47 18.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.754 -0.832 . . . . 0.41 108.754 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' MET . 4.0 m-70 -131.14 130.12 42.69 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.088 -0.645 . . . . 0.67 110.62 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 116.38 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.79 -1.559 . . . . 0.81 106.79 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' HE1' ' N ' ' A' ' 27' ' ' GLY . 73.1 m-85 -85.63 155.28 21.19 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.72 -0.673 . . . . 0.64 111.316 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 12.8 ptmm? -57.49 -22.85 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.964 -1.016 . . . . 2.87 112.273 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -94.46 2.52 55.73 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.843 -0.799 . . . . 1.97 108.843 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.39 -11.57 59.91 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.83 -1.077 . . . . 0.58 114.386 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.66 179.87 7.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.082 0.941 . . . . 1.74 111.19 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.622 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -139.44 143.62 37.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.144 0.497 . . . . 1.07 109.983 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -136.79 146.28 18.21 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.932 -0.867 . . . . 0.39 110.932 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.4 ttt -122.62 144.73 48.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.932 0.396 . . . . 0.87 111.302 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.664 ' OE1' ' HB ' ' A' ' 1' ' ' VAL . 22.9 mt-10 -126.75 148.89 49.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.946 -1.131 . . . . 1.14 107.946 172.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -86.38 170.44 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.231 -0.588 . . . . 1.41 110.121 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 19.3 pttm -58.02 1.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.626 0.972 . . . . 1.77 113.626 173.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -107.47 -1.84 21.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 1.08 109.521 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.3 22.17 52.4 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.819 -0.705 . . . . 0.54 112.268 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -110.97 137.82 48.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.413 0.625 . . . . 3.25 111.414 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -74.65 139.12 43.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.163 -1.38 . . . . 1.55 111.869 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.1 ptm -150.45 178.82 8.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.612 -0.722 . . . . 1.38 109.602 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -104.84 158.95 16.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 2.78 110.629 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.8 ttt -101.45 130.2 25.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 1.32 110.091 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.98 132.86 17.4 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.71 2.273 . . . . 1.24 112.772 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 54' ' ' MET . 36.6 tt0 -73.89 138.42 44.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.15 110.23 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.93 62.73 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.824 -0.703 . . . . 0.68 112.979 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -102.93 127.02 50.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 2.3 111.887 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.609 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.7 p -95.6 132.27 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.582 -0.735 . . . . 0.93 109.138 178.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.6 mtm -119.48 148.55 43.13 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.792 -0.447 . . . . 1.31 109.792 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -102.99 147.32 27.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.228 0.537 . . . . 1.64 110.746 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.83 162.34 14.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.325 -0.852 . . . . 0.53 111.264 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.562 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 99.7 mtt180 -58.85 -26.2 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.88 -0.6 . . . . 3.73 111.786 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.68 -14.94 38.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 2.7 110.402 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.79 26.33 6.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.912 -0.661 . . . . 0.77 112.95 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.786 HG21 HH11 ' A' ' 61' ' ' ARG . 43.6 m -111.13 165.16 12.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.505 -0.554 . . . . 1.35 109.505 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' N ' HG22 ' A' ' 50' ' ' THR . 68.1 mttm -122.42 143.83 49.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.592 -0.522 . . . . 1.84 109.592 176.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 20.6 pt -136.32 150.5 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 0.66 111.141 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.699 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.15 144.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.313 -0.403 . . . . 0.98 110.732 177.073 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 25.8 ttt -99.99 138.18 37.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.597 -0.52 . . . . 1.5 109.597 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 21.0 tptp -144.41 103.35 3.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 1.69 107.883 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 -152.1 45.63 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.055 -1.618 . . . . 1.21 109.055 -164.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.63 8.48 14.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.106 0.479 . . . . 2.9 110.644 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -104.76 177.87 4.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.994 0.425 . . . . 1.66 110.481 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.622 HD12 ' HG2' ' A' ' 26' ' ' MET . 11.2 tt -143.59 141.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.746 0.784 . . . . 0.92 110.884 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.935 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -82.49 114.72 21.1 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.438 -1.319 . . . . 0.71 107.438 169.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.786 HH11 HG21 ' A' ' 50' ' ' THR . 0.4 OUTLIER -114.49 102.75 10.36 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.527 -1.657 . . . . 3.56 106.527 170.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.955 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER 60.4 -25.44 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.768 0 O-C-N 124.457 1.098 . . . . 1.4 111.746 -172.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.935 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 22.0 t0 71.18 60.33 0.17 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.39 1.476 . . . . 2.14 111.723 -176.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.749 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 40.7 tt0 168.16 -40.92 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.467 -1.242 . . . . 3.8 108.992 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.955 ' H ' HD12 ' A' ' 62' ' ' LEU . . . -49.84 -59.36 3.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.119 -0.946 . . . . 1.76 111.45 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -89.56 -11.48 42.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.475 -0.784 . . . . 2.36 109.907 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.749 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 78.4 ttt180 -77.83 -59.82 2.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.665 -1.152 . . . . 4.45 111.403 -172.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -107.92 74.18 0.93 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.102 0.477 . . . . 5.92 110.495 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.43 51.85 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.581 -0.819 . . . . 5.06 112.134 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -86.42 -35.23 19.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.88 0.371 . . . . 6.88 110.584 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.2 m -105.64 105.35 15.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.208 -0.451 . . . . 8.52 110.568 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -119.41 175.75 5.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.979 -0.555 . . . . 10.75 110.306 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.39 23.11 77.92 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.731 -0.747 . . . . 11.62 111.806 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 N-CA-C 111.072 -0.811 . . . . 12.99 111.072 -177.224 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 19' ' ' HIS . 83.9 t . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.753 0.311 . . . . 2.46 110.599 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.94 162.51 13.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.922 -0.581 . . . . 3.48 110.387 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mmt -92.89 1.6 57.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.039 0.447 . . . . 2.17 111.117 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 p -81.52 -7.21 59.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.57 0.7 . . . . 1.47 110.917 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -129.44 11.75 5.86 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.068 0.937 . . . . 1.89 109.039 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -117.37 133.47 64.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.016 -1.447 . . . . 1.25 111.658 -175.369 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 22' ' ' LYS . 35.6 m -88.24 -26.37 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.541 -0.754 . . . . 1.03 111.536 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -167.15 135.79 2.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.344 0.593 . . . . 1.41 111.167 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 m -114.23 144.45 43.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.907 -1.042 . . . . 0.4 110.102 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.49 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 30.9 m-85 -120.15 132.19 55.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.552 0.692 . . . . 1.06 111.136 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.55 125.76 51.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.238 -1.346 . . . . 1.94 108.698 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 16' ' ' SER . 17.4 mt -81.16 153.63 27.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.377 -1.283 . . . . 1.5 107.832 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -65.85 -7.31 15.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.217 0.532 . . . . 1.68 111.232 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.615 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 31.6 t70 -98.45 -13.52 20.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 2.11 109.98 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.551 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 116.07 -13.45 16.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.651 -0.785 . . . . 1.28 113.425 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.602 ' HB2' HD12 ' A' ' 12' ' ' LEU . 4.9 m -72.96 148.19 44.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.792 0.296 . . . . 1.07 110.592 -176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -118.93 127.58 53.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.308 0.575 . . . . 1.84 112.454 -172.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.9 t -109.57 143.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.165 -1.05 . . . . 0.41 108.165 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' MET . 5.5 m-70 -132.28 137.98 47.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.738 -0.785 . . . . 0.67 110.602 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.48 ' O ' HG22 ' A' ' 7' ' ' VAL . 46.5 t -97.67 115.21 36.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.131 -1.433 . . . . 0.81 107.131 169.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 49.5 m-85 -80.6 153.66 27.88 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.933 -0.576 . . . . 0.64 111.167 -173.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.768 ' HA ' HG13 ' A' ' 7' ' ' VAL . 16.7 pttm -57.58 -27.01 62.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.998 -1.001 . . . . 2.87 111.756 -176.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.36 -1.23 54.12 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.209 -0.663 . . . . 1.97 109.209 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.41 41.0 Favored Glycine 0 N--CA 1.423 -2.168 0 C-N-CA 119.92 -1.133 . . . . 0.58 114.879 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -75.05 176.38 7.29 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.934 1.367 . . . . 1.74 111.737 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 2.2 mpp? -140.44 148.82 41.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.07 109.945 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.83 145.26 17.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.619 -0.801 . . . . 0.39 111.724 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 ttt -119.27 137.8 53.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.511 . . . . 0.87 110.924 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 23.1 mt-10 -130.58 154.25 48.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.308 -0.86 . . . . 1.14 109.035 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 41.7 p30 -88.42 169.1 12.08 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.275 -0.57 . . . . 1.41 110.053 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 14' ' ' ASP . 40.6 pttt -53.6 -10.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.097 1.147 . . . . 1.77 114.097 175.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -99.03 -1.52 39.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 1.08 110.602 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.52 20.53 51.28 Favored Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.856 -0.688 . . . . 0.54 111.909 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 27.9 mmmt -102.17 135.62 43.45 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.644 0.735 . . . . 3.25 111.334 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -74.7 127.57 33.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.032 -1.44 . . . . 1.55 111.011 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.3 ptm -138.27 176.49 8.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 1.38 110.736 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.56 131.19 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.118 -0.492 . . . . 2.78 109.849 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.8 ttp -85.2 117.64 69.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.965 -0.562 . . . . 1.32 110.445 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.46 147.43 64.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.86 2.373 . . . . 1.24 112.809 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 34.6 tt0 -88.82 144.82 25.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.001 -0.545 . . . . 1.15 110.385 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.87 -16.73 60.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.014 -0.613 . . . . 0.68 112.569 176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 42' ' ' LYS . 42.3 mmtm -94.88 119.73 33.93 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.116 0.413 . . . . 2.3 112.116 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.576 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 10.7 p -94.02 119.58 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.078 -0.712 . . . . 0.93 109.078 174.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 65.3 mtm -107.74 152.17 24.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.603 -0.726 . . . . 1.31 110.613 -170.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 50' ' ' THR . 38.1 tt0 -104.64 145.41 30.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.538 0.685 . . . . 1.64 111.497 -176.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.0 p -94.93 166.63 11.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.746 -1.115 . . . . 0.53 109.925 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -35.92 -49.37 0.62 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.57 1.322 . . . . 3.73 114.57 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.84 -33.69 15.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.48 -0.488 . . . . 2.7 111.978 -170.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.79 34.23 0.17 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.985 -1.102 . . . . 0.77 112.837 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.5 m -100.87 153.32 19.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.486 -0.931 . . . . 1.35 108.486 176.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB3' HG22 ' A' ' 43' ' ' VAL . 93.4 mttt -124.26 139.55 53.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.432 -0.507 . . . . 1.84 112.075 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.479 ' HA ' ' CE1' ' A' ' 60' ' ' PHE . 31.6 pt -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.148 -0.933 . . . . 0.66 110.201 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.733 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -163.41 155.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.825 0.345 . . . . 0.98 111.137 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.67 ' N ' HG12 ' A' ' 53' ' ' ILE . 13.4 tmm? -104.79 117.22 33.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.247 -1.019 . . . . 1.5 108.247 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 20.2 tptp -134.0 125.6 28.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.31 -0.626 . . . . 1.69 109.31 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.07 38.13 88.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.756 -0.735 . . . . 1.21 112.155 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.6 t30 62.46 28.57 16.85 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.607 0.718 . . . . 2.9 110.852 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' MET . 46.0 mt-10 -141.29 159.87 41.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.656 -0.702 . . . . 1.66 110.409 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -102.16 126.64 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.456 0.646 . . . . 0.92 111.404 -177.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.733 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.81 110.35 18.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.313 -1.736 . . . . 0.71 106.313 164.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.607 ' C ' ' H ' ' A' ' 63' ' ' ASP . 1.2 tmm_? -114.47 103.64 11.24 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.632 -1.618 . . . . 3.56 106.632 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.603 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 4.0 mm? 55.72 -37.49 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.385 1.053 . . . . 1.4 113.404 -165.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.689 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 0.3 OUTLIER 79.89 -58.73 0.35 Allowed 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.839 1.255 . . . . 2.14 109.076 -168.645 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -19.13 65.32 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.417 -0.811 . . . . 3.8 111.219 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 62' ' ' LEU . . . -67.49 -28.06 67.53 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.437 0.637 . . . . 1.76 110.654 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.7 -33.61 14.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.151 -0.931 . . . . 2.36 110.526 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.689 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 16.2 mmt180 -69.43 -64.83 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.263 1.03 . . . . 4.45 110.647 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.494 ' HG2' ' HB2' ' A' ' 67' ' ' ARG . 60.6 mmtt -90.4 139.53 30.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.881 -1.509 . . . . 5.92 110.564 -164.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.92 9.86 70.36 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.016 -0.612 . . . . 5.06 112.258 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -120.0 -83.39 0.65 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.946 -0.391 . . . . 6.88 109.946 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.6 m 56.97 -152.2 0.4 Allowed 'General case' 0 C--O 1.235 0.322 0 O-C-N 123.655 0.597 . . . . 8.52 111.149 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -153.4 -73.99 0.13 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.092 0.473 . . . . 10.75 109.893 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.99 25.84 1.01 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.937 -0.649 . . . . 11.62 111.715 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.822 -0.988 . . . . 12.99 111.347 -179.146 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 52.7 t . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.785 0.326 . . . . 2.46 110.85 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.7 t70 67.08 105.42 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.208 -0.905 . . . . 3.48 110.809 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.573 ' HA ' HG12 ' A' ' 6' ' ' VAL . 22.6 mmt -84.62 11.36 9.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.348 -0.842 . . . . 2.17 111.466 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -92.74 -37.36 12.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 1.47 111.004 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.56 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -107.0 -6.47 17.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.235 0.541 . . . . 1.89 111.417 -176.269 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 19' ' ' HIS . 4.8 p -94.73 141.1 15.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.95 -0.469 . . . . 1.25 110.502 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -94.98 -23.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.865 -0.334 . . . . 1.03 110.9 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -160.15 136.53 8.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.383 0.611 . . . . 1.41 110.82 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -121.2 135.2 55.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.024 -0.989 . . . . 0.4 109.538 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 27.8 m-85 -117.26 134.06 55.25 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.864 0.84 . . . . 1.06 111.754 -177.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 10.7 t70 -104.08 126.15 50.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.188 -1.369 . . . . 1.94 108.517 176.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 16' ' ' SER . 8.8 mt -71.51 0.09 9.26 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.423 -1.262 . . . . 1.5 112.623 -172.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 7.6 tt0 86.87 -24.37 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.963 -0.754 . . . . 1.68 108.963 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -95.15 -21.13 18.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.102 -0.954 . . . . 2.11 109.16 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.584 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 139.36 -29.97 2.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.543 -0.837 . . . . 1.28 113.945 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' HD12 ' A' ' 12' ' ' LEU . 3.8 m -66.05 149.07 50.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 117.09 0.445 . . . . 1.07 110.264 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 46.8 mttm -124.44 126.72 46.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 1.84 111.432 -172.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.58 141.81 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.897 -0.779 . . . . 0.41 108.897 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.585 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.9 m-70 -130.59 130.19 43.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.331 -0.547 . . . . 0.67 110.27 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.09 111.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.058 -1.46 . . . . 0.81 107.058 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 85.6 m-85 -89.72 163.09 15.24 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.02 -0.536 . . . . 0.64 110.888 -168.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 24.9 mtpp -66.82 -21.05 66.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.423 0.63 . . . . 2.87 110.387 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.41 -13.33 59.95 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.276 -1.009 . . . . 1.97 108.276 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.99 71.14 Favored Glycine 0 N--CA 1.422 -2.258 0 CA-C-N 114.043 -1.435 . . . . 0.58 112.93 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -78.49 171.9 14.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.622 0.725 . . . . 1.74 111.452 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.707 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.0 mpp? -130.74 138.14 49.82 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.625 -1.171 . . . . 1.07 110.022 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.37 139.27 10.83 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 111.218 -0.753 . . . . 0.39 111.218 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.9 ttt -117.73 133.97 55.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.253 0.549 . . . . 0.87 110.877 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.03 149.33 42.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.11 -0.95 . . . . 1.14 108.64 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 32' ' ' PHE . 43.9 p30 -86.96 169.5 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.658 -0.417 . . . . 1.41 110.132 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 45.8 pttt -59.24 5.08 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.44 0.904 . . . . 1.77 113.44 172.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 30' ' ' ASN . 89.5 m-85 -106.78 -2.9 21.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.169 -0.678 . . . . 1.08 109.169 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.07 27.48 40.6 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.789 -0.641 . . . . 0.54 114.074 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 157.14 42.55 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.054 -0.658 . . . . 3.25 111.332 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 p -74.66 126.52 31.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 1.55 111.181 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -126.27 -175.61 3.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.977 -0.556 . . . . 1.38 110.804 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.22 132.06 35.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 2.78 110.233 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 27.6 ttt -97.62 123.55 51.65 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.204 -0.453 . . . . 1.32 110.41 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.73 152.09 82.62 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.81 2.34 . . . . 1.24 111.731 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 53' ' ' ILE . 32.8 tt0 -83.75 -90.59 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.052 -0.259 . . . . 1.15 111.042 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.539 ' HA2' HD11 ' A' ' 53' ' ' ILE . . . -81.15 40.76 2.56 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.179 -0.534 . . . . 0.68 113.85 -170.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -109.44 119.63 40.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.652 0.263 . . . . 2.3 110.818 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.544 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.4 p -81.34 117.91 28.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 0.93 109.361 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.8 mtm -103.2 146.4 28.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 1.31 110.996 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 51' ' ' LYS . 32.9 tt0 -98.75 151.64 20.55 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.353 -0.839 . . . . 1.64 109.866 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -126.41 164.75 20.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.004 0.431 . . . . 0.53 112.14 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -60.43 -28.7 68.49 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.749 -0.659 . . . . 3.73 111.91 176.169 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 20.0 t70 -90.71 -19.15 23.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.618 -0.719 . . . . 2.7 110.87 -171.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.25 15.62 18.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.632 -0.794 . . . . 0.77 112.488 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.519 HG23 HD22 ' A' ' 62' ' ' LEU . 63.8 m -94.75 142.93 26.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.906 -0.405 . . . . 1.35 109.906 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' NZ ' ' HB2' ' A' ' 45' ' ' GLU . 67.1 mmtt -108.67 132.33 54.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 1.84 108.848 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.3 pt -135.99 156.91 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.763 0.283 . . . . 0.66 111.763 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -165.19 150.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.764 -0.653 . . . . 0.98 110.121 176.218 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 16.6 tmm? -111.43 129.94 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.968 -0.382 . . . . 1.5 109.968 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -144.35 124.69 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.589 -0.278 . . . . 1.69 110.272 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 62.54 39.51 97.94 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.835 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 72.55 -10.66 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.213 0.53 . . . . 2.9 111.208 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 54' ' ' MET . 45.2 mt-10 -89.79 167.84 12.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.138 -0.483 . . . . 1.66 109.98 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -126.26 125.66 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.879 0.847 . . . . 0.92 110.875 -178.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.762 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -81.56 110.41 16.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.248 -1.39 . . . . 0.71 107.248 169.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.596 ' C ' ' H ' ' A' ' 63' ' ' ASP . 38.7 ttp-105 -125.96 112.01 15.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.43 -1.693 . . . . 3.56 106.43 174.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.6 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 4.2 mm? 59.89 -37.05 0.08 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.196 0.935 . . . . 1.4 112.668 -166.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.678 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 2.1 t70 81.54 -34.22 0.1 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.768 1.227 . . . . 2.14 110.088 -174.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -94.21 -16.07 23.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.115 -0.948 . . . . 3.8 111.127 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . . . -64.3 -49.2 72.74 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.251 0.548 . . . . 1.76 111.181 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 mp -73.25 -31.96 64.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.56 -0.745 . . . . 2.36 110.487 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.63 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 37.2 ttm180 -68.48 -64.23 0.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.029 -0.987 . . . . 4.45 111.172 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.63 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 73.7 mmtt -105.28 78.99 1.43 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.921 -0.581 . . . . 5.92 110.474 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.7 65.5 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.66 -0.781 . . . . 5.06 112.334 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -72.26 122.08 20.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.269 0.556 . . . . 6.88 109.682 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.9 t -82.06 121.49 26.62 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.364 -0.835 . . . . 8.52 112.392 -167.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -76.22 -42.8 44.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.308 -0.997 . . . . 10.75 108.308 168.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.82 153.99 13.41 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.325 -0.852 . . . . 11.62 112.451 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.567 -1.129 . . . . 12.99 111.583 177.912 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.464 -0.198 . . . . 2.46 110.464 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -77.03 149.33 35.85 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.065 -0.346 . . . . 3.48 110.065 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.9 mmt -101.04 -3.16 29.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.806 0.336 . . . . 2.17 111.444 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -73.57 -24.94 60.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.903 0.859 . . . . 1.47 109.873 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -105.3 10.39 33.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.664 -1.153 . . . . 1.89 110.595 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 19' ' ' HIS . 74.5 t -105.87 135.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.479 -0.782 . . . . 1.25 109.959 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -105.84 -18.46 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.035 -0.53 . . . . 1.03 111.072 -178.121 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -169.01 132.95 1.4 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.123 0.487 . . . . 1.41 110.613 171.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.0 m -110.89 143.8 40.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.381 -0.827 . . . . 0.4 110.583 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.563 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 20.7 m-85 -124.9 139.82 53.49 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.425 0.631 . . . . 1.06 111.441 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.723 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 16' ' ' SER . 43.3 mt -83.21 148.96 27.12 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.99 -1.004 . . . . 1.5 109.654 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.27 -15.49 35.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.309 0.576 . . . . 1.68 111.618 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 20.7 t70 -96.39 -1.79 46.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.545 -0.752 . . . . 2.11 109.785 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 104.58 -19.3 42.37 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.113 -0.949 . . . . 1.28 112.832 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.669 ' HB2' HD12 ' A' ' 12' ' ' LEU . 40.1 m -72.84 159.97 32.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.574 -0.313 . . . . 1.07 110.671 -177.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 32.8 mttt -119.43 152.55 36.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.136 0.493 . . . . 1.84 110.694 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.408 HG11 HD12 ' A' ' 52' ' ' ILE . 75.4 t -131.48 144.25 38.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.855 -0.794 . . . . 0.41 108.855 174.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HB3' HG13 ' A' ' 6' ' ' VAL . 3.1 m-70 -134.6 135.15 42.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.48 -0.563 . . . . 0.67 109.48 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 7' ' ' VAL . 48.2 t -93.63 118.24 39.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 106.579 -1.638 . . . . 0.81 106.579 168.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.401 ' HE1' ' HA3' ' A' ' 27' ' ' GLY . 48.7 m-85 -81.98 150.36 27.68 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.77 -0.65 . . . . 0.64 110.9 -172.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -61.34 -22.33 64.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 2.87 111.768 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -99.69 6.65 45.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.76 0.791 . . . . 1.97 109.079 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.24 1.49 60.97 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.711 -1.131 . . . . 0.58 115.007 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -75.89 173.11 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.827 1.314 . . . . 1.74 111.21 172.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.701 ' HG2' HD12 ' A' ' 59' ' ' ILE . 3.2 mpp? -138.07 131.33 30.43 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.343 -0.984 . . . . 1.07 108.343 171.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA3' ' HE1' ' A' ' 21' ' ' PHE . . . -124.0 141.92 13.82 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.249 -0.977 . . . . 0.39 111.922 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.5 ttt -113.64 141.0 47.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.793 0.33 . . . . 0.87 110.191 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 16.6 mt-10 -123.53 144.66 49.42 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.619 -1.252 . . . . 1.14 107.619 169.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.434 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 29.9 p-10 -87.62 165.91 15.09 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.87 -0.732 . . . . 1.41 109.169 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 pttm -52.22 -13.21 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.607 0.966 . . . . 1.77 113.607 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.434 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 93.7 m-85 -98.73 7.77 45.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.923 0.392 . . . . 1.08 110.669 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.02 20.57 64.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.248 -0.501 . . . . 0.54 113.0 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.3 mmtm -102.01 140.83 35.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.746 0.784 . . . . 3.25 111.024 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.3 p -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.913 -1.494 . . . . 1.55 112.327 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.2 mtp -139.07 178.34 7.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.032 -0.985 . . . . 1.38 109.83 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -114.79 139.25 49.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.058 -0.719 . . . . 2.78 109.058 173.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.0 ttm -71.24 127.11 91.78 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.648 0.261 . . . . 1.32 110.86 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.87 114.49 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.19 1.927 . . . . 1.24 111.253 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.5 tt0 -61.87 129.45 41.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.807 -0.633 . . . . 1.15 110.373 -176.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.41 -20.22 30.51 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.125 -0.56 . . . . 0.68 112.781 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 42' ' ' LYS . 22.2 mmmt -88.55 119.83 29.36 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 2.3 111.907 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.675 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.98 136.47 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.554 -0.535 . . . . 0.93 109.554 172.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 68.2 mtm -132.22 157.12 45.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.579 -0.282 . . . . 1.31 110.751 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.33 150.75 20.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.882 0.849 . . . . 1.64 111.941 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 30.1 p -97.19 165.78 11.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.29 -1.323 . . . . 0.53 108.87 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -46.66 -36.33 6.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.996 0.739 . . . . 3.73 112.996 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -96.78 -49.96 4.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.356 0.502 . . . . 2.7 112.356 -168.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.9 32.24 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.411 -1.376 . . . . 0.77 113.712 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.6 t -114.03 156.65 23.72 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.457 -0.942 . . . . 1.35 108.457 168.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -120.38 145.67 46.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.651 0.263 . . . . 1.84 110.596 -171.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 12' ' ' LEU . 22.6 pt -136.46 152.28 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.887 -0.597 . . . . 0.66 110.863 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.97 147.38 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.066 -0.515 . . . . 0.98 110.549 176.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 26.2 ttt -97.53 129.66 44.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.26 -0.644 . . . . 1.5 109.26 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -144.99 128.33 16.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.159 -0.311 . . . . 1.69 110.159 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.32 37.25 93.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.471 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 61.24 25.33 15.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.674 0.749 . . . . 2.9 111.05 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -128.06 -169.51 2.08 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.807 -1.088 . . . . 1.66 108.45 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.701 HD12 ' HG2' ' A' ' 26' ' ' MET . 3.3 tt -143.54 136.43 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.792 0.806 . . . . 0.92 111.529 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.665 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.1 109.41 17.13 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.795 -1.557 . . . . 0.71 106.795 167.18 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.563 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 1.3 tmm_? -121.35 108.87 14.22 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 105.031 -2.211 . . . . 3.56 105.031 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 4.5 mm? 62.41 -60.04 0.13 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 1.4 109.163 -156.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.613 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 5.3 t70 139.23 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.065 2.146 . . . . 2.14 107.771 175.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 67' ' ' ARG . 8.5 pt-20 -101.9 -29.75 11.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.198 -1.365 . . . . 3.8 111.546 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.41 -53.18 61.25 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.016 -0.538 . . . . 1.76 112.1 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -89.64 -16.06 31.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.995 0.426 . . . . 2.36 110.486 179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.602 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 63.4 ttt180 -56.0 -57.38 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.134 -0.939 . . . . 4.45 110.324 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.32 82.59 2.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.85 -0.796 . . . . 5.92 108.85 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.41 -52.62 0.17 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.713 -1.13 . . . . 5.06 111.087 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -98.81 89.79 4.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.423 -0.584 . . . . 6.88 109.423 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.1 p -128.93 165.96 20.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.532 -0.758 . . . . 8.52 110.094 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 61.56 28.27 17.55 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.685 0.615 . . . . 10.75 111.191 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.71 24.58 6.06 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.879 -0.6 . . . . 11.62 111.665 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.802 -0.999 . . . . 12.99 111.76 178.435 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.51 HG11 ' CE1' ' A' ' 19' ' ' HIS . 29.9 m . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 110.741 -0.096 . . . . 2.46 110.741 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 45.59 65.57 1.11 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.638 0.732 . . . . 3.48 111.921 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.594 ' H ' HG12 ' A' ' 6' ' ' VAL . 21.0 mmt -69.92 -20.91 63.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.08 -0.963 . . . . 2.17 111.89 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 3' ' ' MET . 73.6 m 73.53 -27.62 0.19 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.809 0.843 . . . . 1.47 109.335 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 3' ' ' MET . 2.4 t-20 -95.85 -14.7 22.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.939 -1.028 . . . . 1.89 109.914 168.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.8 p -89.18 136.11 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 119.384 -0.926 . . . . 1.25 110.088 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.25 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.962 -0.295 . . . . 1.03 111.499 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 16.7 tppt? -169.32 151.49 4.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.228 0.537 . . . . 1.41 111.286 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 3.9 m -133.08 145.75 51.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.553 -0.749 . . . . 0.4 109.795 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 61' ' ' ARG . 38.7 m-85 -128.61 144.63 51.19 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.723 0.773 . . . . 1.06 112.333 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.948 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 6.5 m-20 -106.56 123.7 48.5 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.782 -1.553 . . . . 1.94 110.026 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -77.34 1.84 17.63 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.92 -1.491 . . . . 1.5 113.022 -173.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 47' ' ' ARG . 62.7 tt0 83.68 -32.61 0.07 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.059 0.544 . . . . 1.68 109.998 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.8 t70 -79.87 -20.14 46.63 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.429 -1.323 . . . . 2.11 107.429 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.598 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.54 -17.2 6.53 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.266 -1.334 . . . . 1.28 113.485 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' HD12 ' A' ' 12' ' ' LEU . 11.3 m -62.51 143.74 56.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.841 0.353 . . . . 1.07 110.414 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 65.7 mttm -116.46 126.96 54.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.088 -0.505 . . . . 1.84 110.713 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' THR . 97.1 t -109.58 136.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.524 -0.547 . . . . 0.41 109.524 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.65 ' HB3' HG21 ' A' ' 6' ' ' VAL . 2.5 m-70 -123.34 127.43 48.49 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.366 -0.534 . . . . 0.67 110.418 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.46 115.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.555 -1.276 . . . . 0.81 107.555 171.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HE1' ' HG3' ' A' ' 3' ' ' MET . 91.0 m-85 -94.93 164.41 12.92 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.273 -0.421 . . . . 0.64 111.248 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 54.1 mttm -60.53 -26.25 66.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.931 0.492 . . . . 2.87 112.26 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -91.07 3.56 54.42 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.653 0.739 . . . . 1.97 109.07 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.08 -2.02 81.01 Favored Glycine 0 N--CA 1.427 -1.919 0 CA-C-N 114.562 -1.199 . . . . 0.58 113.589 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -81.05 173.35 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.332 0.566 . . . . 1.74 110.792 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 3.7 mpp? -134.43 138.64 44.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.498 -0.773 . . . . 1.07 109.627 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.55 134.22 9.89 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.096 -0.802 . . . . 0.39 111.096 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' SER . 1.7 tmt? -113.73 134.63 54.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.811 0.339 . . . . 0.87 110.211 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 35.8 mt-10 -126.49 148.52 49.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 1.14 109.294 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.588 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.2 p-10 -85.95 171.33 11.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.678 -0.49 . . . . 1.41 109.678 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.598 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 37.3 pttt -59.18 5.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.982 1.104 . . . . 1.77 113.982 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.1 m-85 -113.05 3.28 16.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.306 0.574 . . . . 1.08 109.711 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.36 23.56 65.2 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.54 113.711 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.588 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -112.55 144.86 41.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.333 -0.547 . . . . 3.25 110.48 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 28' ' ' MET . 24.9 t -78.83 136.69 37.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.203 -0.908 . . . . 1.55 111.553 -173.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.6 mtm -133.62 175.04 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.05 -0.722 . . . . 1.38 109.05 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -96.19 140.49 30.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.9 0.381 . . . . 2.78 110.618 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -95.52 121.6 61.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.828 -0.624 . . . . 1.32 110.953 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.547 ' HG2' ' HG3' ' A' ' 42' ' ' LYS . 59.3 Cg_endo -75.18 125.23 9.07 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.407 2.071 . . . . 1.24 112.299 176.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.512 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 43.9 tt0 -66.72 142.0 57.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.15 110.606 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.04 -2.85 51.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.862 -0.685 . . . . 0.68 112.835 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HG3' ' HG2' ' A' ' 39' ' ' PRO . 11.7 mmpt? -100.8 122.73 43.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.749 -0.265 . . . . 2.3 111.384 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.644 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.84 124.59 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.678 0.751 . . . . 0.93 109.084 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtt -116.6 148.32 41.04 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.359 -0.837 . . . . 1.31 109.257 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -102.85 155.95 17.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.981 0.42 . . . . 1.64 110.587 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.6 p -104.24 163.42 12.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 0.53 110.951 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.948 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 1.7 ptt180 -50.12 -30.03 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.686 0.995 . . . . 3.73 113.686 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.49 -31.06 16.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.461 -0.336 . . . . 2.7 111.318 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.92 19.64 1.58 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.164 -1.017 . . . . 0.77 113.299 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.2 m -100.38 160.02 14.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 1.35 109.072 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -117.08 139.07 51.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.713 0.292 . . . . 1.84 110.589 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.824 HG22 ' HD3' ' A' ' 61' ' ' ARG . 17.1 pt -132.89 158.39 43.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.146 -0.479 . . . . 0.66 109.719 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.686 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -158.28 143.15 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.252 0.548 . . . . 0.98 111.765 175.271 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.452 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.1 ttt -90.96 112.62 24.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.489 -0.93 . . . . 1.5 108.489 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 50.9 tptt -145.13 130.25 18.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.198 -0.456 . . . . 1.69 110.059 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.7 40.43 37.6 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.132 -0.556 . . . . 1.21 112.559 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.14 31.74 20.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.456 0.646 . . . . 2.9 110.402 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -149.27 175.81 11.08 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.722 -0.844 . . . . 1.66 108.722 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -126.77 134.98 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.704 0.764 . . . . 0.92 111.158 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -93.81 131.4 39.23 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.855 -1.066 . . . . 0.71 108.748 171.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.824 ' HD3' HG22 ' A' ' 52' ' ' ILE . 14.8 tpt85 -157.12 100.42 1.86 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 104.56 -2.385 . . . . 3.56 104.56 170.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.9 mm? 74.77 -48.82 0.65 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.677 0.671 . . . . 1.4 111.117 -174.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 11.0 t70 71.29 -56.7 0.62 Allowed 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 123.974 0.796 . . . . 2.14 109.696 -175.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -57.73 -36.06 71.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.173 -0.921 . . . . 3.8 111.488 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.72 2.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.126 -0.488 . . . . 1.76 111.946 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.648 ' HA ' ' HB3' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -83.75 -14.52 51.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.216 -0.447 . . . . 2.36 111.343 -178.372 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.57 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 41.4 ttt180 -70.6 -68.37 0.43 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.121 -0.491 . . . . 4.45 110.04 176.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.57 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 31.3 mmmt -132.56 106.04 7.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.812 -0.631 . . . . 5.92 109.657 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.89 -65.67 0.41 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.5 -1.04 . . . . 5.06 110.5 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.648 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 76.5 t60 -69.34 -33.12 72.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.001 0.429 . . . . 6.88 110.174 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.5 m -84.37 3.94 33.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.0 -0.546 . . . . 8.52 111.343 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -82.15 -72.26 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.234 0.54 . . . . 10.75 109.588 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.23 130.05 2.2 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.632 -0.713 . . . . 11.62 111.461 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.637 -1.091 . . . . 12.99 111.859 -177.729 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.578 0.228 . . . . 2.46 110.45 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -80.16 157.55 26.56 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.024 0.44 . . . . 3.48 110.892 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.422 ' HE2' HG21 ' A' ' 6' ' ' VAL . 31.8 mmt -92.51 0.76 57.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.783 -0.644 . . . . 2.17 110.741 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 m -71.59 -27.25 63.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.814 0.816 . . . . 1.47 110.191 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 19.5 p30 -115.13 17.76 16.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.597 -1.183 . . . . 1.89 111.238 -174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 19' ' ' HIS . 76.3 t -111.79 115.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.666 -0.697 . . . . 1.25 109.974 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 20' ' ' VAL . 2.8 p -90.71 -18.54 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.575 -0.738 . . . . 1.03 110.578 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -167.23 130.09 1.73 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.482 0.658 . . . . 1.41 110.782 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 6' ' ' VAL . 83.7 m -108.35 145.81 33.92 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.646 -1.161 . . . . 0.4 109.935 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HE2' ' HD3' ' A' ' 61' ' ' ARG . 26.7 m-85 -123.91 133.23 53.78 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 121.743 0.783 . . . . 1.06 111.384 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.674 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -101.53 122.71 44.32 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.024 -1.444 . . . . 1.94 109.071 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.587 HD12 ' HB2' ' A' ' 16' ' ' SER . 41.0 mt -83.46 151.24 25.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.898 -1.046 . . . . 1.5 108.487 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 47' ' ' ARG . 75.8 mt-30 -66.69 -8.16 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.643 0.735 . . . . 1.68 111.355 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 3.9 t70 -87.14 -23.14 24.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.051 -0.977 . . . . 2.11 109.378 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.566 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 115.34 -25.2 9.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.758 -1.11 . . . . 1.28 111.699 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.587 ' HB2' HD12 ' A' ' 12' ' ' LEU . 49.5 m -66.53 157.13 33.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.97 0.414 . . . . 1.07 110.234 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -125.51 147.41 49.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.243 0.544 . . . . 1.84 112.056 -171.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.95 148.59 24.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.993 -1.003 . . . . 0.41 108.487 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.552 ' HB3' HG13 ' A' ' 6' ' ' VAL . 12.8 m-70 -135.06 137.15 42.63 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.254 -0.579 . . . . 0.67 109.923 172.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 7' ' ' VAL . 49.7 t -95.52 109.41 22.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 106.573 -1.64 . . . . 0.81 106.573 166.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.57 155.82 29.48 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.37 -0.832 . . . . 0.64 110.714 -171.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 47.7 mtpt -68.85 -18.53 64.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.68 0.752 . . . . 2.87 110.217 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.43 -6.22 59.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.571 -1.195 . . . . 1.97 108.056 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.23 6.3 71.51 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 113.986 -1.461 . . . . 0.58 112.995 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -86.75 177.44 7.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.297 0.57 . . . . 1.74 110.653 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.961 ' HG2' HD12 ' A' ' 59' ' ' ILE . 4.5 mpp? -139.91 140.21 36.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.122 -0.945 . . . . 1.07 109.221 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.78 151.2 21.91 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.252 -0.975 . . . . 0.39 112.242 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 ttt -122.05 142.28 50.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.999 0.428 . . . . 0.87 110.746 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 34.5 mt-10 -130.68 151.47 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.013 -1.106 . . . . 1.14 108.013 175.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 32' ' ' PHE . 27.4 p-10 -84.6 167.71 16.01 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.41 109.657 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.566 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 15.0 pttm -50.9 4.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.868 1.433 . . . . 1.77 114.868 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.3 m-85 -122.96 2.82 9.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.255 -0.278 . . . . 1.08 111.155 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.39 27.61 43.03 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.479 -0.867 . . . . 0.54 112.964 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 25.7 mmmt -100.85 130.09 46.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.717 0.77 . . . . 3.25 110.247 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -80.82 127.55 32.66 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.152 -1.386 . . . . 1.55 112.593 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 65.4 mtm -127.63 -171.96 2.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.58 -0.736 . . . . 1.38 109.431 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -97.86 156.01 16.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.885 -0.413 . . . . 2.78 109.885 176.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.457 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 17.4 tpt -82.81 122.77 78.38 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 1.32 110.809 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 69.5 Cg_endo -79.13 117.83 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.517 2.144 . . . . 1.24 112.841 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -87.64 139.54 30.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.624 -0.716 . . . . 1.15 110.447 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.62 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 108.13 -9.37 36.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.988 -0.625 . . . . 0.68 113.284 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 42' ' ' LYS . 29.4 mtpp -109.64 131.19 55.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.242 0.46 . . . . 2.3 112.242 -175.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.638 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.5 p -100.91 131.18 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.136 -0.69 . . . . 0.93 109.136 170.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.4 mtm -135.16 173.12 12.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.812 -0.631 . . . . 1.31 109.927 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -107.12 164.75 11.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.308 1.051 . . . . 1.64 112.259 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -108.85 162.35 14.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.359 -1.746 . . . . 0.53 108.93 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.674 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 75.9 mtp180 -55.47 -23.52 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.233 0.457 . . . . 3.73 112.233 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.43 -2.99 37.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.323 . . . . 2.7 111.091 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.24 23.9 13.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.547 -0.835 . . . . 0.77 113.326 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.753 HG23 HD23 ' A' ' 62' ' ' LEU . 64.4 m -95.04 137.08 34.57 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.773 -0.251 . . . . 1.35 110.431 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -99.59 127.98 45.69 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.044 -0.354 . . . . 1.84 110.044 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 18.8 pt -135.09 155.07 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.984 -0.553 . . . . 0.66 110.685 -176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -157.35 149.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.922 0.391 . . . . 0.98 110.41 174.278 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.3 ttt -108.19 118.73 37.52 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.073 -1.084 . . . . 1.5 108.073 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.62 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 23.9 tptp -144.68 135.52 24.83 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.203 -0.665 . . . . 1.69 109.203 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.83 32.12 82.69 Favored Glycine 0 C--N 1.322 -0.212 0 C-N-CA 121.018 -0.61 . . . . 1.21 112.647 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 62.81 19.6 11.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.232 0.539 . . . . 2.9 111.31 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.74 152.56 39.3 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.593 -0.73 . . . . 1.66 109.276 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.961 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -114.22 127.86 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.62 0.724 . . . . 0.92 111.889 177.76 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.621 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -96.06 130.81 42.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.728 -1.212 . . . . 0.71 107.728 167.309 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.557 ' HD3' ' HE2' ' A' ' 10' ' ' TYR . 7.8 ptt180 -156.46 100.39 1.96 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.047 -1.834 . . . . 3.56 106.047 173.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.753 HD23 HG23 ' A' ' 50' ' ' THR . 0.4 OUTLIER 77.58 -42.01 0.37 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.002 -0.74 . . . . 1.4 109.002 178.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 61' ' ' ARG . 1.3 t70 71.27 -25.75 0.17 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.535 1.134 . . . . 2.14 111.493 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 62' ' ' LEU . 39.2 mt-10 -90.01 -37.45 14.3 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.74 -0.663 . . . . 3.8 110.389 174.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.53 -42.37 87.62 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.595 -0.729 . . . . 1.76 112.72 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -97.75 6.34 48.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.872 0.844 . . . . 2.36 110.583 -178.124 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -101.94 -53.35 2.96 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.803 -1.09 . . . . 4.45 109.975 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 25.8 mtpp -145.42 -163.8 1.8 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.041 -0.725 . . . . 5.92 109.041 174.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.22 41.4 9.36 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.528 -0.844 . . . . 5.06 112.173 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -133.2 157.12 46.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.676 0.274 . . . . 6.88 110.313 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.8 m -113.15 147.63 37.01 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.693 -0.484 . . . . 8.52 109.693 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.03 139.98 53.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.451 . . . . 10.75 110.872 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.69 86.85 1.4 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.82 -0.705 . . . . 11.62 111.726 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-O 118.718 -1.046 . . . . 12.99 111.555 -179.491 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.309 0.099 . . . . 2.46 111.183 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 69.3 142.19 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.505 0.669 . . . . 3.48 111.515 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.5 mmt -98.54 3.51 48.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.907 -0.588 . . . . 2.17 112.108 -171.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -78.34 -33.01 49.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.453 . . . . 1.47 110.449 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.617 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 25.4 p-10 -97.79 1.81 48.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 1.89 110.696 -178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.7 t -94.03 130.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 1.25 110.204 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 20' ' ' VAL . 20.2 m -93.3 -25.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.465 -0.494 . . . . 1.03 111.918 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -164.16 142.61 7.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 1.41 110.489 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 53.4 m -125.05 140.84 52.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.226 -0.443 . . . . 0.4 110.458 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 36.2 m-85 -112.38 128.83 56.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.693 0.759 . . . . 1.06 112.001 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -102.15 114.9 29.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.717 -1.583 . . . . 1.94 109.826 -178.102 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' A' ' 13' ' ' GLN . 6.6 mt -75.22 -0.8 20.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.352 1.242 . . . . 1.5 114.352 -168.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.656 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 56.9 mt-30 90.84 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.672 0.789 . . . . 1.68 110.17 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.58 -28.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.412 -0.959 . . . . 2.11 108.412 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.693 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 140.24 -22.66 2.74 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.42 -1.264 . . . . 1.28 113.57 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.623 ' HB3' HD12 ' A' ' 12' ' ' LEU . 23.0 t -64.39 141.89 58.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.772 0.796 . . . . 1.07 110.456 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -120.78 126.72 50.84 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.201 -1.363 . . . . 1.84 110.297 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 9' ' ' THR . 86.3 t -112.69 126.25 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.437 -0.801 . . . . 0.41 109.041 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 26' ' ' MET . 11.9 m-70 -115.62 128.7 56.13 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.565 -0.854 . . . . 0.67 109.733 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.496 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 46.3 t -90.33 112.55 24.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 106.737 -1.579 . . . . 0.81 106.737 172.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -88.16 161.8 17.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.857 -0.61 . . . . 0.64 110.614 -173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 8.1 mtpm? -61.02 -26.35 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.331 0.586 . . . . 2.87 111.28 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.08 -7.2 59.68 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.162 -0.926 . . . . 1.97 108.836 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.62 -0.99 68.33 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.573 -1.194 . . . . 0.58 113.172 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -85.82 179.68 7.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.309 0.576 . . . . 1.74 110.775 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.747 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 59.5 mtm -143.15 148.1 36.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.955 -1.021 . . . . 1.07 110.381 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.12 135.28 8.74 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.228 -0.896 . . . . 0.39 111.052 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 35' ' ' SER . 26.8 ttt -111.05 126.61 55.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.082 -0.34 . . . . 0.87 110.082 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 48.6 mt-10 -128.11 155.83 43.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.662 -0.866 . . . . 1.14 108.662 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 39.4 p30 -91.79 175.32 6.93 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.418 -0.513 . . . . 1.41 110.238 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.693 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 4.4 pttm -51.53 -11.45 0.13 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.604 0.964 . . . . 1.77 113.604 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -105.28 -5.02 20.93 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.321 -0.237 . . . . 1.08 111.179 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.41 25.38 28.43 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.798 -0.715 . . . . 0.54 112.417 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 26.3 mmtp -108.68 137.66 46.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.324 0.583 . . . . 3.25 111.845 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 28' ' ' MET . 47.3 t -71.97 131.33 42.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.438 -1.255 . . . . 1.55 111.266 -175.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 64.0 mtm -126.04 177.03 6.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 1.38 109.45 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -97.82 127.11 43.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.895 -0.409 . . . . 2.78 109.895 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.456 ' HE2' ' HB2' ' A' ' 54' ' ' MET . 23.9 ttt -83.01 126.18 73.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.855 -0.611 . . . . 1.32 111.044 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.68 153.32 38.54 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.999 2.466 . . . . 1.24 112.88 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.5 tt0 -112.51 141.89 45.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 1.15 109.983 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.03 2.84 64.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.43 -0.89 . . . . 0.68 112.603 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -109.58 138.73 45.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.585 0.231 . . . . 2.3 111.38 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 59.4 t -90.0 119.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.513 -0.551 . . . . 0.93 109.513 171.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -109.74 154.0 23.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 1.31 110.303 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -104.26 155.61 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.546 0.689 . . . . 1.64 111.517 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 47.8 p -111.32 156.83 20.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.28 -1.327 . . . . 0.53 109.869 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.536 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 47.8 mtp180 -57.53 -21.89 41.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.798 0.296 . . . . 3.73 111.798 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -89.99 -3.39 58.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 2.7 110.84 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 26.9 25.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.73 -0.748 . . . . 0.77 113.669 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.2 p -108.19 159.69 16.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.331 0.566 . . . . 1.35 110.038 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -111.01 135.72 51.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.244 -0.435 . . . . 1.84 109.953 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.563 HG22 ' CG ' ' A' ' 61' ' ' ARG . 8.8 pt -132.17 165.98 30.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 0.66 111.067 -173.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.678 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -159.44 142.22 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.342 -0.39 . . . . 0.98 110.974 167.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.456 ' HB2' ' HE2' ' A' ' 38' ' ' MET . 17.1 tmm? -95.62 120.71 36.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.922 -1.14 . . . . 1.5 107.922 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.6 tptt -137.43 112.5 9.08 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.323 -0.621 . . . . 1.69 109.323 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 67.26 52.2 33.19 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.811 -0.631 . . . . 1.21 112.61 -176.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 73.99 -35.24 0.3 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.818 0.847 . . . . 2.9 111.796 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' GLY . 43.1 mt-10 -78.92 156.27 28.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.106 -0.497 . . . . 1.66 110.841 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.747 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -113.79 129.69 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.47 0.652 . . . . 0.92 109.681 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.678 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -93.91 112.93 24.85 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.874 -0.787 . . . . 0.71 108.874 169.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.68 ' HD3' HD23 ' A' ' 62' ' ' LEU . 2.7 tmt_? -140.29 103.75 4.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.442 -2.059 . . . . 3.56 105.442 160.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.68 HD23 ' HD3' ' A' ' 61' ' ' ARG . 3.5 mm? 75.22 -38.38 0.37 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.607 0.639 . . . . 1.4 111.658 -175.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 12.4 t70 76.28 -57.47 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.941 0.775 . . . . 2.14 111.286 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 40.0 tt0 -77.67 -26.31 50.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.139 -0.482 . . . . 3.8 110.483 -176.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.75 77.78 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.465 0.65 . . . . 1.76 110.898 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 63' ' ' ASP . 3.5 pp -96.82 -16.98 20.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.091 -0.959 . . . . 2.36 110.606 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.68 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 15.8 ttm180 -71.64 -54.11 11.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.717 -0.674 . . . . 4.45 110.559 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.68 ' HG3' ' HG2' ' A' ' 67' ' ' ARG . 97.0 mttt -139.81 -174.85 4.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.862 -0.608 . . . . 5.92 110.073 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.1 -163.02 30.18 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.792 -0.718 . . . . 5.06 112.351 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 71.8 -63.66 0.42 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.559 0.744 . . . . 6.88 111.425 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.9 t -126.01 170.69 11.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 8.52 110.279 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.31 -35.84 7.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 10.75 110.728 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.32 34.87 0.51 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.404 -0.903 . . . . 11.62 112.706 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.332 -1.26 . . . . 12.99 112.026 179.492 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.65 HG21 ' CD2' ' A' ' 19' ' ' HIS . 7.1 p . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.409 0.147 . . . . 2.46 110.745 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -76.1 143.89 41.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.744 -0.836 . . . . 3.48 108.744 170.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.478 ' HA ' HG12 ' A' ' 6' ' ' VAL . 36.5 mtp -118.42 21.22 12.75 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.544 0.688 . . . . 2.17 109.76 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -92.8 -45.07 8.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.042 . . . . 1.47 110.704 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.42 -5.54 35.97 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.321 0.582 . . . . 1.89 110.891 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.9 p -86.81 125.36 40.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.68 -0.808 . . . . 1.25 109.932 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.87 -23.42 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 1.03 111.001 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -167.5 133.21 2.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.43 0.633 . . . . 1.41 111.2 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.41 HG23 ' ND1' ' A' ' 19' ' ' HIS . 2.3 m -111.63 139.78 46.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.946 -1.025 . . . . 0.4 109.635 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -115.14 129.66 56.72 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.227 1.013 . . . . 1.06 111.727 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -100.73 124.49 46.42 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.14 -1.845 . . . . 1.94 108.176 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.897 HD22 ' HB2' ' A' ' 16' ' ' SER . 10.2 mp -77.68 4.78 10.68 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.455 -0.793 . . . . 1.5 112.231 -174.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.722 ' HG3' ' HD2' ' A' ' 47' ' ' ARG . 25.2 tt0 82.36 -26.99 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.127 0.489 . . . . 1.68 110.315 167.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -103.39 -49.58 3.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.572 -0.74 . . . . 2.11 110.149 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.634 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . -166.32 -52.58 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.366 -1.397 . . . . 1.28 115.301 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.897 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.2 m -70.86 161.95 30.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.327 0.564 . . . . 1.07 111.163 -171.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -129.6 145.98 51.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 1.84 110.772 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.635 HG23 HD11 ' A' ' 12' ' ' LEU . 48.6 t -122.34 145.38 29.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.433 -0.951 . . . . 0.41 108.433 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.678 ' HB3' HG21 ' A' ' 6' ' ' VAL . 3.0 m-70 -135.55 134.05 39.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.804 -0.759 . . . . 0.67 110.969 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.93 114.97 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.204 -1.406 . . . . 0.81 107.204 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 95.2 m-85 -91.73 159.56 15.78 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.974 -0.557 . . . . 0.64 110.524 -171.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -68.97 -18.66 64.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.512 0.672 . . . . 2.87 110.053 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD2' ' HE3' ' A' ' 25' ' ' LYS . 26.2 t70 -79.22 -7.95 58.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.812 -1.181 . . . . 1.97 107.812 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.07 -5.86 75.82 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.74 -1.573 . . . . 0.58 113.257 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HE3' ' OD2' ' A' ' 23' ' ' ASP . 9.4 mtmp? -80.3 175.4 10.68 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.413 0.625 . . . . 1.74 111.479 177.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.582 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.3 mpp? -136.2 138.03 41.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.78 -1.1 . . . . 1.07 109.572 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.42 142.36 13.74 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.39 111.854 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.705 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 23.6 ttt -118.54 142.86 47.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.961 0.41 . . . . 0.87 111.099 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.556 ' OE1' ' HB ' ' A' ' 1' ' ' VAL . 19.5 mt-10 -128.53 147.71 50.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.802 -0.814 . . . . 1.14 108.802 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.499 ' HB3' ' SD ' ' A' ' 36' ' ' MET . 41.6 p30 -87.54 172.34 9.83 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.574 -0.451 . . . . 1.41 110.294 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.634 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.4 ptpt -51.75 -16.73 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.418 0.896 . . . . 1.77 113.418 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.61 -4.43 50.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.721 0.296 . . . . 1.08 110.543 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.67 20.86 49.68 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.902 -0.666 . . . . 0.54 111.827 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.7 mmtm -106.69 139.52 41.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.419 0.628 . . . . 3.25 111.756 -176.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 p -70.25 131.84 44.81 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.516 -1.22 . . . . 1.55 110.549 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.499 ' SD ' ' HB3' ' A' ' 30' ' ' ASN . 19.4 ptm -153.47 174.65 14.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.304 -0.407 . . . . 1.38 110.83 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -123.55 140.89 52.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.745 -0.661 . . . . 2.78 109.562 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.705 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 22.3 ptt? -100.45 150.42 36.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.179 -0.464 . . . . 1.32 110.565 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.84 142.06 50.97 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.825 2.35 . . . . 1.24 112.221 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 29.7 tt0 -71.35 136.6 47.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 1.15 109.833 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -16.04 27.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.362 -0.923 . . . . 0.68 113.459 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -97.31 132.17 43.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.122 0.461 . . . . 2.3 111.756 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.605 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.8 p -99.41 133.92 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.861 -0.608 . . . . 0.93 110.159 174.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.94 151.4 32.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.807 -0.633 . . . . 1.31 109.946 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -94.78 145.73 24.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.678 -0.49 . . . . 1.64 109.678 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -115.96 159.95 20.9 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.82 -0.627 . . . . 0.53 111.057 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.722 ' HD2' ' HG3' ' A' ' 13' ' ' GLN . 18.0 mmm180 -49.13 -28.03 3.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.593 0.757 . . . . 3.73 112.901 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.67 -6.89 59.44 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.567 -0.742 . . . . 2.7 111.363 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.32 58.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.385 -0.912 . . . . 0.77 111.396 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.71 174.42 5.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.208 -0.496 . . . . 1.35 110.392 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 71.3 mmtt -119.24 148.18 43.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.417 -0.356 . . . . 1.84 110.142 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.51 152.39 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 0.66 110.565 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.632 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -159.21 153.95 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.302 -0.408 . . . . 0.98 110.167 176.729 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.506 ' N ' HG12 ' A' ' 53' ' ' ILE . 56.7 ttp -108.51 109.09 20.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.775 -0.824 . . . . 1.5 108.775 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 51.7 tptt -127.42 131.14 50.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.266 -0.642 . . . . 1.69 109.266 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.99 73.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.831 -0.699 . . . . 1.21 111.859 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.26 27.21 16.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.479 0.657 . . . . 2.9 110.112 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 54' ' ' MET . 47.4 mt-10 -123.84 147.6 47.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.536 -0.756 . . . . 1.66 109.36 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.582 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -93.67 118.89 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 122.095 0.95 . . . . 0.92 111.152 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -84.34 116.12 22.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.397 -1.274 . . . . 0.71 108.152 168.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 63' ' ' ASP . 19.5 tpt180 -114.94 102.28 9.82 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 106.604 -1.628 . . . . 3.56 106.604 169.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER 41.22 4.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.089 1.493 . . . . 1.4 113.179 -163.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.571 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 34.7 t70 55.67 149.14 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.653 1.181 . . . . 2.14 112.112 -169.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.884 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 23.2 tt0 82.66 -22.64 0.24 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.887 -1.051 . . . . 3.8 111.201 177.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.22 -33.07 72.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.927 0.87 . . . . 1.76 109.877 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 61' ' ' ARG . 1.8 mp -96.88 -22.2 17.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.385 -1.28 . . . . 2.36 109.792 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.884 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 64.2 ttt180 -69.07 -50.01 52.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.384 -0.825 . . . . 4.45 110.519 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -145.34 125.22 13.47 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.184 0.516 . . . . 5.92 110.975 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.1 -42.21 0.56 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.447 -0.797 . . . . 5.06 111.518 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -160.12 38.54 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.852 0.834 . . . . 6.88 108.854 175.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -77.6 144.81 37.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.801 -1.09 . . . . 8.52 111.424 -172.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.52 92.93 9.27 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.815 -0.809 . . . . 10.75 108.815 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.69 89.18 0.16 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.701 -0.761 . . . . 11.62 112.277 -176.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 CA-C-O 118.43 -1.205 . . . . 12.99 111.493 177.845 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.526 ' HB ' ' NE2' ' A' ' 19' ' ' HIS . 7.3 p . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.877 0.37 . . . . 2.46 110.987 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -86.42 132.98 33.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.998 -0.741 . . . . 3.48 108.998 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 mmt -78.54 -3.93 46.16 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.177 0.436 . . . . 2.17 112.177 -172.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -87.68 -35.21 18.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.801 0.334 . . . . 1.47 111.309 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -105.42 3.13 29.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 1.89 111.846 -169.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 19' ' ' HIS . 10.4 p -106.62 135.9 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.014 -0.539 . . . . 1.25 111.493 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.453 HG23 HG13 ' A' ' 20' ' ' VAL . 14.6 m -94.17 -30.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.989 0.423 . . . . 1.03 111.701 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -157.21 138.17 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.389 0.614 . . . . 1.41 110.917 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 1.4 m -119.47 138.54 53.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.294 -0.866 . . . . 0.4 110.083 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 24.4 m-85 -108.9 125.66 52.25 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.738 0.78 . . . . 1.06 111.487 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 71.7 m-20 -98.57 115.35 28.42 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.037 -1.438 . . . . 1.94 110.501 -176.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 16' ' ' SER . 10.2 mt -81.2 149.75 28.93 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.691 -0.855 . . . . 1.5 108.691 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -60.7 -19.44 58.69 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.794 0.665 . . . . 1.68 112.794 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.6 -26.24 23.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 2.11 109.646 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.07 -15.41 6.5 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.277 -0.874 . . . . 1.28 112.284 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.623 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -58.03 140.19 52.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.861 -0.792 . . . . 1.07 108.861 176.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.487 ' HG2' ' CE1' ' A' ' 19' ' ' HIS . 24.4 ttmm -125.35 124.22 41.07 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.024 0.44 . . . . 1.84 110.613 -171.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 47.0 t -109.17 151.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.95 -0.759 . . . . 0.41 108.95 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.526 ' NE2' ' HB ' ' A' ' 1' ' ' VAL . 0.3 OUTLIER -141.29 137.37 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.153 -0.619 . . . . 0.67 110.924 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.597 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 7.2 p -102.8 125.39 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 0.81 108.03 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.426 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . 71.3 m-85 -93.1 161.59 14.37 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.155 -0.929 . . . . 0.64 111.883 -168.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -67.04 -20.48 65.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.621 -0.718 . . . . 2.87 110.966 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.452 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 29.0 t70 -83.73 -6.05 59.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.153 0.978 . . . . 1.97 108.527 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.79 0.98 68.35 Favored Glycine 0 N--CA 1.427 -1.939 0 CA-C-N 114.287 -1.324 . . . . 0.58 112.718 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 23' ' ' ASP . 31.3 pttt -91.56 179.73 5.58 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.597 -0.149 . . . . 1.74 110.597 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.847 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mtm -141.62 153.89 45.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.742 0.306 . . . . 1.07 110.192 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.63 147.24 18.9 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.558 -0.617 . . . . 0.39 111.558 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.0 ttt -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.293 0.568 . . . . 0.87 111.148 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.4 mt-10 -128.15 157.17 41.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.796 -0.816 . . . . 1.14 108.796 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.444 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 35.3 p-10 -91.51 173.11 8.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.093 -0.336 . . . . 1.41 110.093 174.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.639 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 43.2 pttt -55.92 5.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.409 1.263 . . . . 1.77 114.409 175.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 97.0 m-85 -115.91 1.18 13.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.018 0.437 . . . . 1.08 110.196 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.25 21.52 62.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.616 -0.802 . . . . 0.54 111.648 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 67.7 mmtt -103.62 131.53 50.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.377 0.608 . . . . 3.25 110.706 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.3 t -67.42 133.76 50.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.434 -1.257 . . . . 1.55 110.597 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.8 ptm -143.46 160.17 41.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.934 -0.576 . . . . 1.38 110.323 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.78 147.59 39.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.193 -0.458 . . . . 2.78 110.213 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.33 130.82 22.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 1.32 110.67 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.41 160.0 29.07 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.933 2.422 . . . . 1.24 112.963 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 54' ' ' MET . 35.1 tt0 -118.89 145.59 45.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.248 -0.433 . . . . 1.15 110.551 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.57 4.26 68.09 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.68 113.009 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.77 138.44 48.35 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.923 -0.163 . . . . 2.3 110.762 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 63.1 t -87.94 120.42 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.831 -0.433 . . . . 0.93 109.831 172.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -106.79 149.84 26.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.741 -0.663 . . . . 1.31 109.788 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -109.68 148.45 31.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.131 0.967 . . . . 1.64 112.208 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 46.0 p -97.72 168.54 10.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.872 -1.513 . . . . 0.53 109.966 -175.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.426 ' HE ' ' CB ' ' A' ' 11' ' ' ASP . 9.2 ptt85 -59.93 -21.96 61.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.971 0.891 . . . . 3.73 110.976 170.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.22 -13.72 49.02 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.025 -1.443 . . . . 2.7 110.984 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.39 53.06 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.684 -0.77 . . . . 0.77 111.993 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.87 153.62 19.34 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.955 -0.387 . . . . 1.35 109.955 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -112.18 129.3 56.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.979 -0.555 . . . . 1.84 109.753 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.702 HG22 ' HG2' ' A' ' 61' ' ' ARG . 1.8 pt -129.87 164.97 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.333 -0.394 . . . . 0.66 110.08 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.497 HG22 ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -164.63 143.14 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.062 0.458 . . . . 0.98 111.336 173.493 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.45 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 21.6 ttt -99.87 134.1 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 1.5 110.112 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -145.7 121.89 10.83 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.775 -0.454 . . . . 1.69 109.775 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.61 52.67 51.68 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.202 -0.523 . . . . 1.21 113.529 177.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.69 -13.27 0.49 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.81 0.444 . . . . 2.9 112.054 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' GLY . 44.1 mt-10 -96.96 148.84 22.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.206 -0.294 . . . . 1.66 110.206 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.847 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -115.96 124.45 72.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.58 0.705 . . . . 0.92 109.694 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -84.83 128.33 34.56 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.833 0.825 . . . . 0.71 109.102 171.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.702 ' HG2' HG22 ' A' ' 52' ' ' ILE . 2.3 tmm_? -158.23 102.41 1.77 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 103.863 -2.643 . . . . 3.56 103.863 170.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.1 mm? 75.8 -52.12 0.63 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.312 0.96 . . . . 1.4 110.816 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 72.85 -48.32 0.68 Allowed 'General case' 0 C--O 1.219 -0.516 0 O-C-N 124.071 0.857 . . . . 2.14 110.958 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.62 -24.78 63.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.921 -0.581 . . . . 3.8 110.626 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.12 -64.51 0.86 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.197 0.523 . . . . 1.76 110.904 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.562 ' H ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -91.87 -15.8 27.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.443 -0.799 . . . . 2.36 111.104 -177.271 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 41.41 82.05 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.424 1.09 . . . . 4.45 113.01 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.7 pttm 42.06 49.08 4.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.125 0.97 . . . . 5.92 112.746 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' H ' ' CD2' ' A' ' 66' ' ' LEU . . . -78.82 60.62 4.12 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.66 -0.976 . . . . 5.06 110.66 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -88.35 117.21 27.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.428 -0.386 . . . . 6.88 110.197 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.2 m 72.97 161.77 0.25 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.104 0.877 . . . . 8.52 110.71 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -121.66 144.3 48.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.072 -0.513 . . . . 10.75 109.981 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.21 -147.43 17.89 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.359 -0.924 . . . . 11.62 112.604 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.202 -1.332 . . . . 12.99 111.33 -178.938 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 109.97 -0.381 . . . . 2.46 109.97 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 58.72 103.57 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.575 0.75 . . . . 3.48 112.698 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.4 mmt -71.4 1.47 6.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.863 0.364 . . . . 2.17 111.553 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.2 m -89.7 -35.4 15.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.286 -0.416 . . . . 1.47 111.215 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.502 ' HB2' ' HD3' ' A' ' 22' ' ' LYS . 12.2 p-10 -91.9 11.26 25.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.886 0.851 . . . . 1.89 109.608 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 19' ' ' HIS . 57.6 t -108.64 106.85 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.223 -1.353 . . . . 1.25 108.768 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.95 -12.63 11.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.641 -0.709 . . . . 1.03 110.993 -173.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -163.86 139.55 6.38 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.798 -0.637 . . . . 1.41 110.564 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 m -119.23 138.37 53.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.373 -0.83 . . . . 0.4 110.056 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 21.3 m-85 -108.84 123.14 48.58 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.934 0.874 . . . . 1.06 110.958 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.554 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -91.71 113.24 25.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.382 -1.735 . . . . 1.94 110.406 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.78 HD12 ' HB2' ' A' ' 16' ' ' SER . 45.2 mt -85.47 144.5 27.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.678 -0.86 . . . . 1.5 108.678 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 8.0 tt0 -72.84 -0.9 14.74 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.497 0.554 . . . . 1.68 112.497 -170.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -98.44 -16.5 19.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.406 0.622 . . . . 2.11 109.666 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 124.49 -21.39 6.78 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.06 -0.973 . . . . 1.28 112.44 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.78 ' HB2' HD12 ' A' ' 12' ' ' LEU . 25.5 m -70.29 158.1 36.5 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.118 0.485 . . . . 1.07 110.848 -176.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 57.7 mttt -125.19 149.88 47.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.335 -0.393 . . . . 1.84 110.896 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 60.8 t -129.79 122.3 54.4 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.13 -0.693 . . . . 0.41 109.13 173.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 26' ' ' MET . 54.1 m-70 -108.8 132.0 54.42 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.161 -1.016 . . . . 0.67 110.114 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.82 102.08 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 106.47 -1.678 . . . . 0.81 106.47 168.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.71 155.53 38.86 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.262 -0.881 . . . . 0.64 110.694 -172.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HD3' ' HB2' ' A' ' 5' ' ' ASN . 19.5 pttm -51.63 -32.33 28.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.177 -0.919 . . . . 2.87 112.04 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 2.7 p-10 -97.75 10.17 40.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.61 0.719 . . . . 1.97 109.432 -171.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.89 4.68 72.02 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 114.872 -1.058 . . . . 0.58 114.586 172.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -87.68 175.94 7.65 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.124 0.962 . . . . 1.74 111.095 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 4.2 mpp? -140.36 141.72 35.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.888 -1.051 . . . . 1.07 110.339 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.03 146.65 18.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.37 -0.832 . . . . 0.39 111.336 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 24.7 ttt -114.62 129.01 56.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.261 0.553 . . . . 0.87 111.061 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.0 mt-10 -110.0 147.13 34.09 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.159 -1.052 . . . . 1.14 108.159 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.779 ' H ' ' HB2' ' A' ' 34' ' ' LYS . 63.8 t30 -92.05 162.68 14.27 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.742 -1.207 . . . . 1.41 107.742 170.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.629 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 22.3 ptmt -50.72 -20.68 1.31 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.363 0.875 . . . . 1.77 113.363 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 21.9 m-85 -96.52 -6.74 36.35 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.941 -0.475 . . . . 1.08 110.905 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.82 38.73 3.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.826 -0.702 . . . . 0.54 112.807 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.779 ' HB2' ' H ' ' A' ' 30' ' ' ASN . 24.4 mmtt -43.91 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.657 0.614 . . . . 3.25 112.657 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 34' ' ' LYS . 36.5 t 89.09 68.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.233 0.958 . . . . 1.55 109.073 175.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 34' ' ' LYS . 31.6 mtm -119.76 -171.46 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.309 -1.314 . . . . 1.38 109.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -98.07 157.74 15.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.506 0.193 . . . . 2.78 110.695 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.513 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 16.7 tpt -80.24 125.16 81.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.229 -0.441 . . . . 1.32 111.173 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 70.7 Cg_endo -76.37 153.9 35.75 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.615 2.21 . . . . 1.24 112.707 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 38.2 tt0 -94.23 144.13 25.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 1.15 111.359 -177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.98 57.65 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.171 -0.538 . . . . 0.68 113.591 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.3 mtpt -90.99 119.36 31.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.076 0.438 . . . . 2.3 111.632 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.638 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 14.5 p -91.85 126.75 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.331 -0.618 . . . . 0.93 109.331 171.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 68.9 mtm -124.17 154.97 39.3 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.22 -0.659 . . . . 1.31 109.22 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.47 149.68 23.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.087 0.946 . . . . 1.64 112.408 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 47.2 p -103.13 162.09 13.25 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.726 -1.579 . . . . 0.53 110.221 -176.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 80.3 mtm180 -59.52 -19.42 48.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 3.73 110.971 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.09 -24.47 43.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 2.7 111.12 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.06 21.17 12.16 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.77 111.289 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.0 m -115.83 160.81 19.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.545 -0.539 . . . . 1.35 109.545 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.19 144.88 43.02 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.297 -0.261 . . . . 1.84 110.297 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.8 pt -136.84 150.76 26.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 120.439 0.161 . . . . 0.66 111.428 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.675 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.96 149.46 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 0.98 109.719 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.5 ttt -112.29 133.71 54.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.074 -0.343 . . . . 1.5 110.074 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.578 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.2 tptp -142.32 127.68 18.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.571 -0.286 . . . . 1.69 110.583 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 73.15 -28.81 0.8 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 115.244 0.857 . . . . 1.21 115.244 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 56' ' ' GLY . 8.7 t30 150.39 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.584 0.754 . . . . 2.9 109.058 -165.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.764 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 35.3 mt-10 -97.94 144.71 27.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.293 -0.867 . . . . 1.66 111.796 -171.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.518 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.36 124.31 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.019 0.914 . . . . 0.92 111.473 176.108 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.5 128.31 34.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.644 -1.162 . . . . 0.71 108.743 170.218 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.717 ' HB3' HD12 ' A' ' 66' ' ' LEU . 52.2 ttt-85 -125.28 126.54 45.29 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.14 -1.8 . . . . 3.56 106.14 162.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.4 OUTLIER 58.16 -16.41 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 O-C-N 125.176 1.548 . . . . 1.4 113.288 -177.21 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.579 ' HB3' ' H ' ' A' ' 65' ' ' ALA . 4.6 t70 174.9 -170.47 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.675 -1.602 . . . . 2.14 106.675 -167.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.626 ' HB2' ' HE ' ' A' ' 67' ' ' ARG . 12.4 pt-20 -93.69 15.17 16.97 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.233 1.015 . . . . 3.8 108.402 169.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.579 ' H ' ' HB3' ' A' ' 63' ' ' ASP . . . -54.46 -25.49 25.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 112.774 -2.012 . . . . 1.76 112.656 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.717 HD12 ' HB3' ' A' ' 61' ' ' ARG . 16.5 mt -115.14 -1.18 13.06 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.143 0.423 . . . . 2.36 112.143 -174.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.783 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 25.5 ptt180 -98.07 -33.37 11.19 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.104 -0.702 . . . . 4.45 109.104 173.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.783 ' HG3' ' HG3' ' A' ' 67' ' ' ARG . 60.4 mttm -125.14 -176.21 3.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.262 -0.881 . . . . 5.92 108.855 177.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.34 -42.75 2.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 5.06 111.386 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -76.24 17.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.967 0.413 . . . . 6.88 111.038 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 m -105.62 19.04 21.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.375 -0.602 . . . . 8.52 109.375 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -83.45 -18.4 38.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.159 -0.928 . . . . 10.75 111.594 -174.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.28 15.27 51.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.656 -0.783 . . . . 11.62 111.224 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.027 0 CA-C-O 118.759 -1.023 . . . . 12.99 111.317 -178.795 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.445 ' HA ' HG12 ' A' ' 6' ' ' VAL . 76.5 mmm . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.145 0.498 . . . . 2.17 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -91.45 -23.82 19.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.857 -0.611 . . . . 1.47 111.006 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.541 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -109.44 7.77 25.05 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 120.526 -0.47 . . . . 1.89 111.399 -176.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.8 p -108.47 128.9 63.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.32 -0.4 . . . . 1.25 110.991 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.48 HG13 ' HG2' ' A' ' 22' ' ' LYS . 4.7 m -81.77 -27.85 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.094 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -167.35 134.31 2.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 1.41 110.582 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -108.22 137.25 46.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.26 -0.882 . . . . 0.4 109.943 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.656 ' CD1' HG21 ' A' ' 46' ' ' THR . 1.4 m-85 -110.61 127.29 55.18 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.348 -0.842 . . . . 1.06 111.133 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -100.09 119.25 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.711 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 9.4 mp -80.5 149.56 29.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.998 -1.001 . . . . 1.5 109.581 -175.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -65.55 -11.83 47.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.663 0.744 . . . . 1.68 110.595 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.46 -16.49 28.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.11 109.702 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.542 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 110.49 -22.19 22.63 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.803 -1.09 . . . . 1.28 112.223 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.587 ' HB2' HD22 ' A' ' 12' ' ' LEU . 19.6 m -67.71 161.92 24.9 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.071 -0.714 . . . . 1.07 109.071 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -133.81 146.53 50.76 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.43 0.529 . . . . 1.84 112.43 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.643 HG23 HD11 ' A' ' 12' ' ' LEU . 68.9 t -123.58 148.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.264 -0.88 . . . . 0.41 109.073 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HB3' HG21 ' A' ' 6' ' ' VAL . 6.0 m-70 -134.46 130.4 36.67 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.317 -0.553 . . . . 0.67 109.995 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 40.4 t -93.5 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.922 -1.51 . . . . 0.81 106.922 171.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 81.2 m-85 -89.35 155.9 19.05 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.018 0.437 . . . . 0.64 111.236 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 40.1 mtpt -68.19 -12.0 60.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.705 -0.68 . . . . 2.87 110.563 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -90.76 -4.33 56.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.613 -0.884 . . . . 1.97 108.613 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.57 -12.61 64.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 114.875 -1.057 . . . . 0.58 114.766 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 -177.03 5.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 117.892 0.846 . . . . 1.74 110.824 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.79 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -140.31 145.61 37.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.726 -0.67 . . . . 1.07 109.76 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.07 136.74 9.76 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.861 -0.896 . . . . 0.39 110.861 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.485 ' HG2' ' SD ' ' A' ' 36' ' ' MET . 28.4 ttt -118.51 140.9 49.16 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.392 0.615 . . . . 0.87 110.957 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 33.1 mt-10 -130.66 154.88 47.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.116 -0.947 . . . . 1.14 108.831 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.465 ' C ' ' H ' ' A' ' 32' ' ' PHE . 32.0 p-10 -87.51 169.8 11.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.049 -0.352 . . . . 1.41 110.049 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.542 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 55.2 pttt -52.84 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.607 1.336 . . . . 1.77 114.607 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.7 m-85 -119.81 7.7 11.03 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.893 -0.504 . . . . 1.08 110.392 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.42 24.85 58.19 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.762 -0.732 . . . . 0.54 112.36 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 38.8 mmtm -114.02 136.98 52.32 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.693 0.758 . . . . 3.25 111.924 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 m -78.13 129.47 35.21 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.923 -1.49 . . . . 1.55 111.548 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.485 ' SD ' ' HG2' ' A' ' 28' ' ' MET . 1.3 ppp? -148.12 153.52 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.38 110.18 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -67.25 141.12 57.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 2.78 111.129 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.47 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 28.1 ttt -87.77 122.71 70.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.668 -0.696 . . . . 1.32 109.956 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.81 122.28 9.84 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.064 2.51 . . . . 1.24 112.446 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.6 tt0 -69.46 142.91 53.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.224 -0.444 . . . . 1.15 110.362 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.55 -11.1 73.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.516 -0.85 . . . . 0.68 112.862 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -99.75 123.32 43.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.922 0.391 . . . . 2.3 111.957 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.562 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.2 p -91.36 129.71 41.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.563 -0.744 . . . . 0.93 109.403 174.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.7 mtm -126.98 159.96 32.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 1.31 110.526 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -104.63 160.43 14.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.063 0.935 . . . . 1.64 112.429 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.659 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 50.6 p -113.95 165.25 12.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.006 -1.452 . . . . 0.53 109.732 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 15.4 ptt180 -65.35 -18.17 65.1 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.669 0.747 . . . . 3.73 110.966 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.99 -15.19 30.08 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.561 -1.2 . . . . 2.7 110.62 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.35 17.87 20.81 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.518 -0.848 . . . . 0.77 112.585 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -97.74 154.74 17.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.338 -0.616 . . . . 1.35 109.338 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -117.87 135.73 53.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.393 -0.595 . . . . 1.84 109.393 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.24 157.99 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.671 -0.695 . . . . 0.66 110.92 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.694 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -157.11 148.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 0.98 110.486 174.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.554 ' N ' HG12 ' A' ' 53' ' ' ILE . 26.8 ttt -100.19 118.29 36.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.415 -0.957 . . . . 1.5 108.415 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 52.4 tptt -140.61 130.77 24.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.918 -0.401 . . . . 1.69 109.918 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 38.79 94.88 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.979 -0.555 . . . . 1.21 113.061 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.62 9.52 7.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.496 0.665 . . . . 2.9 110.425 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.61 -177.64 3.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.881 -0.599 . . . . 1.66 110.455 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.79 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -134.49 122.16 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 121.347 0.594 . . . . 0.92 110.192 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.694 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.06 117.07 22.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.079 -1.082 . . . . 0.71 108.079 171.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.497 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 42.9 ttt180 -112.65 100.89 9.07 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.594 -1.632 . . . . 3.56 106.594 168.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 O-C-N 124.477 1.111 . . . . 1.4 112.919 -163.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.9 mtp . . . . . 0 N--CA 1.447 -0.603 0 CA-C-O 121.6 0.715 . . . . 2.17 110.544 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.6 t -90.26 -22.3 21.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.542 -0.753 . . . . 1.47 109.929 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.49 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -104.44 14.92 29.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 1.89 112.091 -177.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.6 p -101.24 137.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.954 -0.298 . . . . 1.25 111.348 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.59 HG13 ' HA ' ' A' ' 22' ' ' LYS . 27.5 m -83.6 -29.23 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.022 0.439 . . . . 1.03 110.064 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -168.48 130.6 1.37 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.602 0.715 . . . . 1.41 110.946 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 m -100.89 140.84 34.61 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.727 -1.124 . . . . 0.4 109.389 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.891 ' OH ' ' HD2' ' A' ' 61' ' ' ARG . 25.7 m-85 -121.4 134.14 55.1 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.967 0.889 . . . . 1.06 111.755 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.53 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 2.9 m-20 -96.47 120.96 37.73 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.613 -1.631 . . . . 1.94 108.853 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 16' ' ' SER . 23.4 mt -78.99 146.12 33.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.414 -1.328 . . . . 1.5 107.414 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 2.7 tt0 -66.17 -4.36 7.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.205 0.526 . . . . 1.68 111.925 -173.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -98.44 -17.81 18.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.495 -0.775 . . . . 2.11 110.326 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.07 -28.48 4.85 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.686 -0.688 . . . . 1.28 113.199 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.632 ' HB2' HD12 ' A' ' 12' ' ' LEU . 12.4 m -65.75 155.81 35.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.768 0.318 . . . . 1.07 110.77 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -124.0 129.81 51.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.908 0.385 . . . . 1.84 111.06 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.98 143.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.898 -0.779 . . . . 0.41 108.898 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.42 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 5.7 m-70 -130.56 129.91 43.39 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.214 -0.595 . . . . 0.67 110.494 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.565 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 28.3 t -96.43 114.81 34.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 106.537 -1.653 . . . . 0.81 106.537 168.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 92.9 m-85 -85.47 152.44 23.2 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.045 -0.525 . . . . 0.64 110.355 -172.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.59 ' HA ' HG13 ' A' ' 7' ' ' VAL . 87.7 mttt -62.08 -15.32 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.923 -0.58 . . . . 2.87 111.553 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.99 -6.99 53.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.83 -0.804 . . . . 1.97 108.83 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.88 -9.59 51.5 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.376 -0.916 . . . . 0.58 114.989 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -92.85 177.6 6.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 118.692 1.246 . . . . 1.74 110.648 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.76 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -137.77 146.23 43.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.151 -0.477 . . . . 1.07 110.483 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.51 146.06 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.074 -0.811 . . . . 0.39 111.074 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.2 ttt -120.5 142.36 49.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.088 0.471 . . . . 0.87 110.979 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.82 150.55 49.13 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.037 -1.098 . . . . 1.14 108.037 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 32' ' ' PHE . 30.7 p-10 -86.58 167.03 14.95 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.322 -0.551 . . . . 1.41 110.133 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 27.8 pttt -50.54 2.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.771 1.397 . . . . 1.77 114.771 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.2 m-85 -118.97 2.04 11.49 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.051 -0.406 . . . . 1.08 110.701 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.37 19.88 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.425 -0.893 . . . . 0.54 112.997 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 11.9 mmmm -100.17 132.73 45.37 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.887 0.851 . . . . 3.25 110.899 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 p -79.05 133.78 36.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.732 -1.576 . . . . 1.55 111.93 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 ptm -147.41 -172.94 4.13 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.641 -0.709 . . . . 1.38 109.829 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.68 150.87 24.34 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.124 -0.324 . . . . 2.78 110.124 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.13 132.47 43.42 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 1.32 110.786 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.12 120.49 7.65 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.623 2.216 . . . . 1.24 112.843 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -80.66 128.3 33.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 1.15 110.132 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.98 -9.65 51.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.92 -0.657 . . . . 0.68 112.389 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -101.69 122.98 44.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.899 0.333 . . . . 2.3 111.899 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.521 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 12.7 p -94.25 128.4 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.706 -0.85 . . . . 0.93 108.706 171.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.5 mtm -124.6 160.29 28.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 1.31 110.651 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 20.5 mt-10 -93.13 145.22 24.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.786 0.803 . . . . 1.64 111.635 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -105.16 160.2 15.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.254 -1.339 . . . . 0.53 109.522 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.53 ' HD2' ' HB3' ' A' ' 11' ' ' ASP . 98.8 mtt180 -64.45 -17.89 64.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.437 0.637 . . . . 3.73 109.59 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.89 -22.97 45.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.125 -0.943 . . . . 2.7 110.3 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.03 55.72 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.794 -0.717 . . . . 0.77 111.522 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -97.15 155.31 16.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.886 -0.783 . . . . 1.35 108.886 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.513 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 40.1 mmtm -112.88 136.95 51.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.943 -0.762 . . . . 1.84 108.943 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 39.0 pt -136.17 153.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 0.66 110.549 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.675 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -154.01 145.61 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.935 -0.575 . . . . 0.98 110.23 176.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.35 122.04 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.106 -1.442 . . . . 1.5 107.106 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -144.0 121.96 12.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.843 -0.343 . . . . 1.69 110.924 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.37 45.04 93.31 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 1.21 112.863 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.523 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 67.74 10.98 8.15 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.848 0.459 . . . . 2.9 111.481 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.47 -173.01 2.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.66 109.826 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.76 HD12 ' HG2' ' A' ' 26' ' ' MET . 2.5 tt -139.22 128.87 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 122.009 0.909 . . . . 0.92 110.062 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.19 121.44 27.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.091 -1.448 . . . . 0.71 107.091 170.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.891 ' HD2' ' OH ' ' A' ' 10' ' ' TYR . 33.1 ttp180 -109.29 96.1 6.07 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.319 -2.104 . . . . 3.56 105.319 164.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.564 1.501 0 O-C-N 125.011 1.444 . . . . 1.4 113.52 -171.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.4 mtp . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 112.22 0.452 . . . . 2.17 112.22 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 p -78.63 -26.29 45.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.399 0.619 . . . . 1.47 110.334 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.489 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -104.74 5.19 33.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 1.89 110.837 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.439 HG23 HD22 ' A' ' 5' ' ' ASN . 89.5 t -103.66 115.42 45.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.56 -0.745 . . . . 1.25 110.144 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 m -79.15 -23.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 1.03 111.267 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -167.99 137.77 2.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.176 0.512 . . . . 1.41 110.854 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 6' ' ' VAL . 34.3 m -114.0 143.52 44.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.463 -0.79 . . . . 0.4 109.898 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.52 ' OH ' ' HD2' ' A' ' 61' ' ' ARG . 35.9 m-85 -121.26 133.74 55.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.877 0.846 . . . . 1.06 111.948 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 1.2 m-20 -100.44 124.46 45.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.742 -1.572 . . . . 1.94 109.73 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 16' ' ' SER . 7.6 mt -87.73 148.41 24.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.02 -0.733 . . . . 1.5 109.02 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.9 tt0 -62.74 -25.49 68.22 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.23 1.196 . . . . 1.68 114.23 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -98.99 -50.89 4.02 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.684 0.754 . . . . 2.11 110.205 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 166.44 67.86 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.664 -1.153 . . . . 1.28 112.267 -170.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.608 ' HB2' HD12 ' A' ' 12' ' ' LEU . 2.5 m -157.5 143.36 17.49 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.175 -1.046 . . . . 1.07 108.175 172.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -127.5 125.18 39.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.146 0.498 . . . . 1.84 109.906 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.19 148.1 13.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.84 -0.8 . . . . 0.41 108.84 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.559 ' O ' ' HA ' ' A' ' 26' ' ' MET . 7.3 m-70 -131.16 133.15 45.28 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.156 -0.618 . . . . 0.67 109.432 173.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.67 114.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.613 -1.625 . . . . 0.81 106.613 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -83.43 150.58 25.96 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.738 -0.665 . . . . 0.64 110.119 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.486 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 21.2 pttm -61.24 -20.3 62.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 2.87 110.574 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.65 -0.78 57.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.735 -0.839 . . . . 1.97 108.735 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.48 -8.15 62.02 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 114.727 -1.124 . . . . 0.58 115.05 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -85.3 177.24 7.9 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.731 1.265 . . . . 1.74 110.663 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.906 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.7 mpp? -137.69 141.19 41.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.07 109.86 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.27 128.18 7.97 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.735 -0.666 . . . . 0.39 111.51 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.25 124.15 49.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.76 0.314 . . . . 0.87 110.255 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 25.3 mt-10 -124.01 153.89 40.66 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.374 -0.602 . . . . 1.14 109.374 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.547 HD21 ' HB2' ' A' ' 34' ' ' LYS . 10.9 p30 -104.5 174.59 5.81 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.287 -0.565 . . . . 1.41 110.148 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 14.0 pttm -49.63 -19.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.543 1.312 . . . . 1.77 114.543 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 92.2 m-85 -92.97 6.43 47.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.353 0.524 . . . . 1.08 110.586 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.67 26.91 59.94 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.706 -0.557 . . . . 0.54 111.706 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HB2' HD21 ' A' ' 30' ' ' ASN . 35.8 mmtm -113.31 136.07 53.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 3.25 111.329 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t -83.52 129.74 34.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.121 -1.4 . . . . 1.55 110.428 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.13 179.84 6.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.323 -0.399 . . . . 1.38 110.919 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -80.24 143.14 33.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.058 0.456 . . . . 2.78 111.287 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.3 ttt -94.65 127.16 44.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.655 . . . . 1.32 110.529 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.06 138.72 20.88 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.714 2.276 . . . . 1.24 112.834 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 33.3 tt0 -94.11 147.99 22.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.958 -0.565 . . . . 1.15 110.616 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.47 68.02 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.034 -0.603 . . . . 0.68 112.622 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -107.57 129.57 54.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.827 0.346 . . . . 2.3 111.562 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.58 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 8.1 p -90.85 127.23 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.888 -0.782 . . . . 0.93 108.888 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.404 ' SD ' HD11 ' A' ' 12' ' ' LEU . 17.8 ptp -117.03 147.57 42.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.059 -0.519 . . . . 1.31 110.003 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.03 151.35 24.76 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.338 0.59 . . . . 1.64 110.741 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.5 p -100.75 162.86 12.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.218 -0.901 . . . . 0.53 110.103 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.506 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 48.9 mtt180 -57.86 -21.24 41.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.145 0.424 . . . . 3.73 112.145 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.07 -17.48 19.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 121.064 -0.254 . . . . 2.7 111.202 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.25 22.83 6.0 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.291 -0.957 . . . . 0.77 113.319 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -99.83 147.49 25.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 1.35 109.293 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -111.79 132.74 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.055 -0.35 . . . . 1.84 110.055 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 61' ' ' ARG . 38.7 pt -136.63 160.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 0.66 110.83 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.619 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -162.45 151.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.044 -0.525 . . . . 0.98 109.891 175.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.566 ' N ' HG12 ' A' ' 53' ' ' ILE . 14.1 tmm? -104.63 121.48 43.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.057 -1.09 . . . . 1.5 108.057 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 49.6 tptt -134.85 116.58 14.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.288 -0.414 . . . . 1.69 110.216 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.93 44.19 98.16 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.815 -0.63 . . . . 1.21 112.752 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 72.59 -1.74 2.88 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.361 0.6 . . . . 2.9 111.42 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -105.72 147.99 27.93 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.519 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.906 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -100.32 124.32 53.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.727 0.775 . . . . 0.92 111.277 177.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.619 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.02 118.36 23.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.702 -1.222 . . . . 0.71 107.702 168.211 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.651 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 47.0 ttp180 -113.68 100.56 8.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.344 -1.354 . . . . 3.56 107.344 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 1.1 pp . . . . . 0 CA--C 1.548 0.876 0 O-C-N 125.164 1.54 . . . . 1.4 113.654 -167.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.512 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 42.7 mtp . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 113.57 0.952 . . . . 2.17 113.57 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 m -83.82 -27.31 28.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.238 0.542 . . . . 1.47 110.696 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.531 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -103.72 6.0 36.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.734 0.778 . . . . 1.89 110.019 175.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 3' ' ' MET . 72.0 t -102.74 116.59 46.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.97 -1.013 . . . . 1.25 109.806 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.83 -20.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.689 -0.405 . . . . 1.03 111.403 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -168.18 128.35 1.29 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.411 0.624 . . . . 1.41 110.987 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 m -101.64 138.45 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.987 -1.006 . . . . 0.4 109.611 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.608 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 18.6 m-85 -113.64 128.45 56.44 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.736 0.779 . . . . 1.06 111.379 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 3.0 m-20 -95.14 115.04 26.91 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.02 -1.445 . . . . 1.94 108.296 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 16' ' ' SER . 10.4 mt -80.57 149.43 29.93 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.009 -0.737 . . . . 1.5 109.009 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -67.79 -7.71 29.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.1 0.476 . . . . 1.68 112.019 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.0 -20.98 19.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.422 0.63 . . . . 2.11 109.895 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 122.07 -14.32 8.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.188 -0.914 . . . . 1.28 112.534 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -66.3 153.19 43.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.539 0.209 . . . . 1.07 110.758 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 30.2 mttp -113.56 143.49 44.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.144 0.497 . . . . 1.84 110.813 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 93.4 t -126.36 149.47 31.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.808 -1.182 . . . . 0.41 107.808 171.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' MET . 6.5 m-70 -139.0 128.89 24.97 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.291 -0.633 . . . . 0.67 109.291 175.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.11 116.77 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.423 -1.695 . . . . 0.81 106.423 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -85.92 153.12 22.42 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.797 -0.638 . . . . 0.64 110.628 -173.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 53.6 pttt -59.53 -16.51 25.29 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 2.87 111.539 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.31 -15.41 46.69 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.038 -0.727 . . . . 1.97 109.038 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.24 -2.35 54.48 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.107 -1.044 . . . . 0.58 113.876 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -94.46 -175.37 3.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.821 0.811 . . . . 1.74 110.776 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 1.017 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.1 mpp? -144.42 149.29 35.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.721 -0.672 . . . . 1.07 110.438 -175.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.95 139.49 11.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.285 -0.726 . . . . 0.39 111.285 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.566 ' SD ' ' HG3' ' A' ' 36' ' ' MET . 1.6 tmt? -117.77 137.51 52.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.163 0.506 . . . . 0.87 111.001 -175.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 30.2 mt-10 -124.6 149.78 46.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.47 -0.786 . . . . 1.14 109.034 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.633 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.8 p-10 -85.91 166.16 16.19 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.44 -0.578 . . . . 1.41 109.44 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 38.0 pttt -56.92 5.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.217 1.192 . . . . 1.77 114.217 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 45.3 m-85 -113.66 5.82 16.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.064 0.459 . . . . 1.08 109.778 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.77 25.1 60.98 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.972 -0.558 . . . . 0.54 114.264 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.633 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.3 145.96 43.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.16 0.505 . . . . 3.25 110.218 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -80.28 142.16 34.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.489 -0.778 . . . . 1.55 111.588 -171.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.566 ' HG3' ' SD ' ' A' ' 28' ' ' MET . 9.6 ptm -153.53 -179.52 7.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.746 -0.661 . . . . 1.38 109.856 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -100.42 151.08 21.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 2.78 110.751 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 ttm -101.42 126.63 33.85 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.2 -0.455 . . . . 1.32 110.714 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.51 142.34 23.34 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.723 2.282 . . . . 1.24 112.181 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.544 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.7 tt0 -79.81 154.35 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.493 -0.321 . . . . 1.15 110.646 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.604 ' H ' HD11 ' A' ' 53' ' ' ILE . . . 97.27 -19.56 54.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.68 113.337 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.557 ' O ' HD13 ' A' ' 53' ' ' ILE . 48.6 mtpt -98.5 126.65 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.244 0.522 . . . . 2.3 111.582 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.89 124.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.655 -0.498 . . . . 0.93 109.655 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.81 149.97 28.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.1 -0.5 . . . . 1.31 110.205 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' THR . 32.8 mt-10 -109.77 157.99 18.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.001 0.905 . . . . 1.64 112.01 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 72.2 p -105.29 165.34 11.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.03 -1.441 . . . . 0.53 110.319 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 58.6 mtp180 -51.25 -27.83 10.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.82 -0.627 . . . . 3.73 111.803 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -92.62 -21.8 19.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.385 -0.825 . . . . 2.7 111.2 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.36 27.25 5.1 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.145 -1.026 . . . . 0.77 112.339 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 26.5 m -100.73 145.27 28.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.396 -0.594 . . . . 1.35 109.396 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.512 ' O ' ' HE1' ' A' ' 60' ' ' PHE . 55.9 mttp -109.21 131.4 55.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.064 -0.347 . . . . 1.84 110.064 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 12' ' ' LEU . 36.0 pt -137.02 159.17 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.929 0.395 . . . . 0.66 111.383 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.604 HD11 ' H ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -159.35 143.34 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.824 -0.625 . . . . 0.98 110.438 175.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.503 ' H ' HD12 ' A' ' 53' ' ' ILE . 1.5 tmt? -97.28 106.01 18.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.689 -1.226 . . . . 1.5 107.689 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.544 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 74.8 tttt -138.36 136.33 36.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.975 -0.557 . . . . 1.69 110.489 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.36 33.5 82.32 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.787 -0.642 . . . . 1.21 112.733 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.485 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 66.81 19.76 10.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.587 0.708 . . . . 2.9 110.991 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.34 -165.61 1.71 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.289 -0.869 . . . . 1.66 109.403 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.017 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.5 OUTLIER -135.82 131.3 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.184 0.992 . . . . 0.92 110.994 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.512 ' HE1' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -82.75 111.75 18.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.863 -1.532 . . . . 0.71 106.863 168.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.608 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -119.27 107.51 13.49 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.128 -1.804 . . . . 3.56 106.128 173.106 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 4.3 mm? . . . . . 0 N--CA 1.474 0.736 0 O-C-N 123.925 0.765 . . . . 1.4 111.881 -165.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.7 mmm . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 112.638 0.607 . . . . 2.17 112.638 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.6 p -94.4 -27.01 16.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.298 -0.561 . . . . 1.47 110.639 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.472 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -101.95 13.69 34.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.436 -0.347 . . . . 1.89 111.901 -177.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 13.3 p -111.68 130.03 66.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 120.162 -0.615 . . . . 1.25 111.936 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -96.19 -22.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.038 -0.528 . . . . 1.03 111.399 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -160.29 138.52 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 1.41 111.156 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -123.4 141.34 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.407 -0.815 . . . . 0.4 110.276 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.614 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 33.7 m-85 -121.51 134.51 55.05 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-O 121.679 0.752 . . . . 1.06 111.837 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 46' ' ' THR . 11.6 t70 -101.38 126.63 48.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.878 -1.51 . . . . 1.94 109.092 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.873 HD22 ' HB2' ' A' ' 16' ' ' SER . 10.5 mp -78.47 -2.2 37.42 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.415 -1.266 . . . . 1.5 112.947 -171.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.567 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.4 tt0 86.88 -31.26 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.138 0.575 . . . . 1.68 110.48 172.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.74 -9.58 28.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.338 0.59 . . . . 2.11 109.428 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' A' ' 31' ' ' LYS . . . 138.23 -36.82 1.87 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.056 -1.068 . . . . 1.28 114.434 172.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.873 ' HB2' HD22 ' A' ' 12' ' ' LEU . 11.3 m -71.59 160.0 33.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.615 -0.513 . . . . 1.07 109.615 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -133.36 143.52 49.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.289 0.566 . . . . 1.84 111.732 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.657 HG23 HD11 ' A' ' 12' ' ' LEU . 36.1 t -118.22 142.67 31.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.64 -0.709 . . . . 0.41 109.251 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 10.0 m-70 -128.82 133.02 47.86 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 120.225 -0.59 . . . . 0.67 111.074 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.84 111.65 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 106.566 -1.642 . . . . 0.81 106.566 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.517 ' HE2' ' N ' ' A' ' 27' ' ' GLY . 87.7 m-85 -83.77 156.18 22.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.929 -0.578 . . . . 0.64 110.807 -171.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -60.61 -20.46 60.69 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.122 -0.945 . . . . 2.87 111.798 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.95 7.39 46.75 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.496 0.665 . . . . 1.97 109.297 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.17 -7.59 80.55 Favored Glycine 0 N--CA 1.427 -1.91 0 CA-C-N 114.868 -1.06 . . . . 0.58 114.517 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -86.53 175.51 8.3 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 117.86 0.83 . . . . 1.74 110.651 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.854 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.2 mpp? -135.88 148.7 48.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.967 0.413 . . . . 1.07 110.193 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.517 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -143.47 148.84 20.74 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.636 -0.711 . . . . 0.39 111.403 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ttt -117.62 144.51 45.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.857 0.361 . . . . 0.87 110.637 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -123.01 146.64 47.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.304 -0.998 . . . . 1.14 108.304 171.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.717 ' ND2' ' HG3' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -89.63 164.72 14.62 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.619 -0.882 . . . . 1.41 108.619 176.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.403 ' CB ' ' HA3' ' A' ' 15' ' ' GLY . 9.7 ptpp? -51.03 -11.21 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.951 1.093 . . . . 1.77 113.951 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -96.65 9.19 42.32 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.107 -0.371 . . . . 1.08 110.81 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.65 26.23 65.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.167 -0.54 . . . . 0.54 113.67 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.717 ' HG3' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.23 147.44 42.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.067 -0.653 . . . . 3.25 110.273 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 p -83.64 139.1 33.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.332 -0.849 . . . . 1.55 112.159 -172.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.0 ptm -148.78 175.26 11.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 1.38 109.577 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -95.11 151.82 18.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.913 0.387 . . . . 2.78 110.132 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.03 128.91 45.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.993 -0.549 . . . . 1.32 110.768 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.3 114.72 3.16 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.45 2.1 . . . . 1.24 112.066 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 54' ' ' MET . 42.3 tt0 -74.51 133.3 42.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.652 -0.704 . . . . 1.15 110.696 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.517 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 117.12 -8.96 15.77 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.68 113.773 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.55 142.05 48.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 117.63 0.715 . . . . 2.3 112.304 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.633 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -99.43 135.64 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.93 108.885 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 70.2 mtm -127.4 159.26 35.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.249 -0.432 . . . . 1.31 109.872 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -99.66 163.63 12.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.741 0.781 . . . . 1.64 111.995 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 45.7 p -119.68 162.69 18.59 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.28 -1.327 . . . . 0.53 110.79 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.567 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 6.8 mtt180 -55.63 -27.38 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.757 0.651 . . . . 3.73 112.757 177.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -95.76 -2.52 47.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.503 -0.479 . . . . 2.7 111.969 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.31 20.7 19.47 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.853 -1.165 . . . . 0.77 114.053 170.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -112.63 167.22 10.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.717 0.758 . . . . 1.35 109.514 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -122.66 143.8 49.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.79 -0.448 . . . . 1.84 109.79 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 pt -139.55 154.22 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.346 -0.388 . . . . 0.66 111.247 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.728 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -155.02 149.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.957 0.408 . . . . 0.98 110.596 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.524 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 27.5 ttt -108.39 113.17 26.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.777 -1.194 . . . . 1.5 107.777 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 22.4 tptm -144.35 138.91 28.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.177 -0.675 . . . . 1.69 109.177 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.29 31.01 76.1 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 1.21 111.742 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.406 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 62.12 23.42 13.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.171 0.51 . . . . 2.9 111.339 -178.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 54' ' ' MET . 36.7 mt-10 -132.07 160.02 37.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.519 -0.764 . . . . 1.66 110.19 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.854 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.49 124.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.523 0.678 . . . . 0.92 110.906 177.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.728 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -82.46 109.76 16.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.508 -1.664 . . . . 0.71 106.508 166.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.614 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 2.0 tmm_? -121.49 105.51 10.55 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.817 -1.549 . . . . 3.56 106.817 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 62' ' ' LEU . 3.9 mm? . . . . . 0 C--N 1.323 -0.57 0 O-C-N 124.222 0.951 . . . . 1.4 112.898 -164.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.486 ' HA ' HG12 ' A' ' 6' ' ' VAL . 20.7 mmt . . . . . 0 C--O 1.228 -0.071 0 CA-C-O 120.914 0.387 . . . . 2.17 111.291 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 m -86.37 -26.93 24.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.281 0.563 . . . . 1.47 110.793 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.48 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -114.42 12.39 17.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.715 -0.675 . . . . 1.89 111.511 -173.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.575 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.2 p -109.9 134.65 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.195 -0.457 . . . . 1.25 111.393 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 20' ' ' VAL . 22.4 m -86.84 -26.45 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.3 -0.409 . . . . 1.03 111.164 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -168.5 132.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.42 . . . . 1.41 110.566 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -110.41 143.47 40.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.61 -0.723 . . . . 0.4 109.98 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -117.98 133.2 56.14 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.766 0.793 . . . . 1.06 111.353 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.29 119.49 37.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.088 -1.414 . . . . 1.94 109.203 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 16' ' ' SER . 7.3 mt -83.1 138.99 33.47 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.686 -0.688 . . . . 1.5 109.378 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -61.99 -19.2 62.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.41 0.893 . . . . 1.68 113.41 -166.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -44.0 5.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 2.11 110.41 -175.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.72 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 159.77 78.86 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 119.621 -1.276 . . . . 1.28 113.144 -172.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.622 ' HB3' HD12 ' A' ' 12' ' ' LEU . 48.3 t -176.59 153.49 1.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.199 -0.667 . . . . 1.07 109.199 175.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -128.3 125.71 39.35 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.193 -0.458 . . . . 1.84 110.61 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.82 148.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.788 . . . . 0.41 108.871 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.575 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -138.83 131.99 29.83 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.858 -0.526 . . . . 0.67 109.992 177.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 7' ' ' VAL . 46.8 t -96.96 118.49 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.085 -1.45 . . . . 0.81 107.085 170.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 78.3 m-85 -86.58 155.35 20.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.132 0.492 . . . . 0.64 111.46 -171.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 28.9 mtpp -64.24 -22.08 66.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.335 -0.848 . . . . 2.87 111.526 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.02 -1.87 57.75 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.031 -1.1 . . . . 1.97 108.031 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.8 -8.1 50.23 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.81 -1.087 . . . . 0.58 114.555 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.94 174.02 5.78 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 118.627 1.213 . . . . 1.74 112.747 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.61 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -138.13 131.43 30.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.266 -1.334 . . . . 1.07 109.168 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.23 144.15 15.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.885 -0.674 . . . . 0.39 112.088 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.3 ttt -123.76 139.87 53.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.816 0.308 . . . . 0.87 110.996 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 19.6 mm-40 -113.15 158.21 20.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.727 -0.842 . . . . 1.14 108.727 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 38.6 p30 -88.14 164.78 15.53 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.613 -0.514 . . . . 1.41 109.613 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.72 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 ptpt -51.63 -2.86 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.978 1.103 . . . . 1.77 113.978 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 30' ' ' ASN . 65.8 m-85 -106.73 0.21 24.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.647 -0.501 . . . . 1.08 109.647 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.33 37.11 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.738 -0.744 . . . . 0.54 112.864 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 14.6 mmmm -112.15 145.57 39.59 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.339 0.59 . . . . 3.25 111.639 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.4 m -86.75 123.71 32.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.487 -1.233 . . . . 1.55 110.753 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -138.52 178.31 7.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.863 -0.608 . . . . 1.38 110.421 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -91.3 141.38 28.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.874 0.369 . . . . 2.78 110.623 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ttt -86.88 126.44 63.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 1.32 110.815 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.37 124.91 9.76 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.752 2.301 . . . . 1.24 112.864 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.556 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 47.3 tt0 -79.33 134.71 36.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 1.15 111.365 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.3 24.36 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.788 -0.72 . . . . 0.68 113.647 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 53' ' ' ILE . 48.7 mtpt -105.07 126.9 52.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 117.075 0.438 . . . . 2.3 111.941 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.657 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.7 p -91.1 122.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.014 -0.735 . . . . 0.93 109.014 171.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.0 mtm -119.11 155.69 31.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.389 -0.823 . . . . 1.31 109.548 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -107.33 156.55 18.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.245 1.021 . . . . 1.64 112.515 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.7 p -109.48 159.78 16.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.446 -1.706 . . . . 0.53 110.28 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 47' ' ' ARG . 57.7 mtt-85 -59.34 -24.0 62.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.588 0.588 . . . . 3.73 112.588 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -96.07 -2.44 46.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.178 0.513 . . . . 2.7 110.64 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.68 15.12 32.61 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.761 -0.733 . . . . 0.77 113.068 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.8 m -93.9 146.11 24.14 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 110.201 -0.296 . . . . 1.35 110.201 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -107.73 134.07 51.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.691 -0.485 . . . . 1.84 109.691 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 12' ' ' LEU . 33.0 pt -138.17 156.83 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 0.66 111.462 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.79 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -158.41 154.03 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.811 -0.631 . . . . 0.98 109.678 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.608 ' N ' HG12 ' A' ' 53' ' ' ILE . 28.0 ttt -107.73 119.53 39.7 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.658 -1.238 . . . . 1.5 107.658 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 1.9 mmmt -138.57 134.85 34.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.083 -0.34 . . . . 1.69 110.083 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.22 30.35 75.65 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.836 -0.697 . . . . 1.21 111.821 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.406 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 62.44 25.78 15.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.37 0.605 . . . . 2.9 111.542 -176.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 54' ' ' MET . 41.8 mt-10 -123.59 151.41 42.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.384 -0.825 . . . . 1.66 110.251 175.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.61 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.19 121.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.774 0.797 . . . . 0.92 111.353 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.79 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -83.91 111.9 19.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.893 -1.049 . . . . 0.71 108.277 168.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 2.8 tmm_? -122.14 108.86 13.82 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.613 -1.625 . . . . 3.56 106.613 171.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 3.8 mm? . . . . . 0 N--CA 1.476 0.872 0 O-C-N 124.268 0.98 . . . . 1.4 112.749 -166.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.8 mmm . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 112.411 0.522 . . . . 2.17 112.411 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -101.49 -25.71 13.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 1.47 110.985 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.531 ' ND2' ' HD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -99.94 13.54 33.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.006 0.431 . . . . 1.89 111.177 -177.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 12.9 p -102.35 129.3 54.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 1.25 110.257 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.32 -21.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.642 -0.423 . . . . 1.03 111.46 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -166.64 142.84 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.437 0.637 . . . . 1.41 111.211 176.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -121.02 144.73 48.37 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.961 -1.018 . . . . 0.4 109.823 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.474 ' CD1' HG21 ' A' ' 46' ' ' THR . 29.9 m-85 -123.03 133.14 54.35 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.855 0.836 . . . . 1.06 111.953 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.6 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 9.8 m-20 -97.94 121.83 40.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.928 -1.487 . . . . 1.94 108.911 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.903 ' HG ' ' HB2' ' A' ' 16' ' ' SER . 0.6 OUTLIER -67.48 -10.11 48.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.497 -1.229 . . . . 1.5 112.458 -173.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 35.9 tt0 94.03 -22.65 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.4 1.062 . . . . 1.68 109.253 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -96.25 -34.9 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.688 -0.687 . . . . 2.11 109.473 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 155.19 -30.91 0.65 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.478 -0.868 . . . . 1.28 112.926 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.903 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.7 OUTLIER -57.79 141.37 49.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 1.07 110.29 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 127.44 50.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.236 -0.438 . . . . 1.84 111.071 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.511 HG23 HD21 ' A' ' 12' ' ' LEU . 75.0 t -107.19 138.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.212 -0.662 . . . . 0.41 109.212 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 4.3 m-70 -127.01 132.82 50.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 109.641 -0.503 . . . . 0.67 109.641 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 59' ' ' ILE . 69.4 t -102.12 122.4 54.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 106.947 -1.501 . . . . 0.81 106.947 170.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.531 ' HD2' ' ND2' ' A' ' 5' ' ' ASN . 94.2 m-85 -92.11 155.26 18.18 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.559 -0.746 . . . . 0.64 110.757 -169.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.75 -8.61 29.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.303 -0.862 . . . . 2.87 111.755 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -92.48 0.96 57.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.17 -13.81 64.34 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.807 -1.088 . . . . 0.58 113.878 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.87 -174.52 4.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.603 0.702 . . . . 1.74 109.448 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.551 ' HG3' HG12 ' A' ' 59' ' ' ILE . 1.6 pmm? -152.83 154.2 34.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.901 0.381 . . . . 1.07 110.15 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.6 153.49 24.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.5 -0.64 . . . . 0.39 111.5 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 ttt -125.75 139.8 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.27 0.557 . . . . 0.87 111.539 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.41 155.67 36.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 1.14 109.441 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.463 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 65.2 t30 -94.12 159.73 15.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.285 -0.635 . . . . 1.41 109.285 175.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.679 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.8 ptmt -48.73 -23.73 1.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.076 1.139 . . . . 1.77 114.076 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.463 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 36.2 m-85 -90.45 -2.63 57.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.472 . . . . 1.08 110.152 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.13 26.36 16.45 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.54 112.01 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -100.7 135.82 41.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.724 0.773 . . . . 3.25 111.855 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 p -79.33 110.69 14.86 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.948 -1.478 . . . . 1.55 110.243 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -127.25 177.07 6.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.321 -0.4 . . . . 1.38 111.128 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -88.4 132.9 34.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.234 0.54 . . . . 2.78 111.755 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.1 ttt -91.83 125.55 56.83 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.743 -0.662 . . . . 1.32 109.948 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.87 124.08 7.22 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.605 2.204 . . . . 1.24 113.037 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.653 ' HG2' ' HD2' ' A' ' 55' ' ' LYS . 38.2 tt0 -82.11 133.98 35.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 1.15 110.34 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 102.88 -12.4 56.2 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.783 -0.723 . . . . 0.68 111.901 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -96.53 123.9 40.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.626 0.25 . . . . 2.3 111.41 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.636 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -90.7 127.56 43.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.885 -0.783 . . . . 0.93 108.885 172.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.4 mtm -126.16 156.95 39.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.069 -0.514 . . . . 1.31 109.901 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.553 ' HG2' ' HG3' ' A' ' 51' ' ' LYS . 38.9 mt-10 -108.58 169.4 8.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.982 0.896 . . . . 1.64 112.281 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.474 HG21 ' CD1' ' A' ' 10' ' ' TYR . 42.7 p -120.33 168.31 11.41 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.862 -1.517 . . . . 0.53 110.73 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 11.2 ptt180 -59.49 -21.83 60.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.473 0.654 . . . . 3.73 111.086 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -97.81 -5.86 33.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.94 -1.027 . . . . 2.7 110.921 -170.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.56 11.26 58.35 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.52 -0.848 . . . . 0.77 112.999 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.704 HG22 HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -90.05 148.18 23.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.426 -0.583 . . . . 1.35 109.426 177.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.595 ' O ' ' HE1' ' A' ' 60' ' ' PHE . 1.9 mptp? -111.87 130.55 55.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.157 -0.683 . . . . 1.84 109.157 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.46 157.64 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.238 -0.437 . . . . 0.66 110.826 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -158.81 150.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 0.98 110.266 177.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.535 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 60.2 ttp -105.72 123.79 48.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.581 -1.266 . . . . 1.5 107.581 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HD2' ' HG2' ' A' ' 40' ' ' GLU . 21.6 tptp -144.5 133.63 22.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.88 -0.415 . . . . 1.69 109.88 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.56 30.58 78.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.117 -0.563 . . . . 1.21 111.768 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.27 24.77 14.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.445 0.64 . . . . 2.9 111.009 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.25 152.22 36.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.198 -0.91 . . . . 1.66 109.581 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.38 120.21 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.054 0.931 . . . . 0.92 110.879 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.595 ' HE1' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -84.03 119.18 24.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.188 -1.369 . . . . 0.71 107.435 166.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -111.28 100.18 8.85 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.54 -2.022 . . . . 3.56 105.54 166.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.704 HD21 HG22 ' A' ' 50' ' ' THR . 29.7 mt . . . . . 0 C--N 1.321 -0.645 0 O-C-N 124.327 1.017 . . . . 1.4 113.076 -171.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.754 0.311 . . . . 2.17 111.033 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -82.29 -32.41 29.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.418 0.628 . . . . 1.47 110.245 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 4.3 t30 -94.74 -1.29 53.25 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.333 -0.849 . . . . 1.89 111.065 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.6 p -107.39 131.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 119.102 -1.039 . . . . 1.25 111.643 -175.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.65 -25.59 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.961 -0.563 . . . . 1.03 112.398 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -167.38 136.08 2.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.81 0.814 . . . . 1.41 112.036 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 m -108.54 142.09 39.48 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.198 -1.365 . . . . 0.4 109.819 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -122.85 136.69 54.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.852 0.834 . . . . 1.06 112.122 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.98 120.36 34.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.81 -1.541 . . . . 1.94 109.114 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 16' ' ' SER . 15.1 mt -80.4 145.88 31.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.531 -1.285 . . . . 1.5 107.531 173.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.556 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 7.9 tt0 -62.8 -13.98 39.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.22 0.452 . . . . 1.68 112.22 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.68 -20.99 21.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.093 0.473 . . . . 2.11 110.151 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.65 -20.44 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.854 -0.689 . . . . 1.28 113.325 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 12' ' ' LEU . 15.8 m -63.34 152.28 38.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.93 0.395 . . . . 1.07 110.466 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' MET . 59.0 mttp -122.98 127.9 49.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.05 0.452 . . . . 1.84 111.362 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.04 149.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.041 -0.725 . . . . 0.41 109.041 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.663 ' HB3' HG21 ' A' ' 6' ' ' VAL . 1.2 m-70 -140.14 139.82 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.769 -0.582 . . . . 0.67 110.377 172.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.599 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 47.2 t -102.1 122.57 54.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.42 -1.326 . . . . 0.81 107.42 171.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.454 ' HE1' ' N ' ' A' ' 27' ' ' GLY . 95.9 m-85 -96.27 157.21 16.0 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.233 -0.44 . . . . 0.64 111.512 -169.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 22.7 mtpp -62.67 -23.15 66.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.181 0.592 . . . . 2.87 111.765 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.99 6.37 48.13 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.342 -0.984 . . . . 1.97 108.342 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.64 -5.38 76.91 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 114.347 -1.297 . . . . 0.58 114.923 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -90.3 178.34 6.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.266 1.033 . . . . 1.74 110.757 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 1.048 ' HG2' HD12 ' A' ' 59' ' ' ILE . 4.2 mpp? -138.35 145.55 41.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.954 -0.566 . . . . 1.07 109.979 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -132.48 148.21 19.11 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.838 -0.696 . . . . 0.39 111.713 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 27.4 ttt -127.88 146.84 50.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.407 0.622 . . . . 0.87 112.09 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' CD ' ' HE2' ' A' ' 19' ' ' HIS . 3.1 mp0 -129.73 157.89 40.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.101 -1.074 . . . . 1.14 108.101 171.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -86.47 171.0 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.028 -0.36 . . . . 1.41 110.028 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 62.6 pttt -54.06 -14.23 1.01 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.129 0.788 . . . . 1.77 113.129 174.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -91.15 -0.82 57.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.011 0.434 . . . . 1.08 110.22 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.44 65.06 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.079 -0.581 . . . . 0.54 112.047 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 34' ' ' LYS . 1.7 mmmp? -103.12 135.36 44.93 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.739 0.78 . . . . 3.25 111.0 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 p -77.31 122.1 24.64 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 113.85 -1.523 . . . . 1.55 111.451 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -151.07 148.59 28.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 1.38 110.168 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.55 140.87 32.14 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.662 -0.415 . . . . 2.78 110.221 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.42 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -98.78 150.44 36.69 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.062 -0.517 . . . . 1.32 110.888 -177.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.6 154.45 64.41 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.062 2.508 . . . . 1.24 112.183 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.573 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 26.7 tt0 -75.62 141.23 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 1.15 110.416 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.4 -10.76 19.55 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.508 -0.853 . . . . 0.68 113.758 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.6 mtpt -92.61 115.65 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.832 0.678 . . . . 2.3 112.832 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.2 p -86.32 125.35 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.563 -0.902 . . . . 0.93 108.563 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.9 mtm -120.56 152.92 37.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.333 -0.394 . . . . 1.31 110.62 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.59 140.53 29.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.629 0.728 . . . . 1.64 111.247 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 44.4 p -103.18 162.47 12.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.661 -1.154 . . . . 0.53 110.225 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 2.8 mmt85 -59.42 -21.08 59.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.582 0.706 . . . . 3.73 111.289 171.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -88.9 0.82 56.25 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.921 -1.036 . . . . 2.7 111.418 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.03 72.72 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.57 -0.824 . . . . 0.77 111.272 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.541 ' CG2' HD21 ' A' ' 62' ' ' LEU . 11.1 p -115.08 171.74 7.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.803 -0.443 . . . . 1.35 109.803 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.62 145.08 50.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.31 -0.404 . . . . 1.84 110.07 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 61' ' ' ARG . 34.5 pt -137.77 159.2 34.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.801 -0.636 . . . . 0.66 110.719 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.73 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -156.88 153.34 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 0.98 109.817 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.62 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -114.05 106.76 14.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.609 -0.886 . . . . 1.5 108.609 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 36.0 tttm -144.27 145.96 32.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.868 0.366 . . . . 1.69 110.524 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.28 31.92 82.37 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.637 -0.711 . . . . 1.21 112.379 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 72.37 -9.35 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.409 0.623 . . . . 2.9 110.902 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -96.17 -179.07 4.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.487 -0.779 . . . . 1.66 110.51 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.048 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.0 OUTLIER -135.98 128.38 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.581 0.705 . . . . 0.92 109.86 173.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.73 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.39 111.99 19.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.008 -0.996 . . . . 0.71 108.612 172.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.639 ' HG3' HH11 ' A' ' 61' ' ' ARG . 6.0 tpt85 -120.55 107.17 12.53 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.951 -1.5 . . . . 3.56 106.951 171.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' A' ' 50' ' ' THR . 4.0 mm? . . . . . 0 N--CA 1.472 0.634 0 CA-C-N 114.724 -1.126 . . . . 1.4 112.982 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 mmt . . . . . 0 C--O 1.234 0.255 0 CA-C-O 120.912 0.387 . . . . 2.17 111.431 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.7 m -97.25 -27.49 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.833 0.349 . . . . 1.47 111.044 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.695 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -101.46 12.37 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.315 0.579 . . . . 1.89 111.026 -178.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 9.2 p -107.69 127.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.092 -0.643 . . . . 1.25 111.659 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 20' ' ' VAL . 23.5 m -80.3 -23.88 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.639 -0.71 . . . . 1.03 111.025 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -167.87 129.21 1.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 1.41 111.029 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.8 m -102.48 138.19 39.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.808 -1.087 . . . . 0.4 109.558 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 39.2 m-85 -108.09 123.19 48.33 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.076 0.941 . . . . 1.06 111.809 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.961 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 6.1 m-20 -94.9 114.0 25.79 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.442 -1.708 . . . . 1.94 109.92 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -87.68 152.49 22.11 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.386 -0.825 . . . . 1.5 109.089 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -69.45 -6.32 29.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.432 0.634 . . . . 1.68 110.746 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -95.09 -7.94 38.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.582 -0.735 . . . . 2.11 109.29 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 101.43 -19.08 52.3 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.22 -0.9 . . . . 1.28 111.88 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.624 ' HB2' HD12 ' A' ' 12' ' ' LEU . 5.0 m -61.96 145.9 51.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 1.07 110.491 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.7 125.16 46.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.16 0.505 . . . . 1.84 110.594 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -105.76 154.71 6.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.482 -0.933 . . . . 0.41 108.482 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.607 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 51.8 m-70 -136.58 134.65 37.66 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.848 -0.532 . . . . 0.67 109.737 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 7' ' ' VAL . 47.3 t -97.31 111.98 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 106.298 -1.741 . . . . 0.81 106.298 166.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 19' ' ' HIS . 80.9 m-85 -84.39 154.83 22.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.715 -0.675 . . . . 0.64 110.72 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 7.7 ptmm? -58.58 -23.45 58.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.318 -0.856 . . . . 2.87 112.68 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.646 ' HB2' ' HE2' ' A' ' 25' ' ' LYS . 7.7 m-20 -98.01 6.66 47.4 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.156 -0.683 . . . . 1.97 109.156 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 -5.03 66.79 Favored Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 115.078 -0.964 . . . . 0.58 114.787 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -81.88 171.75 14.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.272 1.036 . . . . 1.74 110.382 176.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.719 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.5 mpp? -137.0 143.51 42.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.974 -0.557 . . . . 1.07 109.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.87 143.21 14.81 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.383 -0.687 . . . . 0.39 111.383 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.125 0.488 . . . . 0.87 110.799 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 45.8 mt-10 -125.78 153.88 43.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.338 -0.847 . . . . 1.14 109.149 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.57 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 38.3 p-10 -88.98 168.31 12.47 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.61 -0.515 . . . . 1.41 109.61 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 63.9 pttt -53.31 1.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.053 1.131 . . . . 1.77 114.053 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 30' ' ' ASN . 84.7 m-85 -111.09 -2.7 15.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.939 -0.476 . . . . 1.08 110.522 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.92 32.69 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.294 -0.955 . . . . 0.54 113.598 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.57 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -120.42 147.46 45.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.129 -0.628 . . . . 3.25 110.683 174.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -74.57 128.05 34.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.991 -1.004 . . . . 1.55 111.351 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 ptm -126.85 -179.72 4.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.08 -0.509 . . . . 1.38 110.666 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.05 154.38 37.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 2.78 110.109 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.2 ttt -119.88 127.28 26.47 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.178 -0.305 . . . . 1.32 110.178 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.43 148.57 33.85 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.458 2.106 . . . . 1.24 112.863 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.15 139.72 43.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.722 -0.672 . . . . 1.15 109.512 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.52 -31.53 5.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.495 -0.86 . . . . 0.68 112.648 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -82.08 142.19 32.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.72 0.295 . . . . 2.3 110.848 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.596 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.0 p -97.55 130.21 46.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.215 0.531 . . . . 0.93 110.472 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -102.83 140.55 36.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.777 -0.647 . . . . 1.31 109.7 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.51 146.99 27.71 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.21 0.528 . . . . 1.64 110.314 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.3 p -100.46 168.23 9.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.573 -0.74 . . . . 0.53 110.72 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.961 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 39.3 mtt180 -46.57 -41.29 14.19 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.413 0.894 . . . . 3.73 113.413 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.02 -43.48 7.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.871 -0.731 . . . . 2.7 112.098 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.26 28.82 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 119.308 -1.425 . . . . 0.77 113.587 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.0 m -102.44 149.28 24.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.291 -1.003 . . . . 1.35 108.291 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 94.3 mttt -126.15 144.17 50.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.614 -0.434 . . . . 1.84 111.794 -173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 61' ' ' ARG . 39.3 pt -138.0 157.92 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.44 -0.8 . . . . 0.66 110.786 -176.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.94 148.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.818 0.342 . . . . 0.98 110.359 176.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.47 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -111.52 127.02 55.58 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.562 -0.533 . . . . 1.5 109.562 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 55' ' ' LYS . 51.3 tptt -145.24 129.38 17.59 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.791 -0.448 . . . . 1.69 109.791 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.19 36.58 89.33 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.941 -0.647 . . . . 1.21 112.711 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 71.85 -9.63 0.95 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.483 0.713 . . . . 2.9 111.355 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 56' ' ' GLY . 55.4 mm-40 -86.05 139.15 31.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.161 -0.472 . . . . 1.66 111.16 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.719 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -102.08 124.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.576 0.703 . . . . 0.92 110.901 176.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.48 119.63 25.37 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.076 -1.083 . . . . 0.71 108.076 169.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.555 ' HG3' ' OH ' ' A' ' 10' ' ' TYR . 11.1 ttm180 -116.07 101.01 8.36 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.515 -1.661 . . . . 3.56 106.515 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 O-C-N 124.895 1.372 . . . . 1.4 113.532 -163.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.3 mtp . . . . . 0 N--CA 1.444 -0.772 0 CA-C-O 121.207 0.527 . . . . 2.17 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 m -112.95 -36.53 5.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.629 -0.714 . . . . 1.47 111.271 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 1.008 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 3.4 t30 -114.84 -0.57 13.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.55 0.691 . . . . 1.89 111.779 -174.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.689 HG21 ' HB3' ' A' ' 19' ' ' HIS . 7.8 p -102.73 134.38 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.917 -1.114 . . . . 1.25 111.381 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -87.13 -23.86 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.932 0.345 . . . . 1.03 111.932 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.9 131.45 1.65 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.727 0.775 . . . . 1.41 111.736 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -105.64 142.62 35.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.439 -1.255 . . . . 0.4 109.479 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.483 ' CD1' HG21 ' A' ' 46' ' ' THR . 21.2 m-85 -121.7 134.74 54.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.382 -0.827 . . . . 1.06 111.15 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.602 ' CB ' ' HD3' ' A' ' 47' ' ' ARG . 1.2 m-20 -97.03 117.24 30.76 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.987 -1.46 . . . . 1.94 108.454 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 16' ' ' SER . 5.9 mt -72.15 0.81 8.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.891 0.7 . . . . 1.5 112.891 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.548 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 88.72 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.787 0.803 . . . . 1.68 108.999 173.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -80.52 -35.74 34.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.685 -1.143 . . . . 2.11 108.564 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.633 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 148.3 -26.72 1.39 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.431 -1.258 . . . . 1.28 113.315 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.677 ' HB2' HD12 ' A' ' 12' ' ' LEU . 1.4 m -60.64 146.39 45.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.758 -0.46 . . . . 1.07 109.758 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -121.94 126.42 48.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.107 0.479 . . . . 1.84 110.538 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.3 t -108.46 141.79 22.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.04 -0.726 . . . . 0.41 109.04 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.689 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -137.53 131.11 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.174 -0.61 . . . . 0.67 110.428 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 59' ' ' ILE . 60.7 t -102.89 123.98 56.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 107.522 -1.288 . . . . 0.81 107.522 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.516 ' HB3' HD21 ' A' ' 5' ' ' ASN . 97.9 m-85 -98.61 161.4 13.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.963 -0.562 . . . . 0.64 111.219 -167.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.008 ' HE2' ' HA ' ' A' ' 5' ' ' ASN . 41.4 mtmt -62.15 -19.56 63.18 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.179 -0.464 . . . . 2.87 111.95 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.911 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 2.1 m-20 -83.98 -9.39 58.71 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.275 -1.009 . . . . 1.97 108.275 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.89 -5.06 59.5 Favored Glycine 0 N--CA 1.421 -2.358 0 CA-C-N 114.731 -1.122 . . . . 0.58 113.338 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.911 ' HD3' ' HB2' ' A' ' 23' ' ' ASP . 1.6 mppt? -82.62 -177.1 6.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 117.748 0.774 . . . . 1.74 109.417 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 1.7 pmm? -153.81 147.61 25.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.757 -0.656 . . . . 1.07 109.676 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.406 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.27 155.05 21.91 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.786 -0.721 . . . . 0.39 111.964 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.6 ttt -124.95 141.53 52.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.121 0.486 . . . . 0.87 111.656 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 27.2 mt-10 -126.45 153.49 44.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.098 -1.075 . . . . 1.14 108.098 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -93.42 172.63 8.16 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.403 -0.519 . . . . 1.41 110.542 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.633 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 60.8 pttt -53.07 -14.78 0.67 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.605 0.965 . . . . 1.77 113.605 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -95.9 -3.12 45.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.065 -0.397 . . . . 1.08 110.914 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.34 22.65 47.04 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.825 -0.702 . . . . 0.54 112.199 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 mmtt -102.34 134.04 46.29 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.875 0.845 . . . . 3.25 110.81 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 p -76.75 129.21 35.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.665 -1.607 . . . . 1.55 111.545 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 55.4 mtm -136.77 162.9 31.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 1.38 110.064 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -90.96 156.47 17.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.343 -0.389 . . . . 2.78 110.03 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 41.5 ttm -99.98 127.66 32.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 1.32 111.612 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.13 118.5 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.539 2.159 . . . . 1.24 111.922 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.1 tt0 -68.58 137.06 53.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.759 -0.655 . . . . 1.15 110.802 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -9.14 37.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.68 113.471 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -104.22 130.29 51.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.335 0.568 . . . . 2.3 112.132 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.696 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.2 p -93.78 132.66 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 0.93 110.366 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.4 mtm -124.8 153.18 42.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.487 -0.779 . . . . 1.31 109.712 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -107.4 167.78 9.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.523 0.678 . . . . 1.64 111.688 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 54.3 p -127.59 164.87 21.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.655 -1.157 . . . . 0.53 112.067 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.602 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 75.0 mtp180 -59.65 -29.66 68.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.413 -0.812 . . . . 3.73 111.423 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -95.18 -7.33 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 2.7 111.333 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.37 16.42 27.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.328 -0.939 . . . . 0.77 112.913 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.519 HG23 ' CD2' ' A' ' 62' ' ' LEU . 99.3 m -93.31 139.8 30.25 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.95 -0.389 . . . . 1.35 109.95 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -106.64 132.7 52.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.104 -0.702 . . . . 1.84 109.104 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.417 ' HA ' ' HD1' ' A' ' 60' ' ' PHE . 17.3 pt -136.6 152.82 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.901 0.334 . . . . 0.66 111.901 -175.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.696 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.56 149.81 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.945 -0.571 . . . . 0.98 110.359 174.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.563 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.6 ttt -103.86 123.33 46.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.102 -0.703 . . . . 1.5 109.102 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 23.2 tptm -145.48 128.14 16.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.754 -0.461 . . . . 1.69 109.754 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.14 43.32 97.34 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.61 -0.596 . . . . 1.21 111.61 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 50.12 21.17 0.71 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.182 0.993 . . . . 2.9 112.174 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -116.9 152.09 35.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 1.66 110.511 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.507 HG13 HG22 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -98.93 122.63 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.133 0.968 . . . . 0.92 111.666 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.501 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -82.66 111.6 18.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.238 -1.393 . . . . 0.71 107.238 164.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.506 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 5.8 ttm180 -116.47 103.93 10.93 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.709 -1.96 . . . . 3.56 105.709 170.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD2' HG23 ' A' ' 50' ' ' THR . 3.8 mm? . . . . . 0 N--CA 1.473 0.709 0 O-C-N 124.082 0.864 . . . . 1.4 112.202 -166.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.0 mtp . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.9 0.381 . . . . 2.17 111.65 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m -78.93 -27.77 43.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.35 0.595 . . . . 1.47 110.504 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -108.28 9.61 27.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.769 0.795 . . . . 1.89 110.558 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.415 HG11 ' OG1' ' A' ' 9' ' ' THR . 84.5 t -102.48 127.74 55.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.399 -0.819 . . . . 1.25 110.842 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 22' ' ' LYS . 24.5 m -86.7 -23.27 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 1.03 110.964 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.37 138.76 3.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 1.41 110.581 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.415 ' OG1' HG11 ' A' ' 6' ' ' VAL . 3.4 m -120.76 143.97 48.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.484 -0.78 . . . . 0.4 109.728 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.76 129.39 51.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.372 1.082 . . . . 1.06 111.653 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -96.76 125.47 41.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.117 -1.856 . . . . 1.94 108.99 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.613 HD12 ' HB2' ' A' ' 16' ' ' SER . 16.7 mt -80.84 148.81 29.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.117 -1.068 . . . . 1.5 108.117 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.562 ' HG2' ' HA ' ' A' ' 47' ' ' ARG . 51.9 mt-30 -65.06 -5.34 6.2 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.98 0.363 . . . . 1.68 111.98 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.33 -27.11 14.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.518 . . . . 2.11 110.129 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 135.24 -19.58 3.84 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.771 -0.728 . . . . 1.28 113.124 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.613 ' HB2' HD12 ' A' ' 12' ' ' LEU . 6.3 m -68.56 155.55 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.827 0.346 . . . . 1.07 110.584 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -124.99 127.72 47.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.265 -0.425 . . . . 1.84 111.069 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -108.23 143.47 18.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.754 -0.832 . . . . 0.41 108.754 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' MET . 4.0 m-70 -131.14 130.12 42.69 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.088 -0.645 . . . . 0.67 110.62 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 116.38 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.79 -1.559 . . . . 0.81 106.79 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' HE1' ' N ' ' A' ' 27' ' ' GLY . 73.1 m-85 -85.63 155.28 21.19 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.72 -0.673 . . . . 0.64 111.316 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 12.8 ptmm? -57.49 -22.85 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.964 -1.016 . . . . 2.87 112.273 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -94.46 2.52 55.73 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.843 -0.799 . . . . 1.97 108.843 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.39 -11.57 59.91 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.83 -1.077 . . . . 0.58 114.386 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.66 179.87 7.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.082 0.941 . . . . 1.74 111.19 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.622 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -139.44 143.62 37.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.144 0.497 . . . . 1.07 109.983 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -136.79 146.28 18.21 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.932 -0.867 . . . . 0.39 110.932 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.4 ttt -122.62 144.73 48.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.932 0.396 . . . . 0.87 111.302 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -126.75 148.89 49.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.946 -1.131 . . . . 1.14 107.946 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -86.38 170.44 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.231 -0.588 . . . . 1.41 110.121 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 19.3 pttm -58.02 1.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.626 0.972 . . . . 1.77 113.626 173.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -107.47 -1.84 21.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 1.08 109.521 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.3 22.17 52.4 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.819 -0.705 . . . . 0.54 112.268 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -110.97 137.82 48.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.413 0.625 . . . . 3.25 111.414 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -74.65 139.12 43.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.163 -1.38 . . . . 1.55 111.869 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.1 ptm -150.45 178.82 8.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.612 -0.722 . . . . 1.38 109.602 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -104.84 158.95 16.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 2.78 110.629 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.8 ttt -101.45 130.2 25.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 1.32 110.091 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.98 132.86 17.4 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.71 2.273 . . . . 1.24 112.772 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 54' ' ' MET . 36.6 tt0 -73.89 138.42 44.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.15 110.23 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.93 62.73 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.824 -0.703 . . . . 0.68 112.979 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -102.93 127.02 50.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 2.3 111.887 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.609 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.7 p -95.6 132.27 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.582 -0.735 . . . . 0.93 109.138 178.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.6 mtm -119.48 148.55 43.13 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.792 -0.447 . . . . 1.31 109.792 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -102.99 147.32 27.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.228 0.537 . . . . 1.64 110.746 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.83 162.34 14.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.325 -0.852 . . . . 0.53 111.264 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.562 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 99.7 mtt180 -58.85 -26.2 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.88 -0.6 . . . . 3.73 111.786 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.68 -14.94 38.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 2.7 110.402 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.79 26.33 6.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.912 -0.661 . . . . 0.77 112.95 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.786 HG21 HH11 ' A' ' 61' ' ' ARG . 43.6 m -111.13 165.16 12.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.505 -0.554 . . . . 1.35 109.505 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' N ' HG22 ' A' ' 50' ' ' THR . 68.1 mttm -122.42 143.83 49.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.592 -0.522 . . . . 1.84 109.592 176.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 20.6 pt -136.32 150.5 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 0.66 111.141 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.699 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.15 144.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.313 -0.403 . . . . 0.98 110.732 177.073 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 25.8 ttt -99.99 138.18 37.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.597 -0.52 . . . . 1.5 109.597 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 21.0 tptp -144.41 103.35 3.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 1.69 107.883 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 -152.1 45.63 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.055 -1.618 . . . . 1.21 109.055 -164.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.63 8.48 14.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.106 0.479 . . . . 2.9 110.644 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -104.76 177.87 4.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.994 0.425 . . . . 1.66 110.481 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.622 HD12 ' HG2' ' A' ' 26' ' ' MET . 11.2 tt -143.59 141.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.746 0.784 . . . . 0.92 110.884 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -82.49 114.72 21.1 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.438 -1.319 . . . . 0.71 107.438 169.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.786 HH11 HG21 ' A' ' 50' ' ' THR . 0.4 OUTLIER -114.49 102.75 10.36 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.527 -1.657 . . . . 3.56 106.527 170.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.66 HD13 ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.571 1.768 0 O-C-N 124.457 1.098 . . . . 1.4 111.746 -172.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 121.039 0.447 . . . . 2.17 111.117 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 p -81.52 -7.21 59.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.57 0.7 . . . . 1.47 110.917 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.455 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -129.44 11.75 5.86 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.068 0.937 . . . . 1.89 109.039 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -117.37 133.47 64.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.016 -1.447 . . . . 1.25 111.658 -175.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 22' ' ' LYS . 35.6 m -88.24 -26.37 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.541 -0.754 . . . . 1.03 111.536 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -167.15 135.79 2.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.344 0.593 . . . . 1.41 111.167 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 m -114.23 144.45 43.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.907 -1.042 . . . . 0.4 110.102 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.49 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 30.9 m-85 -120.15 132.19 55.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.552 0.692 . . . . 1.06 111.136 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.55 125.76 51.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.238 -1.346 . . . . 1.94 108.698 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 16' ' ' SER . 17.4 mt -81.16 153.63 27.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.377 -1.283 . . . . 1.5 107.832 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -65.85 -7.31 15.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.217 0.532 . . . . 1.68 111.232 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.615 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 31.6 t70 -98.45 -13.52 20.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 2.11 109.98 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.551 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 116.07 -13.45 16.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.651 -0.785 . . . . 1.28 113.425 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.602 ' HB2' HD12 ' A' ' 12' ' ' LEU . 4.9 m -72.96 148.19 44.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.792 0.296 . . . . 1.07 110.592 -176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -118.93 127.58 53.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.308 0.575 . . . . 1.84 112.454 -172.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.9 t -109.57 143.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.165 -1.05 . . . . 0.41 108.165 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' MET . 5.5 m-70 -132.28 137.98 47.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.738 -0.785 . . . . 0.67 110.602 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.48 ' O ' HG22 ' A' ' 7' ' ' VAL . 46.5 t -97.67 115.21 36.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.131 -1.433 . . . . 0.81 107.131 169.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 49.5 m-85 -80.6 153.66 27.88 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.933 -0.576 . . . . 0.64 111.167 -173.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.768 ' HA ' HG13 ' A' ' 7' ' ' VAL . 16.7 pttm -57.58 -27.01 62.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.998 -1.001 . . . . 2.87 111.756 -176.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.36 -1.23 54.12 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.209 -0.663 . . . . 1.97 109.209 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.41 41.0 Favored Glycine 0 N--CA 1.423 -2.168 0 C-N-CA 119.92 -1.133 . . . . 0.58 114.879 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -75.05 176.38 7.29 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.934 1.367 . . . . 1.74 111.737 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 2.2 mpp? -140.44 148.82 41.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.07 109.945 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.83 145.26 17.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.619 -0.801 . . . . 0.39 111.724 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 ttt -119.27 137.8 53.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.511 . . . . 0.87 110.924 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 23.1 mt-10 -130.58 154.25 48.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.308 -0.86 . . . . 1.14 109.035 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 41.7 p30 -88.42 169.1 12.08 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.275 -0.57 . . . . 1.41 110.053 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 14' ' ' ASP . 40.6 pttt -53.6 -10.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.097 1.147 . . . . 1.77 114.097 175.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -99.03 -1.52 39.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 1.08 110.602 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.52 20.53 51.28 Favored Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.856 -0.688 . . . . 0.54 111.909 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 27.9 mmmt -102.17 135.62 43.45 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.644 0.735 . . . . 3.25 111.334 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -74.7 127.57 33.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.032 -1.44 . . . . 1.55 111.011 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.3 ptm -138.27 176.49 8.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 1.38 110.736 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.497 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -96.56 131.19 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.118 -0.492 . . . . 2.78 109.849 179.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.8 ttp -85.2 117.64 69.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.965 -0.562 . . . . 1.32 110.445 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.46 147.43 64.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.86 2.373 . . . . 1.24 112.809 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 34.6 tt0 -88.82 144.82 25.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.001 -0.545 . . . . 1.15 110.385 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.87 -16.73 60.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.014 -0.613 . . . . 0.68 112.569 176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 42' ' ' LYS . 42.3 mmtm -94.88 119.73 33.93 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.116 0.413 . . . . 2.3 112.116 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.576 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 10.7 p -94.02 119.58 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.078 -0.712 . . . . 0.93 109.078 174.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 65.3 mtm -107.74 152.17 24.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.603 -0.726 . . . . 1.31 110.613 -170.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 50' ' ' THR . 38.1 tt0 -104.64 145.41 30.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.538 0.685 . . . . 1.64 111.497 -176.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.0 p -94.93 166.63 11.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.746 -1.115 . . . . 0.53 109.925 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -35.92 -49.37 0.62 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.57 1.322 . . . . 3.73 114.57 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.84 -33.69 15.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.48 -0.488 . . . . 2.7 111.978 -170.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.79 34.23 0.17 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.985 -1.102 . . . . 0.77 112.837 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.5 m -100.87 153.32 19.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.486 -0.931 . . . . 1.35 108.486 176.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB3' HG22 ' A' ' 43' ' ' VAL . 93.4 mttt -124.26 139.55 53.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.432 -0.507 . . . . 1.84 112.075 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.479 ' HA ' ' CE1' ' A' ' 60' ' ' PHE . 31.6 pt -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.148 -0.933 . . . . 0.66 110.201 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.733 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -163.41 155.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.825 0.345 . . . . 0.98 111.137 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.67 ' N ' HG12 ' A' ' 53' ' ' ILE . 13.4 tmm? -104.79 117.22 33.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.247 -1.019 . . . . 1.5 108.247 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 20.2 tptp -134.0 125.6 28.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.31 -0.626 . . . . 1.69 109.31 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.07 38.13 88.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.756 -0.735 . . . . 1.21 112.155 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 62.46 28.57 16.85 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.607 0.718 . . . . 2.9 110.852 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' MET . 46.0 mt-10 -141.29 159.87 41.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.656 -0.702 . . . . 1.66 110.409 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -102.16 126.64 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.456 0.646 . . . . 0.92 111.404 -177.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.733 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.81 110.35 18.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.313 -1.736 . . . . 0.71 106.313 164.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 1.2 tmm_? -114.47 103.64 11.24 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.632 -1.618 . . . . 3.56 106.632 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.476 0.845 0 O-C-N 124.385 1.053 . . . . 1.4 113.404 -165.442 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.573 ' HA ' HG12 ' A' ' 6' ' ' VAL . 22.6 mmt . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.731 0.3 . . . . 2.17 111.466 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -92.74 -37.36 12.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 1.47 111.004 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.56 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -107.0 -6.47 17.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.235 0.541 . . . . 1.89 111.417 -176.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 19' ' ' HIS . 4.8 p -94.73 141.1 15.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.95 -0.469 . . . . 1.25 110.502 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -94.98 -23.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.865 -0.334 . . . . 1.03 110.9 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -160.15 136.53 8.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.383 0.611 . . . . 1.41 110.82 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -121.2 135.2 55.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.024 -0.989 . . . . 0.4 109.538 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 27.8 m-85 -117.26 134.06 55.25 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.864 0.84 . . . . 1.06 111.754 -177.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 10.7 t70 -104.08 126.15 50.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.188 -1.369 . . . . 1.94 108.517 176.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 16' ' ' SER . 8.8 mt -71.51 0.09 9.26 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.423 -1.262 . . . . 1.5 112.623 -172.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 7.6 tt0 86.87 -24.37 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.963 -0.754 . . . . 1.68 108.963 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -95.15 -21.13 18.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.102 -0.954 . . . . 2.11 109.16 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.584 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 139.36 -29.97 2.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.543 -0.837 . . . . 1.28 113.945 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' HD12 ' A' ' 12' ' ' LEU . 3.8 m -66.05 149.07 50.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 117.09 0.445 . . . . 1.07 110.264 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 46.8 mttm -124.44 126.72 46.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 1.84 111.432 -172.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.58 141.81 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.897 -0.779 . . . . 0.41 108.897 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.585 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.9 m-70 -130.59 130.19 43.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.331 -0.547 . . . . 0.67 110.27 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.09 111.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.058 -1.46 . . . . 0.81 107.058 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 85.6 m-85 -89.72 163.09 15.24 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.02 -0.536 . . . . 0.64 110.888 -168.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 24.9 mtpp -66.82 -21.05 66.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.423 0.63 . . . . 2.87 110.387 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.41 -13.33 59.95 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.276 -1.009 . . . . 1.97 108.276 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.99 71.14 Favored Glycine 0 N--CA 1.422 -2.258 0 CA-C-N 114.043 -1.435 . . . . 0.58 112.93 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -78.49 171.9 14.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.622 0.725 . . . . 1.74 111.452 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.707 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.0 mpp? -130.74 138.14 49.82 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.625 -1.171 . . . . 1.07 110.022 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.37 139.27 10.83 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 111.218 -0.753 . . . . 0.39 111.218 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.9 ttt -117.73 133.97 55.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.253 0.549 . . . . 0.87 110.877 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.03 149.33 42.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.11 -0.95 . . . . 1.14 108.64 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 32' ' ' PHE . 43.9 p30 -86.96 169.5 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.658 -0.417 . . . . 1.41 110.132 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 45.8 pttt -59.24 5.08 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.44 0.904 . . . . 1.77 113.44 172.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 30' ' ' ASN . 89.5 m-85 -106.78 -2.9 21.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.169 -0.678 . . . . 1.08 109.169 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.07 27.48 40.6 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.789 -0.641 . . . . 0.54 114.074 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 157.14 42.55 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.054 -0.658 . . . . 3.25 111.332 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 p -74.66 126.52 31.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 1.55 111.181 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -126.27 -175.61 3.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.977 -0.556 . . . . 1.38 110.804 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.22 132.06 35.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 2.78 110.233 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 27.6 ttt -97.62 123.55 51.65 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.204 -0.453 . . . . 1.32 110.41 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.73 152.09 82.62 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.81 2.34 . . . . 1.24 111.731 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 53' ' ' ILE . 32.8 tt0 -83.75 -90.59 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.052 -0.259 . . . . 1.15 111.042 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.539 ' HA2' HD11 ' A' ' 53' ' ' ILE . . . -81.15 40.76 2.56 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.179 -0.534 . . . . 0.68 113.85 -170.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -109.44 119.63 40.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.652 0.263 . . . . 2.3 110.818 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.544 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.4 p -81.34 117.91 28.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 0.93 109.361 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.8 mtm -103.2 146.4 28.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 1.31 110.996 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 51' ' ' LYS . 32.9 tt0 -98.75 151.64 20.55 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.353 -0.839 . . . . 1.64 109.866 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -126.41 164.75 20.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.004 0.431 . . . . 0.53 112.14 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -60.43 -28.7 68.49 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.749 -0.659 . . . . 3.73 111.91 176.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 20.0 t70 -90.71 -19.15 23.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.618 -0.719 . . . . 2.7 110.87 -171.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.25 15.62 18.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.632 -0.794 . . . . 0.77 112.488 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.519 HG23 HD22 ' A' ' 62' ' ' LEU . 63.8 m -94.75 142.93 26.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.906 -0.405 . . . . 1.35 109.906 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' NZ ' ' HB2' ' A' ' 45' ' ' GLU . 67.1 mmtt -108.67 132.33 54.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 1.84 108.848 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.3 pt -135.99 156.91 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.763 0.283 . . . . 0.66 111.763 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -165.19 150.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.764 -0.653 . . . . 0.98 110.121 176.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 16.6 tmm? -111.43 129.94 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.968 -0.382 . . . . 1.5 109.968 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -144.35 124.69 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.589 -0.278 . . . . 1.69 110.272 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 62.54 39.51 97.94 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.835 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 72.55 -10.66 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.213 0.53 . . . . 2.9 111.208 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 54' ' ' MET . 45.2 mt-10 -89.79 167.84 12.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.138 -0.483 . . . . 1.66 109.98 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -126.26 125.66 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.879 0.847 . . . . 0.92 110.875 -178.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.762 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -81.56 110.41 16.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.248 -1.39 . . . . 0.71 107.248 169.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 38.7 ttp-105 -125.96 112.01 15.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.43 -1.693 . . . . 3.56 106.43 174.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 50' ' ' THR . 4.2 mm? . . . . . 0 N--CA 1.474 0.771 0 O-C-N 124.196 0.935 . . . . 1.4 112.668 -166.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.806 0.336 . . . . 2.17 111.444 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -73.57 -24.94 60.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.903 0.859 . . . . 1.47 109.873 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.504 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -105.3 10.39 33.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.664 -1.153 . . . . 1.89 110.595 -177.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 19' ' ' HIS . 74.5 t -105.87 135.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.479 -0.782 . . . . 1.25 109.959 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -105.84 -18.46 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.035 -0.53 . . . . 1.03 111.072 -178.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -169.01 132.95 1.4 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.123 0.487 . . . . 1.41 110.613 171.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.0 m -110.89 143.8 40.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.381 -0.827 . . . . 0.4 110.583 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.563 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 20.7 m-85 -124.9 139.82 53.49 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.425 0.631 . . . . 1.06 111.441 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.723 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 16' ' ' SER . 43.3 mt -83.21 148.96 27.12 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.99 -1.004 . . . . 1.5 109.654 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.27 -15.49 35.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.309 0.576 . . . . 1.68 111.618 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 20.7 t70 -96.39 -1.79 46.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.545 -0.752 . . . . 2.11 109.785 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 104.58 -19.3 42.37 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.113 -0.949 . . . . 1.28 112.832 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.669 ' HB2' HD12 ' A' ' 12' ' ' LEU . 40.1 m -72.84 159.97 32.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.574 -0.313 . . . . 1.07 110.671 -177.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 32.8 mttt -119.43 152.55 36.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.136 0.493 . . . . 1.84 110.694 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.408 HG11 HD12 ' A' ' 52' ' ' ILE . 75.4 t -131.48 144.25 38.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.855 -0.794 . . . . 0.41 108.855 174.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HB3' HG13 ' A' ' 6' ' ' VAL . 3.1 m-70 -134.6 135.15 42.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.48 -0.563 . . . . 0.67 109.48 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 7' ' ' VAL . 48.2 t -93.63 118.24 39.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 106.579 -1.638 . . . . 0.81 106.579 168.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.401 ' HE1' ' HA3' ' A' ' 27' ' ' GLY . 48.7 m-85 -81.98 150.36 27.68 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.77 -0.65 . . . . 0.64 110.9 -172.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -61.34 -22.33 64.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 2.87 111.768 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -99.69 6.65 45.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.76 0.791 . . . . 1.97 109.079 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.24 1.49 60.97 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.711 -1.131 . . . . 0.58 115.007 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -75.89 173.11 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.827 1.314 . . . . 1.74 111.21 172.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.701 ' HG2' HD12 ' A' ' 59' ' ' ILE . 3.2 mpp? -138.07 131.33 30.43 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.343 -0.984 . . . . 1.07 108.343 171.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA3' ' HE1' ' A' ' 21' ' ' PHE . . . -124.0 141.92 13.82 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.249 -0.977 . . . . 0.39 111.922 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.5 ttt -113.64 141.0 47.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.793 0.33 . . . . 0.87 110.191 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 16.6 mt-10 -123.53 144.66 49.42 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.619 -1.252 . . . . 1.14 107.619 169.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.434 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 29.9 p-10 -87.62 165.91 15.09 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.87 -0.732 . . . . 1.41 109.169 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 pttm -52.22 -13.21 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.607 0.966 . . . . 1.77 113.607 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.434 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 93.7 m-85 -98.73 7.77 45.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.923 0.392 . . . . 1.08 110.669 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.02 20.57 64.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.248 -0.501 . . . . 0.54 113.0 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.3 mmtm -102.01 140.83 35.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.746 0.784 . . . . 3.25 111.024 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.3 p -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.913 -1.494 . . . . 1.55 112.327 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.2 mtp -139.07 178.34 7.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.032 -0.985 . . . . 1.38 109.83 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -114.79 139.25 49.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.058 -0.719 . . . . 2.78 109.058 173.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.0 ttm -71.24 127.11 91.78 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.648 0.261 . . . . 1.32 110.86 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.87 114.49 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.19 1.927 . . . . 1.24 111.253 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.5 tt0 -61.87 129.45 41.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.807 -0.633 . . . . 1.15 110.373 -176.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.41 -20.22 30.51 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.125 -0.56 . . . . 0.68 112.781 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 42' ' ' LYS . 22.2 mmmt -88.55 119.83 29.36 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 2.3 111.907 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.675 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.98 136.47 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.554 -0.535 . . . . 0.93 109.554 172.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 68.2 mtm -132.22 157.12 45.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.579 -0.282 . . . . 1.31 110.751 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.33 150.75 20.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.882 0.849 . . . . 1.64 111.941 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 30.1 p -97.19 165.78 11.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.29 -1.323 . . . . 0.53 108.87 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -46.66 -36.33 6.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.996 0.739 . . . . 3.73 112.996 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -96.78 -49.96 4.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.356 0.502 . . . . 2.7 112.356 -168.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.9 32.24 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.411 -1.376 . . . . 0.77 113.712 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.6 t -114.03 156.65 23.72 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.457 -0.942 . . . . 1.35 108.457 168.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -120.38 145.67 46.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.651 0.263 . . . . 1.84 110.596 -171.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 12' ' ' LEU . 22.6 pt -136.46 152.28 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.887 -0.597 . . . . 0.66 110.863 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.97 147.38 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.066 -0.515 . . . . 0.98 110.549 176.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 26.2 ttt -97.53 129.66 44.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.26 -0.644 . . . . 1.5 109.26 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -144.99 128.33 16.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.159 -0.311 . . . . 1.69 110.159 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.32 37.25 93.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.471 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.402 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 61.24 25.33 15.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.674 0.749 . . . . 2.9 111.05 -178.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -128.06 -169.51 2.08 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.807 -1.088 . . . . 1.66 108.45 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.701 HD12 ' HG2' ' A' ' 26' ' ' MET . 3.3 tt -143.54 136.43 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.792 0.806 . . . . 0.92 111.529 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.665 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.1 109.41 17.13 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.795 -1.557 . . . . 0.71 106.795 167.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.563 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 1.3 tmm_? -121.35 108.87 14.22 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 105.031 -2.211 . . . . 3.56 105.031 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 4.5 mm? . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 1.4 109.163 -156.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.582 ' HG3' ' HE1' ' A' ' 21' ' ' PHE . 21.0 mmt . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 111.89 0.33 . . . . 2.17 111.89 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 3' ' ' MET . 73.6 m 73.53 -27.62 0.19 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.809 0.843 . . . . 1.47 109.335 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 3' ' ' MET . 1.3 t30 -95.85 -14.7 22.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.939 -1.028 . . . . 1.89 109.914 168.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.8 p -89.18 136.11 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 119.384 -0.926 . . . . 1.25 110.088 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.25 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.962 -0.295 . . . . 1.03 111.499 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 16.7 tppt? -169.32 151.49 4.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.228 0.537 . . . . 1.41 111.286 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 3.9 m -133.08 145.75 51.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.553 -0.749 . . . . 0.4 109.795 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 61' ' ' ARG . 38.7 m-85 -128.61 144.63 51.19 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.723 0.773 . . . . 1.06 112.333 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.948 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 6.5 m-20 -106.56 123.7 48.5 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.782 -1.553 . . . . 1.94 110.026 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -77.34 1.84 17.63 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.92 -1.491 . . . . 1.5 113.022 -173.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 47' ' ' ARG . 62.7 tt0 83.68 -32.61 0.07 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.059 0.544 . . . . 1.68 109.998 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.8 t70 -79.87 -20.14 46.63 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.429 -1.323 . . . . 2.11 107.429 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.598 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.54 -17.2 6.53 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.266 -1.334 . . . . 1.28 113.485 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' HD12 ' A' ' 12' ' ' LEU . 11.3 m -62.51 143.74 56.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.841 0.353 . . . . 1.07 110.414 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 65.7 mttm -116.46 126.96 54.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.088 -0.505 . . . . 1.84 110.713 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' THR . 97.1 t -109.58 136.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.524 -0.547 . . . . 0.41 109.524 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.65 ' HB3' HG21 ' A' ' 6' ' ' VAL . 2.5 m-70 -123.34 127.43 48.49 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.366 -0.534 . . . . 0.67 110.418 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.46 115.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.555 -1.276 . . . . 0.81 107.555 171.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HE1' ' HG3' ' A' ' 3' ' ' MET . 91.0 m-85 -94.93 164.41 12.92 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.273 -0.421 . . . . 0.64 111.248 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 54.1 mttm -60.53 -26.25 66.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.931 0.492 . . . . 2.87 112.26 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -91.07 3.56 54.42 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.653 0.739 . . . . 1.97 109.07 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.08 -2.02 81.01 Favored Glycine 0 N--CA 1.427 -1.919 0 CA-C-N 114.562 -1.199 . . . . 0.58 113.589 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -81.05 173.35 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.332 0.566 . . . . 1.74 110.792 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 3.7 mpp? -134.43 138.64 44.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.498 -0.773 . . . . 1.07 109.627 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.55 134.22 9.89 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.096 -0.802 . . . . 0.39 111.096 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' SER . 1.7 tmt? -113.73 134.63 54.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.811 0.339 . . . . 0.87 110.211 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 35.8 mt-10 -126.49 148.52 49.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 1.14 109.294 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.588 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.2 p-10 -85.95 171.33 11.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.678 -0.49 . . . . 1.41 109.678 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.598 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 37.3 pttt -59.18 5.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.982 1.104 . . . . 1.77 113.982 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.1 m-85 -113.05 3.28 16.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.306 0.574 . . . . 1.08 109.711 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.36 23.56 65.2 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.54 113.711 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.588 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -112.55 144.86 41.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.333 -0.547 . . . . 3.25 110.48 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 28' ' ' MET . 24.9 t -78.83 136.69 37.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.203 -0.908 . . . . 1.55 111.553 -173.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.6 mtm -133.62 175.04 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.05 -0.722 . . . . 1.38 109.05 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -96.19 140.49 30.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.9 0.381 . . . . 2.78 110.618 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -95.52 121.6 61.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.828 -0.624 . . . . 1.32 110.953 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.547 ' HG2' ' HG3' ' A' ' 42' ' ' LYS . 59.3 Cg_endo -75.18 125.23 9.07 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.407 2.071 . . . . 1.24 112.299 176.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.512 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 43.9 tt0 -66.72 142.0 57.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.15 110.606 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.04 -2.85 51.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.862 -0.685 . . . . 0.68 112.835 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HG3' ' HG2' ' A' ' 39' ' ' PRO . 11.7 mmpt? -100.8 122.73 43.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.749 -0.265 . . . . 2.3 111.384 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.644 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.84 124.59 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.678 0.751 . . . . 0.93 109.084 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtt -116.6 148.32 41.04 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.359 -0.837 . . . . 1.31 109.257 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -102.85 155.95 17.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.981 0.42 . . . . 1.64 110.587 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.6 p -104.24 163.42 12.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 0.53 110.951 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.948 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 1.7 ptt180 -50.12 -30.03 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.686 0.995 . . . . 3.73 113.686 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.49 -31.06 16.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.461 -0.336 . . . . 2.7 111.318 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.92 19.64 1.58 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.164 -1.017 . . . . 0.77 113.299 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.2 m -100.38 160.02 14.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 1.35 109.072 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -117.08 139.07 51.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.713 0.292 . . . . 1.84 110.589 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.824 HG22 ' HD3' ' A' ' 61' ' ' ARG . 17.1 pt -132.89 158.39 43.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.146 -0.479 . . . . 0.66 109.719 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.686 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -158.28 143.15 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.252 0.548 . . . . 0.98 111.765 175.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.452 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.1 ttt -90.96 112.62 24.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.489 -0.93 . . . . 1.5 108.489 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 50.9 tptt -145.13 130.25 18.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.198 -0.456 . . . . 1.69 110.059 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.7 40.43 37.6 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.132 -0.556 . . . . 1.21 112.559 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.14 31.74 20.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.456 0.646 . . . . 2.9 110.402 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -149.27 175.81 11.08 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.722 -0.844 . . . . 1.66 108.722 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -126.77 134.98 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.704 0.764 . . . . 0.92 111.158 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -93.81 131.4 39.23 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.855 -1.066 . . . . 0.71 108.748 171.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.824 ' HD3' HG22 ' A' ' 52' ' ' ILE . 14.8 tpt85 -157.12 100.42 1.86 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 104.56 -2.385 . . . . 3.56 104.56 170.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.9 mm? . . . . . 0 CA--C 1.516 -0.357 0 CA-C-N 118.677 0.671 . . . . 1.4 111.117 -174.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 31.8 mmt . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.857 0.36 . . . . 2.17 110.741 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 m -71.59 -27.25 63.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.814 0.816 . . . . 1.47 110.191 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.505 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -115.13 17.76 16.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.597 -1.183 . . . . 1.89 111.238 -174.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 19' ' ' HIS . 76.3 t -111.79 115.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.666 -0.697 . . . . 1.25 109.974 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 20' ' ' VAL . 2.8 p -90.71 -18.54 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.575 -0.738 . . . . 1.03 110.578 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -167.23 130.09 1.73 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.482 0.658 . . . . 1.41 110.782 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 6' ' ' VAL . 83.7 m -108.35 145.81 33.92 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.646 -1.161 . . . . 0.4 109.935 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HE2' ' HD3' ' A' ' 61' ' ' ARG . 26.7 m-85 -123.91 133.23 53.78 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 121.743 0.783 . . . . 1.06 111.384 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.674 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -101.53 122.71 44.32 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.024 -1.444 . . . . 1.94 109.071 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.587 HD12 ' HB2' ' A' ' 16' ' ' SER . 41.0 mt -83.46 151.24 25.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.898 -1.046 . . . . 1.5 108.487 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 47' ' ' ARG . 75.8 mt-30 -66.69 -8.16 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.643 0.735 . . . . 1.68 111.355 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 3.9 t70 -87.14 -23.14 24.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.051 -0.977 . . . . 2.11 109.378 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.566 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 115.34 -25.2 9.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.758 -1.11 . . . . 1.28 111.699 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.587 ' HB2' HD12 ' A' ' 12' ' ' LEU . 49.5 m -66.53 157.13 33.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.97 0.414 . . . . 1.07 110.234 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -125.51 147.41 49.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.243 0.544 . . . . 1.84 112.056 -171.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.95 148.59 24.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.993 -1.003 . . . . 0.41 108.487 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.552 ' HB3' HG13 ' A' ' 6' ' ' VAL . 12.8 m-70 -135.06 137.15 42.63 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.254 -0.579 . . . . 0.67 109.923 172.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 7' ' ' VAL . 49.7 t -95.52 109.41 22.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 106.573 -1.64 . . . . 0.81 106.573 166.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.57 155.82 29.48 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.37 -0.832 . . . . 0.64 110.714 -171.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 47.7 mtpt -68.85 -18.53 64.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.68 0.752 . . . . 2.87 110.217 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.43 -6.22 59.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.571 -1.195 . . . . 1.97 108.056 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.23 6.3 71.51 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 113.986 -1.461 . . . . 0.58 112.995 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -86.75 177.44 7.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.297 0.57 . . . . 1.74 110.653 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.961 ' HG2' HD12 ' A' ' 59' ' ' ILE . 4.5 mpp? -139.91 140.21 36.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.122 -0.945 . . . . 1.07 109.221 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.78 151.2 21.91 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.252 -0.975 . . . . 0.39 112.242 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 ttt -122.05 142.28 50.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.999 0.428 . . . . 0.87 110.746 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 34.5 mt-10 -130.68 151.47 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.013 -1.106 . . . . 1.14 108.013 175.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 32' ' ' PHE . 27.4 p-10 -84.6 167.71 16.01 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.41 109.657 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.566 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 15.0 pttm -50.9 4.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.868 1.433 . . . . 1.77 114.868 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.3 m-85 -122.96 2.82 9.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.255 -0.278 . . . . 1.08 111.155 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.39 27.61 43.03 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.479 -0.867 . . . . 0.54 112.964 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 25.7 mmmt -100.85 130.09 46.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.717 0.77 . . . . 3.25 110.247 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -80.82 127.55 32.66 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.152 -1.386 . . . . 1.55 112.593 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 65.4 mtm -127.63 -171.96 2.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.58 -0.736 . . . . 1.38 109.431 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -97.86 156.01 16.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.885 -0.413 . . . . 2.78 109.885 176.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.457 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 17.4 tpt -82.81 122.77 78.38 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 1.32 110.809 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 69.5 Cg_endo -79.13 117.83 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.517 2.144 . . . . 1.24 112.841 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -87.64 139.54 30.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.624 -0.716 . . . . 1.15 110.447 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.62 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 108.13 -9.37 36.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.988 -0.625 . . . . 0.68 113.284 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 42' ' ' LYS . 29.4 mtpp -109.64 131.19 55.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.242 0.46 . . . . 2.3 112.242 -175.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.638 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.5 p -100.91 131.18 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.136 -0.69 . . . . 0.93 109.136 170.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.4 mtm -135.16 173.12 12.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.812 -0.631 . . . . 1.31 109.927 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -107.12 164.75 11.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.308 1.051 . . . . 1.64 112.259 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -108.85 162.35 14.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.359 -1.746 . . . . 0.53 108.93 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.674 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 75.9 mtp180 -55.47 -23.52 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.233 0.457 . . . . 3.73 112.233 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.43 -2.99 37.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.323 . . . . 2.7 111.091 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.24 23.9 13.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.547 -0.835 . . . . 0.77 113.326 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.753 HG23 HD23 ' A' ' 62' ' ' LEU . 64.4 m -95.04 137.08 34.57 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.773 -0.251 . . . . 1.35 110.431 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -99.59 127.98 45.69 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.044 -0.354 . . . . 1.84 110.044 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 18.8 pt -135.09 155.07 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.984 -0.553 . . . . 0.66 110.685 -176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -157.35 149.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.922 0.391 . . . . 0.98 110.41 174.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.3 ttt -108.19 118.73 37.52 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.073 -1.084 . . . . 1.5 108.073 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.62 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 23.9 tptp -144.68 135.52 24.83 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.203 -0.665 . . . . 1.69 109.203 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.83 32.12 82.69 Favored Glycine 0 C--N 1.322 -0.212 0 C-N-CA 121.018 -0.61 . . . . 1.21 112.647 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.81 19.6 11.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.232 0.539 . . . . 2.9 111.31 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.74 152.56 39.3 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.593 -0.73 . . . . 1.66 109.276 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.961 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -114.22 127.86 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.62 0.724 . . . . 0.92 111.889 177.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.621 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -96.06 130.81 42.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.728 -1.212 . . . . 0.71 107.728 167.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.557 ' HD3' ' HE2' ' A' ' 10' ' ' TYR . 7.8 ptt180 -156.46 100.39 1.96 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.047 -1.834 . . . . 3.56 106.047 173.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.753 HD23 HG23 ' A' ' 50' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 109.002 -0.74 . . . . 1.4 109.002 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 C--O 1.231 0.082 0 N-CA-C 112.108 0.41 . . . . 2.17 112.108 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -78.34 -33.01 49.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.453 . . . . 1.47 110.449 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.617 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -97.79 1.81 48.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 1.89 110.696 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.405 HG23 ' ND2' ' A' ' 5' ' ' ASN . 77.7 t -94.03 130.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 1.25 110.204 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 20' ' ' VAL . 20.2 m -93.3 -25.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.465 -0.494 . . . . 1.03 111.918 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -164.16 142.61 7.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 1.41 110.489 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 53.4 m -125.05 140.84 52.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.226 -0.443 . . . . 0.4 110.458 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 36.2 m-85 -112.38 128.83 56.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.693 0.759 . . . . 1.06 112.001 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -102.15 114.9 29.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.717 -1.583 . . . . 1.94 109.826 -178.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' A' ' 13' ' ' GLN . 6.6 mt -75.22 -0.8 20.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.352 1.242 . . . . 1.5 114.352 -168.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.656 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 56.9 mt-30 90.84 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.672 0.789 . . . . 1.68 110.17 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.58 -28.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.412 -0.959 . . . . 2.11 108.412 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.693 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 140.24 -22.66 2.74 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.42 -1.264 . . . . 1.28 113.57 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.623 ' HB3' HD12 ' A' ' 12' ' ' LEU . 23.0 t -64.39 141.89 58.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.772 0.796 . . . . 1.07 110.456 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -120.78 126.72 50.84 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.201 -1.363 . . . . 1.84 110.297 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 9' ' ' THR . 86.3 t -112.69 126.25 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.437 -0.801 . . . . 0.41 109.041 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 26' ' ' MET . 11.9 m-70 -115.62 128.7 56.13 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.565 -0.854 . . . . 0.67 109.733 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.496 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 46.3 t -90.33 112.55 24.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 106.737 -1.579 . . . . 0.81 106.737 172.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -88.16 161.8 17.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.857 -0.61 . . . . 0.64 110.614 -173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 8.1 mtpm? -61.02 -26.35 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.331 0.586 . . . . 2.87 111.28 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.08 -7.2 59.68 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.162 -0.926 . . . . 1.97 108.836 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.62 -0.99 68.33 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.573 -1.194 . . . . 0.58 113.172 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -85.82 179.68 7.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.309 0.576 . . . . 1.74 110.775 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.747 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 59.5 mtm -143.15 148.1 36.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.955 -1.021 . . . . 1.07 110.381 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.12 135.28 8.74 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.228 -0.896 . . . . 0.39 111.052 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 35' ' ' SER . 26.8 ttt -111.05 126.61 55.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.082 -0.34 . . . . 0.87 110.082 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 48.6 mt-10 -128.11 155.83 43.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.662 -0.866 . . . . 1.14 108.662 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 39.4 p30 -91.79 175.32 6.93 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.418 -0.513 . . . . 1.41 110.238 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.693 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 4.4 pttm -51.53 -11.45 0.13 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.604 0.964 . . . . 1.77 113.604 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -105.28 -5.02 20.93 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.321 -0.237 . . . . 1.08 111.179 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.41 25.38 28.43 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.798 -0.715 . . . . 0.54 112.417 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 26.3 mmtp -108.68 137.66 46.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.324 0.583 . . . . 3.25 111.845 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 28' ' ' MET . 47.3 t -71.97 131.33 42.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.438 -1.255 . . . . 1.55 111.266 -175.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 64.0 mtm -126.04 177.03 6.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 1.38 109.45 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -97.82 127.11 43.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.895 -0.409 . . . . 2.78 109.895 179.042 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.456 ' HE2' ' HB2' ' A' ' 54' ' ' MET . 23.9 ttt -83.01 126.18 73.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.855 -0.611 . . . . 1.32 111.044 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.68 153.32 38.54 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.999 2.466 . . . . 1.24 112.88 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.5 tt0 -112.51 141.89 45.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 1.15 109.983 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.03 2.84 64.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.43 -0.89 . . . . 0.68 112.603 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -109.58 138.73 45.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.585 0.231 . . . . 2.3 111.38 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 59.4 t -90.0 119.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.513 -0.551 . . . . 0.93 109.513 171.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -109.74 154.0 23.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 1.31 110.303 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -104.26 155.61 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.546 0.689 . . . . 1.64 111.517 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 47.8 p -111.32 156.83 20.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.28 -1.327 . . . . 0.53 109.869 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.536 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 47.8 mtp180 -57.53 -21.89 41.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.798 0.296 . . . . 3.73 111.798 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -89.99 -3.39 58.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 2.7 110.84 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 26.9 25.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.73 -0.748 . . . . 0.77 113.669 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.2 p -108.19 159.69 16.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.331 0.566 . . . . 1.35 110.038 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -111.01 135.72 51.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.244 -0.435 . . . . 1.84 109.953 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.563 HG22 ' CG ' ' A' ' 61' ' ' ARG . 8.8 pt -132.17 165.98 30.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 0.66 111.067 -173.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.678 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -159.44 142.22 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.342 -0.39 . . . . 0.98 110.974 167.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.456 ' HB2' ' HE2' ' A' ' 38' ' ' MET . 17.1 tmm? -95.62 120.71 36.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.922 -1.14 . . . . 1.5 107.922 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.6 tptt -137.43 112.5 9.08 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.323 -0.621 . . . . 1.69 109.323 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 67.26 52.2 33.19 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.811 -0.631 . . . . 1.21 112.61 -176.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 73.99 -35.24 0.3 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.818 0.847 . . . . 2.9 111.796 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' GLY . 43.1 mt-10 -78.92 156.27 28.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.106 -0.497 . . . . 1.66 110.841 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.747 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -113.79 129.69 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.47 0.652 . . . . 0.92 109.681 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.678 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -93.91 112.93 24.85 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.874 -0.787 . . . . 0.71 108.874 169.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.68 ' HD3' HD23 ' A' ' 62' ' ' LEU . 2.7 tmt_? -140.29 103.75 4.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.442 -2.059 . . . . 3.56 105.442 160.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.68 HD23 ' HD3' ' A' ' 61' ' ' ARG . 3.5 mm? . . . . . 0 N--CA 1.471 0.603 0 CA-C-N 118.607 0.639 . . . . 1.4 111.658 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.478 ' HA ' HG12 ' A' ' 6' ' ' VAL . 36.5 mtp . . . . . 0 N--CA 1.442 -0.837 0 CA-C-O 121.544 0.688 . . . . 2.17 109.76 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -92.8 -45.07 8.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.042 . . . . 1.47 110.704 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.42 -5.54 35.97 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.321 0.582 . . . . 1.89 110.891 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.9 p -86.81 125.36 40.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.68 -0.808 . . . . 1.25 109.932 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.87 -23.42 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 1.03 111.001 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -167.5 133.21 2.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.43 0.633 . . . . 1.41 111.2 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.41 HG23 ' ND1' ' A' ' 19' ' ' HIS . 2.3 m -111.63 139.78 46.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.946 -1.025 . . . . 0.4 109.635 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -115.14 129.66 56.72 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.227 1.013 . . . . 1.06 111.727 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -100.73 124.49 46.42 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.14 -1.845 . . . . 1.94 108.176 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.897 HD22 ' HB2' ' A' ' 16' ' ' SER . 10.2 mp -77.68 4.78 10.68 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.455 -0.793 . . . . 1.5 112.231 -174.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.722 ' HG3' ' HD2' ' A' ' 47' ' ' ARG . 25.2 tt0 82.36 -26.99 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.127 0.489 . . . . 1.68 110.315 167.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -103.39 -49.58 3.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.572 -0.74 . . . . 2.11 110.149 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.634 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . -166.32 -52.58 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.366 -1.397 . . . . 1.28 115.301 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.897 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.2 m -70.86 161.95 30.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.327 0.564 . . . . 1.07 111.163 -171.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -129.6 145.98 51.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 1.84 110.772 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.635 HG23 HD11 ' A' ' 12' ' ' LEU . 48.6 t -122.34 145.38 29.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.433 -0.951 . . . . 0.41 108.433 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.678 ' HB3' HG21 ' A' ' 6' ' ' VAL . 3.0 m-70 -135.55 134.05 39.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.804 -0.759 . . . . 0.67 110.969 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.93 114.97 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.204 -1.406 . . . . 0.81 107.204 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 95.2 m-85 -91.73 159.56 15.78 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.974 -0.557 . . . . 0.64 110.524 -171.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -68.97 -18.66 64.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.512 0.672 . . . . 2.87 110.053 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD2' ' HE3' ' A' ' 25' ' ' LYS . 26.2 t70 -79.22 -7.95 58.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.812 -1.181 . . . . 1.97 107.812 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.07 -5.86 75.82 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.74 -1.573 . . . . 0.58 113.257 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HE3' ' OD2' ' A' ' 23' ' ' ASP . 9.4 mtmp? -80.3 175.4 10.68 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.413 0.625 . . . . 1.74 111.479 177.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.582 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.3 mpp? -136.2 138.03 41.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.78 -1.1 . . . . 1.07 109.572 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.42 142.36 13.74 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.39 111.854 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.705 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 23.6 ttt -118.54 142.86 47.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.961 0.41 . . . . 0.87 111.099 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 19.5 mt-10 -128.53 147.71 50.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.802 -0.814 . . . . 1.14 108.802 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.499 ' HB3' ' SD ' ' A' ' 36' ' ' MET . 41.6 p30 -87.54 172.34 9.83 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.574 -0.451 . . . . 1.41 110.294 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.634 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.4 ptpt -51.75 -16.73 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.418 0.896 . . . . 1.77 113.418 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.61 -4.43 50.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.721 0.296 . . . . 1.08 110.543 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.67 20.86 49.68 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.902 -0.666 . . . . 0.54 111.827 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.7 mmtm -106.69 139.52 41.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.419 0.628 . . . . 3.25 111.756 -176.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 p -70.25 131.84 44.81 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.516 -1.22 . . . . 1.55 110.549 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.499 ' SD ' ' HB3' ' A' ' 30' ' ' ASN . 19.4 ptm -153.47 174.65 14.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.304 -0.407 . . . . 1.38 110.83 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -123.55 140.89 52.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.745 -0.661 . . . . 2.78 109.562 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.705 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 22.3 ptt? -100.45 150.42 36.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.179 -0.464 . . . . 1.32 110.565 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.84 142.06 50.97 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.825 2.35 . . . . 1.24 112.221 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 29.7 tt0 -71.35 136.6 47.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 1.15 109.833 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -16.04 27.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.362 -0.923 . . . . 0.68 113.459 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -97.31 132.17 43.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.122 0.461 . . . . 2.3 111.756 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.605 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.8 p -99.41 133.92 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.861 -0.608 . . . . 0.93 110.159 174.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.94 151.4 32.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.807 -0.633 . . . . 1.31 109.946 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -94.78 145.73 24.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.678 -0.49 . . . . 1.64 109.678 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -115.96 159.95 20.9 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.82 -0.627 . . . . 0.53 111.057 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.722 ' HD2' ' HG3' ' A' ' 13' ' ' GLN . 18.0 mmm180 -49.13 -28.03 3.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.593 0.757 . . . . 3.73 112.901 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.67 -6.89 59.44 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.567 -0.742 . . . . 2.7 111.363 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.32 58.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.385 -0.912 . . . . 0.77 111.396 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.71 174.42 5.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.208 -0.496 . . . . 1.35 110.392 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 71.3 mmtt -119.24 148.18 43.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.417 -0.356 . . . . 1.84 110.142 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.51 152.39 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 0.66 110.565 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.632 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -159.21 153.95 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.302 -0.408 . . . . 0.98 110.167 176.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.506 ' N ' HG12 ' A' ' 53' ' ' ILE . 56.7 ttp -108.51 109.09 20.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.775 -0.824 . . . . 1.5 108.775 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 51.7 tptt -127.42 131.14 50.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.266 -0.642 . . . . 1.69 109.266 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.99 73.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.831 -0.699 . . . . 1.21 111.859 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.26 27.21 16.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.479 0.657 . . . . 2.9 110.112 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 54' ' ' MET . 47.4 mt-10 -123.84 147.6 47.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.536 -0.756 . . . . 1.66 109.36 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.582 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -93.67 118.89 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 122.095 0.95 . . . . 0.92 111.152 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -84.34 116.12 22.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.397 -1.274 . . . . 0.71 108.152 168.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.494 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 19.5 tpt180 -114.94 102.28 9.82 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 106.604 -1.628 . . . . 3.56 106.604 169.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.072 0 O-C-N 125.089 1.493 . . . . 1.4 113.179 -163.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 N--CA 1.46 0.034 0 N-CA-C 112.177 0.436 . . . . 2.17 112.177 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -87.68 -35.21 18.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.801 0.334 . . . . 1.47 111.309 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.452 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -105.42 3.13 29.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 1.89 111.846 -169.047 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 19' ' ' HIS . 10.4 p -106.62 135.9 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.014 -0.539 . . . . 1.25 111.493 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.453 HG23 HG13 ' A' ' 20' ' ' VAL . 14.6 m -94.17 -30.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.989 0.423 . . . . 1.03 111.701 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -157.21 138.17 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.389 0.614 . . . . 1.41 110.917 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 1.4 m -119.47 138.54 53.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.294 -0.866 . . . . 0.4 110.083 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 24.4 m-85 -108.9 125.66 52.25 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.738 0.78 . . . . 1.06 111.487 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 71.7 m-20 -98.57 115.35 28.42 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.037 -1.438 . . . . 1.94 110.501 -176.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 16' ' ' SER . 10.2 mt -81.2 149.75 28.93 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.691 -0.855 . . . . 1.5 108.691 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -60.7 -19.44 58.69 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.794 0.665 . . . . 1.68 112.794 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.6 -26.24 23.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 2.11 109.646 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.07 -15.41 6.5 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.277 -0.874 . . . . 1.28 112.284 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.623 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -58.03 140.19 52.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.861 -0.792 . . . . 1.07 108.861 176.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.487 ' HG2' ' CE1' ' A' ' 19' ' ' HIS . 24.4 ttmm -125.35 124.22 41.07 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.024 0.44 . . . . 1.84 110.613 -171.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 47.0 t -109.17 151.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.95 -0.759 . . . . 0.41 108.95 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -141.29 137.37 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.153 -0.619 . . . . 0.67 110.924 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.597 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 7.2 p -102.8 125.39 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 0.81 108.03 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.426 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . 71.3 m-85 -93.1 161.59 14.37 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.155 -0.929 . . . . 0.64 111.883 -168.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -67.04 -20.48 65.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.621 -0.718 . . . . 2.87 110.966 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.452 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 29.0 t70 -83.73 -6.05 59.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.153 0.978 . . . . 1.97 108.527 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.79 0.98 68.35 Favored Glycine 0 N--CA 1.427 -1.939 0 CA-C-N 114.287 -1.324 . . . . 0.58 112.718 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 23' ' ' ASP . 31.3 pttt -91.56 179.73 5.58 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.597 -0.149 . . . . 1.74 110.597 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.847 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mtm -141.62 153.89 45.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.742 0.306 . . . . 1.07 110.192 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.63 147.24 18.9 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.558 -0.617 . . . . 0.39 111.558 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.0 ttt -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.293 0.568 . . . . 0.87 111.148 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.4 mt-10 -128.15 157.17 41.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.796 -0.816 . . . . 1.14 108.796 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.444 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 35.3 p-10 -91.51 173.11 8.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.093 -0.336 . . . . 1.41 110.093 174.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.639 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 43.2 pttt -55.92 5.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.409 1.263 . . . . 1.77 114.409 175.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.444 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 97.0 m-85 -115.91 1.18 13.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.018 0.437 . . . . 1.08 110.196 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.25 21.52 62.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.616 -0.802 . . . . 0.54 111.648 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 67.7 mmtt -103.62 131.53 50.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.377 0.608 . . . . 3.25 110.706 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.3 t -67.42 133.76 50.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.434 -1.257 . . . . 1.55 110.597 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.8 ptm -143.46 160.17 41.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.934 -0.576 . . . . 1.38 110.323 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.78 147.59 39.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.193 -0.458 . . . . 2.78 110.213 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.33 130.82 22.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 1.32 110.67 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.41 160.0 29.07 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.933 2.422 . . . . 1.24 112.963 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 54' ' ' MET . 35.1 tt0 -118.89 145.59 45.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.248 -0.433 . . . . 1.15 110.551 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.57 4.26 68.09 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.68 113.009 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.77 138.44 48.35 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.923 -0.163 . . . . 2.3 110.762 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 63.1 t -87.94 120.42 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.831 -0.433 . . . . 0.93 109.831 172.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -106.79 149.84 26.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.741 -0.663 . . . . 1.31 109.788 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -109.68 148.45 31.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.131 0.967 . . . . 1.64 112.208 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 46.0 p -97.72 168.54 10.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.872 -1.513 . . . . 0.53 109.966 -175.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.426 ' HE ' ' CB ' ' A' ' 11' ' ' ASP . 9.2 ptt85 -59.93 -21.96 61.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.971 0.891 . . . . 3.73 110.976 170.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.22 -13.72 49.02 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.025 -1.443 . . . . 2.7 110.984 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.39 53.06 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.684 -0.77 . . . . 0.77 111.993 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.87 153.62 19.34 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.955 -0.387 . . . . 1.35 109.955 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -112.18 129.3 56.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.979 -0.555 . . . . 1.84 109.753 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.702 HG22 ' HG2' ' A' ' 61' ' ' ARG . 1.8 pt -129.87 164.97 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.333 -0.394 . . . . 0.66 110.08 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.497 HG22 ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -164.63 143.14 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.062 0.458 . . . . 0.98 111.336 173.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.45 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 21.6 ttt -99.87 134.1 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 1.5 110.112 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -145.7 121.89 10.83 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.775 -0.454 . . . . 1.69 109.775 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.61 52.67 51.68 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.202 -0.523 . . . . 1.21 113.529 177.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.69 -13.27 0.49 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.81 0.444 . . . . 2.9 112.054 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' GLY . 44.1 mt-10 -96.96 148.84 22.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.206 -0.294 . . . . 1.66 110.206 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.847 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -115.96 124.45 72.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.58 0.705 . . . . 0.92 109.694 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -84.83 128.33 34.56 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.833 0.825 . . . . 0.71 109.102 171.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.702 ' HG2' HG22 ' A' ' 52' ' ' ILE . 2.3 tmm_? -158.23 102.41 1.77 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 103.863 -2.643 . . . . 3.56 103.863 170.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.1 mm? . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 119.312 0.96 . . . . 1.4 110.816 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.863 0.364 . . . . 2.17 111.553 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.2 m -89.7 -35.4 15.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.286 -0.416 . . . . 1.47 111.215 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.502 ' HB2' ' HD3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -91.9 11.26 25.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.886 0.851 . . . . 1.89 109.608 -177.188 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 19' ' ' HIS . 57.6 t -108.64 106.85 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.223 -1.353 . . . . 1.25 108.768 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.95 -12.63 11.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.641 -0.709 . . . . 1.03 110.993 -173.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -163.86 139.55 6.38 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.798 -0.637 . . . . 1.41 110.564 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 m -119.23 138.37 53.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.373 -0.83 . . . . 0.4 110.056 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 21.3 m-85 -108.84 123.14 48.58 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.934 0.874 . . . . 1.06 110.958 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.554 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -91.71 113.24 25.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.382 -1.735 . . . . 1.94 110.406 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.78 HD12 ' HB2' ' A' ' 16' ' ' SER . 45.2 mt -85.47 144.5 27.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.678 -0.86 . . . . 1.5 108.678 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 8.0 tt0 -72.84 -0.9 14.74 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.497 0.554 . . . . 1.68 112.497 -170.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -98.44 -16.5 19.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.406 0.622 . . . . 2.11 109.666 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 124.49 -21.39 6.78 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.06 -0.973 . . . . 1.28 112.44 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.78 ' HB2' HD12 ' A' ' 12' ' ' LEU . 25.5 m -70.29 158.1 36.5 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.118 0.485 . . . . 1.07 110.848 -176.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 57.7 mttt -125.19 149.88 47.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.335 -0.393 . . . . 1.84 110.896 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 60.8 t -129.79 122.3 54.4 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.13 -0.693 . . . . 0.41 109.13 173.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 26' ' ' MET . 54.1 m-70 -108.8 132.0 54.42 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.161 -1.016 . . . . 0.67 110.114 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.82 102.08 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 106.47 -1.678 . . . . 0.81 106.47 168.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.71 155.53 38.86 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.262 -0.881 . . . . 0.64 110.694 -172.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HD3' ' HB2' ' A' ' 5' ' ' ASN . 19.5 pttm -51.63 -32.33 28.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.177 -0.919 . . . . 2.87 112.04 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 2.7 p-10 -97.75 10.17 40.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.61 0.719 . . . . 1.97 109.432 -171.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.89 4.68 72.02 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 114.872 -1.058 . . . . 0.58 114.586 172.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -87.68 175.94 7.65 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.124 0.962 . . . . 1.74 111.095 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 4.2 mpp? -140.36 141.72 35.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.888 -1.051 . . . . 1.07 110.339 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.03 146.65 18.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.37 -0.832 . . . . 0.39 111.336 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 24.7 ttt -114.62 129.01 56.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.261 0.553 . . . . 0.87 111.061 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.0 mt-10 -110.0 147.13 34.09 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.159 -1.052 . . . . 1.14 108.159 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.779 ' H ' ' HB2' ' A' ' 34' ' ' LYS . 63.8 t30 -92.05 162.68 14.27 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.742 -1.207 . . . . 1.41 107.742 170.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.629 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 22.3 ptmt -50.72 -20.68 1.31 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.363 0.875 . . . . 1.77 113.363 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 21.9 m-85 -96.52 -6.74 36.35 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.941 -0.475 . . . . 1.08 110.905 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.82 38.73 3.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.826 -0.702 . . . . 0.54 112.807 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.779 ' HB2' ' H ' ' A' ' 30' ' ' ASN . 24.4 mmtt -43.91 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.657 0.614 . . . . 3.25 112.657 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 34' ' ' LYS . 36.5 t 89.09 68.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.233 0.958 . . . . 1.55 109.073 175.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 34' ' ' LYS . 31.6 mtm -119.76 -171.46 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.309 -1.314 . . . . 1.38 109.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -98.07 157.74 15.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.506 0.193 . . . . 2.78 110.695 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.513 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 16.7 tpt -80.24 125.16 81.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.229 -0.441 . . . . 1.32 111.173 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 70.7 Cg_endo -76.37 153.9 35.75 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.615 2.21 . . . . 1.24 112.707 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 38.2 tt0 -94.23 144.13 25.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 1.15 111.359 -177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.98 57.65 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.171 -0.538 . . . . 0.68 113.591 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.3 mtpt -90.99 119.36 31.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.076 0.438 . . . . 2.3 111.632 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.638 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 14.5 p -91.85 126.75 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.331 -0.618 . . . . 0.93 109.331 171.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 68.9 mtm -124.17 154.97 39.3 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.22 -0.659 . . . . 1.31 109.22 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.47 149.68 23.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.087 0.946 . . . . 1.64 112.408 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 47.2 p -103.13 162.09 13.25 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.726 -1.579 . . . . 0.53 110.221 -176.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 80.3 mtm180 -59.52 -19.42 48.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 3.73 110.971 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.09 -24.47 43.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 2.7 111.12 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.06 21.17 12.16 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.77 111.289 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.0 m -115.83 160.81 19.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.545 -0.539 . . . . 1.35 109.545 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.19 144.88 43.02 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.297 -0.261 . . . . 1.84 110.297 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.8 pt -136.84 150.76 26.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 120.439 0.161 . . . . 0.66 111.428 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.675 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.96 149.46 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 0.98 109.719 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.5 ttt -112.29 133.71 54.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.074 -0.343 . . . . 1.5 110.074 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.578 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.2 tptp -142.32 127.68 18.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.571 -0.286 . . . . 1.69 110.583 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 73.15 -28.81 0.8 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 115.244 0.857 . . . . 1.21 115.244 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 56' ' ' GLY . 8.7 t30 150.39 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.584 0.754 . . . . 2.9 109.058 -165.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -97.94 144.71 27.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.293 -0.867 . . . . 1.66 111.796 -171.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.36 124.31 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.019 0.914 . . . . 0.92 111.473 176.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.5 128.31 34.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.644 -1.162 . . . . 0.71 108.743 170.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.531 ' HD2' ' OH ' ' A' ' 10' ' ' TYR . 52.2 ttt-85 -125.28 126.54 45.29 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.14 -1.8 . . . . 3.56 106.14 162.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.268 0 O-C-N 125.176 1.548 . . . . 1.4 113.288 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 73.4 t . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 110.334 -0.247 . . . . 2.46 110.334 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 67.27 108.56 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 123.912 0.758 . . . . 3.48 110.224 -175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.445 ' HA ' HG12 ' A' ' 6' ' ' VAL . 76.5 mmm -80.62 0.44 34.12 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.145 0.498 . . . . 2.17 110.688 -176.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -91.45 -23.82 19.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.857 -0.611 . . . . 1.47 111.006 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.541 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -109.44 7.77 25.05 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 120.526 -0.47 . . . . 1.89 111.399 -176.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.8 p -108.47 128.9 63.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.32 -0.4 . . . . 1.25 110.991 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.48 HG13 ' HG2' ' A' ' 22' ' ' LYS . 4.7 m -81.77 -27.85 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.214 -0.448 . . . . 1.03 111.094 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -167.35 134.31 2.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.179 0.514 . . . . 1.41 110.582 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -108.22 137.25 46.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.26 -0.882 . . . . 0.4 109.943 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.656 ' CD1' HG21 ' A' ' 46' ' ' THR . 1.4 m-85 -110.61 127.29 55.18 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.348 -0.842 . . . . 1.06 111.133 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -100.09 119.25 38.01 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.711 178.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 9.4 mp -80.5 149.56 29.99 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.998 -1.001 . . . . 1.5 109.581 -175.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -65.55 -11.83 47.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.663 0.744 . . . . 1.68 110.595 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -90.46 -16.49 28.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.829 -1.078 . . . . 2.11 109.702 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.542 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 110.49 -22.19 22.63 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.803 -1.09 . . . . 1.28 112.223 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.587 ' HB2' HD22 ' A' ' 12' ' ' LEU . 19.6 m -67.71 161.92 24.9 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.071 -0.714 . . . . 1.07 109.071 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -133.81 146.53 50.76 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.43 0.529 . . . . 1.84 112.43 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.643 HG23 HD11 ' A' ' 12' ' ' LEU . 68.9 t -123.58 148.54 27.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.264 -0.88 . . . . 0.41 109.073 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.567 ' HB3' HG21 ' A' ' 6' ' ' VAL . 6.0 m-70 -134.46 130.4 36.67 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.317 -0.553 . . . . 0.67 109.995 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 40.4 t -93.5 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.922 -1.51 . . . . 0.81 106.922 171.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 81.2 m-85 -89.35 155.9 19.05 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.018 0.437 . . . . 0.64 111.236 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 40.1 mtpt -68.19 -12.0 60.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.705 -0.68 . . . . 2.87 110.563 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -90.76 -4.33 56.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.613 -0.884 . . . . 1.97 108.613 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.57 -12.61 64.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 114.875 -1.057 . . . . 0.58 114.766 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.1 -177.03 5.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 117.892 0.846 . . . . 1.74 110.824 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.79 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -140.31 145.61 37.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.726 -0.67 . . . . 1.07 109.76 -175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.07 136.74 9.76 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.861 -0.896 . . . . 0.39 110.861 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.485 ' HG2' ' SD ' ' A' ' 36' ' ' MET . 28.4 ttt -118.51 140.9 49.16 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.392 0.615 . . . . 0.87 110.957 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 33.1 mt-10 -130.66 154.88 47.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.116 -0.947 . . . . 1.14 108.831 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' C ' ' H ' ' A' ' 32' ' ' PHE . 32.0 p-10 -87.51 169.8 11.89 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.049 -0.352 . . . . 1.41 110.049 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 55.2 pttt -52.84 5.75 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.607 1.336 . . . . 1.77 114.607 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.465 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.7 m-85 -119.81 7.7 11.03 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 121.893 -0.504 . . . . 1.08 110.392 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.42 24.85 58.19 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.762 -0.732 . . . . 0.54 112.36 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 38.8 mmtm -114.02 136.98 52.32 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.693 0.758 . . . . 3.25 111.924 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 m -78.13 129.47 35.21 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.923 -1.49 . . . . 1.55 111.548 -171.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.485 ' SD ' ' HG2' ' A' ' 28' ' ' MET . 1.3 ppp? -148.12 153.52 38.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 1.38 110.18 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -67.25 141.12 57.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.43 . . . . 2.78 111.129 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.47 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 28.1 ttt -87.77 122.71 70.14 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.668 -0.696 . . . . 1.32 109.956 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.81 122.28 9.84 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.064 2.51 . . . . 1.24 112.446 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.6 tt0 -69.46 142.91 53.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.224 -0.444 . . . . 1.15 110.362 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.55 -11.1 73.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.516 -0.85 . . . . 0.68 112.862 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -99.75 123.32 43.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.922 0.391 . . . . 2.3 111.957 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.562 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.2 p -91.36 129.71 41.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.563 -0.744 . . . . 0.93 109.403 174.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 74.7 mtm -126.98 159.96 32.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.275 -0.421 . . . . 1.31 110.526 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -104.63 160.43 14.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.063 0.935 . . . . 1.64 112.429 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.659 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 50.6 p -113.95 165.25 12.79 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.006 -1.452 . . . . 0.53 109.732 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 15.4 ptt180 -65.35 -18.17 65.1 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.669 0.747 . . . . 3.73 110.966 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -90.99 -15.19 30.08 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.561 -1.2 . . . . 2.7 110.62 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.35 17.87 20.81 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.518 -0.848 . . . . 0.77 112.585 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -97.74 154.74 17.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.338 -0.616 . . . . 1.35 109.338 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -117.87 135.73 53.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.393 -0.595 . . . . 1.84 109.393 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.3 pt -136.24 157.99 38.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.671 -0.695 . . . . 0.66 110.92 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.694 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -157.11 148.87 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 0.98 110.486 174.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.554 ' N ' HG12 ' A' ' 53' ' ' ILE . 26.8 ttt -100.19 118.29 36.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.415 -0.957 . . . . 1.5 108.415 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 52.4 tptt -140.61 130.77 24.9 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.918 -0.401 . . . . 1.69 109.918 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 38.79 94.88 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.979 -0.555 . . . . 1.21 113.061 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.62 9.52 7.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.496 0.665 . . . . 2.9 110.425 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.61 -177.64 3.24 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.881 -0.599 . . . . 1.66 110.455 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.79 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -134.49 122.16 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 121.347 0.594 . . . . 0.92 110.192 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.694 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.06 117.07 22.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.079 -1.082 . . . . 0.71 108.079 171.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.497 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 42.9 ttt180 -112.65 100.89 9.07 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.594 -1.632 . . . . 3.56 106.594 168.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.5 OUTLIER 36.97 15.11 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.477 1.111 . . . . 1.4 112.919 -163.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB2' ' HD2' ' A' ' 60' ' ' PHE . 8.2 t70 63.66 -51.45 0.24 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.711 1.204 . . . . 2.14 113.353 -176.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' HA ' ' CB ' ' A' ' 67' ' ' ARG . 36.4 mt-10 -69.77 -15.54 63.15 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.359 0.503 . . . . 3.8 112.359 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.0 -25.77 63.75 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.84 0.829 . . . . 1.76 109.636 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 59' ' ' ILE . 11.1 mt -87.35 -31.24 20.25 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.661 -1.154 . . . . 2.36 109.304 174.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.477 ' CB ' ' HA ' ' A' ' 64' ' ' GLU . 75.0 ttt180 -59.39 -66.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.92 -1.036 . . . . 4.45 111.264 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -132.23 16.06 4.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.165 0.507 . . . . 5.92 111.178 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.78 24.35 31.35 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.837 -0.696 . . . . 5.06 112.528 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -86.15 110.07 19.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.102 0.477 . . . . 6.88 109.906 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 m -114.56 -22.16 9.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.693 -0.685 . . . . 8.52 111.298 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 64.2 88.21 0.1 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.576 0.703 . . . . 10.75 109.408 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.11 -101.79 1.15 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.097 -0.801 . . . . 11.62 111.097 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.346 -1.252 . . . . 12.99 111.769 178.215 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.673 HG21 ' CD2' ' A' ' 19' ' ' HIS . 20.6 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.629 0.252 . . . . 2.46 110.361 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.64 135.08 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.516 -0.55 . . . . 3.48 109.516 172.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.9 mtp -112.13 15.8 20.4 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.6 0.715 . . . . 2.17 110.544 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.6 t -90.26 -22.3 21.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.542 -0.753 . . . . 1.47 109.929 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.49 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -104.44 14.92 29.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.912 -0.585 . . . . 1.89 112.091 -177.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 11.6 p -101.24 137.38 29.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.954 -0.298 . . . . 1.25 111.348 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.59 HG13 ' HA ' ' A' ' 22' ' ' LYS . 27.5 m -83.6 -29.23 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.022 0.439 . . . . 1.03 110.064 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -168.48 130.6 1.37 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.602 0.715 . . . . 1.41 110.946 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 m -100.89 140.84 34.61 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.727 -1.124 . . . . 0.4 109.389 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.891 ' OH ' ' HD2' ' A' ' 61' ' ' ARG . 25.7 m-85 -121.4 134.14 55.1 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 121.967 0.889 . . . . 1.06 111.755 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.53 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 2.9 m-20 -96.47 120.96 37.73 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.613 -1.631 . . . . 1.94 108.853 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.632 HD12 ' HB2' ' A' ' 16' ' ' SER . 23.4 mt -78.99 146.12 33.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.414 -1.328 . . . . 1.5 107.414 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 47' ' ' ARG . 2.7 tt0 -66.17 -4.36 7.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.205 0.526 . . . . 1.68 111.925 -173.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -98.44 -17.81 18.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.495 -0.775 . . . . 2.11 110.326 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.07 -28.48 4.85 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.686 -0.688 . . . . 1.28 113.199 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.632 ' HB2' HD12 ' A' ' 12' ' ' LEU . 12.4 m -65.75 155.81 35.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.768 0.318 . . . . 1.07 110.77 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -124.0 129.81 51.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.908 0.385 . . . . 1.84 111.06 -172.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.98 143.95 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.898 -0.779 . . . . 0.41 108.898 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.673 ' CD2' HG21 ' A' ' 1' ' ' VAL . 5.7 m-70 -130.56 129.91 43.39 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.214 -0.595 . . . . 0.67 110.494 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.565 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 28.3 t -96.43 114.81 34.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 106.537 -1.653 . . . . 0.81 106.537 168.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 92.9 m-85 -85.47 152.44 23.2 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.045 -0.525 . . . . 0.64 110.355 -172.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.59 ' HA ' HG13 ' A' ' 7' ' ' VAL . 87.7 mttt -62.08 -15.32 44.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.923 -0.58 . . . . 2.87 111.553 -175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.99 -6.99 53.24 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.83 -0.804 . . . . 1.97 108.83 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.88 -9.59 51.5 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.376 -0.916 . . . . 0.58 114.989 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -92.85 177.6 6.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 118.692 1.246 . . . . 1.74 110.648 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.76 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -137.77 146.23 43.36 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.151 -0.477 . . . . 1.07 110.483 -174.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.51 146.06 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.074 -0.811 . . . . 0.39 111.074 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.2 ttt -120.5 142.36 49.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.088 0.471 . . . . 0.87 110.979 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -126.82 150.55 49.13 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.037 -1.098 . . . . 1.14 108.037 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 32' ' ' PHE . 30.7 p-10 -86.58 167.03 14.95 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.322 -0.551 . . . . 1.41 110.133 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 27.8 pttt -50.54 2.76 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.771 1.397 . . . . 1.77 114.771 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' A' ' 30' ' ' ASN . 98.2 m-85 -118.97 2.04 11.49 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.051 -0.406 . . . . 1.08 110.701 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.37 19.88 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.425 -0.893 . . . . 0.54 112.997 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 11.9 mmmm -100.17 132.73 45.37 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.887 0.851 . . . . 3.25 110.899 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 p -79.05 133.78 36.78 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.732 -1.576 . . . . 1.55 111.93 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 20.9 ptm -147.41 -172.94 4.13 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.641 -0.709 . . . . 1.38 109.829 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -104.68 150.87 24.34 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.124 -0.324 . . . . 2.78 110.124 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.7 ttt -86.13 132.47 43.42 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.117 -0.492 . . . . 1.32 110.786 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.12 120.49 7.65 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.623 2.216 . . . . 1.24 112.843 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -80.66 128.3 33.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 1.15 110.132 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.98 -9.65 51.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.92 -0.657 . . . . 0.68 112.389 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -101.69 122.98 44.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.899 0.333 . . . . 2.3 111.899 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.521 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 12.7 p -94.25 128.4 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.706 -0.85 . . . . 0.93 108.706 171.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.5 mtm -124.6 160.29 28.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 1.31 110.651 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 20.5 mt-10 -93.13 145.22 24.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.786 0.803 . . . . 1.64 111.635 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -105.16 160.2 15.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.254 -1.339 . . . . 0.53 109.522 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.53 ' HD2' ' HB3' ' A' ' 11' ' ' ASP . 98.8 mtt180 -64.45 -17.89 64.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.437 0.637 . . . . 3.73 109.59 174.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -78.89 -22.97 45.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.125 -0.943 . . . . 2.7 110.3 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.03 55.72 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.794 -0.717 . . . . 0.77 111.522 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 98.1 m -97.15 155.31 16.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.886 -0.783 . . . . 1.35 108.886 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.513 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 40.1 mmtm -112.88 136.95 51.96 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.943 -0.762 . . . . 1.84 108.943 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 39.0 pt -136.17 153.93 32.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.411 -0.359 . . . . 0.66 110.549 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.675 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -154.01 145.61 14.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.935 -0.575 . . . . 0.98 110.23 176.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.35 122.04 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.106 -1.442 . . . . 1.5 107.106 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -144.0 121.96 12.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.843 -0.343 . . . . 1.69 110.924 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.37 45.04 93.31 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 1.21 112.863 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.523 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 67.74 10.98 8.15 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.848 0.459 . . . . 2.9 111.481 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -119.47 -173.01 2.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.897 -0.592 . . . . 1.66 109.826 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.76 HD12 ' HG2' ' A' ' 26' ' ' MET . 2.5 tt -139.22 128.87 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-O 122.009 0.909 . . . . 0.92 110.062 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.19 121.44 27.47 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.091 -1.448 . . . . 0.71 107.091 170.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.891 ' HD2' ' OH ' ' A' ' 10' ' ' TYR . 33.1 ttp180 -109.29 96.1 6.07 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.319 -2.104 . . . . 3.56 105.319 164.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.603 HD23 ' HB2' ' A' ' 65' ' ' ALA . 0.1 OUTLIER 53.03 -13.16 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.501 0 O-C-N 125.011 1.444 . . . . 1.4 113.52 -171.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.601 ' H ' ' C ' ' A' ' 61' ' ' ARG . 12.5 t70 67.06 148.15 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.56 1.144 . . . . 2.14 110.872 -171.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 12.1 tp10 78.9 -45.83 0.38 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.512 1.125 . . . . 3.8 110.35 -174.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.643 ' HB1' HH21 ' A' ' 61' ' ' ARG . . . -50.13 -56.56 10.44 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.98 0.895 . . . . 1.76 112.609 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.7 ' H ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -95.0 -7.72 38.94 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.325 -1.307 . . . . 2.36 110.779 -174.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.459 ' HG2' ' H ' ' A' ' 68' ' ' LYS . 14.2 ttt180 -102.3 -166.46 1.29 Allowed 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.008 -0.996 . . . . 4.45 108.608 -170.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' H ' ' HG2' ' A' ' 67' ' ' ARG . 21.1 ptmt -108.82 168.67 9.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.725 -0.472 . . . . 5.92 109.725 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.41 121.87 25.88 Favored Glycine 0 N--CA 1.45 -0.396 0 O-C-N 123.773 0.671 . . . . 5.06 112.377 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -69.21 127.82 34.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.89 -0.411 . . . . 6.88 109.89 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.2 m -58.88 123.18 15.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 8.52 111.381 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.77 -29.07 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 10.75 111.521 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.66 -74.3 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.4 -0.905 . . . . 11.62 111.911 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.996 0 CA-C-O 119.005 -0.886 . . . . 12.99 111.101 179.361 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 121.024 0.44 . . . . 2.46 110.571 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -86.12 149.98 24.75 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.552 -0.907 . . . . 3.48 108.552 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.4 mtp -102.12 7.35 41.05 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.22 0.452 . . . . 2.17 112.22 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 p -78.63 -26.29 45.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.399 0.619 . . . . 1.47 110.334 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.489 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -104.74 5.19 33.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 1.89 110.837 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.439 HG23 HD22 ' A' ' 5' ' ' ASN . 89.5 t -103.66 115.42 45.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.56 -0.745 . . . . 1.25 110.144 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 m -79.15 -23.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 1.03 111.267 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -167.99 137.77 2.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.176 0.512 . . . . 1.41 110.854 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 6' ' ' VAL . 34.3 m -114.0 143.52 44.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.463 -0.79 . . . . 0.4 109.898 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' OH ' ' HD2' ' A' ' 61' ' ' ARG . 35.9 m-85 -121.26 133.74 55.15 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.877 0.846 . . . . 1.06 111.948 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 1.2 m-20 -100.44 124.46 45.98 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.742 -1.572 . . . . 1.94 109.73 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 16' ' ' SER . 7.6 mt -87.73 148.41 24.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.02 -0.733 . . . . 1.5 109.02 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.9 tt0 -62.74 -25.49 68.22 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.23 1.196 . . . . 1.68 114.23 -167.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -98.99 -50.89 4.02 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.684 0.754 . . . . 2.11 110.205 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 166.44 67.86 0.03 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 114.664 -1.153 . . . . 1.28 112.267 -170.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.608 ' HB2' HD12 ' A' ' 12' ' ' LEU . 2.5 m -157.5 143.36 17.49 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.175 -1.046 . . . . 1.07 108.175 172.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -127.5 125.18 39.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.146 0.498 . . . . 1.84 109.906 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.19 148.1 13.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.84 -0.8 . . . . 0.41 108.84 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.559 ' O ' ' HA ' ' A' ' 26' ' ' MET . 7.3 m-70 -131.16 133.15 45.28 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 120.156 -0.618 . . . . 0.67 109.432 173.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.9 t -93.67 114.75 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.613 -1.625 . . . . 0.81 106.613 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -83.43 150.58 25.96 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.738 -0.665 . . . . 0.64 110.119 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.486 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 21.2 pttm -61.24 -20.3 62.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.729 -0.668 . . . . 2.87 110.574 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.65 -0.78 57.25 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.735 -0.839 . . . . 1.97 108.735 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.48 -8.15 62.02 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-N 114.727 -1.124 . . . . 0.58 115.05 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -85.3 177.24 7.9 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.731 1.265 . . . . 1.74 110.663 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.906 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.7 mpp? -137.69 141.19 41.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.07 109.86 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -115.27 128.18 7.97 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.735 -0.666 . . . . 0.39 111.51 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.25 124.15 49.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.76 0.314 . . . . 0.87 110.255 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 25.3 mt-10 -124.01 153.89 40.66 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.374 -0.602 . . . . 1.14 109.374 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.547 HD21 ' HB2' ' A' ' 34' ' ' LYS . 10.9 p30 -104.5 174.59 5.81 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.287 -0.565 . . . . 1.41 110.148 175.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 14.0 pttm -49.63 -19.54 0.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.543 1.312 . . . . 1.77 114.543 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.484 ' HD2' ' OD1' ' A' ' 30' ' ' ASN . 92.2 m-85 -92.97 6.43 47.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.353 0.524 . . . . 1.08 110.586 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.67 26.91 59.94 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.706 -0.557 . . . . 0.54 111.706 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.547 ' HB2' HD21 ' A' ' 30' ' ' ASN . 35.8 mmtm -113.31 136.07 53.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.326 0.584 . . . . 3.25 111.329 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t -83.52 129.74 34.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.121 -1.4 . . . . 1.55 110.428 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.13 179.84 6.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.323 -0.399 . . . . 1.38 110.919 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -80.24 143.14 33.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.058 0.456 . . . . 2.78 111.287 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.3 ttt -94.65 127.16 44.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.655 . . . . 1.32 110.529 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.06 138.72 20.88 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.714 2.276 . . . . 1.24 112.834 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 33.3 tt0 -94.11 147.99 22.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.958 -0.565 . . . . 1.15 110.616 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.47 68.02 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.034 -0.603 . . . . 0.68 112.622 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -107.57 129.57 54.97 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.827 0.346 . . . . 2.3 111.562 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.58 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 8.1 p -90.85 127.23 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.888 -0.782 . . . . 0.93 108.888 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.404 ' SD ' HD11 ' A' ' 12' ' ' LEU . 17.8 ptp -117.03 147.57 42.23 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.059 -0.519 . . . . 1.31 110.003 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.03 151.35 24.76 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.338 0.59 . . . . 1.64 110.741 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.5 p -100.75 162.86 12.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.218 -0.901 . . . . 0.53 110.103 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.506 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 48.9 mtt180 -57.86 -21.24 41.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.145 0.424 . . . . 3.73 112.145 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -98.07 -17.48 19.08 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 121.064 -0.254 . . . . 2.7 111.202 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 111.25 22.83 6.0 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.291 -0.957 . . . . 0.77 113.319 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.6 m -99.83 147.49 25.44 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.293 -0.632 . . . . 1.35 109.293 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -111.79 132.74 54.47 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.055 -0.35 . . . . 1.84 110.055 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 61' ' ' ARG . 38.7 pt -136.63 160.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.177 -0.465 . . . . 0.66 110.83 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.619 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -162.45 151.44 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.044 -0.525 . . . . 0.98 109.891 175.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.566 ' N ' HG12 ' A' ' 53' ' ' ILE . 14.1 tmm? -104.63 121.48 43.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.057 -1.09 . . . . 1.5 108.057 177.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 49.6 tptt -134.85 116.58 14.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.288 -0.414 . . . . 1.69 110.216 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.93 44.19 98.16 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.815 -0.63 . . . . 1.21 112.752 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 72.59 -1.74 2.88 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.361 0.6 . . . . 2.9 111.42 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -105.72 147.99 27.93 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.519 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.906 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -100.32 124.32 53.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.727 0.775 . . . . 0.92 111.277 177.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.619 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.02 118.36 23.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.702 -1.222 . . . . 0.71 107.702 168.211 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.651 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 47.0 ttp180 -113.68 100.56 8.57 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.344 -1.354 . . . . 3.56 107.344 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 1.1 pp 37.81 14.21 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 O-C-N 125.164 1.54 . . . . 1.4 113.654 -167.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 25.8 t70 36.31 76.56 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.156 0.982 . . . . 2.14 111.973 -174.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.627 ' HB3' HD12 ' A' ' 62' ' ' LEU . 35.9 tt0 177.77 -41.19 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.866 -1.061 . . . . 3.8 108.701 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.55 -5.97 13.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.196 -0.911 . . . . 1.76 110.915 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.445 HD11 ' H ' ' A' ' 61' ' ' ARG . 9.6 mt -117.04 -14.02 10.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.683 -1.144 . . . . 2.36 110.214 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.449 ' HA ' ' HD2' ' A' ' 67' ' ' ARG . 22.8 tpt180 -74.98 -51.68 13.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.874 -0.603 . . . . 4.45 111.392 -170.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -95.63 11.56 32.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.227 0.537 . . . . 5.92 110.438 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.65 -153.31 43.97 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.033 -0.827 . . . . 5.06 111.033 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -158.85 102.04 1.65 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.409 -0.589 . . . . 6.88 109.409 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.0 m -133.71 106.12 7.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.267 -0.424 . . . . 8.52 110.553 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -71.96 -38.96 69.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.044 -0.525 . . . . 10.75 110.796 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.99 73.39 0.46 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.653 -0.784 . . . . 11.62 112.285 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.654 -1.081 . . . . 12.99 112.003 -179.85 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 3' ' ' MET . 29.8 m . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.925 -0.398 . . . . 2.46 109.925 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.62 -12.06 35.34 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 122.21 1.005 . . . . 3.48 110.241 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.512 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 42.7 mtp 61.2 4.85 0.95 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.583 -1.644 . . . . 2.17 113.57 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 m -83.82 -27.31 28.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.238 0.542 . . . . 1.47 110.696 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.531 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -103.72 6.0 36.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.734 0.778 . . . . 1.89 110.019 175.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 3' ' ' MET . 72.0 t -102.74 116.59 46.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.97 -1.013 . . . . 1.25 109.806 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.83 -20.02 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.689 -0.405 . . . . 1.03 111.403 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -168.18 128.35 1.29 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.411 0.624 . . . . 1.41 110.987 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 m -101.64 138.45 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.987 -1.006 . . . . 0.4 109.611 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.608 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 18.6 m-85 -113.64 128.45 56.44 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.736 0.779 . . . . 1.06 111.379 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 3.0 m-20 -95.14 115.04 26.91 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.02 -1.445 . . . . 1.94 108.296 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 16' ' ' SER . 10.4 mt -80.57 149.43 29.93 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.009 -0.737 . . . . 1.5 109.009 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -67.79 -7.71 29.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.1 0.476 . . . . 1.68 112.019 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.0 -20.98 19.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.422 0.63 . . . . 2.11 109.895 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 122.07 -14.32 8.97 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.188 -0.914 . . . . 1.28 112.534 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -66.3 153.19 43.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.539 0.209 . . . . 1.07 110.758 -179.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 30.2 mttp -113.56 143.49 44.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.144 0.497 . . . . 1.84 110.813 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 93.4 t -126.36 149.47 31.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.808 -1.182 . . . . 0.41 107.808 171.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 26' ' ' MET . 6.5 m-70 -139.0 128.89 24.97 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.291 -0.633 . . . . 0.67 109.291 175.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.3 t -90.11 116.77 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.423 -1.695 . . . . 0.81 106.423 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -85.92 153.12 22.42 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.797 -0.638 . . . . 0.64 110.628 -173.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 53.6 pttt -59.53 -16.51 25.29 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.462 -0.79 . . . . 2.87 111.539 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.31 -15.41 46.69 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.038 -0.727 . . . . 1.97 109.038 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.24 -2.35 54.48 Favored Glycine 0 N--CA 1.425 -2.07 0 C-N-CA 120.107 -1.044 . . . . 0.58 113.876 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -94.46 -175.37 3.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.821 0.811 . . . . 1.74 110.776 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 1.017 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.1 mpp? -144.42 149.29 35.82 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.721 -0.672 . . . . 1.07 110.438 -175.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.95 139.49 11.01 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.285 -0.726 . . . . 0.39 111.285 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.566 ' SD ' ' HG3' ' A' ' 36' ' ' MET . 1.6 tmt? -117.77 137.51 52.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.163 0.506 . . . . 0.87 111.001 -175.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 30.2 mt-10 -124.6 149.78 46.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.47 -0.786 . . . . 1.14 109.034 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.633 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.8 p-10 -85.91 166.16 16.19 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.44 -0.578 . . . . 1.41 109.44 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 38.0 pttt -56.92 5.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.217 1.192 . . . . 1.77 114.217 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 45.3 m-85 -113.66 5.82 16.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.064 0.459 . . . . 1.08 109.778 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.77 25.1 60.98 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.972 -0.558 . . . . 0.54 114.264 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.633 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.3 145.96 43.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.16 0.505 . . . . 3.25 110.218 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -80.28 142.16 34.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.489 -0.778 . . . . 1.55 111.588 -171.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.566 ' HG3' ' SD ' ' A' ' 28' ' ' MET . 9.6 ptm -153.53 -179.52 7.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.746 -0.661 . . . . 1.38 109.856 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -100.42 151.08 21.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.824 0.345 . . . . 2.78 110.751 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 ttm -101.42 126.63 33.85 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.2 -0.455 . . . . 1.32 110.714 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.51 142.34 23.34 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.723 2.282 . . . . 1.24 112.181 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.544 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 35.7 tt0 -79.81 154.35 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.493 -0.321 . . . . 1.15 110.646 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.604 ' H ' HD11 ' A' ' 53' ' ' ILE . . . 97.27 -19.56 54.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.68 113.337 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.557 ' O ' HD13 ' A' ' 53' ' ' ILE . 48.6 mtpt -98.5 126.65 44.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.244 0.522 . . . . 2.3 111.582 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.89 124.48 42.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.655 -0.498 . . . . 0.93 109.655 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.81 149.97 28.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.1 -0.5 . . . . 1.31 110.205 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' THR . 32.8 mt-10 -109.77 157.99 18.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.001 0.905 . . . . 1.64 112.01 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 72.2 p -105.29 165.34 11.18 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.03 -1.441 . . . . 0.53 110.319 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 58.6 mtp180 -51.25 -27.83 10.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.82 -0.627 . . . . 3.73 111.803 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -92.62 -21.8 19.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.385 -0.825 . . . . 2.7 111.2 -172.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.36 27.25 5.1 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.145 -1.026 . . . . 0.77 112.339 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 26.5 m -100.73 145.27 28.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.396 -0.594 . . . . 1.35 109.396 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.512 ' O ' ' HE1' ' A' ' 60' ' ' PHE . 55.9 mttp -109.21 131.4 55.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.064 -0.347 . . . . 1.84 110.064 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 12' ' ' LEU . 36.0 pt -137.02 159.17 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.929 0.395 . . . . 0.66 111.383 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.604 HD11 ' H ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -159.35 143.34 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.824 -0.625 . . . . 0.98 110.438 175.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.503 ' H ' HD12 ' A' ' 53' ' ' ILE . 1.5 tmt? -97.28 106.01 18.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.689 -1.226 . . . . 1.5 107.689 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.544 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 74.8 tttt -138.36 136.33 36.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.975 -0.557 . . . . 1.69 110.489 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.36 33.5 82.32 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.787 -0.642 . . . . 1.21 112.733 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.485 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 66.81 19.76 10.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.587 0.708 . . . . 2.9 110.991 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.34 -165.61 1.71 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.289 -0.869 . . . . 1.66 109.403 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.017 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.5 OUTLIER -135.82 131.3 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-O 122.184 0.992 . . . . 0.92 110.994 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.791 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -82.75 111.75 18.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.863 -1.532 . . . . 0.71 106.863 168.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.647 ' C ' ' H ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -119.27 107.51 13.49 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.128 -1.804 . . . . 3.56 106.128 173.106 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.547 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 4.3 mm? 62.23 -35.22 0.12 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.925 0.765 . . . . 1.4 111.881 -165.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.791 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 16.9 t70 83.75 -39.66 0.08 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.349 1.459 . . . . 2.14 110.101 -171.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 26.1 tt0 -95.84 -8.38 34.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.735 -0.666 . . . . 3.8 111.087 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . . . -62.89 -41.09 99.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.449 0.642 . . . . 1.76 109.64 175.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -85.33 -24.55 27.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.841 -1.072 . . . . 2.36 110.317 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.601 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 54.8 ttt180 -67.21 -61.52 1.88 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.218 -0.901 . . . . 4.45 110.991 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.61 ' HG3' ' HG2' ' A' ' 64' ' ' GLU . 26.8 mtmm -84.24 161.31 20.56 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.824 -0.435 . . . . 5.92 109.824 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.97 12.76 15.1 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.93 -0.868 . . . . 5.06 110.93 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -171.43 -46.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.37 -0.415 . . . . 6.88 110.001 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -102.57 77.57 1.63 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.46 0.648 . . . . 8.52 109.946 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -82.03 -39.24 23.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.496 -0.774 . . . . 10.75 110.116 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.13 175.54 22.65 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.255 -0.884 . . . . 11.62 111.337 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 CA-C-O 118.783 -1.01 . . . . 12.99 111.963 -178.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.444 ' HB ' ' OE1' ' A' ' 29' ' ' GLU . 4.4 p . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.711 -0.477 . . . . 2.46 109.711 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.43 134.16 37.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.698 -0.482 . . . . 3.48 109.698 173.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 81.7 mmm -101.87 8.43 41.24 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.638 0.607 . . . . 2.17 112.638 -172.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.6 p -94.4 -27.01 16.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.298 -0.561 . . . . 1.47 110.639 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.472 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -101.95 13.69 34.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.436 -0.347 . . . . 1.89 111.901 -177.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 13.3 p -111.68 130.03 66.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 120.162 -0.615 . . . . 1.25 111.936 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -96.19 -22.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.038 -0.528 . . . . 1.03 111.399 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -160.29 138.52 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 1.41 111.156 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -123.4 141.34 52.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.407 -0.815 . . . . 0.4 110.276 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.614 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 33.7 m-85 -121.51 134.51 55.05 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-O 121.679 0.752 . . . . 1.06 111.837 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 46' ' ' THR . 11.6 t70 -101.38 126.63 48.17 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 113.878 -1.51 . . . . 1.94 109.092 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.873 HD22 ' HB2' ' A' ' 16' ' ' SER . 10.5 mp -78.47 -2.2 37.42 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.415 -1.266 . . . . 1.5 112.947 -171.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.567 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 20.4 tt0 86.88 -31.26 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.138 0.575 . . . . 1.68 110.48 172.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -96.74 -9.58 28.64 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.338 0.59 . . . . 2.11 109.428 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' A' ' 31' ' ' LYS . . . 138.23 -36.82 1.87 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.056 -1.068 . . . . 1.28 114.434 172.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.873 ' HB2' HD22 ' A' ' 12' ' ' LEU . 11.3 m -71.59 160.0 33.45 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.615 -0.513 . . . . 1.07 109.615 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -133.36 143.52 49.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.289 0.566 . . . . 1.84 111.732 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.657 HG23 HD11 ' A' ' 12' ' ' LEU . 36.1 t -118.22 142.67 31.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.64 -0.709 . . . . 0.41 109.251 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 10.0 m-70 -128.82 133.02 47.86 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 120.225 -0.59 . . . . 0.67 111.074 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.84 111.65 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 106.566 -1.642 . . . . 0.81 106.566 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.517 ' HE2' ' N ' ' A' ' 27' ' ' GLY . 87.7 m-85 -83.77 156.18 22.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.929 -0.578 . . . . 0.64 110.807 -171.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -60.61 -20.46 60.69 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.122 -0.945 . . . . 2.87 111.798 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -96.95 7.39 46.75 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 121.496 0.665 . . . . 1.97 109.297 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.17 -7.59 80.55 Favored Glycine 0 N--CA 1.427 -1.91 0 CA-C-N 114.868 -1.06 . . . . 0.58 114.517 172.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -86.53 175.51 8.3 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 117.86 0.83 . . . . 1.74 110.651 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.854 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.2 mpp? -135.88 148.7 48.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.967 0.413 . . . . 1.07 110.193 -176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.517 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -143.47 148.84 20.74 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.636 -0.711 . . . . 0.39 111.403 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ttt -117.62 144.51 45.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.857 0.361 . . . . 0.87 110.637 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.444 ' OE1' ' HB ' ' A' ' 1' ' ' VAL . 28.8 mt-10 -123.01 146.64 47.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.304 -0.998 . . . . 1.14 108.304 171.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.717 ' ND2' ' HG3' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -89.63 164.72 14.62 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.619 -0.882 . . . . 1.41 108.619 176.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.403 ' CB ' ' HA3' ' A' ' 15' ' ' GLY . 9.7 ptpp? -51.03 -11.21 0.09 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.951 1.093 . . . . 1.77 113.951 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -96.65 9.19 42.32 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.107 -0.371 . . . . 1.08 110.81 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.65 26.23 65.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.167 -0.54 . . . . 0.54 113.67 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.717 ' HG3' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -117.23 147.44 42.51 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.067 -0.653 . . . . 3.25 110.273 178.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 p -83.64 139.1 33.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.332 -0.849 . . . . 1.55 112.159 -172.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.0 ptm -148.78 175.26 11.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.406 -0.815 . . . . 1.38 109.577 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -95.11 151.82 18.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.913 0.387 . . . . 2.78 110.132 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.03 128.91 45.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.993 -0.549 . . . . 1.32 110.768 -174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.3 114.72 3.16 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.45 2.1 . . . . 1.24 112.066 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 54' ' ' MET . 42.3 tt0 -74.51 133.3 42.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.652 -0.704 . . . . 1.15 110.696 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.517 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 117.12 -8.96 15.77 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.44 -0.886 . . . . 0.68 113.773 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.55 142.05 48.7 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 117.63 0.715 . . . . 2.3 112.304 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.633 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -99.43 135.64 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.93 108.885 173.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 70.2 mtm -127.4 159.26 35.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.249 -0.432 . . . . 1.31 109.872 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -99.66 163.63 12.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.741 0.781 . . . . 1.64 111.995 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 45.7 p -119.68 162.69 18.59 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.28 -1.327 . . . . 0.53 110.79 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.567 ' CG ' ' HA ' ' A' ' 13' ' ' GLN . 6.8 mtt180 -55.63 -27.38 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.757 0.651 . . . . 3.73 112.757 177.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -95.76 -2.52 47.56 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.503 -0.479 . . . . 2.7 111.969 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.31 20.7 19.47 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 119.853 -1.165 . . . . 0.77 114.053 170.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.2 t -112.63 167.22 10.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.717 0.758 . . . . 1.35 109.514 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -122.66 143.8 49.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.79 -0.448 . . . . 1.84 109.79 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.4 pt -139.55 154.22 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.346 -0.388 . . . . 0.66 111.247 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.728 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -155.02 149.84 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 120.957 0.408 . . . . 0.98 110.596 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.524 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 27.5 ttt -108.39 113.17 26.01 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.777 -1.194 . . . . 1.5 107.777 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 22.4 tptm -144.35 138.91 28.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.177 -0.675 . . . . 1.69 109.177 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.29 31.01 76.1 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.763 -0.732 . . . . 1.21 111.742 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.406 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 62.12 23.42 13.83 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.171 0.51 . . . . 2.9 111.339 -178.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 54' ' ' MET . 36.7 mt-10 -132.07 160.02 37.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.519 -0.764 . . . . 1.66 110.19 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.854 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.49 124.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.523 0.678 . . . . 0.92 110.906 177.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.728 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -82.46 109.76 16.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.508 -1.664 . . . . 0.71 106.508 166.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.614 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 2.0 tmm_? -121.49 105.51 10.55 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.817 -1.549 . . . . 3.56 106.817 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.554 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 3.9 mm? 57.82 -47.99 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.222 0.951 . . . . 1.4 112.898 -164.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.554 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 11.9 t70 80.78 -26.71 0.15 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 124.939 1.295 . . . . 2.14 109.581 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.2 tm-20 -84.79 -38.63 19.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.055 -0.975 . . . . 3.8 109.935 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.53 -35.61 78.24 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.581 0.705 . . . . 1.76 110.64 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 61' ' ' ARG . 8.6 mt -89.96 -1.55 57.99 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.622 -1.172 . . . . 2.36 110.527 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -77.5 -66.93 0.77 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.606 -0.725 . . . . 4.45 110.83 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -108.75 160.51 15.91 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.803 -0.635 . . . . 5.92 110.947 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.55 -16.82 9.66 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.073 -0.584 . . . . 5.06 111.671 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -158.74 130.13 6.4 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.063 -0.347 . . . . 6.88 110.063 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.2 m -71.47 -42.7 67.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.383 0.611 . . . . 8.52 109.523 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.82 -60.93 0.81 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.865 -1.061 . . . . 10.75 109.273 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 160.9 114.59 0.35 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.2 -0.76 . . . . 11.62 111.2 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.364 -1.242 . . . . 12.99 111.455 -179.105 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.432 -0.581 . . . . 2.46 109.432 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.85 124.2 25.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 3.48 110.639 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.486 ' HA ' HG12 ' A' ' 6' ' ' VAL . 20.7 mmt -87.62 9.04 22.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.286 -0.416 . . . . 2.17 111.291 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 m -86.37 -26.93 24.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.281 0.563 . . . . 1.47 110.793 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.48 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -114.42 12.39 17.46 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.715 -0.675 . . . . 1.89 111.511 -173.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.575 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.2 p -109.9 134.65 51.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.195 -0.457 . . . . 1.25 111.393 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 20' ' ' VAL . 22.4 m -86.84 -26.45 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.3 -0.409 . . . . 1.03 111.164 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -168.5 132.68 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.42 . . . . 1.41 110.566 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -110.41 143.47 40.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.61 -0.723 . . . . 0.4 109.98 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -117.98 133.2 56.14 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 121.766 0.793 . . . . 1.06 111.353 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -98.29 119.49 37.06 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.088 -1.414 . . . . 1.94 109.203 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 16' ' ' SER . 7.3 mt -83.1 138.99 33.47 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.686 -0.688 . . . . 1.5 109.378 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -61.99 -19.2 62.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.41 0.893 . . . . 1.68 113.41 -166.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -44.0 5.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 2.11 110.41 -175.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.72 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 159.77 78.86 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 119.621 -1.276 . . . . 1.28 113.144 -172.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.622 ' HB3' HD12 ' A' ' 12' ' ' LEU . 48.3 t -176.59 153.49 1.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.199 -0.667 . . . . 1.07 109.199 175.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -128.3 125.71 39.35 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.193 -0.458 . . . . 1.84 110.61 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.82 148.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.871 -0.788 . . . . 0.41 108.871 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.575 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -138.83 131.99 29.83 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.858 -0.526 . . . . 0.67 109.992 177.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 7' ' ' VAL . 46.8 t -96.96 118.49 43.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 107.085 -1.45 . . . . 0.81 107.085 170.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 78.3 m-85 -86.58 155.35 20.49 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.132 0.492 . . . . 0.64 111.46 -171.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 28.9 mtpp -64.24 -22.08 66.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.335 -0.848 . . . . 2.87 111.526 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.02 -1.87 57.75 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.031 -1.1 . . . . 1.97 108.031 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.8 -8.1 50.23 Favored Glycine 0 N--CA 1.426 -2.017 0 CA-C-N 114.81 -1.087 . . . . 0.58 114.555 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -69.94 174.02 5.78 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 118.627 1.213 . . . . 1.74 112.747 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.61 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.4 mpp? -138.13 131.43 30.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.266 -1.334 . . . . 1.07 109.168 171.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.23 144.15 15.43 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.885 -0.674 . . . . 0.39 112.088 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.3 ttt -123.76 139.87 53.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.816 0.308 . . . . 0.87 110.996 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 19.6 mm-40 -113.15 158.21 20.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.727 -0.842 . . . . 1.14 108.727 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 38.6 p30 -88.14 164.78 15.53 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.613 -0.514 . . . . 1.41 109.613 169.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.72 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 ptpt -51.63 -2.86 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.978 1.103 . . . . 1.77 113.978 172.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 30' ' ' ASN . 65.8 m-85 -106.73 0.21 24.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.647 -0.501 . . . . 1.08 109.647 -177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.25 25.33 37.11 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.738 -0.744 . . . . 0.54 112.864 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 14.6 mmmm -112.15 145.57 39.59 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.339 0.59 . . . . 3.25 111.639 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.4 m -86.75 123.71 32.2 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.487 -1.233 . . . . 1.55 110.753 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -138.52 178.31 7.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.863 -0.608 . . . . 1.38 110.421 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -91.3 141.38 28.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.874 0.369 . . . . 2.78 110.623 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.2 ttt -86.88 126.44 63.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 1.32 110.815 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.37 124.91 9.76 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.752 2.301 . . . . 1.24 112.864 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.556 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 47.3 tt0 -79.33 134.71 36.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 1.15 111.365 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.08 -12.3 24.36 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.788 -0.72 . . . . 0.68 113.647 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 53' ' ' ILE . 48.7 mtpt -105.07 126.9 52.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 117.075 0.438 . . . . 2.3 111.941 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.657 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.7 p -91.1 122.39 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.014 -0.735 . . . . 0.93 109.014 171.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.0 mtm -119.11 155.69 31.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.389 -0.823 . . . . 1.31 109.548 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -107.33 156.55 18.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.245 1.021 . . . . 1.64 112.515 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.7 p -109.48 159.78 16.76 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.446 -1.706 . . . . 0.53 110.28 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 47' ' ' ARG . 57.7 mtt-85 -59.34 -24.0 62.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.588 0.588 . . . . 3.73 112.588 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -96.07 -2.44 46.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.178 0.513 . . . . 2.7 110.64 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.68 15.12 32.61 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.761 -0.733 . . . . 0.77 113.068 171.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.8 m -93.9 146.11 24.14 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 110.201 -0.296 . . . . 1.35 110.201 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -107.73 134.07 51.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.691 -0.485 . . . . 1.84 109.691 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 12' ' ' LEU . 33.0 pt -138.17 156.83 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 0.66 111.462 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.79 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -158.41 154.03 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.811 -0.631 . . . . 0.98 109.678 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.608 ' N ' HG12 ' A' ' 53' ' ' ILE . 28.0 ttt -107.73 119.53 39.7 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.658 -1.238 . . . . 1.5 107.658 174.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.556 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 1.9 mmmt -138.57 134.85 34.36 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.083 -0.34 . . . . 1.69 110.083 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.22 30.35 75.65 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.836 -0.697 . . . . 1.21 111.821 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.406 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 62.44 25.78 15.37 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.37 0.605 . . . . 2.9 111.542 -176.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 54' ' ' MET . 41.8 mt-10 -123.59 151.41 42.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.384 -0.825 . . . . 1.66 110.251 175.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.61 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.19 121.38 48.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.774 0.797 . . . . 0.92 111.353 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.79 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -83.91 111.9 19.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.893 -1.049 . . . . 0.71 108.277 168.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.631 ' C ' ' H ' ' A' ' 63' ' ' ASP . 2.8 tmm_? -122.14 108.86 13.82 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.613 -1.625 . . . . 3.56 106.613 171.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 3.8 mm? 59.64 -35.53 0.07 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 124.268 0.98 . . . . 1.4 112.749 -166.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.631 ' H ' ' C ' ' A' ' 61' ' ' ARG . 2.6 t70 79.33 -48.33 0.39 Allowed 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.738 1.215 . . . . 2.14 109.54 -167.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 40.1 mt-10 -68.61 -27.07 65.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.326 -0.852 . . . . 3.8 110.891 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.41 77.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 1.76 110.885 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.0 mp -74.63 -31.27 61.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.426 0.631 . . . . 2.36 109.857 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 41.8 ttt180 -54.12 -62.03 1.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.906 -1.043 . . . . 4.45 111.644 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -152.85 5.03 0.36 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.916 0.339 . . . . 5.92 111.916 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.12 56.25 2.13 Favored Glycine 0 C--N 1.316 -0.573 0 C-N-CA 120.894 -0.669 . . . . 5.06 112.556 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -86.86 70.89 10.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.897 0.379 . . . . 6.88 110.468 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.5 t -164.83 102.93 0.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.961 -0.563 . . . . 8.52 109.822 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -126.54 150.28 48.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.176 -0.466 . . . . 10.75 109.871 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.91 104.25 2.31 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.846 -0.692 . . . . 11.62 112.246 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 CA-C-O 118.693 -1.06 . . . . 12.99 111.502 177.108 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 111.538 0.199 . . . . 2.46 111.538 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 65.09 121.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.44 0.638 . . . . 3.48 110.656 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.8 mmm -91.81 17.15 9.47 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.752 -0.593 . . . . 2.17 112.411 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.8 m -101.49 -25.71 13.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.937 0.399 . . . . 1.47 110.985 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.531 ' ND2' ' HD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -99.94 13.54 33.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.006 0.431 . . . . 1.89 111.177 -177.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 12.9 p -102.35 129.3 54.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 1.25 110.257 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -94.32 -21.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.642 -0.423 . . . . 1.03 111.46 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -166.64 142.84 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.437 0.637 . . . . 1.41 111.211 176.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -121.02 144.73 48.37 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.961 -1.018 . . . . 0.4 109.823 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.474 ' CD1' HG21 ' A' ' 46' ' ' THR . 29.9 m-85 -123.03 133.14 54.35 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 121.855 0.836 . . . . 1.06 111.953 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.6 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 9.8 m-20 -97.94 121.83 40.33 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.928 -1.487 . . . . 1.94 108.911 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.903 ' HG ' ' HB2' ' A' ' 16' ' ' SER . 0.6 OUTLIER -67.48 -10.11 48.46 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.497 -1.229 . . . . 1.5 112.458 -173.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 35.9 tt0 94.03 -22.65 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.4 1.062 . . . . 1.68 109.253 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -96.25 -34.9 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.688 -0.687 . . . . 2.11 109.473 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 155.19 -30.91 0.65 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.478 -0.868 . . . . 1.28 112.926 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.903 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.7 OUTLIER -57.79 141.37 49.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 1.07 110.29 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -122.01 127.44 50.29 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.236 -0.438 . . . . 1.84 111.071 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.511 HG23 HD21 ' A' ' 12' ' ' LEU . 75.0 t -107.19 138.2 34.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.212 -0.662 . . . . 0.41 109.212 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 4.3 m-70 -127.01 132.82 50.67 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 109.641 -0.503 . . . . 0.67 109.641 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 59' ' ' ILE . 69.4 t -102.12 122.4 54.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 106.947 -1.501 . . . . 0.81 106.947 170.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.531 ' HD2' ' ND2' ' A' ' 5' ' ' ASN . 94.2 m-85 -92.11 155.26 18.18 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.559 -0.746 . . . . 0.64 110.757 -169.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -66.75 -8.61 29.42 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.303 -0.862 . . . . 2.87 111.755 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -92.48 0.96 57.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.17 -13.81 64.34 Favored Glycine 0 N--CA 1.428 -1.879 0 CA-C-N 114.807 -1.088 . . . . 0.58 113.878 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.87 -174.52 4.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 117.603 0.702 . . . . 1.74 109.448 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.551 ' HG3' HG12 ' A' ' 59' ' ' ILE . 1.6 pmm? -152.83 154.2 34.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.901 0.381 . . . . 1.07 110.15 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.6 153.49 24.58 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.5 -0.64 . . . . 0.39 111.5 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 ttt -125.75 139.8 53.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.27 0.557 . . . . 0.87 111.539 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -123.41 155.67 36.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 1.14 109.441 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.463 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 65.2 t30 -94.12 159.73 15.02 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.285 -0.635 . . . . 1.41 109.285 175.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.679 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.8 ptmt -48.73 -23.73 1.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.076 1.139 . . . . 1.77 114.076 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.463 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 36.2 m-85 -90.45 -2.63 57.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.092 0.472 . . . . 1.08 110.152 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.13 26.36 16.45 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.54 112.01 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -100.7 135.82 41.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.724 0.773 . . . . 3.25 111.855 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 p -79.33 110.69 14.86 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.948 -1.478 . . . . 1.55 110.243 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -127.25 177.07 6.94 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.321 -0.4 . . . . 1.38 111.128 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -88.4 132.9 34.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.234 0.54 . . . . 2.78 111.755 -172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.1 ttt -91.83 125.55 56.83 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.743 -0.662 . . . . 1.32 109.948 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.87 124.08 7.22 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.605 2.204 . . . . 1.24 113.037 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.653 ' HG2' ' HD2' ' A' ' 55' ' ' LYS . 38.2 tt0 -82.11 133.98 35.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 1.15 110.34 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 102.88 -12.4 56.2 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.783 -0.723 . . . . 0.68 111.901 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -96.53 123.9 40.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.626 0.25 . . . . 2.3 111.41 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.636 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 15.0 p -90.7 127.56 43.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.885 -0.783 . . . . 0.93 108.885 172.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 67.4 mtm -126.16 156.95 39.32 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.069 -0.514 . . . . 1.31 109.901 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.553 ' HG2' ' HG3' ' A' ' 51' ' ' LYS . 38.9 mt-10 -108.58 169.4 8.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.982 0.896 . . . . 1.64 112.281 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.474 HG21 ' CD1' ' A' ' 10' ' ' TYR . 42.7 p -120.33 168.31 11.41 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.862 -1.517 . . . . 0.53 110.73 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 11.2 ptt180 -59.49 -21.83 60.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.473 0.654 . . . . 3.73 111.086 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -97.81 -5.86 33.87 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.94 -1.027 . . . . 2.7 110.921 -170.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.56 11.26 58.35 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.52 -0.848 . . . . 0.77 112.999 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.704 HG22 HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -90.05 148.18 23.2 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.426 -0.583 . . . . 1.35 109.426 177.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.595 ' O ' ' HE1' ' A' ' 60' ' ' PHE . 1.9 mptp? -111.87 130.55 55.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.157 -0.683 . . . . 1.84 109.157 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.46 157.64 39.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.238 -0.437 . . . . 0.66 110.826 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -158.81 150.82 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.909 -0.587 . . . . 0.98 110.266 177.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.535 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 60.2 ttp -105.72 123.79 48.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.581 -1.266 . . . . 1.5 107.581 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HD2' ' HG2' ' A' ' 40' ' ' GLU . 21.6 tptp -144.5 133.63 22.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.88 -0.415 . . . . 1.69 109.88 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.56 30.58 78.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.117 -0.563 . . . . 1.21 111.768 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.27 24.77 14.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.445 0.64 . . . . 2.9 111.009 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.25 152.22 36.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.198 -0.91 . . . . 1.66 109.581 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' A' ' 26' ' ' MET . 0.3 OUTLIER -98.38 120.21 47.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 122.054 0.931 . . . . 0.92 110.879 175.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.595 ' HE1' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -84.03 119.18 24.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.188 -1.369 . . . . 0.71 107.435 166.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 63' ' ' ASP . 12.0 ttm180 -111.28 100.18 8.85 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 105.54 -2.022 . . . . 3.56 105.54 166.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.704 HD21 HG22 ' A' ' 50' ' ' THR . 29.7 mt 57.67 -17.92 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 O-C-N 124.327 1.017 . . . . 1.4 113.076 -171.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.611 ' H ' ' C ' ' A' ' 61' ' ' ARG . 0.4 OUTLIER 76.07 -25.38 0.2 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.151 0.98 . . . . 2.14 110.092 -170.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 62' ' ' LEU . 11.7 tp10 -100.94 -14.24 17.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.294 -0.866 . . . . 3.8 110.914 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . . . -65.52 -33.37 75.77 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.468 0.651 . . . . 1.76 110.561 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.501 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.6 mm? -83.55 14.5 3.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 2.36 111.149 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -101.94 -165.01 1.15 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.391 0.615 . . . . 4.45 109.848 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -111.79 108.47 17.89 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.315 -0.857 . . . . 5.92 109.861 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.08 78.9 0.98 Allowed Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.523 -0.762 . . . . 5.06 111.385 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.455 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 17.6 m-70 -64.75 137.98 58.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.814 0.34 . . . . 6.88 111.676 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -92.96 -31.9 14.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.174 -0.466 . . . . 8.52 110.776 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.455 ' OE1' ' HB3' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -86.08 -36.65 19.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.999 -0.546 . . . . 10.75 110.342 -175.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 129.59 -57.19 0.73 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.865 -0.607 . . . . 11.62 111.702 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.491 -1.171 . . . . 12.99 111.701 179.696 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.501 HG13 ' CZ ' ' A' ' 21' ' ' PHE . 72.2 t . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.418 -0.216 . . . . 2.46 110.418 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -88.55 141.19 28.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.898 0.38 . . . . 3.48 110.717 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.8 mmt -90.13 -16.85 28.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.764 -0.653 . . . . 2.17 111.033 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -82.29 -32.41 29.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.418 0.628 . . . . 1.47 110.245 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 4.3 t30 -94.74 -1.29 53.25 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 115.333 -0.849 . . . . 1.89 111.065 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 19' ' ' HIS . 8.6 p -107.39 131.81 56.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 119.102 -1.039 . . . . 1.25 111.643 -175.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.65 -25.59 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.961 -0.563 . . . . 1.03 112.398 -174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -167.38 136.08 2.62 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.81 0.814 . . . . 1.41 112.036 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.0 m -108.54 142.09 39.48 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.198 -1.365 . . . . 0.4 109.819 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -122.85 136.69 54.95 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 121.852 0.834 . . . . 1.06 112.122 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.98 120.36 34.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.81 -1.541 . . . . 1.94 109.114 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 16' ' ' SER . 15.1 mt -80.4 145.88 31.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.531 -1.285 . . . . 1.5 107.531 173.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.556 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 7.9 tt0 -62.8 -13.98 39.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.22 0.452 . . . . 1.68 112.22 -172.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -90.68 -20.99 21.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.093 0.473 . . . . 2.11 110.151 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.65 -20.44 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.854 -0.689 . . . . 1.28 113.325 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 12' ' ' LEU . 15.8 m -63.34 152.28 38.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.93 0.395 . . . . 1.07 110.466 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' MET . 59.0 mttp -122.98 127.9 49.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.05 0.452 . . . . 1.84 111.362 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.04 149.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.041 -0.725 . . . . 0.41 109.041 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.663 ' HB3' HG21 ' A' ' 6' ' ' VAL . 1.2 m-70 -140.14 139.82 35.84 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 121.769 -0.582 . . . . 0.67 110.377 172.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.599 ' HA ' ' HG3' ' A' ' 26' ' ' MET . 47.2 t -102.1 122.57 54.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 107.42 -1.326 . . . . 0.81 107.42 171.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.501 ' CZ ' HG13 ' A' ' 1' ' ' VAL . 95.9 m-85 -96.27 157.21 16.0 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.233 -0.44 . . . . 0.64 111.512 -169.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 22.7 mtpp -62.67 -23.15 66.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.181 0.592 . . . . 2.87 111.765 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -92.99 6.37 48.13 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.342 -0.984 . . . . 1.97 108.342 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.64 -5.38 76.91 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 114.347 -1.297 . . . . 0.58 114.923 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -90.3 178.34 6.17 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.266 1.033 . . . . 1.74 110.757 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 1.048 ' HG2' HD12 ' A' ' 59' ' ' ILE . 4.2 mpp? -138.35 145.55 41.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.954 -0.566 . . . . 1.07 109.979 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -132.48 148.21 19.11 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.838 -0.696 . . . . 0.39 111.713 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 27.4 ttt -127.88 146.84 50.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.407 0.622 . . . . 0.87 112.09 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' CD ' ' HE2' ' A' ' 19' ' ' HIS . 3.1 mp0 -129.73 157.89 40.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.101 -1.074 . . . . 1.14 108.101 171.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -86.47 171.0 11.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.028 -0.36 . . . . 1.41 110.028 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 62.6 pttt -54.06 -14.23 1.01 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.129 0.788 . . . . 1.77 113.129 174.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -91.15 -0.82 57.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.011 0.434 . . . . 1.08 110.22 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.44 65.06 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 121.079 -0.581 . . . . 0.54 112.047 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 34' ' ' LYS . 1.7 mmmp? -103.12 135.36 44.93 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.739 0.78 . . . . 3.25 111.0 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 p -77.31 122.1 24.64 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 113.85 -1.523 . . . . 1.55 111.451 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -151.07 148.59 28.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 1.38 110.168 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -98.55 140.87 32.14 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.662 -0.415 . . . . 2.78 110.221 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.42 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -98.78 150.44 36.69 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.062 -0.517 . . . . 1.32 110.888 -177.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.6 154.45 64.41 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.062 2.508 . . . . 1.24 112.183 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 26.7 tt0 -75.62 141.23 42.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 1.15 110.416 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.4 -10.76 19.55 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.508 -0.853 . . . . 0.68 113.758 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.6 mtpt -92.61 115.65 28.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.832 0.678 . . . . 2.3 112.832 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.2 p -86.32 125.35 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.563 -0.902 . . . . 0.93 108.563 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 52.9 mtm -120.56 152.92 37.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.333 -0.394 . . . . 1.31 110.62 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.59 140.53 29.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.629 0.728 . . . . 1.64 111.247 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 44.4 p -103.18 162.47 12.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.661 -1.154 . . . . 0.53 110.225 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 2.8 mmt85 -59.42 -21.08 59.46 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.582 0.706 . . . . 3.73 111.289 171.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -88.9 0.82 56.25 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.921 -1.036 . . . . 2.7 111.418 -171.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.22 18.03 72.72 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.57 -0.824 . . . . 0.77 111.272 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.541 ' CG2' HD21 ' A' ' 62' ' ' LEU . 11.1 p -115.08 171.74 7.49 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.803 -0.443 . . . . 1.35 109.803 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -126.62 145.08 50.69 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.31 -0.404 . . . . 1.84 110.07 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 61' ' ' ARG . 34.5 pt -137.77 159.2 34.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.801 -0.636 . . . . 0.66 110.719 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.73 HG22 ' CD1' ' A' ' 60' ' ' PHE . 1.1 tt -156.88 153.34 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 0.98 109.817 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.62 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -114.05 106.76 14.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.609 -0.886 . . . . 1.5 108.609 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 36.0 tttm -144.27 145.96 32.34 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.868 0.366 . . . . 1.69 110.524 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.28 31.92 82.37 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.637 -0.711 . . . . 1.21 112.379 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 72.37 -9.35 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.409 0.623 . . . . 2.9 110.902 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -96.17 -179.07 4.54 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.487 -0.779 . . . . 1.66 110.51 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.048 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.0 OUTLIER -135.98 128.38 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 121.581 0.705 . . . . 0.92 109.86 173.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.73 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.39 111.99 19.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.008 -0.996 . . . . 0.71 108.612 172.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.639 ' HG3' HH11 ' A' ' 61' ' ' ARG . 6.0 tpt85 -120.55 107.17 12.53 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.951 -1.5 . . . . 3.56 106.951 171.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 4.0 mm? 58.91 -46.76 0.06 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.724 -1.126 . . . . 1.4 112.982 -166.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 16.6 t70 77.09 -46.67 0.5 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.176 0.99 . . . . 2.14 109.332 -169.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.503 ' HA ' ' HG2' ' A' ' 67' ' ' ARG . 5.8 mm-40 -61.12 -40.75 94.96 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.894 -1.048 . . . . 3.8 111.361 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.28 90.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.29 0.567 . . . . 1.76 111.117 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mt -81.89 -40.66 22.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.099 -0.955 . . . . 2.36 111.353 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.612 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 5.4 ptm180 -66.81 -38.18 85.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.748 0.309 . . . . 4.45 111.039 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.612 ' HG3' ' HG3' ' A' ' 67' ' ' ARG . 53.8 mtmt -100.05 65.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.706 . . . . 5.92 110.593 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.64 48.89 0.62 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.882 -1.054 . . . . 5.06 110.747 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -116.0 102.91 10.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.014 0.435 . . . . 6.88 110.703 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.1 t -90.86 110.73 21.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.218 -0.446 . . . . 8.52 110.142 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -101.46 -21.8 14.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.324 0.583 . . . . 10.75 109.946 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.35 -138.87 14.4 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.537 -0.756 . . . . 11.62 111.634 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 CA-C-O 117.995 -1.447 . . . . 12.99 111.34 178.903 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.044 -0.354 . . . . 2.46 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.61 133.96 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.478 -0.328 . . . . 3.48 111.253 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 mmt -104.23 10.76 35.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 2.17 111.431 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.7 m -97.25 -27.49 14.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.833 0.349 . . . . 1.47 111.044 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.695 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -101.46 12.37 37.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.315 0.579 . . . . 1.89 111.026 -178.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.607 ' CG2' ' HB3' ' A' ' 19' ' ' HIS . 9.2 p -107.69 127.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.092 -0.643 . . . . 1.25 111.659 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 20' ' ' VAL . 23.5 m -80.3 -23.88 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.639 -0.71 . . . . 1.03 111.025 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -167.87 129.21 1.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 1.41 111.029 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.8 m -102.48 138.19 39.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.808 -1.087 . . . . 0.4 109.558 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 39.2 m-85 -108.09 123.19 48.33 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.076 0.941 . . . . 1.06 111.809 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.961 ' HB3' ' HE ' ' A' ' 47' ' ' ARG . 6.1 m-20 -94.9 114.0 25.79 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.442 -1.708 . . . . 1.94 109.92 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -87.68 152.49 22.11 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.386 -0.825 . . . . 1.5 109.089 -177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -69.45 -6.32 29.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.432 0.634 . . . . 1.68 110.746 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -95.09 -7.94 38.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.582 -0.735 . . . . 2.11 109.29 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 101.43 -19.08 52.3 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.22 -0.9 . . . . 1.28 111.88 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.624 ' HB2' HD12 ' A' ' 12' ' ' LEU . 5.0 m -61.96 145.9 51.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 1.07 110.491 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.7 125.16 46.96 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.16 0.505 . . . . 1.84 110.594 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 77.5 t -105.76 154.71 6.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.482 -0.933 . . . . 0.41 108.482 176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.607 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 51.8 m-70 -136.58 134.65 37.66 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 121.848 -0.532 . . . . 0.67 109.737 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 7' ' ' VAL . 47.3 t -97.31 111.98 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 106.298 -1.741 . . . . 0.81 106.298 166.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 19' ' ' HIS . 80.9 m-85 -84.39 154.83 22.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.715 -0.675 . . . . 0.64 110.72 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 7.7 ptmm? -58.58 -23.45 58.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.318 -0.856 . . . . 2.87 112.68 -174.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.646 ' HB2' ' HE2' ' A' ' 25' ' ' LYS . 7.7 m-20 -98.01 6.66 47.4 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.156 -0.683 . . . . 1.97 109.156 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 -5.03 66.79 Favored Glycine 0 N--CA 1.428 -1.84 0 CA-C-N 115.078 -0.964 . . . . 0.58 114.787 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -81.88 171.75 14.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.272 1.036 . . . . 1.74 110.382 176.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.719 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.5 mpp? -137.0 143.51 42.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.974 -0.557 . . . . 1.07 109.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.87 143.21 14.81 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.383 -0.687 . . . . 0.39 111.383 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -118.55 135.81 54.2 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.125 0.488 . . . . 0.87 110.799 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 45.8 mt-10 -125.78 153.88 43.36 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.338 -0.847 . . . . 1.14 109.149 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.57 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 38.3 p-10 -88.98 168.31 12.47 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.61 -0.515 . . . . 1.41 109.61 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 63.9 pttt -53.31 1.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.053 1.131 . . . . 1.77 114.053 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 30' ' ' ASN . 84.7 m-85 -111.09 -2.7 15.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.939 -0.476 . . . . 1.08 110.522 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.92 32.69 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.294 -0.955 . . . . 0.54 113.598 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.57 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -120.42 147.46 45.06 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.129 -0.628 . . . . 3.25 110.683 174.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -74.57 128.05 34.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.991 -1.004 . . . . 1.55 111.351 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 21.9 ptm -126.85 -179.72 4.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.08 -0.509 . . . . 1.38 110.666 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.05 154.38 37.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 2.78 110.109 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.2 ttt -119.88 127.28 26.47 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.178 -0.305 . . . . 1.32 110.178 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -75.43 148.57 33.85 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.458 2.106 . . . . 1.24 112.863 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -109.15 139.72 43.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.722 -0.672 . . . . 1.15 109.512 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.52 -31.53 5.15 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.495 -0.86 . . . . 0.68 112.648 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -82.08 142.19 32.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.72 0.295 . . . . 2.3 110.848 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.596 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.0 p -97.55 130.21 46.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.215 0.531 . . . . 0.93 110.472 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -102.83 140.55 36.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.777 -0.647 . . . . 1.31 109.7 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -103.51 146.99 27.71 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.21 0.528 . . . . 1.64 110.314 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 38.3 p -100.46 168.23 9.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.573 -0.74 . . . . 0.53 110.72 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.961 ' HE ' ' HB3' ' A' ' 11' ' ' ASP . 39.3 mtt180 -46.57 -41.29 14.19 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.413 0.894 . . . . 3.73 113.413 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.02 -43.48 7.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.871 -0.731 . . . . 2.7 112.098 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.26 28.82 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 119.308 -1.425 . . . . 0.77 113.587 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.0 m -102.44 149.28 24.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.291 -1.003 . . . . 1.35 108.291 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 94.3 mttt -126.15 144.17 50.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.614 -0.434 . . . . 1.84 111.794 -173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 61' ' ' ARG . 39.3 pt -138.0 157.92 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.44 -0.8 . . . . 0.66 110.786 -176.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.94 148.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.818 0.342 . . . . 0.98 110.359 176.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.47 ' N ' HG12 ' A' ' 53' ' ' ILE . 24.0 ttt -111.52 127.02 55.58 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.562 -0.533 . . . . 1.5 109.562 -178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 55' ' ' LYS . 51.3 tptt -145.24 129.38 17.59 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.791 -0.448 . . . . 1.69 109.791 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.19 36.58 89.33 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.941 -0.647 . . . . 1.21 112.711 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 71.85 -9.63 0.95 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.483 0.713 . . . . 2.9 111.355 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 56' ' ' GLY . 55.4 mm-40 -86.05 139.15 31.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.161 -0.472 . . . . 1.66 111.16 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.719 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -102.08 124.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.576 0.703 . . . . 0.92 110.901 176.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -84.48 119.63 25.37 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.076 -1.083 . . . . 0.71 108.076 169.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.623 ' H ' HD11 ' A' ' 66' ' ' LEU . 11.1 ttm180 -116.07 101.01 8.36 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.515 -1.661 . . . . 3.56 106.515 169.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER 38.44 5.9 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.895 1.372 . . . . 1.4 113.532 -163.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 61' ' ' ARG . 21.5 t0 54.17 168.6 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.203 1.001 . . . . 2.14 111.24 -168.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.59 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 10.0 tp10 76.05 -40.6 0.4 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.938 0.895 . . . . 3.8 110.466 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.33 -38.2 62.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.629 0.728 . . . . 1.76 111.096 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.818 ' HA ' ' HB2' ' A' ' 70' ' ' HIS . 1.9 mp -96.08 -24.38 16.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.119 -0.946 . . . . 2.36 110.018 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 25.9 ttm180 -61.87 -53.75 51.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.207 -0.906 . . . . 4.45 110.088 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -132.68 105.4 7.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.004 -0.544 . . . . 5.92 110.422 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.91 21.47 3.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.2 -1.0 . . . . 5.06 112.973 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.818 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 10.1 t-160 -87.21 -75.8 0.39 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.52 -0.548 . . . . 6.88 109.52 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.1 m 49.53 40.05 18.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.457 0.646 . . . . 8.52 111.247 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -80.2 146.08 31.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.316 -0.857 . . . . 10.75 110.927 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.78 -52.59 4.72 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.863 -0.684 . . . . 11.62 111.789 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.462 -1.188 . . . . 12.99 111.294 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 2' ' ' ASP . 12.2 p . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.483 0.182 . . . . 2.46 111.007 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 1' ' ' VAL . 1.8 p-10 -80.89 170.92 15.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.05 -0.722 . . . . 3.48 109.05 171.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.3 mtp -131.03 27.84 4.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.207 0.527 . . . . 2.17 110.569 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 m -112.95 -36.53 5.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.629 -0.714 . . . . 1.47 111.271 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 1.008 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 3.4 t30 -114.84 -0.57 13.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.55 0.691 . . . . 1.89 111.779 -174.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.689 HG21 ' HB3' ' A' ' 19' ' ' HIS . 7.8 p -102.73 134.38 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.917 -1.114 . . . . 1.25 111.381 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.5 m -87.13 -23.86 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.932 0.345 . . . . 1.03 111.932 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.9 131.45 1.65 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.727 0.775 . . . . 1.41 111.736 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -105.64 142.62 35.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.439 -1.255 . . . . 0.4 109.479 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' CD1' HG21 ' A' ' 46' ' ' THR . 21.2 m-85 -121.7 134.74 54.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.382 -0.827 . . . . 1.06 111.15 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.602 ' CB ' ' HD3' ' A' ' 47' ' ' ARG . 1.2 m-20 -97.03 117.24 30.76 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.987 -1.46 . . . . 1.94 108.454 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 16' ' ' SER . 5.9 mt -72.15 0.81 8.73 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.891 0.7 . . . . 1.5 112.891 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.548 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 88.72 -36.58 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.787 0.803 . . . . 1.68 108.999 173.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -80.52 -35.74 34.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.685 -1.143 . . . . 2.11 108.564 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.633 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 148.3 -26.72 1.39 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.431 -1.258 . . . . 1.28 113.315 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.677 ' HB2' HD12 ' A' ' 12' ' ' LEU . 1.4 m -60.64 146.39 45.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.758 -0.46 . . . . 1.07 109.758 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -121.94 126.42 48.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.107 0.479 . . . . 1.84 110.538 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.3 t -108.46 141.79 22.78 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.04 -0.726 . . . . 0.41 109.04 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.689 ' HB3' HG21 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -137.53 131.11 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.174 -0.61 . . . . 0.67 110.428 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 59' ' ' ILE . 60.7 t -102.89 123.98 56.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 107.522 -1.288 . . . . 0.81 107.522 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.516 ' HB3' HD21 ' A' ' 5' ' ' ASN . 97.9 m-85 -98.61 161.4 13.68 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.963 -0.562 . . . . 0.64 111.219 -167.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.008 ' HE2' ' HA ' ' A' ' 5' ' ' ASN . 41.4 mtmt -62.15 -19.56 63.18 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.179 -0.464 . . . . 2.87 111.95 -175.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.911 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 2.1 m-20 -83.98 -9.39 58.71 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 108.275 -1.009 . . . . 1.97 108.275 -175.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.89 -5.06 59.5 Favored Glycine 0 N--CA 1.421 -2.358 0 CA-C-N 114.731 -1.122 . . . . 0.58 113.338 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.911 ' HD3' ' HB2' ' A' ' 23' ' ' ASP . 1.6 mppt? -82.62 -177.1 6.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 117.748 0.774 . . . . 1.74 109.417 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 1.7 pmm? -153.81 147.61 25.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.757 -0.656 . . . . 1.07 109.676 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' N ' ' HE2' ' A' ' 21' ' ' PHE . . . -135.27 155.05 21.91 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.786 -0.721 . . . . 0.39 111.964 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.6 ttt -124.95 141.53 52.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.121 0.486 . . . . 0.87 111.656 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 27.2 mt-10 -126.45 153.49 44.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.098 -1.075 . . . . 1.14 108.098 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -93.42 172.63 8.16 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.403 -0.519 . . . . 1.41 110.542 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.633 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 60.8 pttt -53.07 -14.78 0.67 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.605 0.965 . . . . 1.77 113.605 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -95.9 -3.12 45.91 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.065 -0.397 . . . . 1.08 110.914 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.34 22.65 47.04 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.825 -0.702 . . . . 0.54 112.199 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 66.0 mmtt -102.34 134.04 46.29 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.875 0.845 . . . . 3.25 110.81 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 p -76.75 129.21 35.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.665 -1.607 . . . . 1.55 111.545 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 55.4 mtm -136.77 162.9 31.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.904 -0.589 . . . . 1.38 110.064 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -90.96 156.47 17.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.343 -0.389 . . . . 2.78 110.03 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 41.5 ttm -99.98 127.66 32.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 1.32 111.612 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.13 118.5 5.57 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.539 2.159 . . . . 1.24 111.922 174.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.1 tt0 -68.58 137.06 53.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.759 -0.655 . . . . 1.15 110.802 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -9.14 37.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.82 -0.705 . . . . 0.68 113.471 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -104.22 130.29 51.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.335 0.568 . . . . 2.3 112.132 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.696 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.2 p -93.78 132.66 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 0.93 110.366 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.4 mtm -124.8 153.18 42.88 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.487 -0.779 . . . . 1.31 109.712 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -107.4 167.78 9.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.523 0.678 . . . . 1.64 111.688 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 54.3 p -127.59 164.87 21.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.655 -1.157 . . . . 0.53 112.067 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.602 ' HD3' ' CB ' ' A' ' 11' ' ' ASP . 75.0 mtp180 -59.65 -29.66 68.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.413 -0.812 . . . . 3.73 111.423 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -95.18 -7.33 39.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.665 0.269 . . . . 2.7 111.333 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.37 16.42 27.27 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.328 -0.939 . . . . 0.77 112.913 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.519 HG23 ' CD2' ' A' ' 62' ' ' LEU . 99.3 m -93.31 139.8 30.25 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.95 -0.389 . . . . 1.35 109.95 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -106.64 132.7 52.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.104 -0.702 . . . . 1.84 109.104 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.417 ' HA ' ' HD1' ' A' ' 60' ' ' PHE . 17.3 pt -136.6 152.82 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.901 0.334 . . . . 0.66 111.901 -175.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.696 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.56 149.81 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.945 -0.571 . . . . 0.98 110.359 174.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.563 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.6 ttt -103.86 123.33 46.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.102 -0.703 . . . . 1.5 109.102 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 23.2 tptm -145.48 128.14 16.18 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.754 -0.461 . . . . 1.69 109.754 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.14 43.32 97.34 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.61 -0.596 . . . . 1.21 111.61 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 50.12 21.17 0.71 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.182 0.993 . . . . 2.9 112.174 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -116.9 152.09 35.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.576 -0.738 . . . . 1.66 110.511 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.507 HG13 HG22 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -98.93 122.63 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.133 0.968 . . . . 0.92 111.666 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.854 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -82.66 111.6 18.77 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.238 -1.393 . . . . 0.71 107.238 164.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.649 ' C ' ' H ' ' A' ' 63' ' ' ASP . 5.8 ttm180 -116.47 103.93 10.93 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 105.709 -1.96 . . . . 3.56 105.709 170.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD2' HG23 ' A' ' 50' ' ' THR . 3.8 mm? 62.54 -34.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.709 0 O-C-N 124.082 0.864 . . . . 1.4 112.202 -166.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.854 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 14.6 t70 81.83 -43.88 0.17 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.266 1.426 . . . . 2.14 109.168 -169.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.76 -32.63 63.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.898 -1.046 . . . . 3.8 110.839 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 61' ' ' ARG . . . -56.13 -40.47 73.85 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.056 -0.52 . . . . 1.76 111.59 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.5 mm? -64.12 -30.57 71.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.487 -0.779 . . . . 2.36 112.267 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HD2' ' N ' ' A' ' 67' ' ' ARG . 3.0 mmm180 -83.0 -41.98 18.07 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.592 0.71 . . . . 4.45 109.332 -174.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -74.42 116.89 15.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.392 -1.276 . . . . 5.92 110.926 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.61 90.28 0.24 Allowed Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.835 -0.621 . . . . 5.06 112.135 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -74.21 79.26 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.731 0.777 . . . . 6.88 110.666 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.9 t -164.78 -57.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.174 -1.375 . . . . 8.52 107.413 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.53 -48.53 15.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.782 -1.099 . . . . 10.75 108.652 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -107.49 61.41 0.32 Allowed Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.293 -0.867 . . . . 11.62 111.284 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.657 -1.079 . . . . 12.99 111.751 -178.312 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.664 ' HB ' ' OE1' ' A' ' 29' ' ' GLU . 7.3 p . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.116 -0.327 . . . . 2.46 110.116 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.04 111.3 18.06 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.998 -0.741 . . . . 3.48 108.998 170.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.0 mtp -86.21 17.8 3.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.693 -0.685 . . . . 2.17 111.65 -170.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m -78.93 -27.77 43.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.35 0.595 . . . . 1.47 110.504 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -108.28 9.61 27.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.769 0.795 . . . . 1.89 110.558 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.415 HG11 ' OG1' ' A' ' 9' ' ' THR . 84.5 t -102.48 127.74 55.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.399 -0.819 . . . . 1.25 110.842 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 22' ' ' LYS . 24.5 m -86.7 -23.27 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.848 0.356 . . . . 1.03 110.964 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -167.37 138.76 3.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 1.41 110.581 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.415 ' OG1' HG11 ' A' ' 6' ' ' VAL . 3.4 m -120.76 143.97 48.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.484 -0.78 . . . . 0.4 109.728 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.76 129.39 51.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 122.372 1.082 . . . . 1.06 111.653 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -96.76 125.47 41.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.117 -1.856 . . . . 1.94 108.99 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.613 HD12 ' HB2' ' A' ' 16' ' ' SER . 16.7 mt -80.84 148.81 29.8 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.117 -1.068 . . . . 1.5 108.117 177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.562 ' HG2' ' HA ' ' A' ' 47' ' ' ARG . 51.9 mt-30 -65.06 -5.34 6.2 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.98 0.363 . . . . 1.68 111.98 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.33 -27.11 14.64 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.189 0.518 . . . . 2.11 110.129 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 135.24 -19.58 3.84 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.771 -0.728 . . . . 1.28 113.124 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.613 ' HB2' HD12 ' A' ' 12' ' ' LEU . 6.3 m -68.56 155.55 39.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.827 0.346 . . . . 1.07 110.584 -177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -124.99 127.72 47.44 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.265 -0.425 . . . . 1.84 111.069 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.4 t -108.23 143.47 18.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.754 -0.832 . . . . 0.41 108.754 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' MET . 4.0 m-70 -131.14 130.12 42.69 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.088 -0.645 . . . . 0.67 110.62 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 116.38 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.79 -1.559 . . . . 0.81 106.79 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' HE1' ' N ' ' A' ' 27' ' ' GLY . 73.1 m-85 -85.63 155.28 21.19 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.72 -0.673 . . . . 0.64 111.316 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 5' ' ' ASN . 12.8 ptmm? -57.49 -22.85 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.964 -1.016 . . . . 2.87 112.273 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -94.46 2.52 55.73 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.843 -0.799 . . . . 1.97 108.843 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.39 -11.57 59.91 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.83 -1.077 . . . . 0.58 114.386 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.66 179.87 7.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.082 0.941 . . . . 1.74 111.19 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.622 ' HG2' HD12 ' A' ' 59' ' ' ILE . 2.5 mpp? -139.44 143.62 37.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.144 0.497 . . . . 1.07 109.983 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' N ' ' HE1' ' A' ' 21' ' ' PHE . . . -136.79 146.28 18.21 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.932 -0.867 . . . . 0.39 110.932 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.4 ttt -122.62 144.73 48.93 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.932 0.396 . . . . 0.87 111.302 -175.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.664 ' OE1' ' HB ' ' A' ' 1' ' ' VAL . 22.9 mt-10 -126.75 148.89 49.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.946 -1.131 . . . . 1.14 107.946 172.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -86.38 170.44 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.231 -0.588 . . . . 1.41 110.121 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 19.3 pttm -58.02 1.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.626 0.972 . . . . 1.77 113.626 173.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -107.47 -1.84 21.03 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.521 -0.548 . . . . 1.08 109.521 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.3 22.17 52.4 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.819 -0.705 . . . . 0.54 112.268 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -110.97 137.82 48.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.413 0.625 . . . . 3.25 111.414 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -74.65 139.12 43.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.163 -1.38 . . . . 1.55 111.869 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.1 ptm -150.45 178.82 8.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.612 -0.722 . . . . 1.38 109.602 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -104.84 158.95 16.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.774 0.321 . . . . 2.78 110.629 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.8 ttt -101.45 130.2 25.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 1.32 110.091 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.98 132.86 17.4 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.71 2.273 . . . . 1.24 112.772 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 54' ' ' MET . 36.6 tt0 -73.89 138.42 44.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.15 110.23 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.93 62.73 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.824 -0.703 . . . . 0.68 112.979 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -102.93 127.02 50.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.955 0.407 . . . . 2.3 111.887 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.609 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.7 p -95.6 132.27 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.582 -0.735 . . . . 0.93 109.138 178.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 71.6 mtm -119.48 148.55 43.13 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.792 -0.447 . . . . 1.31 109.792 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -102.99 147.32 27.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.228 0.537 . . . . 1.64 110.746 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.83 162.34 14.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.325 -0.852 . . . . 0.53 111.264 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.562 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 99.7 mtt180 -58.85 -26.2 63.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.88 -0.6 . . . . 3.73 111.786 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.68 -14.94 38.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 2.7 110.402 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.79 26.33 6.82 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.912 -0.661 . . . . 0.77 112.95 175.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.786 HG21 HH11 ' A' ' 61' ' ' ARG . 43.6 m -111.13 165.16 12.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.505 -0.554 . . . . 1.35 109.505 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' N ' HG22 ' A' ' 50' ' ' THR . 68.1 mttm -122.42 143.83 49.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.592 -0.522 . . . . 1.84 109.592 176.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 20.6 pt -136.32 150.5 27.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 0.66 111.141 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.699 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.15 144.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 116.313 -0.403 . . . . 0.98 110.732 177.073 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 25.8 ttt -99.99 138.18 37.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.597 -0.52 . . . . 1.5 109.597 -173.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 21.0 tptp -144.41 103.35 3.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 1.69 107.883 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 73.63 -152.1 45.63 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.055 -1.618 . . . . 1.21 109.055 -164.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.63 8.48 14.19 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.106 0.479 . . . . 2.9 110.644 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -104.76 177.87 4.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-O 120.994 0.425 . . . . 1.66 110.481 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.622 HD12 ' HG2' ' A' ' 26' ' ' MET . 11.2 tt -143.59 141.21 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.746 0.784 . . . . 0.92 110.884 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.935 ' CD2' ' HB2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -82.49 114.72 21.1 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.438 -1.319 . . . . 0.71 107.438 169.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.786 HH11 HG21 ' A' ' 50' ' ' THR . 0.4 OUTLIER -114.49 102.75 10.36 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 106.527 -1.657 . . . . 3.56 106.527 170.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.955 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER 60.4 -25.44 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.768 0 O-C-N 124.457 1.098 . . . . 1.4 111.746 -172.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.935 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 22.0 t0 71.18 60.33 0.17 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.39 1.476 . . . . 2.14 111.723 -176.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.749 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 40.7 tt0 168.16 -40.92 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 114.467 -1.242 . . . . 3.8 108.992 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.955 ' H ' HD12 ' A' ' 62' ' ' LEU . . . -49.84 -59.36 3.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.119 -0.946 . . . . 1.76 111.45 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -89.56 -11.48 42.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.475 -0.784 . . . . 2.36 109.907 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.749 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 78.4 ttt180 -77.83 -59.82 2.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.665 -1.152 . . . . 4.45 111.403 -172.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -107.92 74.18 0.93 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.102 0.477 . . . . 5.92 110.495 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.43 51.85 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.581 -0.819 . . . . 5.06 112.134 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -86.42 -35.23 19.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.88 0.371 . . . . 6.88 110.584 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.2 m -105.64 105.35 15.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.208 -0.451 . . . . 8.52 110.568 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -119.41 175.75 5.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.979 -0.555 . . . . 10.75 110.306 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.39 23.11 77.92 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.731 -0.747 . . . . 11.62 111.806 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 N-CA-C 111.072 -0.811 . . . . 12.99 111.072 -177.224 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 19' ' ' HIS . 83.9 t . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.753 0.311 . . . . 2.46 110.599 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.94 162.51 13.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.922 -0.581 . . . . 3.48 110.387 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mmt -92.89 1.6 57.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.039 0.447 . . . . 2.17 111.117 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 p -81.52 -7.21 59.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.57 0.7 . . . . 1.47 110.917 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.455 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -129.44 11.75 5.86 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.068 0.937 . . . . 1.89 109.039 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -117.37 133.47 64.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.016 -1.447 . . . . 1.25 111.658 -175.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 22' ' ' LYS . 35.6 m -88.24 -26.37 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.541 -0.754 . . . . 1.03 111.536 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -167.15 135.79 2.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.344 0.593 . . . . 1.41 111.167 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 m -114.23 144.45 43.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.907 -1.042 . . . . 0.4 110.102 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.49 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 30.9 m-85 -120.15 132.19 55.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.552 0.692 . . . . 1.06 111.136 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.55 125.76 51.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.238 -1.346 . . . . 1.94 108.698 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 16' ' ' SER . 17.4 mt -81.16 153.63 27.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.377 -1.283 . . . . 1.5 107.832 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -65.85 -7.31 15.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.217 0.532 . . . . 1.68 111.232 -175.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.615 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 31.6 t70 -98.45 -13.52 20.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.895 -0.593 . . . . 2.11 109.98 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.551 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 116.07 -13.45 16.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.651 -0.785 . . . . 1.28 113.425 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.602 ' HB2' HD12 ' A' ' 12' ' ' LEU . 4.9 m -72.96 148.19 44.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.792 0.296 . . . . 1.07 110.592 -176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -118.93 127.58 53.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.308 0.575 . . . . 1.84 112.454 -172.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.9 t -109.57 143.2 20.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.165 -1.05 . . . . 0.41 108.165 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' MET . 5.5 m-70 -132.28 137.98 47.68 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.738 -0.785 . . . . 0.67 110.602 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.48 ' O ' HG22 ' A' ' 7' ' ' VAL . 46.5 t -97.67 115.21 36.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.131 -1.433 . . . . 0.81 107.131 169.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 49.5 m-85 -80.6 153.66 27.88 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.933 -0.576 . . . . 0.64 111.167 -173.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.768 ' HA ' HG13 ' A' ' 7' ' ' VAL . 16.7 pttm -57.58 -27.01 62.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.998 -1.001 . . . . 2.87 111.756 -176.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.36 -1.23 54.12 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.209 -0.663 . . . . 1.97 109.209 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.41 41.0 Favored Glycine 0 N--CA 1.423 -2.168 0 C-N-CA 119.92 -1.133 . . . . 0.58 114.879 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -75.05 176.38 7.29 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.934 1.367 . . . . 1.74 111.737 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 2.2 mpp? -140.44 148.82 41.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.957 -0.565 . . . . 1.07 109.945 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.83 145.26 17.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.619 -0.801 . . . . 0.39 111.724 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 ttt -119.27 137.8 53.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.511 . . . . 0.87 110.924 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 23.1 mt-10 -130.58 154.25 48.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.308 -0.86 . . . . 1.14 109.035 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 41.7 p30 -88.42 169.1 12.08 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.275 -0.57 . . . . 1.41 110.053 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 14' ' ' ASP . 40.6 pttt -53.6 -10.64 0.28 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 114.097 1.147 . . . . 1.77 114.097 175.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -99.03 -1.52 39.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 1.08 110.602 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.52 20.53 51.28 Favored Glycine 0 CA--C 1.503 -0.685 0 C-N-CA 120.856 -0.688 . . . . 0.54 111.909 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 27.9 mmmt -102.17 135.62 43.45 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.644 0.735 . . . . 3.25 111.334 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -74.7 127.57 33.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.032 -1.44 . . . . 1.55 111.011 -177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.3 ptm -138.27 176.49 8.66 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 1.38 110.736 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.497 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -96.56 131.19 43.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.118 -0.492 . . . . 2.78 109.849 179.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.8 ttp -85.2 117.64 69.19 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.965 -0.562 . . . . 1.32 110.445 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.46 147.43 64.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.86 2.373 . . . . 1.24 112.809 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 34.6 tt0 -88.82 144.82 25.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.001 -0.545 . . . . 1.15 110.385 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.87 -16.73 60.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.014 -0.613 . . . . 0.68 112.569 176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 42' ' ' LYS . 42.3 mmtm -94.88 119.73 33.93 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.116 0.413 . . . . 2.3 112.116 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.576 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 10.7 p -94.02 119.58 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.078 -0.712 . . . . 0.93 109.078 174.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 65.3 mtm -107.74 152.17 24.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.603 -0.726 . . . . 1.31 110.613 -170.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 50' ' ' THR . 38.1 tt0 -104.64 145.41 30.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.538 0.685 . . . . 1.64 111.497 -176.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 62.0 p -94.93 166.63 11.86 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.746 -1.115 . . . . 0.53 109.925 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -35.92 -49.37 0.62 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.57 1.322 . . . . 3.73 114.57 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.84 -33.69 15.57 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.48 -0.488 . . . . 2.7 111.978 -170.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.79 34.23 0.17 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.985 -1.102 . . . . 0.77 112.837 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 23.5 m -100.87 153.32 19.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.486 -0.931 . . . . 1.35 108.486 176.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB3' HG22 ' A' ' 43' ' ' VAL . 93.4 mttt -124.26 139.55 53.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.432 -0.507 . . . . 1.84 112.075 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.479 ' HA ' ' CE1' ' A' ' 60' ' ' PHE . 31.6 pt -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 115.148 -0.933 . . . . 0.66 110.201 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.733 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -163.41 155.74 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.825 0.345 . . . . 0.98 111.137 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.67 ' N ' HG12 ' A' ' 53' ' ' ILE . 13.4 tmm? -104.79 117.22 33.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.247 -1.019 . . . . 1.5 108.247 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 20.2 tptp -134.0 125.6 28.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.31 -0.626 . . . . 1.69 109.31 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.07 38.13 88.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.756 -0.735 . . . . 1.21 112.155 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 62.46 28.57 16.85 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.607 0.718 . . . . 2.9 110.852 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 54' ' ' MET . 46.0 mt-10 -141.29 159.87 41.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.656 -0.702 . . . . 1.66 110.409 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -102.16 126.64 56.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.456 0.646 . . . . 0.92 111.404 -177.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.733 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.81 110.35 18.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.313 -1.736 . . . . 0.71 106.313 164.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.607 ' C ' ' H ' ' A' ' 63' ' ' ASP . 1.2 tmm_? -114.47 103.64 11.24 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.632 -1.618 . . . . 3.56 106.632 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.603 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 4.0 mm? 55.72 -37.49 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.385 1.053 . . . . 1.4 113.404 -165.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.689 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 0.3 OUTLIER 79.89 -58.73 0.35 Allowed 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 124.839 1.255 . . . . 2.14 109.076 -168.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -19.13 65.32 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.417 -0.811 . . . . 3.8 111.219 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 62' ' ' LEU . . . -67.49 -28.06 67.53 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.437 0.637 . . . . 1.76 110.654 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.7 -33.61 14.27 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.151 -0.931 . . . . 2.36 110.526 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.689 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 16.2 mmt180 -69.43 -64.83 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.263 1.03 . . . . 4.45 110.647 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.494 ' HG2' ' HB2' ' A' ' 67' ' ' ARG . 60.6 mmtt -90.4 139.53 30.59 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.881 -1.509 . . . . 5.92 110.564 -164.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.92 9.86 70.36 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.016 -0.612 . . . . 5.06 112.258 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -120.0 -83.39 0.65 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.946 -0.391 . . . . 6.88 109.946 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.6 m 56.97 -152.2 0.4 Allowed 'General case' 0 C--O 1.235 0.322 0 O-C-N 123.655 0.597 . . . . 8.52 111.149 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -153.4 -73.99 0.13 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.092 0.473 . . . . 10.75 109.893 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.99 25.84 1.01 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.937 -0.649 . . . . 11.62 111.715 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.822 -0.988 . . . . 12.99 111.347 -179.146 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 52.7 t . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.785 0.326 . . . . 2.46 110.85 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.7 t70 67.08 105.42 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.208 -0.905 . . . . 3.48 110.809 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.573 ' HA ' HG12 ' A' ' 6' ' ' VAL . 22.6 mmt -84.62 11.36 9.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.348 -0.842 . . . . 2.17 111.466 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -92.74 -37.36 12.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.946 0.403 . . . . 1.47 111.004 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.56 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -107.0 -6.47 17.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.235 0.541 . . . . 1.89 111.417 -176.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 19' ' ' HIS . 4.8 p -94.73 141.1 15.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.95 -0.469 . . . . 1.25 110.502 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -94.98 -23.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.865 -0.334 . . . . 1.03 110.9 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -160.15 136.53 8.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.383 0.611 . . . . 1.41 110.82 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -121.2 135.2 55.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.024 -0.989 . . . . 0.4 109.538 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 27.8 m-85 -117.26 134.06 55.25 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.864 0.84 . . . . 1.06 111.754 -177.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 10.7 t70 -104.08 126.15 50.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.188 -1.369 . . . . 1.94 108.517 176.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 16' ' ' SER . 8.8 mt -71.51 0.09 9.26 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.423 -1.262 . . . . 1.5 112.623 -172.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 7.6 tt0 86.87 -24.37 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.963 -0.754 . . . . 1.68 108.963 173.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -95.15 -21.13 18.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.102 -0.954 . . . . 2.11 109.16 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.584 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 139.36 -29.97 2.46 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.543 -0.837 . . . . 1.28 113.945 175.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' HD12 ' A' ' 12' ' ' LEU . 3.8 m -66.05 149.07 50.84 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 117.09 0.445 . . . . 1.07 110.264 -176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 46.8 mttm -124.44 126.72 46.39 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.133 0.492 . . . . 1.84 111.432 -172.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.58 141.81 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.897 -0.779 . . . . 0.41 108.897 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.585 ' HB3' HG21 ' A' ' 6' ' ' VAL . 4.9 m-70 -130.59 130.19 43.71 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.331 -0.547 . . . . 0.67 110.27 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.09 111.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.058 -1.46 . . . . 0.81 107.058 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 85.6 m-85 -89.72 163.09 15.24 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.02 -0.536 . . . . 0.64 110.888 -168.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 24.9 mtpp -66.82 -21.05 66.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.423 0.63 . . . . 2.87 110.387 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -77.41 -13.33 59.95 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.276 -1.009 . . . . 1.97 108.276 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.58 -6.99 71.14 Favored Glycine 0 N--CA 1.422 -2.258 0 CA-C-N 114.043 -1.435 . . . . 0.58 112.93 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -78.49 171.9 14.44 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.622 0.725 . . . . 1.74 111.452 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.707 ' HG2' HG13 ' A' ' 59' ' ' ILE . 4.0 mpp? -130.74 138.14 49.82 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.625 -1.171 . . . . 1.07 110.022 176.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.37 139.27 10.83 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 111.218 -0.753 . . . . 0.39 111.218 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.9 ttt -117.73 133.97 55.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.253 0.549 . . . . 0.87 110.877 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -121.03 149.33 42.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.11 -0.95 . . . . 1.14 108.64 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 32' ' ' PHE . 43.9 p30 -86.96 169.5 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.658 -0.417 . . . . 1.41 110.132 176.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 45.8 pttt -59.24 5.08 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.44 0.904 . . . . 1.77 113.44 172.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 30' ' ' ASN . 89.5 m-85 -106.78 -2.9 21.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.169 -0.678 . . . . 1.08 109.169 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.07 27.48 40.6 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.789 -0.641 . . . . 0.54 114.074 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 157.14 42.55 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.054 -0.658 . . . . 3.25 111.332 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.4 p -74.66 126.52 31.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.039 -0.982 . . . . 1.55 111.181 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.4 ptm -126.27 -175.61 3.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.977 -0.556 . . . . 1.38 110.804 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -82.22 132.06 35.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.133 -0.485 . . . . 2.78 110.233 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 27.6 ttt -97.62 123.55 51.65 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.204 -0.453 . . . . 1.32 110.41 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 38' ' ' MET . 19.0 Cg_exo -65.73 152.09 82.62 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.81 2.34 . . . . 1.24 111.731 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 53' ' ' ILE . 32.8 tt0 -83.75 -90.59 0.09 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.052 -0.259 . . . . 1.15 111.042 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.539 ' HA2' HD11 ' A' ' 53' ' ' ILE . . . -81.15 40.76 2.56 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.179 -0.534 . . . . 0.68 113.85 -170.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -109.44 119.63 40.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.652 0.263 . . . . 2.3 110.818 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.544 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 7.4 p -81.34 117.91 28.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.47 0.652 . . . . 0.93 109.361 177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.8 mtm -103.2 146.4 28.48 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.698 -0.683 . . . . 1.31 110.996 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 51' ' ' LYS . 32.9 tt0 -98.75 151.64 20.55 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.353 -0.839 . . . . 1.64 109.866 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -126.41 164.75 20.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.004 0.431 . . . . 0.53 112.14 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HG2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -60.43 -28.7 68.49 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.749 -0.659 . . . . 3.73 111.91 176.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.471 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 20.0 t70 -90.71 -19.15 23.89 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.618 -0.719 . . . . 2.7 110.87 -171.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.25 15.62 18.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.632 -0.794 . . . . 0.77 112.488 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.519 HG23 HD22 ' A' ' 62' ' ' LEU . 63.8 m -94.75 142.93 26.89 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.906 -0.405 . . . . 1.35 109.906 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' NZ ' ' HB2' ' A' ' 45' ' ' GLU . 67.1 mmtt -108.67 132.33 54.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 1.84 108.848 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.3 pt -135.99 156.91 37.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.763 0.283 . . . . 0.66 111.763 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.762 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -165.19 150.88 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.764 -0.653 . . . . 0.98 110.121 176.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 16.6 tmm? -111.43 129.94 55.86 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.968 -0.382 . . . . 1.5 109.968 -174.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -144.35 124.69 13.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.589 -0.278 . . . . 1.69 110.272 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 57' ' ' ASN . . . 62.54 39.51 97.94 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.835 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER 72.55 -10.66 0.91 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.213 0.53 . . . . 2.9 111.208 -178.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 54' ' ' MET . 45.2 mt-10 -89.79 167.84 12.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.138 -0.483 . . . . 1.66 109.98 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.707 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -126.26 125.66 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.879 0.847 . . . . 0.92 110.875 -178.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.762 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -81.56 110.41 16.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.248 -1.39 . . . . 0.71 107.248 169.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.596 ' C ' ' H ' ' A' ' 63' ' ' ASP . 38.7 ttp-105 -125.96 112.01 15.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.43 -1.693 . . . . 3.56 106.43 174.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.6 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 4.2 mm? 59.89 -37.05 0.08 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 124.196 0.935 . . . . 1.4 112.668 -166.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.678 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 2.1 t70 81.54 -34.22 0.1 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.768 1.227 . . . . 2.14 110.088 -174.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -94.21 -16.07 23.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.115 -0.948 . . . . 3.8 111.127 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . . . -64.3 -49.2 72.74 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.251 0.548 . . . . 1.76 111.181 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 mp -73.25 -31.96 64.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.56 -0.745 . . . . 2.36 110.487 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.63 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 37.2 ttm180 -68.48 -64.23 0.9 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.029 -0.987 . . . . 4.45 111.172 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.63 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 73.7 mmtt -105.28 78.99 1.43 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.921 -0.581 . . . . 5.92 110.474 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.7 65.5 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.66 -0.781 . . . . 5.06 112.334 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -72.26 122.08 20.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.269 0.556 . . . . 6.88 109.682 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.9 t -82.06 121.49 26.62 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.364 -0.835 . . . . 8.52 112.392 -167.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -76.22 -42.8 44.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.308 -0.997 . . . . 10.75 108.308 168.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.82 153.99 13.41 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.325 -0.852 . . . . 11.62 112.451 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.567 -1.129 . . . . 12.99 111.583 177.912 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.464 -0.198 . . . . 2.46 110.464 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -77.03 149.33 35.85 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.065 -0.346 . . . . 3.48 110.065 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.9 mmt -101.04 -3.16 29.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.806 0.336 . . . . 2.17 111.444 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -73.57 -24.94 60.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.903 0.859 . . . . 1.47 109.873 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.504 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -105.3 10.39 33.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.664 -1.153 . . . . 1.89 110.595 -177.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 19' ' ' HIS . 74.5 t -105.87 135.64 43.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.479 -0.782 . . . . 1.25 109.959 -173.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -105.84 -18.46 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.035 -0.53 . . . . 1.03 111.072 -178.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -169.01 132.95 1.4 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.123 0.487 . . . . 1.41 110.613 171.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.0 m -110.89 143.8 40.93 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.381 -0.827 . . . . 0.4 110.583 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.563 ' OH ' ' HD3' ' A' ' 61' ' ' ARG . 20.7 m-85 -124.9 139.82 53.49 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 121.425 0.631 . . . . 1.06 111.441 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.323 -1.308 . . . . 1.94 108.723 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 16' ' ' SER . 43.3 mt -83.21 148.96 27.12 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.99 -1.004 . . . . 1.5 109.654 -177.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.27 -15.49 35.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.309 0.576 . . . . 1.68 111.618 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 20.7 t70 -96.39 -1.79 46.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.545 -0.752 . . . . 2.11 109.785 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 104.58 -19.3 42.37 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.113 -0.949 . . . . 1.28 112.832 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.669 ' HB2' HD12 ' A' ' 12' ' ' LEU . 40.1 m -72.84 159.97 32.9 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.574 -0.313 . . . . 1.07 110.671 -177.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 32.8 mttt -119.43 152.55 36.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.136 0.493 . . . . 1.84 110.694 -177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.408 HG11 HD12 ' A' ' 52' ' ' ILE . 75.4 t -131.48 144.25 38.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.855 -0.794 . . . . 0.41 108.855 174.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HB3' HG13 ' A' ' 6' ' ' VAL . 3.1 m-70 -134.6 135.15 42.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.48 -0.563 . . . . 0.67 109.48 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 7' ' ' VAL . 48.2 t -93.63 118.24 39.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 106.579 -1.638 . . . . 0.81 106.579 168.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.401 ' HE1' ' HA3' ' A' ' 27' ' ' GLY . 48.7 m-85 -81.98 150.36 27.68 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.77 -0.65 . . . . 0.64 110.9 -172.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -61.34 -22.33 64.81 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.416 -0.811 . . . . 2.87 111.768 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -99.69 6.65 45.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.76 0.791 . . . . 1.97 109.079 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.24 1.49 60.97 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.711 -1.131 . . . . 0.58 115.007 171.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -75.89 173.11 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.827 1.314 . . . . 1.74 111.21 172.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.701 ' HG2' HD12 ' A' ' 59' ' ' ILE . 3.2 mpp? -138.07 131.33 30.43 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.343 -0.984 . . . . 1.07 108.343 171.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA3' ' HE1' ' A' ' 21' ' ' PHE . . . -124.0 141.92 13.82 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.249 -0.977 . . . . 0.39 111.922 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.5 ttt -113.64 141.0 47.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.793 0.33 . . . . 0.87 110.191 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 16.6 mt-10 -123.53 144.66 49.42 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.619 -1.252 . . . . 1.14 107.619 169.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.434 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 29.9 p-10 -87.62 165.91 15.09 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.87 -0.732 . . . . 1.41 109.169 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 17.9 pttm -52.22 -13.21 0.31 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.607 0.966 . . . . 1.77 113.607 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.434 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 93.7 m-85 -98.73 7.77 45.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.923 0.392 . . . . 1.08 110.669 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.02 20.57 64.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.248 -0.501 . . . . 0.54 113.0 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.3 mmtm -102.01 140.83 35.77 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.746 0.784 . . . . 3.25 111.024 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.3 p -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.913 -1.494 . . . . 1.55 112.327 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 57.2 mtp -139.07 178.34 7.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.032 -0.985 . . . . 1.38 109.83 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -114.79 139.25 49.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.058 -0.719 . . . . 2.78 109.058 173.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.0 ttm -71.24 127.11 91.78 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.648 0.261 . . . . 1.32 110.86 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -65.87 114.49 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.19 1.927 . . . . 1.24 111.253 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 54' ' ' MET . 34.5 tt0 -61.87 129.45 41.0 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.807 -0.633 . . . . 1.15 110.373 -176.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.41 -20.22 30.51 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.125 -0.56 . . . . 0.68 112.781 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 42' ' ' LYS . 22.2 mmmt -88.55 119.83 29.36 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.907 0.336 . . . . 2.3 111.907 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.675 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.98 136.47 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.554 -0.535 . . . . 0.93 109.554 172.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 68.2 mtm -132.22 157.12 45.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.579 -0.282 . . . . 1.31 110.751 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.33 150.75 20.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.882 0.849 . . . . 1.64 111.941 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 30.1 p -97.19 165.78 11.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.29 -1.323 . . . . 0.53 108.87 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -46.66 -36.33 6.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.996 0.739 . . . . 3.73 112.996 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -96.78 -49.96 4.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.356 0.502 . . . . 2.7 112.356 -168.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.9 32.24 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.411 -1.376 . . . . 0.77 113.712 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.6 t -114.03 156.65 23.72 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.457 -0.942 . . . . 1.35 108.457 168.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -120.38 145.67 46.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.651 0.263 . . . . 1.84 110.596 -171.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 12' ' ' LEU . 22.6 pt -136.46 152.28 29.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.887 -0.597 . . . . 0.66 110.863 177.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.97 147.38 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.066 -0.515 . . . . 0.98 110.549 176.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 26.2 ttt -97.53 129.66 44.66 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.26 -0.644 . . . . 1.5 109.26 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -144.99 128.33 16.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.159 -0.311 . . . . 1.69 110.159 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.32 37.25 93.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.151 -0.547 . . . . 1.21 112.471 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.402 HD22 ' N ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 61.24 25.33 15.33 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.674 0.749 . . . . 2.9 111.05 -178.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -128.06 -169.51 2.08 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 114.807 -1.088 . . . . 1.66 108.45 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.701 HD12 ' HG2' ' A' ' 26' ' ' MET . 3.3 tt -143.54 136.43 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-O 121.792 0.806 . . . . 0.92 111.529 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.665 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.1 109.41 17.13 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 106.795 -1.557 . . . . 0.71 106.795 167.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.563 ' HD3' ' OH ' ' A' ' 10' ' ' TYR . 1.3 tmm_? -121.35 108.87 14.22 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 105.031 -2.211 . . . . 3.56 105.031 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 4.5 mm? 62.41 -60.04 0.13 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 1.4 109.163 -156.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.613 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 5.3 t70 139.23 -35.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.065 2.146 . . . . 2.14 107.771 175.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 67' ' ' ARG . 8.5 pt-20 -101.9 -29.75 11.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.198 -1.365 . . . . 3.8 111.546 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.41 -53.18 61.25 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.016 -0.538 . . . . 1.76 112.1 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -89.64 -16.06 31.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.995 0.426 . . . . 2.36 110.486 179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.602 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 63.4 ttt180 -56.0 -57.38 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.134 -0.939 . . . . 4.45 110.324 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -99.32 82.59 2.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.85 -0.796 . . . . 5.92 108.85 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.41 -52.62 0.17 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.713 -1.13 . . . . 5.06 111.087 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -98.81 89.79 4.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.423 -0.584 . . . . 6.88 109.423 174.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.1 p -128.93 165.96 20.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.532 -0.758 . . . . 8.52 110.094 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 61.56 28.27 17.55 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.685 0.615 . . . . 10.75 111.191 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.71 24.58 6.06 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.879 -0.6 . . . . 11.62 111.665 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.802 -0.999 . . . . 12.99 111.76 178.435 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.51 HG11 ' CE1' ' A' ' 19' ' ' HIS . 29.9 m . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 110.741 -0.096 . . . . 2.46 110.741 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 45.59 65.57 1.11 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.638 0.732 . . . . 3.48 111.921 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.594 ' H ' HG12 ' A' ' 6' ' ' VAL . 21.0 mmt -69.92 -20.91 63.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.08 -0.963 . . . . 2.17 111.89 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 3' ' ' MET . 73.6 m 73.53 -27.62 0.19 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 123.809 0.843 . . . . 1.47 109.335 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 3' ' ' MET . 1.3 t30 -95.85 -14.7 22.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.939 -1.028 . . . . 1.89 109.914 168.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.8 p -89.18 136.11 24.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 119.384 -0.926 . . . . 1.25 110.088 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.25 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.962 -0.295 . . . . 1.03 111.499 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 16.7 tppt? -169.32 151.49 4.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.228 0.537 . . . . 1.41 111.286 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 3.9 m -133.08 145.75 51.04 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.553 -0.749 . . . . 0.4 109.795 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 61' ' ' ARG . 38.7 m-85 -128.61 144.63 51.19 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.723 0.773 . . . . 1.06 112.333 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.948 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 6.5 m-20 -106.56 123.7 48.5 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.782 -1.553 . . . . 1.94 110.026 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 16' ' ' SER . 9.5 mt -77.34 1.84 17.63 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.92 -1.491 . . . . 1.5 113.022 -173.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.559 ' HB2' ' HA ' ' A' ' 47' ' ' ARG . 62.7 tt0 83.68 -32.61 0.07 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.059 0.544 . . . . 1.68 109.998 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 10.8 t70 -79.87 -20.14 46.63 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.429 -1.323 . . . . 2.11 107.429 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.598 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 126.54 -17.2 6.53 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.266 -1.334 . . . . 1.28 113.485 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.618 ' HB2' HD12 ' A' ' 12' ' ' LEU . 11.3 m -62.51 143.74 56.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.841 0.353 . . . . 1.07 110.414 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 10' ' ' TYR . 65.7 mttm -116.46 126.96 54.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.088 -0.505 . . . . 1.84 110.713 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' THR . 97.1 t -109.58 136.09 46.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.524 -0.547 . . . . 0.41 109.524 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.65 ' HB3' HG21 ' A' ' 6' ' ' VAL . 2.5 m-70 -123.34 127.43 48.49 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.366 -0.534 . . . . 0.67 110.418 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.46 115.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.555 -1.276 . . . . 0.81 107.555 171.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HE1' ' HG3' ' A' ' 3' ' ' MET . 91.0 m-85 -94.93 164.41 12.92 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.273 -0.421 . . . . 0.64 111.248 -171.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 54.1 mttm -60.53 -26.25 66.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.931 0.492 . . . . 2.87 112.26 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -91.07 3.56 54.42 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.653 0.739 . . . . 1.97 109.07 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.08 -2.02 81.01 Favored Glycine 0 N--CA 1.427 -1.919 0 CA-C-N 114.562 -1.199 . . . . 0.58 113.589 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -81.05 173.35 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.332 0.566 . . . . 1.74 110.792 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 3.7 mpp? -134.43 138.64 44.94 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.498 -0.773 . . . . 1.07 109.627 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.55 134.22 9.89 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 111.096 -0.802 . . . . 0.39 111.096 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' SER . 1.7 tmt? -113.73 134.63 54.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.811 0.339 . . . . 0.87 110.211 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 35.8 mt-10 -126.49 148.52 49.68 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.705 -0.68 . . . . 1.14 109.294 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.588 ' OD1' ' HG3' ' A' ' 34' ' ' LYS . 36.2 p-10 -85.95 171.33 11.54 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.678 -0.49 . . . . 1.41 109.678 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.598 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 37.3 pttt -59.18 5.28 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.982 1.104 . . . . 1.77 113.982 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.1 m-85 -113.05 3.28 16.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.306 0.574 . . . . 1.08 109.711 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.36 23.56 65.2 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.54 113.711 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.588 ' HG3' ' OD1' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -112.55 144.86 41.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.333 -0.547 . . . . 3.25 110.48 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 28' ' ' MET . 24.9 t -78.83 136.69 37.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.203 -0.908 . . . . 1.55 111.553 -173.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.6 mtm -133.62 175.04 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.05 -0.722 . . . . 1.38 109.05 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -96.19 140.49 30.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.9 0.381 . . . . 2.78 110.618 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.1 ttm -95.52 121.6 61.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.828 -0.624 . . . . 1.32 110.953 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.547 ' HG2' ' HG3' ' A' ' 42' ' ' LYS . 59.3 Cg_endo -75.18 125.23 9.07 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.407 2.071 . . . . 1.24 112.299 176.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.512 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 43.9 tt0 -66.72 142.0 57.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.954 -0.566 . . . . 1.15 110.606 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.04 -2.85 51.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.862 -0.685 . . . . 0.68 112.835 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HG3' ' HG2' ' A' ' 39' ' ' PRO . 11.7 mmpt? -100.8 122.73 43.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.749 -0.265 . . . . 2.3 111.384 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.644 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.8 p -93.84 124.59 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.678 0.751 . . . . 0.93 109.084 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 55.5 mtt -116.6 148.32 41.04 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.359 -0.837 . . . . 1.31 109.257 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -102.85 155.95 17.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.981 0.42 . . . . 1.64 110.587 -175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.6 p -104.24 163.42 12.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.723 -0.671 . . . . 0.53 110.951 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.948 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 1.7 ptt180 -50.12 -30.03 10.3 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.686 0.995 . . . . 3.73 113.686 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.49 -31.06 16.92 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.461 -0.336 . . . . 2.7 111.318 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.92 19.64 1.58 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.164 -1.017 . . . . 0.77 113.299 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 51.2 m -100.38 160.02 14.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.072 -0.714 . . . . 1.35 109.072 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -117.08 139.07 51.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.713 0.292 . . . . 1.84 110.589 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.824 HG22 ' HD3' ' A' ' 61' ' ' ARG . 17.1 pt -132.89 158.39 43.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 116.146 -0.479 . . . . 0.66 109.719 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.686 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -158.28 143.15 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 121.252 0.548 . . . . 0.98 111.765 175.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.452 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 23.1 ttt -90.96 112.62 24.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.489 -0.93 . . . . 1.5 108.489 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 50.9 tptt -145.13 130.25 18.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.198 -0.456 . . . . 1.69 110.059 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.7 40.43 37.6 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.132 -0.556 . . . . 1.21 112.559 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.14 31.74 20.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.456 0.646 . . . . 2.9 110.402 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -149.27 175.81 11.08 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.722 -0.844 . . . . 1.66 108.722 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 tt -126.77 134.98 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.704 0.764 . . . . 0.92 111.158 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -93.81 131.4 39.23 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.855 -1.066 . . . . 0.71 108.748 171.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.824 ' HD3' HG22 ' A' ' 52' ' ' ILE . 14.8 tpt85 -157.12 100.42 1.86 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 104.56 -2.385 . . . . 3.56 104.56 170.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.9 mm? 74.77 -48.82 0.65 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.677 0.671 . . . . 1.4 111.117 -174.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 11.0 t70 71.29 -56.7 0.62 Allowed 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 123.974 0.796 . . . . 2.14 109.696 -175.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -57.73 -36.06 71.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.173 -0.921 . . . . 3.8 111.488 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.72 2.1 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.126 -0.488 . . . . 1.76 111.946 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.648 ' HA ' ' HB3' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -83.75 -14.52 51.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.216 -0.447 . . . . 2.36 111.343 -178.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.57 ' HG2' ' HG2' ' A' ' 68' ' ' LYS . 41.4 ttt180 -70.6 -68.37 0.43 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.121 -0.491 . . . . 4.45 110.04 176.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.57 ' HG2' ' HG2' ' A' ' 67' ' ' ARG . 31.3 mmmt -132.56 106.04 7.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.812 -0.631 . . . . 5.92 109.657 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.89 -65.67 0.41 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.5 -1.04 . . . . 5.06 110.5 -174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.648 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 76.5 t60 -69.34 -33.12 72.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.001 0.429 . . . . 6.88 110.174 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.5 m -84.37 3.94 33.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.0 -0.546 . . . . 8.52 111.343 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -82.15 -72.26 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.234 0.54 . . . . 10.75 109.588 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.23 130.05 2.2 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.632 -0.713 . . . . 11.62 111.461 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.637 -1.091 . . . . 12.99 111.859 -177.729 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.578 0.228 . . . . 2.46 110.45 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -80.16 157.55 26.56 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.024 0.44 . . . . 3.48 110.892 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.422 ' HE2' HG21 ' A' ' 6' ' ' VAL . 31.8 mmt -92.51 0.76 57.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.783 -0.644 . . . . 2.17 110.741 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 m -71.59 -27.25 63.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.814 0.816 . . . . 1.47 110.191 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.505 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.2 OUTLIER -115.13 17.76 16.57 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.597 -1.183 . . . . 1.89 111.238 -174.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 19' ' ' HIS . 76.3 t -111.79 115.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.666 -0.697 . . . . 1.25 109.974 -174.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 20' ' ' VAL . 2.8 p -90.71 -18.54 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.575 -0.738 . . . . 1.03 110.578 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -167.23 130.09 1.73 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.482 0.658 . . . . 1.41 110.782 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.421 ' OG1' HG11 ' A' ' 6' ' ' VAL . 83.7 m -108.35 145.81 33.92 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.646 -1.161 . . . . 0.4 109.935 177.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HE2' ' HD3' ' A' ' 61' ' ' ARG . 26.7 m-85 -123.91 133.23 53.78 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 121.743 0.783 . . . . 1.06 111.384 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.674 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -101.53 122.71 44.32 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.024 -1.444 . . . . 1.94 109.071 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.587 HD12 ' HB2' ' A' ' 16' ' ' SER . 41.0 mt -83.46 151.24 25.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.898 -1.046 . . . . 1.5 108.487 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 47' ' ' ARG . 75.8 mt-30 -66.69 -8.16 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.643 0.735 . . . . 1.68 111.355 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 3.9 t70 -87.14 -23.14 24.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.051 -0.977 . . . . 2.11 109.378 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.566 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 115.34 -25.2 9.98 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.758 -1.11 . . . . 1.28 111.699 -176.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.587 ' HB2' HD12 ' A' ' 12' ' ' LEU . 49.5 m -66.53 157.13 33.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.97 0.414 . . . . 1.07 110.234 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -125.51 147.41 49.25 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.243 0.544 . . . . 1.84 112.056 -171.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.95 148.59 24.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.993 -1.003 . . . . 0.41 108.487 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.552 ' HB3' HG13 ' A' ' 6' ' ' VAL . 12.8 m-70 -135.06 137.15 42.63 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.254 -0.579 . . . . 0.67 109.923 172.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 7' ' ' VAL . 49.7 t -95.52 109.41 22.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 106.573 -1.64 . . . . 0.81 106.573 166.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.57 155.82 29.48 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.37 -0.832 . . . . 0.64 110.714 -171.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 47.7 mtpt -68.85 -18.53 64.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.68 0.752 . . . . 2.87 110.217 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -82.43 -6.22 59.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.571 -1.195 . . . . 1.97 108.056 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.23 6.3 71.51 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 113.986 -1.461 . . . . 0.58 112.995 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -86.75 177.44 7.32 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.297 0.57 . . . . 1.74 110.653 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.961 ' HG2' HD12 ' A' ' 59' ' ' ILE . 4.5 mpp? -139.91 140.21 36.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.122 -0.945 . . . . 1.07 109.221 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -139.78 151.2 21.91 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.252 -0.975 . . . . 0.39 112.242 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 ttt -122.05 142.28 50.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.999 0.428 . . . . 0.87 110.746 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 34.5 mt-10 -130.68 151.47 51.09 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.013 -1.106 . . . . 1.14 108.013 175.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 32' ' ' PHE . 27.4 p-10 -84.6 167.71 16.01 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.142 -0.623 . . . . 1.41 109.657 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.566 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 15.0 pttm -50.9 4.8 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.868 1.433 . . . . 1.77 114.868 174.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 30' ' ' ASN . 96.3 m-85 -122.96 2.82 9.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.255 -0.278 . . . . 1.08 111.155 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.39 27.61 43.03 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.479 -0.867 . . . . 0.54 112.964 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 25.7 mmmt -100.85 130.09 46.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.717 0.77 . . . . 3.25 110.247 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 p -80.82 127.55 32.66 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.152 -1.386 . . . . 1.55 112.593 -171.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 65.4 mtm -127.63 -171.96 2.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.58 -0.736 . . . . 1.38 109.431 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.0 OUTLIER -97.86 156.01 16.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.885 -0.413 . . . . 2.78 109.885 176.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.457 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 17.4 tpt -82.81 122.77 78.38 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 1.32 110.809 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.457 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 69.5 Cg_endo -79.13 117.83 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.517 2.144 . . . . 1.24 112.841 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -87.64 139.54 30.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.624 -0.716 . . . . 1.15 110.447 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.62 ' HA2' ' HD3' ' A' ' 55' ' ' LYS . . . 108.13 -9.37 36.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.988 -0.625 . . . . 0.68 113.284 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 42' ' ' LYS . 29.4 mtpp -109.64 131.19 55.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.242 0.46 . . . . 2.3 112.242 -175.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.638 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 9.5 p -100.91 131.18 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.136 -0.69 . . . . 0.93 109.136 170.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 64.4 mtm -135.16 173.12 12.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.812 -0.631 . . . . 1.31 109.927 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -107.12 164.75 11.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.308 1.051 . . . . 1.64 112.259 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -108.85 162.35 14.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.359 -1.746 . . . . 0.53 108.93 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.674 ' HD3' ' HB3' ' A' ' 11' ' ' ASP . 75.9 mtp180 -55.47 -23.52 26.04 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.233 0.457 . . . . 3.73 112.233 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -98.43 -2.99 37.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.323 . . . . 2.7 111.091 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.24 23.9 13.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.547 -0.835 . . . . 0.77 113.326 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.753 HG23 HD23 ' A' ' 62' ' ' LEU . 64.4 m -95.04 137.08 34.57 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.773 -0.251 . . . . 1.35 110.431 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -99.59 127.98 45.69 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.044 -0.354 . . . . 1.84 110.044 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 18.8 pt -135.09 155.07 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.984 -0.553 . . . . 0.66 110.685 -176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -157.35 149.69 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.922 0.391 . . . . 0.98 110.41 174.278 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.3 ttt -108.19 118.73 37.52 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.073 -1.084 . . . . 1.5 108.073 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.62 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 23.9 tptp -144.68 135.52 24.83 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.203 -0.665 . . . . 1.69 109.203 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.83 32.12 82.69 Favored Glycine 0 C--N 1.322 -0.212 0 C-N-CA 121.018 -0.61 . . . . 1.21 112.647 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.81 19.6 11.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.232 0.539 . . . . 2.9 111.31 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.74 152.56 39.3 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.593 -0.73 . . . . 1.66 109.276 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.961 HD12 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -114.22 127.86 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-O 121.62 0.724 . . . . 0.92 111.889 177.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.621 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -96.06 130.81 42.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.728 -1.212 . . . . 0.71 107.728 167.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.557 ' HD3' ' HE2' ' A' ' 10' ' ' TYR . 7.8 ptt180 -156.46 100.39 1.96 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.047 -1.834 . . . . 3.56 106.047 173.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.753 HD23 HG23 ' A' ' 50' ' ' THR . 0.4 OUTLIER 77.58 -42.01 0.37 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.002 -0.74 . . . . 1.4 109.002 178.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 61' ' ' ARG . 1.3 t70 71.27 -25.75 0.17 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.535 1.134 . . . . 2.14 111.493 177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 62' ' ' LEU . 39.2 mt-10 -90.01 -37.45 14.3 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.74 -0.663 . . . . 3.8 110.389 174.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.53 -42.37 87.62 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.595 -0.729 . . . . 1.76 112.72 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -97.75 6.34 48.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.872 0.844 . . . . 2.36 110.583 -178.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -101.94 -53.35 2.96 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.803 -1.09 . . . . 4.45 109.975 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 25.8 mtpp -145.42 -163.8 1.8 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.041 -0.725 . . . . 5.92 109.041 174.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.22 41.4 9.36 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.528 -0.844 . . . . 5.06 112.173 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -133.2 157.12 46.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.676 0.274 . . . . 6.88 110.313 178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.8 m -113.15 147.63 37.01 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.693 -0.484 . . . . 8.52 109.693 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.03 139.98 53.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.451 . . . . 10.75 110.872 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.69 86.85 1.4 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.82 -0.705 . . . . 11.62 111.726 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-O 118.718 -1.046 . . . . 12.99 111.555 -179.491 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.309 0.099 . . . . 2.46 111.183 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 69.3 142.19 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.505 0.669 . . . . 3.48 111.515 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.5 mmt -98.54 3.51 48.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.907 -0.588 . . . . 2.17 112.108 -171.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.3 m -78.34 -33.01 49.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.05 0.453 . . . . 1.47 110.449 -175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.617 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -97.79 1.81 48.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 1.89 110.696 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.405 HG23 ' ND2' ' A' ' 5' ' ' ASN . 77.7 t -94.03 130.3 43.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.834 -1.075 . . . . 1.25 110.204 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 20' ' ' VAL . 20.2 m -93.3 -25.72 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.465 -0.494 . . . . 1.03 111.918 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -164.16 142.61 7.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.675 0.274 . . . . 1.41 110.489 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 53.4 m -125.05 140.84 52.54 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.226 -0.443 . . . . 0.4 110.458 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 36.2 m-85 -112.38 128.83 56.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 121.693 0.759 . . . . 1.06 112.001 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -102.15 114.9 29.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.717 -1.583 . . . . 1.94 109.826 -178.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.656 ' O ' ' HB2' ' A' ' 13' ' ' GLN . 6.6 mt -75.22 -0.8 20.66 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.352 1.242 . . . . 1.5 114.352 -168.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.656 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 56.9 mt-30 90.84 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.672 0.789 . . . . 1.68 110.17 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.58 -28.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.412 -0.959 . . . . 2.11 108.412 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.693 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 140.24 -22.66 2.74 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.42 -1.264 . . . . 1.28 113.57 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.623 ' HB3' HD12 ' A' ' 12' ' ' LEU . 23.0 t -64.39 141.89 58.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.772 0.796 . . . . 1.07 110.456 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -120.78 126.72 50.84 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.201 -1.363 . . . . 1.84 110.297 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 9' ' ' THR . 86.3 t -112.69 126.25 70.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.437 -0.801 . . . . 0.41 109.041 177.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 26' ' ' MET . 11.9 m-70 -115.62 128.7 56.13 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.565 -0.854 . . . . 0.67 109.733 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.496 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 46.3 t -90.33 112.55 24.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 106.737 -1.579 . . . . 0.81 106.737 172.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -88.16 161.8 17.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.857 -0.61 . . . . 0.64 110.614 -173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 8.1 mtpm? -61.02 -26.35 67.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.331 0.586 . . . . 2.87 111.28 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -83.08 -7.2 59.68 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.162 -0.926 . . . . 1.97 108.836 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.62 -0.99 68.33 Favored Glycine 0 N--CA 1.427 -1.938 0 CA-C-N 114.573 -1.194 . . . . 0.58 113.172 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -85.82 179.68 7.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.309 0.576 . . . . 1.74 110.775 174.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.747 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 59.5 mtm -143.15 148.1 36.0 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.955 -1.021 . . . . 1.07 110.381 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.12 135.28 8.74 Favored Glycine 0 N--CA 1.44 -1.098 0 CA-C-N 115.228 -0.896 . . . . 0.39 111.052 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 35' ' ' SER . 26.8 ttt -111.05 126.61 55.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.082 -0.34 . . . . 0.87 110.082 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 48.6 mt-10 -128.11 155.83 43.8 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.662 -0.866 . . . . 1.14 108.662 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 34' ' ' LYS . 39.4 p30 -91.79 175.32 6.93 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.418 -0.513 . . . . 1.41 110.238 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.693 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 4.4 pttm -51.53 -11.45 0.13 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.604 0.964 . . . . 1.77 113.604 174.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -105.28 -5.02 20.93 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.321 -0.237 . . . . 1.08 111.179 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.41 25.38 28.43 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.798 -0.715 . . . . 0.54 112.417 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 26.3 mmtp -108.68 137.66 46.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.324 0.583 . . . . 3.25 111.845 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 28' ' ' MET . 47.3 t -71.97 131.33 42.78 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.438 -1.255 . . . . 1.55 111.266 -175.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 64.0 mtm -126.04 177.03 6.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.744 -0.662 . . . . 1.38 109.45 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -97.82 127.11 43.54 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.895 -0.409 . . . . 2.78 109.895 179.042 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.456 ' HE2' ' HB2' ' A' ' 54' ' ' MET . 23.9 ttt -83.01 126.18 73.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.855 -0.611 . . . . 1.32 111.044 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.68 153.32 38.54 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.999 2.466 . . . . 1.24 112.88 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 32.5 tt0 -112.51 141.89 45.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 1.15 109.983 176.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.03 2.84 64.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.43 -0.89 . . . . 0.68 112.603 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -109.58 138.73 45.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.585 0.231 . . . . 2.3 111.38 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 59.4 t -90.0 119.71 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.513 -0.551 . . . . 0.93 109.513 171.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -109.74 154.0 23.52 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.18 -0.464 . . . . 1.31 110.303 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -104.26 155.61 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.546 0.689 . . . . 1.64 111.517 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 11' ' ' ASP . 47.8 p -111.32 156.83 20.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.28 -1.327 . . . . 0.53 109.869 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.536 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 47.8 mtp180 -57.53 -21.89 41.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.798 0.296 . . . . 3.73 111.798 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -89.99 -3.39 58.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.07 0.462 . . . . 2.7 110.84 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 26.9 25.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.73 -0.748 . . . . 0.77 113.669 171.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.2 p -108.19 159.69 16.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.331 0.566 . . . . 1.35 110.038 173.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -111.01 135.72 51.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.244 -0.435 . . . . 1.84 109.953 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.563 HG22 ' CG ' ' A' ' 61' ' ' ARG . 8.8 pt -132.17 165.98 30.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.753 -0.658 . . . . 0.66 111.067 -173.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.678 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -159.44 142.22 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.342 -0.39 . . . . 0.98 110.974 167.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.456 ' HB2' ' HE2' ' A' ' 38' ' ' MET . 17.1 tmm? -95.62 120.71 36.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.922 -1.14 . . . . 1.5 107.922 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 46.6 tptt -137.43 112.5 9.08 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.323 -0.621 . . . . 1.69 109.323 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 67.26 52.2 33.19 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.811 -0.631 . . . . 1.21 112.61 -176.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 73.99 -35.24 0.3 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.818 0.847 . . . . 2.9 111.796 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' GLY . 43.1 mt-10 -78.92 156.27 28.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.106 -0.497 . . . . 1.66 110.841 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.747 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -113.79 129.69 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-O 121.47 0.652 . . . . 0.92 109.681 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.678 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -93.91 112.93 24.85 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.874 -0.787 . . . . 0.71 108.874 169.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.68 ' HD3' HD23 ' A' ' 62' ' ' LEU . 2.7 tmt_? -140.29 103.75 4.65 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.442 -2.059 . . . . 3.56 105.442 160.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.68 HD23 ' HD3' ' A' ' 61' ' ' ARG . 3.5 mm? 75.22 -38.38 0.37 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.607 0.639 . . . . 1.4 111.658 -175.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 12.4 t70 76.28 -57.47 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.941 0.775 . . . . 2.14 111.286 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 40.0 tt0 -77.67 -26.31 50.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.139 -0.482 . . . . 3.8 110.483 -176.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.06 -37.75 77.78 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.465 0.65 . . . . 1.76 110.898 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 63' ' ' ASP . 3.5 pp -96.82 -16.98 20.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.091 -0.959 . . . . 2.36 110.606 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.68 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 15.8 ttm180 -71.64 -54.11 11.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.717 -0.674 . . . . 4.45 110.559 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.68 ' HG3' ' HG2' ' A' ' 67' ' ' ARG . 97.0 mttt -139.81 -174.85 4.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.862 -0.608 . . . . 5.92 110.073 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.1 -163.02 30.18 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.792 -0.718 . . . . 5.06 112.351 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 71.8 -63.66 0.42 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.559 0.744 . . . . 6.88 111.425 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.9 t -126.01 170.69 11.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 8.52 110.279 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.31 -35.84 7.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 10.75 110.728 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.32 34.87 0.51 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.404 -0.903 . . . . 11.62 112.706 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.332 -1.26 . . . . 12.99 112.026 179.492 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.65 HG21 ' CD2' ' A' ' 19' ' ' HIS . 7.1 p . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.409 0.147 . . . . 2.46 110.745 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -76.1 143.89 41.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.744 -0.836 . . . . 3.48 108.744 170.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.478 ' HA ' HG12 ' A' ' 6' ' ' VAL . 36.5 mtp -118.42 21.22 12.75 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.544 0.688 . . . . 2.17 109.76 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -92.8 -45.07 8.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.042 . . . . 1.47 110.704 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.42 -5.54 35.97 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.321 0.582 . . . . 1.89 110.891 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' A' ' 19' ' ' HIS . 9.9 p -86.81 125.36 40.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 119.68 -0.808 . . . . 1.25 109.932 -174.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.87 -23.42 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 1.03 111.001 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -167.5 133.21 2.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.43 0.633 . . . . 1.41 111.2 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.41 HG23 ' ND1' ' A' ' 19' ' ' HIS . 2.3 m -111.63 139.78 46.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.946 -1.025 . . . . 0.4 109.635 175.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -115.14 129.66 56.72 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 122.227 1.013 . . . . 1.06 111.727 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -100.73 124.49 46.42 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.14 -1.845 . . . . 1.94 108.176 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.897 HD22 ' HB2' ' A' ' 16' ' ' SER . 10.2 mp -77.68 4.78 10.68 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.455 -0.793 . . . . 1.5 112.231 -174.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.722 ' HG3' ' HD2' ' A' ' 47' ' ' ARG . 25.2 tt0 82.36 -26.99 0.13 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.127 0.489 . . . . 1.68 110.315 167.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -103.39 -49.58 3.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.572 -0.74 . . . . 2.11 110.149 -178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.634 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . -166.32 -52.58 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.366 -1.397 . . . . 1.28 115.301 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.897 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.2 m -70.86 161.95 30.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.327 0.564 . . . . 1.07 111.163 -171.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -129.6 145.98 51.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.978 -0.555 . . . . 1.84 110.772 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.635 HG23 HD11 ' A' ' 12' ' ' LEU . 48.6 t -122.34 145.38 29.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.433 -0.951 . . . . 0.41 108.433 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.678 ' HB3' HG21 ' A' ' 6' ' ' VAL . 3.0 m-70 -135.55 134.05 39.01 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.804 -0.759 . . . . 0.67 110.969 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.93 114.97 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 107.204 -1.406 . . . . 0.81 107.204 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 95.2 m-85 -91.73 159.56 15.78 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.974 -0.557 . . . . 0.64 110.524 -171.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -68.97 -18.66 64.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.512 0.672 . . . . 2.87 110.053 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.454 ' OD2' ' HE3' ' A' ' 25' ' ' LYS . 26.2 t70 -79.22 -7.95 58.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.812 -1.181 . . . . 1.97 107.812 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.07 -5.86 75.82 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.74 -1.573 . . . . 0.58 113.257 176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HE3' ' OD2' ' A' ' 23' ' ' ASP . 9.4 mtmp? -80.3 175.4 10.68 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.413 0.625 . . . . 1.74 111.479 177.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.582 ' HG2' HG13 ' A' ' 59' ' ' ILE . 3.3 mpp? -136.2 138.03 41.46 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.78 -1.1 . . . . 1.07 109.572 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.42 142.36 13.74 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.39 111.854 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.705 ' SD ' ' HB3' ' A' ' 38' ' ' MET . 23.6 ttt -118.54 142.86 47.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.961 0.41 . . . . 0.87 111.099 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.556 ' OE1' ' HB ' ' A' ' 1' ' ' VAL . 19.5 mt-10 -128.53 147.71 50.71 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.802 -0.814 . . . . 1.14 108.802 173.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.499 ' HB3' ' SD ' ' A' ' 36' ' ' MET . 41.6 p30 -87.54 172.34 9.83 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.574 -0.451 . . . . 1.41 110.294 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.634 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 16.4 ptpt -51.75 -16.73 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.418 0.896 . . . . 1.77 113.418 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -93.61 -4.43 50.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.721 0.296 . . . . 1.08 110.543 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.67 20.86 49.68 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.902 -0.666 . . . . 0.54 111.827 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 42.7 mmtm -106.69 139.52 41.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.419 0.628 . . . . 3.25 111.756 -176.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 p -70.25 131.84 44.81 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.516 -1.22 . . . . 1.55 110.549 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.499 ' SD ' ' HB3' ' A' ' 30' ' ' ASN . 19.4 ptm -153.47 174.65 14.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.304 -0.407 . . . . 1.38 110.83 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -123.55 140.89 52.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.745 -0.661 . . . . 2.78 109.562 176.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.705 ' HB3' ' SD ' ' A' ' 28' ' ' MET . 22.3 ptt? -100.45 150.42 36.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.179 -0.464 . . . . 1.32 110.565 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.84 142.06 50.97 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.825 2.35 . . . . 1.24 112.221 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 29.7 tt0 -71.35 136.6 47.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.856 -0.611 . . . . 1.15 109.833 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -16.04 27.23 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.362 -0.923 . . . . 0.68 113.459 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -97.31 132.17 43.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.122 0.461 . . . . 2.3 111.756 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.605 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 11.8 p -99.41 133.92 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.861 -0.608 . . . . 0.93 110.159 174.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.94 151.4 32.35 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.807 -0.633 . . . . 1.31 109.946 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -94.78 145.73 24.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.678 -0.49 . . . . 1.64 109.678 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.0 p -115.96 159.95 20.9 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.82 -0.627 . . . . 0.53 111.057 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.722 ' HD2' ' HG3' ' A' ' 13' ' ' GLN . 18.0 mmm180 -49.13 -28.03 3.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.593 0.757 . . . . 3.73 112.901 177.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.67 -6.89 59.44 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.567 -0.742 . . . . 2.7 111.363 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 15.32 58.73 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.385 -0.912 . . . . 0.77 111.396 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.71 174.42 5.9 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.208 -0.496 . . . . 1.35 110.392 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . 71.3 mmtt -119.24 148.18 43.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.417 -0.356 . . . . 1.84 110.142 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.51 152.39 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.14 -0.482 . . . . 0.66 110.565 174.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.632 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -159.21 153.95 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.302 -0.408 . . . . 0.98 110.167 176.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.506 ' N ' HG12 ' A' ' 53' ' ' ILE . 56.7 ttp -108.51 109.09 20.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.775 -0.824 . . . . 1.5 108.775 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 51.7 tptt -127.42 131.14 50.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.266 -0.642 . . . . 1.69 109.266 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.99 73.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.831 -0.699 . . . . 1.21 111.859 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.26 27.21 16.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.479 0.657 . . . . 2.9 110.112 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 54' ' ' MET . 47.4 mt-10 -123.84 147.6 47.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.536 -0.756 . . . . 1.66 109.36 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.582 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -93.67 118.89 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 122.095 0.95 . . . . 0.92 111.152 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -84.34 116.12 22.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.397 -1.274 . . . . 0.71 108.152 168.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 63' ' ' ASP . 19.5 tpt180 -114.94 102.28 9.82 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 106.604 -1.628 . . . . 3.56 106.604 169.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.6 OUTLIER 41.22 4.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 O-C-N 125.089 1.493 . . . . 1.4 113.179 -163.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.571 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 34.7 t70 55.67 149.14 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.653 1.181 . . . . 2.14 112.112 -169.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.884 ' HA ' ' HB3' ' A' ' 67' ' ' ARG . 23.2 tt0 82.66 -22.64 0.24 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.887 -1.051 . . . . 3.8 111.201 177.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.22 -33.07 72.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.927 0.87 . . . . 1.76 109.877 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 61' ' ' ARG . 1.8 mp -96.88 -22.2 17.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.385 -1.28 . . . . 2.36 109.792 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.884 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . 64.2 ttt180 -69.07 -50.01 52.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.384 -0.825 . . . . 4.45 110.519 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -145.34 125.22 13.47 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.184 0.516 . . . . 5.92 110.975 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 156.1 -42.21 0.56 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.447 -0.797 . . . . 5.06 111.518 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -160.12 38.54 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.852 0.834 . . . . 6.88 108.854 175.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -77.6 144.81 37.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.801 -1.09 . . . . 8.52 111.424 -172.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.52 92.93 9.27 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.815 -0.809 . . . . 10.75 108.815 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.69 89.18 0.16 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.701 -0.761 . . . . 11.62 112.277 -176.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 CA-C-O 118.43 -1.205 . . . . 12.99 111.493 177.845 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.526 ' HB ' ' NE2' ' A' ' 19' ' ' HIS . 7.3 p . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.877 0.37 . . . . 2.46 110.987 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -86.42 132.98 33.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.998 -0.741 . . . . 3.48 108.998 175.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 mmt -78.54 -3.93 46.16 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.177 0.436 . . . . 2.17 112.177 -172.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -87.68 -35.21 18.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.801 0.334 . . . . 1.47 111.309 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.452 ' C ' HD22 ' A' ' 5' ' ' ASN . 0.3 OUTLIER -105.42 3.13 29.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.076 0.465 . . . . 1.89 111.846 -169.047 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 19' ' ' HIS . 10.4 p -106.62 135.9 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.014 -0.539 . . . . 1.25 111.493 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.453 HG23 HG13 ' A' ' 20' ' ' VAL . 14.6 m -94.17 -30.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.989 0.423 . . . . 1.03 111.701 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -157.21 138.17 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.389 0.614 . . . . 1.41 110.917 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 1.4 m -119.47 138.54 53.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.294 -0.866 . . . . 0.4 110.083 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 24.4 m-85 -108.9 125.66 52.25 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.738 0.78 . . . . 1.06 111.487 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 71.7 m-20 -98.57 115.35 28.42 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.037 -1.438 . . . . 1.94 110.501 -176.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 16' ' ' SER . 10.2 mt -81.2 149.75 28.93 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.691 -0.855 . . . . 1.5 108.691 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -60.7 -19.44 58.69 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.794 0.665 . . . . 1.68 112.794 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -87.6 -26.24 23.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 2.11 109.646 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 127.07 -15.41 6.5 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.277 -0.874 . . . . 1.28 112.284 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.623 ' HB2' HD12 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -58.03 140.19 52.98 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.861 -0.792 . . . . 1.07 108.861 176.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.487 ' HG2' ' CE1' ' A' ' 19' ' ' HIS . 24.4 ttmm -125.35 124.22 41.07 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.024 0.44 . . . . 1.84 110.613 -171.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 47.0 t -109.17 151.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.95 -0.759 . . . . 0.41 108.95 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.526 ' NE2' ' HB ' ' A' ' 1' ' ' VAL . 0.3 OUTLIER -141.29 137.37 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.153 -0.619 . . . . 0.67 110.924 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.597 ' HA ' ' HG2' ' A' ' 26' ' ' MET . 7.2 p -102.8 125.39 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.03 -1.1 . . . . 0.81 108.03 171.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.426 ' HB2' ' HG2' ' A' ' 25' ' ' LYS . 71.3 m-85 -93.1 161.59 14.37 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.155 -0.929 . . . . 0.64 111.883 -168.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -67.04 -20.48 65.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.621 -0.718 . . . . 2.87 110.966 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.452 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 29.0 t70 -83.73 -6.05 59.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.153 0.978 . . . . 1.97 108.527 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.79 0.98 68.35 Favored Glycine 0 N--CA 1.427 -1.939 0 CA-C-N 114.287 -1.324 . . . . 0.58 112.718 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 23' ' ' ASP . 31.3 pttt -91.56 179.73 5.58 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.597 -0.149 . . . . 1.74 110.597 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.847 ' SD ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mtm -141.62 153.89 45.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.742 0.306 . . . . 1.07 110.192 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.63 147.24 18.9 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.558 -0.617 . . . . 0.39 111.558 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.0 ttt -119.36 139.9 51.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.293 0.568 . . . . 0.87 111.148 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.4 mt-10 -128.15 157.17 41.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.796 -0.816 . . . . 1.14 108.796 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.444 ' ND2' ' HD2' ' A' ' 32' ' ' PHE . 35.3 p-10 -91.51 173.11 8.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.093 -0.336 . . . . 1.41 110.093 174.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.639 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 43.2 pttt -55.92 5.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.409 1.263 . . . . 1.77 114.409 175.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 97.0 m-85 -115.91 1.18 13.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.018 0.437 . . . . 1.08 110.196 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.25 21.52 62.46 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.616 -0.802 . . . . 0.54 111.648 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 67.7 mmtt -103.62 131.53 50.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.377 0.608 . . . . 3.25 110.706 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.3 t -67.42 133.76 50.16 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.434 -1.257 . . . . 1.55 110.597 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.8 ptm -143.46 160.17 41.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.934 -0.576 . . . . 1.38 110.323 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -75.78 147.59 39.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.193 -0.458 . . . . 2.78 110.213 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.33 130.82 22.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 1.32 110.67 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.41 160.0 29.07 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.933 2.422 . . . . 1.24 112.963 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 54' ' ' MET . 35.1 tt0 -118.89 145.59 45.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.248 -0.433 . . . . 1.15 110.551 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.57 4.26 68.09 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.643 -0.789 . . . . 0.68 113.009 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -111.77 138.44 48.35 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.923 -0.163 . . . . 2.3 110.762 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 63.1 t -87.94 120.42 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.831 -0.433 . . . . 0.93 109.831 172.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -106.79 149.84 26.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.741 -0.663 . . . . 1.31 109.788 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -109.68 148.45 31.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 122.131 0.967 . . . . 1.64 112.208 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 46.0 p -97.72 168.54 10.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.872 -1.513 . . . . 0.53 109.966 -175.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.426 ' HE ' ' CB ' ' A' ' 11' ' ' ASP . 9.2 ptt85 -59.93 -21.96 61.83 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.971 0.891 . . . . 3.73 110.976 170.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.22 -13.72 49.02 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.025 -1.443 . . . . 2.7 110.984 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.39 53.06 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.684 -0.77 . . . . 0.77 111.993 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.87 153.62 19.34 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.955 -0.387 . . . . 1.35 109.955 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -112.18 129.3 56.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.979 -0.555 . . . . 1.84 109.753 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.702 HG22 ' HG2' ' A' ' 61' ' ' ARG . 1.8 pt -129.87 164.97 31.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.333 -0.394 . . . . 0.66 110.08 -171.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.497 HG22 ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -164.63 143.14 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.062 0.458 . . . . 0.98 111.336 173.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.45 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 21.6 ttt -99.87 134.1 43.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 1.5 110.112 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -145.7 121.89 10.83 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.775 -0.454 . . . . 1.69 109.775 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLU . . . 59.61 52.67 51.68 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 121.202 -0.523 . . . . 1.21 113.529 177.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.69 -13.27 0.49 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.81 0.444 . . . . 2.9 112.054 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' GLY . 44.1 mt-10 -96.96 148.84 22.56 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.206 -0.294 . . . . 1.66 110.206 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.847 ' HB ' ' SD ' ' A' ' 26' ' ' MET . 0.4 OUTLIER -115.96 124.45 72.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.58 0.705 . . . . 0.92 109.694 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -84.83 128.33 34.56 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.833 0.825 . . . . 0.71 109.102 171.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.702 ' HG2' HG22 ' A' ' 52' ' ' ILE . 2.3 tmm_? -158.23 102.41 1.77 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 103.863 -2.643 . . . . 3.56 103.863 170.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 61' ' ' ARG . 2.1 mm? 75.8 -52.12 0.63 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.312 0.96 . . . . 1.4 110.816 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.7 t70 72.85 -48.32 0.68 Allowed 'General case' 0 C--O 1.219 -0.516 0 O-C-N 124.071 0.857 . . . . 2.14 110.958 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.62 -24.78 63.7 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.921 -0.581 . . . . 3.8 110.626 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.12 -64.51 0.86 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.197 0.523 . . . . 1.76 110.904 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.562 ' H ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -91.87 -15.8 27.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.443 -0.799 . . . . 2.36 111.104 -177.271 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 41.41 82.05 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.424 1.09 . . . . 4.45 113.01 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.7 pttm 42.06 49.08 4.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.125 0.97 . . . . 5.92 112.746 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' H ' ' CD2' ' A' ' 66' ' ' LEU . . . -78.82 60.62 4.12 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.66 -0.976 . . . . 5.06 110.66 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -88.35 117.21 27.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.428 -0.386 . . . . 6.88 110.197 -174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.2 m 72.97 161.77 0.25 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.104 0.877 . . . . 8.52 110.71 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -121.66 144.3 48.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.072 -0.513 . . . . 10.75 109.981 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.21 -147.43 17.89 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.359 -0.924 . . . . 11.62 112.604 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.202 -1.332 . . . . 12.99 111.33 -178.938 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 109.97 -0.381 . . . . 2.46 109.97 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 58.72 103.57 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.575 0.75 . . . . 3.48 112.698 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.4 mmt -71.4 1.47 6.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.863 0.364 . . . . 2.17 111.553 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.2 m -89.7 -35.4 15.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.286 -0.416 . . . . 1.47 111.215 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.502 ' HB2' ' HD3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -91.9 11.26 25.54 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.886 0.851 . . . . 1.89 109.608 -177.188 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 19' ' ' HIS . 57.6 t -108.64 106.85 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 114.223 -1.353 . . . . 1.25 108.768 -175.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 p -84.95 -12.63 11.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.641 -0.709 . . . . 1.03 110.993 -173.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -163.86 139.55 6.38 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.798 -0.637 . . . . 1.41 110.564 171.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 m -119.23 138.37 53.02 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.373 -0.83 . . . . 0.4 110.056 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 21.3 m-85 -108.84 123.14 48.58 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 121.934 0.874 . . . . 1.06 110.958 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.554 ' HB2' ' HE ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -91.71 113.24 25.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.382 -1.735 . . . . 1.94 110.406 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.78 HD12 ' HB2' ' A' ' 16' ' ' SER . 45.2 mt -85.47 144.5 27.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.678 -0.86 . . . . 1.5 108.678 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 47' ' ' ARG . 8.0 tt0 -72.84 -0.9 14.74 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.497 0.554 . . . . 1.68 112.497 -170.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -98.44 -16.5 19.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.406 0.622 . . . . 2.11 109.666 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 31' ' ' LYS . . . 124.49 -21.39 6.78 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.06 -0.973 . . . . 1.28 112.44 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.78 ' HB2' HD12 ' A' ' 12' ' ' LEU . 25.5 m -70.29 158.1 36.5 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.118 0.485 . . . . 1.07 110.848 -176.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 57.7 mttt -125.19 149.88 47.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.335 -0.393 . . . . 1.84 110.896 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 10' ' ' TYR . 60.8 t -129.79 122.3 54.4 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 N-CA-C 109.13 -0.693 . . . . 0.41 109.13 173.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 26' ' ' MET . 54.1 m-70 -108.8 132.0 54.42 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.161 -1.016 . . . . 0.67 110.114 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.82 102.08 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 106.47 -1.678 . . . . 0.81 106.47 168.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -73.71 155.53 38.86 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.262 -0.881 . . . . 0.64 110.694 -172.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.502 ' HD3' ' HB2' ' A' ' 5' ' ' ASN . 19.5 pttm -51.63 -32.33 28.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.177 -0.919 . . . . 2.87 112.04 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 2.7 p-10 -97.75 10.17 40.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.61 0.719 . . . . 1.97 109.432 -171.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.89 4.68 72.02 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 114.872 -1.058 . . . . 0.58 114.586 172.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -87.68 175.94 7.65 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.124 0.962 . . . . 1.74 111.095 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 19' ' ' HIS . 4.2 mpp? -140.36 141.72 35.62 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.888 -1.051 . . . . 1.07 110.339 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.03 146.65 18.64 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.37 -0.832 . . . . 0.39 111.336 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 24.7 ttt -114.62 129.01 56.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.261 0.553 . . . . 0.87 111.061 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.0 mt-10 -110.0 147.13 34.09 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.159 -1.052 . . . . 1.14 108.159 175.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.779 ' H ' ' HB2' ' A' ' 34' ' ' LYS . 63.8 t30 -92.05 162.68 14.27 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.742 -1.207 . . . . 1.41 107.742 170.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.629 ' HB3' ' HA3' ' A' ' 15' ' ' GLY . 22.3 ptmt -50.72 -20.68 1.31 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.363 0.875 . . . . 1.77 113.363 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HD2' ' ND2' ' A' ' 30' ' ' ASN . 21.9 m-85 -96.52 -6.74 36.35 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.941 -0.475 . . . . 1.08 110.905 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.82 38.73 3.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.826 -0.702 . . . . 0.54 112.807 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.779 ' HB2' ' H ' ' A' ' 30' ' ' ASN . 24.4 mmtt -43.91 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.657 0.614 . . . . 3.25 112.657 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 34' ' ' LYS . 36.5 t 89.09 68.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.233 0.958 . . . . 1.55 109.073 175.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 34' ' ' LYS . 31.6 mtm -119.76 -171.46 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.309 -1.314 . . . . 1.38 109.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -98.07 157.74 15.95 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.506 0.193 . . . . 2.78 110.695 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.513 ' SD ' ' HD2' ' A' ' 39' ' ' PRO . 16.7 tpt -80.24 125.16 81.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.229 -0.441 . . . . 1.32 111.173 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HD2' ' SD ' ' A' ' 38' ' ' MET . 70.7 Cg_endo -76.37 153.9 35.75 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.615 2.21 . . . . 1.24 112.707 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 55' ' ' LYS . 38.2 tt0 -94.23 144.13 25.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.069 -0.514 . . . . 1.15 111.359 -177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 -15.98 57.65 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.171 -0.538 . . . . 0.68 113.591 172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 42' ' ' LYS . 50.3 mtpt -90.99 119.36 31.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 117.076 0.438 . . . . 2.3 111.632 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.638 ' HA ' ' HB ' ' A' ' 53' ' ' ILE . 14.5 p -91.85 126.75 44.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.331 -0.618 . . . . 0.93 109.331 171.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 68.9 mtm -124.17 154.97 39.3 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.22 -0.659 . . . . 1.31 109.22 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.47 149.68 23.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.087 0.946 . . . . 1.64 112.408 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 12' ' ' LEU . 47.2 p -103.13 162.09 13.25 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.726 -1.579 . . . . 0.53 110.221 -176.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HE ' ' HB2' ' A' ' 11' ' ' ASP . 80.3 mtm180 -59.52 -19.42 48.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.887 0.375 . . . . 3.73 110.971 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.09 -24.47 43.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.864 -0.607 . . . . 2.7 111.12 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.06 21.17 12.16 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.541 -0.837 . . . . 0.77 111.289 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 78.0 m -115.83 160.81 19.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.545 -0.539 . . . . 1.35 109.545 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.19 144.88 43.02 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.297 -0.261 . . . . 1.84 110.297 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 36.8 pt -136.84 150.76 26.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 120.439 0.161 . . . . 0.66 111.428 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.675 HG22 ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -158.96 149.46 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.719 -0.474 . . . . 0.98 109.719 177.143 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.5 ttt -112.29 133.71 54.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.074 -0.343 . . . . 1.5 110.074 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.578 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 24.2 tptp -142.32 127.68 18.83 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.571 -0.286 . . . . 1.69 110.583 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 57' ' ' ASN . . . 73.15 -28.81 0.8 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 115.244 0.857 . . . . 1.21 115.244 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 56' ' ' GLY . 8.7 t30 150.39 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.584 0.754 . . . . 2.9 109.058 -165.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.764 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 35.3 mt-10 -97.94 144.71 27.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.293 -0.867 . . . . 1.66 111.796 -171.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.518 HG13 ' HG2' ' A' ' 26' ' ' MET . 0.3 OUTLIER -103.36 124.31 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.019 0.914 . . . . 0.92 111.473 176.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.675 ' CD1' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -85.5 128.31 34.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.644 -1.162 . . . . 0.71 108.743 170.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.717 ' HB3' HD12 ' A' ' 66' ' ' LEU . 52.2 ttt-85 -125.28 126.54 45.29 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 106.14 -1.8 . . . . 3.56 106.14 162.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 61' ' ' ARG . 0.4 OUTLIER 58.16 -16.41 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 O-C-N 125.176 1.548 . . . . 1.4 113.288 -177.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.579 ' HB3' ' H ' ' A' ' 65' ' ' ALA . 4.6 t70 174.9 -170.47 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.675 -1.602 . . . . 2.14 106.675 -167.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.626 ' HB2' ' HE ' ' A' ' 67' ' ' ARG . 12.4 pt-20 -93.69 15.17 16.97 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.233 1.015 . . . . 3.8 108.402 169.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.579 ' H ' ' HB3' ' A' ' 63' ' ' ASP . . . -54.46 -25.49 25.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 112.774 -2.012 . . . . 1.76 112.656 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.717 HD12 ' HB3' ' A' ' 61' ' ' ARG . 16.5 mt -115.14 -1.18 13.06 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.143 0.423 . . . . 2.36 112.143 -174.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.783 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 25.5 ptt180 -98.07 -33.37 11.19 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.104 -0.702 . . . . 4.45 109.104 173.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.783 ' HG3' ' HG3' ' A' ' 67' ' ' ARG . 60.4 mttm -125.14 -176.21 3.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.262 -0.881 . . . . 5.92 108.855 177.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.34 -42.75 2.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.779 -0.724 . . . . 5.06 111.386 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -76.24 17.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.967 0.413 . . . . 6.88 111.038 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 m -105.62 19.04 21.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.375 -0.602 . . . . 8.52 109.375 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -83.45 -18.4 38.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.159 -0.928 . . . . 10.75 111.594 -174.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.28 15.27 51.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.656 -0.783 . . . . 11.62 111.224 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.027 0 CA-C-O 118.759 -1.023 . . . . 12.99 111.317 -178.795 . . . . . . . . 0 0 . 1 stop_ save_